Citrus Sinensis ID: 005923
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 669 | 2.2.26 [Sep-21-2011] | |||||||
| O22808 | 664 | Protein LYK5 OS=Arabidops | yes | no | 0.950 | 0.957 | 0.535 | 1e-178 | |
| O64825 | 612 | LysM domain receptor-like | no | no | 0.883 | 0.965 | 0.383 | 1e-108 | |
| A8R7E6 | 617 | Chitin elicitor receptor | no | no | 0.753 | 0.816 | 0.313 | 5e-68 | |
| Q9SGI7 | 654 | Protein LYK2 OS=Arabidops | no | no | 0.801 | 0.819 | 0.278 | 3e-58 | |
| F4IB81 | 651 | LysM domain receptor-like | no | no | 0.445 | 0.457 | 0.379 | 9e-56 | |
| D7UPN3 | 605 | Chitin elicitor receptor | no | no | 0.757 | 0.838 | 0.304 | 2e-55 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.496 | 0.647 | 0.316 | 1e-45 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.505 | 0.443 | 0.322 | 2e-45 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.565 | 0.533 | 0.317 | 5e-44 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.536 | 0.5 | 0.291 | 6e-44 |
| >sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 625 bits (1612), Expect = e-178, Method: Compositional matrix adjust.
Identities = 366/683 (53%), Positives = 464/683 (67%), Gaps = 47/683 (6%)
Query: 6 CRCWLVQVEVVLVLVWSI---QGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYL 62
C + V + L+L +++ + QQ YV+NHQLAC Y+NIT GF CNG PSC++YL
Sbjct: 4 CTLHALSVTLFLLLFFAVSPAKAQQPYVNNHQLACEVRVYDNITNGFTCNG-PPSCRSYL 62
Query: 63 TFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGD 122
TF S P YNT +I L S I SIN++ T +PT V+IP NCS G
Sbjct: 63 TFWSQPPYNTADSIAKLLNVSAAE-IQSINNLPTATTRIPTRELVVIPANCS-CSSSSGG 120
Query: 123 YYQFNTTYTIQNHV--ETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCA 180
+YQ N TY + + ETY SVAN+TYQ L+TCQAMMSQN R LT GL+L VPLRCA
Sbjct: 121 FYQHNATYNLSGNRGDETYFSVANDTYQALSTCQAMMSQNRYGERQLTPGLNLLVPLRCA 180
Query: 181 CPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVP 240
CP+ Q +GF +LLTY+V GDSIS IA++FN ++ + N+L+ D++ F FTP+LVP
Sbjct: 181 CPTAKQTTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAITEGNELTSDNIFF-FTPVLVP 239
Query: 241 LKTAPSKIQL----PVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLF 296
L T P+KI + P P + P T + PP S+SS KW++IG GIGA LLLL++ L
Sbjct: 240 LTTEPTKIVISPSPPPPPVVATPPQTPVDPP--GSSSSHKWIYIGIGIGAGLLLLLSILA 297
Query: 297 AFLFCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQA---------SNSLSHP 347
C Y+RR K P +P D + P SNS S
Sbjct: 298 L---CFYKRRSKKKS------LPSSLPEENKLFDSSTKQSIPTTTTTQWSIDLSNS-SEA 347
Query: 348 QGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDV-SSEIN 406
G +SA+ESLTLY+F DL+ AT +FS+ENRI+GSVYR + GDDAAVKV+KGDV SSEIN
Sbjct: 348 FGLKSAIESLTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEIN 407
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
+LKK+NHSNIIRLSGFC+ EG +YLV+E+++NG++SDWLHS+ ++ LTWKQRV+IA
Sbjct: 408 LLKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLHSSGKKS---LTWKQRVEIAR 464
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
DVA AL+YLH Y PP++HKNL+++NILLD+N RAKI NFG+AR ++G LQL
Sbjct: 465 DVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARIL-----DEGDLDLQL 519
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT----GDQNCEAELLY 582
TRHV GT GY+APEY+ENGVIT KLDVFAFGV VLELLSGREAVT + E E+L
Sbjct: 520 TRHVEGTQGYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLC 579
Query: 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642
I+ VL NVREKL+ F+DPSL NEYPL+LA++MAQLAK+C A DLN+RPS+++V T
Sbjct: 580 KVINSVLGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTT 639
Query: 643 LSKIWSSSSDWDPSDELNNSRSL 665
LS I SSS DW+PSD+L S SL
Sbjct: 640 LSMIVSSSIDWEPSDDLLRSGSL 662
|
May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) |
| >sp|O64825|LYK4_ARATH LysM domain receptor-like kinase 4 OS=Arabidopsis thaliana GN=LYK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1012), Expect = e-108, Method: Compositional matrix adjust.
Identities = 251/654 (38%), Positives = 374/654 (57%), Gaps = 63/654 (9%)
Query: 13 VEVVLVLVWSIQGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSNPSYNT 72
V ++L L QQ YV C G+ CNGL +CQAY+ FRS PS++T
Sbjct: 10 VFILLSLSSFATAQQPYVGISTTDCSVSDNTTSVFGYSCNGLNKTCQAYVIFRSTPSFST 69
Query: 73 PVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTI 132
+I LF P+L++S+N + T+ P+ V+IP+ CSC+G D Q N TYTI
Sbjct: 70 VTSISSLFSVD-PSLVSSLNDASPSTS-FPSGQQVIIPLTCSCTG----DDSQSNITYTI 123
Query: 133 QNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQA-ASGF 191
Q + ++Y ++AN+T QGL+TCQA+ QN V S++L G+ + VP+RCACP+ Q G
Sbjct: 124 QPN-DSYFAIANDTLQGLSTCQALAKQNNVSSQSLFPGMRIVVPIRCACPTAKQINEDGV 182
Query: 192 NHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLS-QDDLIFPFTPILVPLKTAPSKIQ- 249
+L++Y V + D+I+ I+ F V+ L AN++S ++ +FPFT IL+PL P+
Sbjct: 183 KYLMSYTVVFEDTIAIISDRFGVETSKTLKANEMSFENSEVFPFTTILIPLVNPPANTNS 242
Query: 250 LPVPSPPPSSPHTTLTPPSHSSTSSKK--WVFIGAGI--GAFLLLLVATLFAFLFCLYRR 305
L P PPP + P S SKK WV+ AG+ GA +L ++ A +FCL ++
Sbjct: 243 LIPPPPPPPPQSVSPPPLSPDGRKSKKKTWVYALAGVLGGALVLSVIG---AAIFCLSKK 299
Query: 306 RRNSK-KNPTPVLTP--GRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKF 362
+ ++ + T L G+ PP + Q + L G VESL +YKF
Sbjct: 300 KTKTQTQEETGNLDSFMGKKPP-----------MSDQEFDPLDGLSGM--VVESLKVYKF 346
Query: 363 QDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGF 422
+L+ AT F+ + I GS Y G GD A +K ++G+ S E+N+L K+NH NIIRLSGF
Sbjct: 347 HELQSATSDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGF 406
Query: 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPP 482
C HEG+ YLVYE A NG+LS+W+H+ T L+ Q++QIA D+A LNYLH + +PP
Sbjct: 407 CFHEGDWYLVYEHASNGSLSEWIHT----TKSLLSLTQKLQIALDIATGLNYLHNFADPP 462
Query: 483 YVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI 542
YVH++L ++N+ LD RAKI + G ARS D LT+HV GT GY+APEY+
Sbjct: 463 YVHRDLNSNNVFLDLEFRAKIGSLGSARSTTED--------FVLTKHVEGTRGYLAPEYL 514
Query: 543 ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFI 602
E+G+++ KLDV+AFGVV+LE+++G+EA + + + ++E + +L
Sbjct: 515 EHGLVSTKLDVYAFGVVLLEIVTGKEASELKKEIDE-------GKAIDEILIHGRL---- 563
Query: 603 DPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPS 656
P L + +L +C D RPS+ E ++LSKI +++ +W+ S
Sbjct: 564 -------LPEGLTSFVERLVVDCLKKDHLNRPSMDENVMSLSKILAATQNWEES 610
|
Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to the pathogenic fungus Alternaria brassicicola and to the bacterial pathogen the bacterial pathogen Pseudomonas syringae pv tomato DC3000, probably by sensing microbe-associated molecular pattern (MAMP) and pathogen-associated molecular patterns (PAMP). May play a role in detecting peptidoglycans (e.g. PGNs) during bacterial growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 176/561 (31%), Positives = 282/561 (50%), Gaps = 57/561 (10%)
Query: 107 VLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRN 166
VL+P C C GD+ N +Y+++ +TY VA + Y LTT +++ ++NP + N
Sbjct: 85 VLVPFPCECQ---PGDFLGHNFSYSVRQE-DTYERVAISNYANLTTMESLQARNPFPATN 140
Query: 167 LTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLS 226
+ + L V + C+C + + F +TY + DS+S+IA+ V
Sbjct: 141 IPLSATLNVLVNCSC-GDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSA---------- 189
Query: 227 QDDLIFPFTPILVPLKTAPSKIQLPVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGI-- 284
D++ + P V + + +P P + PP SS K +GAG+
Sbjct: 190 --DILQRYNP-GVNFNSGNGIVYVPGRDPNGA------FPPFKSS----KQDGVGAGVIA 236
Query: 285 GAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSL 344
G + ++VA L Y R+N K + +P + SL
Sbjct: 237 GIVIGVIVALLLILFIVYYAYRKNKSKGDS---FSSSIPLSTKADHASSTSLQSGGLGGA 293
Query: 345 SHPQGFRS-AVESLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSFKGDDAAVKVMKG 399
G + +V+ + ++L AT +F+ +I G+VY +G+ AA+K M
Sbjct: 294 GVSPGIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDM 353
Query: 400 DVS----SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN 455
+ S +E+ +L +++H N++RL G+CV EG+ +LVYE+ +NG L LH + +
Sbjct: 354 EASKQFLAELKVLTRVHHVNLVRLIGYCV-EGSLFLVYEYVENGNLGQHLHGS---GREP 409
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515
L W +RVQIA D A L Y+H++T P YVH+++K++NIL+D RAK+ +FGL + E
Sbjct: 410 LPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTE-- 467
Query: 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575
G TR +GT+GYMAPE + G ++ K+DV+AFGVV+ EL+S + AV
Sbjct: 468 ------VGGSATRGAMGTFGYMAPETV-YGEVSAKVDVYAFGVVLYELISAKGAVVKMTE 520
Query: 576 CEAEL--LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633
E L +E++ E LR IDP L + YP D + MA+L K CT + R
Sbjct: 521 AVGEFRGLVGVFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLR 580
Query: 634 PSISEVFVTLSKIWSSSSDWD 654
PS+ + V LS ++SS+ +WD
Sbjct: 581 PSMRYIVVALSTLFSSTGNWD 601
|
Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGI7|LYK2_ARATH Protein LYK2 OS=Arabidopsis thaliana GN=LYK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 3e-58, Method: Compositional matrix adjust.
Identities = 177/635 (27%), Positives = 295/635 (46%), Gaps = 99/635 (15%)
Query: 48 GFDCNGLYPSCQAYLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPV 107
G+ C+ C + R+ P + + + + H L A +P +
Sbjct: 47 GYVCHSNLQKCHTFAILRAKPPFYSLSDL-----SRHLGLDAD-------DEYVPKGQLL 94
Query: 108 LIPVNCSCSGGGDGDYYQFNTTYTIQNHV--ETYLSVANNTYQGLTTCQAMMSQNP-VDS 164
LIP+ C C +G Y+ + I+N V +T+ SV+ + QGLTTC ++ +NP +
Sbjct: 95 LIPIECRC----NGSIYEASL---IKNCVKGDTFRSVSQ-SLQGLTTCLSIREKNPHISE 146
Query: 165 RNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANK 224
L + L + +RC+CP + S + L+TY V DS+S++A FN E +++ AN
Sbjct: 147 DKLGDNIKLRLAIRCSCP--QEGVSNASFLVTYPVGVRDSVSSLAVRFNTTEDAIVSANN 204
Query: 225 LSQDDLIFPFTPILVPLKTAPSKIQLPVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGI 284
S + P P L+PL P K P + K + + + I
Sbjct: 205 KSG---VVPLKPALIPLDHKPEK-----------QGSRKRNPSKKKRSKMKLMIAVSSAI 250
Query: 285 GAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPPK----TPLDCADYSLFPQA 340
L+ +F +L + ++ + T + P + + +D + +
Sbjct: 251 AGVCGLVTLMVFGYL---HWKKETQIQTQTQKWISNKDPETRQLSLSIRTTSDKKISFEG 307
Query: 341 SNSLSHPQGFRSAVES------LTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAV 394
S S + + L +Y F++L+ AT +FS N I+GSVY GS KG D A+
Sbjct: 308 SQDGSILDSHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAI 367
Query: 395 KVMKGDVSSEIN--ILKKINH---SNIIRLSGFCVHE--GNTYLVYEFADNGALSDWLHS 447
K + D + +L +H N+IR+ G C E ++YLV+E+A NG+L DW+
Sbjct: 368 KQVNADEMKRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQ- 426
Query: 448 NRYQTSDN--------LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499
N+ + L WKQR++I +DVA AL Y+H+ YVH N+K+ NI L+ +L
Sbjct: 427 NKLAIKNQFIESCYCFLAWKQRIKICHDVAIALKYMHRIN---YVHGNIKSRNIFLNEDL 483
Query: 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVV 559
R K+ NFG+++ T E + ++P D+FA+G++
Sbjct: 484 RGKVGNFGMSKCV--------------------TNELATEENLIESSLSPASDIFAYGII 523
Query: 560 VLELLSGR--EAVTGDQNCEAELLYASISRVLEESNVR------EKLRGFIDPSLRNEYP 611
V+E+LSG+ + + G Q E L + V E S +R EKLR +D +L Y
Sbjct: 524 VMEVLSGQTPDMLLGLQEVETTSLGTQETFVSEWSRLRRLLGDKEKLREVMDSTLGESYS 583
Query: 612 LDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
+D AF +A +A++CTA + +RPS E+ +S++
Sbjct: 584 VDSAFEIASIARDCTAEEAESRPSAVEIAERVSRL 618
|
May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) |
| >sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (556), Expect = 9e-56, Method: Compositional matrix adjust.
Identities = 121/319 (37%), Positives = 189/319 (59%), Gaps = 21/319 (6%)
Query: 354 VESLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSFKGDDAAVKVMKG----DVSSEI 405
+E ++ +++++ AT FS+ N + GSVY G + + AVK M + ++E+
Sbjct: 323 IEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEM 382
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+L K++HSN++ L G+ ++VYE+ G L LH + + + L+W R QIA
Sbjct: 383 KVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQIA 442
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
D A L Y+H++T YVH+++KTSNILLD RAKI++FGLA+ E+ G G
Sbjct: 443 LDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLV-----EKTGEGEI 497
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV-----TGDQNCEAEL 580
VVGTYGY+APEY+ +G+ T K D++AFGVV+ E++SGREAV G +N E
Sbjct: 498 SVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKNPERRP 557
Query: 581 LYASISRVLE---ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
L + + VL+ +S L+ F+DP++ + YP D F +A LAK C D RP++
Sbjct: 558 LASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMK 617
Query: 638 EVFVTLSKIWSSSSDWDPS 656
+V ++LS+I SS +W+ +
Sbjct: 618 QVVISLSQILLSSIEWEAT 636
|
Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (554), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 174/571 (30%), Positives = 273/571 (47%), Gaps = 64/571 (11%)
Query: 93 SITNVTATLPTDTPVLIPVNCSCSG---GGDGDYYQFNTTYTI---QNHVETYLSVANNT 146
+ITN + D VL+P CSC G + Y + + +TY +VA N
Sbjct: 68 AITNPDYVVTGDR-VLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAAN- 125
Query: 147 YQGLTTCQAMMSQNPVDSRNLTVGLD-LFVPLRCACPSRDQAASGFNHLLTYMVTWGDSI 205
Y LTT + + N + G + V + C+C ++ + + LTY + G+++
Sbjct: 126 YADLTTAAWLEATNAYPPGRIPGGDGRVNVTINCSC-GDERVSPRYGLFLTYPLWDGETL 184
Query: 206 SAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAPSKIQLPVPSPPPSSPHTTLT 265
++A + + ++ LI + P + K + +P P+ + L
Sbjct: 185 ESVAAQYGFSSPAEME--------LIRRYNP---GMGGVSGKGIVFIPVKDPNGSYHPLK 233
Query: 266 PPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPP 325
++ S + G I + +VA +F +++ R + P+P T
Sbjct: 234 SGGMGNSLSGGAI-AGIVIACIAIFIVAIWLIIMFYRWQKFRKATSRPSPEET------- 285
Query: 326 KTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQ----GS 381
+ LD A S +G + VE + ++++ AT FS E++I GS
Sbjct: 286 -SHLDDA------------SQAEGIK--VERSIEFSYEEIFNATQGFSMEHKIGQGGFGS 330
Query: 382 VYRGSFKGDDAAVKVMKGDVS----SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD 437
VY +G+ A+K M + +E+ +L ++H N++RL G+CV E +LVYEF D
Sbjct: 331 VYYAELRGEKTAIKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCV-ENCLFLVYEFID 389
Query: 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
NG LS L Y L+W RVQIA D A L YLH++ P YVH+++K++NILLD
Sbjct: 390 NGNLSQHLQRTGYAP---LSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDK 446
Query: 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFG 557
+ RAKI +FGLA+ E Q L+ V GT+GYM PE G ++PK+DV+AFG
Sbjct: 447 DFRAKIADFGLAKLTEVGSMSQ-----SLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAFG 500
Query: 558 VVVLELLSGREAVTGDQNCEAEL--LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLA 615
VV+ ELLS ++A+ +E L L N E L IDPSL+ +YP+D A
Sbjct: 501 VVLYELLSAKQAIVRSSESVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSA 560
Query: 616 FSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
+A LAK+CT + RP++ V V L +
Sbjct: 561 LKIASLAKSCTHEEPGMRPTMRSVVVALMAL 591
|
Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 185 bits (469), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 131/414 (31%), Positives = 196/414 (47%), Gaps = 82/414 (19%)
Query: 253 PSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKN 312
P+ P +P +L+PPS S S+ V I G G F+L L+ F C +R R+ K
Sbjct: 102 PTTPTMTPGFSLSPPSPSRLSTGAVVGISIGGGVFVLTLI-----FFLCKKKRPRDDKAL 156
Query: 313 PTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSF 372
P P+ G + T + + +L AT F
Sbjct: 157 PAPI--------------------------------GLVLGIHQST-FTYGELARATNKF 183
Query: 373 SEENRIQ----GSVYRGSFK-GDDAAVKVMK-------GDVSSEINILKKINHSNIIRLS 420
SE N + G VY+G G++ AVK +K + +E+NI+ +I+H N++ L
Sbjct: 184 SEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLV 243
Query: 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
G+C+ LVYEF N L LH T + W R++IA + L+YLH+ N
Sbjct: 244 GYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPT---MEWSLRLKIAVSSSKGLSYLHENCN 300
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHVVGTYGYMAP 539
P +H+++K +NIL+D AK+ +FGLA+ A +++ H ++ V+GT+GY+AP
Sbjct: 301 PKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTH--------VSTRVMGTFGYLAP 352
Query: 540 EYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV----------L 589
EY +G +T K DV++FGVV+LEL++GR V +A +YA S V L
Sbjct: 353 EYAASGKLTEKSDVYSFGVVLLELITGRRPV------DANNVYADDSLVDWARPLLVQAL 406
Query: 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
EESN G D L NEY + M A C + RP + +V L
Sbjct: 407 EESN----FEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVL 456
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 184 bits (467), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 126/391 (32%), Positives = 197/391 (50%), Gaps = 53/391 (13%)
Query: 280 IGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCA----DYS 335
+G IG L+LL TL + C ++R+ + G V P TP++ + D +
Sbjct: 331 VGVSIGVALVLL--TLIGVVVCCLKKRKKRLS----TIGGGYVMP--TPMESSSPRSDSA 382
Query: 336 LFPQASN--------------SLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQ-- 379
L S+ S S P GF + E L+ +++L IAT FS+EN +
Sbjct: 383 LLKTQSSAPLVGNRSSNRTYLSQSEPGGFGQSRE---LFSYEELVIATNGFSDENLLGEG 439
Query: 380 --GSVYRGSFKGDDA-AVKVMK-----GD--VSSEINILKKINHSNIIRLSGFCVHEGNT 429
G VY+G + AVK +K GD +E++ + +++H N++ + G+C+ E
Sbjct: 440 GFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRR 499
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
L+Y++ N L LH+ + L W RV+IA A L YLH+ +P +H+++K
Sbjct: 500 LLIYDYVPNNNLYFHLHA---AGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 556
Query: 490 TSNILLDTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVIT 548
+SNILL+ N A +++FGLA+ A + + H +T V+GT+GYMAPEY +G +T
Sbjct: 557 SSNILLENNFHALVSDFGLAKLALDCNTH--------ITTRVMGTFGYMAPEYASSGKLT 608
Query: 549 PKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRN 608
K DVF+FGVV+LEL++GR+ V Q E L +L + E+ DP L
Sbjct: 609 EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGR 668
Query: 609 EYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
Y F M + A C H RP +S++
Sbjct: 669 NYVGVEMFRMIEAAAACIRHSATKRPRMSQI 699
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (455), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 135/425 (31%), Positives = 208/425 (48%), Gaps = 47/425 (11%)
Query: 237 ILVPLKTAPSKIQLPVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLF 296
ILVP PS+ P PP +P++T ++S + V GI + L+V TLF
Sbjct: 246 ILVPGSNNPSQNN-PTLRPPLDAPNST----NNSGIGTGAVV----GISVAVALVVFTLF 296
Query: 297 A-FLFCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASN--------SLSHP 347
F++CL +R +K + V P P + +D + F S+ S S+
Sbjct: 297 GIFVWCLRKR----EKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQ 352
Query: 348 QGFRSAVESLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSF-KGDDAAVKVMK---- 398
S L+ +++L AT FS+EN + G VY+G G AVK +K
Sbjct: 353 SQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG 412
Query: 399 -GD--VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN 455
GD +E+ L +I+H +++ + G C+ L+Y++ N L LH +
Sbjct: 413 QGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK----SV 468
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA-ES 514
L W RV+IA A L YLH+ +P +H+++K+SNILL+ N A++++FGLAR A +
Sbjct: 469 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDC 528
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
+ H +T V+GT+GYMAPEY +G +T K DVF+FGVV+LEL++GR+ V Q
Sbjct: 529 NTH--------ITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQ 580
Query: 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
E L ++ + E+ DP L Y F M + A C H RP
Sbjct: 581 PLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRP 640
Query: 635 SISEV 639
+ ++
Sbjct: 641 RMGQI 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 119/408 (29%), Positives = 202/408 (49%), Gaps = 49/408 (12%)
Query: 268 SHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPPKT 327
S+ S ++K V IG GI L++L F+ ++ RR KK + + +PP
Sbjct: 253 SNESNYTEKTV-IGIGIAGVLVIL------FIAGVFFVRRKQKKGSSSPRSNQYLPPANV 305
Query: 328 PLDCADYSLFPQA--------------SNSLSHPQGFRSAVESLTL------YKFQDLKI 367
++ + + Q +NSL +P+ R +S + + +++L
Sbjct: 306 SVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHFTYEELSQ 365
Query: 368 ATGSFSEENRIQ----GSVYRGS-FKGDDAAVKVMKG-------DVSSEINILKKINHSN 415
T F + + G VY+G F+G A+K +K + +E+ I+ +++H +
Sbjct: 366 ITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEIISRVHHRH 425
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
++ L G+C+ E + +L+YEF N L LH L W +RV+IA A L YL
Sbjct: 426 LVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPV---LEWSRRVRIAIGAAKGLAYL 482
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
H+ +P +H+++K+SNILLD A++ +FGLAR ++ + ++ V+GT+G
Sbjct: 483 HEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQS-------HISTRVMGTFG 535
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595
Y+APEY +G +T + DVF+FGVV+LEL++GR+ V Q E L L E+ +
Sbjct: 536 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEK 595
Query: 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
+ +DP L N+Y + M + A +C H RP + +V L
Sbjct: 596 GDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 669 | ||||||
| 224086140 | 659 | predicted protein [Populus trichocarpa] | 0.938 | 0.952 | 0.630 | 0.0 | |
| 359491890 | 665 | PREDICTED: wall-associated receptor kina | 0.961 | 0.966 | 0.605 | 0.0 | |
| 255539382 | 634 | kinase, putative [Ricinus communis] gi|2 | 0.899 | 0.949 | 0.610 | 0.0 | |
| 290490582 | 666 | LysM type receptor kinase [Lotus japonic | 0.941 | 0.945 | 0.563 | 0.0 | |
| 255563130 | 624 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.896 | 0.961 | 0.577 | 0.0 | |
| 290490580 | 667 | LysM type receptor kinase [Lotus japonic | 0.940 | 0.943 | 0.552 | 0.0 | |
| 148362068 | 663 | LYK8 [Glycine max] | 0.922 | 0.930 | 0.570 | 0.0 | |
| 357493275 | 715 | Wall-associated receptor kinase-like pro | 0.937 | 0.876 | 0.554 | 0.0 | |
| 357462213 | 701 | Receptor-like protein kinase [Medicago t | 0.925 | 0.883 | 0.537 | 0.0 | |
| 15226133 | 664 | protein kinase family protein [Arabidops | 0.950 | 0.957 | 0.535 | 1e-176 |
| >gi|224086140|ref|XP_002307830.1| predicted protein [Populus trichocarpa] gi|222857279|gb|EEE94826.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/653 (63%), Positives = 494/653 (75%), Gaps = 25/653 (3%)
Query: 23 IQGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSNPSYNTPVTIDYLFKT 82
+QGQQTYV NHQL CY+ +N T+GF CNG+ SCQ+YLTFRS P YN+PV I YL
Sbjct: 24 VQGQQTYVANHQLDCYNNAFNETTKGFLCNGVQSSCQSYLTFRSMPPYNSPVLIAYLLGV 83
Query: 83 SH-PNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLS 141
IASIN++++ TAT+PT+T V++PVNCSC YYQ N+TY +++ ETY S
Sbjct: 84 PQSATRIASINNLSSDTATIPTNTQVVVPVNCSCYAR---QYYQHNSTYQLKDKSETYFS 140
Query: 142 VANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTW 201
VANNTYQGLTTCQ++MSQNP RNL++GL L +PLRCACP+ +Q ASG NHLLTYMVTW
Sbjct: 141 VANNTYQGLTTCQSLMSQNPYGDRNLSLGLTLQIPLRCACPTSNQNASGINHLLTYMVTW 200
Query: 202 GDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAPSKIQLPVPSPPPSSPH 261
GDSIS+IAQLF VD++ VLDANKLS ++IFPFTPILVPL T P+KI+ P +PPP++P
Sbjct: 201 GDSISSIAQLFGVDKQRVLDANKLSSSNIIFPFTPILVPLPTEPTKIEQPSAAPPPAAPS 260
Query: 262 TTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGR 321
S +S K +++G GIGA L+L+ F FLF R S+K PV T
Sbjct: 261 PQTPNVSVGGSSDHKALYVGVGIGAAFLILLFAAFGFLFW----HRKSRKQQKPVSTS-- 314
Query: 322 VPPPKTPLDCADYSLFPQASN---SLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRI 378
P P D+++ P ++N SLS R A+ESLT+YK++DL++ATG F++ N I
Sbjct: 315 -EPETLPSVSTDFTVLPVSNNKSWSLSSHDA-RYAIESLTVYKYEDLQVATGYFAQANLI 372
Query: 379 QGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADN 438
+GSVYRGSFKGD AAVKV+KGDVSSEINILK INHSN+IRLSGFC+HEGNTYLVYE+ADN
Sbjct: 373 KGSVYRGSFKGDTAAVKVVKGDVSSEINILKMINHSNVIRLSGFCLHEGNTYLVYEYADN 432
Query: 439 GALSDWLHSNR-YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
G+L+DWLHSN Y+ L WKQRV+IAYDVA+ALNYLH YTNP Y+HKNLKTSNILLD
Sbjct: 433 GSLTDWLHSNNIYRI---LAWKQRVRIAYDVADALNYLHNYTNPSYIHKNLKTSNILLDA 489
Query: 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFG 557
NLRAK+ NFGLAR+ E+ Q G GLQLTRHVVGT GY+APEYIENGVITPKLDVFAFG
Sbjct: 490 NLRAKVANFGLARTLENG---QDG-GLQLTRHVVGTQGYLAPEYIENGVITPKLDVFAFG 545
Query: 558 VVVLELLSGREAVTG--DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLA 615
VV+LELLSG+EA D+ +LL I RVLE NVREKL F+DP LR+EYPLDLA
Sbjct: 546 VVMLELLSGKEAAATAIDKIAGDDLLSVMIMRVLEGDNVREKLSAFLDPCLRDEYPLDLA 605
Query: 616 FSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDELNNSRSLSRG 668
FSMAQLAK+C HDLN RPS+ +VF+ LSKI SSS DWDPSDELN SRS+ G
Sbjct: 606 FSMAQLAKSCVEHDLNTRPSMPQVFMMLSKILSSSLDWDPSDELNRSRSIDSG 658
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491890|ref|XP_002277331.2| PREDICTED: wall-associated receptor kinase-like 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/669 (60%), Positives = 499/669 (74%), Gaps = 26/669 (3%)
Query: 4 KFCRCWLVQVEVVLVLVW--SIQGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAY 61
KF W V+L+LVW Q QQ+YV+NHQL C D +N T GF CNG SC +Y
Sbjct: 18 KFGGWWWRMRMVLLLLVWISVAQAQQSYVNNHQLDC-DNNFNE-TNGFQCNGPR-SCHSY 74
Query: 62 LTFRSNP-SYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGD 120
LTFRS P SY++P +I YL S P IA+IN +++V T+ DT +++PVNCSCSG
Sbjct: 75 LTFRSAPPSYDSPPSIAYLL-NSEPAQIATINEVSDVD-TISKDTVLIVPVNCSCSG--- 129
Query: 121 GDYYQFNTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCA 180
D+YQ NTTYT+++ ETY S+ANNTYQGLTTCQA+ +QNP D RNL+VGL L VPL CA
Sbjct: 130 -DFYQHNTTYTLKSASETYFSLANNTYQGLTTCQALKAQNPYDYRNLSVGLHLQVPLMCA 188
Query: 181 CPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDE-RSVLDANKLSQDDLIFPFTPILV 239
CP+ +Q A+GFN+LL+Y+VTWGD+I +IA++F VD+ +S+ DAN+LS +I+PFTPILV
Sbjct: 189 CPTANQTAAGFNYLLSYLVTWGDTIDSIAKIFGVDDVQSIYDANRLSSTSVIYPFTPILV 248
Query: 240 PLKTAPSKIQLPVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFL 299
PLK PSKIQ V SPP SP T + P S SSKKWVFIGAGIGA LL+L+ + +
Sbjct: 249 PLKNPPSKIQTTVSSPPAPSPETPMVPSGGGSNSSKKWVFIGAGIGAALLVLLIS-SGMM 307
Query: 300 FCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTL 359
FC +RRRR S ++ PVL G T L SL + S S+S +G R +ESLT+
Sbjct: 308 FCFFRRRRQSGQD-KPVLDLGEA----TKLS---KSLENKTSMSISL-EGIRIEMESLTV 358
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRL 419
YK+++L+ A G F E NRI+GSVYR SFKGDDAA+K+MKGDVS EINILK+INHS +IRL
Sbjct: 359 YKYEELQKAAGYFGEANRIKGSVYRASFKGDDAAIKMMKGDVSEEINILKQINHSKVIRL 418
Query: 420 SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT 479
SGFC+H GNTYLVYE+A+NGAL DWLH + +T L WKQRVQIAYD A+ALNYLH +
Sbjct: 419 SGFCIHAGNTYLVYEYAENGALRDWLHGDG-ETCSTLGWKQRVQIAYDAADALNYLHNFI 477
Query: 480 NPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAP 539
+PP +HKNLK SNILLD N+R K+TNFGLAR ++E + GG LQLTRHVVGT GYMAP
Sbjct: 478 SPPCIHKNLKISNILLDGNMRGKVTNFGLARRLGNEEGDGGG--LQLTRHVVGTQGYMAP 535
Query: 540 EYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLR 599
EY+ENGV+TPKLD+FAFGVV+LELL+G+EA + ELL SI+ VL+ NVR+KLR
Sbjct: 536 EYVENGVVTPKLDIFAFGVVILELLTGKEAAPSQKKEGGELLSVSINEVLQGDNVRDKLR 595
Query: 600 GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDEL 659
GFIDP L +EYP DLAFSMAQLAK+C AHDLNARP++S++FV LSKI SSS DWDPSD+
Sbjct: 596 GFIDPCLAHEYPFDLAFSMAQLAKSCVAHDLNARPTMSDIFVILSKILSSSLDWDPSDDF 655
Query: 660 NNSRSLSRG 668
S SLS G
Sbjct: 656 QASGSLSHG 664
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539382|ref|XP_002510756.1| kinase, putative [Ricinus communis] gi|223551457|gb|EEF52943.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/639 (61%), Positives = 478/639 (74%), Gaps = 37/639 (5%)
Query: 26 QQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSNPSY-NTPVTIDYLFK-TS 83
QQTYV+N QL CY+ +N T+GF+CNGL SCQ+YLTFRS P Y TPVTI YLF
Sbjct: 25 QQTYVNNKQLDCYNDSFNYTTKGFECNGLRSSCQSYLTFRSAPPYYTTPVTISYLFSLQD 84
Query: 84 HPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLSVA 143
+LIAS+N+I++ +++P + + IPVNCSC GG +YQ N +YT++ ETY SVA
Sbjct: 85 SASLIASLNNISSDVSSIPPQSQLFIPVNCSCFGG---QFYQHNASYTLKFSSETYFSVA 141
Query: 144 NNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGD 203
N+TYQGL+TCQA+MSQNP RNL+VG+ L VPLRCACP+ +Q A GF +LLTYMVTWGD
Sbjct: 142 NDTYQGLSTCQALMSQNPYGDRNLSVGMRLQVPLRCACPTSNQTALGFRYLLTYMVTWGD 201
Query: 204 SISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAPSKIQLPVPSPPPSSPHTT 263
+IS+IA+LF V +S+LDAN+LS +IFPFTPILVPL T P+ I+ PPP
Sbjct: 202 TISSIAELFGVRPQSILDANQLSSTSIIFPFTPILVPLTTPPTTIK--ASPPPPVVSPPP 259
Query: 264 LTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVP 323
LTP S SS+KW ++G G+GA LLL+ A + FLF + + S+K T VP
Sbjct: 260 LTPVLPSGGSSRKWTYVGVGLGAALLLIFA-VSGFLF--WYPKSKSRKLTT-------VP 309
Query: 324 PPKTPLDCADYSLFPQASNSLSHPQGFRSA---VESLTLYKFQDLKIATGSFSEENRIQG 380
P L ++ P +S S RSA +ESLTLYKF DL++AT FSE+NRI+G
Sbjct: 310 IPSKALQSDSSAVPPDSSTPWS-----RSAYGVIESLTLYKFHDLQLATDYFSEKNRIKG 364
Query: 381 SVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGA 440
SVY+GSFKGD AAVKVMKGDVSSEI+ILKKINHSNIIRLSG C+++ NTYLVYEFA+NG+
Sbjct: 365 SVYKGSFKGDAAAVKVMKGDVSSEISILKKINHSNIIRLSGVCLYDANTYLVYEFAENGS 424
Query: 441 LSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500
L++ + + LTWKQRVQIA+DVA+ALNYLH YTNPPY+HKNLKTSNILLD N+R
Sbjct: 425 LAENVQT--------LTWKQRVQIAHDVADALNYLHNYTNPPYIHKNLKTSNILLDANMR 476
Query: 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560
AKI NFGLAR+ +++ GL LTRHVVGT GYMAPEY+ENGVITPKLDVFAFGVV+
Sbjct: 477 AKIANFGLARTLQNEAEG----GLHLTRHVVGTQGYMAPEYMENGVITPKLDVFAFGVVI 532
Query: 561 LELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQ 620
LELLSG+EA T D+N E+L ASI RVLE NVR KL GF+DPSL +YPLDLAFS+AQ
Sbjct: 533 LELLSGKEAATYDKNAREEMLSASICRVLEGDNVRHKLCGFMDPSLGKQYPLDLAFSLAQ 592
Query: 621 LAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDEL 659
LA+ C +HD+NARPS+S+VF++LSKI SSS DWDPS EL
Sbjct: 593 LAQTCISHDINARPSVSQVFISLSKILSSSLDWDPSLEL 631
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490582|dbj|BAI79278.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/657 (56%), Positives = 481/657 (73%), Gaps = 27/657 (4%)
Query: 19 LVWSIQGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSN-PSYNTPVTID 77
++ S Q QQ YV+N QL C D +YN T G CN + SCQ+YLTF+S+ P YNTP +I
Sbjct: 29 MIPSTQAQQEYVNNKQLDC-DTQYNT-TYGNVCNSV-TSCQSYLTFKSSSPEYNTPSSIS 85
Query: 78 YLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVE 137
YL ++ P+L+A N+IT+VT + TDT V +PV CSCSGG YQ N TY ++ E
Sbjct: 86 YLLNST-PSLVAKSNNITDVTPII-TDTMVTVPVTCSCSGG----RYQHNATYNLKKTGE 139
Query: 138 TYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTY 197
TY S+ANNTYQ LTTCQA+M+QNP D++NL G DL VPLRCACP++ Q+ +GF +LLTY
Sbjct: 140 TYFSIANNTYQSLTTCQALMAQNPYDAKNLFAGDDLHVPLRCACPTKKQSDAGFKYLLTY 199
Query: 198 MVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTA-PSKIQLPVPSPP 256
+V+ G+S +IA++F VD +SVLDAN+L ++F FTP+LVPLKT P+++Q+
Sbjct: 200 LVSQGESPDSIAEIFGVDTQSVLDANELDSKSVVFYFTPLLVPLKTEPPARLQIAASP-- 257
Query: 257 PSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPV 316
+ SS+SSKKWV +G +G + L+VA L F C Y N ++
Sbjct: 258 -PESPPPAPAGNDSSSSSKKWVIVGVTVGVAVCLVVA-LLVFFLCFY----NRRRRQPAP 311
Query: 317 LTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEEN 376
P + + + S SLS +G R A+ESLT YKF D++ AT FSEEN
Sbjct: 312 PPVSVKDFPDSAVKMVSETTPTTESWSLS-SEGVRYAIESLTAYKFGDIQTATKFFSEEN 370
Query: 377 RIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436
+I+GSVYR SFKGDDAAVK++ GDVS+EIN+LK+INH+NIIRLSGFCVH+GNTYLVYEFA
Sbjct: 371 KIKGSVYRASFKGDDAAVKILNGDVSAEINLLKRINHANIIRLSGFCVHKGNTYLVYEFA 430
Query: 437 DNGALSDWLHSN-RYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL 495
+N +L DWLHS+ +YQ S +L+W QRVQIAYDVA+ALNYLH YTNP ++HKNLK+ N+LL
Sbjct: 431 ENDSLDDWLHSDKKYQNSVSLSWMQRVQIAYDVADALNYLHNYTNPIHIHKNLKSGNVLL 490
Query: 496 DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFA 555
D RAK++NFGLAR E D+ E GG+ Q+TRHVVGT GYM PEYIE+G+ITPK+DVFA
Sbjct: 491 DGKFRAKVSNFGLARVME-DQGEDGGF--QMTRHVVGTQGYMPPEYIESGLITPKMDVFA 547
Query: 556 FGVVVLELLSGREAV-TGDQN--CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPL 612
FGVV+LELLSGREA +G++N E ++L +++ VLE NVR+KLRGF+DP+LR+EYPL
Sbjct: 548 FGVVMLELLSGREATSSGEKNGLGENKMLSETVNHVLEGDNVRDKLRGFMDPTLRDEYPL 607
Query: 613 DLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDELNNSRSLSRGS 669
DLA+SMA++AK C AHDLN+RP+ISEV +TLSK+ S++ DWDPSDEL SRS+S+ S
Sbjct: 608 DLAYSMAEIAKRCVAHDLNSRPNISEVLMTLSKVQSTTLDWDPSDELERSRSVSQIS 664
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255563130|ref|XP_002522569.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223538260|gb|EEF39869.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/637 (57%), Positives = 461/637 (72%), Gaps = 37/637 (5%)
Query: 20 VWSIQGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSNPSYNTPVTIDYL 79
V ++ QQ YVDNHQL C+D + T+G+ CNG+ SCQ+Y+TFR+NP YN+P I YL
Sbjct: 21 VLVLEAQQAYVDNHQLDCHDS--DPSTKGYLCNGVQSSCQSYITFRANPPYNSPAKIGYL 78
Query: 80 FKT-SHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVET 138
+ S LIAS+N+I+ AT+PT+ V++PVNCSC G YYQ N TY I++ E
Sbjct: 79 LGSQSEATLIASMNNISCDVATIPTNKQVVVPVNCSCHAGL---YYQHNATYRIKDENEN 135
Query: 139 YLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYM 198
Y ++AN+TYQGLTTCQ++ QNP D L G DL VPLRCACP+ +Q ASG +LTYM
Sbjct: 136 YFTLANDTYQGLTTCQSLWEQNPYDLNELYAGSDLHVPLRCACPTPNQTASGVKCMLTYM 195
Query: 199 VTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAPSKIQLPVPSPPPS 258
VTWGD IS IA+LFN +E+SVLDAN+L +DDLI+PFTPILVPL + PS + LP SPPP+
Sbjct: 196 VTWGDYISLIAELFNANEQSVLDANELLEDDLIYPFTPILVPLLSEPSTVDLPGYSPPPT 255
Query: 259 SPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVA-TLFAF-LFCLYRRRRNSKKNPTPV 316
P S++SKKWVF G GIGA LL+LVA + F+F FC RR S+K+ P
Sbjct: 256 RTPPVEVFPVTESSNSKKWVFFGTGIGAVLLVLVAFSAFSFWYFC----RRPSQKSQEPN 311
Query: 317 LTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEEN 376
T + P +S+SH G +ESL +YKF ++ ATG+FSE+N
Sbjct: 312 AT--KTDP-----------------SSVSH-VGIEFFIESLIIYKFDSIQTATGNFSEDN 351
Query: 377 RIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436
R++GSVY+G F+GD AAVK M+GDVSSEI+ILKK+NHSNI+RLSGFCVHEGNTYLVY++A
Sbjct: 352 RVKGSVYKGIFEGDHAAVKAMRGDVSSEIDILKKMNHSNIVRLSGFCVHEGNTYLVYQYA 411
Query: 437 DNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL 495
+NG+L DWLH + S +L+WKQR+QIAY+VA+A YLH YT PP+VHKNL TSNILL
Sbjct: 412 ENGSLDDWLHLYKNDPVSSSLSWKQRLQIAYNVADAFTYLHNYTTPPFVHKNLTTSNILL 471
Query: 496 DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFA 555
N RA ITNFGLAR +D +QG QLTRHVVGT GYMAPEY+ENG+ITPKLDVFA
Sbjct: 472 HGNFRAMITNFGLARKLSND--DQG--APQLTRHVVGTNGYMAPEYLENGLITPKLDVFA 527
Query: 556 FGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLA 615
+GVV+LELLSG++AV + N E ++L+A I+ VLE NVREKL+ FIDP LR PL A
Sbjct: 528 YGVVILELLSGKKAVMSETNGEEKMLFALINNVLEGDNVREKLKAFIDPCLRGNIPLHFA 587
Query: 616 FSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652
FS+AQLAK+C AHD N RPS+ EVF++LSKI SS+ D
Sbjct: 588 FSIAQLAKDCVAHDPNDRPSMLEVFMSLSKILSSALD 624
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490580|dbj|BAI79277.1| LysM type receptor kinase [Lotus japonicus] gi|290490600|dbj|BAI79287.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/657 (55%), Positives = 474/657 (72%), Gaps = 28/657 (4%)
Query: 19 LVWSIQGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSN-PSYNTPVTID 77
++ Q QQ Y++N+QL C + +N T G CN + SCQ+YLTF+S+ P YNTP +I
Sbjct: 26 MISETQAQQEYLNNNQLDCDNT--HNSTYGNVCNSV-TSCQSYLTFKSSSPEYNTPSSIS 82
Query: 78 YLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVE 137
YL ++ P+L+A N+IT+VT + TDT V +PV CSCSGG YQ N TY ++ E
Sbjct: 83 YLLNST-PSLVAKSNNITDVTPII-TDTMVTVPVTCSCSGG----RYQHNATYNLKKTGE 136
Query: 138 TYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTY 197
TY S+ANNTYQ LTTCQA+M+QNP D++NL G DL VPLRCACP++ Q+ +GF +LLTY
Sbjct: 137 TYFSIANNTYQSLTTCQALMAQNPYDAKNLFAGDDLHVPLRCACPTKKQSDAGFKYLLTY 196
Query: 198 MVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTA-PSKIQLPVPSPP 256
+V+ G+S +IA++F VD +SVLDAN+L ++F FTP+LVPLKT P+++Q+
Sbjct: 197 LVSQGESPDSIAEIFGVDTQSVLDANELDSKSVVFYFTPLLVPLKTEPPARLQIAASP-- 254
Query: 257 PSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPV 316
+ SS+SSKKWV +G +G + L+VA L F C Y N ++
Sbjct: 255 -PESPPPAPAGNDSSSSSKKWVIVGVTVGVAVCLVVA-LLVFFLCFY----NRRRRQPAP 308
Query: 317 LTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEEN 376
P + + + S SLS +G R A+ESLT YKF D++ AT FSEEN
Sbjct: 309 PPVSVKDFPDSAVKMVSETTPTTESWSLS-SEGVRYAIESLTAYKFGDIQTATKFFSEEN 367
Query: 377 RIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436
+I+GSVYR SFKGDDAAVK++ GDVS+EIN+LK+INH+NIIRLSGFCVH+GNTYLVYEFA
Sbjct: 368 KIKGSVYRASFKGDDAAVKILNGDVSAEINLLKRINHANIIRLSGFCVHKGNTYLVYEFA 427
Query: 437 DNGALSDWLHS-NRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL 495
+N +L DWLHS +YQ S +L+W QRVQIAYDVA+ALNYLH YTNP +HKNLK+ N+LL
Sbjct: 428 ENDSLDDWLHSEKKYQNSVSLSWMQRVQIAYDVADALNYLHNYTNPVLIHKNLKSGNVLL 487
Query: 496 DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFA 555
+ RAK++NFGLAR+ E D+ E GG G Q+TRHVVGT GYM PEY ENG+ITPK+DV+A
Sbjct: 488 NGKFRAKVSNFGLARAME-DQGEDGG-GFQMTRHVVGTQGYMPPEYTENGLITPKMDVYA 545
Query: 556 FGVVVLELLSGREAV-TGDQN--CEAELLYASISRVLE--ESNVREKLRGFIDPSLRNEY 610
FGVV+LELLSG+EA GD+N E +L +++ VLE NVR+KLRGF+D +LR+EY
Sbjct: 546 FGVVMLELLSGKEATGNGDKNGLGEKMVLSETVNHVLEGDNDNVRDKLRGFMDQTLRDEY 605
Query: 611 PLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDELNNSRSLSR 667
PLDLA+SMA++AK C AHDLN+RP+ISEVF+TLSK+ SS+ DWDPS E+ SRS+S+
Sbjct: 606 PLDLAYSMAEIAKRCVAHDLNSRPNISEVFMTLSKVQSSTLDWDPSSEVERSRSVSQ 662
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|148362068|gb|ABQ59614.1| LYK8 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/656 (57%), Positives = 467/656 (71%), Gaps = 39/656 (5%)
Query: 26 QQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSNP-SYNTPVTIDYLFKTSH 84
QQ YV+N QL C + YN+ T+G CN L PSC +YLTF+S+P Y TP I +L ++
Sbjct: 27 QQEYVNNKQLDC-NNEYNS-TKGNLCNSL-PSCTSYLTFKSSPPEYTTPAAISFLLNST- 82
Query: 85 PNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLSVAN 144
P LIA+ N+IT+V TLP DT V +PVNCSCSG YYQ N +YTI+ ETY S+AN
Sbjct: 83 PALIAAANNITDVQ-TLPADTLVTVPVNCSCSG----PYYQHNASYTIKVQGETYFSIAN 137
Query: 145 NTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDS 204
NTYQ LTTCQA+ QN V R+L G +L VPLRCACP++ Q +GF +LLTY+V+ G+S
Sbjct: 138 NTYQALTTCQALELQNTVGMRDLLKGQNLHVPLRCACPTQKQREAGFKYLLTYLVSQGES 197
Query: 205 ISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAPSKIQLPVPSPPPS------ 258
+SAI +F VDE+S+LDAN+LS +IF FTPI VPLKT P PV P +
Sbjct: 198 VSAIGDIFGVDEQSILDANELSTSSVIFYFTPISVPLKTEP-----PVTIPRAAIPPEDS 252
Query: 259 --SPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPV 316
P S SSKKWV +G +G +LL++ F C YRRRR + P P
Sbjct: 253 PSPPLPPAPAGDGDSDSSKKWVIVGIVVGVVVLLILGAAL-FYLCFYRRRRRVEHPPPP- 310
Query: 317 LTPGRVPPPKTPLDCADYSLFPQASNSLS-HPQGFRSAVESLTLYKFQDLKIATGSFSEE 375
P K + S S +G R A+ESL++YKF++L+ ATG F EE
Sbjct: 311 ------PSAKAFSGSTTTKATIPTTQSWSLSSEGVRYAIESLSVYKFEELQKATGFFGEE 364
Query: 376 NRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435
N+I+GSVYR SFKGD AAVK++KGDVS EIN+L++INH NIIRLSGFCV++G+TYLVYEF
Sbjct: 365 NKIKGSVYRASFKGDYAAVKILKGDVSGEINLLRRINHFNIIRLSGFCVYKGDTYLVYEF 424
Query: 436 ADNGALSDWLH--SNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493
A+N +L DWLH S +Y+ S +L+W QRV IA+DVA+ALNYLH YT+PP+VHKNLK+ N+
Sbjct: 425 AENDSLEDWLHSGSKKYENSTSLSWVQRVHIAHDVADALNYLHNYTSPPHVHKNLKSGNV 484
Query: 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDV 553
LLD N RAK++N GLAR+ E D + GG+ QLTRHVVGT+GYMAPEYIENG+ITPK+DV
Sbjct: 485 LLDGNFRAKVSNLGLARAVE-DHGDDGGF--QLTRHVVGTHGYMAPEYIENGLITPKMDV 541
Query: 554 FAFGVVVLELLSGREAVT-GDQNCEAE-LLYASISRVLEESNVREKLRGFIDPSLRNEYP 611
FAFGVV+LELLSGREAV GDQN E +L A+++ VLE NVREKLRGF+DP+LR+EYP
Sbjct: 542 FAFGVVLLELLSGREAVVGGDQNGSGEKMLSATVNHVLEGENVREKLRGFMDPNLRDEYP 601
Query: 612 LDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDELNNSRSLSR 667
L+LA+SMA+LAK C A DLNARP ISE F+ LSKI SS+ DWDPSDEL SRS+ +
Sbjct: 602 LELAYSMAELAKLCVARDLNARPQISEAFMILSKIQSSTLDWDPSDELERSRSVGQ 657
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493275|ref|XP_003616926.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355518261|gb|AES99884.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/651 (55%), Positives = 472/651 (72%), Gaps = 24/651 (3%)
Query: 24 QGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSNPSYNTPVTIDYLFKTS 83
+ QQ YV+N QL C + YN+ T G CN + PSCQ+YLTF+S P +NTP +I +L +S
Sbjct: 22 KSQQEYVNNKQLDC-ENTYNS-TLGNICNSI-PSCQSYLTFKSTPQFNTPSSISHLLNSS 78
Query: 84 HPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLSVA 143
+LI+ N+I+ V TLPTDT + +P+NC+CS + YYQ NT+YTIQN ETY +VA
Sbjct: 79 -ASLISQSNNISTV-QTLPTDTIITVPINCTCSN--NNTYYQHNTSYTIQNTGETYFTVA 134
Query: 144 NNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGD 203
NNTYQ L+TCQA+++QNP + R + G +L VPLRCACP++ Q+ GF +LLTY+V+ G+
Sbjct: 135 NNTYQALSTCQALIAQNPYNERKIVRGNNLTVPLRCACPTKKQSDEGFKYLLTYLVSEGE 194
Query: 204 SISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAPSKIQLPVPSPPPSSPHTT 263
S+S+IA++FNVD +S+ +AN+LS IF FTP+L+PLK P + + SPP S P
Sbjct: 195 SVSSIAEIFNVDPQSINEANELSSTSFIFYFTPLLIPLKNEPPQKIVKPASPPESPPPPP 254
Query: 264 LTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVP 323
+ SS+SS KWV G+ +++L+ A F +RRRR K P V G+
Sbjct: 255 PAAENGSSSSSTKWVI--VGVVVGVVVLLLVGVALFFLCFRRRRQQKLQPPAV---GKAF 309
Query: 324 PPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVY 383
++ + + + +G R AV+SLT+YK++DL+ AT FSEEN+I+GSVY
Sbjct: 310 SDSNTKKVSEVTS--TSQSWSLSSEGIRYAVDSLTVYKYEDLQNATNFFSEENKIKGSVY 367
Query: 384 RGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSD 443
R SFKGDDAAVK++KGDVSSEINILK+INH+NIIRLSGFCV++GNTYLVYEFA+N +L D
Sbjct: 368 RASFKGDDAAVKILKGDVSSEINILKRINHANIIRLSGFCVYKGNTYLVYEFAENNSLDD 427
Query: 444 WLHSNR-----YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498
WLHS + Y S L+W QRVQIA+DVA+ALNYLH Y NPP+VHKNLK+ NILLD
Sbjct: 428 WLHSEKNKDKNYSNSMCLSWFQRVQIAHDVADALNYLHNYANPPHVHKNLKSGNILLDGK 487
Query: 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGV 558
R K++NFGLAR E+E G G QLTRHV+GT GYMAPEYIENG+ITPK+DVFAFGV
Sbjct: 488 FRGKVSNFGLARVM---ENEGGDEGFQLTRHVIGTQGYMAPEYIENGLITPKMDVFAFGV 544
Query: 559 VVLELLSGREAVTGDQN--CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAF 616
V+LELLSGRE V D++ +LL +++++VLE NVREKLRGF+DP+LR+EYPLDLAF
Sbjct: 545 VILELLSGREVVGSDKSNGLGDQLLASTVNQVLEGDNVREKLRGFMDPNLRDEYPLDLAF 604
Query: 617 SMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDELNNSRSLSR 667
SMA++AK C A DLN+RP++SEVF+ LSKI SS+ +WDPS +L SRS S
Sbjct: 605 SMAEIAKRCVARDLNSRPNVSEVFMILSKIQSSTLEWDPSGDLERSRSGSE 655
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357462213|ref|XP_003601388.1| Receptor-like protein kinase [Medicago truncatula] gi|355490436|gb|AES71639.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/644 (53%), Positives = 448/644 (69%), Gaps = 25/644 (3%)
Query: 24 QGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYLTFRSNP-SYNTPVTIDYLFKT 82
+ QQ Y+DNHQL C DP + T G CN + SCQ+YLTF+S+P YNTP TI YL +
Sbjct: 69 KSQQEYLDNHQLDCDDPSKS--TYGNICNSI-NSCQSYLTFKSSPPHYNTPATIAYLLNS 125
Query: 83 SHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLSV 142
+ P LIA+ N+I+ V +PTDT + +PVNC CSG YYQ N++YT++ E Y ++
Sbjct: 126 TVP-LIANANNISYVDP-IPTDTMITVPVNCYCSG----HYYQHNSSYTLKTEDENYFTL 179
Query: 143 ANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWG 202
ANNTY+ LTTCQA+ +QN NLT GL++ VPLRCACP+ Q +GF ++LTY+V+ G
Sbjct: 180 ANNTYESLTTCQALDAQNIYGLTNLTAGLNMHVPLRCACPTSKQIENGFKYILTYLVSEG 239
Query: 203 DSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAP-SKIQ--LPVPSPPPSS 259
+ IA++F VD +SVLDANKL +D +IF FTP++VPLK P +KIQ LP PS P S
Sbjct: 240 EYPELIAEIFGVDSQSVLDANKLIEDQVIFYFTPLMVPLKDKPPTKIQRTLPPPSTPLSK 299
Query: 260 PHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTP 319
PH + S+SSKKWV +G +GA LLL+ + F FC + + + T
Sbjct: 300 PHVENLARNKDSSSSKKWVVVGIAVGAAFLLLIFFVLLFCFCQQHKNKKKLSSAATKTTT 359
Query: 320 GRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQ 379
V T + +SL + G R A ESLT+Y+F++L AT FSE NRI+
Sbjct: 360 EEVSNTNTSITNPSFSLCSE---------GLRYAFESLTVYEFEELHKATSFFSEANRIR 410
Query: 380 GS-VYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADN 438
GS YR S KGDDAAVKV+KGDVS EINIL++INH+NI R+SG VH+G+TYLVYEFA+N
Sbjct: 411 GSSAYRASLKGDDAAVKVLKGDVSVEINILRRINHANITRISGLSVHKGSTYLVYEFAEN 470
Query: 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498
G+L DW+H ++ S LTWKQRVQIA DVA+ALNYLH Y NPP++HKNLK+ N+LLD N
Sbjct: 471 GSLDDWIHFSKCINSVALTWKQRVQIAQDVADALNYLHNYVNPPHIHKNLKSDNVLLDGN 530
Query: 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGV 558
R K+ NFGLAR D+++ G G Q TRHVVGT+GYM PEYIENG+++PK+DVFAFGV
Sbjct: 531 FRGKLCNFGLARVV--DDYDFGEEGFQFTRHVVGTHGYMPPEYIENGLVSPKMDVFAFGV 588
Query: 559 VVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSM 618
V+LELLSGREA+ GD+N + L A +S VLE NVREKL F+DP+LR EYPL++ +SM
Sbjct: 589 VMLELLSGREAIVGDKNGGEKRLSAVVSEVLEGDNVREKLHAFMDPTLRGEYPLNMGYSM 648
Query: 619 AQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDELNNS 662
A++AK C A+ N RP++SEV V LSKI SSS + DPSD + +
Sbjct: 649 AEIAKRCVANYHNLRPNVSEVLVILSKIQSSSVNRDPSDVMEKT 692
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15226133|ref|NP_180916.1| protein kinase family protein [Arabidopsis thaliana] gi|75318032|sp|O22808.1|LYK5_ARATH RecName: Full=Protein LYK5; AltName: Full=LysM domain receptor-like kinase 5; AltName: Full=LysM-containing receptor-like kinase 5; Flags: Precursor gi|13877683|gb|AAK43919.1|AF370600_1 putative protein kinase [Arabidopsis thaliana] gi|2459440|gb|AAB80675.1| putative protein kinase [Arabidopsis thaliana] gi|209529791|gb|ACI49790.1| At2g33580 [Arabidopsis thaliana] gi|330253761|gb|AEC08855.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1612), Expect = e-176, Method: Compositional matrix adjust.
Identities = 366/683 (53%), Positives = 464/683 (67%), Gaps = 47/683 (6%)
Query: 6 CRCWLVQVEVVLVLVWSI---QGQQTYVDNHQLACYDPRYNNITRGFDCNGLYPSCQAYL 62
C + V + L+L +++ + QQ YV+NHQLAC Y+NIT GF CNG PSC++YL
Sbjct: 4 CTLHALSVTLFLLLFFAVSPAKAQQPYVNNHQLACEVRVYDNITNGFTCNG-PPSCRSYL 62
Query: 63 TFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGD 122
TF S P YNT +I L S I SIN++ T +PT V+IP NCS G
Sbjct: 63 TFWSQPPYNTADSIAKLLNVSAAE-IQSINNLPTATTRIPTRELVVIPANCS-CSSSSGG 120
Query: 123 YYQFNTTYTIQNHV--ETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCA 180
+YQ N TY + + ETY SVAN+TYQ L+TCQAMMSQN R LT GL+L VPLRCA
Sbjct: 121 FYQHNATYNLSGNRGDETYFSVANDTYQALSTCQAMMSQNRYGERQLTPGLNLLVPLRCA 180
Query: 181 CPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVP 240
CP+ Q +GF +LLTY+V GDSIS IA++FN ++ + N+L+ D++ F FTP+LVP
Sbjct: 181 CPTAKQTTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAITEGNELTSDNIFF-FTPVLVP 239
Query: 241 LKTAPSKIQL----PVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLF 296
L T P+KI + P P + P T + PP S+SS KW++IG GIGA LLLL++ L
Sbjct: 240 LTTEPTKIVISPSPPPPPVVATPPQTPVDPP--GSSSSHKWIYIGIGIGAGLLLLLSILA 297
Query: 297 AFLFCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQA---------SNSLSHP 347
C Y+RR K P +P D + P SNS S
Sbjct: 298 L---CFYKRRSKKKS------LPSSLPEENKLFDSSTKQSIPTTTTTQWSIDLSNS-SEA 347
Query: 348 QGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDV-SSEIN 406
G +SA+ESLTLY+F DL+ AT +FS+ENRI+GSVYR + GDDAAVKV+KGDV SSEIN
Sbjct: 348 FGLKSAIESLTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEIN 407
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
+LKK+NHSNIIRLSGFC+ EG +YLV+E+++NG++SDWLHS+ ++ LTWKQRV+IA
Sbjct: 408 LLKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLHSSGKKS---LTWKQRVEIAR 464
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
DVA AL+YLH Y PP++HKNL+++NILLD+N RAKI NFG+AR ++G LQL
Sbjct: 465 DVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARIL-----DEGDLDLQL 519
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT----GDQNCEAELLY 582
TRHV GT GY+APEY+ENGVIT KLDVFAFGV VLELLSGREAVT + E E+L
Sbjct: 520 TRHVEGTQGYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLC 579
Query: 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642
I+ VL NVREKL+ F+DPSL NEYPL+LA++MAQLAK+C A DLN+RPS+++V T
Sbjct: 580 KVINSVLGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTT 639
Query: 643 LSKIWSSSSDWDPSDELNNSRSL 665
LS I SSS DW+PSD+L S SL
Sbjct: 640 LSMIVSSSIDWEPSDDLLRSGSL 662
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 669 | ||||||
| TAIR|locus:2050987 | 664 | LYK5 "LysM-containing receptor | 0.523 | 0.527 | 0.568 | 1.4e-164 | |
| TAIR|locus:2049029 | 612 | LYK4 "LysM-containing receptor | 0.304 | 0.333 | 0.513 | 5e-106 | |
| TAIR|locus:2195814 | 651 | LYK3 "LysM-containing receptor | 0.428 | 0.440 | 0.383 | 1.4e-62 | |
| TAIR|locus:2089860 | 617 | CERK1 "chitin elicitor recepto | 0.420 | 0.455 | 0.378 | 3.7e-62 | |
| UNIPROTKB|D7UPN3 | 605 | CERK1 "Chitin elicitor recepto | 0.428 | 0.474 | 0.398 | 3.8e-56 | |
| TAIR|locus:2082359 | 654 | LYK2 "LysM-containing receptor | 0.399 | 0.408 | 0.352 | 1.1e-53 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.421 | 0.370 | 0.350 | 4.1e-44 | |
| TAIR|locus:2120683 | 703 | SRF8 "STRUBBELIG-receptor fami | 0.424 | 0.403 | 0.361 | 1.2e-43 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.409 | 0.373 | 0.358 | 1.2e-43 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.434 | 0.412 | 0.343 | 1.2e-41 |
| TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 997 (356.0 bits), Expect = 1.4e-164, Sum P(3) = 1.4e-164
Identities = 213/375 (56%), Positives = 270/375 (72%)
Query: 303 YRRRRNSKKNPTPVLTPGRVPPPKT----PLDCA-DYSLFPQASNSLSHPQGFRSAVESL 357
Y+RR K P+ + ++ T P +S+ SNS S G +SA+ESL
Sbjct: 301 YKRRSKKKSLPSSLPEENKLFDSSTKQSIPTTTTTQWSI--DLSNS-SEAFGLKSAIESL 357
Query: 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS-EINILKKINHSNI 416
TLY+F DL+ AT +FS+ENRI+GSVYR + GDDAAVKV+KGDVSS EIN+LKK+NHSNI
Sbjct: 358 TLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINLLKKLNHSNI 417
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
IRLSGFC+ EG +YLV+E+++NG++SDWLHS+ ++ LTWKQRV+IA DVA AL+YLH
Sbjct: 418 IRLSGFCIREGTSYLVFEYSENGSISDWLHSSGKKS---LTWKQRVEIARDVAEALDYLH 474
Query: 477 KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGY 536
Y PP++HKNL+++NILLD+N RAKI NFG+AR + +G LQLTRHV GT GY
Sbjct: 475 NYITPPHIHKNLESTNILLDSNFRAKIANFGVARILD-----EGDLDLQLTRHVEGTQGY 529
Query: 537 MAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT------GDQNCEAELLYASISRVLE 590
+APEY+ENGVIT KLDVFAFGV VLELLSGREAVT G++ E E+L I+ VL
Sbjct: 530 LAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEE--EVEMLCKVINSVLG 587
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIXXXX 650
NVREKL+ F+DPSL NEYPL+LA++MAQLAK+C A DLN+RPS+++V TLS I
Sbjct: 588 GENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSMIVSSS 647
Query: 651 XXXXXXXELNNSRSL 665
+L S SL
Sbjct: 648 IDWEPSDDLLRSGSL 662
|
|
| TAIR|locus:2049029 LYK4 "LysM-containing receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 5.0e-106, Sum P(4) = 5.0e-106
Identities = 111/216 (51%), Positives = 153/216 (70%)
Query: 354 VESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINH 413
VESL +YKF +L+ AT F+ + I GS Y G GD A +K ++G+ S E+N+L K+NH
Sbjct: 338 VESLKVYKFHELQSATSDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNH 397
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
NIIRLSGFC HEG+ YLVYE A NG+LS+W+H+ T L+ Q++QIA D+A LN
Sbjct: 398 LNIIRLSGFCFHEGDWYLVYEHASNGSLSEWIHT----TKSLLSLTQKLQIALDIATGLN 453
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
YLH + +PPYVH++L ++N+ LD RAKI + G ARS D LT+HV GT
Sbjct: 454 YLHNFADPPYVHRDLNSNNVFLDLEFRAKIGSLGSARSTTED--------FVLTKHVEGT 505
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569
GY+APEY+E+G+++ KLDV+AFGVV+LE+++G+EA
Sbjct: 506 RGYLAPEYLEHGLVSTKLDVYAFGVVLLEIVTGKEA 541
|
|
| TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 532 (192.3 bits), Expect = 1.4e-62, Sum P(2) = 1.4e-62
Identities = 119/310 (38%), Positives = 187/310 (60%)
Query: 354 VESLTLYKFQDLKIATGSFSEENRI----QGSVYRGSFKGDDAAVKVMKG----DVSSEI 405
+E ++ +++++ AT FS+ N + GSVY G + + AVK M + ++E+
Sbjct: 323 IEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEM 382
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+L K++HSN++ L G+ ++VYE+ G L LH + + + L+W R QIA
Sbjct: 383 KVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQIA 442
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
D A L Y+H++T YVH+++KTSNILLD RAKI++FGLA+ E + G +
Sbjct: 443 LDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVE----KTGEGEIS 498
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT-----GDQNCEAEL 580
+T+ VVGTYGY+APEY+ +G+ T K D++AFGVV+ E++SGREAV G +N E
Sbjct: 499 VTK-VVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKNPERRP 557
Query: 581 LYASISRVLEES----NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636
L + + VL+ S N+ L+ F+DP++ + YP D F +A LAK C D RP++
Sbjct: 558 LASIMLAVLKNSPDSMNM-SSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNM 616
Query: 637 SEVFVTLSKI 646
+V ++LS+I
Sbjct: 617 KQVVISLSQI 626
|
|
| TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 3.7e-62, Sum P(2) = 3.7e-62
Identities = 115/304 (37%), Positives = 176/304 (57%)
Query: 353 AVESLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSFKGDDAAVKVMKGDVS----SE 404
+V+ + ++L AT +F+ +I G+VY +G+ AA+K M + S +E
Sbjct: 303 SVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAE 362
Query: 405 INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
+ +L +++H N++RL G+CV EG+ +LVYE+ +NG L LH + + L W +RVQI
Sbjct: 363 LKVLTRVHHVNLVRLIGYCV-EGSLFLVYEYVENGNLGQHLHGSGREP---LPWTKRVQI 418
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
A D A L Y+H++T P YVH+++K++NIL+D RAK+ +FGL + E GG
Sbjct: 419 ALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEV-----GG--- 470
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL--LY 582
TR +GT+GYMAPE + G ++ K+DV+AFGVV+ EL+S + AV E L
Sbjct: 471 SATRGAMGTFGYMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLV 529
Query: 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642
+E++ E LR IDP L + YP D + MA+L K CT + RPS+ + V
Sbjct: 530 GVFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVA 589
Query: 643 LSKI 646
LS +
Sbjct: 590 LSTL 593
|
|
| UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 3.8e-56, Sum P(2) = 3.8e-56
Identities = 123/309 (39%), Positives = 178/309 (57%)
Query: 345 SHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSFKGDDAAVKVMKGD 400
S +G + VE + ++++ AT FS E++I GSVY +G+ A+K M
Sbjct: 292 SQAEGIK--VERSIEFSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQ 349
Query: 401 VS----SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
+ +E+ +L ++H N++RL G+CV E +LVYEF DNG LS L Y L
Sbjct: 350 ATQEFLAELKVLTHVHHLNLVRLIGYCV-ENCLFLVYEFIDNGNLSQHLQRTGYAP---L 405
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+W RVQIA D A L YLH++ P YVH+++K++NILLD + RAKI +FGLA+ E
Sbjct: 406 SWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEV-- 463
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV--TGDQ 574
G L+ V GT+GYM PE G ++PK+DV+AFGVV+ ELLS ++A+ + +
Sbjct: 464 ---GSMSQSLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSES 519
Query: 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
E++ L L N E L IDPSL+ +YP+D A +A LAK+CT + RP
Sbjct: 520 VSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRP 579
Query: 635 SISEVFVTL 643
++ V V L
Sbjct: 580 TMRSVVVAL 588
|
|
| TAIR|locus:2082359 LYK2 "LysM-containing receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 1.1e-53, Sum P(2) = 1.1e-53
Identities = 110/312 (35%), Positives = 175/312 (56%)
Query: 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS--EINILKKINH- 413
L +Y F++L+ AT +FS N I+GSVY GS KG D A+K + D + +L +H
Sbjct: 330 LEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNADEMKRFDFGLLNDQSHY 389
Query: 414 --SNIIRLSGFCVHE--GNTYLVYEFADNGALSDWLHS-----NRYQTSDN--LTWKQRV 462
N+IR+ G C E ++YLV+E+A NG+L DW+ + N++ S L WKQR+
Sbjct: 390 YNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLAIKNQFIESCYCFLAWKQRI 449
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+I +DVA AL Y+H+ YVH N+K+ NI L+ +LR K+ NFG+++ ++
Sbjct: 450 KICHDVAIALKYMHRIN---YVHGNIKSRNIFLNEDLRGKVGNFGMSKCVTNE------- 499
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR--EAVTGDQNCEAEL 580
+ T IE+ ++P D+FA+G++V+E+LSG+ + + G Q E
Sbjct: 500 --------LAT----EENLIESS-LSPASDIFAYGIIVMEVLSGQTPDMLLGLQEVETTS 546
Query: 581 LYASISRVLEESNVR------EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
L + V E S +R EKLR +D +L Y +D AF +A +A++CTA + +RP
Sbjct: 547 LGTQETFVSEWSRLRRLLGDKEKLREVMDSTLGESYSVDSAFEIASIARDCTAEEAESRP 606
Query: 635 SISEVFVTLSKI 646
S E+ +S++
Sbjct: 607 SAVEIAERVSRL 618
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 4.1e-44, Sum P(2) = 4.1e-44
Identities = 109/311 (35%), Positives = 171/311 (54%)
Query: 343 SLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSFKGDDA-AVKVM 397
S S P GF + E L+ +++L IAT FS+EN + G VY+G + AVK +
Sbjct: 404 SQSEPGGFGQSRE---LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQL 460
Query: 398 K-----GD--VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRY 450
K GD +E++ + +++H N++ + G+C+ E L+Y++ N L LH+
Sbjct: 461 KIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHA--- 517
Query: 451 QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510
+ L W RV+IA A L YLH+ +P +H+++K+SNILL+ N A +++FGLA+
Sbjct: 518 AGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK 577
Query: 511 SA-ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569
A + + H +T V+GT+GYMAPEY +G +T K DVF+FGVV+LEL++GR+
Sbjct: 578 LALDCNTH--------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 629
Query: 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSL-RNEYPLDLAFSMAQLAKNCTAH 628
V Q E L +L + E+ DP L RN +++ F M + A C H
Sbjct: 630 VDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEM-FRMIEAAAACIRH 688
Query: 629 DLNARPSISEV 639
RP +S++
Sbjct: 689 SATKRPRMSQI 699
|
|
| TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 1.2e-43, Sum P(2) = 1.2e-43
Identities = 112/310 (36%), Positives = 167/310 (53%)
Query: 351 RSAVESLTLYKFQDLKIATGSFSEENRI-QGS---VYRGSF---------KGDDAAVKVM 397
RS + + + Y L++AT SFS+EN I +GS VYR F K D+AA+ +
Sbjct: 375 RSPITA-SQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQ 433
Query: 398 KGDVSSE-INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
+ D E ++ + ++ H NI+ L+G+C G LVYE+ NG L D LH+N S NL
Sbjct: 434 EEDNFLEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTND-DRSMNL 492
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
TW RV++A A AL YLH+ P VH+N K++NILLD L +++ GLA + E
Sbjct: 493 TWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTE 552
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576
Q++ VVG++GY APE+ +G+ T K DV+ FGVV+LELL+GR+ + +
Sbjct: 553 R-------QVSTQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTR 605
Query: 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636
+ L + L + + K+ +DPSL YP A + C + RP +
Sbjct: 606 AEQSLVRWATPQLHDIDALSKM---VDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPM 662
Query: 637 SEVFVTLSKI 646
SEV L ++
Sbjct: 663 SEVVQQLVRL 672
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 447 (162.4 bits), Expect = 1.2e-43, Sum P(2) = 1.2e-43
Identities = 108/301 (35%), Positives = 170/301 (56%)
Query: 359 LYKFQDLKIATGSFSEENRI----QGSVYRGSFKGDDAAVKVMK---GDVS------SEI 405
++ + +K AT ++E + QG+VY+G + D++ V + K GD S +E+
Sbjct: 395 IFTEEGMKEATDGYNESRILGQGGQGTVYKGILQ-DNSIVAIKKARLGDRSQVEQFINEV 453
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+L +INH N+++L G C+ LVYEF +G L D LH + + +S LTW+ R++IA
Sbjct: 454 LVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSS--LTWEHRLRIA 511
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
+VA L YLH Y + P +H+++KT+NILLD NL AK+ +FG +R D+ Q
Sbjct: 512 IEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQE-------Q 564
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
LT V GT GY+ PEY G++ K DV++FGVV++ELLSG +A+ ++ ++ L +
Sbjct: 565 LTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYF 624
Query: 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
++E+ + E ID + NEY A++A CT RPS+ EV L
Sbjct: 625 VSAMKENRLHE----IIDGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEA 680
Query: 646 I 646
+
Sbjct: 681 L 681
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 446 (162.1 bits), Expect = 1.2e-41, P = 1.2e-41
Identities = 109/317 (34%), Positives = 171/317 (53%)
Query: 341 SNSLSHP-QGFRSAVESLT-LYKFQDLKIATGSFSEENRI-QGS---VYRGSFK-GDDAA 393
SN++ +G S L+ ++++ T +F+ EN + +G VYRG G + A
Sbjct: 329 SNNIPEELEGLHEKYSSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGRELA 388
Query: 394 VKVMKG--DVSSE----INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHS 447
VK++K DV E I ++ ++H NI+ L GFC N LVY++ G+L + LH
Sbjct: 389 VKILKPCLDVLKEFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLEENLHG 448
Query: 448 NRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507
NR + + W +R ++A VA AL+YLH +P +H+++K+SN+LL + ++++FG
Sbjct: 449 NR-KDAKKFGWMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFG 507
Query: 508 LARSAES-DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
A A S +H GG + GT+GY+APEY +G +T K+DV+AFGVV+LEL+SG
Sbjct: 508 FASLASSTSQHVAGG-------DIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISG 560
Query: 567 REAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCT 626
R+ + DQ+ E L + +L+ K +DPSL N+ DL + A C
Sbjct: 561 RKPICVDQSKGQESLVLWANPILDSG----KFAQLLDPSLENDNSNDLIEKLLLAATLCI 616
Query: 627 AHDLNARPSISEVFVTL 643
+ RP I V L
Sbjct: 617 KRTPHDRPQIGLVLKIL 633
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O22808 | LYK5_ARATH | No assigned EC number | 0.5358 | 0.9506 | 0.9578 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.V.2345.1 | hypothetical protein (655 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 669 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-19 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-06 | |
| smart00257 | 44 | smart00257, LysM, Lysin motif | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-05 | |
| cd00118 | 45 | cd00118, LysM, Lysine Motif is a small domain invo | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| pfam01476 | 43 | pfam01476, LysM, LysM domain | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| pfam02480 | 437 | pfam02480, Herpes_gE, Alphaherpesvirus glycoprotei | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 7e-49
Identities = 82/289 (28%), Positives = 130/289 (44%), Gaps = 56/289 (19%)
Query: 366 KIATGSFSEENRIQGSVYRG------SFKGDDAAVKVMKGDVS--------SEINILKKI 411
K+ G+F G VY+G K + AVK +K D S E I++K+
Sbjct: 6 KLGEGAF-------GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
+H N+++L G C E Y+V E+ + G L +L NR L+ + A +A
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQIARG 114
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
+ YL ++H++L N L+ NL KI++FGL+R D++ Y + +
Sbjct: 115 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY----YRKRGGK--- 164
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591
+MAPE ++ G T K DV++FGV++ E+ + E Y +S EE
Sbjct: 165 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-----------GEQPYPGMS--NEE 211
Query: 592 SNVREKLR-GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
V E L+ G+ R P + + L C A D RP+ SE+
Sbjct: 212 --VLEYLKNGY-----RLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-48
Identities = 83/289 (28%), Positives = 133/289 (46%), Gaps = 55/289 (19%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGD------DAAVKVMKGDVS--------SEINILKKI 411
K+ G+F G VY+G+ KG + AVK +K D S E I++K+
Sbjct: 6 KLGEGAF-------GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
+H NI++L G C E +V E+ G L D+L NR + L+ + A +A
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARG 115
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
+ YL ++H++L N L+ NL KI++FGL+R D++ Y ++ +
Sbjct: 116 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY----YKVKGGK--- 165
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591
+MAPE ++ G T K DV++FGV++ E+ + E Y +S E
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-----------GEEPYPGMS--NAE 212
Query: 592 SNVREKLR-GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
V E L+ G+ R P + + +L C A D RP+ SE+
Sbjct: 213 --VLEYLKKGY-----RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-47
Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 34/209 (16%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKGDVSS--------EINILKKINHSNI 416
+ G F G+VY K A+K++K + SS EI ILKK+NH NI
Sbjct: 1 LGEGGF-------GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI 53
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
++L G E + YLV E+ + G+L D L N L+ + ++I + L YLH
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLH 109
Query: 477 KYTNPPYVHKNLKTSNILLD-TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
+H++LK NILLD N + K+ +FGL++ SD+ L + +VGT
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--------SLLKTIVGTPA 158
Query: 536 YMAPEYIENGV-ITPKLDVFAFGVVVLEL 563
YMAPE + + K D+++ GV++ EL
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 6e-47
Identities = 89/294 (30%), Positives = 136/294 (46%), Gaps = 56/294 (19%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVS--------SEINILKKIN 412
K+ G+F G VY+G KG D AVK +K D S E ++KK+
Sbjct: 2 KLGEGAF-------GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG 54
Query: 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR----YQTSDNLTWKQRVQIAYDV 468
H N++RL G C E YLV E+ + G L D+L +R L+ K + A +
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL-T 527
A + YL +VH++L N L+ +L KI++FGL+R D++ + G +L
Sbjct: 115 AKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
R +MAPE +++G+ T K DV++FGV++ E+ + G Y +S
Sbjct: 172 R-------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTL-----GATP------YPGLS- 212
Query: 588 VLEESNVREKLR-GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
EE V E LR G+ R P + +L +C D RP+ SE+
Sbjct: 213 -NEE--VLEYLRKGY-----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 91/302 (30%), Positives = 137/302 (45%), Gaps = 67/302 (22%)
Query: 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVSS------- 403
L L K K+ G+F G VY+G+ KGD AVK +K S
Sbjct: 1 LELGK----KLGEGAF-------GEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL 49
Query: 404 -EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E +I+KK++H NI+RL G C Y+V E+ G L D+L + + LT K +
Sbjct: 50 EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLL 105
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
Q+A +A + YL + +VH++L N L+ NL KI++FGL+R D+
Sbjct: 106 QMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD------ 156
Query: 523 GLQLTRHVVGTYGY-----MAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577
+ G MAPE +++G T K DV++FGV++ E+ + G+Q
Sbjct: 157 -----YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL-----GEQP-- 204
Query: 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
Y +S EE V E L R P + + +L C A+D RP+ S
Sbjct: 205 ----YPGMS--NEE--VLELLED----GYRLPRPENCPDELYELMLQCWAYDPEDRPTFS 252
Query: 638 EV 639
E+
Sbjct: 253 EL 254
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-44
Identities = 80/287 (27%), Positives = 125/287 (43%), Gaps = 49/287 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKGD---------VSSEINILKKINHS 414
K+ +GSF G+VY+ KG AVK++K EI IL++++H
Sbjct: 6 KLGSGSF-------GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHP 58
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
NI+RL + + YLV E+ + G L D+L L+ + +IA + L Y
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEY 113
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
LH +H++LK NILLD N KI +FGLA+ + VGT
Sbjct: 114 LHSN---GIIHRDLKPENILLDENGVVKIADFGLAK--------KLLKSSSSLTTFVGTP 162
Query: 535 GYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593
YMAPE + G PK+DV++ GV++ ELL+G+ ++ + + +
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK------------PPFSGENILDQLQL 210
Query: 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
+R L ++ L K C D + RP+ E+
Sbjct: 211 IRRILGPPLEFDEPKWSSGSE--EAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 8e-43
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMK--------GDVSSEINILKKINHSN 415
K+ GSF G VY K A+KV+K + EI ILKK+ H N
Sbjct: 6 KLGEGSF-------GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN 58
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
I+RL E YLV E+ + G L D L L+ + + +AL YL
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-----LSEDEARFYLRQILSALEYL 113
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
H VH++LK NILLD + K+ +FGLAR + E VGT
Sbjct: 114 HSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---------LTTFVGTPE 161
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
YMAPE + +D+++ GV++ ELL+G+
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 366 KIATGSFSEENRIQGSVYRG--SFKGDDAAVKVMKGD---------VSSEINILKKINHS 414
+ GSF GSVY G+ AVK ++ + EI IL + H
Sbjct: 7 LLGRGSF-------GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHP 59
Query: 415 NIIRLSGFCVH-EGNTYLVY-EFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANA 471
NI+R G E NT ++ E+ G+LS L + + + ++ +
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPV-----IRKYTRQILEG 113
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
L YLH VH+++K +NIL+D++ K+ +FG A+ E +G T V
Sbjct: 114 LAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG------TGSVR 164
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
GT +MAPE I D+++ G V+E+ +G+
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-------GDVSSEINILKK 410
F+ L KI G F G VY+ K G + A+KV+K + +EI ILKK
Sbjct: 1 LFEILEKIGKGGF-------GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKK 53
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY---D 467
H NI++ G + + ++V EF G+L D L S +++ QIAY +
Sbjct: 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-------QIAYVCKE 106
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+ L YLH +H+++K +NILL ++ K+ +FGL+ +
Sbjct: 107 LLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD---------TKAR 154
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+VGT +MAPE I K D+++ G+ +EL G+
Sbjct: 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (295), Expect = 9e-29
Identities = 86/319 (26%), Positives = 133/319 (41%), Gaps = 40/319 (12%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS----------EINILKKINH-S 414
K+ GSF G VY + A+KV+ + S EI IL +NH
Sbjct: 7 KLGEGSF-------GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
NI++L F EG+ YLV E+ D G+L D L + L+ + + I + +AL Y
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG--PLSESEALFILAQILSALEY 116
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
LH +H+++K NILLD + K+ +FGLA+ + L VGT
Sbjct: 117 LHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAK--LLPDPGSTSSIPALPSTSVGT 171
Query: 534 YGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590
GYMAPE + + D+++ G+ + ELL+G G++N A I
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----- 226
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV--TLSKIWS 648
+ E + L P ++ + + L K A D R S S L+ +
Sbjct: 227 ---ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283
Query: 649 SSSDWDPSDELNNSRSLSR 667
SD + ++S L
Sbjct: 284 KESDLSDLLKPDDSAPLRL 302
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS------EINILKKINHSNIIRLS 420
I G F G V G ++G AVK +K D ++ E +++ + H N+++L
Sbjct: 14 IGKGEF-------GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
G + Y+V E+ G+L D+L S +T Q++ A DV + YL +
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV---ITLAQQLGFALDVCEGMEYLEEKN- 122
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540
+VH++L N+L+ +L AK+++FGLA+ A + G ++ T APE
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-GQDSGKLPVKWT----------APE 169
Query: 541 YIENGVITPKLDVFAFGVVVLELLS-GR 567
+ + K DV++FG+++ E+ S GR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 50/286 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA--AVKVM---------KGDVSSEINILKKINHS 414
+I GSF G VY K D +K + + D +E+ ILKK+NH
Sbjct: 7 QIGKGSF-------GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
NII+ +G +V E+AD G LS + + + +Q + + AL Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
LH +H+++K NI L +N K+ +FG+++ S + L + VVGT
Sbjct: 119 LHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--------VDLAKTVVGTP 167
Query: 535 GYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594
Y++PE +N K D+++ G V+ EL + + G+ EL I
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--NLLELAL-KI--------- 215
Query: 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
L+G P + ++Y +L L + D RPSI+++
Sbjct: 216 ---LKGQYPP-IPSQYSSEL----RNLVSSLLQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 63/288 (21%)
Query: 380 GSVYRGSF-----KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426
G V RG K D A+K +K D +E +I+ + +H NIIRL G
Sbjct: 18 GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
++ E+ +NG+L +L N + T Q V + +A+ + YL + YVH+
Sbjct: 78 RPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYL---SEMNYVHR 130
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYM--------- 537
+L NIL+++NL K+++FGL+R E E TY
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRRLEDSE---------------ATYTTKGGKIPIRWT 175
Query: 538 APEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREK 597
APE I T DV++FG+V+ E++S E D S V++
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM---------SNQDVIKA------ 220
Query: 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
++ R P+D ++ QL +C D N RP+ S++ TL K
Sbjct: 221 ----VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 71/224 (31%), Positives = 105/224 (46%), Gaps = 38/224 (16%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMK------GDVSSEINI 407
ESL L + K+ G F G V+ G++ G AVK +K E I
Sbjct: 6 ESLKLER----KLGAGQF-------GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQI 54
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+KK+ H +++L C E Y+V E+ G+L D+L S L Q V +A
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQ 111
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE---HEQGGYGL 524
+A + YL Y+H++L NIL+ NL KI +FGLAR E DE E + +
Sbjct: 112 IAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GR 567
+ T APE G T K DV++FG+++ E+++ GR
Sbjct: 169 KWT----------APEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 81/298 (27%), Positives = 126/298 (42%), Gaps = 63/298 (21%)
Query: 380 GSVYRGSFKGDD-------AAVKVMKGDVS--------SEINILKKI-NHSNIIRLSGFC 423
G V + G D AVK++K D + SE+ ++K I H NII L G C
Sbjct: 26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85
Query: 424 VHEGNTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANAL 472
EG Y+V E+A +G L D+L + R + LT K V AY VA +
Sbjct: 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM 145
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
+L + +H++L N+L+ + KI +FGLAR D H Y + G
Sbjct: 146 EFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYY----RKTTNG 194
Query: 533 --TYGYMAPEYIENGVITPKLDVFAFGVVVLEL--LSGREAVTGDQNCEAELLYASISRV 588
+MAPE + + V T + DV++FGV++ E+ L G Y I
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-------------YPGIP-- 239
Query: 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
E+L + R E P + + L ++C + RP+ ++ L ++
Sbjct: 240 ------VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINIL 408
Y+ DL I G+F G VY+G GD A+K + + EI++L
Sbjct: 2 YQLGDL-IGRGAF-------GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLL 53
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA--- 465
K + H NI++ G + Y++ E+A+NG+L + +A
Sbjct: 54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSL-----RQIIKKFGPF---PESLVAVYV 105
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
Y V L YLH +H+++K +NIL + K+ +FG+A +
Sbjct: 106 YQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD------- 155
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
VVGT +MAPE IE + D+++ G V+ELL+G
Sbjct: 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 95/316 (30%), Positives = 143/316 (45%), Gaps = 75/316 (23%)
Query: 361 KFQDLKIATGSFSEENRIQGSVYRGSFKGD----DAAVKVMKG--------DVSSEINIL 408
KFQD+ I G+F G V + K D DAA+K MK D + E+ +L
Sbjct: 10 KFQDV-IGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 61
Query: 409 KKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR-----------YQTSDNL 456
K+ H NII L G C H G YL E+A +G L D+L +R T+ L
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+ +Q + A DVA ++YL + ++H++L NIL+ N AKI +FGL+R E
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-- 176
Query: 517 HEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571
+V T G +MA E + V T DV+++GV++ E++S
Sbjct: 177 ------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
Query: 572 GDQNCEAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL 630
C AEL EKL +G+ R E PL+ + L + C
Sbjct: 225 CGMTC-AELY--------------EKLPQGY-----RLEKPLNCDDEVYDLMRQCWREKP 264
Query: 631 NARPSISEVFVTLSKI 646
RPS +++ V+L+++
Sbjct: 265 YERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 76/297 (25%)
Query: 380 GSVYRGSFKGDDA--AVKVMKGD-------VSS--EINILKKINHSNIIRLSGFCVHE-- 426
G VY+ K A+K ++ + +++ EI +L+K+ H NI+RL +
Sbjct: 13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK 72
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
G+ Y+V+E+ D+ L+ L S + T Q + L YLH + +H+
Sbjct: 73 GSIYMVFEYMDHD-LTGLLDSPEVK----FTESQIKCYMKQLLEGLQYLH---SNGILHR 124
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE------ 540
++K SNIL++ + K+ +FGLAR T V+ T Y PE
Sbjct: 125 DIKGSNILINNDGVLKLADFGLARPYTKRNSA------DYTNRVI-TLWYRPPELLLGAT 177
Query: 541 -YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL---------- 589
Y P++D+++ G ++ EL G+ G E E L I +
Sbjct: 178 RY------GPEVDMWSVGCILAELFLGKPIFQGST--ELEQLEK-IFELCGSPTDENWPG 228
Query: 590 ---------------EESNVREKLRGFIDPSLRNEYPLDLAFSMAQL--AKNCTAHD 629
+ +RE + IDPS LDL + L K +A
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSA-----LDLLDKLLTLDPKKRISADQ 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 56/282 (19%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-DVSS-----------EINILKKINH 413
KI GSF G V++ K D V MK D+S E +L K++
Sbjct: 7 KIGKGSF-------GVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANAL 472
S IIR + +G +V E+A+NG L L R + ++ W+ +QI L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GL 114
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
+LH +H+++K+ N+ LD KI + G+A+ + + +VG
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--------FANTIVG 163
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592
T Y++PE E+ K DV+A GVV+ E +G+ D N + L
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF--DANNQGAL------------ 209
Query: 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
+ + +RG P + Y L AQL C D RP
Sbjct: 210 -ILKIIRGVFPP-VSQMYSQQL----AQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 41/233 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMK----------GDVSSEINI 407
+KF + I GSFS V K + A+K++ V E +
Sbjct: 3 FKFGKI-IGEGSFST-------VVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV 54
Query: 408 LKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
L ++N H II+L E N Y V E+A NG + L R S + + A
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG---ELLQYIRKYGSLDEKCTR--FYAA 109
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR------------SAES 514
++ AL YLH + +H++LK NILLD ++ KIT+FG A+ +
Sbjct: 110 EILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ Q + VGT Y++PE + D++A G ++ ++L+G+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-23
Identities = 110/389 (28%), Positives = 167/389 (42%), Gaps = 75/389 (19%)
Query: 277 WVFIGAGIGAFLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSL 336
W +I +GAFL+L + AF F R R N + RV
Sbjct: 629 WFYITCTLGAFLVLALV---AFGFVFIRGRNNLELK--------RV-------------- 663
Query: 337 FPQASNSLSHPQGFRSAV-ESLTLYKFQDLKIATGSFSEENRI----QGSVYRGSFKGDD 391
+ + Q F S V +S+T+ S EEN I +G+ Y+G +
Sbjct: 664 --ENEDGTWELQFFDSKVSKSITI------NDILSSLKEENVISRGKKGASYKGKSIKNG 715
Query: 392 A--AVKVMKGDV----SSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL 445
VK + DV SSEI + K+ H NI++L G C E YL++E+ + LS+ L
Sbjct: 716 MQFVVKEIN-DVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 446 HSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505
NL+W++R +IA +A AL +LH +P V NL I++D +
Sbjct: 775 R--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825
Query: 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
L +D + Y+APE E IT K D++ FG++++ELL+
Sbjct: 826 LSLPGLLCTDTKC------------FISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873
Query: 566 GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPL---DLAFSMAQLA 622
G+ + E ++ SI L +IDPS+R + + ++ M LA
Sbjct: 874 GK----SPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM-NLA 927
Query: 623 KNCTAHDLNARPSISEVFVTLSKIWSSSS 651
+CTA D ARP ++V TL SSS
Sbjct: 928 LHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 75/316 (23%)
Query: 361 KFQDLKIATGSFSEENRIQGSVYRGSFKGD----DAAVKVMKG--------DVSSEINIL 408
KF+D+ I G+F G V R K D +AA+K++K D + E+ +L
Sbjct: 5 KFEDV-IGEGNF-------GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVL 56
Query: 409 KKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR-----------YQTSDNL 456
K+ +H NII L G C + G Y+ E+A G L D+L +R + T+ L
Sbjct: 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
T +Q +Q A DVA + YL + ++H++L N+L+ NL +KI +FGL+R E
Sbjct: 117 TSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-- 171
Query: 517 HEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571
+V T G +MA E + V T K DV++FGV++ E++S
Sbjct: 172 ------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
Query: 572 GDQNCEAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL 630
C AEL EKL +G+ R E P + + +L + C
Sbjct: 220 CGMTC-AELY--------------EKLPQGY-----RMEKPRNCDDEVYELMRQCWRDRP 259
Query: 631 NARPSISEVFVTLSKI 646
RP +++ V LS++
Sbjct: 260 YERPPFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 51/227 (22%)
Query: 358 TLYKFQDLKIATGSFSEENRIQGSVYRG--SFKGDDAAVKVMK--GDVSS----EINILK 409
LYK + KI G+ G VY+ G + A+K M+ EI I+K
Sbjct: 19 ELYKNLE-KIGEGAS-------GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMK 70
Query: 410 KINHSNIIRLSGFCVHEGNT-YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY-- 466
H NI+ G+ ++V E+ D G+L+D + Q + QIAY
Sbjct: 71 DCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDII----TQNFVRMN---EPQIAYVC 122
Query: 467 -DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
+V L YLH +H+++K+ NILL + K+ +FG + Q
Sbjct: 123 REVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG--------------FAAQ 165
Query: 526 LT-----RH-VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
LT R+ VVGT +MAPE I+ PK+D+++ G++ +E+ G
Sbjct: 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 57/291 (19%)
Query: 370 GSFSEENRIQGSVYRGSFKG---DDA----AVKVMKGDVSS--------EINILKKINHS 414
GSF G VY G KG + A+K + + S E +++K+ N
Sbjct: 17 GSF-------GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN-----LTWKQRVQIAYDVA 469
+++RL G T +V E G L +L S R + +N T ++ +Q+A ++A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTR 528
+ + YL +VH++L N ++ +L KI +FG+ R E+D + +GG GL R
Sbjct: 130 DGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 529 HVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588
+MAPE +++GV T K DV++FGVV+ E+ + AE Y +S
Sbjct: 187 -------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT-----------LAEQPYQGLS-- 226
Query: 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
E++ F+ + P + + +L + C ++ RP+ E+
Sbjct: 227 ------NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 42/233 (18%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD----------VSSEINILKKINHS 414
+ GSF G V K A+KV+K +E NIL +INH
Sbjct: 1 LGKGSF-------GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 415 NIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ-IAYDVANAL 472
I++L + E YLV E+A G L L + + R + A ++ AL
Sbjct: 54 FIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE------RARFYAAEIVLAL 106
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
YLH ++++LK NILLD + K+T+FGLA+ S+ T G
Sbjct: 107 EYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--------SRTNTFCG 155
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
T Y+APE + +D ++ GV++ E+L+G+ + E +Y I
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 39/250 (15%)
Query: 379 QGSVYRGSFKGDDA--AVKVMKGD--------VSSEINILKKINHSNIIRLSGFCVHEGN 428
G VY+ K A+K + D + E+ L+ +++ G EG
Sbjct: 14 SGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73
Query: 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV--QIAYDVANALNYLHKYTNPPYVHK 486
+V E+ D G+L+D L + V IA + L+YLH + +H+
Sbjct: 74 ISIVLEYMDGGSLADLLKKVG-------KIPEPVLAYIARQILKGLDYLHTKRH--IIHR 124
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV 546
++K SN+L+++ KI +FG+++ E+ L VGT YM+PE I+
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLEN--------TLDQCNTFVGTVTYMSPERIQGES 176
Query: 547 ITPKLDVFAFGVVVLELLSGR---EAVTGDQNCEAELLYASISRV----LEESNVREKLR 599
+ D+++ G+ +LE G+ Q EL+ A I L + R
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPP--GQPSFFELMQA-ICDGPPPSLPAEEFSPEFR 233
Query: 600 GFIDPSLRNE 609
FI L+ +
Sbjct: 234 DFISACLQKD 243
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 380 GSVYRGS----FKGDDA---AVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424
G V+ G +D AVK +K D E +L H NI++ G C
Sbjct: 19 GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT 78
Query: 425 HEGNTYLVYEFADNGALSDWLHSN---------RYQTSDNLTWKQRVQIAYDVANALNYL 475
+V+E+ ++G L+ +L S+ LT Q +QIA +A+ + YL
Sbjct: 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL 138
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES-DEHEQGGYGLQLTRHVVGTY 534
+ +VH++L T N L+ +L KI +FG++R + D + GG+ + R
Sbjct: 139 ---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR------ 189
Query: 535 GYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEA 578
+M PE I T + DV++FGVV+ E+ + G++ G N E
Sbjct: 190 -WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 49/231 (21%)
Query: 380 GSVYRG--SFKGDDAAVKVMKGD-----VSS----EINILKKINHSNIIRLSGFCVHEGN 428
G VY+ G+ A+K ++ D + S EI++LK++ H NI++L E
Sbjct: 13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK 72
Query: 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ-IAYDVANALNYLHKYTNPPYVHKN 487
YLV+E+ D L +L S NL ++ I Y + L Y H ++ +H++
Sbjct: 73 LYLVFEYCDMD-LKKYLDKRPGPLSPNL-----IKSIMYQLLRGLAYCH--SH-RILHRD 123
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR--HVVGTYGYMAPE----- 540
LK NIL++ + K+ +FGLAR+ +G+ L H V T Y APE
Sbjct: 124 LKPQNILINRDGVLKLADFGLARA----------FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 541 --YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
Y + +D+++ G + E+++G+ GD E + L+ I ++L
Sbjct: 174 KHY------STAVDIWSVGCIFAEMITGKPLFPGD--SEIDQLF-KIFQIL 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 55/296 (18%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDD-----AAVKVMKG--------DVSSEINILKKINH 413
I G F G V RG K A+K +K D SE +I+ + +H
Sbjct: 12 IGAGEF-------GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
NII L G ++ EF +NGAL +L N Q T Q V + +A +
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ----FTVIQLVGMLRGIAAGMK 120
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE---SDEHEQGGYGLQLTRHV 530
YL + YVH++L NIL+++NL K+++FGL+R E SD G ++
Sbjct: 121 YLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR- 176
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590
+ APE I T DV+++G+V+ E++S E D
Sbjct: 177 -----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---------------- 215
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
SN + + I+ R P+D ++ QL +C D NARP ++ TL K+
Sbjct: 216 -SN--QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 61/195 (31%), Positives = 106/195 (54%), Gaps = 24/195 (12%)
Query: 380 GSVYRGSFKGDDAAVKVMKGDVSS-----EINILKKINHSNIIRLSGFCVHEGNTYLVYE 434
G+V +G + G AVK +K DV++ E ++ K++H N++RL G +H G Y+V E
Sbjct: 20 GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME 78
Query: 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494
G L ++L + R + ++ Q +Q + DVA + YL + VH++L NIL
Sbjct: 79 LMSKGNLVNFLRT-RGRALVSVI--QLLQFSLDVAEGMEYLE---SKKLVHRDLAARNIL 132
Query: 495 LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVF 554
+ + AK+++FGLAR G G+ ++ V + APE +++ + K DV+
Sbjct: 133 VSEDGVAKVSDFGLARV--------GSMGVDNSKLPV---KWTAPEALKHKKFSSKSDVW 181
Query: 555 AFGVVVLELLS-GRE 568
++GV++ E+ S GR
Sbjct: 182 SYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 63/284 (22%), Positives = 121/284 (42%), Gaps = 33/284 (11%)
Query: 380 GSVYRGSF------KGDDAAVKVMK--------GDVSSEINILKKINHSNIIRLSGFC-- 423
G V + G+ AVK + D EI IL+ ++H NI++ G C
Sbjct: 18 GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK 77
Query: 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPY 483
+ L+ E+ +G+L D+L +R D + K+ + + + ++YL + Y
Sbjct: 78 PGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRY 130
Query: 484 VHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE 543
+H++L NIL+++ KI++FGLA+ D + Y + + Y APE +
Sbjct: 131 IHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEPGESPIFWY---APECLR 185
Query: 544 NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFID 603
+ DV++FGV + EL + GD + + + + + + +L +
Sbjct: 186 TSKFSSASDVWSFGVTLYELFT-----YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 604 PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647
R P + L K C + RPS +++ + + ++
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 84/292 (28%), Positives = 136/292 (46%), Gaps = 59/292 (20%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMK-GDVS-----SEINI 407
ESL L ++K+ G F G V+ G++ G A+K +K G +S E +
Sbjct: 6 ESLRL----EVKLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV 54
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+KK+ H +++L V E Y+V E+ G+L D+L + + L Q V +A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQ 110
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH--EQGG-YGL 524
+A+ + Y+ + YVH++L+ +NIL+ NL K+ +FGLAR E +E+ QG + +
Sbjct: 111 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 167
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583
+ T APE G T K DV++FG+++ EL + GR G N E
Sbjct: 168 KWT----------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------ 211
Query: 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
VL++ RG+ P P + S+ L C + RP+
Sbjct: 212 ----VLDQVE-----RGYRMPC-----PPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 89/292 (30%), Positives = 134/292 (45%), Gaps = 59/292 (20%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMK-GDVS-----SEINI 407
ESL L K K+ G F E V+ G++ G+ AVK +K G +S E I
Sbjct: 6 ESLQLIK----KLGNGQFGE-------VWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQI 54
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+KK+ H +++L V E Y+V E+ G+L D+L L V +A
Sbjct: 55 MKKLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGE---GRALKLPNLVDMAAQ 110
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH--EQGG-YGL 524
VA + Y+ + Y+H++L+++NIL+ L KI +FGLAR E +E+ QG + +
Sbjct: 111 VAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583
+ T APE G T K DV++FG+++ EL++ GR G N E
Sbjct: 168 KWT----------APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------ 211
Query: 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
VLE+ RG+ R P D S+ +L C D RP+
Sbjct: 212 ----VLEQVE-----RGY-----RMPCPQDCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 69/234 (29%), Positives = 118/234 (50%), Gaps = 39/234 (16%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMK-GDVS-----SEINI 407
E+L L K K+ G F G V+ G + G A+K +K G +S +E N+
Sbjct: 6 ETLKLVK----KLGAGQF-------GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANL 54
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+K++ H ++RL E Y++ E+ +NG+L D+L + LT + + +A
Sbjct: 55 MKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTP---EGIKLTINKLIDMAAQ 110
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH---EQGGYGL 524
+A + ++ + Y+H++L+ +NIL+ L KI +FGLAR E +E+ E + +
Sbjct: 111 IAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI 167
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577
+ T APE I G T K DV++FG+++ E+++ GR G N E
Sbjct: 168 KWT----------APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 55/289 (19%)
Query: 380 GSVYRGSFKGDDA--------AVKVM-KGDVSSE-------INILKKINHSNIIRLSGFC 423
G VY G+ AVK + KG E +++ NH NI++L G C
Sbjct: 9 GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68
Query: 424 VHEGNTYLVYEFADNGALSDWLHSNRYQT--SDNLTWKQRVQIAYDVANALNYLHKYTNP 481
+ Y++ E + G L +L R + LT K+ + I DVA YL +
Sbjct: 69 LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-- 126
Query: 482 PYVHKNLKTSNILL-----DTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHVVGTYG 535
++H++L N L+ D + KI +FGLAR +SD + + G GL R
Sbjct: 127 -FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR------- 178
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNV 594
+MAPE + +G T + DV++FGV++ E+L+ G++ N E + R+ + N
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238
Query: 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
+K+ QL NC A D + RP+ + L
Sbjct: 239 PDKIY--------------------QLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 76/289 (26%), Positives = 122/289 (42%), Gaps = 62/289 (21%)
Query: 380 GSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426
G V+RG K A+K +K D SE +I+ + +H NIIRL G
Sbjct: 19 GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
++ E+ +NGAL +L + + Q V + +A + YL ++ YVH+
Sbjct: 79 KPAMIITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHR 131
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG---------YM 537
+L NIL+++NL K+++FGL+R E D GTY +
Sbjct: 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPE--------------GTYTTSGGKIPIRWT 177
Query: 538 APEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREK 597
APE I T DV++FG+V+ E++S E R + + E
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGE------------------RPYWDMSNHEV 219
Query: 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
++ I+ R P+D ++ QL C D RP ++ L K+
Sbjct: 220 MKA-INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 22/200 (11%)
Query: 380 GSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKINHSNIIRL-SGFCVHE 426
G V+ K GD A+KV+K V +E +IL + +++L F +
Sbjct: 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-GK 65
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
N YLV E+ G L+ L + D ++ AL YLH +H+
Sbjct: 66 KNLYLVMEYLPGGDLASLLENVGSLDEDVAR-----IYIAEIVLALEYLHSNG---IIHR 117
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV 546
+LK NIL+D+N K+T+FGL++ + + +VGT Y+APE I
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 547 ITPKLDVFAFGVVVLELLSG 566
+ +D ++ G ++ E L G
Sbjct: 178 HSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 76/296 (25%), Positives = 119/296 (40%), Gaps = 56/296 (18%)
Query: 366 KIATGSFSEENRIQGSVYRG-----SFKGDDAAVKVMKGDVSS--------EINILKKIN 412
K+ GSF G V RG K AVK +K D S E I+ ++
Sbjct: 2 KLGDGSF-------GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRY-QTSDNLTWKQRVQIAYDVANA 471
H N+IRL G V +V E A G+L D L + + VQIA N
Sbjct: 55 HENLIRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NG 109
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS-AESDEHEQGGYGLQLTRHV 530
+ YL ++H++L NILL ++ + KI +FGL R+ ++++H Y ++ V
Sbjct: 110 MRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH----YVMEEHLKV 162
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVL 589
+ + APE + + DV+ FGV + E+ + G E G + I +
Sbjct: 163 --PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG---LSGSQILKKIDKEG 217
Query: 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
E R E P + + C AH+ RP+ + + L +
Sbjct: 218 E----------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 50/290 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKGDVSSEI--------NILKKINHSNI 416
KI G+F G VY+G KG+ + AVK + + ++ ILK+ +H NI
Sbjct: 2 KIGKGNF-------GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
++L G CV + Y+V E G+L +L + LT K+ +Q++ D A + YL
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 477 KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGY 536
+H++L N L+ N KI++FG++R E E G Y + + +
Sbjct: 111 SKN---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQI-PIKW 161
Query: 537 MAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVR 595
APE + G T + DV+++G+++ E S G G N +
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT----------------- 204
Query: 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
R I+ R P + +L C A+D RPS SE++ L
Sbjct: 205 ---RERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKV--MKGDVSS---EINILKKINHSNIIR 418
K+ GS+ GSVY+ K G A+KV ++ D+ EI+ILK+ + I++
Sbjct: 10 KLGEGSY-------GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 419 LSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY 478
G + ++V E+ G++SD + T+ LT ++ I Y L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMA 538
+H+++K NILL+ +AK+ +FG++ Q + V+GT +MA
Sbjct: 119 KK---IHRDIKAGNILLNEEGQAKLADFGVS--------GQLTDTMAKRNTVIGTPFWMA 167
Query: 539 PEYIENGVITPKLDVFAFGVVVLELLSGR 567
PE I+ K D+++ G+ +E+ G+
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
SE+NIL+++ H NI+R + N Y+V E+ + G L+ L + + +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEF 106
Query: 461 RVQIAYDVANALNYLHKYTNPPYV--HKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
+I + AL H ++P H++LK +NI LD N K+ +FGLA+ D
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--- 163
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ VGT YM+PE + + K D+++ G ++ EL +
Sbjct: 164 -----SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 46/215 (21%)
Query: 380 GSVYRGSFKGD----DAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCVHE 426
G V + K D DAA+K MK D + E+ +L K+ +H NII L G C H
Sbjct: 9 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 68
Query: 427 GNTYLVYEFADNGALSDWLHSNR-----------YQTSDNLTWKQRVQIAYDVANALNYL 475
G YL E+A +G L D+L +R T+ L+ +Q + A DVA ++YL
Sbjct: 69 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
+ ++H++L NIL+ N AKI +FGL+R E +V T G
Sbjct: 129 ---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------------YVKKTMG 171
Query: 536 -----YMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+MA E + V T DV+++GV++ E++S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 71/271 (26%), Positives = 118/271 (43%), Gaps = 46/271 (16%)
Query: 380 GSVYRGSFK--GDDAAVKVMKGDVS------SEINILKKINHSNIIRLSGFCVHEGNTYL 431
G VY G +K AVK +K D E ++K+I H N+++L G C E Y+
Sbjct: 20 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79
Query: 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTS 491
+ EF G L D+L Q + + + +A +++A+ YL K ++H++L
Sbjct: 80 ITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEKKN---FIHRDLAAR 133
Query: 492 NILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY--GYMAPEYIENGVITP 549
N L+ N K+ +FGL+R D + T H + + APE + +
Sbjct: 134 NCLVGENHLVKVADFGLSRLMTGDTY---------TAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 550 KLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRN 608
K DV+AFGV++ E+ + G G ++ S V E L + R
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELL----EKGYRM 224
Query: 609 EYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
E P + +L + C + + RPS +E+
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK---GD------VSSEINILKKINHS 414
KI G+F G VY G+ AVK ++ D ++ E+ +L+ + H
Sbjct: 7 KIGGGTF-------GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
N+++ G VH Y+ E+ G L + L R +++ +Q+ L Y
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQL----LEGLAY 114
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
LH + VH+++K +NI LD N K+ +FG A +++ G + GT
Sbjct: 115 LHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ----SLAGTP 167
Query: 535 GYMAPEYIENGVITPKL---DVFAFGVVVLELLSGR 567
YMAPE I G D+++ G VVLE+ +G+
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA-AVKVMKG------DVSSEINILKKINHSNIIR 418
K+ G F G V+ G + AVK +K D +E I+KK+ H +I+
Sbjct: 13 KLGAGQF-------GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQ 65
Query: 419 LSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY 478
L C E Y+V E G+L ++L L Q + +A VA+ + YL
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT---YG 535
Y+H++L N+L+ N K+ +FGLAR + D +E R G
Sbjct: 123 N---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE--------ARE--GAKFPIK 169
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577
+ APE + K DV++FG+++ E+++ GR G N E
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 71/281 (25%), Positives = 133/281 (47%), Gaps = 55/281 (19%)
Query: 393 AVKVMKGDVS--------SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
AVK++K + S SE N+LK++NH ++I+L G C +G L+ E+A G+L +
Sbjct: 34 AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93
Query: 445 LHSNR-----YQTSDN--------------LTWKQRVQIAYDVANALNYLHKYTNPPYVH 485
L +R Y SD LT + A+ ++ + YL + VH
Sbjct: 94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVH 150
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
++L N+L+ + KI++FGL+R D +E+ Y ++ ++ + +MA E + +
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSR----DVYEEDSY-VKRSKGRIPV-KWMAIESLFDH 204
Query: 546 VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPS 605
+ T + DV++FGV++ E+++ + G+ Y I+ E+L +
Sbjct: 205 IYTTQSDVWSFGVLLWEIVT----LGGNP-------YPGIAP--------ERLFNLLKTG 245
Query: 606 LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
R E P + + M L C + + RP+ +++ L K+
Sbjct: 246 YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 56/249 (22%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR----YQTSDNLTWK 459
E+++ +K++H N++RL G C Y++ E+ D G L +L + + L+ K
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
Q+V + +A +++L +N +VH++L N L+ + K++ L++ + E+
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-- 172
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579
R+ + ++APE ++ + K DV++FGV++ E+ + E + E E
Sbjct: 173 -----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-E 226
Query: 580 LLYASISRVLE---ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636
+L + LE +L +L C A + RPS
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLY--------------------KLMTRCWAVNPKDRPSF 266
Query: 637 SEVFVTLSK 645
SE+ L +
Sbjct: 267 SELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 89/296 (30%), Positives = 136/296 (45%), Gaps = 59/296 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMK-GDVS-----SEINI 407
ESL L D+K+ G F G V+ G++ G A+K +K G + E I
Sbjct: 6 ESLRL----DVKLGQGCF-------GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQI 54
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+KK+ H ++ L V E Y+V EF G+L D+L L Q V +A
Sbjct: 55 MKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEG---DGKYLKLPQLVDMAAQ 110
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH--EQGG-YGL 524
+A+ + Y+ + Y+H++L+ +NIL+ NL KI +FGLAR E +E+ QG + +
Sbjct: 111 IADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583
+ T APE G T K DV++FG+++ EL++ GR G N E
Sbjct: 168 KWT----------APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------ 211
Query: 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
VLE+ RG+ P P S+ +L K C D + RP+ +
Sbjct: 212 ----VLEQVE-----RGYRMPC-----PQGCPESLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 39/262 (14%)
Query: 393 AVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
A+K +K D SE +I+ + +H NII L G +V E+ +NG+L +
Sbjct: 36 AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF 95
Query: 445 LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504
L + Q T Q V + +A+ + YL ++ YVH++L NIL+++NL K++
Sbjct: 96 LRKHDGQ----FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVS 148
Query: 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564
+FGL+R E D + Y TR + APE I T DV+++G+V+ E++
Sbjct: 149 DFGLSRVLEDD--PEAAY---TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
Query: 565 SGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKN 624
S E R E + ++ ++ I+ R P+D ++ QL +
Sbjct: 204 SYGE------------------RPYWEMSNQDVIKA-IEEGYRLPAPMDCPAALHQLMLD 244
Query: 625 CTAHDLNARPSISEVFVTLSKI 646
C D N RP ++ L K+
Sbjct: 245 CWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 64/272 (23%), Positives = 105/272 (38%), Gaps = 44/272 (16%)
Query: 387 FKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLH 446
FK + V K + E+ +L+++ H NI+ L +G YLV+E+ + L + L
Sbjct: 34 FKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL-ELLE 91
Query: 447 SNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506
++ + + + A+ Y H + +H+++K NIL+ + K+ +F
Sbjct: 92 ASPGGLPPDAVRS----YIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144
Query: 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE----YIENGVITPKLDVFAFGVVVLE 562
G AR+ + LT +V T Y APE G +DV+A G ++ E
Sbjct: 145 GFARAL------RARPASPLTDYVA-TRWYRAPELLVGDTNYG---KPVDVWAIGCIMAE 194
Query: 563 LLSGREAVTGDQNCEAELLYASISRVL----------EESNVREKLRGFIDPSLRNEYPL 612
LL G GD + + LY I + L SN R G P L
Sbjct: 195 LLDGEPLFPGD--SDIDQLY-LIQKCLGPLPPSHQELFSSNPR--FAGVAFPEPSQPESL 249
Query: 613 DLAFSMA------QLAKNCTAHDLNARPSISE 638
+ + K C D R + E
Sbjct: 250 ERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 48/274 (17%)
Query: 380 GSVYRGSFK----GDDAAVKVMKGDVSS---------EINILKKINHSNIIRLSGFCVHE 426
G+V +G +K AVK++K D + E N+++++++ I+R+ G C E
Sbjct: 9 GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE 68
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
+ LV E A+ G L+ +L N++ T N+T ++ + V+ + YL + +VH+
Sbjct: 69 -SWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEETN---FVHR 119
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV 546
+L N+LL T AKI++FGL+++ +DE+ + H + APE +
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENY-----YKAKTHGKWPVKWYAPECMNYYK 174
Query: 547 ITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPS 605
+ K DV++FGV++ E S G++ G + E + I+
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------------------VTQMIESG 214
Query: 606 LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
R E P M L K C + ++ RP + V
Sbjct: 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 43/218 (19%)
Query: 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EINILKKINHS 414
KI G++ G VY+ K G+ A+K +K S EI +LK++NH
Sbjct: 6 KIGEGTY-------GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP 58
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN----LTWKQRVQIAYDVAN 470
NII+L H+G+ YLV+EF + ++ Y+ + L Y +
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEF---------MDTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
L + H + +H++LK N+L++T K+ +FGLARS S Y H
Sbjct: 110 GLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP---VRPY-----THY 158
Query: 531 VGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGR 567
V T Y APE + + +D+++ G + ELLS R
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 64/296 (21%)
Query: 369 TGSFSEENRIQGSVYRGSFKGD------DAAVKVMKGDVSSEIN--------ILKKINHS 414
+G+F G+VY+G + + A+KV++ + S + N ++ ++H
Sbjct: 17 SGAF-------GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP 69
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
+++RL G C+ L+ + G L D++ +++ DN+ + + +A ++Y
Sbjct: 70 HVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSY 124
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
L + VH++L N+L+ T KIT+FGLA+ + DE E G ++
Sbjct: 125 LEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV------PI 175
Query: 535 GYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESN 593
+MA E I + + T K DV+++GV V EL++ G + Y I +E +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP------------YEGI-PAVEIPD 222
Query: 594 VREKLRGFIDPSLRNEYP----LDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
+ EK R P +D+ + + C D +RP+ E+ SK
Sbjct: 223 LLEK-------GERLPQPPICTIDVYMVLVK----CWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 34/202 (16%)
Query: 380 GSVYRGSFKGDDA--AVKVMKGDVSSEIN--------ILKKINHSNIIRLSGFCVHEGNT 429
G V + + AVK ++ +++ I IL K N I+ G + G+
Sbjct: 15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
+ E+ D G+L L + + + + K IA V L YLH +H+++K
Sbjct: 75 SICMEYMDGGSLDKILKEVQGRIPERILGK----IAVAVLKGLTYLH--EKHKIIHRDVK 128
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV----VGTYGYMAPEYIENG 545
SNIL+++ + K+ +FG++ QL + VGT YMAPE I+
Sbjct: 129 PSNILVNSRGQIKLCDFGVSG--------------QLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 546 VITPKLDVFAFGVVVLELLSGR 567
+ K D+++ G+ ++EL +GR
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 380 GSVYRGSFKG----------------DDAAVKVMKGDVSSEINILKKINHSNIIRLSGFC 423
G VY+G G ++A KV + + E ++ + H NI+ L G C
Sbjct: 19 GKVYKGELTGPNERLSATSVAIKTLKENAEPKV-QQEFRQEAELMSDLQHPNIVCLLGVC 77
Query: 424 VHEGNTYLVYEFADNGALSDWL-----HSNRYQTSDNLTWKQR------VQIAYDVANAL 472
E T +++E+ +G L ++L HS+ S + T K + IA +A +
Sbjct: 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGM 137
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES-DEHEQGGYGLQLTRHVV 531
YL + +VH++L N L+ L KI++FGL+R S D + L R
Sbjct: 138 EYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR--- 191
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+M PE I G T + D+++FGVV+ E+ S
Sbjct: 192 ----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 67/234 (28%), Positives = 115/234 (49%), Gaps = 39/234 (16%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMK-GDVS-----SEINI 407
ESL L + K+ G F G V+ ++ K AVK MK G +S +E N+
Sbjct: 6 ESLKL----EKKLGAGQF-------GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV 54
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+K + H +++L E Y++ EF G+L D+L S+ + + +
Sbjct: 55 MKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQ 110
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH---EQGGYGL 524
+A + ++ + Y+H++L+ +NIL+ +L KI +FGLAR E +E+ E + +
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577
+ T APE I G T K DV++FG++++E+++ GR G N E
Sbjct: 168 KWT----------APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 36/233 (15%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK-GDVS-----SEINIL 408
ES+ L K K+ G F E + Y S K AVK +K G +S E N++
Sbjct: 6 ESIKLVK----KLGAGQFGE---VWMGYYNNSTK---VAVKTLKPGTMSVQAFLEEANLM 55
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
K + H ++RL E Y++ E+ G+L D+L S + + + + +
Sbjct: 56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQI 112
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH---EQGGYGLQ 525
A + Y+ + Y+H++L+ +N+L+ +L KI +FGLAR E +E+ E + ++
Sbjct: 113 AEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 169
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577
T APE I G T K DV++FG+++ E+++ G+ G N +
Sbjct: 170 WT----------APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 53/282 (18%)
Query: 379 QGSVYRGSFKGDDAAVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHEGN 428
Q S+Y+G F + ++ K +EI L++I+ +NI+++ GF + +
Sbjct: 33 QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 429 TY----LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484
L+ E+ G L + L + +L++K ++ +A D L L+KYTN PY
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKPY- 146
Query: 485 HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN 544
KNL + + L+ N + KI GL + S + V Y + + + +
Sbjct: 147 -KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-----------VNFMVYFSYKMLND 194
Query: 545 --GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFI 602
T K D+++ GVV+ E+ +G+ L I ++ N KL
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-------LTTKEIYDLIINKNNSLKL---- 243
Query: 603 DPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644
PLD + + + CT+HD RP+I E+ LS
Sbjct: 244 --------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 36/220 (16%)
Query: 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKGDVSSE------INIL 408
LT K ++ +G F G V+ G ++G D A+K+++ SE ++
Sbjct: 5 ELTFLK----ELGSGQF-------GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVM 53
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
K++H N+++L G C + ++V E+ NG L ++L + + L + + + DV
Sbjct: 54 MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK----LGTEWLLDMCSDV 109
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH--EQGGYGLQL 526
A+ YL ++H++L N L+ + K+++FGLAR D++ QG
Sbjct: 110 CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG------ 160
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T+ V + PE + + K DV++FGV++ E+ S
Sbjct: 161 TKFPV---KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 42/223 (18%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMK-GDVSS-----EINI 407
+ LT K ++ TG F G V G ++G D A+K++K G +S E +
Sbjct: 4 KDLTFLK----ELGTGQF-------GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKV 52
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL--HSNRYQTSDNLTWKQRVQIA 465
+ K++H +++L G C + Y+V E+ NG L ++L H R+Q S Q +++
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS------QLLEMC 106
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
DV + YL ++H++L N L+D K+++FGL+R DE+
Sbjct: 107 KDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----- 158
Query: 526 LTRHVVGT---YGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
VG+ + PE + + K DV+AFGV++ E+ S
Sbjct: 159 -----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMK-------GDVSSEINILKKINHSNII 417
K+ +G F E V+ G +K A+K++K D E+ LK++ H ++I
Sbjct: 13 KLGSGYFGE-------VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 418 RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK 477
L C Y++ E + G+L +L S Q L + +A VA + YL +
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ---VLPVASLIDMACQVAEGMAYLEE 122
Query: 478 YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYM 537
+H++L NIL+ +L K+ +FGLAR + D + L+ Y +
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED--------VYLSSDKKIPYKWT 171
Query: 538 APEYIENGVITPKLDVFAFGVVVLELLS 565
APE +G + K DV++FG+++ E+ +
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 58/286 (20%)
Query: 380 GSVYRG-----SFKGDDAAVKVMKGDVSS--------EINILKKINHSNIIRLSGFCVHE 426
GSV +G S K + AVK +K + + E +++ +++H I+RL G C E
Sbjct: 9 GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE 68
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
LV E A G L +L R +L ++A+ VA + YL +VH+
Sbjct: 69 P-LMLVMELAPLGPLLKYLKKRREIPVSDLK-----ELAHQVAMGMAYLESKH---FVHR 119
Query: 487 NLKTSNILLDTNLRAKITNFGLARS--AESDEH--EQGGYGLQLTRHVVGTYGYMAPEYI 542
+L N+LL +AKI++FG++R+ A SD + G R + Y APE I
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG------RWPLKWY---APECI 170
Query: 543 ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS--RVLEESNVREKLRG 600
G + K DV+++GV + E S G + Y + V+
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS-----YGAKP------YGEMKGAEVIA---------- 209
Query: 601 FIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
++ R P + + + +C + RP+ SE+ T +
Sbjct: 210 MLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 36/259 (13%)
Query: 400 DVSSEINILKKINHSNIIRLSGFCVHEG--NTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
D EI ILK + H NI++ G C G N LV E+ G+L D+L +R + L
Sbjct: 51 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR----ERLD 106
Query: 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
++ + A + + YL + YVH++L T NIL+++ R KI +FGL + D+
Sbjct: 107 HRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163
Query: 518 EQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTG 572
+ V G + APE + + DV++FGVV+ EL +
Sbjct: 164 ----------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-----YS 208
Query: 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEY----PLDLAFSMAQLAKNCTAH 628
D++C + + + + + + I+ L+N P + + K C +
Sbjct: 209 DKSCSPPAEF--MRMMGNDKQGQMIVYHLIE-LLKNNGRLPAPPGCPAEIYAIMKECWNN 265
Query: 629 DLNARPSISEVFVTLSKIW 647
D + RPS SE+ + + I
Sbjct: 266 DPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 68/290 (23%), Positives = 121/290 (41%), Gaps = 53/290 (18%)
Query: 380 GSVYRGSFKGDDA-----AVKVMKGDVSSEINI---------LKKINHSNIIRLSGFCVH 425
GSV G DD AVK MK D+ + I +K +H N+++L G C
Sbjct: 13 GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72
Query: 426 EGNT------YLVYEFADNGALSDWLHSNRYQT-SDNLTWKQRVQIAYDVANALNYLHKY 478
+ ++ F +G L +L +R + L + ++ D+A + YL
Sbjct: 73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL--- 129
Query: 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES-DEHEQGGYGLQLTRHVVGTYGYM 537
+N ++H++L N +L ++ + +FGL++ S D + QG ++ + V ++
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG----RIAKMPVK---WI 182
Query: 538 APEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVRE 596
A E + + V T K DV+AFGV + E+ + G+ G +N E + +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----------------IYD 226
Query: 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
LR + +L M C D RP+ +++ L I
Sbjct: 227 YLRHGNRLKQPEDCLDELYDLMYS----CWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 38/219 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKG---DDAAVKVMKGDVS------------SEINILKK 410
++ GSF G VY G KG D+ +V V+ +E +++K+
Sbjct: 13 ELGQGSF-------GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL-----TWKQRVQIA 465
N +++RL G T ++ E G L +L S R + +N + K+ +Q+A
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA-ESDEHEQGGYGL 524
++A+ + YL+ +VH++L N ++ + KI +FG+ R E+D + +GG GL
Sbjct: 126 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563
R +M+PE +++GV T DV++FGVV+ E+
Sbjct: 183 LPVR-------WMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 31/194 (15%)
Query: 393 AVKVMK--------GDVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSD 443
AVK++K D+ SE+ ++K I H NII L G C EG Y++ E+A G L +
Sbjct: 48 AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLRE 107
Query: 444 WLHSNRYQTSDN-----------LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSN 492
+L + R D L++K V AY VA + YL + +H++L N
Sbjct: 108 FLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARN 164
Query: 493 ILLDTNLRAKITNFGLARSAES-DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKL 551
+L+ + KI +FGLAR D +++ G + +MAPE + + V T +
Sbjct: 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK-------WMAPEALFDRVYTHQS 217
Query: 552 DVFAFGVVVLELLS 565
DV++FG+++ E+ +
Sbjct: 218 DVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 29/193 (15%)
Query: 393 AVKVMKGDVS--------SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSD 443
AVK++K D + SE+ ++K I H NII L G C +G Y++ E+A G L +
Sbjct: 54 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 113
Query: 444 WLHSNR-------YQTS----DNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSN 492
+L + R Y + + L++K V AY VA + YL + +H++L N
Sbjct: 114 YLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 170
Query: 493 ILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLD 552
+L+ + KI +FGLAR D H Y + T + +MAPE + + + T + D
Sbjct: 171 VLVTEDNVMKIADFGLAR----DIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 553 VFAFGVVVLELLS 565
V++FGV++ E+ +
Sbjct: 225 VWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 52/282 (18%)
Query: 380 GSVYRGSFKGDDA-------AVKVMKGDVSS--------EINILKKINHSNIIRLSGFCV 424
G VY G ++G D AVK + S E I+ K NH NI+RL G
Sbjct: 20 GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79
Query: 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSD--NLTWKQRVQIAYDVANALNYLHKYTNPP 482
+++ E G L +L NR + +LT K + A DVA YL +
Sbjct: 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--- 136
Query: 483 YVHKNLKTSNILLDT---NLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHVVGTYGYMA 538
++H+++ N LL AKI +FG+AR + + +GG + + +M
Sbjct: 137 FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-------WMP 189
Query: 539 PEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREK 597
PE +G+ T K DV++FGV++ E+ S G G N E V+E
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----------VME------- 232
Query: 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
F+ R + P + ++ +C H RP+ + +
Sbjct: 233 ---FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 58/188 (30%), Positives = 96/188 (51%), Gaps = 22/188 (11%)
Query: 390 DDAAVKVMKGDVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSN 448
DDA K + D+ SE+ ++K I H NII L G C +G Y++ E+A G L ++L +
Sbjct: 57 DDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 115
Query: 449 R-----YQ------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
R Y + +T+K V Y VA + YL + +H++L N+L+
Sbjct: 116 RPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTE 172
Query: 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFG 557
N KI +FGLAR + ++ + +L +MAPE + + V T + DV++FG
Sbjct: 173 NNVMKIADFGLARDVNNIDYYKKTTNGRL------PVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 558 VVVLELLS 565
V++ E+ +
Sbjct: 227 VLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 54/188 (28%), Positives = 97/188 (51%), Gaps = 24/188 (12%)
Query: 393 AVKVMKGDVSS--------EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
AVK+++ DV+ EI I+ ++ + NIIRL G CV + ++ E+ +NG L+ +
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 445 LHS----NRYQTSDNL---TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
L + + ++N+ + + +A +A+ + YL +VH++L T N L+
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGN 164
Query: 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFG 557
+ KI +FG++R+ S ++ Y +Q V +MA E I G T DV+AFG
Sbjct: 165 HYTIKIADFGMSRNLYSGDY----YRIQ--GRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 558 VVVLELLS 565
V + E+ +
Sbjct: 219 VTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 42/232 (18%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGS----FKGD---DAAVKVMKGDVS----- 402
E +TL + ++ GSF G VY G+ KG+ AVK + S
Sbjct: 6 EKITLLR----ELGQGSF-------GMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 54
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL--- 456
+E +++K +++RL G T +V E +G L +L S R + +N
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 457 --TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA-E 513
T ++ +Q+A ++A+ + YL+ +VH++L N ++ + KI +FG+ R E
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+D + +GG GL R +MAPE +++GV T D+++FGVV+ E+ S
Sbjct: 172 TDYYRKGGKGLLPVR-------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 25/184 (13%)
Query: 393 AVKVMKGD--------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSD 443
AVK++K + SE+ I+ + NH NI+ L G C G ++ E+ G L +
Sbjct: 69 AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128
Query: 444 WLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503
+L R LT + + +Y VA + +L + +H++L N+LL KI
Sbjct: 129 FLRRKRESF---LTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182
Query: 504 TNFGLARSAESDEH--EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVL 561
+FGLAR +D + +G L + +MAPE I N V T + DV+++G+++
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVK--------WMAPESIFNCVYTFESDVWSYGILLW 234
Query: 562 ELLS 565
E+ S
Sbjct: 235 EIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 35/218 (16%)
Query: 361 KFQDLK----IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS-----EINILKKI 411
++LK I G F G V G ++G+ AVK +K D ++ E +++ ++
Sbjct: 4 NMKELKLLQTIGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQL 56
Query: 412 NHSNIIRLSGFCVHE-GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
HSN+++L G V E G Y+V E+ G+L D+L R + L ++ + DV
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCE 113
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
A+ YL +VH++L N+L+ + AK+++FGL + A S + + G ++ T
Sbjct: 114 AMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWT--- 166
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GR 567
APE + + K DV++FG+++ E+ S GR
Sbjct: 167 -------APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 49/287 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDD-AAVKVMKG------DVSSEINILKKINHSNIIR 418
+I +G F G V+ G + A+K ++ D E ++ K++H +++
Sbjct: 11 EIGSGQF-------GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 419 LSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY 478
L G C LV+EF ++G LSD+L + R + + + + DV + YL
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESS 119
Query: 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMA 538
+H++L N L+ N K+++FG+ R D++ T+ V + +
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS----TGTKFPV---KWSS 169
Query: 539 PEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREK 597
PE + K DV++FGV++ E+ S G+ N E V+E N +
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----------VVETINAGFR 219
Query: 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644
L P L ++ S+ +L ++C RPS S + L+
Sbjct: 220 L---YKPRLASQ-------SVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 45/250 (18%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYL-VYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
+E L + +HSNI+RL G + GNT + V E+ NGAL +L + Q L Q
Sbjct: 55 AEALTLGQFDHSNIVRLEG-VITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQL 109
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ-- 519
+ + +A+ + YL + YVHK L +L++++L KI+ F R + D+ E
Sbjct: 110 MGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIY 163
Query: 520 ---GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576
G L + APE I+ + DV++FG+V+ E++S E D +
Sbjct: 164 TTMSGKSPVL---------WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214
Query: 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636
+ + + +E+ GF P+ RN L + QL +C + RP
Sbjct: 215 Q------DVIKAVED--------GFRLPAPRNCPNL-----LHQLMLDCWQKERGERPRF 255
Query: 637 SEVFVTLSKI 646
S++ LSK+
Sbjct: 256 SQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 37/218 (16%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS--------EINILK 409
F L I GSF G VY+ K A+KV+ + + EI L
Sbjct: 2 LFTLLECIGKGSF-------GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLS 54
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
+ I + G + +++ E+ G+ D L + L I +V
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVL 108
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
L YLH+ +H+++K +NILL K+ +FG++ S R+
Sbjct: 109 LGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTS---------TMSKRN 156
Query: 530 V-VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
VGT +MAPE I+ K D+++ G+ +EL G
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 59/188 (31%), Positives = 96/188 (51%), Gaps = 22/188 (11%)
Query: 390 DDAAVKVMKGDVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSN 448
DDA K + D+ SE+ ++K I H NII L G C +G Y++ E+A G L ++L +
Sbjct: 54 DDATDKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRAR 112
Query: 449 RYQTSD-----------NLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
R D LT+K V AY VA + YL + +H++L N+L+
Sbjct: 113 RPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTE 169
Query: 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFG 557
+ KI +FGLAR + ++ + +L +MAPE + + V T + DV++FG
Sbjct: 170 DNVMKIADFGLARDVHNIDYYKKTTNGRL------PVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 558 VVVLELLS 565
V++ E+ +
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 54/192 (28%), Positives = 96/192 (50%), Gaps = 22/192 (11%)
Query: 384 RGSFKGDDAAVKVMK--------GDVSSEINILKKINHSNIIRLSGFCVHEGNT--YLVY 433
G G+ AVK +K D+ EI IL+ + H NI++ G C +G L+
Sbjct: 28 EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87
Query: 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493
EF +G+L ++L N+ + + KQ+++ A + ++YL YVH++L N+
Sbjct: 88 EFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNV 140
Query: 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDV 553
L+++ + KI +FGL ++ E+D+ Y ++ + APE + DV
Sbjct: 141 LVESEHQVKIGDFGLTKAIETDK---EYYTVKDDLD--SPVFWYAPECLIQSKFYIASDV 195
Query: 554 FAFGVVVLELLS 565
++FGV + ELL+
Sbjct: 196 WSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 53/228 (23%)
Query: 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---GD----VSSEINI 407
Y+ +I +G++ G VY+ G+ A+KV+K GD + EI++
Sbjct: 2 QEDYELIQ-RIGSGTY-------GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISM 53
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY- 466
LK+ H NI+ G + ++V E+ G+L D T L+ +QIAY
Sbjct: 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ----VTRGPLS---ELQIAYV 106
Query: 467 --DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
+ L YLH +H+++K +NILL + K+ +FG++
Sbjct: 107 CRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSA-------------- 149
Query: 525 QLTRHV------VGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLEL 563
QLT + +GT +MAPE G K D++A G+ +EL
Sbjct: 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 49/288 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKV----------MKGDVSSEINILKKINHSN 415
+I G+F G V+ G + D+ V V +K E ILK+ +H N
Sbjct: 2 RIGRGNF-------GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 54
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
I+RL G C + Y+V E G +L + L K+ +Q+ + A + YL
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYL 110
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
+ +H++L N L+ KI++FG++R E + G Q+
Sbjct: 111 E---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI------PVK 161
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595
+ APE + G + + DV++FG+++ E S + YA++S
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWEAFS-----------LGAVPYANLS--------N 202
Query: 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
++ R I+ +R P ++ +L + C +D RPS S V L
Sbjct: 203 QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 28/174 (16%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT-----YLVYEFADNGALSD---WLHSNRYQTSDN 455
EI +L+ + H NII L Y+V E + +D + S + T D
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDD- 103
Query: 456 LTWKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
+Q Y + L YLH N +H++LK SNIL+++N KI +FGLAR +
Sbjct: 104 -----HIQYFLYQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGR 567
DE E+G LT +VV T Y APE + + T +D+++ G + ELL+ +
Sbjct: 156 DEDEKG----FLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 28/199 (14%)
Query: 380 GSVYRGSF---KGD--DAAVKVMKGDVS--------SEINILKKINHSNIIRLSGFCVHE 426
G VY+G + + + AVK K S E I+++ +H +I++L G E
Sbjct: 20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-E 78
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
++V E A G L +L N+Y L + +Y ++ AL YL +VH+
Sbjct: 79 NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLES-KR--FVHR 131
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV 546
++ N+L+ + K+ +FGL+R E + + Y + + +MAPE I
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESY----YKASKGKLPI---KWMAPESINFRR 184
Query: 547 ITPKLDVFAFGVVVLELLS 565
T DV+ FGV + E+L
Sbjct: 185 FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 19/169 (11%)
Query: 399 GDVSSEINILKK-INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHS---NRYQTSD 454
GD+ SE+ I+K+ + H NI+R + Y+V + + L + +S + + ++
Sbjct: 53 GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE 112
Query: 455 NLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
W VQ+ AL YLHK VH++L +NI+L + + IT+FGLA+
Sbjct: 113 ERIWNIFVQMVL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---- 162
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563
Q +LT VVGT Y PE ++N K DV+AFG ++ ++
Sbjct: 163 ----QKQPESKLTS-VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 372 FSEENRIQGSVYRGSFKGDDA------AVKVMKGDVSS--------EINILKKINHSNII 417
E + +Q + + D+A AVKV++ D S E+ IL +++ NI
Sbjct: 23 LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82
Query: 418 RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN------LTWKQRVQIAYDVANA 471
RL G C + ++ E+ +NG L+ +L + +TS L++ + +A +A+
Sbjct: 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG 142
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHV 530
+ YL + +VH++L T N L+ N KI +FG++R+ SD + G R
Sbjct: 143 MRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR-- 197
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568
+MA E + G T K DV+AFGV + E+L+ RE
Sbjct: 198 -----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 43/218 (19%)
Query: 367 IATGSFSEENRIQGSVYRG--SFKGDDAAVKVMKGDVSS------------EINILKKIN 412
+ +GSF GSVY G GD AVK + EI +L K+
Sbjct: 8 LGSGSF-------GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY--DVAN 470
H NI++ G E N Y+ E G+L+ L +Y + + + V Y +
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGS-----FPEPVIRLYTRQILL 113
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
L YLH + VH+++K +NIL+DTN K+ +FG+A+ E +
Sbjct: 114 GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV----EFSF-----AKSF 161
Query: 531 VGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSGR 567
G+ +MAPE I + G D+++ G VLE+ +G+
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 51/226 (22%)
Query: 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVM------KGDVSSEINILKKI-NHSNII 417
I G++ + VY+ K G A+K+M + ++ E NIL+K NH NI
Sbjct: 14 IGEGTYGK-------VYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 418 RLSGF------CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV---QIAY-- 466
G ++ +LV E G+++D + R + +R+ IAY
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-------GKRLKEEWIAYIL 119
Query: 467 -DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
+ L YLH+ +H+++K NILL N K+ +FG++ +S + +
Sbjct: 120 RETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--- 173
Query: 526 LTRHVVGTYGYMAPEYI-----ENGVITPKLDVFAFGVVVLELLSG 566
+GT +MAPE I + + DV++ G+ +EL G
Sbjct: 174 -----IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 23/195 (11%)
Query: 380 GSVYRGSFKGDDA-AVKVMKGDVSSEINI--------LKKINHSNIIRLSGFCVHEGNTY 430
G V++G+ K AVK K D+ E+ I LK+ +H NI++L G C Y
Sbjct: 9 GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIY 68
Query: 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
+V E G +L + D L KQ V+ A D A + YL +H++L
Sbjct: 69 IVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAA 121
Query: 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK 550
N L+ N KI++FG++R + + G Y + + + APE + G + +
Sbjct: 122 RNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSE 174
Query: 551 LDVFAFGVVVLELLS 565
DV+++G+++ E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 42/246 (17%)
Query: 400 DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
D +EI IL + H NII + + + E+A+ G L D + + L ++
Sbjct: 45 DALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV----RQKGQL-FE 99
Query: 460 QRVQIAY--DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
+ + + Y + +A++Y+HK +H+++KT NI L K+ +FG+++ S+
Sbjct: 100 EEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-- 154
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577
+ VVGT YM+PE + K D++A G V+ ELL+
Sbjct: 155 ------YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT------------ 196
Query: 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFS--MAQLAKNCTAHDLNARPS 635
+ R + +N + + N P+ +S + L + D RP+
Sbjct: 197 -------LKRTFDATNPLNLVVKIVQ---GNYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
Query: 636 ISEVFV 641
EV
Sbjct: 247 ADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD----------VSSEINILKKINHS 414
+ TGSF G V KG A+K++ V +E IL+ I H
Sbjct: 9 LGTGSF-------GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
++ L G + N YLV E+ G L L + A V AL Y
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEY 116
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
LH + V+++LK N+LLD++ KIT+FG A+ +G T + GT
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK------RVKGR-----TYTLCGTP 162
Query: 535 GYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
Y+APE I + +D +A G+++ E+L+G
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 404 EINILKKINHSNIIRLSGFCV--HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
E+ I K I++ G + + + E+ + G+L D ++ + + K
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL 107
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
+IA V L+YLH +H+++K SNILL + K+ +FG++ G
Sbjct: 108 GKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS----------GE 154
Query: 522 YGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
L GT YMAPE I+ + DV++ G+ +LE+ R
Sbjct: 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 73/286 (25%), Positives = 114/286 (39%), Gaps = 56/286 (19%)
Query: 309 SKKNPTPVLTPGRVPPPKTPLDCADYSL---FPQASNSLSHPQGFRSAVESLTLYKFQDL 365
S T P R P PL D SL P S S S+
Sbjct: 14 STARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSA------- 66
Query: 366 KIATGSFSEENRIQ-------GSVY----RGSFKGDDAAVKVMKGD--------VSSEIN 406
A S SE R+ G+VY R + G A+KV+ G+ + EI
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPT--GRLYALKVIYGNHEDTVRRQICREIE 124
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
IL+ +NH N+++ H G ++ EF D G+L ++ +D +A
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD---------VAR 175
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
+ + + YLH+ VH+++K SN+L+++ KI +FG++R +
Sbjct: 176 QILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--------MDP 224
Query: 527 TRHVVGTYGYMAPEYIENGVITPKL-----DVFAFGVVVLELLSGR 567
VGT YM+PE I + D+++ GV +LE GR
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 51/268 (19%)
Query: 389 GDDAAVKVMKGDVSS--------EINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADN 438
G+ AVK +K + EINILK + H NI++ G C +G L+ E+
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498
G+L D+L + L Q + A + + YLH + Y+H++L N+LLD +
Sbjct: 93 GSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDND 143
Query: 499 LRAKITNFGLARSAESDE-----HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDV 553
KI +FGLA++ E G + A E ++ + DV
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGD----------SPVFWYAVECLKENKFSYASDV 193
Query: 554 FAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE------KLRGFIDPSLR 607
++FGV + ELL+ +C+++ + + E ++ +L ++ +R
Sbjct: 194 WSFGVTLYELLT---------HCDSKQ--SPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 608 NEYPLDLAFSMAQLAKNCTAHDLNARPS 635
P + + L KNC + RP+
Sbjct: 243 LPCPKNCPQEVYILMKNCWETEAKFRPT 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 49/180 (27%), Positives = 79/180 (43%), Gaps = 35/180 (19%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSN--RYQTSDNLTWKQR 461
EI +L+++ H NII L H+ N LV+EF + L + +D ++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYML- 109
Query: 462 VQIAYDVANALNYLHKYTNPPYV-HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
L YLH ++ H++LK +N+L+ ++ K+ +FGLARS S
Sbjct: 110 -MTL----RGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP----- 155
Query: 521 GYGLQLTRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
++T VV T Y APE Y +D+++ G + ELL + GD
Sbjct: 156 --NRKMTHQVV-TRWYRAPELLFGARHY------GVGVDMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 55/163 (33%), Positives = 86/163 (52%), Gaps = 16/163 (9%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E +IL ++NH I++L EG YL+ +F G L L T +++ +
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV----KFY 103
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
+A ++A AL++LH ++++LK NILLD K+T+FGL S ES +HE+ Y
Sbjct: 104 LA-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL--SKESIDHEKKAYS 157
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
GT YMAPE + T D ++FGV++ E+L+G
Sbjct: 158 F------CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 393 AVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL 445
AVK +K D E +L + H +I++ G C +V+E+ +G L+ +L
Sbjct: 39 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 98
Query: 446 HSN-----------RYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494
++ Q L Q + IA +A+ + YL + +VH++L T N L
Sbjct: 99 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCL 155
Query: 495 LDTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDV 553
+ NL KI +FG++R +D + GG+ + R +M PE I T + DV
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDV 208
Query: 554 FAFGVVVLELLS 565
++FGV++ E+ +
Sbjct: 209 WSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 70/294 (23%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA--AVKVM---------KGDVSSEINILKKINHS 414
K+ GS+ GSVY+ D+ A+K + + D +EI IL +NH
Sbjct: 7 KLGKGSY-------GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 415 NIIRLSGFCVHE----GNT-YLVYEFADNGALSDWLHSNRYQTSDNLT----WKQRVQIA 465
NII E GN +V E+A G LS + S R + + W+ +Q+
Sbjct: 60 NII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLL 113
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
L LH+ +H++LK++NILL N KI + G+++ +
Sbjct: 114 ----RGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK----------N 156
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
+ + +GT YMAPE + + K D+++ G ++ E+ +
Sbjct: 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA------------- 203
Query: 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
R +++ + + RG P + Y DL ++ RP+ ++
Sbjct: 204 -RSMQDLRYKVQ-RGKYPP-IPPIYSQDL----QNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD----------VSSEINILKKINHS 414
+ G F G V K + A+K +K + SE IL++ NH
Sbjct: 1 LGVGGF-------GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHP 53
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHS----NRYQTSDNLTWKQRVQIAYDVAN 470
I++L + Y++ E+ G L L + Y R IA V
Sbjct: 54 FIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA--------RFYIAC-VVL 104
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
A YLH N ++++LK N+LLD+N K+ +FG A+ Q T
Sbjct: 105 AFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---------KSGQKTWTF 152
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
GT Y+APE I N +D ++ G+++ ELL+GR D
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
EI ++ ++NH +IIR+ G + + L E+ G++S L +K+ V
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-------KYGAFKEAVI 105
Query: 464 IAY--DVANALNYLHKYTNPPYVHKNLKTSNILLD-TNLRAKITNFGLARSAESDEHEQG 520
I Y + L+YLH+ +H+++K +N+L+D T R +I +FG A + G
Sbjct: 106 INYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
+ QL +GT +MAPE + DV++ G V++E+ + + +++
Sbjct: 163 EFQGQL----LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218
Query: 581 LYASISRVLEESNVREKLRGFIDPSLRN 608
L I+ ++ E L P LR+
Sbjct: 219 LIFKIASATTAPSIPEHLS----PGLRD 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 34/198 (17%)
Query: 393 AVKVMKGDVSS--------EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
AVK++K + S+ E ++ + +H NI++L G C L++E+ G L+++
Sbjct: 39 AVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 98
Query: 445 LHSN--RYQTSDN---------------LTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487
L R Q S + L+ +++ IA VA + YL + +VH++
Sbjct: 99 LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRD 155
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI 547
L T N L+ N+ KI +FGL+R+ S ++ + + +M PE I
Sbjct: 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR------WMPPESIFYNRY 209
Query: 548 TPKLDVFAFGVVVLELLS 565
T + DV+A+GVV+ E+ S
Sbjct: 210 TTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 46/268 (17%)
Query: 390 DDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR 449
DD VK + EI +LK++ H N++ L + YLV+EF D+ L D
Sbjct: 39 DDKMVKKI---AMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-- 93
Query: 450 YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509
+ L + + + + + + H + +H+++K NIL+ + K+ +FG A
Sbjct: 94 ---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 147
Query: 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK----LDVFAFGVVVLELLS 565
R+ + Y V T Y APE + V K +D++A G +V E+L+
Sbjct: 148 RTLAAPGEVYTDY--------VATRWYRAPELL---VGDTKYGRAVDIWAVGCLVTEMLT 196
Query: 566 GREAVTGDQNCEAELLYASISRVLEESNVREKLR----------GFIDPSLRNEYPLDLA 615
G GD + + LY I + L N+ + + G P ++ PL+
Sbjct: 197 GEPLFPGDS--DIDQLY-HIIKCL--GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR 251
Query: 616 F-----SMAQLAKNCTAHDLNARPSISE 638
F + LAK C D + RPS S+
Sbjct: 252 FPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 65/229 (28%)
Query: 366 KIATGSFSEENRIQGSVYRGS--FKGDDAAVKVMKGDVSS--------EINILKKIN-HS 414
++ G+F GSVY G+ A+K MK S E+ L+K+N H
Sbjct: 6 QLGDGTF-------GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ----------I 464
NI++L Y V+E+ + N YQ K R I
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEG---------NLYQL-----MKDRKGKPFSESVIRSI 104
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES-----DEHEQ 519
Y + L ++HK+ + H++LK N+L+ KI +FGLAR S D
Sbjct: 105 IYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD---- 157
Query: 520 GGYGLQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSGR 567
Y V T Y APE + + + +D++A G ++ EL + R
Sbjct: 158 --Y--------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
+E+ I++ +H N++ + + ++V EF + GAL+D + R + +Q
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIA 121
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+ V AL+YLH N +H+++K+ +ILL ++ R K+++FG + ++
Sbjct: 122 TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--- 175
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA--EL 580
+ +VGT +MAPE I ++D+++ G++V+E++ G + +A +
Sbjct: 176 -----KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
Query: 581 LYASISRVLEESNVREKLRGFIDPSLRNE 609
RV + V LRGF+D L E
Sbjct: 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-14
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 389 GDDAAVKVMKGDVSS----------EINILKKINHSNIIRL--SGFCVHEGNTYLVYEFA 436
G + A+K+++ D E + ++ H NI+ L SG G + V+E+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL- 495
L + L L + ++ V +AL H N VH++LK NI++
Sbjct: 62 PGRTLREVL-----AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113
Query: 496 --DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDV 553
AK+ +FG+ + + L T V+GT Y APE + +TP D+
Sbjct: 114 QTGVRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 554 FAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588
+A+G++ LE L+G+ V G AE+LY +S V
Sbjct: 173 YAWGLIFLECLTGQRVVQGASV--AEILYQQLSPV 205
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 71/260 (27%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 393 AVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ- 451
A K + D EI I+ ++ NIIRL C+ ++ E+ +NG L+ +L + Q
Sbjct: 58 ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 452 -----TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506
+++ + +A +A+ + YL +VH++L T N L+ N KI +F
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADF 174
Query: 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
G++R+ S ++ Y +Q R V+ +M+ E I G T DV+AFGV + E+L+
Sbjct: 175 GMSRNLYSGDY----YRIQ-GRAVLPIR-WMSWESILLGKFTTASDVWAFGVTLWEILT- 227
Query: 567 REAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAF---SMAQLAK 623
C+ E Y+ +S + V E F R Y A S+ +L
Sbjct: 228 --------LCK-EQPYSQLS----DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLML 274
Query: 624 NCTAHDLNARPSISEVFVTL 643
+C + RPS E+ TL
Sbjct: 275 SCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 26/189 (13%)
Query: 393 AVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL 445
AVK +K D E +L + H +I++ G CV +V+E+ +G L+ +L
Sbjct: 39 AVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL 98
Query: 446 HSN--------RYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
++ LT Q + IA +A + YL + +VH++L T N L+
Sbjct: 99 RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGE 155
Query: 498 NLRAKITNFGLARSAES-DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAF 556
NL KI +FG++R S D + GG+ + R +M PE I T + DV++
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSL 208
Query: 557 GVVVLELLS 565
GVV+ E+ +
Sbjct: 209 GVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 54/290 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK------------GDVSSEINILKKINH 413
KI G FSE VYR + D V + K D EI++LK++NH
Sbjct: 9 KIGRGQFSE-------VYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ---TSDNLTWKQRVQIAYDVAN 470
N+I+ + + +V E AD G LS + + Q + WK VQ+ +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL----CS 117
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
AL ++H +H+++K +N+ + K+ + GL R S +
Sbjct: 118 ALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------TAAHSL 166
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590
VGT YM+PE I K D+++ G ++ E+ + + GD+ LY S+ + +E
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY-SLCKKIE 221
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
+ + P L +++ + + QL C D RP I+ V+
Sbjct: 222 QCDY---------PPLPSDH---YSEELRQLVNMCINPDPEKRPDITYVY 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 31/195 (15%)
Query: 393 AVKVMKGDVSS--------EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
AVK+++ D + E+ IL ++ NIIRL G CV E ++ E+ +NG L+ +
Sbjct: 50 AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109
Query: 445 LHSNRYQTSDN--------------LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
L S+ + +++ + +A +A+ + YL +VH++L T
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLAT 166
Query: 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK 550
N L+ NL KI +FG++R+ + ++ Y +Q R V+ +MA E I G T
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDY----YRIQ-GRAVLPIR-WMAWECILMGKFTTA 220
Query: 551 LDVFAFGVVVLELLS 565
DV+AFGV + E+L
Sbjct: 221 SDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 400 DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL-HSNRYQTSDNLTW 458
++ E+ + + NH N+++ V +LV + G+L D + S L
Sbjct: 45 ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP---RGGLDE 101
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
+ +V L YLH +H+++K NILL + KI +FG++ S
Sbjct: 102 AIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL-----A 153
Query: 519 QGGYGLQLTRH-VVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGR 567
GG + R VGT +MAPE +E K D+++FG+ +EL +G
Sbjct: 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 50/203 (24%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 404 EINILKKINHSNIIRL-SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E+ I++ H NI+ + S + V + ++V EF + GAL+D + T + +Q
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGD-ELWVVMEFLEGGALTDIV------THTRMNEEQIA 118
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+ V AL++LH +H+++K+ +ILL ++ R K+++FG +
Sbjct: 119 TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------- 168
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA-ELL 581
+ + +VGT +MAPE I ++D+++ G++V+E++ G + +A + +
Sbjct: 169 -VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227
Query: 582 YASISRVLEES-NVREKLRGFID 603
++ L+ V +LR F+D
Sbjct: 228 RDNLPPKLKNLHKVSPRLRSFLD 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 44/223 (19%)
Query: 367 IATGSFSEENRIQGSVY--RGSFKGDDAAVKVMK----------GDVSSEINILKKINHS 414
+ TG+F G V+ R A+KVM V +E +LK+++H
Sbjct: 9 VGTGTF-------GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 415 NIIRLSGFCVH--EGNTYLVYEFADNGALSDWLH-SNRYQTSDNLTWKQRVQIAYDVANA 471
IIRL F + Y++ E+ G L +L S R+ S L + A ++ A
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVCA 113
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
L YLH V+++LK NILLD K+T+FG A+ D T +
Sbjct: 114 LEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDR----------TWTLC 159
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
GT Y+APE I++ +D +A G+++ E+L G D
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 42/241 (17%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR- 461
+E +LK ++H NII + + +V E+A G L++++ D T
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLAR--SAESDEHE 518
VQI AL+++H +H++LKT NILLD + + KI +FG+++ S++S +
Sbjct: 108 VQILL----ALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578
VVGT Y++PE E K D++A G V+ EL S + A EA
Sbjct: 161 -----------VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF------EA 203
Query: 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638
L A + ++ + G P + + Y DL QL + D + RP +S+
Sbjct: 204 ANLPALVLKI---------MSGTFAP-ISDRYSPDL----RQLILSMLNLDPSKRPQLSQ 249
Query: 639 V 639
+
Sbjct: 250 I 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 31/203 (15%)
Query: 380 GSVYRGSFKGDD--AAVKVMK-------GDVSSEINILKKINHSNIIRLSGFCVHEGNTY 430
G VY+ K AA K+++ D EI+IL + H NI+ L +E +
Sbjct: 19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78
Query: 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
++ EF D GAL + + LT Q + + ALN+LH + +H++LK
Sbjct: 79 ILIEFCDGGALDSIM----LELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKA 131
Query: 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV-VGTYGYMAPEYI--ENGVI 547
NILL + K+ +FG+ SA++ Q R +GT +MAPE + E
Sbjct: 132 GNILLTLDGDVKLADFGV--SAKNKSTLQ-------KRDTFIGTPYWMAPEVVACETFKD 182
Query: 548 TP---KLDVFAFGVVVLELLSGR 567
P K D+++ G+ ++EL
Sbjct: 183 NPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 393 AVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL 445
AVK +K D E +L + H +I+R G C +V+E+ +G L+ +L
Sbjct: 39 AVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFL 98
Query: 446 HSN----------RYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL 495
S+ LT Q + IA +A+ + YL + +VH++L T N L+
Sbjct: 99 RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLV 155
Query: 496 DTNLRAKITNFGLARSAES-DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVF 554
L KI +FG++R S D + GG + R +M PE I T + D++
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDIW 208
Query: 555 AFGVVVLELLS-GREAVTGDQNCEA 578
+FGVV+ E+ + G++ N EA
Sbjct: 209 SFGVVLWEIFTYGKQPWYQLSNTEA 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 362 FQDLK-IATGSFSEENRIQGSVY--RGSFKGDDAAVKVMK----------GDVSSEINIL 408
F DL+ I GSF G+VY R + A+K M D+ E+ L
Sbjct: 17 FTDLREIGHGSF-------GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA--- 465
+++ H N I G + E +LV E+ G+ SD L ++ Q V+IA
Sbjct: 70 QQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPL-------QEVEIAAIC 121
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG---LARSAESDEHEQGGY 522
+ L YLH + +H+++K NILL K+ +FG L A S
Sbjct: 122 HGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-------- 170
Query: 523 GLQLTRHVVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLEL 563
VGT +MAPE I + G K+DV++ G+ +EL
Sbjct: 171 -------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 66/281 (23%), Positives = 123/281 (43%), Gaps = 62/281 (22%)
Query: 378 IQGSVYRGSFKGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429
++ VY+ K D A+KV+K ++ E I+ ++++ I+R+ G C E
Sbjct: 11 VKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-AL 69
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
LV E A G L+ +L + D +T V++ + V+ + YL +VH++L
Sbjct: 70 MLVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLA 122
Query: 490 TSNILLDTNLRAKITNFGLARSAESDE-----HEQGGYGLQLTRHVVGTYGYMAPEYIEN 544
N+LL AKI++FGL+++ +D+ G + L+ + APE I
Sbjct: 123 ARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----------WYAPECINF 172
Query: 545 GVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLRG--- 600
+ + DV+++G+ + E S G++ +K++G
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPY-------------------------KKMKGPEV 207
Query: 601 --FIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
FI+ R + P + M L K+C + RP+ ++V
Sbjct: 208 MSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 23/167 (13%)
Query: 404 EINILKKINHSNIIRL-SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ-R 461
E IL+++NH ++ L F E N YLV + G L RY S + + + +
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEE-NMYLVVDLLLGGDL-------RYHLSQKVKFSEEQ 101
Query: 462 VQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
V+ ++ AL YLH + +H+++K NILLD IT+F +A D
Sbjct: 102 VKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----- 153
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
LT GT GYMAPE + + +D ++ GV E L G+
Sbjct: 154 ----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 25/200 (12%)
Query: 380 GSVYRGSFKGDDA-----AVKVMK-----GDVSS---EINILKKINHSNIIRLSGFCV-H 425
G VY G+ D AVK + +V E I+K +H N++ L G C+
Sbjct: 9 GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS 68
Query: 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVH 485
EG+ +V + +G L +++ S + N T K + VA + YL + +VH
Sbjct: 69 EGSPLVVLPYMKHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYL---ASKKFVH 121
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
++L N +LD + K+ +FGLAR D +++ Y + +MA E ++
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 546 VITPKLDVFAFGVVVLELLS 565
T K DV++FGV++ EL++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 63/241 (26%), Positives = 95/241 (39%), Gaps = 51/241 (21%)
Query: 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS-----------E 404
L Y+ K+ G+F G VY+ V + K + + E
Sbjct: 6 KLRDYEI-LGKLGEGTF-------GEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE 57
Query: 405 INILKKINHSNIIRLSGFCVHE--------GNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
I ILKK+ H N++ L V G+ Y+V + D+ LS L + L
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLLENPSV----KL 112
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
T Q + +NYLH+ +H+++K +NIL+D KI +FGLAR +
Sbjct: 113 TESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 517 HEQGGYGLQLTRH---VVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSG 566
G G TR +V T Y PE Y T +D++ G V E+ +
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY------TTAVDIWGIGCVFAEMFTR 223
Query: 567 R 567
R
Sbjct: 224 R 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 56/171 (32%), Positives = 86/171 (50%), Gaps = 23/171 (13%)
Query: 404 EINILKKINHSNII------RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
EI IL++ H NII R F + Y+V E + +D L+ + + +L+
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFN-DVYIVQELME----TD-LY--KLIKTQHLS 104
Query: 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
Y + L Y+H +H++LK SN+LL+TN KI +FGLAR A+ EH
Sbjct: 105 NDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP-EH 160
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGR 567
+ G LT + V T Y APE + N T +D+++ G ++ E+LS R
Sbjct: 161 DHTG---FLTEY-VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 56/237 (23%), Positives = 108/237 (45%), Gaps = 26/237 (10%)
Query: 382 VYRGSFKGDDAAVKVM-------KGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434
+ R G AVK+M + + +E+ I++ H N++ + + +++ E
Sbjct: 39 IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98
Query: 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494
F GAL+D + R L +Q + V AL YLH + +H+++K+ +IL
Sbjct: 99 FLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSIL 149
Query: 495 LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVF 554
L + R K+++FG D ++ + +VGT +MAPE I ++D++
Sbjct: 150 LTLDGRVKLSDFGFCAQISKDVPKR--------KSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 555 AFGVVVLELLSGREAVTGDQNCEA--ELLYASISRVLEESNVREKLRGFIDPSLRNE 609
+ G++V+E++ G D +A L + ++ + LR F++ L E
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 36/225 (16%)
Query: 380 GSVYRGSF--KGDD----AAVKVMK--------GDVSSEINILKKINHSNIIRLSGFCVH 425
G +Y+G G D A+K +K G+ E +++ +++H NI+ L G
Sbjct: 19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78
Query: 426 EGNTYLVYEFADNGALSDWL-----HSNRYQTSD-------NLTWKQRVQIAYDVANALN 473
E +++E+ + G L ++L HS+ +SD +L + IA +A +
Sbjct: 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
YL + +VHK+L NIL+ L KI++ GL+R S ++ Y +Q +
Sbjct: 139 YLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY----YRVQ--PKSLLP 189
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577
+M PE I G + D+++FGVV+ E+ S G + G N E
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 59/237 (24%), Positives = 108/237 (45%), Gaps = 40/237 (16%)
Query: 345 SHPQGFRSAVESLT------LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK 398
SH Q FR+A++ + Y +KI GS G V + K V V K
Sbjct: 1 SHEQ-FRAALQMVVDPGDPRTYLDNFIKIGEGS-------TGIVCIATVKSSGKLVAVKK 52
Query: 399 GDVS---------SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR 449
D+ +E+ I++ H N++ + + ++V EF + GAL+D + R
Sbjct: 53 MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR 112
Query: 450 YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509
+ +Q + V AL+ LH +H+++K+ +ILL + R K+++FG
Sbjct: 113 ------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 163
Query: 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ + + +VGT +MAPE I P++D+++ G++V+E++ G
Sbjct: 164 AQVSKE--------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV---SSEINILKKINHSNIIRLSG 421
+ GSF G V KG D AVKV+K DV ++ + ++ L+G
Sbjct: 3 LGKGSF-------GKVLLAELKGTDELYAVKVLKKDVILQDDDVECT--MTEKRVLALAG 53
Query: 422 ---FCVH-------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
F + + V E+ + G L H Q S + A ++
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFH---IQRSGRFDEPRARFYAAEIVLG 108
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
L +LH+ ++++LK N+LLD+ KI +FG+ + E G T
Sbjct: 109 LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK-------EGILGG-VTTSTFC 157
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
GT Y+APE + P +D +A GV++ E+L+G+ GD
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 31/206 (15%)
Query: 380 GSVYRGSF------KGDDAAVKVMKGDVSSEINI---------LKKINHSNIIRLSGFCV 424
G ++ G K ++ VK +K D +SEI + L ++H NI+ + C+
Sbjct: 20 GRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78
Query: 425 HEGNTYLV-YEFADNGALSDWLHSNRYQTSDN---LTWKQRVQIAYDVANALNYLHKYTN 480
+G V Y + + G L +L R ++N L+ +Q V +A +A ++YLHK
Sbjct: 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG- 137
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHVVGTYGYMAP 539
+HK++ N ++D L+ KIT+ L+R D H G R V +MA
Sbjct: 138 --VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD---NENRPV----KWMAL 188
Query: 540 EYIENGVITPKLDVFAFGVVVLELLS 565
E + N + DV++FGV++ EL++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 61/243 (25%), Positives = 107/243 (44%), Gaps = 46/243 (18%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR---YQTSDNLTWKQ 460
E+ +L + H NI++ GN Y+V ++ + G L +++ R + L W
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW-- 106
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
VQI AL ++H + +H+++K+ NI L + K+ +FG+AR S
Sbjct: 107 FVQICL----ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
++L R +GT Y++PE EN K D++A G V+ E+ + + A
Sbjct: 155 ---VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA----------- 200
Query: 581 LYASISRVLEESNVREKLRGFID---PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
E N++ + I P + + Y DL ++QL K D RPS++
Sbjct: 201 --------FEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR-NPRD---RPSVN 248
Query: 638 EVF 640
+
Sbjct: 249 SIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 43/223 (19%)
Query: 367 IATGSFSEENRIQGSVYRG--SFKGDDAAVKVMKGDVSS----------------EINIL 408
I +GSF GSVY G + G+ AVK ++ S EI +L
Sbjct: 8 IGSGSF-------GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
K++ H NI++ G + + + E+ G+++ L N Y + + V+ +
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVR---QI 115
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG----L 524
LNYLH N +H+++K +NIL+D KI++FG+++ E++ G L
Sbjct: 116 LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
Q G+ +MAPE ++ T K D+++ G +V+E+L+G+
Sbjct: 173 Q------GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 69/290 (23%), Positives = 126/290 (43%), Gaps = 51/290 (17%)
Query: 380 GSVYRGSFKGDD-----AAVKVMKGDVSSEINI---------LKKINHSNIIRLSGFCVH 425
GSV K +D AVK++K D+ S +I +K+ +H N+I+L G +
Sbjct: 13 GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLR 72
Query: 426 EGNT------YLVYEFADNGALSDWLHSNRY-QTSDNLTWKQRVQIAYDVANALNYLHKY 478
++ F +G L +L +R + L + V+ D+A+ + YL
Sbjct: 73 SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL--- 129
Query: 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMA 538
++ ++H++L N +L+ N+ + +FGL++ S ++ + G +L ++A
Sbjct: 130 SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL------PVKWLA 183
Query: 539 PEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREK 597
E + + V T DV+AFGV + E+++ G+ G +N E I L + N
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIKGN---- 232
Query: 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647
R + P D + +L C + + RPS + L IW
Sbjct: 233 ---------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 52/289 (17%)
Query: 380 GSVYRGSFKGDDA----AVKVMK---------GDVSSEINILKKINHSNIIRLSGFCVH- 425
GSV G DD+ AVK MK D SE +K+ +H N++RL G C+
Sbjct: 13 GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT 72
Query: 426 -EGNTY----LVYEFADNGALSDWLHSNRY-QTSDNLTWKQRVQIAYDVANALNYLHKYT 479
E Y ++ F +G L +L +R L + V+ D+A+ + YL +
Sbjct: 73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---S 129
Query: 480 NPPYVHKNLKTSNILLDTNLRAKITNFGLARSA-ESDEHEQGGYGLQLTRHVVGTYGYMA 538
+ ++H++L N +L+ N+ + +FGL++ D + QG ++ + V ++A
Sbjct: 130 SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG----RIAKMPV---KWIA 182
Query: 539 PEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREK 597
E + + V T K DV++FGV + E+ + G+ G +N E I L + N
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGN---- 231
Query: 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
R + P D + L +C + RPS + L K
Sbjct: 232 ---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 22/183 (12%)
Query: 390 DDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYL--VYEFADNGALSDWLHS 447
D+ K M + SEI LK ++H NI++ GF YL E+ G++ L +
Sbjct: 44 HDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRT 101
Query: 448 -NRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506
R++ L Q+ +A YLH + +H++LK N+L+D + KI++F
Sbjct: 102 YGRFEEQ--LVRFFTEQVLEGLA----YLH---SKGILHRDLKADNLLVDADGICKISDF 152
Query: 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELL 564
G+++ Y + G+ +MAPE I + + K+D+++ G VVLE+
Sbjct: 153 GISK------KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206
Query: 565 SGR 567
+GR
Sbjct: 207 AGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 40/234 (17%)
Query: 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK------------GDVSSE 404
L +K + KI G FS VY+ D V + K D E
Sbjct: 1 LGNFKIEK-KIGKGQFSV-------VYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE 52
Query: 405 INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTS---DNLTWKQR 461
I++LK+++H N+I+ + +V E AD G LS + + Q + WK
Sbjct: 53 IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
VQ+ +AL ++H +H+++K +N+ + K+ + GL R S
Sbjct: 113 VQL----CSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--A 163
Query: 522 YGLQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
+ L VGT YM+PE I ENG K D+++ G ++ E+ + + GD+
Sbjct: 164 HSL------VGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 361 KFQDLKI-ATGSFSEENRIQGSVYRGSFKGDD------AAVKVMKGDVSSEIN------- 406
+F+ +K+ +G+F G+VY+G + + A+K ++ S + N
Sbjct: 8 EFKKIKVLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60
Query: 407 -ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
++ +++ ++ RL G C+ L+ + G L D++ ++ DN+ + +
Sbjct: 61 YVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWC 115
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
+A +NYL + VH++L N+L+ T KIT+FGLA+ +DE E G +
Sbjct: 116 VQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ +MA E I + + T + DV+++GV V EL++
Sbjct: 173 V------PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 40/172 (23%), Positives = 81/172 (47%), Gaps = 26/172 (15%)
Query: 400 DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
D E ++ K++H +++L G C + Y+V EF +NG L ++L + + S ++
Sbjct: 45 DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-- 102
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ + DV + YL + + ++H++L N L+ + K+++FG+ R DE+
Sbjct: 103 --LSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-- 155
Query: 520 GGYGLQLTRHVVGTYG------YMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ G + PE + K DV++FGV++ E+ +
Sbjct: 156 -----------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 28/200 (14%)
Query: 380 GSVYRGSFKGDDAAVKVM------------KGDVS--SEINILKKINHSNIIRLSGFCVH 425
G+VY+G + + VK+ K +V E I+ ++H +++RL G C+
Sbjct: 21 GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80
Query: 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVH 485
LV + +G L D++H ++ DN+ + + +A + YL + VH
Sbjct: 81 P-TIQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVH 132
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
++L N+L+ + KIT+FGLAR E DE E G ++ +MA E I
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM------PIKWMALECIHYR 186
Query: 546 VITPKLDVFAFGVVVLELLS 565
T + DV+++GV + EL++
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 76/264 (28%), Positives = 112/264 (42%), Gaps = 52/264 (19%)
Query: 404 EINILKKINHSNIIRL----------SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTS 453
EI IL+++NH NI+ L F +G YLV+E+ D+ L L S S
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-LMGLLESGLVHFS 114
Query: 454 DNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513
++ + LNY HK N ++H+++K SNILL+ + K+ +FGLAR
Sbjct: 115 ED----HIKSFMKQLLEGLNYCHK-KN--FLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 514 SDEHEQGGYGLQLTRHVVGTYGYMAPE-YIENGVITPKLDVFAFGVVVLELLSGREAVTG 572
S+E T V+ T Y PE + P +DV++ G ++ EL + +
Sbjct: 168 SEESR------PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220
Query: 573 DQNCEA-ELLYASISRVLEESNVR-----EKLRGF--IDPS------LRNEY------PL 612
+Q EL ISR+ KL F + P LR E+ L
Sbjct: 221 NQELAQLEL----ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPAL 276
Query: 613 DLAFSMAQL--AKNCTAHDLNARP 634
DL M L +K CTA + P
Sbjct: 277 DLLDHMLTLDPSKRCTAEEALNSP 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 64/261 (24%), Positives = 106/261 (40%), Gaps = 90/261 (34%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRG----SFKGDDAAVKVMKGDVSS----------E 404
Y+ + I G++ G VY+ G + A+K KGD E
Sbjct: 1 KYEIEG-CIGRGTY-------GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE 52
Query: 405 INILKKINHSNIIRLSGFCVH--EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
I +L+++ H N++ L + + + YL++++A++ D ++ +RV
Sbjct: 53 IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQ-----AKRV 103
Query: 463 QIA--------YDVANALNYLHKYTNPPYV-HKNLKTSNILL----DTNLRAKITNFGLA 509
I + + N ++YLH +N +V H++LK +NIL+ KI + GLA
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLH--SN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 510 R--------SAESDEHEQGGYGLQLTRHVVGTYGYMAPE-------YIENGVITPKLDVF 554
R A+ D VV T Y APE Y T +D++
Sbjct: 160 RLFNAPLKPLADLDP-------------VVVTIWYRAPELLLGARHY------TKAIDIW 200
Query: 555 AFGVVVLELLS------GREA 569
A G + ELL+ GREA
Sbjct: 201 AIGCIFAELLTLEPIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 55/192 (28%)
Query: 404 EINILKKI-NHSNIIRLSGFCVH--EGNT--YLVYEFADNGALSDWLHS----------- 447
EI L+++ +H NI++L V E + YLV+E+ + +D LH+
Sbjct: 56 EIMFLQELGDHPNIVKL--LNVIKAENDKDIYLVFEYME----TD-LHAVIRANILEDVH 108
Query: 448 NRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507
RY I Y + AL Y+H + +H++LK SNILL+++ R K+ +FG
Sbjct: 109 KRY-------------IMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFG 152
Query: 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVV 560
LARS E E+ LT + V T Y APE Y T +D+++ G ++
Sbjct: 153 LARSL--SELEENPENPVLTDY-VATRWYRAPEILLGSTRY------TKGVDMWSVGCIL 203
Query: 561 LELLSGREAVTG 572
E+L G+ G
Sbjct: 204 GEMLLGKPLFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 57/249 (22%), Positives = 106/249 (42%), Gaps = 24/249 (9%)
Query: 366 KIATGSFSE-----ENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLS 420
KI GSF E +NR Q V ++A ++ D+ EI +L + + + +
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEITVLSQCDSPYVTKYY 68
Query: 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
G + + +++ E+ G+ D L L Q I ++ L+YLH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEKK 122
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540
+H+++K +N+LL + K+ +FG+A + ++ + VGT +MAPE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--------VGTPFWMAPE 171
Query: 541 YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRG 600
I+ K D+++ G+ +EL G + + L + E N + L+
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 231
Query: 601 FIDPSLRNE 609
F++ L E
Sbjct: 232 FVEACLNKE 240
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 52/219 (23%)
Query: 376 NRIQ----GSVYRGSFK--GDDAAVKVMKGD-------VSS--EINILKKINHSNIIRLS 420
NRI+ G VYR K G+ A+K +K + ++S EINIL K+ H NI+ +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 421 GFCV--HEGNTYLVYEFADN---GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
V + Y+V E+ ++ + + S + + + + + +L
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMET--MKQPFLQS------EVKCLMLQLLSGVAHL 122
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
H +H++LKTSN+LL+ KI +FGLAR E G T+ VV T
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-------EYGSPLKPYTQLVV-TLW 171
Query: 536 YMAPE-------YIENGVITPKLDVFAFGVVVLELLSGR 567
Y APE Y + +D+++ G + ELL+ +
Sbjct: 172 YRAPELLLGAKEY------STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 30/172 (17%)
Query: 404 EINILKKINHSNIIRL-SGFCVHEGNT-----YLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ +LK ++H N+I L F YLV +D N L+
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----ADL---NNIVKCQKLS 116
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+Q + Y + L Y+H + +H++LK SNI ++ + KI +FGLAR +
Sbjct: 117 -DDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---D 169
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGR 567
E GY V T Y APE + N +D+++ G ++ ELL+G+
Sbjct: 170 DEMTGY--------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQT-SDNLTWKQRV 462
EI +LK + H I++ G + + E+ G++ D L + Y ++ +T K
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTR 111
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
QI V YLH VH+++K +NIL D+ K+ +FG ++ ++ G
Sbjct: 112 QILEGVE----YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG- 163
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ V GT +M+PE I K DV++ G V+E+L+
Sbjct: 164 ----MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR---YQTSDNLTWKQ 460
E+ +L K+ H NI+ G ++V E+ D G L ++ R + L+W
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW-- 106
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAESDEHEQ 519
VQI+ L ++H + +H+++K+ NI L N + AK+ +FG+AR
Sbjct: 107 FVQISL----GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---- 155
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563
++L VGT Y++PE +N K D+++ G V+ EL
Sbjct: 156 ----MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 37/224 (16%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK------------GDVSSEINILKKINH 413
KI G FSE VYR + D V + K D EI++LK++NH
Sbjct: 9 KIGRGQFSE-------VYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSD---WLHSNRYQTSDNLTWKQRVQIAYDVAN 470
N+I+ + + +V E AD G LS + + + WK VQ+ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL----CS 117
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
A+ ++H +H+++K +N+ + K+ + GL R S +
Sbjct: 118 AVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------TAAHSL 166
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
VGT YM+PE I K D+++ G ++ E+ + + GD+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 25/201 (12%)
Query: 378 IQGSVYRGSFKGDDAAVKVMKGDVS--------SEINILKKINHSNIIRLSGFCVHEGNT 429
+ G +RG K VK ++ + E+ +++NH N+++ G C+
Sbjct: 12 LLGEAHRGMSKAR-VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY 70
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
LV EF G L ++L SNR + ++A +VA+ L +LH+ ++H +L
Sbjct: 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLA 127
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN----- 544
N L +L KI ++GLA ++ Y + H V ++APE +E
Sbjct: 128 LRNCQLTADLSVKIGDYGLALEQYPED-----YYITKDCHAV-PLRWLAPELVEIRGQDL 181
Query: 545 --GVITPKLDVFAFGVVVLEL 563
T K ++++ GV + EL
Sbjct: 182 LPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 367 IATGSFSEENRIQGSVY--RGSFKGDDAAVKVM-KGDVSSE---INIL--KKINHS---- 414
I+ G+F GSVY + GD A+KV+ K D+ ++ N+ + I
Sbjct: 4 ISKGAF-------GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES 56
Query: 415 -NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
+ +L + YLV E+ + G + + + D W + Q +V +
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPED---WAK--QYIAEVVLGVE 111
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
LH+ +H+++K N+L+D K+T+FGL+R+ + VGT
Sbjct: 112 DLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------ENKKFVGT 156
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
Y+APE I D ++ G V+ E L G
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 31/199 (15%)
Query: 380 GSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430
G VY+ K G AA KV++ D EI IL NH I++L G +G +
Sbjct: 26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85
Query: 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
++ EF GA+ + + LT Q I + AL YLH + +H++LK
Sbjct: 86 IMIEFCPGGAVD----AIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKA 138
Query: 491 SNILLDTNLRAKITNFGL-ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI--ENGVI 547
N+LL + K+ +FG+ A++ ++ LQ +GT +MAPE + E
Sbjct: 139 GNVLLTLDGDIKLADFGVSAKNVKT---------LQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 548 TP---KLDVFAFGVVVLEL 563
TP K D+++ G+ ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 61/249 (24%), Positives = 109/249 (43%), Gaps = 50/249 (20%)
Query: 405 INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
+++ +++H ++++L G CV + N +V E+ G L +LH + + +L WK + +
Sbjct: 52 ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK--NNVSLHWK--LDV 106
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILL-------DTNLRAKITNFGLARSAESDEH 517
A +A+AL+YL VH N+ NIL+ K+++ G+ + S E
Sbjct: 107 AKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKL--DVFAFGVVVLELLSGREAVTGDQN 575
V ++APE I NG + + D ++FG +LE+ S N
Sbjct: 164 R------------VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS---------N 202
Query: 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
E L +++S EK R + D ++ P+ +A L C +D RPS
Sbjct: 203 GEEPL--STLSS-------SEKERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPS 250
Query: 636 ISEVFVTLS 644
+ L+
Sbjct: 251 FRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 366 KIATGSFSE-----ENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLS 420
+I GSF E +NR Q V ++A ++ D+ EI +L + + + +
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE--DIQQEITVLSQCDSPYVTKYY 68
Query: 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
G + +++ E+ G+ D L + + Q + ++ L+YLH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF------QIATMLKEILKGLDYLHSEKK 122
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540
+H+++K +N+LL K+ +FG+A + ++ + VGT +MAPE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------VGTPFWMAPE 171
Query: 541 YIENGVITPKLDVFAFGVVVLELLSG 566
I+ K D+++ G+ +EL G
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 76/279 (27%), Positives = 119/279 (42%), Gaps = 56/279 (20%)
Query: 350 FRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVY--RGSFKGDDAAVKVMK-------- 398
F+ E L F DL+ I GSF G+VY R + A+K M
Sbjct: 19 FKEDPEKL----FTDLREIGHGSF-------GAVYFARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 399 --GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
D+ E+ L++I H N I G + E +LV E+ G+ SD L ++
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---- 122
Query: 457 TWKQRVQIA---YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513
Q V+IA + L YLH + +H+++K NILL + K+ +FG A A
Sbjct: 123 ---QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
Query: 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSGREAV 570
VGT +MAPE I + G K+DV++ G+ +E L+ R+
Sbjct: 177 P------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPP 223
Query: 571 TGDQNCEAELLYASI--SRVLEESNVREKLRGFIDPSLR 607
+ N + L + + S L+ + + R F+D L+
Sbjct: 224 LFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 59/191 (30%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
EI++LK++NH NI+RL E YLV+EF D L +Y S LT
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-------LDLKKYMDSSPLTGLDPPL 100
Query: 464 IA---YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
I Y + + Y H + +H++LK N+L+D K+ +FGLAR+
Sbjct: 101 IKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF-------- 149
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENG--VITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578
G ++ H V T Y APE + TP +D+++ G + E+++ R GD E
Sbjct: 150 GVPVRTYTHEVVTLWYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRRPLFPGD--SEI 206
Query: 579 ELLYASISRVL 589
+ L+ I R L
Sbjct: 207 DQLF-RIFRTL 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 31/201 (15%)
Query: 380 GSVYRGSF--KGDDAAVKVMK--------GDVSSEINILKKINHS---NIIRLSGFCVHE 426
G+VYRG G A+K++ D+ E+ +L ++ S NI + G +
Sbjct: 15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
+++ E+A+ G++ + + + K I +V AL Y+HK +H+
Sbjct: 75 PRLWIIMEYAEGGSVRTLMKAGP------IAEKYISVIIREVLVALKYIHK---VGVIHR 125
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV 546
++K +NIL+ K+ +FG+A + ++ + VGT +MAPE I G
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--------VGTPYWMAPEVITEGK 177
Query: 547 I-TPKLDVFAFGVVVLELLSG 566
K D+++ G+ + E+ +G
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 32/202 (15%)
Query: 380 GSVYRGSFKGDD------AAVKVMKGDVSSEIN--------ILKKINHSNIIRLSGFCVH 425
G+VY+G + D A+KV++ + S + N ++ + + RL G C+
Sbjct: 21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL- 79
Query: 426 EGNTYLVYEFADNGALSDWL--HSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPY 483
LV + G L D++ + +R + D L W VQIA ++YL +
Sbjct: 80 TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIA----KGMSYLEEVR---L 130
Query: 484 VHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE 543
VH++L N+L+ + KIT+FGLAR + DE E G ++ +MA E I
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV------PIKWMALESIL 184
Query: 544 NGVITPKLDVFAFGVVVLELLS 565
+ T + DV+++GV V EL++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/170 (33%), Positives = 82/170 (48%), Gaps = 31/170 (18%)
Query: 404 EINILKKINHSNIIRLSG-FCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E+ +LK + H NII LS F + Y V E L LH R TS L KQ +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-----LGTDLH--RLLTSRPLE-KQFI 110
Query: 463 Q-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
Q Y + L Y+H + VH++LK SNIL++ N KI +FGLAR + + G
Sbjct: 111 QYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTG 164
Query: 522 YGLQLTRHVVGTYGYMAPEYI----ENGVITPKLDVFAFGVVVLELLSGR 567
Y V T Y APE + + V ++D+++ G + E+L G+
Sbjct: 165 Y--------VSTRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 46/264 (17%)
Query: 362 FQDLK-IATGSFSEENRIQGSVY--RGSFKGDDAAVKVMK----------GDVSSEINIL 408
F DL+ I GSF G+VY R + A+K M D+ E+ L
Sbjct: 17 FSDLREIGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
+K+ H N I+ G + E +LV E+ G+ SD L ++ L + + +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAVTHGA 124
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
L YLH + +H+++K NILL K+ +FG A +
Sbjct: 125 LQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------------MAPAN 169
Query: 529 HVVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
VGT +MAPE I + G K+DV++ G+ +E L+ R+ + N + L + +
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQ 228
Query: 586 --SRVLEESNVREKLRGFIDPSLR 607
S L+ + E R F+D L+
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS-----------EINILKKINHS 414
KI G++ G VY+G K V + K + S EI++LK++ H
Sbjct: 7 KIGEGTY-------GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHP 59
Query: 415 NIIRLSGFCVHEGNTYLVYEF--ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
NI+ L + E YL++EF D D L +Y D K + Y + +
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYM--DAELVKSYL---YQILQGI 114
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
+ H +H++LK N+L+D K+ +FGLAR+ G +++ H V
Sbjct: 115 LFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAF--------GIPVRVYTHEVV 163
Query: 533 TYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
T Y APE + TP +D+++ G + E+ + + GD E + L+ I R+L
Sbjct: 164 TLWYRAPEVLLGSPRYSTP-VDIWSIGTIFAEMATKKPLFHGDS--EIDQLF-RIFRIL 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 376 NRIQGSVYRGSF--KGDDAAVKVM--KGD----VSSEINILKKINH-SNIIRLSGFCVHE 426
N G VY+G G AA+KVM GD + EIN+LKK +H NI G + +
Sbjct: 16 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75
Query: 427 G------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
+LV EF G+++D + + + T L + I ++ L++LH++
Sbjct: 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---LKEEWIAYICREILRGLSHLHQHK- 131
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540
+H+++K N+LL N K+ +FG++ + + + +GT +MAPE
Sbjct: 132 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--------IGTPYWMAPE 181
Query: 541 YI---ENGVITP--KLDVFAFGVVVLELLSG 566
I EN T K D+++ G+ +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 50/169 (29%), Positives = 86/169 (50%), Gaps = 24/169 (14%)
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
+L+ ++ + G L L+ + T + RV IA ++ AL++LH+ +++++K
Sbjct: 81 HLILDYVNGGELFTHLYQREHFTESEV----RVYIA-EIVLALDHLHQLG---IIYRDIK 132
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-- 547
NILLD+ +T+FGL++ ++E E+ GT YMAPE I G
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLAEEEER-------AYSFCGTIEYMAPEVIRGGSGGH 185
Query: 548 TPKLDVFAFGVVVLELLSGRE--AVTGDQNCEAELLYASISRVLEESNV 594
+D ++ GV+ ELL+G V G+QN ++E ISR + +S
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE-----ISRRILKSKP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 15/167 (8%)
Query: 404 EINILKKINHSNIIRL-SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E +L ++ H NI+ + +G Y+V F + G D H + Q L Q V
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVV 105
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+ +A AL YLH+ +H++LKT N+ L K+ + G+AR E+
Sbjct: 106 EWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ------- 155
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569
+ ++GT YM+PE N K DV+A G V E+ + + A
Sbjct: 156 -CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 400 DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
D+ E+ L+++ H N I G + E +LV E+ G+ SD L ++
Sbjct: 67 DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPL------- 118
Query: 460 QRVQIA---YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
Q V+IA + L YLH + +H+++K NILL + K+ +FG A +
Sbjct: 119 QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
VGT +MAPE I + G K+DV++ G+ +E L+ R+ +
Sbjct: 174 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFN 222
Query: 574 QNCEAELLYASI--SRVLEESNVREKLRGFIDPSLR 607
N + L + + S L+ + + RGF+D L+
Sbjct: 223 MNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 47/177 (26%), Positives = 72/177 (40%), Gaps = 28/177 (15%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
EI L+ H +++L H LV E+ + LS+ L L Q
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEE----RPLPEAQVKS 103
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
+ + Y+H +H++LK +N+L+ + KI +FGLAR +E Y
Sbjct: 104 YMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YS 158
Query: 524 LQLTRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
H V T Y APE Y P +D++A G + ELL+G G+
Sbjct: 159 -----HQVATRWYRAPELLYGARKY------DPGVDLWAVGCIFAELLNGSPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 35/210 (16%)
Query: 366 KIATGSFSEENRIQGSVY--RGSFKGDDAAVKVMKGD-------VSSEINILKKINHSNI 416
+I +G++ G VY R G+ AA+KV+K + V EI ++K HSNI
Sbjct: 16 RIGSGTY-------GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
+ G + ++ EF G+L D Y + L+ Q ++ + L YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDI-----YHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 477 KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGY 536
+ +H+++K +NILL N K+ +FG++ + + + +GT +
Sbjct: 124 ---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--------IAKRKSFIGTPYW 172
Query: 537 MAPEYI---ENGVITPKLDVFAFGVVVLEL 563
MAPE G D++A G+ +EL
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 49/197 (24%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 380 GSVYRG--SFKGDDAAVKVM-------KGDVSSEINILKKINHSNIIR-LSGFCVHEGNT 429
G+VY G + A+K M K + +EI ++++ H NI+ L + V +
Sbjct: 33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-EL 91
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
++V E+ G+L+D + T + Q + + AL +LH +H+++K
Sbjct: 92 WVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIK 142
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITP 549
+ NILL + K+T+FG ++ ++ +VGT +MAPE + P
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRST--------MVGTPYWMAPEVVTRKAYGP 194
Query: 550 KLDVFAFGVVVLELLSG 566
K+D+++ G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 45/230 (19%)
Query: 362 FQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSSE---------INILK 409
FQ + KI G++ G VY+ K G+ A+K ++ D +E I++LK
Sbjct: 2 FQKVEKIGEGTY-------GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 54
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSN--RYQTSDNLTWKQRVQIA-- 465
++NH NI++L E YLV+EF LH + ++ + L+ I
Sbjct: 55 ELNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSY 105
Query: 466 -YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
+ + L + H + +H++LK N+L++T K+ +FGLAR+ G +
Sbjct: 106 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--------GVPV 154
Query: 525 QLTRHVVGTYGYMAPE-YIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
+ H V T Y APE + + +D+++ G + E+++ R GD
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 48/273 (17%)
Query: 389 GDDAAVKVM-------KGDVSSEINILKKINHSNIIR-LSGFCVHEGNTYLVYEFADNGA 440
G + A+K M K + +EI ++++ + NI+ L + V + ++V E+ G+
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVMEYLAGGS 102
Query: 441 LSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500
L+D + T + Q + + AL++LH + +H+++K+ NILL +
Sbjct: 103 LTDVV------TETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGS 153
Query: 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560
K+T+FG ++ ++ +VGT +MAPE + PK+D+++ G++
Sbjct: 154 VKLTDFGFCAQITPEQSKRST--------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 561 LELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQ 620
+E++ G + A L A+ P L+N P L+
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNG----------------TPELQN--PERLSAVFRD 247
Query: 621 LAKNCTAHDLNARPSISEV----FVTLSKIWSS 649
C D++ R S E+ F+ L+K SS
Sbjct: 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 34/199 (17%)
Query: 380 GSVY--RGSFKGDDAAVKVMK---GD----VSSEINILKKINHSNIIRLSGFCVHEGNTY 430
G VY R G+ AAVK++K GD + EI ++K+ H NI+ G + +
Sbjct: 23 GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82
Query: 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY---DVANALNYLHKYTNPPYVHKN 487
+ E+ G+L D Y + L+ +QIAY + L YLH +H++
Sbjct: 83 ICMEYCGGGSLQDI-----YHVTGPLS---ELQIAYVCRETLQGLAYLHSKGK---MHRD 131
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI---EN 544
+K +NILL N K+ +FG+A + ++ + +GT +MAPE +N
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--------IGTPYWMAPEVAAVEKN 183
Query: 545 GVITPKLDVFAFGVVVLEL 563
G D++A G+ +EL
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
EI +LK++ H N++ L + +LV+E+ D+ L++ L N ++L +
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLI----KK 104
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
I + A+N+ HK+ +H+++K NIL+ + K+ +FG AR G G
Sbjct: 105 IIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT-------GPG 154
Query: 524 LQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSG 566
T + V T Y APE + + P +DV+A G V ELL+G
Sbjct: 155 DDYTDY-VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 59/254 (23%), Positives = 111/254 (43%), Gaps = 41/254 (16%)
Query: 401 VSSEINILKKINHSNIIR-LSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
+ +EI ++K++ + NI+ L F V + ++V E+ G+L+D + T +
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGD-ELFVVMEYLAGGSLTDVV------TETCMDEA 115
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
Q + + AL +LH +H+++K+ N+LL + K+T+FG ++ ++
Sbjct: 116 QIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579
+VGT +MAPE + PK+D+++ G++ +E++ G + A
Sbjct: 173 ST--------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
L A+ P L+N P L+ C D+ R S E+
Sbjct: 225 YLIATNG----------------TPELQN--PEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266
Query: 640 ----FVTLSKIWSS 649
F+ L+K SS
Sbjct: 267 LQHPFLKLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 28/176 (15%)
Query: 417 IRLSGFCVH-------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDV 468
IR S F V + +L+ ++ + G L L S R + + VQI + ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQ-----EVQIYSGEI 114
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
AL +LHK +++++K NILLD+N +T+FGL++ DE E+
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA-------Y 164
Query: 529 HVVGTYGYMAPEYIENGVI--TPKLDVFAFGVVVLELLSGREAVT--GDQNCEAEL 580
GT YMAP+ + G +D ++ GV++ ELL+G T G++N +AE+
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 70/262 (26%), Positives = 115/262 (43%), Gaps = 63/262 (24%)
Query: 334 YSLFPQASN-----SLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK 388
Y LFP S+ SL P +E+ I G++ G VY+ + K
Sbjct: 2 YGLFPYNSSMLGLESLGDPTDTWEIIET----------IGKGTY-------GKVYKVTNK 44
Query: 389 --GDDAAVKV------MKGDVSSEINILKKI-NHSNIIRLSGF------CVHEGNTYLVY 433
G AAVK+ + ++ +E NIL+ + NH N+++ G V G +LV
Sbjct: 45 KDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG-GQLWLVL 103
Query: 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQ---IAYDVANALNYLHKYTNPPYVHKNLKT 490
E + G++++ + L QR+ I+Y + AL L N +H+++K
Sbjct: 104 ELCNGGSVTELVKGL-------LICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG 156
Query: 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV-VGTYGYMAPEYIE-----N 544
+NILL T K+ +FG++ S +L R+ VGT +MAPE I +
Sbjct: 157 NNILLTTEGGVKLVDFGVSAQLTST---------RLRRNTSVGTPFWMAPEVIACEQQYD 207
Query: 545 GVITPKLDVFAFGVVVLELLSG 566
+ DV++ G+ +EL G
Sbjct: 208 YSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 376 NRIQGSVYRGSF--KGDDAAVKVM------KGDVSSEINILKKINH-SNIIRLSGFCV-- 424
N G VY+G G AA+KVM + ++ EIN+LKK +H NI G +
Sbjct: 26 NGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85
Query: 425 ----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
H+ +LV EF G+++D + + + + L I ++ L +LH +
Sbjct: 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK- 141
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540
+H+++K N+LL N K+ +FG+ SA+ D G + T +GT +MAPE
Sbjct: 142 --VIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDR----TVGRRNT--FIGTPYWMAPE 191
Query: 541 YI---ENGVIT--PKLDVFAFGVVVLELLSG 566
I EN T + D+++ G+ +E+ G
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 37/196 (18%)
Query: 398 KGDVSSEINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDN 455
K + E+N+++++ H NI+R +++ N Y++ EF D G LS + Y+
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC-YKMFGK 114
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPP----YVHKNLKTSNILLDTNLR----------- 500
+ V I + +AL Y H + P +H++LK NI L T +R
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 501 ------AKITNFGLARSAESDEHEQGGYGLQLTRH-VVGTYGYMAPEYI--ENGVITPKL 551
AKI +FGL+++ G++ H VGT Y +PE + E K
Sbjct: 175 LNGRPIAKIGDFGLSKNI----------GIESMAHSCVGTPYYWSPELLLHETKSYDDKS 224
Query: 552 DVFAFGVVVLELLSGR 567
D++A G ++ EL SG+
Sbjct: 225 DMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 380 GSVYRG-SFKGDDAAVKVMKGDVSS-------------EINILKKINHSNIIRLSGFCVH 425
G+VY G + +G AVK ++ D S+ E+++LK + H NI++ G C+
Sbjct: 14 GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73
Query: 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTW-KQRVQIAYDVANALNYLHKYTNPPYV 484
+ + EF G++S L NR+ + K QI VA YLH N V
Sbjct: 74 DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA----YLH---NNCVV 124
Query: 485 HKNLKTSNILLDTNLRAKITNFGLARS-AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE 543
H+++K +N++L N K+ +FG AR A H G + + + GT +MAPE I
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH---GTHSNMLKSMHGTPYWMAPEVIN 181
Query: 544 NGVITPKLDVFAFGVVVLELLSGR 567
K D+++ G V E+ +G+
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+ I+ + I+ G ++E N + EF D G+L Y+ + + +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD-----RIYKKGGPIPVEILGK 107
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
IA V L YL Y +H+++K SNIL+++ + K+ +FG++ G
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----------GELI 155
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ VGT YM+PE I+ G T K DV++ G+ ++EL G+
Sbjct: 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 360 YKFQDLK----IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----------VSSEI 405
+K D + + TGSF R++ + ++G+ G+ A+K +K V+ E
Sbjct: 15 WKLSDFEMGETLGTGSFG---RVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEK 69
Query: 406 NILKKINHSNIIR-LSGFCVHEGNTYLVYEFADNGALSDWLHS-NRYQTSDNLTWKQRVQ 463
+IL +++H I+ + F E Y + EF G L L R+ + +
Sbjct: 70 SILMELSHPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
+A++ YLH + ++++LK N+LLD K+T+FG A+
Sbjct: 129 LAFE------YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---------- 169
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T + GT Y+APE I++ +D + GV++ E ++G
Sbjct: 170 -DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 55/194 (28%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 393 AVKVMK-GDV---------SSEINILKKIN---HSNIIRLSGFCVHEGNTYLVYEFADNG 439
A+K +K GD+ E I + N H ++ L E + V E+A G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 440 ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499
L +H++ + + V A V L YLH+ V+++LK N+LLDT
Sbjct: 88 DLMMHIHTDVFSE------PRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEG 138
Query: 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVV 559
KI +FGL + E G+G T GT ++APE + T +D + GV+
Sbjct: 139 FVKIADFGLCK-------EGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 190
Query: 560 VLELLSGREAVTGD 573
+ E+L G GD
Sbjct: 191 IYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 36/228 (15%)
Query: 372 FSEENRI----QGSVYRG--SFKGDDAAVKVMKGD-------VSS--EINILKKINHSNI 416
F + NRI G VYR + G+ A+K ++ D +SS EI +L + H NI
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 417 IRLSGFCV--HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
+ L V H + +LV E+ + L S + Q + + L Y
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQD-----LASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
LH+ +H++LK SN+LL KI +FGLAR+ +T VV T
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-------PMTPKVV-TL 172
Query: 535 GYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581
Y APE + T +D++A G ++ ELL+ + + G E E L
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG--KSEIEQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 16/137 (11%)
Query: 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
V E+A+ G L L R T + + R A ++ +AL YLH V++++K
Sbjct: 72 FVMEYANGGELFFHLSRERVFTEE----RARFYGA-EIVSALEYLHSRD---VVYRDIKL 123
Query: 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK 550
N++LD + KIT+FGL + SD + GT Y+APE +E+
Sbjct: 124 ENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 551 LDVFAFGVVVLELLSGR 567
+D + GVV+ E++ GR
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 29/198 (14%)
Query: 380 GSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430
G VY+ K G AA KV+ D EI+IL +H NI++L +E N +
Sbjct: 19 GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78
Query: 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
++ EF GA+ + + LT Q + ALNYLH+ +H++LK
Sbjct: 79 ILIEFCAGGAVDAVM----LELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKA 131
Query: 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI--ENGVIT 548
NIL + K+ +FG+ SA++ +Q +GT +MAPE + E
Sbjct: 132 GNILFTLDGDIKLADFGV--SAKNTR------TIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 549 P---KLDVFAFGVVVLEL 563
P K DV++ G+ ++E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 41/232 (17%)
Query: 364 DLKIATGSFSEE---NRIQGSVYRGSFKG-------DDAAVKVMKGDVS--------SEI 405
++ ++T F EE +R G VY+G G A+K +K E
Sbjct: 1 EINLSTVRFMEELGEDRF-GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL-----HSNRYQTSDNLTWKQ 460
+ ++ H NI+ L G E +++ + + L ++L HS+ T D+ T K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 461 R------VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
V I +A + +L + VHK+L T N+L+ L KI++ GL R +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 515 -DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
D ++ G L R +M+PE I G + D++++GVV+ E+ S
Sbjct: 177 ADYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 24/171 (14%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVY-EFADNGALSDWLHSNRYQTSDNLTWKQRV 462
EI + + H NI++ G E + ++ E G+LS L S DN ++
Sbjct: 55 EIALHSYLKHRNIVQYLG-SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN----EQT 109
Query: 463 QIAY--DVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGLARSAESDEHEQ 519
I Y + L YLH VH+++K N+L++T + KI++FG ++
Sbjct: 110 IIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------ 160
Query: 520 GGYGLQ-LTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGR 567
G+ T GT YMAPE I+ G D+++ G ++E+ +G+
Sbjct: 161 ---GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 71/266 (26%), Positives = 120/266 (45%), Gaps = 55/266 (20%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV----------SSEINILK-KINH 413
+ GSF G V K AVKV+K DV +E IL NH
Sbjct: 3 LGKGSF-------GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55
Query: 414 SNIIRLSGFCVHE--GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVAN 470
+ +L +C + + V EF + G L H + + D + R + A ++ +
Sbjct: 56 PFLTQL--YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD----EARARFYAAEITS 107
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
AL +LH + ++++LK N+LLD K+ +FG+ + +G + + T
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--------EGIFNGKTTSTF 156
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR---EAVTGDQNCEA----ELLYA 583
GT Y+APE ++ + P +D +A GV++ E+L G EA D EA E++Y
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216
Query: 584 SISRVLEESNVREKLRGFI--DPSLR 607
+ L + V + L+ F+ +P++R
Sbjct: 217 TW---LSQDAV-DILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 64/284 (22%), Positives = 122/284 (42%), Gaps = 50/284 (17%)
Query: 380 GSVYRGS--FKGDDAAVKVM-------KGDVSSEINILKKINHSNIIR-LSGFCVHEGNT 429
G+VY G + A++ M K + +EI ++++ + NI+ L + V +
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-EL 92
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
++V E+ G+L+D + T + Q + + AL +LH + +H+++K
Sbjct: 93 WVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIK 143
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITP 549
+ NILL + K+T+FG ++ ++ +VGT +MAPE + P
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRS--------TMVGTPYWMAPEVVTRKAYGP 195
Query: 550 KLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNE 609
K+D+++ G++ +E++ G + A L A+ P L+N
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----------------TPELQN- 238
Query: 610 YPLDLAFSMAQLAKNCTAHDLNARPSISEV----FVTLSKIWSS 649
P L+ C D+ R S E+ F+ ++K SS
Sbjct: 239 -PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 404 EINILKKINHSNIIRLSGFCVHEG-----NTYLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI +L+ ++H N+I + + Y+VYE D L + S++ + D+ +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD-LHQIIRSSQTLSDDHCQY 112
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
Y + L Y+H +H++LK SN+LL+ N KI +FGLAR S++ +
Sbjct: 113 -----FLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGD 163
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGRE 568
+T +VV T Y APE + N T +DV++ G + ELL GR+
Sbjct: 164 ------FMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
A + L +LH V+++LK N+LLD + +I++ GLA +GG
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA------VELKGG--- 148
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ + GT GYMAPE ++ V +D FA G + E+++GR
Sbjct: 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 27/172 (15%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT--------YLVYEFADNGALSDWLHSNRYQTSDN 455
EI IL+ + H N++ L C + YLV+EF ++ L+ L SN+
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL-SNKNVKFTL 118
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515
K+ +++ + N L Y+H N +H+++K +NIL+ + K+ +FGLAR+
Sbjct: 119 SEIKKVMKM---LLNGLYYIH--RNK-ILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIEN----GVITPKLDVFAFGVVVLEL 563
++ + + T VV T Y PE + G P +D++ G ++ E+
Sbjct: 173 KNSKPN---RYTNRVV-TLWYRPPELLLGERDYG---PPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 366 KIATGSFSEENRIQGSVYRG--SFKGDDAAVKVMK--------GDVSSEINILKKINHSN 415
+I GSF G VY+G + + A+K++ D+ EI +L + +
Sbjct: 11 RIGKGSF-------GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
I R G + +++ E+ G+ D L + + T I ++ L+YL
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYL 117
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
H +H+++K +N+LL K+ +FG+A + ++ + VGT
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------VGTPF 166
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+MAPE I+ K D+++ G+ +EL G
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 18/178 (10%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+ I+ +I H NI+ L V LV + L + LT Q
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-----LTESQVKC 123
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR-------SAESDE 516
I + N LN LHK+ ++H++L +NI +++ KI +FGLAR S +
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGD 573
E ++T VV T Y APE + +D+++ G + ELL+G+ G+
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 8e-10
Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 23/157 (14%)
Query: 412 NHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
++ N I+L + V L+ ++ +G L D L L+ + +I +
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-----LSEAEVKKIIRQLVE 120
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAESDEHEQGGYGLQLTRH 529
ALN LHK+ +H ++K N+L D R + ++GL + Y
Sbjct: 121 ALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI----IGTPSCYD------ 167
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
GT Y +PE I+ D +A GV+ ELL+G
Sbjct: 168 --GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 18/158 (11%)
Query: 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVH 485
E +L+ ++ G + L+ + D + R ++ AL +LHK V+
Sbjct: 77 EAKLHLILDYVSGGEMFTHLYQRDNFSEDEV----RFYSG-EIILALEHLHKLG---IVY 128
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
+++K NILLD+ +T+FGL++ S+E E+ T GT YMAPE I
Sbjct: 129 RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-------TYSFCGTIEYMAPEIIRGK 181
Query: 546 VITPK-LDVFAFGVVVLELLSGREAVT--GDQNCEAEL 580
K +D ++ G+++ ELL+G T G++N ++E+
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
Y + L YLH + +H+++K N+L+++N KI +FGLAR E DE
Sbjct: 110 YQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE------SKH 160
Query: 526 LTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGR 567
+T+ VV Y Y APE + T +D+++ G + ELL R
Sbjct: 161 MTQEVVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 22/179 (12%)
Query: 394 VKVMKGDVS---SEINILKKINHSNIIRLS-GFCVHEGNTYLVYEFADNGALSDWLHSNR 449
V V K +V+ +E +L+ H + L F H+ + V E+A+ G L + H +R
Sbjct: 32 VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGEL--FFHLSR 88
Query: 450 YQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508
+ + + R + ++ +AL+YLH N V+++LK N++LD + KIT+FGL
Sbjct: 89 ----ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGL 142
Query: 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ D G + + GT Y+APE +E+ +D + GVV+ E++ GR
Sbjct: 143 CKEGIKD-------GATM-KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 38/179 (21%)
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA-RSAESDEHEQGG 521
++ + AL+YL +H+++K SNILLD + K+ +FG++ R +S +
Sbjct: 118 KMTVAIVKALHYLK--EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 522 YGLQLTRHVVGTYGYMAPEYIENGVITPKL----DVFAFGVVVLELLSGREAVTGDQNCE 577
G YMAPE I+ PK DV++ G+ ++EL +G+ +NC+
Sbjct: 176 ----------GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY---KNCK 222
Query: 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFS--MAQLAKNCTAHDLNARP 634
E + ++++L+E PSL P + FS C D RP
Sbjct: 223 TE--FEVLTKILQEE----------PPSL----PPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 51/238 (21%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV-----SSEINILKKINHSNIIRL 419
+ GSF G V KG D A+K++K DV E +++K ++ L
Sbjct: 8 LGKGSF-------GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEK----RVLAL 56
Query: 420 SG---FCVH-------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY--D 467
G F Y V E+ + G L Y +K+ + Y +
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-------MYHIQQVGKFKEPHAVFYAAE 109
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+A L +LH ++++LK N++LD KI +FG+ + E+ GG + T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGG---KTT 158
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
R GT Y+APE I +D +AFGV++ E+L+G+ G+ + + L+ SI
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 20/170 (11%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E++IL K I+ G EG Y+ E+ D G+L D L++ T + + +
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVAT-EGIPEDVLRR 106
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
I Y V L +L + N +H+++K +N+L++ N + K+ +FG++ G
Sbjct: 107 ITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVS----------GNLV 154
Query: 524 LQLTRHVVGTYGYMAPEYI------ENGVITPKLDVFAFGVVVLELLSGR 567
L + +G YMAPE I +N T + DV++ G+ +LE+ GR
Sbjct: 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
++H+ I+RL G C + LV + + G+L D + +R D+L ++ + +A
Sbjct: 66 LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAK 120
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
+ YL ++ VH+NL NILL ++ +I +FG+A D+ +
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK------YFYSEH 171
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVL 589
+MA E I G T + DV+++GV V E++S G E YA + R
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP------------YAGM-RPH 218
Query: 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
E ++ EK P + +D+ M + C D N RP+ E+
Sbjct: 219 EVPDLLEKGERLAQPQICT---IDVYMVMVK----CWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 26/194 (13%)
Query: 384 RGSFKGDDAAVKVMKGDVS----------SEINILKKINHSNIIRLSGFCVHEGNTYLVY 433
R G A+K++K +V +E +LK H + L + V
Sbjct: 15 REKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM 74
Query: 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493
E+ + G L L R + D + ++ +AL+YLH + V+++LK N+
Sbjct: 75 EYVNGGELFFHLSRERVFSEDRTRF-----YGAEIVSALDYLH---SGKIVYRDLKLENL 126
Query: 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDV 553
+LD + KIT+FGL + +D + GT Y+APE +E+ +D
Sbjct: 127 MLDKDGHIKITDFGLCKEGITDAATMKTF--------CGTPEYLAPEVLEDNDYGRAVDW 178
Query: 554 FAFGVVVLELLSGR 567
+ GVV+ E++ GR
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 38/187 (20%)
Query: 393 AVKVMKGDVS--------SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
AVKV+ D++ SE+ IL K + II G E + EF D G+L
Sbjct: 30 AVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL--- 86
Query: 445 LHSNRYQTSDNLTWK--QRV--QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500
++ K + V +IA V L YL +H+++K SN+L++T +
Sbjct: 87 ----------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQ 133
Query: 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560
K+ +FG++ + + + VGT YMAPE I DV++ G+
Sbjct: 134 VKLCDFGVSTQLVN----------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
Query: 561 LELLSGR 567
+EL GR
Sbjct: 184 MELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 404 EINILKKINHSNIIRLSGFCVHEG------NTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ +LK +NH NII L + + YLV E D L +H L
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME-------LD 121
Query: 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
++ + Y + + +LH + +H++LK SNI++ ++ KI +FGLAR+A ++
Sbjct: 122 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-- 176
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+T +VV Y Y APE I +D+++ G ++ EL+ G
Sbjct: 177 ------FMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 7/109 (6%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E + + HSN+++ G C LV EF G L +L S R ++ +T
Sbjct: 44 EEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCR--KAELMTPDPTT 101
Query: 463 --QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509
++A ++A L +LHK ++H +L N LL +L KI ++GL+
Sbjct: 102 LQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGN----TYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
E+ IL+ H NII + G Y+V + ++ L +HS++ T +++ +
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQPLTEEHIRY- 111
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
Y + L Y+H + +H++LK SN+L++ + +I +FG+AR S E
Sbjct: 112 ----FLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164
Query: 520 GGYGLQLTRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSGRE 568
+ +T + V T Y APE Y T +D+++ G + E+L R+
Sbjct: 165 KYF---MTEY-VATRWYRAPELLLSLPEY------TTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 23/175 (13%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV- 462
EI++LK++ H NI+RL E YLV+E+ D L H + +S + R+
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMD---SSPDFAKNPRLI 104
Query: 463 -QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA-KITNFGLARSAESDEHEQG 520
Y + + Y H + +H++LK N+L+D A K+ +FGLAR+
Sbjct: 105 KTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF-------- 153
Query: 521 GYGLQLTRHVVGTYGYMAPEYI--ENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
G ++ H V T Y APE + TP +D+++ G + E+++ + GD
Sbjct: 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 21/171 (12%)
Query: 404 EINILKKINHSNIIRLSGFCVHEG-----NTYLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI +L+ + H +I+ + + + Y+V+E + SD LH + +D+LT
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SD-LHQ-VIKANDDLTP 102
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
+ Y + AL Y+H T + H++LK NIL + + + KI +FGLAR A +D
Sbjct: 103 EHHQFFLYQLLRALKYIH--TANVF-HRDLKPKNILANADCKLKICDFGLARVAFND--- 156
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGR 567
+ T + V T Y APE + TP +D+++ G + E+L+G+
Sbjct: 157 -TPTAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 28/186 (15%)
Query: 393 AVKVMKGDV----------SSEINILKKINHSNIIRLS-GFCVHEGNTYLVYEFADNGAL 441
A+K++K +V +E +L+ H + L F H+ + V E+A+ G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCF-VMEYANGGEL 82
Query: 442 SDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501
L R + D + R A ++ +AL YLH V+++LK N++LD +
Sbjct: 83 FFHLSRERVFSED----RARFYGA-EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHI 134
Query: 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVL 561
KIT+FGL + SD + GT Y+APE +E+ +D + GVV+
Sbjct: 135 KITDFGLCKEGISDGAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 562 ELLSGR 567
E++ GR
Sbjct: 187 EMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 44/235 (18%)
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+++++++H +I+ L G CV + +V EF + G L ++H + SD LT + ++A
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH----RKSDVLTTPWKFKVA 111
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
+A+AL+YL + VH N+ T NILL R I SD G+
Sbjct: 112 KQLASALSYLE---DKDLVHGNVCTKNILL---AREGIDGECGPFIKLSDP------GIP 159
Query: 526 LT----RHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQN-CEAE 579
+T + V ++APE +E+ ++ D ++FG + E+ E D+ E E
Sbjct: 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
Y + + PS + +A L +C +D N RP
Sbjct: 220 RFYEGQCML-------------VTPSCK---------ELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 31/206 (15%)
Query: 380 GSVYRGSFK--GDDAAVKVMK------GDVSSEINILKKI-NHSNIIRLSGF-----CVH 425
G V++ K G AAVK++ ++ +E NILK + +H N+++ G +
Sbjct: 32 GKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91
Query: 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVH 485
+LV E + G+++D L + + + + IAY + AL L +H
Sbjct: 92 GDQLWLVLELCNGGSVTD-LVKGFLKRGERM---EEPIIAYILHEALMGLQHLHVNKTIH 147
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-- 543
+++K +NILL T K+ +FG++ S + VGT +MAPE I
Sbjct: 148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT--------SVGTPFWMAPEVIACE 199
Query: 544 ---NGVITPKLDVFAFGVVVLELLSG 566
+ + DV++ G+ +EL G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 35/203 (17%)
Query: 380 GSVYRGSFKGDDAAVKVMKGDVSS-----------EINILKKI---NHSNIIRLSGFCV- 424
G+VY+ V + K V EI +LK++ H NI+RL C
Sbjct: 13 GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG 72
Query: 425 ----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
E LV+E D L+ +L L + + + +++LH +
Sbjct: 73 PRTDRELKLTLVFEHVDQD-LATYL---SKCPKPGLPPETIKDLMRQLLRGVDFLHSHR- 127
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540
VH++LK NIL+ ++ + KI +FGLAR + + LT VV T Y APE
Sbjct: 128 --IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--------MALTSVVV-TLWYRAPE 176
Query: 541 YIENGVITPKLDVFAFGVVVLEL 563
+ +D+++ G + EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 31/177 (17%)
Query: 404 EINILKKINHSNIIRL-----SGFCVHE-GNTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ +LK + H N+I L S E + YLV + +D + S+
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM----QTDLQKIMGHPLSE--- 116
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+VQ + Y + L Y+H +H++LK N+ ++ + KI +FGLAR A++
Sbjct: 117 --DKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-- 169
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTG 572
E GY V T Y APE I N + +D+++ G ++ E+L+G+ G
Sbjct: 170 -EMTGY--------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 62/234 (26%), Positives = 94/234 (40%), Gaps = 42/234 (17%)
Query: 401 VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSN-RYQTSDNLTWK 459
V SE IL INH + L G E YLV EF G +L N R+ +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
++ + ++ +LN V+++LK N+LLD + K+T+FG A+ ++
Sbjct: 138 AQIVLIFEYLQSLNI---------VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579
T + GT Y+APE + N D + G+ + E+L G + E
Sbjct: 185 -------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN---EPL 234
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633
L+Y I L G I +P L + L K +HDL R
Sbjct: 235 LIYQKI------------LEGII------YFPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 370 GSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSSEIN------ILKKI-----NHSNI 416
GSF G V KG + A+K +K DV E + + +++ H +
Sbjct: 6 GSF-------GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 417 IRLSGFCVHEGNTYL--VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
L FC + +L V E+ + G D + Q+S + A ++ L +
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMF--HIQSSGRFDEARARFYAAEIICGLQF 111
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
LHK ++++LK N+LLD + KI +FG+ + + G GT
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK--------ENMNGEGKASTFCGTP 160
Query: 535 GYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
Y+APE ++ +D ++FGV++ E+L G+ G + + L+ SI
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG---EDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 40/220 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS--------EINILKKI 411
YK KI G+FSE + Q S G + A+K MK S EI L+++
Sbjct: 1 YKILG-KIGEGTFSEVLKAQ-SRKTGKY----YAIKCMKKHFKSLEQVNNLREIQALRRL 54
Query: 412 N-HSNIIRLSGFCVHE---GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ-IAY 466
+ H NI+RL + + G LV+E D L + + + + RV+ Y
Sbjct: 55 SPHPNILRLIE-VLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEK-----RVKSYMY 107
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
+ +L+++H+ H+++K NIL+ ++ K+ +FG R + + Y
Sbjct: 108 QLLKSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGI----YSKPPY---- 155
Query: 527 TRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLS 565
T ++ T Y APE + +G PK+D++A G V E+LS
Sbjct: 156 TEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 367 IATGSFSE----ENRIQGSVYRGSFKGDDAAVKVMKGDVSS--EINILKKINHSNIIRLS 420
+ G F E + R G +Y K + +K KG+ + E IL+K+N ++ L+
Sbjct: 8 LGKGGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480
+ LV + G L ++ + + V A ++ L LH+
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLEDLHQER- 122
Query: 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540
V+++LK NILLD + +I++ GLA + +G VGT GYMAPE
Sbjct: 123 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---------VGTVGYMAPE 171
Query: 541 YIENGVITPKLDVFAFGVVVLELLSGR 567
++N T D +A G ++ E+++G+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 39/225 (17%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDV----------SSEINILKKINHSNI 416
+ G F E +Q V R GD A+KVMK V E +IL N I
Sbjct: 9 VGRGHFGE---VQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI 63
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRY--QTSDNLTWKQRVQIAYDVANALNY 474
+L + N YLV E+ G L L NRY Q +++ + +A ++ A++
Sbjct: 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMA---QFYLA-ELVLAIHS 117
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
+H+ YVH+++K N+L+D K+ +FG A +++ ++ VGT
Sbjct: 118 VHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-------VNSKLPVGTP 167
Query: 535 GYMAPEYIE------NGVITPKLDVFAFGVVVLELLSGREAVTGD 573
Y+APE + G + D ++ GV+ E++ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 50/248 (20%)
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+++ +++H ++ + G CV +V EF ++G L L + + + WK + +A
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP--VAWK--ITVA 123
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILL-------DTNLRAKITNFGLARSAESDEHE 518
+A+AL+YL + VH N+ NILL T+ K+++ G++ +A S E
Sbjct: 124 QQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLEL-LSGREAVTGDQNC 576
V ++APE + G ++ D ++FG +LE+ G +
Sbjct: 181 ------------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228
Query: 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636
E E Y EK +PS + +A L C ++ RPS
Sbjct: 229 EKERFY-------------EKKHRLPEPSCKE---------LATLISQCLTYEPTQRPSF 266
Query: 637 SEVFVTLS 644
+ L+
Sbjct: 267 RTILRDLT 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 33/244 (13%)
Query: 404 EINILKKINHSNIIRL--------------SGFCVHEGNTYLVYEFADNGALSDWLHSNR 449
EI I+++++H NI+++ G + Y+V E+ + L++ L
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGP 110
Query: 450 YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGL 508
L+ + Y + L Y+H +H++LK +N+ ++T +L KI +FGL
Sbjct: 111 ------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGL 161
Query: 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSGR 567
AR + + GY L+ +V + Y +P + T +D++A G + E+L+G+
Sbjct: 162 ARIVDPH-YSHKGY---LSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 568 EAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTA 627
G E L V+ E + E L + PS + + L
Sbjct: 217 PLFAGAHELEQMQLILESVPVVREEDRNELLN--VIPSFVRNDGGEPRRPLRDLLPGVNP 274
Query: 628 HDLN 631
L+
Sbjct: 275 EALD 278
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 34/179 (18%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT------YLVYEF--ADNGALSDWLHSNRYQTSDN 455
E+ +LK + H N+I L + + YLV F D G L +
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKL---------MKHEK 114
Query: 456 LTWKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
L+ + R+Q + Y + L Y+H +H++LK N+ ++ + KI +FGLAR +S
Sbjct: 115 LS-EDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTG 572
E GY V T Y APE I N + T +D+++ G ++ E+L+G+ G
Sbjct: 171 ---EMTGY--------VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 17/167 (10%)
Query: 404 EINILKKINHSNIIRLSGFCV--HEGNTYLVY-EFADNGALSDWLHSNRYQTSDNLTWKQ 460
EI +LK + H I++ G C+ T ++ E+ G++ D L + T +++T K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT-ESVTRKY 111
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
QI ++YLH VH+++K +NIL D+ K+ +FG ++ ++
Sbjct: 112 TRQIL----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--MS 162
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
G G+ R V GT +M+PE I K DV++ G V+E+L+ +
Sbjct: 163 GTGI---RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 401 VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
V +E ++ ++ NH ++ L E + V E+ + G L + R ++ +
Sbjct: 42 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF- 100
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ +++ ALNYLH+ ++++LK N+LLD+ K+T++G+ + +
Sbjct: 101 ----YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--------E 145
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA--VTG----- 572
G T GT Y+APE + +D +A GV++ E+++GR + G
Sbjct: 146 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
Query: 573 DQNCEAELLYASISRVLEESNVR 595
DQN E L +V+ E +R
Sbjct: 206 DQNTEDYLF-----QVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 31/202 (15%)
Query: 385 GSFKGDDAAVKVMK-----------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433
G+ G A+KV+K +E NIL+ + H I+ L G YL+
Sbjct: 20 GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79
Query: 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY--DVANALNYLHKYTNPPYVHKNLKTS 491
E+ G L ++H R + + Y +++ AL +LH+ ++++LK
Sbjct: 80 EYLSGGEL--FMHLEREGI-----FMEDTACFYLSEISLALEHLHQQG---IIYRDLKPE 129
Query: 492 NILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKL 551
NILLD K+T+FGL + E G +T GT YMAPE + +
Sbjct: 130 NILLDAQGHVKLTDFGLCK-----ESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAV 181
Query: 552 DVFAFGVVVLELLSGREAVTGD 573
D ++ G ++ ++L+G T +
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 80/245 (32%)
Query: 390 DDAAVKVMKGDVS--------SEINILKKI-NHSNIIRLSGFCVH-EGNTYLVYEFADNG 439
+ AVK++K + SE+ IL I NH N++ L G C G ++ EF G
Sbjct: 38 NTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97
Query: 440 ALSDWLHS-----------------------------------------NRYQTSDNLT- 457
LS++L + +R+Q S + +
Sbjct: 98 NLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157
Query: 458 ---------WKQRVQI------AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502
WK + + ++ VA + +L + +H++L NILL N K
Sbjct: 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVK 214
Query: 503 ITNFGLARS--AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560
I +FGLAR + D +G L L +MAPE I + V T + DV++FGV++
Sbjct: 215 ICDFGLARDIYKDPDYVRKGSARLPLK--------WMAPESIFDKVYTTQSDVWSFGVLL 266
Query: 561 LELLS 565
E+ S
Sbjct: 267 WEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 28/171 (16%)
Query: 404 EINILKKINHSNIIR-LSGFCVHEG-----NTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ ++K +NH NII L+ F + + YLV E D +N Q
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD---------ANLCQVIQMDL 115
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+R+ + Y + + +LH + +H++LK SNI++ ++ KI +FGLAR+A
Sbjct: 116 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 168
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
G +T +VV Y Y APE I +D+++ G ++ E++ G
Sbjct: 169 ----GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 29/162 (17%)
Query: 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVH 485
E + YLV E+ G L + L R T R IA V AL+ +HK ++H
Sbjct: 73 EEHLYLVMEYMPGGDLMNLL--IRKDVFPEET--ARFYIAELVL-ALDSVHKLG---FIH 124
Query: 486 KNLKTSNILLDTNLRAKITNFGLA-RSAESDEHEQGGYGLQLT----------------- 527
+++K NIL+D + K+ +FGL + ++ + E
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 528 ---RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
VGT Y+APE + + D ++ GV++ E+L G
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 400 DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
D E +L K+ H NI+ +G+ Y+V E+ D G D + + Q
Sbjct: 44 DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG---DLMQKIKLQRGKLFPED 100
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+Q + + ++H+ +H+++K+ NI L N + K+ +FG AR S
Sbjct: 101 TILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS----P 153
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563
G Y VGT Y+ PE EN K D+++ G ++ EL
Sbjct: 154 GAYACTY----VGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 51/238 (21%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV-----SSEINILKKINHSNIIRL 419
+ GSF G V KG D A+K++K DV E +++K ++ L
Sbjct: 8 LGKGSF-------GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEK----RVLAL 56
Query: 420 SG---FCVH-------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY--D 467
SG F Y V E+ + G L YQ +K+ + Y +
Sbjct: 57 SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-------MYQIQQVGRFKEPHAVFYAAE 109
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+A L +LH + ++++LK N++LD+ KI +FG+ + D G+ T
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-------GVT-T 158
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
+ GT Y+APE I +D +AFGV++ E+L+G+ G+ E L+ SI
Sbjct: 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
Y V E+ + G L Q Q V A +++ L +LH+ ++++LK
Sbjct: 77 YFVMEYVNGGDLM-----YHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLK 128
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITP 549
N++LD+ KI +FG+ + EH G TR GT Y+APE I
Sbjct: 129 LDNVMLDSEGHIKIADFGMCK-----EHMVDGV---TTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 550 KLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
+D +A+GV++ E+L+G+ G+ E L+ SI
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 404 EINILKKINHSNIIRLSGFC--VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
EI +LK + H I++ G E + E G++ D L S T +N+T K
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALT-ENVTRKYT 112
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
QI V +YLH VH+++K +NIL D+ K+ +FG ++ ++ G
Sbjct: 113 RQILEGV----SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC--LSG 163
Query: 522 YGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
G+ + V GT +M+PE I K D+++ G V+E+L+ +
Sbjct: 164 TGM---KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 367 IATGSFSE----ENRIQGSVYRGSFKGDDAAVKVMKGDVSS--EINILKKINHSNIIRLS 420
+ G F E + R G +Y + + +K KG+ + E IL+K+N ++ L+
Sbjct: 8 LGKGGFGEVCACQVRATGKMY-ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYT 479
+ LV + G L H Y + ++R A ++ L LH+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLK--FHI--YNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 480 NPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAP 539
V+++LK NILLD +I++ GLA E R VGT GYMAP
Sbjct: 123 T---VYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---------SIRGRVGTVGYMAP 170
Query: 540 EYIENGVITPKLDVFAFGVVVLELLSGREAVTG 572
E + N T D + G ++ E++ G+ G
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 401 VSSEINILKKINHSNIIRLSGFCVHEGNTYLV---YEFADNGALSDWLHSNRYQTSDNLT 457
+ +EI L ++NH NI+++ E NTY++ Y+F L +++ + D
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPL 265
Query: 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
KQ I + A+ Y+H + +H+++K NI L+ + + + +FG A E E
Sbjct: 266 LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-KER 321
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
E YG VGT +PE + D+++ G+++L++LS
Sbjct: 322 EAFDYGW------VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 55/255 (21%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
EI +++ H NI+ + + Y+V G+ D L ++ + L
Sbjct: 49 EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH---FPEGLPELAIAF 105
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS-AESDEHEQGGY 522
I DV NAL+Y+H ++H+++K S+ILL + + ++ + S + + ++ +
Sbjct: 106 ILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVI--TPKLDVFAFGVVVLELLSGR------------- 567
+ V +++PE ++ + K D+++ G+ EL +G
Sbjct: 163 D--FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220
Query: 568 EAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLR--NEYPLDLAFSMA--QLAK 623
E V G LL S + L E ++ + P+ R ++P FS Q +
Sbjct: 221 EKVRG---TVPCLLDKS-TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE 276
Query: 624 NCTAHDLNARPSISE 638
C D +RPS S+
Sbjct: 277 LCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 39/229 (17%)
Query: 370 GSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV----------SSEINILK-KINHSNI 416
GSF G V KG D A+KV+K DV +E IL H +
Sbjct: 6 GSF-------GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
L + + V E+ + G L + Q S + A +V AL +LH
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLM-----FQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 477 KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGY 536
++ ++++LK NILLD K+ +FG+ + +G T GT Y
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--------EGILNGVTTTTFCGTPDY 162
Query: 537 MAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
+APE ++ P +D +A GV++ E+++G+ D + L+ SI
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 31/206 (15%)
Query: 380 GSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHEG 427
G V+ K G+ A+K MK V +E +IL +++L +
Sbjct: 15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE 74
Query: 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487
YL E+ G L++ + D+ R +A A++ LH+ Y+H++
Sbjct: 75 YLYLAMEYVPGGDFRTLLNNLGVLSEDH----ARFYMAEMFE-AVDALHELG---YIHRD 126
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI 547
LK N L+D + K+T+FGL++ + VVG+ YMAPE +
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKG-----------IVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 548 TPKLDVFAFGVVVLELLSGREAVTGD 573
+D ++ G ++ E L G +G
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 36/116 (31%), Positives = 60/116 (51%), Gaps = 18/116 (15%)
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
A ++ L ++H N V+++LK +NILLD + +I++ GLA +
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD----------FSK 149
Query: 525 QLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSG----REAVTGDQN 575
+ VGT+GYMAPE ++ GV D F+ G ++ +LL G R+ T D++
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSD-NLTWKQRV 462
E+ ++K +NH NII L + + + EF D + + + +N Q L ++
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+ Y + + +LH + +H++LK SNI++ ++ KI +FGLAR+A G
Sbjct: 130 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--------GT 178
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+T +VV Y Y APE I +D+++ G ++ E++ G
Sbjct: 179 SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV-----SSEINILKK------INH 413
+ GSF G V+ KG + A+K +K DV E +++K H
Sbjct: 3 LGKGSF-------GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 414 SNIIRLSGFCVHEG--NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
+ L +C + N + V E+ + G L H Q+ + A ++
Sbjct: 56 PFLTHL--YCTFQTKENLFFVMEYLNGGDL--MFH---IQSCHKFDLPRATFYAAEIICG 108
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
L +LH + V+++LK NILLDT+ KI +FG+ + + G T
Sbjct: 109 LQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--------ENMLGDAKTCTFC 157
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
GT Y+APE + +D ++FGV++ E+L G+ G + E L+ SI
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH---DEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 8/103 (7%)
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
Y + L Y+H + +H++LK N+L++ + KI +FGLAR + E G+
Sbjct: 112 YQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF--- 165
Query: 526 LTRHVVGTYGYMAPE-YIENGVITPKLDVFAFGVVVLELLSGR 567
+T +V T Y APE + T +DV++ G ++ ELL +
Sbjct: 166 MTEYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 404 EINILKKINHSNIIRLSGFCVH---EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
EI +LK + H I++ G C+ E + E+ G++ D L + T +N+T +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT-ENVTRRY 111
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
QI V+ YLH VH+++K +NIL D+ K+ +FG ++ ++
Sbjct: 112 TRQILQGVS----YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI--CMS 162
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
G G+ + V GT +M+PE I K DV++ V+E+L+
Sbjct: 163 GTGI---KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSD-NLTWKQRV 462
E+ ++K +NH NII L + + + EF D + + + +N Q L ++
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMS 122
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+ Y + + +LH + +H++LK SNI++ ++ KI +FGLAR+A G
Sbjct: 123 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--------GT 171
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564
+T +VV Y Y APE I +D+++ G ++ E++
Sbjct: 172 SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 44/187 (23%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 397 MKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
++ + E+ +L + N I+ G +G + E D G+L L + + L
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL 105
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+V IA V L YL + +H+++K SNIL+++ K+ +FG++
Sbjct: 106 G---KVSIA--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS------- 151
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576
G + VGT YM+PE ++ + + D+++ G+ ++EL GR +
Sbjct: 152 ---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208
Query: 577 EAELLYA 583
E E ++
Sbjct: 209 ELEAIFG 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 370 GSFSE----ENRIQGSVYRGSFKGDDAAVKVMKGDVSS--EINILKKINHSNIIRLSGFC 423
G F E + R G +Y K + +K KG+ + E IL+K+N ++ L+
Sbjct: 11 GGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 69
Query: 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPP 482
+ LV + G L +++ D ++R A ++ L LH+
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYNMGNPGFD----EERAVFYAAEITCGLEDLHRER--- 122
Query: 483 YVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI 542
V+++LK NILLD +I++ GLA + R VGT GYMAPE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---------ETIRGRVGTVGYMAPEVV 173
Query: 543 ENGVITPKLDVFAFGVVVLELLSGR 567
+N T D + G ++ E++ G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 54/289 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMK----GDV--------SSEINILKKI 411
++ GSF G+VY K A +KV+K G++ + E +L K+
Sbjct: 7 RLGKGSF-------GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
+H I++ + ++ E+ + L L + T L+ Q + +
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLG 118
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
++Y+H+ +H++LK NI L NL KI +FG++R G L T
Sbjct: 119 VHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL------MGSCDLATT--FT 166
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591
GT YM+PE +++ K D+++ G ++ E+ A G QN + + R++E
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QN-----FLSVVLRIVEG 220
Query: 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
PSL Y L M + + RPS +E+
Sbjct: 221 PT----------PSLPETYSRQLNSIMQSMLNKDPSL----RPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 28/176 (15%)
Query: 404 EINILKKINHSNIIRL-----SGFCVHEGN-TYLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ +LK + H N+I L + E N YLV GA + + + T D++
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ 123
Query: 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
+ + Y + L Y+H + +H++LK SN+ ++ + KI +FGLAR +
Sbjct: 124 F-----LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 172
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTG 572
E GY V T Y APE + N + +D+++ G ++ ELL+GR G
Sbjct: 173 EMTGY--------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 39/143 (27%), Positives = 65/143 (45%), Gaps = 24/143 (16%)
Query: 436 ADNGALSDWLHSNRYQTS-----------DNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484
+ + A S ++ + LT + + ++ VA + +L + +
Sbjct: 139 SQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCI 195
Query: 485 HKNLKTSNILLDTNLRAKITNFGLARS--AESDEHEQGGYGLQLTRHVVGTYGYMAPEYI 542
H++L NILL N KI +FGLAR + D +G L L +MAPE I
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK--------WMAPESI 247
Query: 543 ENGVITPKLDVFAFGVVVLELLS 565
+ V T + DV++FGV++ E+ S
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 381 SVYRGSFK--GDDAAVKVMKGDVSS--------EINILKKINHSNIIRLSGFCVHEGNTY 430
+VY+G + G+ A+K + D EI+++K++ H NI+RL E
Sbjct: 15 TVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM 74
Query: 431 LVYEFADNGALSDWLHSNRYQ------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484
LV+E+ D L ++ ++ + T + T++ IA+ N + +
Sbjct: 75 LVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV-----------L 122
Query: 485 HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL---QLTRHVVGTYGYMAPEY 541
H++LK N+L++ K+ +FGLAR+ +G+ + VV T Y AP+
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARA----------FGIPVNTFSNEVV-TLWYRAPDV 171
Query: 542 IENG-VITPKLDVFAFGVVVLELLSGREAVTGDQN 575
+ + +D+++ G ++ E+++GR G N
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 13/114 (11%)
Query: 454 DNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS-- 511
LT + + ++ VA + +L + +H++L NILL N KI +FGLAR
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ D +G L L +MAPE I + V T + DV++FGV++ E+ S
Sbjct: 231 KDPDYVRKGDARLPLK--------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+ +L + N I+ G +G + E D G+L L + L +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----K 103
Query: 464 IAYDVANALNYL---HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
I+ V L YL HK +H+++K SNIL+++ K+ +FG++ G
Sbjct: 104 ISIAVLRGLTYLREKHKI-----MHRDVKPSNILVNSRGEIKLCDFGVS----------G 148
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
+ VGT YM+PE ++ T + D+++ G+ ++E+ GR + E E
Sbjct: 149 QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMA 619
++ E + +P D MA
Sbjct: 209 MFGRPVSEGEAKESHRP---------VSGHPPDSPRPMA 238
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 38/214 (17%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVM----------KGDVSSEINIL-KKINH 413
I GSF G V K D + AVKV+ + + +E N+L K + H
Sbjct: 3 IGKGSF-------GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH 55
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANAL 472
++ L Y V ++ + G L + H R + + R + A +VA+A+
Sbjct: 56 PFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQR----ERCFLEPRARFYAAEVASAI 109
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
YLH ++++LK NILLD+ +T+FGL + E + T G
Sbjct: 110 GYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--------ETTSTFCG 158
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T Y+APE + +D + G V+ E+L G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 367 IATGSFSE----ENRIQGSVYRGSFKGDDAAVKVMKGDVSS--EINILKKINHSNIIRLS 420
+ G F E + R G +Y K + +K KG+ + E IL+K+N ++ L+
Sbjct: 8 LGKGGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR-VQIAYDVANALNYLHKYT 479
+ LV + G L +++ D +QR + A ++ L L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD----EQRAIFYAAELCCGLEDLQRER 122
Query: 480 NPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAP 539
V+++LK NILLD +I++ GLA E +G VGT GYMAP
Sbjct: 123 ---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---------VGTVGYMAP 170
Query: 540 EYIENGVITPKLDVFAFGVVVLELLSGR 567
E I N T D + G ++ E++ G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 26/194 (13%)
Query: 397 MKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
KG E +L+ +NH ++IR+ V T +V SD L++ + S L
Sbjct: 100 QKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS----SD-LYTYLTKRSRPL 154
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
Q + I + L YLH +H+++KT NI ++ + I + G A+
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS------GREAV 570
G + GT APE + K D+++ G+V+ E+L+
Sbjct: 212 AFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262
Query: 571 TGDQ---NCEAELL 581
T ++ +C + LL
Sbjct: 263 TPEEYVKSCHSHLL 276
|
Length = 357 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 42/198 (21%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD-----------NGALSDWLHSNRYQT 452
E+ +L+ + NI+ L G YLV+E+ + NG + + S YQ
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL 109
Query: 453 SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS- 511
+ W + I VH+++K N+L+ N K+ +FG AR+
Sbjct: 110 IKAIHWCHKNDI-------------------VHRDIKPENLLISHNDVLKLCDFGFARNL 150
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571
+E Y V T Y +PE + +D+++ G ++ EL G+
Sbjct: 151 SEGSNANYTEY--------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202
Query: 572 GDQNCEAELLYASISRVL 589
G+ E + L+ +I +VL
Sbjct: 203 GES--EIDQLF-TIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 54/242 (22%), Positives = 97/242 (40%), Gaps = 44/242 (18%)
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNG--ALSDWLHSNRYQT-SDNLTWKQRVQ 463
+++ + I++ G EG+ ++ E D +++ + + K
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK---- 111
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY- 522
IA ALNYL + +H+++K SNILLD N K+ +FG++ G
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS-----------GQL 158
Query: 523 --GLQLTRHVVGTYGYMAPEYIENGVITP---KLDVFAFGVVVLELLSGREAVTGDQNCE 577
+ TR G YMAPE I+ + DV++ G+ + E+ +G+
Sbjct: 159 VDSIAKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK---------- 207
Query: 578 AELLYASISRVLEESNVREKLRGFID-PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636
Y + V ++ + + ++G D P L N + + S C D + RP
Sbjct: 208 --FPYPKWNSVFDQ--LTQVVKG--DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKY 261
Query: 637 SE 638
E
Sbjct: 262 KE 263
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
L +LH+ ++++LK N+LLD + +I++ GLA + + + GY
Sbjct: 110 LEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-------- 158
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
GT G+MAPE ++ +D FA GV + E+++ R
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
+LK + H ++ L Y V +F + G L + H R ++ + R A
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEP--RARFYAA- 103
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS--AESDEHEQGGYGL 524
++A+AL YLH V+++LK NILLD+ +T+FGL + A+SD
Sbjct: 104 EIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-------- 152
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T GT Y+APE I +D + G V+ E+L G
Sbjct: 153 --TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 16/142 (11%)
Query: 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVH 485
+LV E+ + G L + R ++ + A ++ ALN+LH+ ++
Sbjct: 68 TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-----YAAEICIALNFLHERG---IIY 119
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
++LK N+LLD + K+T++G+ + E G G T GT Y+APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPG-DTTSTFCGTPNYIAPEILRGE 171
Query: 546 VITPKLDVFAFGVVVLELLSGR 567
+D +A GV++ E+++GR
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 12/97 (12%)
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
AL +LHKY V+++LK NILLD + +FGL+++ +D + T
Sbjct: 108 ALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--------KTTNTF 156
Query: 531 VGTYGYMAPE-YIENGVITPKLDVFAFGVVVLELLSG 566
GT Y+APE ++ T +D ++ GV+V E+ G
Sbjct: 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 20/117 (17%)
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS-AESDEHEQGGYG 523
A ++ L ++H N V+++LK +NILLD + +I++ GLA ++ H
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 524 LQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSG----REAVTGDQN 575
VGT+GYMAPE ++ G D F+ G ++ +LL G R+ T D++
Sbjct: 156 -------VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE--QGGY 522
+Y VA +++L + +H++L NILL KI +FGLAR +D + +G
Sbjct: 220 SYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
L + +MAPE I N V T + DV+++G+++ E+ S
Sbjct: 277 RLPVK--------WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 44/176 (25%), Positives = 74/176 (42%), Gaps = 23/176 (13%)
Query: 408 LKKINHSNIIRLSGFCV-----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
L+ H N++RL C E LV+E D L+ +L T K
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKD-- 114
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+ + + L++LH + VH++LK NIL+ ++ + K+ +FGLAR Y
Sbjct: 115 -MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI----------Y 160
Query: 523 GLQ-LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577
Q VV T Y APE + +D+++ G + E+ + G + +
Sbjct: 161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 34/121 (28%), Positives = 61/121 (50%), Gaps = 14/121 (11%)
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
A ++ L +LH + ++++LK N++LD + KI +FG+ + + +G
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--------ENVFGD 150
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
GT Y+APE ++ T +D ++FGV++ E+L G+ GD E L+ S
Sbjct: 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFES 207
Query: 585 I 585
I
Sbjct: 208 I 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 38/214 (17%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD----------VSSEINIL-KKINH 413
I GSF G V K D AVKV++ + +E N+L K + H
Sbjct: 3 IGKGSF-------GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANAL 472
++ L Y V ++ + G L L R + R + A ++A+AL
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP------EPRARFYAAEIASAL 109
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
YLH ++++LK NILLD+ +T+FGL + E EH + T G
Sbjct: 110 GYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHS------KTTSTFCG 158
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T Y+APE + +D + G V+ E+L G
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD----------VSSEINIL-KKINH 413
I GSF G V K ++ AVKV++ + SE N+L K + H
Sbjct: 3 IGKGSF-------GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
++ L Y V ++ + G L + H R + L + R A ++A+AL
Sbjct: 56 PFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCF--LEPRARFYAA-EIASALG 110
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
YLH V+++LK NILLD+ +T+FGL + E+ EH T GT
Sbjct: 111 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHN------GTTSTFCGT 159
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
Y+APE + +D + G V+ E+L G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 61/271 (22%)
Query: 398 KGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTS---- 453
+G ++E +IL+ INH +II+L G + T L+ RY+T
Sbjct: 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP--------------RYKTDLYCY 172
Query: 454 ----DNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509
N+ + I V A+ YLH +H+++K NI ++ + +FG A
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-A 228
Query: 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569
D + YG GT APE + P +D+++ G+V+ E+ + ++
Sbjct: 229 ACFPVDINANKYYGW------AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
Query: 570 VTG----DQNCEAELLYASISR----------VLEESNVREKLRGFIDPSLRN------- 608
+ D +C+++ I R + ++N+ E G S R
Sbjct: 283 LFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLW 342
Query: 609 ----EYPLDLAFSMAQLAKNCTAHDLNARPS 635
E P+DL + + ++ A D + RPS
Sbjct: 343 TNLYELPIDLEYLICKM----LAFDAHHRPS 369
|
Length = 391 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 45/204 (22%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 378 IQGSVYRGSFKGDDAAVKVMKGDVSS--EINILKK------INHSNIIRLSGFCVHEGNT 429
+ +Y + VK +K + SS + L++ + H NI++ G CV
Sbjct: 12 LLSEIYTDT-GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY 70
Query: 430 YLVYEFADNGALSDWL--HSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487
LV+E+ + G L +L + S L ++A ++A + ++HK+ ++H +
Sbjct: 71 LLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAGVTHMHKHN---FLHSD 124
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI---EN 544
L N L ++L K+ ++G+ S +++ ++ ++APE +
Sbjct: 125 LALRNCFLTSDLTVKVGDYGIGPSRYKEDY------IETEDDKCVPLRWLAPELVGEFHG 178
Query: 545 GVITPKL----DVFAFGVVVLELL 564
G+IT + +V+A GV + EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 23/90 (25%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+++ +++H +++ G CV + +V E+ G+L +L N+ N++WK +++A
Sbjct: 51 SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI--NISWK--LEVA 106
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILL 495
+A AL++L H N+ N+LL
Sbjct: 107 KQLAWALHFLEDKG---LTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 15/111 (13%)
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
+ Y + L Y+H + +H++LK SN+ ++ + +I +FGLAR A+ E GY
Sbjct: 123 LIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGY- 175
Query: 524 LQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGD 573
V T Y APE + N + +D+++ G ++ ELL G+ G+
Sbjct: 176 -------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 37/211 (17%)
Query: 379 QGSVYRGSFKGDDAAVKVM------KGDVSSEINILKKINHSNIIRL-------SGFC-V 424
+G V+ + GD+ KV+ EI+ILK I+H II L S C V
Sbjct: 105 EGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164
Query: 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484
++ + D S L +Q + I + AL YLH +
Sbjct: 165 MPKYKCDLFTYVDR--------------SGPLPLEQAITIQRRLLEALAYLHGRG---II 207
Query: 485 HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN 544
H+++KT NI LD A + +FG A ++ YG GT +PE +
Sbjct: 208 HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW------SGTLETNSPELLAL 261
Query: 545 GVITPKLDVFAFGVVVLELLSGREAVTGDQN 575
K D+++ G+V+ E+ + G Q
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 484 VHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE 543
V++++K N+LLD ++++ GLA + G +T+ GT GYMAPE ++
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKD--------GKTITQRA-GTNGYMAPEILK 167
Query: 544 NGVITPKLDVFAFGVVVLELLSGR 567
+ +D FA G + E+++GR
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 40/187 (21%), Positives = 85/187 (45%), Gaps = 17/187 (9%)
Query: 397 MKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
++ + E+ +L + N I+ G +G + E D G+L L + + +
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRI 100
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+ +++ V L YL + +H+++K SNIL+++ K+ +FG++
Sbjct: 101 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------- 151
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576
G + VGT YM+PE ++ + + D+++ G+ ++E+ GR +
Sbjct: 152 ---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208
Query: 577 EAELLYA 583
E EL++
Sbjct: 209 ELELMFG 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+++LK + H+NI+ L E LV+E+ D+ L +L NL V+
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSD-LKQYL-----DNCGNLMSMHNVK 106
Query: 464 I-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
I + + L+Y HK +H++LK N+L++ K+ +FGLAR+
Sbjct: 107 IFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT------ 157
Query: 523 GLQLTRHVVGTYGYMAPEYI--ENGVITPKLDVFAFGVVVLELLSGREAVTGDQ-NCEAE 579
+ + V T Y P+ + TP +D++ G ++ E+ +GR G E
Sbjct: 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTP-IDMWGVGCILYEMATGRPMFPGSTVKEELH 214
Query: 580 LLYASISRVLEES----NVREKLRGFIDPSLRNE 609
L++ + EE+ E+ R ++ P R +
Sbjct: 215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQ 248
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 43/239 (17%)
Query: 362 FQDLK-IATGSFSEENRIQ----GSVYRGS-FKGDDAAVKVMKGDVSSEINILKKINHSN 415
F+ LK I G+F E +Q G VY + D K G + +E +IL + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
++++ + N YL+ EF G + L D LT ++ + A++ +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-----MKKDTLTEEETQFYIAETVLAIDSI 117
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA----RSAESDEHEQGGYGL------- 524
H+ ++H+++K N+LLD+ K+++FGL ++ ++ + + L
Sbjct: 118 HQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 525 ----------------QLTRHVVGTYGYMAPE-YIENGVITPKLDVFAFGVVVLELLSG 566
QL VGT Y+APE +++ G D ++ GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 36/115 (31%), Positives = 58/115 (50%), Gaps = 27/115 (23%)
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+IA + AL YLH + +H+++K SN+L++ N + K+ +FG++ GY
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----------GY 153
Query: 523 GLQLTRHVV-----GTYGYMAPEYIENGVITP-----KLDVFAFGVVVLELLSGR 567
L V G YMAPE I N + K DV++ G+ ++EL +GR
Sbjct: 154 ---LVDSVAKTIDAGCKPYMAPERI-NPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 36/115 (31%), Positives = 58/115 (50%), Gaps = 13/115 (11%)
Query: 453 SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512
S L++ V +Y VAN + +L + VH++L N+L+ KI +FGLAR
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 513 ESDEH--EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
D + +G L L +MAPE I N + T DV++FG+++ E+ +
Sbjct: 290 MRDSNYISKGSTFLPLK--------WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
+E +L ++N I+ L YLV F + G L + H R D + R
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL--FHHLQREGRFD--LSRARF 97
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
A ++ AL LHK+ ++++LK NILLD + +FGL + D+ +
Sbjct: 98 YTA-ELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---- 149
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T GT Y+APE + T +D + GV++ E+L+G
Sbjct: 150 ----TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 20/141 (14%)
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
Y+V E+ G L + L SN Y + R A +V AL+ +H ++H+++K
Sbjct: 119 YMVMEYMPGGDLVN-LMSN-YDIPEKWA---RFYTA-EVVLALDAIHSMG---FIHRDVK 169
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN----G 545
N+LLD + K+ +FG +++ G+ VGT Y++PE +++ G
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDAN-------GMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 546 VITPKLDVFAFGVVVLELLSG 566
+ D ++ GV + E+L G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|197609 smart00257, LysM, Lysin motif | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 4e-06
Identities = 11/44 (25%), Positives = 23/44 (52%)
Query: 196 TYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILV 239
TY V GD++S+IA+ + + +L+ N + D + + +
Sbjct: 1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44
|
Length = 44 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 41/219 (18%)
Query: 374 EENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLV- 432
E+ I + RG+F G+ A VK+ D + IL K + R C E LV
Sbjct: 1 EDFEILKVIGRGAF-GEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVN 57
Query: 433 ----------YEFADNGALSDWLHSNRYQTSDNLTWKQRVQ--IAYDVAN--------AL 472
Y F D L +L + Y D LT + + + D+A A+
Sbjct: 58 GDNQWITTLHYAFQDENNL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
+ +H+ YVH+++K NIL+D N ++ +FG D Q VG
Sbjct: 116 DSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-------VG 165
Query: 533 TYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSG 566
T Y++PE ++ G P+ D ++ GV + E+L G
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 404 EINILKKINHSN-IIRLSGFCVH-------EGNTYLVYEFADNGALSDWLHSNRYQTSDN 455
EI++L+ ++ S I+RL V + + YLV+E+ D+ L ++ SN
Sbjct: 50 EISLLQMLSESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRP 106
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARS--- 511
L K Y + + + HK+ +H++LK N+L+D KI + GL R+
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 512 -AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGRE 568
+S HE + T Y APE + TP +D+++ G + E+ +
Sbjct: 164 PVKSYTHE------------IVTLWYRAPEVLLGSTHYSTP-VDIWSVGCIFAEMSRKQP 210
Query: 569 AVTGDQNCEAELLYASISRVL 589
GD E + L I ++L
Sbjct: 211 LFPGD--SELQQLL-HIFKLL 228
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 16/106 (15%)
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR----SAESDEHEQGGYGLQL 526
AL YLH Y VH++LK N+L+ + K+T+FGL++ S ++ +E G+ +
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE--GHIEKD 167
Query: 527 TR-----HVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSG 566
TR V GT Y+APE I G P +D +A G+++ E L G
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 41/222 (18%)
Query: 380 GSVYRGSFKGDDA--AVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHEG 427
G V+ KG A+KV+ V +E IL ++H + L E
Sbjct: 15 GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET 74
Query: 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHK 486
LV ++ G L + ++ + A +V AL YLH V++
Sbjct: 75 YLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYR 127
Query: 487 NLKTSNILLDTNLRAKITNFGLARSAESDEH--EQGGYGLQLTRHV-------------- 530
+LK NILL + +++F L++ ++ + + V
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 531 -----VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
VGT Y+APE I +D + G+++ E+L G
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 25/157 (15%)
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
+ +++ ALN+LH+ ++++LK N+LLD K+T++G+ + E + G
Sbjct: 102 SAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK-----EGIRPG--- 150
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE-------AVTGDQNCE 577
T GT Y+APE + +D +A GV++ E+++GR + DQN E
Sbjct: 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE 210
Query: 578 AELLYASISRVL---EESNVREK--LRGFI--DPSLR 607
L + + + +V+ L+GF+ DP R
Sbjct: 211 DYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 41/171 (23%), Positives = 77/171 (45%), Gaps = 19/171 (11%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+++LK + H+NI+ L E + LV+E+ D L +L N V+
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL-----DDCGNSINMHNVK 107
Query: 464 I-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+ + + LNY H+ +H++LK N+L++ K+ +FGLAR+
Sbjct: 108 LFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS--------I 156
Query: 523 GLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTG 572
+ + V T Y P+ + + ++D++ G + E+ +GR G
Sbjct: 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 35/206 (16%)
Query: 384 RGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLV----------- 432
RG+F G+ A VK+ + + IL K + R C E LV
Sbjct: 11 RGAF-GEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLH 67
Query: 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQ-------IAYDVANALNYLHKYTNPPYVH 485
Y F D L +L + Y D LT + + + +A + +H YVH
Sbjct: 68 YAFQDENYL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN- 544
+++K N+LLD N ++ +FG D Q VGT Y++PE ++
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA-------VGTPDYISPEILQAM 178
Query: 545 ----GVITPKLDVFAFGVVVLELLSG 566
G P+ D ++ GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 20/179 (11%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+++LK + H+NI+ L + + LV+E+ D L ++ N+ V+
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKD-LKQYM-----DDCGNIMSMHNVK 107
Query: 464 I-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
I Y + L Y H+ +H++LK N+L++ K+ +FGLAR+
Sbjct: 108 IFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT------ 158
Query: 523 GLQLTRHVVGTYGYMAPE-YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
+ + V T Y P+ + + + ++D++ G + E+ SGR G E EL
Sbjct: 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG-STVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 57/253 (22%), Positives = 104/253 (41%), Gaps = 68/253 (26%)
Query: 362 FQDLK-IATGSFSE----ENRIQGSVYRGSFKGDDAAVKVMK----------GDVSSEIN 406
F+ +K I G+F E + + G +Y A+K ++ V +E +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIY---------AMKKLRKSEMLEKEQVAHVRAERD 53
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ-RVQIA 465
IL + ++ +++L E YL+ E+ G + L + D T ++ R IA
Sbjct: 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KK---DTFTEEETRFYIA 108
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL- 524
+ A++ +HK Y+H+++K N+LLD K+++FGL + H Y +
Sbjct: 109 -ETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS-HRTEFYRIL 163
Query: 525 ------------------------------QLTRHVVGTYGYMAPE-YIENGVITPKLDV 553
L VGT Y+APE +++ G + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDW 222
Query: 554 FAFGVVVLELLSG 566
++ GV++ E+L G
Sbjct: 223 WSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV- 462
EI +LK++ H NI+RL + LV+E+ D +Y S N +
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDL-------KKYFDSCNGDIDPEIV 101
Query: 463 -QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511
+ + L + H + +H++LK N+L++ N K+ +FGLAR+
Sbjct: 102 KSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 27/156 (17%)
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA--AVKVM-KGDVSSEINILKKINHSNIIRLSG-- 421
I+ G+F G VY G K + AVKV+ K D+ ++ + + + + LS
Sbjct: 12 ISRGAF-------GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 422 FCVH-------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
F VH N YLV E+ G + LH Y + V+ +VA AL+Y
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEVALALDY 119
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510
LH++ +H++LK N+L+ K+T+FGL++
Sbjct: 120 LHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 484 VHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG--YGLQLTRH--------VVGT 533
+H++LK NILL I ++G A + +E + + + +VGT
Sbjct: 135 LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGT 194
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
YMAPE + + D++A GV++ ++L+
Sbjct: 195 PDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
LV ++A+ G L + +R +T+ + + V A++++H + +H+++K+
Sbjct: 116 LVLDYANAGDLRQEI-KSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKS 171
Query: 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK 550
+NILL +N K+ +FG ++ + + G R GT Y+APE + K
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVG------RTFCGTPYYVAPEIWRRKPYSKK 225
Query: 551 LDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEY 610
D+F+ GV++ ELL+ + G ++ V+ ++ L G DP
Sbjct: 226 ADMFSLGVLLYELLTLKRPFDG----------ENMEEVMHKT-----LAGRYDP-----L 265
Query: 611 PLDLAFSMAQLAKNCTAHDLNARPS 635
P ++ M ++ + D RPS
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan | Back alignment and domain information |
|---|
Score = 41.3 bits (98), Expect = 3e-05
Identities = 14/38 (36%), Positives = 21/38 (55%)
Query: 196 TYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFP 233
TY V GD++ +IA+ + V + AN L D I+P
Sbjct: 2 TYTVKPGDTLWSIAKKYGVTVEELAAANPLINPDCIYP 39
|
LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 13/115 (11%)
Query: 453 SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512
S+ LT + Y VA + +L + VH++L N+LL KI +FGLAR
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 513 ESDEH--EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
D + +G L + +MAPE I + + T DV+++G+++ E+ S
Sbjct: 288 MHDSNYVSKGSTFLPVK--------WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|144899 pfam01476, LysM, LysM domain | Back alignment and domain information |
|---|
Score = 40.5 bits (96), Expect = 5e-05
Identities = 11/44 (25%), Positives = 23/44 (52%), Gaps = 1/44 (2%)
Query: 197 YMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVP 240
Y V GD++S+IA+ + + + + N LS ++ + +P
Sbjct: 1 YTVKKGDTLSSIAKRYGITVEELAELNGLS-SPNLYVGQKLKIP 43
|
The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 54/242 (22%), Positives = 97/242 (40%), Gaps = 49/242 (20%)
Query: 362 FQDLK-IATGSFSEENRIQ----GSVYRGS-FKGDDAAVKVMKGDVSSEINILKKINHSN 415
F+ LK I G+F E +Q G +Y + D K + +E +IL + + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
++++ + N YL+ EF G + L D L+ + + A++ +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-----MKKDTLSEEATQFYIAETVLAIDAI 117
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA-------------------------- 509
H+ ++H+++K N+LLD K+++FGL
Sbjct: 118 HQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 510 -----RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564
R AE+ + + QL VGT Y+APE D ++ GV++ E+L
Sbjct: 175 NMNSKRKAETWKKNR----RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 565 SG 566
G
Sbjct: 231 IG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 30/106 (28%), Positives = 57/106 (53%), Gaps = 13/106 (12%)
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE--Q 519
++ + VA +++L + +H+++ N+LL AKI +FGLAR +D + +
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
G L + +MAPE I + V T + DV+++G+++ E+ S
Sbjct: 272 GNARLPVK--------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 39/142 (27%)
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR----SAESDE 516
R IA ++ A+ +HK ++H+++K NIL+D + K+T+FGL + +S
Sbjct: 104 RFYIA-ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 517 HEQGGYGLQ-------------------------------LTRHVVGTYGYMAPEYIENG 545
+++G + Q L +VGT Y+APE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 546 VITPKLDVFAFGVVVLELLSGR 567
T D ++ GV++ E+L G+
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 53/230 (23%), Positives = 100/230 (43%), Gaps = 42/230 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS--------EINILKKINHSN 415
K+ GS++ +VY+G K G A+KV++ E ++LK + H+N
Sbjct: 12 KLGEGSYA-------TVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN----LTWKQRVQIAYDVANA 471
I+ L + LV+E+ +H++ Q D L + + +
Sbjct: 65 IVLLHDIIHTKETLTLVFEY---------VHTDLCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
L+Y+H+ +H++LK N+L+ K+ +FGLAR+ H + VV
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-------TYSNEVV 165
Query: 532 GTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
T Y P+ + + LD++ G + +E++ G A G ++ + +L
Sbjct: 166 -TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 404 EINILKKI---NHSNIIRLSGFCV-----HEGNTYLVYEFADNGALSDWLHSNRYQTSDN 455
E+ +LK++ +H NI+RL C E LV+E D L +L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDK---VPPPG 104
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515
L + + L++LH N VH++LK NIL+ + + K+ +FGLAR
Sbjct: 105 LPAETIKDLMRQFLRGLDFLH--ANC-IVHRDLKPENILVTSGGQVKLADFGLARIYS-- 159
Query: 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575
+ LT VV T Y APE + +D+++ G + E+ + G N
Sbjct: 160 ------CQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG--N 210
Query: 576 CEAELL 581
EA+ L
Sbjct: 211 SEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 30/196 (15%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYL--VYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
E +I+ N +++L FC + + YL V E+ G L + L SN Y + W +
Sbjct: 93 ERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSN-YDVPEK--WAKF 146
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
+V AL+ +H +H+++K N+LLD + K+ +FG +
Sbjct: 147 Y--TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET------ 195
Query: 522 YGLQLTRHVVGTYGYMAPEYIE----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577
G+ VGT Y++PE ++ +G + D ++ GV + E+L GD
Sbjct: 196 -GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML------VGDTPFY 248
Query: 578 AELLYASISRVLEESN 593
A+ L + S++++ N
Sbjct: 249 ADSLVGTYSKIMDHKN 264
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 43/210 (20%)
Query: 384 RGSFKGDDAAVKVMKGDVSSEINILKKINHSNII-RLSGFCVHEGNTYLV---------- 432
RG+F G+ A VK MK + ++ +K +N ++ R C E LV
Sbjct: 11 RGAF-GEVAVVK-MKN--TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 433 -YEFADNGALSDWLHSNRYQTSDNLTWKQRV--QIAYDVAN--------ALNYLHKYTNP 481
Y F D L +L + Y D LT + ++ D+A A++ +H+
Sbjct: 67 HYAFQDENNL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG-- 122
Query: 482 PYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEY 541
YVH+++K N+LLD N ++ +FG +D G + VGT Y++PE
Sbjct: 123 -YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-------GTVQSNVAVGTPDYISPEI 174
Query: 542 IE-----NGVITPKLDVFAFGVVVLELLSG 566
++ G P+ D ++ GV + E+L G
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 40/165 (24%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
SE++ L +H I++ + L+ E+ G L+ + + + ++L +++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPFQEYE 170
Query: 463 Q--IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+ Y + AL+ +H +H++LK++NI L K+ +FG ++ SD
Sbjct: 171 VGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY-SDS---- 222
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
L + GT Y+APE E + K D+++ GV++ ELL+
Sbjct: 223 -VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 26/168 (15%)
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
Y+V E+ G L + L SN Y + W R A +V AL+ +H ++H+++K
Sbjct: 119 YMVMEYMPGGDLVN-LMSN-YDVPEK--WA-RFYTA-EVVLALDAIHSMG---FIHRDVK 169
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE----NG 545
N+LLD + K+ +FG + G+ VGT Y++PE ++ +G
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKE-------GMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 546 VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593
+ D ++ GV + E+L GD A+ L + S+++ N
Sbjct: 223 YYGRECDWWSVGVFLYEML------VGDTPFYADSLVGTYSKIMNHKN 264
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|217059 pfam02480, Herpes_gE, Alphaherpesvirus glycoprotein E | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 16/65 (24%), Positives = 26/65 (40%)
Query: 243 TAPSKIQLPVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLLLVATLFAFLFCL 302
P L PPP T + S ++ ++ + AG+ +LL+ C+
Sbjct: 316 HRPRLGALDSIEPPPPPTPTPPAEIAPPSPGTRPYLLLLAGVLGAAVLLLVVGLLAWVCV 375
Query: 303 YRRRR 307
RRRR
Sbjct: 376 TRRRR 380
|
Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI) (pfam01688), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation. Length = 437 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 38/166 (22%), Positives = 77/166 (46%), Gaps = 11/166 (6%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+++ K NH NI+ + + ++V F G+ D + ++ D ++
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH---FMDGMSELAIAY 105
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
I V AL+Y+H YVH+++K S+IL+ ++ K+ GL + H Q
Sbjct: 106 ILQGVLKALDYIHHMG---YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRV 160
Query: 524 LQ-LTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSG 566
+ ++ V +++PE ++ + K D+++ G+ EL +G
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 19/153 (12%)
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
N++ L + V E + +LV + A+ G L W H +++ N+ + + A ++ AL+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFL---NIPEECVKRWAAEMVVALDA 100
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
LH+ V ++L +NILLD ++T F E V
Sbjct: 101 LHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED----------SCDGEAVENM 147
Query: 535 GYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
Y APE T D ++ G ++ ELL+G+
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 20/164 (12%)
Query: 402 SSEINILKKINHSNIIRLSGFCVHEGNTYLV---YEFADNGALSDWLHSNRYQTSDNLTW 458
E +L++++H ++ L V G T LV Y SD L++ L
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-------SD-LYTYLGARLRPLGL 259
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
Q +A + +A++Y+H +H+++KT N+L++ + +FG A A
Sbjct: 260 AQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLE 562
YG + GT APE + TP +D+++ G+V+ E
Sbjct: 317 PFHYG------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 26/185 (14%)
Query: 404 EINILKKINHSNIIRLSGF----CV--HEGNTYL--VYEFADNGALSDWLHSNRYQTSDN 455
E+ I+K +NH NII L + C +E N +L V EF H R +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168
Query: 456 LTWKQRVQIAYDVANALNYLH-KYTNPPYVHKNLKTSNILLDTNLRA-KITNFGLARSAE 513
L + +Y + AL Y+H K+ H++LK N+L+D N K+ +FG A++
Sbjct: 169 LFLVKLY--SYQLCRALAYIHSKFI----CHRDLKPQNLLIDPNTHTLKLCDFGSAKNL- 221
Query: 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTG 572
Q + + + Y APE + T +D+++ G ++ E++ G +G
Sbjct: 222 --------LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273
Query: 573 DQNCE 577
+ +
Sbjct: 274 QSSVD 278
|
Length = 440 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 669 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.89 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.42 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.04 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.97 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 98.73 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 98.61 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 98.41 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 98.4 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 98.37 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.31 | |
| smart00257 | 44 | LysM Lysin motif. | 98.27 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 98.16 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 98.11 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.06 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 98.01 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.01 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.98 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.98 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 97.97 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 97.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.89 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.83 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.63 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.5 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.36 | |
| smart00257 | 44 | LysM Lysin motif. | 97.35 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 97.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.11 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.54 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-51 Score=431.86 Aligned_cols=278 Identities=40% Similarity=0.718 Sum_probs=238.8
Q ss_pred cccccchhHHHHHhCCCCccccee----eEEEEEEECC-CeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 356 SLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSFKG-DDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 356 ~~~~~~~~~l~~~~g~f~~~~~~~----G~Vy~g~~~g-~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
....|.+.+++.+|.+|+.++.++ |.||+|.+++ ..||||++.. +|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 457799999999999999999886 8999999965 8899998742 588999999999999999999999
Q ss_pred EecC-ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 424 VHEG-NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 424 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
.+++ +.+||||||++|+|.++|+.... . .|+|.+|++||.++|.||+|||+...|+|||||||++|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~--~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG--E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCC--C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 49999999999999999987631 1 799999999999999999999999989999999999999999999999
Q ss_pred EcccCCccccCC-CccccCCcccceeeec-ccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 503 ITNFGLARSAES-DEHEQGGYGLQLTRHV-VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 503 l~DfGla~~~~~-~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
|+|||+|+.... ... .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+.........
T Consensus 218 lsDFGLa~~~~~~~~~---------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~ 288 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS---------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS 288 (361)
T ss_pred ccCccCcccCCccccc---------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence 999999976653 221 1111 79999999999999999999999999999999999999888543222233
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccC-CCCcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLR-NEYPL-DLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+..|+...+.+. .+..++|+.+. ..++. +....+.+++.+|++.+|.+||+|.||++.|+.+...
T Consensus 289 l~~w~~~~~~~~----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 289 LVEWAKPLLEEG----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHHHCc----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 555555555443 78889999987 66664 6788899999999999999999999999999776544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=410.66 Aligned_cols=245 Identities=31% Similarity=0.544 Sum_probs=216.8
Q ss_pred HHHhCCCCcccceeeEEEEEEECCC-eeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADN 438 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~-~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 438 (669)
++|+|.| |.||.|.+++. .||+|.++. +|.+|+++|++|+|+|||+++|+|..++.++||||||+.
T Consensus 213 ~LG~G~F-------G~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 213 ELGSGQF-------GEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HhcCCcc-------ceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 6899999 99999999987 899999864 588999999999999999999999998899999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccc
Q 005923 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518 (669)
Q Consensus 439 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~ 518 (669)
|+|.+||+.. ....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||...++.+
T Consensus 286 GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y- 358 (468)
T KOG0197|consen 286 GSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY- 358 (468)
T ss_pred CcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-
Confidence 9999999873 3467899999999999999999999999 99999999999999999999999999996554432
Q ss_pred cCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhh
Q 005923 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREK 597 (669)
Q Consensus 519 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (669)
.......-+..|.|||++..+.|+.|||||||||+||||+| |+.|+.+....+
T Consensus 359 ------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------------------- 412 (468)
T KOG0197|consen 359 ------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------------------- 412 (468)
T ss_pred ------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------------
Confidence 12223345779999999999999999999999999999999 888888765432
Q ss_pred hhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 598 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
+-..++.+.|.+.|..|+.+++++|..||+.+|++|||++.+...|+.+....
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 22345567888999999999999999999999999999999999999987654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=422.24 Aligned_cols=249 Identities=30% Similarity=0.487 Sum_probs=215.2
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
++|+|.| |+||+|... ...||||.+|+ ||++|+++|..++|||||+|+|+|.+++.++
T Consensus 493 eLGegaF-------GkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 493 ELGEGAF-------GKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hhcCchh-------hhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 5999999 999999873 23589999874 6999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 431 LVYEFADNGALSDWLHSNRYQ-----T----SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~-----~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
||+|||.+|||.+||+.+... . ..+|+..+.++||.|||.||+||-++. +|||||.++|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 999999999999999764211 1 234999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 580 (669)
||+||||+|.....++.. ...+..-+++|||||.+..++||.+||||||||||||+++ |+.|+.+-.+.+.
T Consensus 643 KIsDfGLsRdiYssDYYk------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-- 714 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYK------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-- 714 (774)
T ss_pred Eecccccchhhhhhhhhc------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--
Confidence 999999999988776543 2223455789999999999999999999999999999999 9999987655321
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
+..+-+..+ .+.|++|+.++++||..||+.+|.+||+++||-..|+.....+
T Consensus 715 -----------------Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 -----------------IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -----------------HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 122222333 6789999999999999999999999999999999999887654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=397.02 Aligned_cols=244 Identities=33% Similarity=0.574 Sum_probs=211.1
Q ss_pred HHhCCCCcccceeeEEEEEEECCCe-eEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC-ceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDD-AAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG-NTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~-vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~ 435 (669)
+|+|.| |+||+|.++|+. ||||++.. +|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 49 iG~G~~-------g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 49 LGSGSF-------GTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred cccCCc-------eeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 899999 999999999999 99999974 6899999999999999999999998887 79999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfGla~~~~~ 514 (669)
+++|+|.++|++. ....+++..+++|+.|||+||+|||+++. |||||||++|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999873 23579999999999999999999999863 99999999999999998 999999999997654
Q ss_pred CccccCCcccceeeecccccccccccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIE--NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
.. .......||..|||||++. ...|+.|+||||||++||||+||+.||.+..... .
T Consensus 197 ~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~-------- 254 (362)
T KOG0192|consen 197 SK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------V-------- 254 (362)
T ss_pred cc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------H--------
Confidence 21 1122267999999999999 5699999999999999999999999998765411 1
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
...++....+...|..++..+..|+.+||+.||..||++.|++..|+.+...
T Consensus 255 -----~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 255 -----ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -----HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1111223445666777888999999999999999999999999999988764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=404.59 Aligned_cols=251 Identities=31% Similarity=0.505 Sum_probs=218.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.+++++ ||.|.| |.|++|+++ ...||||.+|. +|..|+.||.++.||||++|.|+.+..
T Consensus 631 i~Ie~V-IGaGEF-------GEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 631 VKIEKV-IGAGEF-------GEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred eEEEEE-Eecccc-------cceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 445554 899999 999999984 34799999963 799999999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
...++|.|||+||+|..||+.+. +.+++-|+.-++++||.||+||.+.+ +|||||.++||||+.+..+||+||
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccc
Confidence 99999999999999999998763 56999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
||+|.+.++... ...+..-.-+++|.|||.+..+++|.++||||||+||||.++ |..|+.+..+.+
T Consensus 776 GLSRvledd~~~-----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------- 842 (996)
T KOG0196|consen 776 GLSRVLEDDPEA-----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------- 842 (996)
T ss_pred cceeecccCCCc-----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--------
Confidence 999988655411 122333344679999999999999999999999999999998 999998765422
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
+...++..++.+.|.+|+..|.+||.+||++|-.+||.+.+|+..|.++.-..
T Consensus 843 ------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 843 ------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 22234456788999999999999999999999999999999999999998554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.90 Aligned_cols=272 Identities=29% Similarity=0.459 Sum_probs=209.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEec----ccHHHHHHHHHh--cCCCCceeEeeEEEecC----
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK----GDVSSEINILKK--INHSNIIRLSGFCVHEG---- 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~----~~~~~E~~~l~~--l~H~niv~l~g~~~~~~---- 427 (669)
....+.++ +|.|+| |.||+|.++++.||||++. ..+..|-+|.+. +.|+||++++++-....
T Consensus 210 ~pl~l~el-i~~Grf-------g~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLEL-IGRGRF-------GCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHH-hhcCcc-------ceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 34455554 899999 9999999999999999995 457777777765 58999999999976555
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeeCCCCCCeeecCCCcE
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY------TNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------~~~~ivHrDik~~NILl~~~~~~ 501 (669)
+++||+||.++|||.+||..+ .++|....+|+..+++||+|||+. .+|+|+|||||++||||.+|+++
T Consensus 282 eywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 789999999999999999875 599999999999999999999963 46899999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCC-CC-----chhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-IT-----PKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-----~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
.|+|||||..+...... ..+...+||.+|||||++++.. +. .+.||||+|.|||||++....+..+..
T Consensus 356 cIaDFGLAl~~~p~~~~------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v 429 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQ------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV 429 (534)
T ss_pred EeeccceeEEecCCCCC------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence 99999999988754321 1233479999999999998743 22 368999999999999998877652222
Q ss_pred hHHHHHHH------HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 576 CEAELLYA------SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 576 ~~~~~~~~------~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.+.+.+++ --..-+++...+++.+..+...++.. .-...+++.+..||+.|++.|.|+.=+.+++.++...
T Consensus 430 p~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 430 PEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 22222222 11112222222333333333333222 2345689999999999999999999999999999877
Q ss_pred CCC
Q 005923 650 SSD 652 (669)
Q Consensus 650 ~~~ 652 (669)
..+
T Consensus 507 ~~~ 509 (534)
T KOG3653|consen 507 WED 509 (534)
T ss_pred CCc
Confidence 655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=353.71 Aligned_cols=237 Identities=26% Similarity=0.426 Sum_probs=200.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec--------ccHHHHHHHHHhcCCCCceeEeeEEEecCc-eeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK--------GDVSSEINILKKINHSNIIRLSGFCVHEGN-TYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~e 434 (669)
.+|.|+- |+||++.++ +..+|+|++. .++.+|++++++.+||+||.++|.|..++. ..++||
T Consensus 86 ~lG~G~g-------G~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 86 VLGSGNG-------GTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred hcccCCC-------cEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3899998 999999985 7788999983 246789999999999999999999999995 999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||++|||.+++... +.+++..+-+|+.+|++||.|||+ ++ ||||||||+|||++..|.+||||||.++.+.
T Consensus 159 YMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999754 569999999999999999999996 77 9999999999999999999999999999875
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
.. .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+...... ....+
T Consensus 231 nS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~----------- 288 (364)
T KOG0581|consen 231 NS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIF----------- 288 (364)
T ss_pred hh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHH-----------
Confidence 43 235579999999999999999999999999999999999999999864110 00111
Q ss_pred HHhhhhcccCCccCCCCcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLD-LAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.+..+++.. ....|.+ +..++++++..||++||.+||++.|++++
T Consensus 289 --~Ll~~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 289 --ELLCAIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --HHHHHHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222333311 1233444 78889999999999999999999999876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=357.60 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=205.9
Q ss_pred HHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|+|.| |.|.....++ ..||||.++. +|.+|+++|.+++|||||+|+|+|..++.+++|+|||
T Consensus 545 kiGeGqF-------GEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 545 KIGEGQF-------GEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hhcCccc-------ceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 6999999 9999999876 8999999974 5889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++|+|.+||..+.. ..+.-...++|+.||+.||+||.+.+ +|||||.++|||+|.++++||+|||++|.+..++
T Consensus 618 EnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred hcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999987731 22455677889999999999999999 9999999999999999999999999999887765
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS--GREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
+. ..-...+-+++|||||.+..+++|.++|||+||++|||+++ ...||....++ ..
T Consensus 692 yy------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----------------~v 749 (807)
T KOG1094|consen 692 YY------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE----------------QV 749 (807)
T ss_pred ce------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH----------------HH
Confidence 42 23344566889999999999999999999999999999876 55666543321 11
Q ss_pred HhhhhcccCCc---cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 595 REKLRGFIDPS---LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 595 ~~~l~~~~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
.+....+.+.. .....|.-|+..++++|.+||..|..+||+++++...|++.
T Consensus 750 ven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 750 VENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12222233221 12345678889999999999999999999999999999865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=391.14 Aligned_cols=249 Identities=31% Similarity=0.547 Sum_probs=211.7
Q ss_pred HHhCCCCcccceeeEEEEEEEC---CC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK---GD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~---g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
+|+|.| |.||+|++. |. .||||.++. +|.+|..+|++++|||||+++|+|.+.+..++
T Consensus 700 lG~G~F-------G~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 700 LGKGAF-------GEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred eccccc-------cceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 899999 999999984 33 389998863 58899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 432 VYEFADNGALSDWLHSNRYQ--TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++|||++|+|..||++.|.. ....|+-..++.++.|||+|++||++++ +|||||.++|+||++...+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999986422 1456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
|.+...++... .....-+.+|||||.+..+.||.|+|||||||+|||++| |..||.+..+.+. +..+
T Consensus 850 rDiy~~~yyr~------~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~ 917 (1025)
T KOG1095|consen 850 RDIYDKDYYRK------HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDV 917 (1025)
T ss_pred Hhhhhchheec------cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHH
Confidence 97665554322 111244578999999999999999999999999999999 8888887654321 1111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCC
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSS 651 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 651 (669)
+..+ +.+.|..|+..+++||..||+.+|++||++..|++.+..+.+...
T Consensus 918 -------------~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 918 -------------LEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -------------HhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1122 567888999999999999999999999999999999999886643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.23 Aligned_cols=240 Identities=28% Similarity=0.458 Sum_probs=208.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
+.|+...+ +|+|+| ..||.++. .|+.||+|++.. .+.+|++|.++|+|||||+++++|++
T Consensus 18 ~~Y~~g~~-LGkGgF-------A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED 89 (592)
T KOG0575|consen 18 KRYKRGRF-LGKGGF-------ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED 89 (592)
T ss_pred ceeeeeee-eccCcc-------eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec
Confidence 45666665 999999 99999998 589999999843 46789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.++.|||.|++++|+|.++++++ +.|++..++.+..||+.||.|||+++ |+|||||..|+|++++.++||+|
T Consensus 90 s~nVYivLELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgD 161 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGD 161 (592)
T ss_pred CCceEEEEEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecc
Confidence 99999999999999999999854 57999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||||..+..++ ......+||+.|+|||++.....+..+||||+|||||-||.|+.||....-.+..
T Consensus 162 FGLAt~le~~~--------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety------ 227 (592)
T KOG0575|consen 162 FGLATQLEYDG--------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY------ 227 (592)
T ss_pred cceeeeecCcc--------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH------
Confidence 99999887553 2235689999999999999999999999999999999999999999865432211
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+... ....|..+..+..+||.++|+.||.+|||+++|+..
T Consensus 228 -------------~~Ik~~--~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 228 -------------NKIKLN--EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -------------HHHHhc--CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111111 123456777889999999999999999999999975
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=361.52 Aligned_cols=245 Identities=29% Similarity=0.496 Sum_probs=215.4
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
++|.|.| |.||.|.|+ .-.||||.+|.| |.+|+.+|+.++|||+|+|+|+|+.+...|+|.|||.
T Consensus 274 KLGGGQY-------GeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 274 KLGGGQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred ccCCCcc-------cceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 5899999 999999996 557999999864 8899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcc
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~ 517 (669)
+|+|.|||+.. +...++--.++.++.||..||+||..++ +|||||.++|+|+.++..+||+||||+|.+..+.+
T Consensus 347 yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 347 YGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred CccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999875 3345777888999999999999999999 99999999999999999999999999999877654
Q ss_pred ccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 518 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
..+ ....-.+.|.|||.+....++.|+|||+|||+|||+.| |..|+.+.+-.
T Consensus 421 TAH-------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------------------- 473 (1157)
T KOG4278|consen 421 TAH-------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------- 473 (1157)
T ss_pred ecc-------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------------------
Confidence 221 11234678999999999999999999999999999998 88888875422
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.+-++++..++.+.|+.|+..+++||+.||+.+|.+||++.|+.+.|+.|.+++
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 223344556778889999999999999999999999999999999999998765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=342.24 Aligned_cols=193 Identities=32% Similarity=0.571 Sum_probs=173.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.. ++|.|.| |.||+|+. ++..||||.+... +..|+.+|+.++|||||+|+++++.+
T Consensus 10 ~~y~~~~-~iG~Gsf-------avVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 10 GDYELSR-EIGSGSF-------AVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred ccceehh-hccCcce-------EEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 4455544 4999999 99999998 4788999988532 46799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC------Cc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN------LR 500 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~------~~ 500 (669)
+..||||||+.+|+|.+|+++. +.+++...+.++.|||.||++||+++ ||||||||.||||+.. -.
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCce
Confidence 9999999999999999999876 36999999999999999999999999 9999999999999764 46
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
+||+|||+||.+.... ......|++.|||||++..++|+.|+|+||.|+++|++++|+.||.....
T Consensus 154 LKIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred EEecccchhhhCCchh---------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 8999999999987543 34557899999999999999999999999999999999999999986554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=356.74 Aligned_cols=235 Identities=28% Similarity=0.482 Sum_probs=209.0
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHh
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLH 446 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 446 (669)
+|.|.- |.||+|++.++.||||+++.--..+|+-|++|+|+||+.+.|+|...-.+|+||||++.|-|.+.|+
T Consensus 132 lGSGaQ-------GAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk 204 (904)
T KOG4721|consen 132 LGSGAQ-------GAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK 204 (904)
T ss_pred hccCcc-------cceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh
Confidence 788888 9999999999999999999877789999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccce
Q 005923 447 SNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526 (669)
Q Consensus 447 ~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 526 (669)
.. ..++...++.|..+||.||+|||.+. |||||||+-||||..+..+||+|||-++...... .
T Consensus 205 a~-----~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---------T 267 (904)
T KOG4721|consen 205 AG-----RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---------T 267 (904)
T ss_pred cc-----CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---------h
Confidence 64 56889999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred eeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCcc
Q 005923 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSL 606 (669)
Q Consensus 527 ~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l 606 (669)
.-.+.||..|||||++.+...+.|+|||||||||||||||..||.+-+.. ..+-..=...+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------------------AIIwGVGsNsL 328 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------------------AIIWGVGSNSL 328 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------------------eeEEeccCCcc
Confidence 23468999999999999999999999999999999999999999753321 11112223456
Q ss_pred CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 607 RNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 607 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
..+.|..|+.-+.=|++.||+..|.+||++++|+.+|.
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 67888899999999999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=330.41 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=204.6
Q ss_pred cccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec---------ccHHHHHHHHHhcCCCCceeEee-EE
Q 005923 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK---------GDVSSEINILKKINHSNIIRLSG-FC 423 (669)
Q Consensus 356 ~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g-~~ 423 (669)
++..|.+.+ ++|.|.| |+|||+.. +|..+|.|.++ .+..+|+.+|++++|||||++++ .+
T Consensus 17 ~l~~y~Il~-~IG~GsF-------g~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 17 TLADYQILK-KIGRGSF-------GEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred cHHHHHHHH-HHcCCcc-------hheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 445677766 5999999 99999976 68899999874 35678999999999999999999 44
Q ss_pred EecCc-eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeeCCCCCCeeecCCCcE
Q 005923 424 VHEGN-TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT-NPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 424 ~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-~~~ivHrDik~~NILl~~~~~~ 501 (669)
.++.. +++||||+..|+|...++.-+ ...+.++++.+++++.|++.||.++|++- +..|+||||||.||+++.+|.+
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence 44444 899999999999999998764 34567999999999999999999999831 1239999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
|++||||+|.+.... ......+||+.||+||.+.+..|+.|+||||+||++|||..-+.||.+++- ..+
T Consensus 168 KLGDfGL~r~l~s~~--------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L 236 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKT--------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSL 236 (375)
T ss_pred eeccchhHhHhcchh--------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHH
Confidence 999999999987653 345668999999999999999999999999999999999999999998631 111
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYP-LDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
.. ++.. +--.+.| .-....+.+|+..|+..||..||+...++..+.
T Consensus 237 ~~-------------KI~q----gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 237 CK-------------KIEQ----GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HH-------------HHHc----CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11 1111 1012234 455677899999999999999999655554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=343.75 Aligned_cols=239 Identities=28% Similarity=0.437 Sum_probs=196.3
Q ss_pred HHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 364 DLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 364 ~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.-.+|.|.| |.|-+|.- .|+.||||++.. ++.+|+++|++++|||||++.+++...+
T Consensus 177 ~~~LGsGaf-------g~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 177 SKTLGSGAF-------GLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred eeeecCCce-------eEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346999999 99999987 489999999852 3568999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC---CcEEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN---LRAKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~ 504 (669)
..||||||++||+|.+++-.+ +.+.+..-.-+++|++.|+.|||++| |+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999765 34777777889999999999999999 9999999999999765 889999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCC---CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI---TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
|||+|+..+.. ...+..+||+.|.|||++.+..+ ..+.|+||+|||||-+++|..||.+..... .+
T Consensus 322 DFGlAK~~g~~---------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl 390 (475)
T KOG0615|consen 322 DFGLAKVSGEG---------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL 390 (475)
T ss_pred ccchhhccccc---------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH
Confidence 99999987643 35677899999999999976543 348899999999999999999998643211 01
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.+ ..+ + ..+....-.....+..+||.+||..||++|||++|++.+
T Consensus 391 ~eQI---~~G-----~------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 391 KEQI---LKG-----R------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHH---hcC-----c------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0110 000 0 011223345667889999999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.16 Aligned_cols=256 Identities=30% Similarity=0.441 Sum_probs=209.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecccH--------HHHHHHHHhcC-CCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGDV--------SSEINILKKIN-HSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~~--------~~E~~~l~~l~-H~niv~l~g~~~~~ 426 (669)
.+|..-+ ++|.|.| |+||+|+- .|+.||||+||..| .+|++.|++|+ ||||++|..++.+.
T Consensus 10 ~RY~~i~-klGDGTf-------GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 10 DRYTVIR-KLGDGTF-------GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHH-HhcCCcc-------eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 3455544 6999999 99999987 48899999998754 47999999999 99999999999988
Q ss_pred C-ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 427 G-NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 427 ~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
+ .+++|||||+. +|.+.++++ .+.+++..+..|+.||+.||+|+|.+| +.|||+||+|||+..+..+||+|
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecc
Confidence 8 89999999986 999999865 367999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+||...+... .+..+.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-+..|.|..+.+ ....
T Consensus 154 FGLARev~SkpP---------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D---qi~K 221 (538)
T KOG0661|consen 154 FGLAREVRSKPP---------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID---QIYK 221 (538)
T ss_pred cccccccccCCC---------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH---HHHH
Confidence 999998865432 34468899999999985 5789999999999999999999999998865422 2345
Q ss_pred HHHHHhhhhHHhh-----hhcccCCc--------cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREK-----LRGFIDPS--------LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~-----l~~~~d~~--------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+..++..+..... +...+.-. +..-.| ....+..+|+.+|+..||.+|||+.|.+++
T Consensus 222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 5666654443221 22222111 111122 256778999999999999999999999976
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.51 Aligned_cols=238 Identities=26% Similarity=0.441 Sum_probs=197.4
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe----cCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH----EGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 431 (669)
.+++|++ |.||+|.++|+.||||.++. .+.+|+++|++++||||++++|++.+ ....++
T Consensus 27 ~i~~g~~-------~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 27 LIKENDQ-------NSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred EEeeCCc-------eEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence 3678888 99999999999999999853 24589999999999999999999977 346799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
||||+++|+|.++++.. +.++|...++++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++
T Consensus 100 v~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 100 ILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred EEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence 99999999999999754 3589999999999999999999984 6 7899999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ...
T Consensus 172 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~---- 233 (283)
T PHA02988 172 ILSSPP-----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDL---- 233 (283)
T ss_pred hhcccc-----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHH----
Confidence 654321 12357889999999976 7899999999999999999999999986543211 000
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
++....+...+..++..+.+++.+||+.||.+|||++|+++.|+.+++
T Consensus 234 ------------i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 234 ------------IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ------------HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 011111223344566789999999999999999999999999998864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=355.12 Aligned_cols=245 Identities=29% Similarity=0.547 Sum_probs=207.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC---C--Ce-eEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK---G--DD-AAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~---g--~~-vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
++|+|+| |.||+|++. + .. ||||..+. ++.+|+++|++++|||||+++|++..+..+
T Consensus 164 kLGeGaF-------GeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 164 KLGEGAF-------GEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred eeecccc-------cEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 6999999 999999983 2 23 89999874 367899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++|||++.||+|.++|++.+ +.++..+++.++.++|.||+|||+++ ++||||.++|+|++.++.+||+|||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999998763 36999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCccccCCcccceee-ecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTR-HVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+..... .... ...-+.+|+|||.+..+.|+.++|||||||++||+++ |..|+.+....+.
T Consensus 310 ~~~~~~---------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--------- 371 (474)
T KOG0194|consen 310 RAGSQY---------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--------- 371 (474)
T ss_pred cCCcce---------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---------
Confidence 865411 1111 2245789999999999999999999999999999999 8899988664311
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
...++...++...|...+..+..++.+||..||++||+|.++.+.|+.+......
T Consensus 372 ----------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 372 ----------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111123445556667788899999999999999999999999999999876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=343.10 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=211.1
Q ss_pred cccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeE
Q 005923 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 356 ~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
....|+|.++ +|.|.| .+|++++.. +..+|||++..+ +..|-++|.+| +||.|++|+..
T Consensus 71 ~~~DF~Fg~~-lGeGSY-------StV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 71 TPNDFKFGKI-LGEGSY-------STVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred Chhhcchhhe-eccccc-------eeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 4456888886 999999 899999874 789999998543 45789999999 89999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
|.++..+|+|+||+++|+|.+++++. +.|++.....++.+|+.||+|||++| ||||||||+|||||+|+++|
T Consensus 143 FQD~~sLYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 143 FQDEESLYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred eecccceEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEE
Confidence 99999999999999999999999865 57999999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCC--ccc-ce--eeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 503 ITNFGLARSAESDEHEQGG--YGL-QL--TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~--~~~-~~--~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
|+|||-|+.+......... ... .. ....+||..|.+||+|..+..++.+|+|+|||+||.|+.|+.||.+.+.
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-- 292 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-- 292 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--
Confidence 9999999987654322110 000 11 2458999999999999999999999999999999999999999987653
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
.+.++.+.. +.-++|.+.++.+.+|+++.|..||.+|+|..+|.++.
T Consensus 293 -yliFqkI~~------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 293 -YLIFQKIQA------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -HHHHHHHHH------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 333333221 12355666678899999999999999999999988763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.70 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=198.4
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEecc----cHHHHHHHHHh--cCCCCceeEeeEEEecC----ceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG----DVSSEINILKK--INHSNIIRLSGFCVHEG----NTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~ 435 (669)
.+|.|+| |.||+|.|.|+.||||++.. .+.+|.++.+. |+|+||+.+++.-..+. .+|||.+|
T Consensus 218 ~IGkGRy-------GEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 218 IIGKGRF-------GEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EecCccc-------cceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 3899999 99999999999999999953 46677777766 59999999999865443 57999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH-----KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH-----~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
.++|||.|||.++ .++-...++++..+|.||+||| .+++|.|.|||||+.||||.+++.+.|+|+|||.
T Consensus 291 He~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 291 HEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred ccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999764 5999999999999999999999 4689999999999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCC------CchhhHHHHHHHHHHHHcCC----------CCCCCCc
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI------TPKLDVFAFGVVVLELLSGR----------EAVTGDQ 574 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------s~~sDV~S~Gvvl~elltg~----------~p~~~~~ 574 (669)
....+...- ....+..+||.+|||||++....- =..+||||||.|+||+.... .||.+--
T Consensus 365 ~h~~~t~~i----di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 365 RHDSDTDTI----DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred EecccCCcc----cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 876553211 233567899999999999975332 12589999999999997633 3333211
Q ss_pred hhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEY-----PLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+ .++..++..+-+...+++... ..++...|.+||+.||..||..|-|+-.|-+.|.++.+.
T Consensus 441 p--------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 441 P--------------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred C--------------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 1 011111122222233333332 346677899999999999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.49 Aligned_cols=252 Identities=28% Similarity=0.399 Sum_probs=201.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEec--CceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVHE--GNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 432 (669)
+||+|.| |.||+|+. .|+.||+|+++-+ ..+||.||++|+||||++|.+..++. +.+|||
T Consensus 124 kIGeGTy-------g~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 124 KIGEGTY-------GQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HhcCcch-------hheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 5899999 99999997 5888999998743 35899999999999999999999877 689999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
+|||++ +|.-++... .-.|+..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+..
T Consensus 197 FeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999998 899988753 245999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... ...+..+-|.+|+|||.|.+ ..|+.+.|+||.||||.||+.|+..+.|..+.+ ..+.|.++...
T Consensus 269 ~~~~~-------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve---Ql~kIfklcGS 338 (560)
T KOG0600|consen 269 TPSGS-------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE---QLHKIFKLCGS 338 (560)
T ss_pred cCCCC-------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH---HHHHHHHHhCC
Confidence 65442 22344677999999999987 679999999999999999999999999876533 23444444433
Q ss_pred hhHH----hhhhcccCCccCCCCc-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVR----EKLRGFIDPSLRNEYP-------LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~----~~l~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+... .++-.+.-......+. ..++....+|+..+|..||.+|.|+.++++.
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 2221 1121111111111121 2345567899999999999999999998854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=340.34 Aligned_cols=241 Identities=32% Similarity=0.548 Sum_probs=211.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC----CC--eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK----GD--DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~----g~--~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|.|-| |.||+|.+. |+ .||||..|. .|..|..+|++++||||++|+|+|. +...|+
T Consensus 396 ~iG~GqF-------GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wi 467 (974)
T KOG4257|consen 396 LIGEGQF-------GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWI 467 (974)
T ss_pred hhcCCcc-------cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeE
Confidence 4899999 999999983 33 478999875 3889999999999999999999995 668899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
|||.++.|.|..||+.++ ..|+...+..++.||+.||.|||+.. +|||||..+|||+.+.-.+|++|||++|.
T Consensus 468 vmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999998764 56899999999999999999999999 99999999999999999999999999999
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
+..+.+... ....-++.|||||.+..+++|.++|||.|||.|||+++ |..||.+-.+.
T Consensus 541 ~ed~~yYka-------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-------------- 599 (974)
T KOG4257|consen 541 LEDDAYYKA-------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-------------- 599 (974)
T ss_pred ccccchhhc-------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--------------
Confidence 887664322 12345678999999999999999999999999999988 99999875432
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
.+...++.+-+.+.|..|+..++.|+.+||..||.+||++.|+...|+.+++
T Consensus 600 ------DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 600 ------DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ------ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1233455566789999999999999999999999999999999999999886
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.42 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=196.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
++|+|+| |.||+.+.+ |+.||||++.. -..+|+++|++++|+|+|.|+.+|..+..++||+|
T Consensus 9 kvGEGSY-------GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 9 KVGEGSY-------GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred ccccCcc-------eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4899999 999999884 88999999853 25689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|++. ++.+-|... ...++...+.++++|++.|+.|+|+++ ++||||||+|||++.++.+||||||+||.+..
T Consensus 82 ~~dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9998 555555543 245889999999999999999999999 99999999999999999999999999998864
Q ss_pred CccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... ..+..+.|.+|+|||.+.+ ..|....||||.||++.||++|...|.|..+-+. ++ .+...+.+-.
T Consensus 154 pgd--------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ--Ly-~I~ktLG~L~ 222 (396)
T KOG0593|consen 154 PGD--------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ--LY-LIRKTLGNLI 222 (396)
T ss_pred Ccc--------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH--HH-HHHHHHcccC
Confidence 321 2344678999999999988 7899999999999999999999999998765432 22 2222222211
Q ss_pred HH--------hhhhcccCCc------cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 VR--------EKLRGFIDPS------LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~~--------~~l~~~~d~~------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+ ....++.-|. +...+| .....+.++++.||+.||.+|++.++++.+
T Consensus 223 prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 223 PRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11 0111111111 111222 233468899999999999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=340.84 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=199.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|.+.+ ++|.|+| |.||+|.. .+..||||+++. .+.+|+.++.++ +||||++++++
T Consensus 8 ~~~~~~-~lG~G~f-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 8 RLRLGK-VLGHGAF-------GKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred Hceeee-EeccCCc-------ceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 344444 3899999 99999975 245799999853 366899999999 89999999999
Q ss_pred EEecC-ceeEEEEecCCCCHHHHHhcCCCC--------------------------------------------------
Q 005923 423 CVHEG-NTYLVYEFADNGALSDWLHSNRYQ-------------------------------------------------- 451 (669)
Q Consensus 423 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------- 451 (669)
|...+ ..++||||+++|+|.+++...+..
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 87654 579999999999999999753210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCccc
Q 005923 452 -------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524 (669)
Q Consensus 452 -------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 524 (669)
....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------~ 230 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------Y 230 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc------h
Confidence 0135889999999999999999999998 99999999999999999999999999986543221 1
Q ss_pred ceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccC
Q 005923 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFID 603 (669)
Q Consensus 525 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d 603 (669)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+. +...+..
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~------------ 292 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKD------------ 292 (338)
T ss_pred hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhc------------
Confidence 11223456778999999999999999999999999999997 9999876432110 0001100
Q ss_pred CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 604 PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 604 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
......+..++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 293 -~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 293 -GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001122334556789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.62 Aligned_cols=235 Identities=24% Similarity=0.446 Sum_probs=203.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|.- |.||.+.- .++.||||.|.. -+..|+.+|+..+|+|||+++..+..++++|+|||||
T Consensus 280 kigqgaS-------G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 280 KIGQGAT-------GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhccccc-------cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 6899988 99999987 577899999842 3678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++|+|.|.+... .+++.++..|+++++.||+|||.++ |+|||||++|||++.++.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999764 4999999999999999999999999 9999999999999999999999999998876543
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
. ....++||+.|||||++....|.+|.||||||++++||+-|+.||..+....+..+
T Consensus 424 ~--------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL--------------- 480 (550)
T KOG0578|consen 424 S--------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------------- 480 (550)
T ss_pred C--------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH---------------
Confidence 2 23458999999999999999999999999999999999999999987554322111
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+. .........++.+...+.+++.+||+.|+.+||++.|+|++
T Consensus 481 -Ia--~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 481 -IA--TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -Hh--hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11 11222345667788899999999999999999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.01 Aligned_cols=232 Identities=28% Similarity=0.407 Sum_probs=194.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
|++..+ +|.|+| |+||..+- .++.+|+|+|+. ....|..+|.+++||.||+++-.|.+.+
T Consensus 27 F~~lkv-iGkG~f-------GkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 27 FEILKV-IGKGSF-------GKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred eeeeee-eeccCC-------ceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 444343 899999 99999876 477899999964 2567999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
.+|||+||+.||.|..+|.+. +.+++....-++.+|+.||.|||+++ ||||||||+|||+|++|+++|+|||
T Consensus 99 kLylVld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred eEEEEEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 999999999999999999765 46899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
|++...... ..++..+||+.|||||++.+..|+..+|+||+|+++|||++|..||.+.+... ....
T Consensus 171 L~k~~~~~~--------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~ 236 (357)
T KOG0598|consen 171 LCKEDLKDG--------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDK 236 (357)
T ss_pred cchhcccCC--------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHH
Confidence 999654332 34566899999999999999999999999999999999999999999765321 1111
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 635 (669)
++ ... ....|.-...+.++++++.|..||.+|..
T Consensus 237 I~-------------~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 237 IL-------------KGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred Hh-------------cCc-CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 11 111 12233345667899999999999999963
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=330.53 Aligned_cols=246 Identities=31% Similarity=0.453 Sum_probs=200.0
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc-------HHHHHHHHHhcCCCCceeEeeEEEecC--c
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD-------VSSEINILKKINHSNIIRLSGFCVHEG--N 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~-------~~~E~~~l~~l~H~niv~l~g~~~~~~--~ 428 (669)
+...++ +|.|.| |+||++... |+..|||.+... +.+|+.+|++++|||||+.+|...... .
T Consensus 19 ~~~~~~-lG~Gs~-------G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 19 WSKGKL-LGRGSF-------GSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred hhhhcc-ccCccc-------eEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 333443 899999 999999985 789999998654 789999999999999999999855444 6
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DfG 507 (669)
++++|||+++|+|.+++.+.+ +.|++..+.++..||++||+|||+++ ||||||||+|||++. ++.+||+|||
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g----~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG 163 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYG----GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFG 163 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCc
Confidence 899999999999999998752 26999999999999999999999999 999999999999999 7999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC-chhHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGD-QNCEAELLYASI 585 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~-~~~~~~~~~~~~ 585 (669)
+++....... .........||+.|||||++..+ ....++|||||||++.||+||+.||... ... ..+
T Consensus 164 ~a~~~~~~~~-----~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~~ 232 (313)
T KOG0198|consen 164 LAKKLESKGT-----KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EAL 232 (313)
T ss_pred cccccccccc-----cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HHH
Confidence 9997764111 01224457899999999999964 3445999999999999999999998752 110 001
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
+....+. .....|..++.+..+++.+|+..||++|||++|++.+--
T Consensus 233 ------------~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 233 ------------LLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ------------HHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1111111 123667778888999999999999999999999998854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.28 Aligned_cols=246 Identities=30% Similarity=0.554 Sum_probs=200.8
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
+||.|+| |+||||.|.| +||||+++. .|.+|+.++++-+|.||+-+.|||..... .+|..++
T Consensus 399 rIGsGsF-------GtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 399 RIGSGSF-------GTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred eeccccc-------cceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence 4799999 9999999976 479999963 48899999999999999999999977766 9999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
+|-+|+.+||-.+ ..|...+.+.||.|||.||.|||.++ |||||||+.|||+.+++++||+||||+..-....
T Consensus 470 eGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 470 EGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred cCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999998653 46888999999999999999999999 9999999999999999999999999997654331
Q ss_pred cccCCcccceeeeccccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
. .+-.....|...|||||+++. ..|++.+||||||+|+|||++|..||..... + ..++.
T Consensus 543 g------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-d-qIifm---------- 604 (678)
T KOG0193|consen 543 G------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-D-QIIFM---------- 604 (678)
T ss_pred c------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-h-heEEE----------
Confidence 1 122334567889999999964 5789999999999999999999999984332 1 11110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.-++...+.+ .....+++.+|.+|+..||..++++||.+.+|+..|+.+.-+
T Consensus 605 ---VGrG~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 605 ---VGRGYLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ---ecccccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0011111111 122346788999999999999999999999999999888763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=341.48 Aligned_cols=239 Identities=29% Similarity=0.477 Sum_probs=207.2
Q ss_pred HHHhCCCCcccceeeEEEEEEEC---CC--eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK---GD--DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~---g~--~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
++|.|+| |.|++|.|+ |+ .||||.++. +|.+|+.+|.+|+|+|+++|+|+..+ ....||
T Consensus 117 ~LG~GsF-------gvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 117 LLGEGSF-------GVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HhcCcce-------eeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 4999999 999999994 44 579999874 68999999999999999999999976 788999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
||+++.|||.+.|++. ....|-...+-.++.|||.||.||.+++ +|||||.++|+||-..-.+||+||||.|.+
T Consensus 189 ~ELaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhhcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 9999999999999873 3456778888999999999999999999 999999999999999999999999999998
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...+.. ..+..+..-...|+|||.+..+.|+.++|||+|||++|||+| |++||.|-....
T Consensus 263 g~ned~-----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------------- 323 (1039)
T KOG0199|consen 263 GENEDM-----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------------- 323 (1039)
T ss_pred CCCCcc-----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------
Confidence 765532 345556667789999999999999999999999999999999 888988755321
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+-+.+|.+-+.+.|..|++.++++|+.||..+|++|||+..|.+.+
T Consensus 324 ------IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ------ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ------HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2223445556778889999999999999999999999999998554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=302.74 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=206.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
|...+ ++|+|.| |.||+|.. .|+.||||+++- ...+|++.|+.++|+||+.|+++|-+.+.
T Consensus 4 Y~~~~-~lGEG~~-------gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 4 YEKLE-KLGEGTY-------GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred hhhhh-hhcCcce-------EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 44334 5999999 99999998 589999999863 35689999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
..||+|||+. +|...+++. ...|+..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+
T Consensus 76 l~lVfEfm~t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 76 LSLVFEFMPT-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred eEEEEEeccc-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccc
Confidence 9999999986 999999864 357999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
||.+..... ...+.+-|.+|+|||.+.| ..|+...|+||.|||+.||+-|..-|.|+.+-+ ....+.+
T Consensus 148 Ar~f~~p~~--------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid---QL~~If~ 216 (318)
T KOG0659|consen 148 ARFFGSPNR--------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID---QLSKIFR 216 (318)
T ss_pred hhccCCCCc--------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH---HHHHHHH
Confidence 999876542 2234478999999999877 679999999999999999999988888876532 2234445
Q ss_pred HHhhhhHHh--hhhcc---------cCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEESNVRE--KLRGF---------IDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~--~l~~~---------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+..+...+ .+..+ -.+.+..-+ ..+...+.+|+..||..||.+|+|+.|++++
T Consensus 217 ~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 217 ALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HcCCCCcccCccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 554333221 11111 122222222 2344567999999999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.06 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=204.1
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
...|++.+. +|.|.- +.||+|.. .++.||||++.- .+.+|+..|+.++||||++++..|..+
T Consensus 25 ~~~YeL~e~-IG~G~s-------a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 25 AKDYELQEV-IGVGAS-------AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccceeEEEE-Eeccce-------eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 355777664 888877 89999998 578999999852 477899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
..+|+||.||.+||+.+.++..- ...+.+..+..|.+++++||.|||.+| .||||||+.||||+++|.+||+||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCc
Confidence 99999999999999999998752 234999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCccccee-eeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLT-RHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|.+..+..... +.... .+.+||+.|||||++.. ..|+.|+||||||++..||.+|..||...... +.+.
T Consensus 171 gvsa~l~~~G~-----R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl- 242 (516)
T KOG0582|consen 171 GVSASLFDSGD-----RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLL- 242 (516)
T ss_pred eeeeeecccCc-----eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHH-
Confidence 99987765431 12222 67899999999999654 67999999999999999999999999864432 1221
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.-++.....- ....+..+........+.+++..||++||.+|||++++++.
T Consensus 243 ---~tLqn~pp~~-----~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 243 ---LTLQNDPPTL-----LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ---HHhcCCCCCc-----ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1122111000 00011122223444578999999999999999999998864
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=322.53 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=199.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.++ +|+|+| |.||+|.++ +..+|+|.++. .+.+|+.++++++||||++++|++..
T Consensus 6 ~~~~~~~-ig~G~f-------g~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 6 SIKIERI-LGTGRF-------GELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred HeEEeee-ecccCC-------CeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 3555554 899999 999999863 45789998763 36689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++... ...++|.+++.++.|++.||+|||+++ ++||||||+|||++.++.+|++|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECC
Confidence 99999999999999999999754 246899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||.+........ .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.+....+ ...
T Consensus 151 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~- 219 (266)
T cd05064 151 FRRLQEDKSEAI-------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK- 219 (266)
T ss_pred Ccccccccccch-------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH-
Confidence 998765432210 11122345678999999999999999999999999999875 999997654321 000
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
.+. .......+..++..+.+++.+||+.+|.+||+++||.+.|+++
T Consensus 220 ---~~~-------------~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 ---AVE-------------DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---HHH-------------CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011 0111233455667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.48 Aligned_cols=250 Identities=28% Similarity=0.509 Sum_probs=202.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
|++.+ .+|.|+| |.||+|...+ ..+++|.++. ++.+|++++.+++||||+++++++.
T Consensus 7 ~~~~~-~lg~G~~-------g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 78 (283)
T cd05048 7 VRFLE-ELGEGAF-------GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78 (283)
T ss_pred cchhh-cccCccC-------CcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence 44444 4899999 9999998743 3589998853 3678999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTS-----------DNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
..+..+++|||+++|+|.+++........ ..+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Ni 155 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNC 155 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceE
Confidence 88999999999999999999976421111 46899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 005923 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~ 572 (669)
++++++.+||+|||+++....... ........++..|+|||.+.++.++.++|||||||++|||++ |..||.+
T Consensus 156 l~~~~~~~~L~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 156 LVGEGLTVKISDFGLSRDIYSADY------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred EEcCCCcEEECCCcceeecccccc------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999986543321 112233456788999999999999999999999999999998 9999876
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
....+. .. .+. .......+.+++.++.+|+.+||+.||++||++.||++.|+++
T Consensus 230 ~~~~~~---~~-------------~i~----~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 230 FSNQEV---IE-------------MIR----SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCHHHH---HH-------------HHH----cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 443210 00 010 1111234556678899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.11 Aligned_cols=239 Identities=36% Similarity=0.644 Sum_probs=189.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|.|.| |.||+|.++ +..|+||.++. ++.+|++.+++++||||++++|+|.+.+..++
T Consensus 6 ~ig~G~f-------g~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 6 QIGEGSF-------GKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEESS-------EEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred EEccCCC-------cEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccc
Confidence 3899999 999999997 56799999953 47789999999999999999999998888999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.++|+.. ....+++.++.+|+.||+.||.|||+.+ ++|+||+++|||+++++.+||+|||+++.
T Consensus 79 v~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 99999999999999875 2356999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... ............|+|||.+....++.++||||||+++|||++ |+.|+......+ ....+ .
T Consensus 153 ~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~-~ 219 (259)
T PF07714_consen 153 ISEKSK------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL-K 219 (259)
T ss_dssp TTTSSS------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-H
T ss_pred cccccc------ccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-c
Confidence 732221 112223456778999999999999999999999999999999 678876543211 00011 0
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
...+...+..++..+.+++.+||+.||.+||++.|+++.|
T Consensus 220 -------------~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 -------------QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------------TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------------ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112234445667789999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=371.52 Aligned_cols=254 Identities=31% Similarity=0.497 Sum_probs=202.5
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCC
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGA 440 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 440 (669)
.+|.|+| |.||+|.. ++..||||.++. ....|++++++++|||||+++|+|.+++..++||||+++|+
T Consensus 697 ~ig~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 697 VISRGKK-------GASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred EEccCCC-------eeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 3899999 99999996 578999998864 23568999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccC
Q 005923 441 LSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520 (669)
Q Consensus 441 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 520 (669)
|.++++. ++|..+.+|+.|++.||+|||+...++++||||||+||+++.++..++. ||........
T Consensus 770 L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----- 835 (968)
T PLN00113 770 LSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----- 835 (968)
T ss_pred HHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----
Confidence 9999952 8999999999999999999997655669999999999999999988876 6655433211
Q ss_pred CcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhc
Q 005923 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRG 600 (669)
Q Consensus 521 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 600 (669)
....++..|+|||++.+..++.++|||||||++|||++|+.|+....... .....+....... .....
T Consensus 836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~----~~~~~ 903 (968)
T PLN00113 836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSD----CHLDM 903 (968)
T ss_pred -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCc----cchhh
Confidence 11357889999999999999999999999999999999999986432211 1111222211111 12344
Q ss_pred ccCCccCC--CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 601 FIDPSLRN--EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 601 ~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
++|+.+.. ..+.+...++.+++.+||+.||.+||||+||++.|+++...+.+
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 55655533 33456667789999999999999999999999999999776554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.06 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=196.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC------------------CCeeEEEEecc--------cHHHHHHHHHhcC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK------------------GDDAAVKVMKG--------DVSSEINILKKIN 412 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~------------------g~~vavK~~~~--------~~~~E~~~l~~l~ 412 (669)
.|.+.+ ++|.|+| |.||++.++ +..||+|.++. ++.+|++++.+++
T Consensus 6 ~~~~~~-~lg~G~f-------g~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 6 HLLFKE-KLGEGQF-------GEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK 77 (304)
T ss_pred hCeeee-EecccCC-------eEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC
Confidence 344545 4899999 999999753 23589999853 4678999999999
Q ss_pred CCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005923 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRY--------------QTSDNLTWKQRVQIAYDVANALNYLHKY 478 (669)
Q Consensus 413 H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~qia~~L~yLH~~ 478 (669)
||||+++++++.+.+..++||||+++|+|.+++..... .....++|..+++++.||+.||.|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999999999999999999999999965421 1123578999999999999999999999
Q ss_pred CCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHH
Q 005923 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGV 558 (669)
Q Consensus 479 ~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gv 558 (669)
+ |+||||||+|||+++++.+||+|||+++....... ........++..|+|||++.++.++.++||||||+
T Consensus 158 ~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 158 N---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred C---ccccCcchhheEEcCCccEEECCCccceecccCce------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9 99999999999999999999999999986643321 11223345678899999999999999999999999
Q ss_pred HHHHHHc--CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 559 VVLELLS--GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 559 vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
++|||++ +..|+.+....+ ....+...+.. ... ......+..++..+.+++.+||+.||.+|||+
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQ---VIENAGEFFRD-----QGR-----QVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhh-----ccc-----cccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 9999987 455665433211 11111111110 000 00111233455678999999999999999999
Q ss_pred HHHHHHHH
Q 005923 637 SEVFVTLS 644 (669)
Q Consensus 637 ~evl~~L~ 644 (669)
.||.+.|+
T Consensus 296 ~~i~~~l~ 303 (304)
T cd05096 296 SDIHAFLT 303 (304)
T ss_pred HHHHHHHh
Confidence 99998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=327.93 Aligned_cols=233 Identities=26% Similarity=0.422 Sum_probs=185.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++|.|.| |.||++... ++.||||++.. .+.+|++++++++|+||+++++++..++..++||||
T Consensus 81 ~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 81 RIGSGAG-------GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred hccCCCC-------eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4899999 999999984 78999999842 367899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++|+|.+.. .+.+..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 154 ~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999986532 2567788899999999999999999 999999999999999999999999999876432
Q ss_pred ccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
.. ......||..|+|||.+.. ...+.++|||||||++|||++|+.||......+.......
T Consensus 222 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------ 287 (353)
T PLN00034 222 MD--------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------ 287 (353)
T ss_pred cc--------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------
Confidence 11 1233578999999998843 2345689999999999999999999974322111110000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+. .......+..+..++.+|+.+||+.||.+|||+.|++++
T Consensus 288 -------~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 -------IC----MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------Hh----ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 001122233455678999999999999999999999976
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.74 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=198.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|++.+ .+|.|+| |.||++.. .+..||||+++. .+.+|+++|..+ +||||++++++
T Consensus 36 ~~~~~~-~LG~G~f-------G~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 36 RLSFGK-TLGAGAF-------GKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred Heehhh-eecCCcc-------ceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 456655 4999999 99999974 244799999863 356899999999 89999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCC----------------------------------------------------
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRY---------------------------------------------------- 450 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------- 450 (669)
|..++..++||||+++|+|.++++..+.
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 9999999999999999999999975321
Q ss_pred ------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 451 ------------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 451 ------------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
.....++|..+++++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceec
Confidence 01125889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... ........++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ..+.
T Consensus 265 ~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~- 331 (375)
T cd05104 265 RNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY----KMIK- 331 (375)
T ss_pred cCccc------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH----HHHH-
Confidence 43321 011122345678999999999999999999999999999998 888886543211 100 1111
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
...+...+...+.++.+|+.+||+.||.+||++.||++.|++.
T Consensus 332 ------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 ------------EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------------hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111122223356789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.49 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=199.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|.+.+ .+|.|+| |.||++... +..||+|.++. .+.+|+++++++ +|+||++++++
T Consensus 39 ~~~~~~-~LG~G~f-------g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 39 NLQFGK-TLGAGAF-------GKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred Hceehh-eecCCCc-------ccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 355554 3899999 999998852 24799999863 356899999999 89999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCC----------------------------------------------------
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRY---------------------------------------------------- 450 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------- 450 (669)
|...+..++||||+++|+|.++++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 9999999999999999999999965310
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcc
Q 005923 451 -------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517 (669)
Q Consensus 451 -------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~ 517 (669)
.....+++.++++|+.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 01235889999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 518 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
........++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ....
T Consensus 268 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~------- 328 (374)
T cd05106 268 ------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMV------- 328 (374)
T ss_pred ------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHH-------
Confidence 111222345678999999999999999999999999999997 999987543211 00 0000
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
........+...+.++.+++.+||+.||.+|||+.||++.|+++.
T Consensus 329 ------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 329 ------KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ------HcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011111222233567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=309.54 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=206.3
Q ss_pred HHhCCCCcccceeeEEEEEEEC-------CCeeEEEEeccc--------HHHHHHHHHhcCCCCceeEeeEEEecC-cee
Q 005923 367 IATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKGD--------VSSEINILKKINHSNIIRLSGFCVHEG-NTY 430 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~~--------~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~ 430 (669)
+.+|.| |.||+|.|. .+.|.||.++.. +..|--++..+.|||+..+.|++.++. ..+
T Consensus 292 lqEGtF-------Gri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 292 LQEGTF-------GRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred hhcCch-------hheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 678999 999999763 335778888753 456888888889999999999998764 568
Q ss_pred EEEEecCCCCHHHHHhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 431 LVYEFADNGALSDWLHSNRY---QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
++|.++..|+|+.||...|. ...+.++..+++.++.|++.||+|||.++ +||.||.++|++||+..++||+|-.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccch
Confidence 89999999999999984332 23356888999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 586 (669)
++|.+...++..-+. .--.+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-++.|.+
T Consensus 442 LSRDLFP~DYhcLGD------nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~------- 508 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGD------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME------- 508 (563)
T ss_pred hccccCcccccccCC------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------
Confidence 999987766544332 1234678999999999999999999999999999998 99998866654322
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
..+..+.|...|.+|+.+++.+|.-||..+|++||++++++.-|++...
T Consensus 509 -------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 509 -------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2333456677888999999999999999999999999999999988753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.71 Aligned_cols=246 Identities=27% Similarity=0.475 Sum_probs=211.5
Q ss_pred HHHHHhCCCCcccceeeEEEEEEE--CCC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 364 DLKIATGSFSEENRIQGSVYRGSF--KGD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 364 ~l~~~~g~f~~~~~~~G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
+.++|.|.| |+||+|.| +|+ +||+|++.. ++.+|+.+|.+++|||+++|+|+|.... .
T Consensus 701 ~kvLGsgAf-------GtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 701 DKVLGSGAF-------GTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hceeccccc-------eeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 335899999 99999998 443 689998853 4788999999999999999999997655 8
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
.||.+||+.|+|.||++.+| ..+-.+..+.|..|||+||.|||++. +|||||.++||||.+-..+||.|||++
T Consensus 773 qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence 99999999999999999875 45888999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
+....+..+.. .....-.+.|||-|.+....|+.++|||||||++||++| |..|+++....
T Consensus 846 ~ll~~d~~ey~------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------ 907 (1177)
T KOG1025|consen 846 KLLAPDEKEYS------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------ 907 (1177)
T ss_pred hccCccccccc------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------
Confidence 99877654332 122334678999999999999999999999999999999 99999875532
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.+.+++....|...|..+...++.++.+||..|++.||+++|+...+.++....
T Consensus 908 --------eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 908 --------EIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred --------HhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 233344445567788899999999999999999999999999999999887554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.60 Aligned_cols=241 Identities=26% Similarity=0.419 Sum_probs=206.9
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
+..|++.. .+|+|.- |.|-.|+. .|+.+|||++.. .+.+|+-+|+.+.||||++|+++++
T Consensus 11 iGpwkLgk-TLG~Gst-------g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 11 IGPWKLGK-TLGKGST-------GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred ccceeccc-cccCCCC-------ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 34566655 5899998 99999987 599999999853 3789999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++.++|||.||+++|-|.++|... +.|++....++++||+.|+.|+|..+ |+||||||+|+|||...++||+
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeee
Confidence 999999999999999999999765 57999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|||+|.....+ .+...-+|.+.|.|||++.+..| ..++||||.|||||.||+|+.||++++-. .++..
T Consensus 155 DFGMAsLe~~g---------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir--~LLlK 223 (786)
T KOG0588|consen 155 DFGMASLEVPG---------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR--VLLLK 223 (786)
T ss_pred ccceeecccCC---------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH--HHHHH
Confidence 99999876543 34566799999999999999988 57899999999999999999999965421 11111
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
.. +..-+.|...+.+..+|+++|+..||..|.|++||+++-
T Consensus 224 V~-------------------~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 224 VQ-------------------RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HH-------------------cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11 112355677888899999999999999999999999873
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.26 Aligned_cols=241 Identities=28% Similarity=0.488 Sum_probs=198.4
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
++|.|.| |.||+|..+ ++.+++|.++. ++.+|++++++++|+||+++++++..++..++||||++
T Consensus 13 ~ig~g~~-------~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 13 KLGGGQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred ecCCccc-------ceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4899999 999999984 77899999864 36689999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcc
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~ 517 (669)
+|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 86 YGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999997542 346899999999999999999999998 99999999999999999999999999987654321
Q ss_pred ccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 518 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.+....+ ....
T Consensus 160 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~------------ 217 (263)
T cd05052 160 T-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL------------ 217 (263)
T ss_pred e-------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH------------
Confidence 1 1112234568999999999999999999999999999998 888887643211 1000
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+. .......+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 218 -~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 -LE----KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -HH----CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11 1112233445567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=300.81 Aligned_cols=220 Identities=29% Similarity=0.458 Sum_probs=194.0
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|+|+| |.|...+. +|..+|+|+++. ...+|..+|+.+.||++++|.+.|.+.+..+||||
T Consensus 52 lGtGSF-------GrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 52 LGTGSF-------GRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred eccCcc-------ceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 799999 99999887 478899999864 24579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|++||.|..+|++. +++++...+-+|.||+.||+|||+.+ |++|||||+|||+|.+|.+||.|||+|+....
T Consensus 125 yv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 125 YVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred ccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999865 56999999999999999999999999 99999999999999999999999999997753
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.+...+||+.|+|||.+....+..++|.|||||++|||+.|..||..++...
T Consensus 197 -----------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------- 248 (355)
T KOG0616|consen 197 -----------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------- 248 (355)
T ss_pred -----------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----------------
Confidence 2567899999999999999999999999999999999999999999766421
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCC
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 633 (669)
...+++... -.+|..+...+.+|+...|+.|-.+|
T Consensus 249 --iY~KI~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 --IYEKILEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --HHHHHHhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 111222222 24677777889999999999999998
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.61 Aligned_cols=247 Identities=28% Similarity=0.501 Sum_probs=197.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|+|+| |.||+|.+ +++ .||+|.++. ++.+|+.+++.++||||++++|+|.. +..++
T Consensus 14 ~lg~G~~-------g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~ 85 (316)
T cd05108 14 VLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 85 (316)
T ss_pred eeecCCC-------ceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCcee
Confidence 3899999 99999987 333 389999752 36679999999999999999999975 46789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
|+||+++|+|.++++... ..+++..+++++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999998642 45899999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.+....+ +...+.
T Consensus 159 ~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~ 225 (316)
T cd05108 159 LGADEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILE 225 (316)
T ss_pred ccCCCcc------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHh
Confidence 6543211 11112234678999999999999999999999999999998 999987643221 111111
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDW 653 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 653 (669)
. ......+..+...+.+++.+||+.||.+||++.+++..|.++......|
T Consensus 226 ~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 226 K-------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred C-------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 1 1111222334557899999999999999999999999999998766544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.14 Aligned_cols=237 Identities=27% Similarity=0.465 Sum_probs=202.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----c-----HHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----D-----VSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----~-----~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
|.+-| .+|.|.| |.||||+.+ .+.||+|.+.+ + +.+|++++++++|||||.++++|+...+
T Consensus 4 yhv~e-~iG~Gsf-------g~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 4 YHVYE-MIGEGSF-------GRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH 75 (808)
T ss_pred hhHHH-HhcCCcc-------ceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence 44444 4999999 999999875 56799998742 2 7789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
+++|.||+.+ +|..+|... +.|+++++..|+.|+..||.|||+.+ |.|||+||+|||++.++.+|++|||+
T Consensus 76 ~~vVte~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEEehhhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhh
Confidence 9999999986 999999765 56999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
||.+.... .+.+.+.||+.|||||.+.++.|+..+|.||+||++||+++|+.||.... ..+.+..+
T Consensus 147 Ar~m~~~t--------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I 212 (808)
T KOG0597|consen 147 ARAMSTNT--------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSI 212 (808)
T ss_pred hhhcccCc--------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHH
Confidence 99886543 35567899999999999999999999999999999999999999997532 11111111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.+ + ..+|......+..++...|.+||.+|.|-.+++.+
T Consensus 213 ~~d------------~---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 213 LKD------------P---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred hcC------------C---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111 1 23455777889999999999999999999998865
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.84 Aligned_cols=247 Identities=27% Similarity=0.451 Sum_probs=195.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|.|+| |.||+|.+ +++ .+++|.+.. ++..|+.++++++||||+++++++. +...++
T Consensus 14 ~lg~G~~-------~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 14 LLGSGVF-------GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred ccCccCC-------cceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 3899999 99999998 344 477787742 3456777889999999999999985 456789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
++||+++|+|.++++..+ ..++|..+..|+.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999997542 46899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... ........++..|+|||.+.++.++.++||||||+++|||++ |+.||.+...... ...++
T Consensus 159 ~~~~~~------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~ 225 (279)
T cd05111 159 LYPDDK------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLE 225 (279)
T ss_pred ccCCCc------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHH
Confidence 643221 111223456778999999999999999999999999999998 9999876443211 11111
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDW 653 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 653 (669)
. ......+..+...+.+++.+||..||.+|||+.|+++.|..+...+..|
T Consensus 226 ~-------------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 226 K-------------GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred C-------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 1 0111112233456789999999999999999999999999988766554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.75 Aligned_cols=243 Identities=27% Similarity=0.445 Sum_probs=201.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc------------HHHHHHHHHhcC-CCCceeEeeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD------------VSSEINILKKIN-HSNIIRLSGF 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~------------~~~E~~~l~~l~-H~niv~l~g~ 422 (669)
..|.+.. .+|.|.| |+|+.|.. .+..||+|++..+ +.+|+.++++++ ||||++++.+
T Consensus 17 g~y~~~~-~lG~Gsf-------gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 17 GKYELGR-TLGSGSF-------GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred Cceeeee-eecCCCC-------eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 4555555 4999999 99999987 5889999976432 347999999999 9999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRA 501 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~ 501 (669)
+......++||||+.+|+|.+++.+. +++.+....+++.|++.|++|||+++ |+||||||+|||+|.+ +++
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCE
Confidence 99999999999999999999999863 56889999999999999999999999 9999999999999999 999
Q ss_pred EEcccCCccccC-CCccccCCcccceeeecccccccccccccccCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 502 KITNFGLARSAE-SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-IT-PKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 502 kl~DfGla~~~~-~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
||+|||++.... .+ .......||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...
T Consensus 161 Kl~DFG~s~~~~~~~---------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~- 230 (370)
T KOG0583|consen 161 KLSDFGLSAISPGED---------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN- 230 (370)
T ss_pred EEeccccccccCCCC---------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-
Confidence 999999999874 22 2345679999999999999977 75 78999999999999999999998744211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDL-AFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
+... +... .-.+|..+ ..++..|+.+|+..||.+|+|+.||+ .-.-+.
T Consensus 231 --l~~k----------------i~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 231 --LYRK----------------IRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred --HHHH----------------HhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 1111 1111 12344445 77889999999999999999999999 433333
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.76 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=203.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|.+.+ .++.|+| |.||++... +..+++|.++. .+.+|++++++++|+||+++++++..
T Consensus 7 ~~~~~-~lg~g~~-------g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 7 IVLKR-ELGEGAF-------GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred eEEee-eecccCC-------CeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 44443 4899999 999999853 34588998863 46789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCee
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NIL 494 (669)
.+..++||||+++++|.+++..+.. .....++|..++.++.||+.||+|||+++ ++||||||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 155 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCL 155 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEE
Confidence 9999999999999999999976421 12245899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 005923 495 LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGD 573 (669)
Q Consensus 495 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~ 573 (669)
+++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EccCCcEEECCCCcccccCCCce------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999986543321 111223456788999999999999999999999999999999 99998754
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
...+. .. ... . ......+..++..+.+++.+||+.||.+||++++|++.|+++...+..
T Consensus 230 ~~~~~---~~----~~~------------~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 230 SNTEV---IE----CIT------------Q-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred CHHHH---HH----HHh------------C-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 43210 00 000 0 001112233456789999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.66 Aligned_cols=238 Identities=23% Similarity=0.470 Sum_probs=193.1
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADN 438 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 438 (669)
++|.|+| |.||++.++ +..+|+|.++. ++.+|++++++++||||+++++++..++..++||||+++
T Consensus 11 ~lg~G~~-------~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 11 ELGSGQF-------GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred EecCCcC-------ceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4899999 999999985 45789998753 467899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccc
Q 005923 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518 (669)
Q Consensus 439 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~ 518 (669)
|+|.++++... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 84 GCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 99999997542 35899999999999999999999999 99999999999999999999999999986543221
Q ss_pred cCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhh
Q 005923 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREK 597 (669)
Q Consensus 519 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (669)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... ....
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~---i~~~------ 217 (256)
T cd05114 156 ------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEM---ISRG------ 217 (256)
T ss_pred ------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH---HHCC------
Confidence 11122345668999999999899999999999999999999 8889876443211 000 1000
Q ss_pred hhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 598 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
.+...+...+..+.+++.+||+.||.+||++.|+++.|+
T Consensus 218 --------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 218 --------FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001112233457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.48 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=203.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|.+.+ .+|.|+| |.||++.. ++..+|+|.++. ++.+|++++++++|+||+++++++..
T Consensus 7 ~~~~~-~lg~G~~-------~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 7 IVLKR-ELGEGAF-------GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred eeecc-ccCCcCC-------eeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 44444 3899999 99999975 134588998753 46789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRY--------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
.+..++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+++ ++||||||+|||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEcc
Confidence 9999999999999999999975421 12235999999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~ 576 (669)
++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred CCcEEeccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999866432211 11123345778999999999999999999999999999998 88888754421
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 005923 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDW 653 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 653 (669)
+ . .. .... ... ...+..++..+.+++.+||+.||.+|||+.|+++.|+++...+..|
T Consensus 230 ~--~-~~---~i~~---------~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~ 286 (288)
T cd05093 230 E--V-IE---CITQ---------GRV-----LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY 286 (288)
T ss_pred H--H-HH---HHHc---------CCc-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence 1 0 00 0000 000 1112234457899999999999999999999999999999876655
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.18 Aligned_cols=241 Identities=29% Similarity=0.503 Sum_probs=194.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE----CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF----KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~----~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
++|.|+| |.||+|.+ .+..+|+|+++. ++..|+.++++++|+||+++++++. ++..++|
T Consensus 2 ~lg~G~~-------g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNF-------GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCC-------cceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 4789999 99999976 367799998853 3677999999999999999999985 5577999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++..
T Consensus 74 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 74 MELAELGPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcccccc
Confidence 9999999999999754 35899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
....... .......++..|+|||.+....++.++|+||||+++|||++ |+.||......+ ....
T Consensus 146 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~------- 210 (257)
T cd05116 146 GADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQM------- 210 (257)
T ss_pred CCCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------
Confidence 5432110 11112234578999999988889999999999999999998 999987543321 0000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
++ .....+.|..++.++.+++.+||+.||.+||++++|.+.|++.+
T Consensus 211 ------i~----~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 211 ------IE----SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred ------HH----CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 11 11122334456678899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.04 Aligned_cols=242 Identities=26% Similarity=0.475 Sum_probs=194.2
Q ss_pred HHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||+|.+. +..+|+|.++. ++.+|+.++++++|+||+++++++. ....++||
T Consensus 2 ~ig~G~~-------g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNF-------GCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCc-------ccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 4799999 999999873 34689998853 3668999999999999999999985 55789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ...+++..+++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 74 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 74 EMASGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred EeCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcccccc
Confidence 999999999999753 246899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+
T Consensus 147 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~--- 211 (257)
T cd05115 147 ADDSYY-----KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFI--- 211 (257)
T ss_pred CCccce-----eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHH---
Confidence 332110 01111233568999999998899999999999999999996 9999876443211 0000
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
....+...+..++.++.+++.+||..||++||++.+|.+.|+.++
T Consensus 212 ----------~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 212 ----------EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred ----------HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 111122344455678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.23 Aligned_cols=248 Identities=27% Similarity=0.493 Sum_probs=198.6
Q ss_pred HHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.+|.|.| |.||+|.... ..+++|.++. ++.+|+.++++++||||+++++.|..++..+
T Consensus 7 ~lg~g~~-------g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 7 TLGEGEF-------GKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred cccCcCC-------cceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4899999 9999998632 4588888752 3667999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 005923 431 LVYEFADNGALSDWLHSNRY-------------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTS 491 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~ 491 (669)
+|+||+.+|+|.+++...+. .....+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence 99999999999999875321 11235899999999999999999999998 999999999
Q ss_pred CeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 005923 492 NILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAV 570 (669)
Q Consensus 492 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~ 570 (669)
|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSY------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccch------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999865432211 01112345678999999999999999999999999999998 99888
Q ss_pred CCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 571 TGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.+....+ +.. . + ....+...+...+..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 231 ~~~~~~~---~~~----~---------~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 231 PGIAPER---LFN----L---------L----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCHHH---HHH----H---------H----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 7644211 111 0 1 11112223344556789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=324.26 Aligned_cols=232 Identities=25% Similarity=0.380 Sum_probs=193.0
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|.| |.||++.. +|+.+|+|+++. .+.+|++++++++||||+++++++..++..++|||
T Consensus 3 lG~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 3 LGKGTF-------GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred eeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 789999 99999987 478899999863 24568999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... +.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 76 YANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 99999999999754 46899999999999999999999999 99999999999999999999999999975432
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+..... .... ...
T Consensus 148 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~---~~~---- 209 (323)
T cd05571 148 DG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILM---- 209 (323)
T ss_pred CC--------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH---HHc----
Confidence 21 11234579999999999999999999999999999999999999997644211 1000 000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
. ...+|......+.+++.+||+.||.+|| ++.|++++
T Consensus 210 ---------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 210 ---------E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---------C--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 1123444566789999999999999999 79998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.44 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=200.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcC-CCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKIN-HSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~-H~niv~l~g~ 422 (669)
.|.+.+ .+|.|+| |.||+|... +..||||+++. .+.+|+++|++++ ||||++++++
T Consensus 38 ~~~~~~-~LG~G~f-------G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 38 GLVLGR-ILGSGAF-------GKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ceehhh-eecCCCC-------ceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 344555 3899999 999999863 23599999853 3668999999996 9999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCC---------------------------------------------------
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQ--------------------------------------------------- 451 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 451 (669)
|.+++..+|||||+++|+|.++|+..+..
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999999999999754210
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 005923 452 ----------------------------------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTS 491 (669)
Q Consensus 452 ----------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~ 491 (669)
....+++..+++++.|++.||+|||+.+ ++||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 1135889999999999999999999998 999999999
Q ss_pred CeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 005923 492 NILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAV 570 (669)
Q Consensus 492 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~ 570 (669)
|||+++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~ 340 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSN------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340 (400)
T ss_pred hEEEeCCCEEEEEeCCcceecccccc------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999986543221 111223456788999999999999999999999999999997 88888
Q ss_pred CCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 571 TGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
........ ... .+.. ..+...+..++..+.+++.+||+.||.+||++.+|.+.|+++..
T Consensus 341 ~~~~~~~~--~~~-------------~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 341 PGMIVDST--FYN-------------KIKS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred cccchhHH--HHH-------------HHhc----CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 75332110 000 0000 11122334556778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.68 Aligned_cols=246 Identities=32% Similarity=0.533 Sum_probs=199.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
|++.+ .+|.|+| |.||+|.+. ...+|+|.++. ++.+|+.++++++||||+++++++..+
T Consensus 6 ~~~~~-~lg~g~~-------g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 6 VTIEK-VIGGGEF-------GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred ceeee-EecCCcc-------ceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 45444 3899999 999999984 24689998753 366799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++.... ..+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECcc
Confidence 99999999999999999997642 36899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 151 g~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~- 220 (266)
T cd05033 151 GLSRRLEDSEA------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKA- 220 (266)
T ss_pred chhhccccccc------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHH-
Confidence 99998752211 111222345678999999999999999999999999999998 988886543211 0000
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+.. ....+.+.+++..+.+++.+||+.+|.+||++.||++.|+++
T Consensus 221 ------------~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 ------------VED----GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------------HHc----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 011122344566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.96 Aligned_cols=249 Identities=25% Similarity=0.461 Sum_probs=198.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|++.+ ++|.|+| |.||+|.+ .+..+++|.++. ++.+|++++++++||||+++++++..
T Consensus 7 ~~~~~-~lg~g~~-------g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 78 (283)
T cd05090 7 VRFME-ELGECAF-------GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78 (283)
T ss_pred ceeee-eccccCC-------cceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence 44444 4899999 99999985 346789999863 47789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRY------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
+...++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+++ ++||||||+||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~ni 155 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNI 155 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceE
Confidence 9999999999999999999964321 01235899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 005923 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~ 572 (669)
|+++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.+
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 156 LIGEQLHVKISDLGLSREIYSADY------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred EEcCCCcEEeccccccccccCCcc------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999987643321 111233445778999999998999999999999999999998 8888876
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
....+. ..... .......+..++..+.+++.+||+.||.+||++.+|.+.|..
T Consensus 230 ~~~~~~-------~~~~~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 230 FSNQEV-------IEMVR-------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHH-------HHHHH-------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 432110 00000 011112334455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=308.31 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=203.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+ .++.|.| |.||++.. ++..++||.++. ++.+|+.++++++|+||+++++++..+
T Consensus 3 ~y~~~~-~ig~g~~-------g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (267)
T cd08229 3 NFRIEK-KIGRGQF-------SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 74 (267)
T ss_pred hhhhhh-hhcccCC-------eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC
Confidence 455555 4999999 99999996 588999997642 466799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..+++|||+++++|.+++.... .....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999987532 22356899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++....... ......++..|+|||++.+..++.++|+||||+++|||++|..||.+........ .
T Consensus 151 g~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~- 217 (267)
T cd08229 151 GLGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL----C- 217 (267)
T ss_pred hhhhccccCCc--------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH----h-
Confidence 99886643221 1123467889999999999999999999999999999999999997543211000 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
..+.....+ ...+......+.+++.+||+.||.+||||.+|++.+++++
T Consensus 218 ---------~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 ---------KKIEQCDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---------hhhhcCCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011111111 1112345667999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.95 Aligned_cols=246 Identities=26% Similarity=0.489 Sum_probs=198.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|++.+ ++|.|+| |.||+|..+ +..+|+|.++. .+.+|+.++++++|+||+++++++..++..+++
T Consensus 8 ~~~~~-~lg~g~~-------g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 8 IKLVK-KLGAGQF-------GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred eEEee-ecCCcCC-------ceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 44444 4899999 999999874 56789998753 466799999999999999999999988999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 80 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 80 TEYMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred EecCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceec
Confidence 9999999999999764 2346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||++.++.++.++||||||+++|||++ |+.||.+....+. ...
T Consensus 154 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~------- 216 (261)
T cd05072 154 EDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA------- 216 (261)
T ss_pred CCCce-------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH-------
Confidence 43221 11122345678999999999999999999999999999998 8999876443211 000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+... .+.+....++..+.+++.+||+.+|.+||+++++.+.|+++
T Consensus 217 ------~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 217 ------LQRG----YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ------HHcC----CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0000 01112223455789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.13 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=200.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|.+.+ .+|+|+| |.||+|... +..+|+|.++. ++.+|++++++++|+||+++++++
T Consensus 6 ~~~~~~-~lg~g~~-------~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 6 TIVLKR-ELGEGAF-------GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred HhhHHh-hccccCC-------ceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 455655 4999999 999999863 35799999853 467899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCee
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRY---------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NIL 494 (669)
..+...++||||+++|+|.++++.... .....+++.++..++.|++.|+.|||+++ ++||||||+||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nil 154 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCL 154 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEE
Confidence 999999999999999999999976421 12346899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 005923 495 LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGD 573 (669)
Q Consensus 495 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~ 573 (669)
++.++.+||+|||+++....... ........++..|+|||.+.++.++.++||||||+++|||++ |..||.+.
T Consensus 155 i~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 155 VGYDLVVKIGDFGMSRDVYTTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EcCCCeEEECCcccceecccCcc------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999986533221 011123345778999999999999999999999999999998 99998765
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
...+. ...+ . .......+...+..+.+++.+||+.||.+||++.||++.|++
T Consensus 229 ~~~~~---~~~~-------------~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 229 SNEEV---IECI-------------T----QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CHHHH---HHHH-------------H----cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 43211 0100 0 001112233455678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=322.26 Aligned_cols=231 Identities=25% Similarity=0.352 Sum_probs=189.9
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++... +..+|+|.++. .+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 lg~G~~-------g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 73 (312)
T cd05585 1 IGKGSF-------GKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLA 73 (312)
T ss_pred CCcCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEc
Confidence 478999 999999984 67899998853 24579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 74 FINGGELFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 99999999999754 35899999999999999999999999 99999999999999999999999999986432
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+ .......
T Consensus 146 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~---- 207 (312)
T cd05585 146 DD--------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ---- 207 (312)
T ss_pred CC--------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc----
Confidence 21 11234578999999999999999999999999999999999999998654211 0111110
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS---ISEVFV 641 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~ 641 (669)
. ....+......+.+++.+||+.||.+||+ +.|++.
T Consensus 208 ---------~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 208 ---------E--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---------C--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1 11233445567899999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.70 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=202.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+ .++.|.| |.||+|.. ++..+|||.++. ++.+|++++++++||||+++++++...
T Consensus 3 ~~~i~~-~l~~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (267)
T cd08228 3 NFQIEK-KIGRGQF-------SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED 74 (267)
T ss_pred ceeeee-eeccCCC-------eeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence 355555 3899999 99999987 578999997642 367799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++|+||+++|+|.+++...+ .....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999986432 12345899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|++........ ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.......... .
T Consensus 151 g~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~----~- 217 (267)
T cd08228 151 GLGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL----C- 217 (267)
T ss_pred ccceeccchhH--------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH----H-
Confidence 99987643221 1123467889999999999899999999999999999999999987543211100 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
..+.... .....+...+..+.+++.+||+.+|.+||++.||++.|+++.
T Consensus 218 ---------~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 ---------QKIEQCD---YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---------HHHhcCC---CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0111111 111122345567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=314.39 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=200.0
Q ss_pred cccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------------------cHHHHHHHHHhcC
Q 005923 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------------------DVSSEINILKKIN 412 (669)
Q Consensus 356 ~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------------------~~~~E~~~l~~l~ 412 (669)
.+..|++.. ++|.|.| |.|-+|.. .++.||||++.. .+.+|+.+|++++
T Consensus 95 ~lNqy~l~~-eiG~G~y-------GkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 95 QLNQYELIK-EIGSGQY-------GKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ehhheehhh-hhcCCcc-------ceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 345566655 6999999 99999987 578899999831 3668999999999
Q ss_pred CCCceeEeeEEEe--cCceeEEEEecCCCCHHHHHhcCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 413 HSNIIRLSGFCVH--EGNTYLVYEFADNGALSDWLHSNRYQTSDN-LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 413 H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
|||||+|+.+..+ .+..|||+||+..|.+...= ..+. |++.+.+++++++..||+|||.++ |||||||
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIK 237 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIK 237 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccc
Confidence 9999999999864 35789999999998875432 2233 999999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCC----CCchhhHHHHHHHHHHHHc
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV----ITPKLDVFAFGVVVLELLS 565 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDV~S~Gvvl~ellt 565 (669)
|+|+||++++++||+|||.+......... +...++.+ .+||+.|+|||...++. .+.+.||||+||+||.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~--~~d~~L~~-tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf 314 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDE--GSDDQLSR-TVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF 314 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCcc--ccHHHHhh-cCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh
Confidence 99999999999999999999876443211 12223333 78999999999997743 3568999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 566 GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 566 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
|+.||.++... +..++++...+.-+...++...+.+|++++|.+||.+|.+..+|..+..-
T Consensus 315 G~~PF~~~~~~-------------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 315 GQLPFFDDFEL-------------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ccCCcccchHH-------------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 99999875421 12233344444333233567789999999999999999999999987653
Q ss_pred h
Q 005923 646 I 646 (669)
Q Consensus 646 i 646 (669)
.
T Consensus 376 t 376 (576)
T KOG0585|consen 376 T 376 (576)
T ss_pred c
Confidence 3
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.13 Aligned_cols=239 Identities=27% Similarity=0.454 Sum_probs=193.0
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++|.|.| |.||+|.. +++.+|+|..+. .+.+|++++++++||||++++++|..++..++||||
T Consensus 2 ~lg~g~~-------g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 2 RIGRGNF-------GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred ccCcccC-------ccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence 3789999 99999988 578899998643 367899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.++++.. ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 75 VQGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred ccCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999999999753 245899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... ........+..|+|||.+.++.++.++||||||+++|||++ |..|+........ .
T Consensus 148 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~-------- 206 (252)
T cd05084 148 VYA------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------R-------- 206 (252)
T ss_pred ccc------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------H--------
Confidence 110 00111223567999999999999999999999999999998 8777764332110 0
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
..+. .......+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 207 -~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 207 -EAIE----QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -HHHH----cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0011 11122334445667899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.55 Aligned_cols=237 Identities=23% Similarity=0.334 Sum_probs=193.4
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++.. +|+.+|+|.++. .+.+|++++++++|+||+++++++.+++..++|||
T Consensus 8 lg~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 8 LGKGGF-------GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred EecCCC-------EEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 899999 99999987 488999998742 24579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999999886532 235899999999999999999999999 99999999999999999999999999987543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||.+....... ..+..
T Consensus 155 ~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~------- 215 (285)
T cd05631 155 GE---------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDR------- 215 (285)
T ss_pred CC---------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHH-------
Confidence 21 123357899999999999999999999999999999999999999865432110 00000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
.+. + ....++......+.+|+++||+.||.+||+ ++|+++.
T Consensus 216 --~~~---~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 216 --RVK---E--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --Hhh---c--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 000 0 112234445567899999999999999997 7787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.11 Aligned_cols=246 Identities=28% Similarity=0.485 Sum_probs=198.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|++.+ .+|.|+| |.||+|..+ +..+|+|.++. ++.+|+.++++++|+||+++++++..++..++|
T Consensus 8 ~~~~~-~lg~g~~-------~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 8 IQLLR-KLGAGQF-------GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred eeeEE-EecccCC-------ccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 44443 4899999 999999984 56799999863 477899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.+++.... ...++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 80 TELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred eecccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999997642 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... .......+..|+|||++.+..++.++||||||+++|||++ |+.||.+..... ....
T Consensus 154 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~------- 216 (261)
T cd05068 154 KEDIYE-------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQ------- 216 (261)
T ss_pred cCCccc-------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH-------
Confidence 532110 0111223467999999999999999999999999999999 888887644211 0000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+ +.......+...+..+.+++.+||+.+|.+||++.++.+.|+.+
T Consensus 217 ------~----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 ------V----DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ------H----HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 01111223334556789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.08 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=200.0
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEec--CceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVHE--GNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 432 (669)
+|++|.| |.||+|+.+ ++.||+|+++.+ ..+|+.+|.+++|||||.+-.+.... +..|||
T Consensus 83 rI~EGty-------GiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 83 RIEEGTY-------GVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred hcccCcc-------eeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4899999 999999984 678999999753 46899999999999999998887643 568999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++ +|...+.+.+ .++...++.-+..|+++|++|||... |+|||||++|+|++..|.+||+|||+||..
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999997 9999998763 57899999999999999999999999 999999999999999999999999999988
Q ss_pred CCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
.... ...+..+-|.+|+|||.+.+ ..|+...|+||+|||+.||++++..|.|.... .....+...+..
T Consensus 228 gsp~--------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~---dQl~~If~llGt 296 (419)
T KOG0663|consen 228 GSPL--------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI---DQLDKIFKLLGT 296 (419)
T ss_pred cCCc--------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH---HHHHHHHHHhCC
Confidence 7642 22345678999999999987 56899999999999999999999999876532 222344444433
Q ss_pred hhHHh-----hhh--------cccCCccCCCCcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVRE-----KLR--------GFIDPSLRNEYPLD-LAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~-----~l~--------~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.... .+. ...-..++..++.. +...-++|+...+..||.+|.|++|.+++
T Consensus 297 Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 22110 000 00001122223322 45667899999999999999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.84 Aligned_cols=242 Identities=24% Similarity=0.461 Sum_probs=195.4
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|.+.+ .+|.|.| |.||++.++ +..+|+|.++. ++.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~-~lg~G~~-------~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 6 LTFLK-ELGSGQF-------GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred cchhh-hhccCCC-------ceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 45555 3899999 999999885 44789998753 467899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.++++... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 78 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 78 TEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred EecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceec
Confidence 99999999999997542 36899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..
T Consensus 151 ~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~-------- 212 (256)
T cd05059 151 LDDQY-------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VE-------- 212 (256)
T ss_pred ccccc-------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HH--------
Confidence 43211 01111233457999999999999999999999999999999 7888875433211 00
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
.+.. ..+...+...+.++.+++.+||..+|.+|||+.|+++.|
T Consensus 213 -----~~~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 213 -----SVSA----GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----HHHc----CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111 111222334566799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=325.08 Aligned_cols=237 Identities=25% Similarity=0.383 Sum_probs=195.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|.+.+ .+|+|+| |.||++... ++.+|+|.++. .+.+|+.++++++||||+++++++.+
T Consensus 18 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 18 SDFEMGE-TLGTGSF-------GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred hheEEEE-EEEecCC-------eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 3455555 3899999 999999984 77899999853 35679999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~D 161 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTD 161 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999754 35889999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++...... ....||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. .
T Consensus 162 fg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~ 224 (329)
T PTZ00263 162 FGFAKKVPDRT-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------Y 224 (329)
T ss_pred ccCceEcCCCc-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------H
Confidence 99998654321 234689999999999999999999999999999999999999986543211 0
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
..+. ... ...|......+.+|+.+||+.||.+||+ ++|++.+
T Consensus 225 ~~i~-------------~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 EKIL-------------AGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHh-------------cCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 111 1223334456889999999999999997 6777754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.59 Aligned_cols=230 Identities=29% Similarity=0.416 Sum_probs=192.4
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|+| |.||++... ++.+|+|.++. .+.+|+.++++++||||+++++++.+++..++||
T Consensus 8 ~lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 8 TVGTGTF-------GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred eeecCCC-------eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3899999 999999985 78899999842 2567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... +.+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... ....|+..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. .. .+..
T Consensus 153 ~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~---~i~~--- 212 (291)
T cd05612 153 DRT-----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YE---KILA--- 212 (291)
T ss_pred CCc-----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHh---
Confidence 321 224689999999999999999999999999999999999999986543211 11 1110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
. ...++......+.+++++||+.||.+||+ ++|++++
T Consensus 213 ----------~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 213 ----------G--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----------C--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 01223334567899999999999999995 8887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.92 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=194.1
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++|.|+| |.||++... +..+|+|.++. .+.+|+++|++++||||+++++++..++..++||||
T Consensus 12 ~lg~G~~-------g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 12 ELGAGNG-------GVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred eecCCCC-------EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 4899999 999999985 67889998753 367899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 85 MDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999764 3589999999999999999999985 5 99999999999999999999999999986543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh-h
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES-N 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 593 (669)
.. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..+....... .
T Consensus 157 ~~----------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~ 223 (331)
T cd06649 157 SM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEE 223 (331)
T ss_pred cc----------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhccccccccc
Confidence 21 22346899999999999999999999999999999999999999754432111 1110000000 0
Q ss_pred -----------------------------HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 594 -----------------------------VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 594 -----------------------------~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
..+..+.+...............++.+|+.+||+.||++|||++|++++-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000000001113456789999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.54 Aligned_cols=232 Identities=25% Similarity=0.372 Sum_probs=192.0
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|+|+| |.||++.. +|..||+|.++.+ +.+|++++++++||||+++++++..++..++|||
T Consensus 3 lG~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 3 LGKGTF-------GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred eeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 789999 99999987 4789999998642 3468999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 76 YANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 99999999998754 35899999999999999999999999 99999999999999999999999999875432
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......||..|+|||.+.+..++.++|||||||++|||++|+.||........ ... .
T Consensus 148 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~---~------ 207 (323)
T cd05595 148 DG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FEL---I------ 207 (323)
T ss_pred CC--------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHH---H------
Confidence 21 112235689999999999999999999999999999999999999976442110 000 0
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
.... ...|......+.+++.+||+.||.+|| ++.+++++
T Consensus 208 -------~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 208 -------LMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -------hcCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0001 123344566789999999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.26 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=191.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|.|.| |.||+++.+ ++.+|+|+++. .+.+|++++++++||||+++++++..++..++||||
T Consensus 9 lg~g~~-------~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 9 VGEGAY-------GVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred ecccCC-------EEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 799999 999999984 67899998853 356899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
++++.|..+... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 82 VEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 998766655432 245899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. .......|+..|+|||++.+..++.++|||||||++|||++|+.||.+....+.......+...+......
T Consensus 154 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 154 SN-------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred cc-------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 21 11223568899999999999999999999999999999999999998654322111111100000000000
Q ss_pred h-----hhhcccCCccC------CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 596 E-----KLRGFIDPSLR------NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 596 ~-----~l~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. .......+... ..+....+..+.+|+.+||+.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00000001000 0111124567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.21 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=199.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|++.+ .+|.|+| |.||+|... ++.||+|+++. .+.+|++++.++ +|+||++++++
T Consensus 8 ~~~i~~-~lG~G~f-------g~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 8 RLKLGK-PLGRGAF-------GKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred Hhhhhc-ccccCcC-------ceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 466665 4899999 999999752 35799998753 245799999999 89999999998
Q ss_pred EEec-CceeEEEEecCCCCHHHHHhcCCCC--------------------------------------------------
Q 005923 423 CVHE-GNTYLVYEFADNGALSDWLHSNRYQ-------------------------------------------------- 451 (669)
Q Consensus 423 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------- 451 (669)
|... ...+++|||+++|+|.+++......
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 8754 5678999999999999999653210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccc
Q 005923 452 ------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525 (669)
Q Consensus 452 ------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 525 (669)
....++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------~~ 230 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------YV 230 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc------hh
Confidence 0136899999999999999999999998 99999999999999999999999999987643221 11
Q ss_pred eeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCC
Q 005923 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDP 604 (669)
Q Consensus 526 ~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~ 604 (669)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+. . ...+. .
T Consensus 231 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~~~-------------~ 291 (337)
T cd05054 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRRLK-------------E 291 (337)
T ss_pred hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHHHh-------------c
Confidence 1223456778999999999999999999999999999998 9999875332110 0 00111 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 605 SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 605 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..+...+.....++.+++.+||+.+|++||++.||+++|+++...
T Consensus 292 ~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred cCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111122333456789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.83 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=198.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
|.+.+ ++|.|+| |.||+|... +..+|+|+++. .+..|+.++++++||||+++++++.
T Consensus 7 ~~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 7 VRFME-ELGEDRF-------GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred HHHHH-HhCCCCC-------CeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 44444 4899999 999999873 35799999863 3567999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNR-----------YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
..+..++++||+++++|.+++.... ......+++..+.+++.|++.||+|||+.+ ++||||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Ni 155 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNV 155 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhhe
Confidence 9999999999999999999986321 011235889999999999999999999999 99999999999
Q ss_pred eecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 005923 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~ 572 (669)
|+++++.+||+|||+++....... ........++..|+|||.+.++.++.++||||||+++|||++ |..|+.+
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 156 LVFDKLNVKISDLGLFREVYAADY------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred EecCCCceEecccccccccccchh------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999987643321 111233456778999999999999999999999999999998 7778765
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
....+ . .. .+ .+. .....+.+++..+.+++.+||+.+|.+||+++||+..|+.
T Consensus 230 ~~~~~--~----~~----------~i---~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 230 YSNQD--V----IE----------MI---RNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCHHH--H----HH----------HH---HcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 43211 0 00 00 011 1123345667779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=306.13 Aligned_cols=246 Identities=28% Similarity=0.527 Sum_probs=201.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.|++.+ ++|.|+| |.||+|... +..+++|.++. ++..|++++++++|+||+++++++...+..+
T Consensus 7 ~y~~~~-~ig~g~~-------~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 7 EFTLER-KLGSGYF-------GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHhh-hhccCCC-------ccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 355555 4899999 999999985 57789998753 4678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++|+|.++++.. ....+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 79 IITELMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred EEEeecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchh
Confidence 999999999999999764 2356899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHH
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
....... ......++..|+|||.+.+..++.++||||||++++||++ |+.||.+....+. ...+
T Consensus 153 ~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~---- 217 (261)
T cd05148 153 LIKEDVY--------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQI---- 217 (261)
T ss_pred hcCCccc--------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHH----
Confidence 7643221 1112345678999999999999999999999999999998 8888875442111 0000
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
. ...+...+..++..+.+++.+||+.||.+|||++++++.|+.+
T Consensus 218 ------------~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 ------------T-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------------H-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0 1112233445567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=324.59 Aligned_cols=247 Identities=28% Similarity=0.501 Sum_probs=198.2
Q ss_pred HHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcC-CCCceeEeeEEEecCce
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKIN-HSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 429 (669)
++|.|+| |.||+|.+.+ ..||+|+++. .+.+|+++|.++. ||||++++++|...+..
T Consensus 44 ~lG~G~f-------G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 44 TLGSGAF-------GRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred hccCCCc-------eeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 5999999 9999998743 4799999863 3567999999997 99999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCC-----------------------------------------------------------
Q 005923 430 YLVYEFADNGALSDWLHSNRY----------------------------------------------------------- 450 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 450 (669)
++||||+++|+|.++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999976421
Q ss_pred ----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec
Q 005923 451 ----------------------------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 451 ----------------------------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~ 496 (669)
.....++|..++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 01134788999999999999999999988 99999999999999
Q ss_pred CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCch
Q 005923 497 TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQN 575 (669)
Q Consensus 497 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~ 575 (669)
+++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred CCCEEEEEecCcceeccccccc------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999865332210 11122356788999999999999999999999999999998 8888865332
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
.+ ..... +....+...+..++.++.+++.+||+.+|.+||+++||+..|+++.
T Consensus 348 ~~--~~~~~-----------------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE--QFYNA-----------------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH--HHHHH-----------------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 10000 1111122334445678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.52 Aligned_cols=245 Identities=28% Similarity=0.479 Sum_probs=192.0
Q ss_pred HHHhCCCCcccceeeEEEEEEECCC----eeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec------
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGD----DAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE------ 426 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~----~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~------ 426 (669)
.+|.|+| |.||+|.++.. .+|+|.++. ++..|++++++++|+||++++++|...
T Consensus 6 ~ig~G~~-------g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 6 TLGEGEF-------GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred ccCcccC-------ceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 4899999 99999998532 589998742 366799999999999999999988542
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
...+++|||+++|+|.+++...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECC
Confidence 2468999999999999998543321 2345899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++........ .......++..|++||.+.+..++.++||||||+++|||++ |+.||.+....+ ...
T Consensus 156 fg~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~- 225 (272)
T cd05075 156 FGLSKKIYNGDYY------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD- 225 (272)
T ss_pred CCcccccCcccce------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH-
Confidence 9999876443211 11122345678999999999999999999999999999999 788886543211 100
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
.+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 226 ---~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 ---YLRQ-------------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---HHHc-------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0110 001112234556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=305.32 Aligned_cols=242 Identities=28% Similarity=0.492 Sum_probs=196.6
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc-----HHHHHHHHHhcCCCCceeEeeEEEe-cCceeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD-----VSSEINILKKINHSNIIRLSGFCVH-EGNTYLVY 433 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~-----~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 433 (669)
|++.+ .+|.|+| |.||++...|..+++|.++.+ +.+|+.++++++|+|++++++++.. ++..++||
T Consensus 8 ~~~~~-~lg~g~~-------~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 8 LKLLQ-TIGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred Ceeee-eecccCC-------CeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 44444 3899999 999999999999999998643 6689999999999999999998654 45689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.++++... ...+++..+++++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 80 EYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred ECCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence 9999999999997642 245899999999999999999999999 9999999999999999999999999988653
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ ....
T Consensus 154 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-------- 211 (256)
T cd05082 154 STQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-------- 211 (256)
T ss_pred ccC-----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--------
Confidence 321 11234567999999999999999999999999999997 888887543211 0000
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+. .......+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 212 -----~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 -----VE----KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----Hh----cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 0111223334566789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=306.30 Aligned_cols=243 Identities=26% Similarity=0.473 Sum_probs=194.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECCC-eeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~-~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|++.+ ++|.|.| |.||+|.+++. .+|+|.++. ++.+|+.++++++||||+++++++...+..++|
T Consensus 6 ~~~~~-~lg~G~~-------~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 6 LTFLK-ELGTGQF-------GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred eEEee-EecCccc-------ceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 34444 4899999 99999998654 599998764 367899999999999999999999988899999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+.+|+|.+++.... ..++|.+++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++..
T Consensus 78 ~e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 78 TEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred EEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceec
Confidence 99999999999997642 35899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... ...
T Consensus 151 ~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~---~~~- 216 (256)
T cd05113 151 LDDEY-------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEK---VSQ- 216 (256)
T ss_pred CCCce-------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH---Hhc-
Confidence 43221 01112245678999999998899999999999999999998 9988875442110 000 000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
..+...+......+.+++.+||+.||.+||++.+++..|+
T Consensus 217 -------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 217 -------------GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011112233467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.24 Aligned_cols=235 Identities=26% Similarity=0.427 Sum_probs=198.9
Q ss_pred cccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhcC-CCCceeEeeE
Q 005923 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKIN-HSNIIRLSGF 422 (669)
Q Consensus 356 ~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l~-H~niv~l~g~ 422 (669)
.+..|.+..+ +|.|+| |+|+++.++ ++.+|||++|++ ...|..|+...+ ||.+++|+..
T Consensus 366 ~l~~F~~l~v-LGkGsF-------GkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 366 TLDDFRLLAV-LGRGSF-------GKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred cccceEEEEE-eccCcC-------ceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence 3445555554 899999 999999995 567899999763 345777777775 9999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
|..++++|+||||+.||++..+.+. +.+++....-++.+|+.||.|||+++ |||||||.+|||||.+|.+|
T Consensus 438 fQT~~~l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred cccCCeEEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEE
Confidence 9999999999999999996555443 45999999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+|||+++..-.. ...+....||+.|||||++.++.|+..+|+|||||+|||||.|..||.+++..+ ++
T Consensus 509 iADFGlcKe~m~~--------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---~F 577 (694)
T KOG0694|consen 509 IADFGLCKEGMGQ--------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---VF 577 (694)
T ss_pred ecccccccccCCC--------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---HH
Confidence 9999999865422 235678999999999999999999999999999999999999999999876432 11
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
+. ++.. ...||..++.+...+++++|.+||.+|.-+
T Consensus 578 ds----------------I~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DS----------------IVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HH----------------HhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 1111 246788899999999999999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.09 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=199.5
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.||.|+| |.||.++- .|+.+|+|+++. .+..|-++|...++|+||+|+..|.+.+.+||||
T Consensus 148 ~IgkGAf-------GeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 148 VIGKGAF-------GEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred eeccccc-------eeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 3899999 99999986 488999999974 2567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||++||++..+|.+. +.|++.....++.+++.|++-||+.| ||||||||+|+|||..|++||+||||+..+.
T Consensus 221 EylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999765 57999999999999999999999999 9999999999999999999999999996432
Q ss_pred CCcccc-----------------CCc----------------------ccceeeecccccccccccccccCCCCchhhHH
Q 005923 514 SDEHEQ-----------------GGY----------------------GLQLTRHVVGTYGYMAPEYIENGVITPKLDVF 554 (669)
Q Consensus 514 ~~~~~~-----------------~~~----------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~ 554 (669)
...... ... ........+||+.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 211000 000 01112345899999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC
Q 005923 555 AFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634 (669)
Q Consensus 555 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 634 (669)
|+||||||||.|-.||.++...+. +..+...- . .+..+....+..+..+||.+|+. ||++|.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T---~rkI~nwr------~--------~l~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET---YRKIVNWR------E--------TLKFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHh------h--------hccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 999999999999999998775432 12221111 0 11112223344678999999999 999998
Q ss_pred CHHHHHHHHHHhhcCCCCCC
Q 005923 635 SISEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 635 t~~evl~~L~~i~~~~~~~~ 654 (669)
-..-+-+.=+--+-...+||
T Consensus 435 G~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 435 GSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred CcccHHHHhcCCccccCCcc
Confidence 63333222222344456665
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=310.25 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=194.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEec--Ccee
Q 005923 366 KIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHE--GNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 430 (669)
.+|.|+| |.||++.+ .+..+|+|.++. .+.+|++++++++||||+++++++... ...+
T Consensus 11 ~lg~g~~-------g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 11 QLGKGNF-------GSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred eccCCCC-------ceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3899999 99999985 367899999853 467899999999999999999987543 4679
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++|+|.+++.+.+ ..++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999997542 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
........ ........++..|+|||.+.+..++.++||||||+++|||++|..++...... ....+.....
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~ 227 (284)
T cd05081 157 VLPQDKEY-----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQ 227 (284)
T ss_pred cccCCCcc-----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccc
Confidence 76443210 01112223445699999999999999999999999999999988765432210 0000000000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
.......+...+........+..++..+.+++.+||..+|++|||+.||++.|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000011111222222233445566799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.54 Aligned_cols=245 Identities=27% Similarity=0.469 Sum_probs=194.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCc---
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGN--- 428 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 428 (669)
.+|.|+| |.||+|... +..+|+|.++. .+.+|++++++++|+||+++++++.....
T Consensus 6 ~lg~G~~-------g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 6 ILGEGEF-------GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred ccCcCCC-------ceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 3899999 999999874 25699998863 35679999999999999999999876554
Q ss_pred ---eeEEEEecCCCCHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 429 ---TYLVYEFADNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 429 ---~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.++||||+++|+|.+++...+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEEC
Confidence 69999999999999998654321 2246899999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+ ...
T Consensus 156 dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~ 226 (273)
T cd05035 156 DFGLSKKIYSGDYYR------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYD 226 (273)
T ss_pred Cccceeecccccccc------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 999998765432110 1112234678999999999999999999999999999999 888886543211 000
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
. +. + ......+..+...+.+++.+||+.||.+||++.|+++.|+++
T Consensus 227 ~-------------~~---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 Y-------------LR---H-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H-------------HH---c-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 0 011123344566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.96 Aligned_cols=248 Identities=25% Similarity=0.459 Sum_probs=195.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
|++.. ++|.|+| |.||+|... +..+|+|.++. ++.+|+.++++++|+||+++++++.
T Consensus 8 ~~~~~-~ig~G~~-------g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 8 ITMSR-ELGQGSF-------GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ceeee-eeccccC-------CeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 44444 4899999 999999864 34699998753 3668999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQ-----TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
.+...++||||+++|+|.+++++.+.. ....++|..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCC
Confidence 889999999999999999999764211 1235789999999999999999999998 99999999999999999
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEA 578 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~ 578 (669)
.+||+|||+++......... ......++..|+|||.+.++.++.++||||||+++|||++ |..||.+....+
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~- 229 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ- 229 (277)
T ss_pred CEEECCCCCccccCCcceee------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 99999999998654332110 1112345778999999999999999999999999999999 677876543211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
. . ... .+... ...+..++..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 230 -~----~-~~~------------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 -V----L-RFV------------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -H----H-HHH------------HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 0 000 00000 1223345567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.43 Aligned_cols=243 Identities=28% Similarity=0.500 Sum_probs=200.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc------HHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD------VSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
.|++.+ .+|.|.| |.||++...|+.+|+|.++.+ +.+|+.++++++|+||+++++++..++..++|
T Consensus 7 ~~~~~~-~ig~g~~-------g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 7 ELKLGA-TIGKGEF-------GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hcccee-eeecCCC-------ceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 344444 3899999 999999999999999998653 56799999999999999999999988899999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.+++... ....++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 79 TEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccc
Confidence 9999999999999764 2236899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... ....+..|+|||.+..+.++.++||||||+++|||++ |..||......+ +. ....
T Consensus 153 ~~~~~-----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~- 213 (256)
T cd05039 153 SQGQD-----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PHVE- 213 (256)
T ss_pred ccccc-----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHh-
Confidence 33211 1234568999999999999999999999999999997 988887543211 00 0000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
...+...+...+..+.+++.+||..+|.+||+++|++++|+++
T Consensus 214 ------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 214 ------------KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ------------cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0111222334456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.64 Aligned_cols=242 Identities=35% Similarity=0.567 Sum_probs=192.4
Q ss_pred HHhCCCCcccceeeEEEEEEECC--C--eeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFKG--D--DAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g--~--~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||+|...+ . .+++|.++. ++.+|++++.++ +||||+++++++..++..++||
T Consensus 3 lg~g~~-------g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 3 IGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CCCCCC-------ceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 688999 9999999843 2 468888763 356799999999 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 434 EFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
||+++|+|.++++..+. .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEE
Confidence 99999999999976431 11235899999999999999999999998 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELL 581 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 581 (669)
|+|||+++...... .......+..|+|||++.+..++.++||||||+++|||++ |..||.+....+ .
T Consensus 153 l~dfgl~~~~~~~~---------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~ 220 (270)
T cd05047 153 IADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L 220 (270)
T ss_pred ECCCCCccccchhh---------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H
Confidence 99999986432111 0111223567999999999999999999999999999997 999987543211 0
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
... + ......+.+..+...+.+++.+||+.||.+|||+.|++..|.+|.
T Consensus 221 ~~~-------------~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 YEK-------------L----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHH-------------H----hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 0 011111223334557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.83 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=202.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
.|.+.+ .+|.|+| |.||++... +..+|+|.++. ++.+|+.+++.+ +||||++++
T Consensus 16 ~~~~~~-~lg~G~~-------g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 16 KLTLGK-PLGEGCF-------GQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred Heeecc-eeeccCC-------ceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 344444 4899999 999999751 33689998853 356799999999 899999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
+++...+..++||||+++|+|.+++...+.. ....++|.+++.++.||+.||+|||+++ ++|||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlk 164 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLA 164 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccc
Confidence 9999999999999999999999999864311 1246899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 238 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238 (304)
T ss_pred cceEEEcCCCcEEECCCccceeccccccc------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999876443211 11222345678999999999999999999999999999998 777
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
|+.+....+ ... .+. ...+...+..++..+.+++.+||+.+|.+||++.|+++.|.++..
T Consensus 239 p~~~~~~~~---~~~----~~~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 239 PYPGIPVEE---LFK----LLK-------------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CcccCCHHH---HHH----HHH-------------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 776543211 000 010 011112234556778999999999999999999999999999987
Q ss_pred CCCC
Q 005923 649 SSSD 652 (669)
Q Consensus 649 ~~~~ 652 (669)
...+
T Consensus 299 ~~~~ 302 (304)
T cd05101 299 LTTN 302 (304)
T ss_pred hhhc
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.53 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=197.8
Q ss_pred HHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec--Cce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE--GNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 429 (669)
.+|.|+| |.||++.+ .+..+|+|..+. .+.+|++++++++||||+++++++... ...
T Consensus 11 ~lg~g~~-------g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 11 VLGEGHF-------GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ecccCCC-------cEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3899999 99988764 356799998863 356799999999999999999998754 357
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++|+|.+++... .+++.++..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++
T Consensus 84 ~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 8999999999999999753 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+........ ........++..|+|||.+.+..++.++||||||+++|||++|+.|+........... .. .
T Consensus 155 ~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~----~ 224 (283)
T cd05080 155 KAVPEGHEY-----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GP----K 224 (283)
T ss_pred cccCCcchh-----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cc----c
Confidence 876543211 0111223456679999999999999999999999999999999999864322110000 00 0
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
........+...++.......+..++.++.+++.+||+.||.+|||++++++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 225 QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000011122223333333445566778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.05 Aligned_cols=232 Identities=25% Similarity=0.379 Sum_probs=192.3
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++.. +|..+|+|+++. .+.+|++++++++||||+++.+++..++..++|||
T Consensus 3 lG~G~~-------g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 3 LGKGTF-------GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred eeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 789999 99999987 478999999864 24568999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 76 y~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 76 YVNGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred CCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 99999999998754 35899999999999999999999999 99999999999999999999999999875432
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. .. ....
T Consensus 148 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~~---~~~~---- 209 (328)
T cd05593 148 DA--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FE---LILM---- 209 (328)
T ss_pred cc--------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---HH---Hhcc----
Confidence 21 112335789999999999999999999999999999999999999976442110 00 0000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
. ....|......+.+++.+||+.||.+|| ++.|++++
T Consensus 210 ---------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 210 ---------E--DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---------C--CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 1123344556789999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.39 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=200.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.|.+.++ +++|.| |.||+|... +..|++|.++. .+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~-i~~g~~-------g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 7 RVTLSDL-LQEGTF-------GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred heEEeee-ecccCC-------ceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4555554 899999 999999984 46789998864 2667999999999999999999987
Q ss_pred e-cCceeEEEEecCCCCHHHHHhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 425 H-EGNTYLVYEFADNGALSDWLHSNRYQ---TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 425 ~-~~~~~lV~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
. +...++++||+++|+|.+++...+.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQ 155 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCc
Confidence 6 46789999999999999999765321 1246999999999999999999999998 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 579 (669)
+||+|||+++........ .......++..|+|||++.+..++.++||||||+++||+++ |+.||......+
T Consensus 156 ~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 227 (280)
T cd05043 156 VKITDNALSRDLFPMDYH------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-- 227 (280)
T ss_pred EEECCCCCcccccCCceE------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--
Confidence 999999999866433211 01112345678999999999999999999999999999999 999987644321
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
... .+. . ......+..++..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 228 -~~~----~~~---------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 228 -MAA----YLK---------D----GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -HHH----HHH---------c----CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 000 0 11111223345678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.62 Aligned_cols=252 Identities=35% Similarity=0.553 Sum_probs=199.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC--C--eeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG--D--DAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g--~--~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~ 425 (669)
.|++.++ +|.|+| |.||+|..+. . .+++|.++. ++.+|++++.++ +||||+++++++..
T Consensus 3 ~~~~~~~-lg~g~~-------g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 3 DIKFEDV-IGEGNF-------GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred cceeeee-ecCCCc-------ceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 3555554 899999 9999998742 2 468888763 467799999999 79999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCee
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NIL 494 (669)
.+..++||||+++|+|.++++..+.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 89999999999999999999764211 1235899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 005923 495 LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGD 573 (669)
Q Consensus 495 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~ 573 (669)
+++++.+||+|||++........ ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+.
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYVK---------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred ECCCCeEEECCcCCCccccceec---------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999874322110 111223557999999999999999999999999999998 99998764
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
...+ ... .+ ........+..++..+.+++.+||+.||.+||+++++++.|.++....
T Consensus 223 ~~~~---~~~-------------~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 223 TCAE---LYE-------------KL----PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CHHH---HHH-------------HH----hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 4311 000 00 011112233345567899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.66 Aligned_cols=257 Identities=23% Similarity=0.388 Sum_probs=195.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
..|.+.+ ++|.|+| |.||+|..+ +..||+|.++. .+.+|+.++++++||||+++++++..++
T Consensus 5 ~~y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 5 ETYVKLD-KLGEGTY-------ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred ccceEee-EEecCCC-------EEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3455544 3899999 999999874 77899998752 3568999999999999999999999888
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 77 ~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG 148 (288)
T cd07871 77 CLTLVFEYLDS-DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFG 148 (288)
T ss_pred eEEEEEeCCCc-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCc
Confidence 99999999985 999998754 235789999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++....... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.. ..+.
T Consensus 149 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~ 217 (288)
T cd07871 149 LARAKSVPTK--------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIF 217 (288)
T ss_pred ceeeccCCCc--------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 9986543211 1223467889999999875 56899999999999999999999999865533211 1111
Q ss_pred HHHhhhhH--------HhhhhcccCCccCCCC----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 587 RVLEESNV--------REKLRGFIDPSLRNEY----PLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 587 ~~~~~~~~--------~~~l~~~~d~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
........ .+.......+...... ......++.+|+.+||+.||.+|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 218 RLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111100 0111111111111100 1123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.37 Aligned_cols=246 Identities=31% Similarity=0.536 Sum_probs=197.9
Q ss_pred HHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEEecCce
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 429 (669)
.+|.|.| |.||++...+ ..+|+|.++. ++.+|+++++++ +|+||+++++++..++..
T Consensus 19 ~ig~g~~-------g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 19 PLGEGAF-------GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred Eeccccc-------ccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 3799999 9999998742 4689998864 256799999999 799999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 430 YLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
+++|||+++|+|.++++..+. .....+++..+++++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCC
Confidence 999999999999999975320 23457999999999999999999999998 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhH
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~ 577 (669)
+.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.+....+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYY------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred CeEEeCccccccccccccce------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999876443211 11112234678999999999999999999999999999998 888887543211
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
. . ..+ ........+..+...+.+|+.+||+.||.+|||+.|+++.|+++.
T Consensus 243 ~---~----~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 L---F----KLL-------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H---H----HHH-------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 0 000 011112234445667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.14 Aligned_cols=238 Identities=22% Similarity=0.353 Sum_probs=194.1
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||+|... ++.||+|+++. .+..|++++.+++||||+++++++..++..++||
T Consensus 8 ~ig~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 8 QVGQGGY-------GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred EEeecCC-------eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3899999 999999984 78999999863 2557999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
.. .....||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+.. ..+..
T Consensus 153 ~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~------ 212 (333)
T cd05600 153 TY-----------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKY------ 212 (333)
T ss_pred cc-----------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHh------
Confidence 31 22356899999999999999999999999999999999999999865432211 11100
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+..............++.+++.+||..+|.+||++.|++++
T Consensus 213 ----~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 ----WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000011000000012345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=333.03 Aligned_cols=245 Identities=20% Similarity=0.334 Sum_probs=197.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC---CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK---GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|.+.++ +|.|+| |.||++... +..|++|.+.. .+..|+.+|+.++||||+++++++..++.
T Consensus 68 ~y~~~~~-lg~G~~-------g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTL-VGRNPT-------TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEE-EEeCCC-------cEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 3555554 899999 999999863 56788887632 35679999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.+|||||+++|+|.++++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcC
Confidence 999999999999999986532 22346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
++....... ........||..|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+...
T Consensus 216 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~ 283 (478)
T PTZ00267 216 SKQYSDSVS------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQV 283 (478)
T ss_pred ceecCCccc------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 987643221 112334578999999999999999999999999999999999999997644211 01111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+. . . ....+..+...+.+++.+||+.||.+||++.+++.
T Consensus 284 ~~---------~----~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 284 LY---------G----K-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred Hh---------C----C-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 10 0 0 01223345567899999999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.72 Aligned_cols=240 Identities=22% Similarity=0.315 Sum_probs=192.4
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|.| |+||++.. +++.+|+|.+.. .+..|++++++++|+||+++.+++..+...++|||
T Consensus 1 lg~G~~-------g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (280)
T cd05608 1 LGKGGF-------GEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMT 73 (280)
T ss_pred CCCCCc-------eeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEe
Confidence 478999 99999987 478899999853 24569999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 74 ~~~~g~L~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 999999999886432 23356999999999999999999999999 99999999999999999999999999986543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 150 ~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-------------- 207 (280)
T cd05608 150 GQS--------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-------------- 207 (280)
T ss_pred CCc--------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--------------
Confidence 221 1223568999999999999999999999999999999999999997543211000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
+......... ..++...+..+.+++.+||+.||.+|| +++|++.+
T Consensus 208 -~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 208 -ELKQRILNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -HHHHhhcccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0001111111 123344566789999999999999999 66777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.31 Aligned_cols=247 Identities=28% Similarity=0.468 Sum_probs=196.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|+|+| |.||+|.+ +|. .||+|.++. ++.+|+.+++.++|+||++++++|.. ...++
T Consensus 14 ~lg~G~~-------g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 14 VLGSGAF-------GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred ecCCCCC-------ceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 3899999 99999987 344 379998853 35679999999999999999999964 45789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
++||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 86 ~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 86 VTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999754 245899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... +...+.
T Consensus 159 ~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~ 225 (279)
T cd05109 159 LDIDETE------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLE 225 (279)
T ss_pred cccccce------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHH
Confidence 6532210 01112234678999999999999999999999999999998 888886543211 011111
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDW 653 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 653 (669)
.......+..++..+.+++.+||+.||++||++.|+++.|.++......|
T Consensus 226 -------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05109 226 -------------KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275 (279)
T ss_pred -------------CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence 01111222344567899999999999999999999999999887765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=314.67 Aligned_cols=239 Identities=26% Similarity=0.416 Sum_probs=199.4
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|+..+ .+|.|.| |.||+|..+ ++.||+|++.- ++.+|+.+|.+++++||.+++|.+..+..+
T Consensus 15 ~~~~~-~IgrGsf-------G~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 15 YTKLE-LIGRGSF-------GEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccch-hcccccc-------ceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 44444 4999999 999999985 77899999852 467899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
+++|||+.+|++.+.|+.. ..+.+..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+|++|||.+
T Consensus 87 wiiMey~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHHHhcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEeccee
Confidence 9999999999999999654 34577777789999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
....... ......+||+.|||||++....|+.|+||||||++.+||.+|..|+........
T Consensus 159 ~ql~~~~--------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------- 219 (467)
T KOG0201|consen 159 GQLTNTV--------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------- 219 (467)
T ss_pred eeeechh--------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----------
Confidence 8776543 223568999999999999999999999999999999999999999976432100
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.-.+.+-..|.+. ..+...+++++..||.+||+.||++.+++++
T Consensus 220 -----lflIpk~~PP~L~----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 -----LFLIPKSAPPRLD----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -----EEeccCCCCCccc----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 0011111223333 2556679999999999999999999998864
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=312.94 Aligned_cols=257 Identities=35% Similarity=0.554 Sum_probs=202.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CC--eeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GD--DAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~--~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~ 425 (669)
.|++.+. +|.|+| |.||+|..+ +. .+++|.++. .+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~-lg~G~~-------g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 8 DIKFQDV-IGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hceeeee-ecCCCC-------ceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 3455543 899999 999999873 43 357777653 356799999999 89999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCee
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NIL 494 (669)
++..++||||+++|+|.++++..+.. ....+++.+++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nil 156 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 156 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEE
Confidence 99999999999999999999764311 1236899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 005923 495 LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGD 573 (669)
Q Consensus 495 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~ 573 (669)
+++++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred ecCCCcEEeCccccCcccchhh---------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 9999999999999986432111 0111234567999999998889999999999999999998 99998754
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDW 653 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 653 (669)
...+. ... +. .......+...+..+.+++.+||+.+|.+||++.++++.|.++......|
T Consensus 228 ~~~~~---~~~-------------~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 228 TCAEL---YEK-------------LP----QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred ChHHH---HHH-------------Hh----cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 32110 000 00 01111223334567899999999999999999999999999998777665
Q ss_pred CC
Q 005923 654 DP 655 (669)
Q Consensus 654 ~~ 655 (669)
..
T Consensus 288 ~~ 289 (303)
T cd05088 288 VN 289 (303)
T ss_pred hh
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.31 Aligned_cols=243 Identities=29% Similarity=0.482 Sum_probs=193.5
Q ss_pred HHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.+|.|+| |.||+|.+.+ ..+++|..+. ++..|+.++++++|+||+++++++.+.+..+
T Consensus 13 ~lg~g~~-------g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 13 ALGHGAF-------GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred ECCCCCC-------CcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 3899999 9999999853 4688888752 3678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC---cEEEcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQ--TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---RAKITN 505 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~D 505 (669)
+||||+++|+|.++++..+.. ....++|.++++++.||+.||+|||+.+ ++||||||+|||++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 999999999999999765321 1235899999999999999999999999 99999999999998654 699999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||.+....+. ..
T Consensus 163 fg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~- 232 (277)
T cd05036 163 FGMARDIYRASYY------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME- 232 (277)
T ss_pred CccccccCCccce------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence 9999876432210 01112233568999999999999999999999999999997 9898876443210 00
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
. +....+...+..++..+.+++.+||+.||++||++.||++.|+
T Consensus 233 ---~-------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 ---F-------------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---H-------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0011112334455677899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.92 Aligned_cols=233 Identities=25% Similarity=0.387 Sum_probs=191.5
Q ss_pred HHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc-----------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG-----------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.+|.|+| |.||++.. .++.+|+|+++. .+..|+++|++++||||+++++++..++..
T Consensus 3 ~lg~G~~-------g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 3 VLGKGGY-------GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred eeeecCC-------eEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 3789999 99999875 467899999863 245799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++|+|.+++.+. +.+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 76 YLILEYLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEEeCCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999999754 35788899999999999999999999 999999999999999999999999998
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.+..... .....
T Consensus 148 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~- 212 (323)
T cd05584 148 KESIHEG--------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKI- 212 (323)
T ss_pred eecccCC--------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHH-
Confidence 7543221 11233578999999999999999999999999999999999999998654311 01111
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
.... ...+......+.+++.+||+.||.+|| ++.+++..
T Consensus 213 ------------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 ------------LKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ------------HcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111 123334456789999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.79 Aligned_cols=241 Identities=28% Similarity=0.439 Sum_probs=193.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
++|.|.| |.||+|.+. +..+|+|.++. ++.+|++++++++|+||+++++++. .+..++|
T Consensus 2 ~ig~G~~-------g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 2 ELGHGNF-------GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred ccCccCc-------eeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 4789999 999999873 25789998763 3567999999999999999999875 5578999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++.+. ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 74 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 74 MELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EEeCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999999764 26899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .... ...
T Consensus 146 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~----~~~ 213 (257)
T cd05060 146 GAGSDY-----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM----LES 213 (257)
T ss_pred ecCCcc-----cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HHc
Confidence 443211 011112234567999999999999999999999999999998 899887543211 1111 100
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
......+..++..+.+++.+||..||.+||++.++++.|+++.
T Consensus 214 -------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 -------------GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -------------CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0111233445567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=319.72 Aligned_cols=236 Identities=29% Similarity=0.409 Sum_probs=194.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC---CeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG---DDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g---~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.+ .+|.|+| |.||+|.+++ ..+|+|.++. .+.+|+.+++.++||||+++++++.+
T Consensus 31 ~y~~~~-~ig~G~~-------g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 31 DFNFIR-TLGTGSF-------GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred hcEEEE-EEeecCC-------eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 455444 3899999 9999998742 4799998852 25579999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEec
Confidence 99999999999999999999764 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ....
T Consensus 175 FG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~- 239 (340)
T PTZ00426 175 FGFAKVVDTR-----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQK- 239 (340)
T ss_pred CCCCeecCCC-----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHH-
Confidence 9999865322 123578999999999999999999999999999999999999998654311 1111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
.. ... ..+|......+.+++++||+.||.+|+ +++|++++
T Consensus 240 --i~-------------~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 --IL-------------EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --Hh-------------cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 000 122334455678999999999999995 88888765
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.16 Aligned_cols=237 Identities=29% Similarity=0.485 Sum_probs=193.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecC
Q 005923 367 IATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
+|.|+| |.||+|..+ +..+|+|..+. .+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ig~g~~-------g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 3 LGKGNF-------GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred cCCCCC-------ceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 788999 999999874 66799998753 36679999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcc
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~ 517 (669)
+|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 76 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 76 GGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc
Confidence 999999997542 35899999999999999999999998 99999999999999999999999999975433211
Q ss_pred ccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 518 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
.......++..|+|||++.++.++.++||||||+++||+++ |..||.+....... .
T Consensus 149 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----------------~ 205 (250)
T cd05085 149 -------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR----------------E 205 (250)
T ss_pred -------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----------------H
Confidence 11112244568999999999999999999999999999998 89898754321100 0
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
.+.. ..+...+..++..+.+++.+||+.+|.+||++.|+++.|.
T Consensus 206 ~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 206 QVEK----GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHc----CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0110 1112233445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.58 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=197.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFC 423 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~ 423 (669)
|.+.+ .+|+|+| |.||++... +..+|+|.++. .+.+|+++++++ +|+||+++++++
T Consensus 37 ~~~~~-~ig~G~~-------g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 37 LSFGK-TLGAGAF-------GKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred eEEcc-eeeccCC-------eeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 44444 4899999 999999751 34689998753 366899999999 799999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
...+..++||||+++|+|.++++..+ ...+++.++..++.|++.||+|||+++ ++|+||||+|||++.++.+|+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999997542 234899999999999999999999998 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 582 (669)
+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+.
T Consensus 183 ~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---- 252 (302)
T cd05055 183 CDFGLARDIMNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---- 252 (302)
T ss_pred CCCcccccccCCCc------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----
Confidence 99999986643221 011222345778999999999999999999999999999998 8998875432110
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
..... +.......+...+..+.+++.+||+.+|.+|||+.|+++.|+++
T Consensus 253 --~~~~~-------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 --FYKLI-------------KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHHHH-------------HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00000 11111122223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.51 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=201.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
.|.+.+ ++|.|+| |.||++... +..+|+|.++. ++..|+.+++++ +|+||++++
T Consensus 19 ~~~i~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 19 RLVLGK-PLGEGCF-------GQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred HeEEee-eeccCCC-------eeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 455545 4899999 999999863 24589998863 255799999999 799999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
++|..++..++||||+++|+|.+++...+. .....++|.++++++.|++.||+|||+.+ ++|||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlk 167 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLA 167 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---ccccccc
Confidence 999999999999999999999999976431 12235899999999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||++.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~ 241 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchh------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999865432210 11112234568999999999999999999999999999998 888
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+....+ +...+. .....+.+..+..++.+++.+||+.+|.+||++.||++.|.++..
T Consensus 242 p~~~~~~~~-------~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 242 PYPGVPVEE-------LFKLLK-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CCCcCCHHH-------HHHHHH-------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 886543211 000111 111123344556688999999999999999999999999999876
Q ss_pred CC
Q 005923 649 SS 650 (669)
Q Consensus 649 ~~ 650 (669)
..
T Consensus 302 ~~ 303 (307)
T cd05098 302 LT 303 (307)
T ss_pred Hh
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.94 Aligned_cols=246 Identities=29% Similarity=0.502 Sum_probs=197.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|++.+ +++.|+| |.||+|..++ ..+|+|.++. ++.+|++++++++|+||+++++++. ++..++|
T Consensus 8 ~~~~~-~lg~g~~-------~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 8 LRLEV-KLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred eeEee-ecCCCCC-------CcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 55555 4899999 9999998854 4789998864 3678999999999999999999874 5668999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 79 TEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EEcCCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeec
Confidence 9999999999999754 2345899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ...
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~------- 215 (262)
T cd05071 153 EDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQ------- 215 (262)
T ss_pred ccccc-------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHH-------
Confidence 43321 11122346678999999999999999999999999999999 7778765432210 000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
+. .......+.+++..+.+++.+||+.||.+||++.++++.|+..+
T Consensus 216 ------~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 216 ------VE----RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ------Hh----cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 00 01111223455667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.00 Aligned_cols=253 Identities=21% Similarity=0.381 Sum_probs=193.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|++.+ ++|.|+| |.||++... +..+|+|.++. .+.+|++++++++|+||++++++|..++..
T Consensus 7 y~~~~-~lg~g~~-------g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 7 FEKIS-ELGAGNG-------GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred hheec-cccCCCC-------EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 44444 4899999 999999984 67789998753 367899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCc
Confidence 9999999999999999754 3588999999999999999999974 5 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
++...... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..... ...
T Consensus 151 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~---~~~ 217 (333)
T cd06650 151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF---GCP 217 (333)
T ss_pred chhhhhhc----------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh---cCc
Confidence 87653221 12346889999999999999999999999999999999999999754321111000 000
Q ss_pred Hhhhh----------------------------HHhhhhcccCCccCCCCc-HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005923 589 LEESN----------------------------VREKLRGFIDPSLRNEYP-LDLAFSMAQLAKNCTAHDLNARPSISEV 639 (669)
Q Consensus 589 ~~~~~----------------------------~~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~ev 639 (669)
..... .......+.... ....+ .....++.+|+.+||+.||.+|||+.|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el 296 (333)
T cd06650 218 VEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP-PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL 296 (333)
T ss_pred ccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCC-CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH
Confidence 00000 000000000000 00001 1234568999999999999999999999
Q ss_pred HHH
Q 005923 640 FVT 642 (669)
Q Consensus 640 l~~ 642 (669)
+++
T Consensus 297 l~h 299 (333)
T cd06650 297 MVH 299 (333)
T ss_pred hhC
Confidence 765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=301.18 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=202.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec----------ccHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK----------GDVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+. +|.|.| |.||+|... |+.+++|.++ ..+.+|++++++++|+|++++++++..+
T Consensus 3 ~y~~~~~-lg~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~ 74 (267)
T cd08224 3 NFKIEKK-IGKGQF-------SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN 74 (267)
T ss_pred ceeeeee-eccCCc-------eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 3555553 899999 999999984 8899999774 1366899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++.+.. .....+++.+++.++.+++.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecc
Confidence 99999999999999999997542 22346899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .
T Consensus 151 ~~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~--- 215 (267)
T cd08224 151 GLGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----S--- 215 (267)
T ss_pred ceeeeccCCCc--------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH----H---
Confidence 99886543221 11234578899999999999999999999999999999999999865431100 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPL-DLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
... .+.. ......+. ..+..+.+++.+||..+|.+|||+.+|++.|++++
T Consensus 216 -~~~------~~~~----~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 -LCK------KIEK----CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -HHh------hhhc----CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 0000 11112222 45567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.63 Aligned_cols=229 Identities=29% Similarity=0.406 Sum_probs=189.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|.|+| |.||++.. .|+.+|+|+++. .+..|++++++++||||+++++++..++..|+
T Consensus 3 ~lg~G~~-------g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 3 VLGQGSF-------GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred eeeeCCC-------EEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 3789999 99998865 478899999863 24569999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++.
T Consensus 76 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999999654 35899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.+....+. .....
T Consensus 148 ~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~-- 211 (318)
T cd05582 148 SIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMIL-- 211 (318)
T ss_pred cCCCC--------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHH--
Confidence 54321 122345789999999999998999999999999999999999999986543211 00000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 638 (669)
.. ....|...+..+.+++.+||+.||.+||++.+
T Consensus 212 -----------~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 212 -----------KA--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----------cC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 11233445567899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.43 Aligned_cols=244 Identities=30% Similarity=0.517 Sum_probs=196.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|.+.+ ++|+|+| |.||++..+ +..+|+|.++. ++.+|+.++++++|+|++++++++. +...+++
T Consensus 8 ~~~~~-~ig~g~~-------~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 8 LQLIK-KLGNGQF-------GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hhhhh-eeccccC-------ceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 44444 4899999 999999875 56789998863 4678999999999999999999884 5678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.++++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 79 TEYMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeec
Confidence 9999999999999754 2345899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+. ...
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~------- 215 (260)
T cd05070 153 EDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ------- 215 (260)
T ss_pred cCccc-------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH-------
Confidence 43221 01112235668999999999999999999999999999999 8888875442210 000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
+ ......+.+.+.+..+.+++.+||..||.+|||++++.+.|++
T Consensus 216 ------~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 ------V----ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------H----HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0111223344556679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.30 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=189.2
Q ss_pred HHHhCCCCcccceeeEEEEEEECC----CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG----DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g----~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|.| |.||+|...+ ..+++|.++. .+.+|+.++++++||||+++++++.+....++||
T Consensus 2 ~lg~G~~-------g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (269)
T cd05087 2 EIGNGWF-------GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVM 74 (269)
T ss_pred cccccCC-------ceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEE
Confidence 3789999 9999998743 4689998753 3667999999999999999999999888999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.++++..+......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999998653223345778888999999999999999999 9999999999999999999999999997543
Q ss_pred CCccccCCcccceeeecccccccccccccccC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-------VITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
..... .......++..|+|||++.+. .++.++|+||||+++|||++ |+.||......+. ....
T Consensus 152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~- 222 (269)
T cd05087 152 KEDYY------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT- 222 (269)
T ss_pred Cccee------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH-
Confidence 32210 111224567889999998642 35889999999999999996 9999975432211 0000
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
..+....+.++.+. ......+.+++..|| .+|.+|||++||+..|+
T Consensus 223 --------~~~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 --------VREQQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --------hhcccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00111112222221 123446788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.45 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=201.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---------HHHHHHHHHhcCCCC-ceeEeeEEEecC------
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---------VSSEINILKKINHSN-IIRLSGFCVHEG------ 427 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 427 (669)
++|+|.| |+||+|+. .|+.||+|+++-+ ..+|+-+|++++|+| ||+|.+++..+.
T Consensus 18 klGeGty-------g~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 18 KLGEGTY-------GVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HhCCCCc-------eEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4899999 99999987 5889999998643 368999999999999 999999998776
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
.++|||||++. +|.+++...... ...++...+..+++||+.||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~-~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKK-PQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhcccc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999986 999999865311 135777899999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+|+...-.. ....+.++|.+|+|||++.+. .|++..|+||+||++.||++++..|.++.+ ......+.
T Consensus 166 lAra~~ip~--------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If 234 (323)
T KOG0594|consen 166 LARAFSIPM--------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIF 234 (323)
T ss_pred hHHHhcCCc--------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHH
Confidence 999765332 223456789999999999986 799999999999999999999999988764 22334444
Q ss_pred HHHhhhhHH--hhhhcccCCc--cCCCC-cHHHH-------HHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 587 RVLEESNVR--EKLRGFIDPS--LRNEY-PLDLA-------FSMAQLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 587 ~~~~~~~~~--~~l~~~~d~~--l~~~~-~~~~~-------~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
+.+..+... ..+..+.+.. ..... +.... ....+++.+||+.+|.+|.|++.++.+ ++.+
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 444443221 1111111111 11111 11111 367899999999999999999999986 4443
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=301.72 Aligned_cols=242 Identities=32% Similarity=0.525 Sum_probs=195.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CC---eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GD---DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~---~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.|+| |.||+|... +. .+++|..+. ++..|++++++++|+|++++.+++...+..++|
T Consensus 12 ~lg~g~~-------g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 12 VIGAGEF-------GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred EecCCCC-------ccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 3899999 999999873 33 589998753 356799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.++++.. ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 85 TEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999753 246899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... .........+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 158 ~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~------- 222 (268)
T cd05063 158 EDDPEG-----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKA------- 222 (268)
T ss_pred cccccc-----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH-------
Confidence 433211 011112233457999999999999999999999999999997 999987543211 1111
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+. .....+.+.+++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 223 ------i~----~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 ------IN----DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------Hh----cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0112223345567789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.06 Aligned_cols=252 Identities=26% Similarity=0.456 Sum_probs=189.6
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC-----ce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG-----NT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 429 (669)
.+|.|+| |.||+|.. +|..||||.++. .+.+|++++++++||||+++++++.... ..
T Consensus 7 ~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 7 VIGKGSY-------GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred EEeecCC-------eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 3899999 99999987 478999998753 2567999999999999999999986432 47
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+. ++|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||++
T Consensus 80 ~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 80 YVVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccc
Confidence 99999996 6999998754 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+........ ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+...... ...+..
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~ 222 (338)
T cd07859 151 RVAFNDTPT-----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITD 222 (338)
T ss_pred cccccccCc-----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHH
Confidence 865332210 111234578999999999876 6789999999999999999999999976543211 111111
Q ss_pred HHhhh-----------hHHhhhhcccC---CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEES-----------NVREKLRGFID---PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~-----------~~~~~l~~~~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..... ...+.+..+.. ..+...++ .....+.+++.+||+.||.+|||++|+++.
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11100 00011111110 00000111 234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.95 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=195.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
.|++.+ ++|.|+| |.||++.. .++.||+|..+. .+.+|+++|++++||||+++++++..+...++|+|+
T Consensus 93 ~y~~~~-~lg~G~~-------g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 93 GFSILE-TFTPGAE-------GFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CcEEEE-EEcCCCC-------eEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 355544 3899999 99999988 478899998753 578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+. ++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 165 YK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 95 6899988654 35899999999999999999999999 999999999999999999999999999754321
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchh----HHHHHHHHHHHHHhh
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC----EAELLYASISRVLEE 591 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~ 591 (669)
. ........||..|+|||++.+..++.++|||||||++|||++|+.|+...... ........+......
T Consensus 236 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 236 N-------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred c-------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 1 01123357999999999999999999999999999999999999887643211 011111111111100
Q ss_pred h----------hHHhhh----hc-ccCCccCCCC--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 S----------NVREKL----RG-FIDPSLRNEY--PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~----------~~~~~l----~~-~~d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ...+.. .. ...+..+... ....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 000000 00 0011111100 11345678999999999999999999999864
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.52 Aligned_cols=235 Identities=27% Similarity=0.429 Sum_probs=194.9
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++.|.| |.||++.. +++.+++|.++. ++.+|++++++++|||++++++++.+++..++||||
T Consensus 8 l~~g~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 8 IGKGSF-------GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ecCCCC-------eEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 889999 99999988 478899998742 366799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.++++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999864 2356899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ......++..|+|||++.+..++.++|+||||+++|||++|+.||....... . ....
T Consensus 155 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~----~~~~------- 213 (256)
T cd08529 155 TN--------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--L----ILKI------- 213 (256)
T ss_pred cc--------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--H----HHHH-------
Confidence 21 1223467889999999999999999999999999999999999997654211 0 0000
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... .....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 214 --~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 214 --IRG-----VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HcC-----CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111 1122333456678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.66 Aligned_cols=254 Identities=29% Similarity=0.499 Sum_probs=200.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEee
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSG 421 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g 421 (669)
|++.. .+|.|+| |.||++... +..+|+|..+. ++.+|+++++++ +|+||+++++
T Consensus 14 ~~i~~-~ig~G~~-------g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 14 LTLGK-PLGEGCF-------GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred eeecc-eeccccC-------CcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 44444 4899999 999999752 22589998763 366799999999 7999999999
Q ss_pred EEEecCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 005923 422 FCVHEGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~ 490 (669)
+|..++..+++|||+++|+|.+++...+. .....++|.+++.++.|++.||+|||+.+ ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 99999999999999999999999976421 12345899999999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCC
Q 005923 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREA 569 (669)
Q Consensus 491 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p 569 (669)
+|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccccc------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999876432211 11122334567999999999999999999999999999998 7888
Q ss_pred CCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
|.+....+ ... .+. .......+..++..+.+++.+||+.+|.+||++.|+++.|.++...
T Consensus 237 ~~~~~~~~---~~~----~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 237 YPGIPVEE---LFK----LLK-------------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred CCCCCHHH---HHH----HHH-------------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 86543211 000 000 0111223334556789999999999999999999999999999854
Q ss_pred C
Q 005923 650 S 650 (669)
Q Consensus 650 ~ 650 (669)
+
T Consensus 297 ~ 297 (334)
T cd05100 297 T 297 (334)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.60 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=200.6
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc---HHHHHHHHHhcCCCCceeEeeEEEecC-----ceeEEEEec
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD---VSSEINILKKINHSNIIRLSGFCVHEG-----NTYLVYEFA 436 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~---~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~ 436 (669)
+|+|.| |.||+|... ++.||||+.-.+ -.+|+++|+++.|||||+|+.+|.... ...||||||
T Consensus 32 iG~GsF-------g~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 32 IGSGSF-------GVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred Eeeccc-------ceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 899999 999999984 678999998544 347999999999999999999887432 346899999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEcccCCccccCCC
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAESD 515 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DfGla~~~~~~ 515 (669)
+. +|.++++..- .....++...+.-+.+||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+..+
T Consensus 105 P~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 PE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred hH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 97 9999997421 12245777778889999999999999999 9999999999999987 99999999999988765
Q ss_pred ccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. ......|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+..|.|+...+ ....+.+++..+..
T Consensus 180 ep---------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d---QL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 180 EP---------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD---QLVEIIKVLGTPTR 247 (364)
T ss_pred CC---------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH---HHHHHHHHhCCCCH
Confidence 42 233567889999999987 679999999999999999999999999866432 23344445543332
Q ss_pred Hhhhhcc-------cCCccCC-----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhcC
Q 005923 595 REKLRGF-------IDPSLRN-----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIWSS 649 (669)
Q Consensus 595 ~~~l~~~-------~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~~ 649 (669)
+ .+..+ -.+.+.. -.....+.+..+|+.+++..+|.+|.++.|++.+ +..+...
T Consensus 248 e-~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 248 E-DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred H-HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 2 11111 1111111 1334556788999999999999999999999865 5555543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=301.86 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=187.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|.| |.||+|... ...+++|.++. .+.+|+.+++.++|+||+++++.|...+..++||
T Consensus 2 ~lg~G~f-------g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWF-------GKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCC-------ceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 4789999 999999763 23578887642 3567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++...+.......++...+.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence 9999999999998764333345678889999999999999999999 9999999999999999999999999987643
Q ss_pred CCccccCCcccceeeeccccccccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-------GVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
..... .......++..|+|||++.. ..++.++||||||+++|||++ |..||....+.+ . .
T Consensus 152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~----~ 219 (269)
T cd05042 152 PEDYY------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--V----L 219 (269)
T ss_pred cchhe------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--H----H
Confidence 32210 11122345678999998753 456889999999999999999 677776543211 1 1
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
...... ....+.++. .+...+..+.+++..|| .||.+|||++||++.|+
T Consensus 220 ~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 220 KQVVRE-----QDIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHhhc-----cCccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111110 011111222 22344556788999999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=302.61 Aligned_cols=238 Identities=24% Similarity=0.443 Sum_probs=202.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+ .+|.|.| |+|-++.. .|+.||||.++.+ +.+|++||+.++||||+.++.+|+++
T Consensus 54 RyE~~e-tLGkGTY-------GKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk 125 (668)
T KOG0611|consen 54 RYEITE-TLGKGTY-------GKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK 125 (668)
T ss_pred HHHHHH-HhcCCcc-------cceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence 577766 5999999 99999976 5899999998753 67899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+...+||||..+|.|.||+... +.|++....++++||..|+.|+|.++ ++|||||.+|||+|.++++||+||
T Consensus 126 dKIvivMEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeecc
Confidence 9999999999999999999865 56999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+-.+... .+....+|.+.|.+||.+.+..| .+..|-||+||+||-|+.|..||+|.+.. .+
T Consensus 198 GLSNly~~~---------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l---- 261 (668)
T KOG0611|consen 198 GLSNLYADK---------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL---- 261 (668)
T ss_pred chhhhhccc---------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH----
Confidence 999876543 34556899999999999999887 58899999999999999999999986531 11
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
++++-...++++ .-+....-||++||..||.+|-|+.+|..+-
T Consensus 262 ------------vrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 262 ------------VRQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------------HHHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112222222221 1223467899999999999999999998764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=317.19 Aligned_cols=232 Identities=24% Similarity=0.368 Sum_probs=191.1
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|+|+| |.||++.. .|..+|+|.++.+ +..|++++++++||||+++.+++..++..++|||
T Consensus 3 lG~G~~-------g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 3 LGKGTF-------GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred eeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 789999 99999987 5788999998642 3568899999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 76 YANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99999999998754 358999999999999999999997 67 9999999999999999999999999987543
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. ... .
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~---i----- 208 (325)
T cd05594 148 KDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FEL---I----- 208 (325)
T ss_pred CCC--------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHH---H-----
Confidence 221 112235689999999999999999999999999999999999999976543110 000 0
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
... ...+|.....++.+++.+||+.||.+|+ ++.+++++
T Consensus 209 --------~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 --------LME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --------hcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 000 0122334556789999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.24 Aligned_cols=248 Identities=31% Similarity=0.517 Sum_probs=197.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--C---CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--G---DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g---~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.+ .+|.|.| |.||+|... + ..+|+|.++. ++.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~-~lg~g~~-------g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 5 CIKIEK-VIGAGEF-------GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred HeEeee-eecccCC-------CceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 344444 4899999 999999872 2 3689998753 46789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~d 149 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSD 149 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCC
Confidence 99999999999999999999754 245899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++........ ........++..|+|||.+.+..++.++||||||+++||+++ |..||......+ ....
T Consensus 150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~ 221 (267)
T cd05066 150 FGLSRVLEDDPEA-----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA 221 (267)
T ss_pred CCcccccccccce-----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH
Confidence 9999876543210 011112233568999999999999999999999999999887 999987543211 0011
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+. . ..+.+.+..++..+.+++.+||+.+|.+||+|.++++.|+++
T Consensus 222 ----~~---------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 222 ----IE---------E----GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----Hh---------C----CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 0 011122334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=309.58 Aligned_cols=255 Identities=30% Similarity=0.507 Sum_probs=200.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
.|.+.. ++|.|.| |.||++... ...+|+|.++. ++.+|+++++++ +||||++++
T Consensus 13 ~~~~~~-~lg~G~~-------g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 13 RLVLGK-PLGEGCF-------GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred Heeeee-eecCCCc-------ccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 344444 4999999 999999752 34689998763 356799999999 699999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
++|..++..++||||+++|+|.+++...+. .....++|..+++++.|++.||.|||+++ ++|||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlk 161 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLA 161 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccc
Confidence 999988999999999999999999976421 12246899999999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||+++++.+||+|||+++........ .......++..|+|||.+.++.++.++||||||+++|||++ |..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~ 235 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYY------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccc------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence 99999999999999999999876432211 11112234567999999999999999999999999999999 888
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+....+ ... .... ......+..++.++.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 236 p~~~~~~~~---~~~----~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 236 PYPGIPVEE---LFK----LLRE-------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCCCCCHHH---HHH----HHHc-------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 886543211 111 0000 11112234455678899999999999999999999999999976
Q ss_pred CC
Q 005923 649 SS 650 (669)
Q Consensus 649 ~~ 650 (669)
..
T Consensus 296 ~~ 297 (314)
T cd05099 296 AV 297 (314)
T ss_pred Hh
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.44 Aligned_cols=244 Identities=28% Similarity=0.503 Sum_probs=197.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|++.+ ++|.|+| |.||+|.. +++.+|+|.++. ++.+|+.++++++|+|++++++++ .++..+++
T Consensus 8 ~~~~~-~ig~G~~-------g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 8 LKLVK-KLGAGQF-------GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYII 78 (260)
T ss_pred ceeee-eeccCcc-------ceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEE
Confidence 34433 4899999 99999988 468899998864 477899999999999999999987 45678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 79 TEYMENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence 9999999999999754 2346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+. ..
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~-------- 214 (260)
T cd05067 153 EDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ-------- 214 (260)
T ss_pred CCCCc-------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH--------
Confidence 53221 11122345678999999999999999999999999999999 9999976443211 00
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
.+. ...+.+.+...+.++.+++.+||+.+|.+||++++++..|+.
T Consensus 215 -----~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 -----NLE----RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----HHH----cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 010 111122333445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=299.83 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=189.3
Q ss_pred HHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe-cCceeEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH-EGNTYLV 432 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 432 (669)
+|.|+| |.||+|.+. ...+|+|.+.. .+..|+.+++.++||||+++++++.. ++..++|
T Consensus 3 lg~g~~-------g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 3 IGKGHF-------GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred ccccCC-------ceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 789999 999999863 23689998742 35579999999999999999998764 5567999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+.+|+|.+++.+.. ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 76 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 76 LPYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred EecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999997542 34788889999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCC-CCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE-AVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
....... ........++..|+|||.+.+..++.++||||||+++|||++|.. |+......+ .. ..+..
T Consensus 149 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~----~~~~~ 217 (262)
T cd05058 149 YDKEYYS----VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT----VYLLQ 217 (262)
T ss_pred cCCccee----ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhc
Confidence 4321100 011123345678999999999999999999999999999999654 444332211 00 00000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
......+...+..+.+++.+||+.+|.+||++.||++.|+++..
T Consensus 218 -------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 218 -------------GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -------------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111222345578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.39 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=200.9
Q ss_pred HHHhCCCCcccceeeEEEEEEECC--CeeEEEEeccc----------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG--DDAAVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g--~~vavK~~~~~----------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|+|.- |+||++.++| ...|+|+|..+ ++.|.+||+.++||.++.|++.++.+...||||
T Consensus 84 ~LG~Gdi-------G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 84 RLGCGDI-------GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HcCCCCc-------eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3899999 9999999976 57899999542 456999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||++||+|...++++ +.+.+++..+.-++.+++.||+|||-.| ||+|||||+||||-++|++.|+||.|+....
T Consensus 157 eyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999874 6778999999999999999999999999 9999999999999999999999999986432
Q ss_pred CCcc------------------------------ccC------------------CcccceeeecccccccccccccccC
Q 005923 514 SDEH------------------------------EQG------------------GYGLQLTRHVVGTYGYMAPEYIENG 545 (669)
Q Consensus 514 ~~~~------------------------------~~~------------------~~~~~~~~~~~gt~~y~aPE~l~~~ 545 (669)
.... ... ..........+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1000 000 0011233457899999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHh
Q 005923 546 VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNC 625 (669)
Q Consensus 546 ~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~C 625 (669)
..+.++|+|+|||++|||+.|..||.|.+..+ .+..++-..+.-+........+.+||++.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKL 371 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------------------hHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence 99999999999999999999999999877542 22222322222222225567789999999
Q ss_pred cccCCCCCCC----HHHHHHH
Q 005923 626 TAHDLNARPS----ISEVFVT 642 (669)
Q Consensus 626 l~~dP~~RPt----~~evl~~ 642 (669)
|.+||.+|.. +.||-++
T Consensus 372 LvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hccChhhhhccccchHHhhcC
Confidence 9999999998 7777654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=303.65 Aligned_cols=239 Identities=21% Similarity=0.296 Sum_probs=190.2
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++..+ |+.+|+|.+.. .+..|++++++++||||+++.+++..+...++|||
T Consensus 1 lg~G~~-------g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGF-------GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCc-------eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEe
Confidence 478999 999999874 78999998853 23458999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 74 ~~~g~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 74 LMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred cCCCCCHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 99999999998654 2245899999999999999999999999 99999999999999999999999999986643
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ......
T Consensus 148 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~------- 209 (277)
T cd05607 148 GK---------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRR------- 209 (277)
T ss_pred Cc---------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHH-------
Confidence 21 122346889999999999999999999999999999999999999753321100 001010
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
........ .....+.++.+|+.+||+.||.+||++.|+++.+
T Consensus 210 ------~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 210 ------TLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ------hhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 11111100 0113455689999999999999999998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.00 Aligned_cols=232 Identities=25% Similarity=0.400 Sum_probs=190.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||+|... ++.+|+|+++.+ +..|.+++..+ +||||+++++++..++..++||
T Consensus 3 lG~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 3 LGKGSF-------GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred cccCCC-------eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence 789999 999999985 668999998642 34688888866 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 76 E~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 76 EYVNGGDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+ ... ....
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~---~i~~--- 210 (321)
T cd05591 148 LNG--------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFE---SILH--- 210 (321)
T ss_pred cCC--------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHH---HHHc---
Confidence 221 11233568999999999999999999999999999999999999998654321 111 1111
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-------SISEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-------t~~evl~~ 642 (669)
.. ...|..+..++.+++.+||+.||.+|| ++.+++++
T Consensus 211 ----------~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 211 ----------DD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ----------CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00 112333456789999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.63 Aligned_cols=247 Identities=33% Similarity=0.544 Sum_probs=196.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--C---CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--G---DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g---~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
|++.+ .+|.|.| |.||+|... + ..||||.++. ++..|+.++++++||||+++.+++..+
T Consensus 6 ~~~~~-~lg~g~~-------g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 6 VKIEE-VIGAGEF-------GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred eEEEe-EecCCCC-------CeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 34444 3899999 999999974 2 2589999753 466799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++... .+.+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCC
Confidence 9999999999999999999754 245899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecc--cccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVV--GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|+++......... ....... .+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 151 g~~~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~ 222 (269)
T cd05065 151 GLSRFLEDDTSDP-----TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN 222 (269)
T ss_pred ccccccccCcccc-----ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH
Confidence 9998654322110 0111111 2457999999999999999999999999999886 999987544211 000
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
. +.. ....+.+.+++..+.+++.+||+.+|.+||++++|+..|+++
T Consensus 223 ~-------------i~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 223 A-------------IEQ----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred H-------------HHc----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 100 011122344566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=298.81 Aligned_cols=244 Identities=31% Similarity=0.518 Sum_probs=195.4
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|.+.+ ++|.|+| |.||++..++ ..+++|..+. .+.+|++++++++|+|++++++++. ++..++|
T Consensus 8 ~~~~~-~ig~g~~-------~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 8 LRLDV-KLGQGCF-------GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred eeeee-eecCcCC-------CeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 33334 4899999 9999999854 4789998753 4678999999999999999999874 5678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.++++.. ....++|..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 79 TEFMGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred EEcCCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEc
Confidence 9999999999999764 2345899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ...
T Consensus 153 ~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~------- 215 (260)
T cd05069 153 EDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ------- 215 (260)
T ss_pred cCCccc-------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-------
Confidence 432210 1112345678999999999999999999999999999999 8888876443211 000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
+.. ......+.+.+..+.+++.+||+.||.+||++++|++.|++
T Consensus 216 ------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 ------VER----GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------HHc----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 11112334556779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=305.03 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=198.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|++.+ .+|+|.| |.||+|..+ +..+|+|.++. ++.+|+.++++++|+||+++++++
T Consensus 7 ~~~i~~-~lg~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 7 KITLLR-ELGQGSF-------GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred Hceeee-eecCCCC-------cEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 345544 4999999 999999753 34789998752 356789999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQ-----TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
...+..++||||+++|+|.+++++.+.. ....+++..+.+++.|++.||.|||+++ ++||||||+|||++++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence 9889999999999999999999754211 1234678899999999999999999998 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhH
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~ 577 (669)
+.+||+|||+++......... ......++..|+|||.+.++.++.++||||||+++|||++ |..||.+....+
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~ 229 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229 (288)
T ss_pred CcEEECcCCcccccccccccc------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999998654322110 1112345678999999999999999999999999999998 677776543211
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
... .+.+.. ....+..++..+.+++.+||+.||.+|||+.++++.|.+....
T Consensus 230 ---~~~----------------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 230 ---VLK----------------FVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred ---HHH----------------HHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 000 001111 1122334456799999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.88 Aligned_cols=243 Identities=28% Similarity=0.467 Sum_probs=195.9
Q ss_pred HHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
++|.|+| |.||+|...+ ..+|+|.+.. .+.+|+.++++++|+||+++++++......+
T Consensus 13 ~lg~g~~-------g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 13 ELGQGSF-------GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred EecCCCC-------ceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 3899999 9999998743 5699999753 3567999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQ-----TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
+||||+++|+|.+++...... ....++|..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 999999999999999754211 1235899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++........ .......++..|+|||.+.++.++.++||||||+++|||++ |+.||.+....+. ..
T Consensus 163 fg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~- 232 (277)
T cd05032 163 FGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK- 232 (277)
T ss_pred cccchhhccCccc------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH-
Confidence 9999876443211 11223456788999999998999999999999999999998 8888865432110 00
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
. +. + ......+..++..+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 233 ---~---------~~---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 ---F---------VI---D-GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---H---------Hh---c-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 00 0 1112234445678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.34 Aligned_cols=255 Identities=22% Similarity=0.389 Sum_probs=189.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE---CCCeeEEEEecc---------cHHHHHHHHHhc---CCCCceeEeeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF---KGDDAAVKVMKG---------DVSSEINILKKI---NHSNIIRLSGFCV 424 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~---~g~~vavK~~~~---------~~~~E~~~l~~l---~H~niv~l~g~~~ 424 (669)
|++.+ ++|.|+| |.||++.. ++..+|+|.++. .+.+|+.+++++ +||||++++++|.
T Consensus 3 Y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 3 YECVA-EIGEGAY-------GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred cceee-EeccCCC-------eEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 44433 4899999 99999987 356799998852 245688777766 6999999999986
Q ss_pred e-----cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 425 H-----EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 425 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
. ....++||||+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 147 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCC
Confidence 3 346899999997 6999999754 2345899999999999999999999999 99999999999999999
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.+||+|||+++...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.+..+.+.
T Consensus 148 ~~kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~- 217 (290)
T cd07862 148 QIKLADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ- 217 (290)
T ss_pred CEEEccccceEeccCCc---------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-
Confidence 99999999998654321 12335689999999999999999999999999999999999999987554321
Q ss_pred HHHHHHHHHHhhhhHHh---hh---hcccCCccCC---CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 580 LLYASISRVLEESNVRE---KL---RGFIDPSLRN---EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~---~l---~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
...+........... .. .....+.... ....+....+.+++.+||+.||++|||+.|+++
T Consensus 218 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 218 --LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred --HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111111111000000 00 0000000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.38 Aligned_cols=231 Identities=24% Similarity=0.389 Sum_probs=187.1
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHh-cCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKK-INHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.|+| |.||+|..+ ++.||+|.++.+ +..|..++.. .+||||+++++++..++..++|
T Consensus 2 ~lG~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv 74 (316)
T cd05592 2 VLGKGSF-------GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV 74 (316)
T ss_pred eeeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence 3789999 999999984 667999998643 2345666654 4899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~e~~~gg~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 75 MEYLNGGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999999754 35899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+ .... +
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~---i---- 208 (316)
T cd05592 147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDS---I---- 208 (316)
T ss_pred CCCC--------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHH---H----
Confidence 3221 11234578999999999999999999999999999999999999998654321 1111 0
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS-EVF 640 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 640 (669)
.. ....++..+..++.+++.+||+.||.+||++. +++
T Consensus 209 ------~~-----~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 209 ------LN-----DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ------Hc-----CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 01223344556788999999999999999976 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.04 Aligned_cols=255 Identities=31% Similarity=0.448 Sum_probs=197.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|++.+. +|.|+| |.||+|.. .++.||||.++. .+.+|+.++.++ +|+||++++++
T Consensus 8 ~~~~~~~-lG~G~f-------g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 8 RLKLGKP-LGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred Hhccccc-ccCCcc-------ceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 4566664 999999 99999974 356899999863 256799999999 78999999998
Q ss_pred EEec-CceeEEEEecCCCCHHHHHhcCCCC--------------------------------------------------
Q 005923 423 CVHE-GNTYLVYEFADNGALSDWLHSNRYQ-------------------------------------------------- 451 (669)
Q Consensus 423 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------- 451 (669)
|... ...++||||+++|+|.++++..+..
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 8654 4578999999999999999753210
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcccc
Q 005923 452 ------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519 (669)
Q Consensus 452 ------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 519 (669)
....++|.++.+++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 235 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY- 235 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch-
Confidence 0124789999999999999999999999 999999999999999999999999999875332110
Q ss_pred CCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhh
Q 005923 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKL 598 (669)
Q Consensus 520 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 598 (669)
.......++..|+|||.+.+..++.++||||||+++|||++ |..|+.+....+. +...+..
T Consensus 236 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~------- 297 (343)
T cd05103 236 -----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKE------- 297 (343)
T ss_pred -----hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhc-------
Confidence 11122345678999999999999999999999999999997 8888865332110 0001100
Q ss_pred hcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 599 RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..+...+......+.+++.+||+.||.+|||+.||++.|+++.+.
T Consensus 298 ------~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 298 ------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ------cCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 011111222345689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=329.92 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=198.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.+. +|.|+| |.||++.. +|+.||||.++. .+.+|+.++..++|+|++++.+.+...
T Consensus 32 ~rY~i~~~-LG~G~f-------G~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 32 KKYWISRV-LGSGAT-------GTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred CCEEEEEE-EecCCC-------EEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 35666664 999999 99999987 588999999853 356799999999999999998877543
Q ss_pred C--------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 427 G--------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 427 ~--------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
+ ..++||||+++|+|.++++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC
Confidence 2 3689999999999999997542 23456899999999999999999999998 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
+.+||+|||+++....... ........||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+
T Consensus 180 ~~vkL~DFGls~~~~~~~~------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~- 252 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVS------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE- 252 (496)
T ss_pred CCEEEEecccCeecccccc------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-
Confidence 9999999999987543211 112334679999999999999999999999999999999999999998654211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+... +... ....+..++.++.+++.+||+.||.+||++.+++.+
T Consensus 253 -----~~~~~---------~~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 -----VMHKT---------LAGR-----YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HHHHH---------hcCC-----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 01011 1111 112344556779999999999999999999999864
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.15 Aligned_cols=232 Identities=26% Similarity=0.419 Sum_probs=190.4
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++... +..+|+|+++.+ +..|..++..+ +||||+++++++...+..++||
T Consensus 3 lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 3 LGKGSF-------GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred eeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 789999 999999984 678999998642 34678888887 6999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+. ..+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 999999999998754 35999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.+....+ .... ..
T Consensus 148 ~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~---i~---- 209 (318)
T cd05570 148 LGG--------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQS---IL---- 209 (318)
T ss_pred cCC--------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHH---HH----
Confidence 221 11233568999999999999999999999999999999999999998654321 1010 00
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI-----SEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 642 (669)
.. ...++...+..+.+++.+||+.||.+||++ .+++..
T Consensus 210 ---------~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 210 ---------ED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---------cC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 00 112233455678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.30 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=192.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|.+.+ ++|.|.| |.||+|.. +++.+|+|+++. .+.+|+.++++++||||+++++++..+...
T Consensus 7 y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 7 YEKLE-KLGEGSY-------ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred ceEee-eEEecCC-------EEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 44433 4899999 99999998 478899999852 356899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+. ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 79 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred EEEEECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 99999996 6898888754 245889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
+....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..+... ....+...
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~ 220 (303)
T cd07869 151 RAKSVPSH--------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLV 220 (303)
T ss_pred eeccCCCc--------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHH
Confidence 75432211 1123467899999999865 4588999999999999999999999986543211 11111111
Q ss_pred HhhhhHH-----hhhhcccCCccCCCCcH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVR-----EKLRGFIDPSLRNEYPL---------DLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~-----~~l~~~~d~~l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+...... .....+....+....+. .....+.+|+.+||+.||.+|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 1111000 00000000001000010 122457899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.46 Aligned_cols=232 Identities=26% Similarity=0.388 Sum_probs=188.0
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.|+| |.||+|... ++.+|+|.++.. +..|..+++.. +||||+++++++.+++..++|
T Consensus 2 ~lG~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 74 (316)
T cd05619 2 MLGKGSF-------GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV 74 (316)
T ss_pred eeeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence 3789999 999999984 678999998643 33577777764 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 75 ~ey~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 75 MEYLNGGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999999753 35899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+ ....+ .
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i----~-- 209 (316)
T cd05619 147 MLGD--------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI----R-- 209 (316)
T ss_pred CCCC--------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH----H--
Confidence 2211 11234578999999999999999999999999999999999999998654321 11110 0
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS-EVFV 641 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 641 (669)
. .. ..++......+.+++.+||+.||.+||++. ++..
T Consensus 210 -------~-~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 210 -------M-DN----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -------h-CC----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0 00 112233445688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.37 Aligned_cols=231 Identities=27% Similarity=0.407 Sum_probs=186.5
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHH---HhcCCCCceeEeeEEEecCceeE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINIL---KKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~l 431 (669)
+|.|+| |.||++..+ ++.+|||+++.. +..|++++ ++++||||+++++++..++..|+
T Consensus 7 lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 7 LGRGHF-------GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred EeecCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 799999 999999884 788999998632 33455544 46689999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|..+++. ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 80 v~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 80 VMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 9999999999998864 35899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. .....
T Consensus 151 ~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~-- 214 (324)
T cd05589 151 GMGFG--------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIV-- 214 (324)
T ss_pred CCCCC--------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHH--
Confidence 43211 112345789999999999999999999999999999999999999986543211 00010
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
.. ...+|..++..+.+++.+||+.||.+|| ++.++++.
T Consensus 215 -----------~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 215 -----------ND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -----------hC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00 1123344566789999999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=299.62 Aligned_cols=241 Identities=28% Similarity=0.470 Sum_probs=195.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.|++.+ .+|+|+| |.||+|...+..+|+|..+. .+.+|+.++++++|||++++++++..+ ..++||
T Consensus 7 ~~~~~~-~lg~g~~-------g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 7 KLTLGE-IIGEGEF-------GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred Hceeee-eeccCCC-------CceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 355544 3899999 99999999999999999864 367899999999999999999998654 579999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 78 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 78 ELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred ECCCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999999999764 2345899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
... .....+..|+|||.+.++.++.++|+||||+++|||++ |+.||......+ .... .
T Consensus 152 ~~~-----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~--- 210 (254)
T cd05083 152 MGV-----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKEC----V--- 210 (254)
T ss_pred ccC-----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH----H---
Confidence 221 11233567999999999999999999999999999998 888887543211 0000 0
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
....+...+...+..+.+++.+||+.+|.+||+++|+++.|++
T Consensus 211 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 ----------EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----------hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0111122233455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=304.49 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=195.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC----------------CeeEEEEecc--------cHHHHHHHHHhcCCC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG----------------DDAAVKVMKG--------DVSSEINILKKINHS 414 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g----------------~~vavK~~~~--------~~~~E~~~l~~l~H~ 414 (669)
.|.+.+ ++|.|+| |.||++...+ ..+|+|.++. ++.+|++++++++|+
T Consensus 6 ~~~~~~-~lg~G~~-------g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~ 77 (295)
T cd05097 6 QLRLKE-KLGEGQF-------GEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNP 77 (295)
T ss_pred hCeehh-ccCCCCC-------ceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC
Confidence 455655 4999999 9999987632 2489998864 366799999999999
Q ss_pred CceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 005923 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ-------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487 (669)
Q Consensus 415 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrD 487 (669)
|++++++++..++..++||||+++++|.+++...... ....++|..++.++.|++.||+|||+.+ ++|||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~d 154 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRD 154 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccc
Confidence 9999999999999999999999999999999653210 1124789999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc--
Q 005923 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-- 565 (669)
Q Consensus 488 ik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-- 565 (669)
|||+||++++++.+||+|||+++....... ........++..|+|||.+.++.++.++||||||++++||++
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDY------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccCcc------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence 999999999999999999999986543221 111223455778999999999999999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 566 GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 566 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
+..||......+ ........... .. .......+...+..+.+++.+||+.||.+||++++|++.|+
T Consensus 229 ~~~p~~~~~~~~---~~~~~~~~~~~-----~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 229 KEQPYSLLSDEQ---VIENTGEFFRN-----QG-----RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCcccChHH---HHHHHHHhhhh-----cc-----ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 556665433211 11111111100 00 00001112234567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.56 Aligned_cols=226 Identities=26% Similarity=0.418 Sum_probs=185.9
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|.| |.||++..+ ++.+|+|+++.+ +..|..++..+ +||||+++++++...+..++||
T Consensus 3 lg~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 3 LGKGSF-------GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred eeeCCC-------eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 789999 999999984 678999998632 34677888776 6999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 76 Ey~~~g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 76 EFVNGGDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred cCCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999987643
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. .. ....
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~---~i~~--- 210 (320)
T cd05590 148 FNG--------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE---AILN--- 210 (320)
T ss_pred cCC--------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH---HHhc---
Confidence 221 112335789999999999999999999999999999999999999986543211 01 1110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
.. ...+......+.+++.+||+.||.+||++
T Consensus 211 ----------~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 211 ----------DE--VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ----------CC--CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 00 11233345678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.49 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=189.5
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++..+ +..+|+|+++.+ +..|..++.++ +||||+++++++..++..++||
T Consensus 3 lG~G~~-------g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 3 IGRGSY-------AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred EeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 689999 999999984 778999998642 45688888888 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... +.+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 76 e~~~~g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 76 EFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 999999999998654 45999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH--HHHHHHHHHHHHhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE--AELLYASISRVLEE 591 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~ 591 (669)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+ .......+...
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--- 216 (329)
T cd05588 148 RPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--- 216 (329)
T ss_pred cCC--------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH---
Confidence 211 11234578999999999999999999999999999999999999996321100 00000011000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS------ISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 642 (669)
+.... ...|..+...+.+++.+||+.||.+||+ +.+++++
T Consensus 217 ---------~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 217 ---------ILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---------HHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11111 1233445567899999999999999997 5676643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=303.63 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=196.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECC------------------CeeEEEEecc--------cHHHHHHHHHhcCC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKG------------------DDAAVKVMKG--------DVSSEINILKKINH 413 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g------------------~~vavK~~~~--------~~~~E~~~l~~l~H 413 (669)
|.+.+ ++|.|+| |.||++...+ ..+|+|.++. ++.+|++++++++|
T Consensus 7 ~~~~~-~lg~G~~-------g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 7 LNFVE-KLGEGQF-------GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD 78 (296)
T ss_pred Ccccc-cccCCCC-------ccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC
Confidence 44444 4899999 9999988642 3479999853 35679999999999
Q ss_pred CCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 005923 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487 (669)
Q Consensus 414 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrD 487 (669)
|||+++++++..++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~d 155 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRD 155 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 99999999999999999999999999999999765311 1236899999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc--
Q 005923 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-- 565 (669)
Q Consensus 488 ik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-- 565 (669)
|||+||++++++.++|+|||+++....... ........++..|+|||.+.++.++.++||||||+++|||++
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDY------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcc------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 999999999999999999999986543321 112233456788999999999899999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 566 GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 566 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
+..|+......+ ........+... +.......+..++.++.+++.+||+.||.+|||+.||++.|+
T Consensus 230 ~~~p~~~~~~~~---~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 230 REQPYEHLTDQQ---VIENAGHFFRDD----------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCcChHH---HHHHHHhccccc----------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 566665433211 111111110000 001111122334467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=298.62 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=196.0
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|+..+ .+|.|.| |.||++.. .+..+++|.++. .+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~~-~lg~g~~-------~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 75 (263)
T cd06625 4 WRRGK-LLGQGAF-------GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD 75 (263)
T ss_pred ccccc-eecCCCc-------eEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence 44444 3899999 99999986 478999998742 35679999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++|+||+++++|.+++... ..+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.++|+|
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 99999999999999999999754 35889999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+. .
T Consensus 148 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~ 216 (263)
T cd06625 148 FGASKRLQTICSSG-----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------I 216 (263)
T ss_pred cccceecccccccc-----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------H
Confidence 99998654321110 011234577899999999999999999999999999999999999875432110 0
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ...........+......+.+++.+||..+|.+|||+.|+++.
T Consensus 217 ~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 F-------------KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred H-------------HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 0011111223444566678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=302.67 Aligned_cols=244 Identities=27% Similarity=0.440 Sum_probs=194.1
Q ss_pred HHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
++|.|+| |.||++.. .+..+++|..+. ++.+|++++++++|+||+++++++..++..++
T Consensus 12 ~lg~g~~-------g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 12 ELGEGAF-------GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred ccCCccC-------CeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 5899999 99999964 245788898753 57789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 432 VYEFADNGALSDWLHSNRY----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
+|||+++|+|.++++..+. .....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999976421 11235899999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 580 (669)
||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 162 kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-- 233 (280)
T ss_pred EECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--
Confidence 99999999865432210 11122345678999999999999999999999999999998 8888865432111
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
.. .... ......+..++..+.+++.+||+.||.+||++.||.+.|++
T Consensus 234 ----~~----------~~~~----~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ----IE----------CITQ----GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HH----------HHHc----CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00 0000 00112233445678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.48 Aligned_cols=230 Identities=25% Similarity=0.399 Sum_probs=187.2
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++... |+.+|+|.++.+ ...|..++... +||||+++++++.+++..++||
T Consensus 3 lg~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 3 LGKGSF-------GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred eeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 789999 999999984 778999998642 33567777654 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 76 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~-------- 208 (316)
T cd05620 148 FGD--------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESI-------- 208 (316)
T ss_pred cCC--------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH--------
Confidence 211 12234578999999999999999999999999999999999999998654311 11110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS-EVF 640 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 640 (669)
.. . ....+.....++.+++.+||+.||.+||++. +++
T Consensus 209 -----~~-~----~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 209 -----RV-D----TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----Hh-C----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 0 1122333456789999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=335.67 Aligned_cols=249 Identities=32% Similarity=0.523 Sum_probs=206.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCVHEG 427 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 427 (669)
.+|.|.| |.|++|... ...||||.++. ++..|+++|+.+ +|+||+.++|+|..++
T Consensus 303 ~lg~g~f-------G~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 303 YLGEGAF-------GQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred eeecccc-------cceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 6899999 999999863 23689999863 477899999999 6999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec
Q 005923 428 NTYLVYEFADNGALSDWLHSNR---------YQTSD--NLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~ 496 (669)
..++|+||+.+|+|.+||+..+ ..... .|+...++.++.|||.||+||++.. +|||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999999876 11122 3999999999999999999999998 99999999999999
Q ss_pred CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCch
Q 005923 497 TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQN 575 (669)
Q Consensus 497 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~ 575 (669)
++..+||+|||++|.......... ...... -+..|||||.+....|+.++|||||||+||||+| |..|+.+-..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~----~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT----KSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe----cCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999997665443210 001111 3567999999999999999999999999999999 7888876321
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
.+ .+-+.+.++.+.+.|..|..+++++|+.||+.+|.+||++.|+.+.|+.+..
T Consensus 528 ~~-------------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TE-------------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH-------------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11 0111334456677888899999999999999999999999999999999654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=298.58 Aligned_cols=238 Identities=26% Similarity=0.486 Sum_probs=193.3
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADN 438 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 438 (669)
.+|.|.| |.||++.+. +..+|+|.++. ++..|++++++++|||++++++++......++||||+++
T Consensus 11 ~ig~g~~-------g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 11 EIGSGQF-------GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred eecCccc-------ceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4899999 999999885 77899998763 477899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccc
Q 005923 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518 (669)
Q Consensus 439 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~ 518 (669)
|+|.+++...+ ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 84 GCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999997542 35899999999999999999999999 99999999999999999999999999986543211
Q ss_pred cCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhh
Q 005923 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREK 597 (669)
Q Consensus 519 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (669)
.......++.+|+|||.+.++.++.++||||||+++|||++ |..||......+ ....
T Consensus 156 ------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~------------- 213 (256)
T cd05112 156 ------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET------------- 213 (256)
T ss_pred ------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH-------------
Confidence 11112335678999999999999999999999999999998 888887544211 1010
Q ss_pred hhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 598 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
+.. ..+...+...+..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 214 ~~~----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 214 INA----GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HhC----CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 000 0011112223467899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.37 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=188.7
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++... ++.+|+|+++.. +..|+.++.++ +||||+++++++..++..++||
T Consensus 3 lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 3 IGRGSY-------AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred eeeCCC-------eEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 789999 999999884 678999998642 44678888776 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 76 E~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 76 EYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 999999999998654 45899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH--HHHHHHHHHHHHhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE--AELLYASISRVLEE 591 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~ 591 (669)
... .......||..|+|||++.+..++.++||||||+++|||++|+.||....... .......+...
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--- 216 (329)
T cd05618 148 RPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--- 216 (329)
T ss_pred CCC--------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---
Confidence 221 11234578999999999999999999999999999999999999996211100 00000000000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS------ISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 642 (669)
+.... ...|......+.+++.+||+.||.+||+ +.+++.+
T Consensus 217 ---------i~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 217 ---------ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---------HhcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11111 1234455667899999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.94 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=200.4
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEec-------ccHHHHHHHHHhcC-CCCceeEeeEE-Eec------Cce
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-------GDVSSEINILKKIN-HSNIIRLSGFC-VHE------GNT 429 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~-------~~~~~E~~~l~~l~-H~niv~l~g~~-~~~------~~~ 429 (669)
|++|+| +.||.+... |..+|+|++- ..+.+|+++|++|. |+|||.+++.. ... -+.
T Consensus 45 LAEGGF-------a~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 45 LAEGGF-------AQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EccCCc-------EEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 899999 999999984 3799999983 23678999999996 99999999932 211 257
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
+|+||||.+|+|-|++..+. ...|++..+++|+.|+++|+.+||.. .|||||||||-+||||+.++..||||||.+
T Consensus 118 llLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 89999999999999998652 23499999999999999999999998 589999999999999999999999999999
Q ss_pred cccCCCccccCCc-ccceeeeccccccccccccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 510 RSAESDEHEQGGY-GLQLTRHVVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 510 ~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~l---~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
.-.........+. ...-.-...-|+-|+|||.+ .+..+++|+|||+|||+||-|+....||++...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 7543222100000 00001123468899999987 467899999999999999999999999986432
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
-.+++..+.-+-.......|.+||+.||+.||.+||++-+|++.+.+|.+..
T Consensus 264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1234444443333467788999999999999999999999999999998664
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=297.77 Aligned_cols=246 Identities=31% Similarity=0.516 Sum_probs=199.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|.+.+ ++|.|+| |.||++..+ +..++||.++. ++.+|+.++++++|+||+++++++..+...++
T Consensus 7 ~~~i~~-~ig~g~~-------~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 7 SLKLER-KLGAGQF-------GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred heeeee-eeccCcc-------eEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 355544 4899999 999999875 46789998864 47789999999999999999999988889999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 79 v~e~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 79 VTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred EEeccCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcccccee
Confidence 99999999999999764 2346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+..... ....
T Consensus 153 ~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~------ 216 (261)
T cd05034 153 IEDDEY-------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ------ 216 (261)
T ss_pred ccchhh-------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH------
Confidence 653211 01112234568999999999999999999999999999998 999987644321 0010
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
+. ...+...+...+..+.+++.+||+.+|.+||+++|+.+.|+.
T Consensus 217 -------~~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 -------VE----RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------HH----cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 011122233445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.60 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=192.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec-ccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
|.+.. .+|.|+| |.||++... ++.||||... ..+.+|+++|++++|+|||++++++..++..++|||++
T Consensus 171 y~i~~-~Lg~G~~-------G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 171 FAIHR-ALTPGSE-------GCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred eEEEE-EEccCCC-------eEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 44444 3788899 999999984 6789999754 35778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
. ++|.+++... ...++|.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 243 ~-~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 243 R-SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred C-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 5 6999998653 236999999999999999999999999 9999999999999999999999999998654321
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchh-----HHHHHHHHHHHHHh-
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC-----EAELLYASISRVLE- 590 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~- 590 (669)
. ........||..|+|||++.+..++.++|||||||+||||++|..++...... ....+...+...-.
T Consensus 315 ~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 315 S------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred c------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 1 11122356999999999999999999999999999999999988766532110 00111111111000
Q ss_pred --hh------hHHhhhhcccCCccCCCC-----c--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 --ES------NVREKLRGFIDPSLRNEY-----P--LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 --~~------~~~~~l~~~~d~~l~~~~-----~--~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .....+........+... . ......+.+|+.+||+.||.+|||+.|++++
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000000000000000 0 0223467899999999999999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=301.09 Aligned_cols=243 Identities=29% Similarity=0.497 Sum_probs=193.8
Q ss_pred HHhCCCCcccceeeEEEEEEECC--------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 367 IATGSFSEENRIQGSVYRGSFKG--------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g--------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
+|.|.| |.||+|...+ ..+++|.++. .+.+|++++++++||||+++++++...+..+
T Consensus 3 lg~g~~-------g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 3 LGSGAF-------GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred cccccc-------eeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeE
Confidence 788999 9999998742 4688887642 3668999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-----cEEE
Q 005923 431 LVYEFADNGALSDWLHSNRYQ--TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-----RAKI 503 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-----~~kl 503 (669)
+||||+++|+|.+++++.... ....++|.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEE
Confidence 999999999999999764211 2345899999999999999999999998 99999999999999877 8999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 582 (669)
+|||+++........ .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+. .
T Consensus 153 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~ 223 (269)
T cd05044 153 GDFGLARDIYKSDYY------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---L 223 (269)
T ss_pred CCccccccccccccc------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---H
Confidence 999999865432211 11122345678999999999999999999999999999998 9999875443210 0
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
.. . +.......+...+..+.+++.+||..+|.+||++++|++.|++
T Consensus 224 ~~----~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 224 QH----V-------------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HH----H-------------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0 0011112334456778999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=303.77 Aligned_cols=237 Identities=24% Similarity=0.335 Sum_probs=193.0
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++.. +++.||+|.++. .+.+|+.++++++||||+++++++..++..++|||
T Consensus 8 lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 8 LGKGGF-------GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred EecCCC-------eEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 799999 99999987 478899998853 24569999999999999999999998899999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999998653 2246899999999999999999999999 99999999999999999999999999986543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.+..... ....+...
T Consensus 155 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~------ 216 (285)
T cd05605 155 GE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERR------ 216 (285)
T ss_pred CC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHH------
Confidence 21 1123468999999999999999999999999999999999999998644311 11111100
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
+.. ....++...+..+.+|+.+||+.||.+|| ++++++.+
T Consensus 217 ---~~~-----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 ---VKE-----DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---hhh-----cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 100 11223344566789999999999999999 77788654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=301.00 Aligned_cols=231 Identities=23% Similarity=0.409 Sum_probs=182.7
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--------------------------CCeeEEEEecc-------cHHHHHHHHHhcC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--------------------------GDDAAVKVMKG-------DVSSEINILKKIN 412 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--------------------------g~~vavK~~~~-------~~~~E~~~l~~l~ 412 (669)
.+|.|+| |.||+|.+. ...|++|.++. .+.+|+.++++++
T Consensus 2 ~lG~G~~-------~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~ 74 (274)
T cd05076 2 HLGQGTR-------TNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS 74 (274)
T ss_pred CcCcccc-------cceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC
Confidence 3799999 999999852 12478888853 3567889999999
Q ss_pred CCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 005923 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSN 492 (669)
Q Consensus 413 H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~N 492 (669)
||||++++++|..+...++||||+++|+|.+++... .+.+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 75 h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~N 147 (274)
T cd05076 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKN 147 (274)
T ss_pred CCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCccc
Confidence 999999999999999999999999999999999753 246899999999999999999999998 9999999999
Q ss_pred eeecCCC-------cEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHH
Q 005923 493 ILLDTNL-------RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELL 564 (669)
Q Consensus 493 ILl~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~ell 564 (669)
||+++++ .+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALSRE------------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred EEEeccCcccCccceeeecCCcccccccccc------------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9997643 48999999986543211 1346778999998876 56899999999999999995
Q ss_pred -cCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 565 -SGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 565 -tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+|+.|+......+... .... . ...+......+.+++.+||+.+|.+|||+.+|++.|
T Consensus 216 ~~g~~p~~~~~~~~~~~-------~~~~-------------~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 216 FDGEVPLKERTPSEKER-------FYEK-------------K--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hCCCCCccccChHHHHH-------HHHh-------------c--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 6888887543321100 0000 0 011112234689999999999999999999999887
Q ss_pred H
Q 005923 644 S 644 (669)
Q Consensus 644 ~ 644 (669)
+
T Consensus 274 ~ 274 (274)
T cd05076 274 T 274 (274)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.55 Aligned_cols=227 Identities=26% Similarity=0.417 Sum_probs=183.9
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHH-HHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEIN-ILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++.. +|+.+|+|++... +..|.. +++.++||||+++++++..++..++||
T Consensus 3 lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 3 IGKGSF-------GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred eeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 789999 99999998 4788999998532 223433 467789999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 76 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 76 DYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred cCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999987542
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+ . ......
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~---~~~i~~--- 210 (323)
T cd05575 148 EHS--------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---M---YDNILN--- 210 (323)
T ss_pred cCC--------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---H---HHHHHc---
Confidence 211 11234578999999999999999999999999999999999999998654211 0 001110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 637 (669)
... ..+...+..+.+++.+||+.||.+||++.
T Consensus 211 ----------~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 211 ----------KPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----------CCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 000 11223356789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=302.91 Aligned_cols=257 Identities=25% Similarity=0.475 Sum_probs=194.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec--Cce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE--GNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 429 (669)
++|+|+| |.||++.+ .+..+|+|.++. ++.+|++++++++|+|++++.+++... ...
T Consensus 11 ~lg~g~~-------g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 11 DLGEGHF-------GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred ecCCCCc-------eeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3899999 99999975 366799999862 467899999999999999999998775 567
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|.+++... ...++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999999654 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+........ ........++..|+|||++.+..++.++||||||+++|||++++.+........... .....
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~----~~~~~ 227 (284)
T cd05079 157 KAIETDKEY-----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM----IGPTH 227 (284)
T ss_pred cccccCccc-----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh----ccccc
Confidence 876433211 112233456778999999999999999999999999999999876643211100000 00000
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
.+......+. .+....+.+.+..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus 228 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 228 GQMTVTRLVR-VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccHHHHHH-HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000000 0111111222334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.70 Aligned_cols=230 Identities=26% Similarity=0.412 Sum_probs=182.2
Q ss_pred HHHhCCCCcccceeeEEEEEEECC--------------CeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG--------------DDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g--------------~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.+|+|.| |.||+|.+.. ..+++|.+.. .+.+|+.++++++||||+++++++.
T Consensus 2 ~lg~G~~-------~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 2 HLGRGTR-------TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred ccccCCc-------ceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3789999 9999998632 2478888753 3567889999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc----
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR---- 500 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~---- 500 (669)
.+...++||||+++|+|..+++.. ...+++..+++++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCC
Confidence 999999999999999999998753 245899999999999999999999998 999999999999987654
Q ss_pred ---EEEcccCCccccCCCccccCCcccceeeecccccccccccccc-cCCCCchhhHHHHHHHHHHHH-cCCCCCCCCch
Q 005923 501 ---AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-NGVITPKLDVFAFGVVVLELL-SGREAVTGDQN 575 (669)
Q Consensus 501 ---~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDV~S~Gvvl~ell-tg~~p~~~~~~ 575 (669)
+|++|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+.....
T Consensus 148 ~~~~~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 148 GPFIKLSDPGIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CceeEeCCCCCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 899999998765322 1235678899999987 567899999999999999998 57777764332
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
.+.. .... .... ........+.+|+.+||+.||.+||++.+|++.|
T Consensus 216 ~~~~-------~~~~-------------~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 216 AEKE-------RFYE-------------GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hHHH-------HHHh-------------cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1100 0000 0000 0111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.14 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=195.0
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|+| |.||++... |+.+|+|+++. .+..|++++..++|+||+++++++.+++..++||
T Consensus 8 ~lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 8 VIGRGAF-------GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred EEEeCCc-------EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3899999 999999985 88999999863 2567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999764 46899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc---------------------CCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 005923 514 SDEHEQ---------------------GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTG 572 (669)
Q Consensus 514 ~~~~~~---------------------~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~ 572 (669)
...... ............||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 432000 00000122345789999999999999999999999999999999999999986
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-ISEVFVT 642 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~ 642 (669)
....+. ...+. .+. ..+..+.....+..+.+++.+|+. ||.+||+ ++|++++
T Consensus 233 ~~~~~~------~~~i~----------~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQET------YNKII----------NWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHHHH------HHHHh----------ccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 543211 00111 000 011111111245678999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.22 Aligned_cols=244 Identities=28% Similarity=0.450 Sum_probs=193.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
++|.|+| |.||++... +..+|+|.++. ++.+|+.++++++||||+++++++..++..+
T Consensus 12 ~lg~g~~-------g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 12 DIGQGAF-------GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred ccccccc-------ccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 4899999 999999863 46789998753 3667999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 431 LVYEFADNGALSDWLHSNRY-----------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
+||||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence 99999999999999975321 11235889999999999999999999998 99999999999
Q ss_pred eecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 005923 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~ 572 (669)
|+++++.+||+|||+++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYY------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred EecCCCceEECccccceecccCccc------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999998865432210 01112234567999999999999999999999999999998 8788865
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 645 (669)
....+ . .. .. .+... ...+..++.++.+++.+||+.||.+|||+.|+++.|++
T Consensus 236 ~~~~~--~----~~-~~------------~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 236 MAHEE--V----IY-YV------------RDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCHHH--H----HH-HH------------hcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 43211 0 00 00 00111 12233455679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=282.00 Aligned_cols=242 Identities=27% Similarity=0.428 Sum_probs=202.7
Q ss_pred cccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 356 ~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
++..|++... +|.|.| |.||.|+.+ +--||+|++.. .+.+|+++-+.++||||++++++|
T Consensus 20 ~l~dfeigr~-LgkgkF-------G~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 20 TLDDFEIGRP-LGKGKF-------GNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred chhhcccccc-ccCCcc-------ccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3344555554 899999 999999985 55789999842 467899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
.++...||++||..+|.|...|+..+ ...+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++.+||
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lki 165 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKI 165 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeec
Confidence 99999999999999999999998543 356888888899999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||-+...... ......||..|.+||..++...+...|+|++|++.+|++.|..||......+ .+.
T Consensus 166 AdfGwsV~~p~~----------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYk 232 (281)
T KOG0580|consen 166 ADFGWSVHAPSN----------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYK 232 (281)
T ss_pred cCCCceeecCCC----------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHH
Confidence 999998765432 2345789999999999999999999999999999999999999998544221 111
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.+ .+-.+|........++|.+|+..+|.+|.+..|+++.
T Consensus 233 rI~k------------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 233 RIRK------------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHH------------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111 1223455667788999999999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.53 Aligned_cols=238 Identities=25% Similarity=0.367 Sum_probs=189.4
Q ss_pred HHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc-----------cHHHHHHHHHhc-CCCCceeEeeEEEecCc
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG-----------DVSSEINILKKI-NHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 428 (669)
.+|.|+| |.||++.. .+..+|+|+++. .+..|+++++++ +|+||+++++++..++.
T Consensus 7 ~lg~G~~-------g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 7 VLGTGAY-------GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred EEeecCC-------EEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 3899999 99999875 467899999853 245699999999 59999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999999999999754 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++....... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+.
T Consensus 152 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~- 220 (332)
T cd05614 152 SKEFLSEEK-------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVS- 220 (332)
T ss_pred CccccccCC-------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHH-
Confidence 986543221 112345789999999999865 47889999999999999999999997432211000 000
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
..+.. .+ ...+......+.+++.+||+.||.+|| ++.+++++
T Consensus 221 --------~~~~~-~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 --------RRILK-CD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --------HHHhc-CC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00000 11 123334556789999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=294.11 Aligned_cols=239 Identities=31% Similarity=0.524 Sum_probs=194.3
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|.| |.||++..+ ++.+++|..+. .+.+|++++++++|+||+++++++......++||||+
T Consensus 2 ~lg~g~~-------g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 2 KIGKGNF-------GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred ccccCCC-------ceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcC
Confidence 3788999 999999985 78899998753 3667999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++++|.+++.+. ...+++..++.++.+++.||+|||+++ ++||||+|+|||++.++.+||+|||+++......
T Consensus 75 ~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 75 PGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 999999999754 235889999999999999999999999 9999999999999999999999999998654321
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ........+..|+|||.+.++.++.++|+||||+++|||++ |..||.........
T Consensus 148 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---------------- 205 (251)
T cd05041 148 YT------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---------------- 205 (251)
T ss_pred ce------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----------------
Confidence 10 00112234567999999999999999999999999999999 77777654321100
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
..+ ........+...+..+.+++.+||..+|.+|||+.|+++.|.
T Consensus 206 ~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 206 ERI----ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHH----hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 001 111122234455678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.73 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=196.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC------------------CCeeEEEEecc--------cHHHHHHHHHhcC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK------------------GDDAAVKVMKG--------DVSSEINILKKIN 412 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~------------------g~~vavK~~~~--------~~~~E~~~l~~l~ 412 (669)
.|++.+ ++|.|+| |.||++... +..+|+|.++. ++.+|++++++++
T Consensus 6 ~~~~~~-~lg~G~~-------g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (296)
T cd05095 6 RLTFKE-KLGEGQF-------GEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK 77 (296)
T ss_pred hceeee-eccCCCC-------CeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC
Confidence 355555 4999999 999988542 23589998863 3668999999999
Q ss_pred CCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 005923 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486 (669)
Q Consensus 413 H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHr 486 (669)
|+||+++++++..++..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+.+ ++||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~ 154 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHR 154 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 999999999999999999999999999999999865311 1235889999999999999999999999 9999
Q ss_pred CCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-
Q 005923 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS- 565 (669)
Q Consensus 487 Dik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt- 565 (669)
||||+|||+++++.+||+|||+++....... ........++..|++||...++.++.++||||||+++|||++
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDY------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred cCChheEEEcCCCCEEeccCcccccccCCcc------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 9999999999999999999999986543221 011122344678999999988999999999999999999998
Q ss_pred -CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 566 -GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 566 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
|..|+......+. .......... .... ...+.+..++..+.+++.+||+.||.+||++.||.+.|+
T Consensus 229 ~~~~p~~~~~~~~~---~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 229 CKEQPYSQLSDEQV---IENTGEFFRD-----QGRQ-----VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCCccccChHHH---HHHHHHHHhh-----cccc-----ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 6677764332111 1111110000 0000 001122334567899999999999999999999999986
Q ss_pred H
Q 005923 645 K 645 (669)
Q Consensus 645 ~ 645 (669)
+
T Consensus 296 ~ 296 (296)
T cd05095 296 E 296 (296)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.24 Aligned_cols=243 Identities=33% Similarity=0.568 Sum_probs=199.0
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.|+| |.||++... +..+++|.++. .+.+|++++++++|+|++++++++..+...++|
T Consensus 2 ~ig~g~~-------g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 2 KLGEGAF-------GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred ccccCCc-------eEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 3789999 999999985 67899999864 355799999999999999999999998999999
Q ss_pred EEecCCCCHHHHHhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 433 YEFADNGALSDWLHSNRYQ----TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
|||+++|+|.+++...... ....+++..+.+++.|++.||+|||+++ ++||||+|+||++++++.+||+|||.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 9999999999999764210 1356999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++....... ........++..|+|||.+....++.++||||||++++||++ |..||......+ ...
T Consensus 152 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---- 218 (262)
T cd00192 152 SRDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE---- 218 (262)
T ss_pred ccccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----
Confidence 987754321 112234567889999999998899999999999999999999 588887653211 100
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
.+.. ......+..++.++.+++.+||+.||.+|||+.|++..|+
T Consensus 219 ---------~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 ---------YLRK----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------HHHc----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 1122334455678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.96 Aligned_cols=230 Identities=27% Similarity=0.388 Sum_probs=184.8
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHH-HHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEI-NILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++... ++.+|+|+++.. +..|. .+++.++|+||+++++++..++..++||
T Consensus 3 lg~G~f-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 3 IGKGSF-------GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred eeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 789999 999999884 667999998531 22333 3467789999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 76 DYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999999999754 35788889999999999999999999 9999999999999999999999999997543
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. .. ....
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~~--- 210 (325)
T cd05602 148 EHN--------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD---NILN--- 210 (325)
T ss_pred cCC--------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH---HHHh---
Confidence 221 112345789999999999999999999999999999999999999986543211 01 1110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 640 (669)
.. ...+......+.+++.+||+.||.+||++.+.+
T Consensus 211 ----------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 211 ----------KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ----------CC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 00 111223455789999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=323.05 Aligned_cols=264 Identities=23% Similarity=0.390 Sum_probs=195.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---HHHHHHHHHhcCCCCceeEeeEEEec-------
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---VSSEINILKKINHSNIIRLSGFCVHE------- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l~H~niv~l~g~~~~~------- 426 (669)
.|++.+. +|.|+| |.||+|.. .++.||||++..+ ..+|+.+|++++||||+++++++...
T Consensus 67 ~y~~~~~-LG~G~f-------g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 67 SYKLGNI-IGNGSF-------GVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred eEEEeEE-EEeCCC-------EEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4555553 899999 99999987 4788999988543 45799999999999999999886432
Q ss_pred -CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEc
Q 005923 427 -GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKIT 504 (669)
Q Consensus 427 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~ 504 (669)
...++||||+++ +|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence 236789999985 7888775431 22356999999999999999999999999 99999999999998664 79999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|||+++....... .....||..|+|||++.+ ..++.++|||||||++|||++|..||.+....+. + .
T Consensus 214 DFGla~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~-~ 281 (440)
T PTZ00036 214 DFGSAKNLLAGQR---------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--L-V 281 (440)
T ss_pred ccccchhccCCCC---------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-H
Confidence 9999987643221 123467899999999876 4689999999999999999999999987654221 1 1
Q ss_pred HHHHHHhhhhHHhhhh-------c-----ccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhc
Q 005923 584 SISRVLEESNVREKLR-------G-----FIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIWS 648 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~-------~-----~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~ 648 (669)
.+...+..... +.+. . .....+...+|...+.++.+|+.+||+.||.+|||+.|++.+ +..+..
T Consensus 282 ~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 282 RIIQVLGTPTE-DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhCCCCH-HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 11111111110 0000 0 001111122333445678999999999999999999999955 555544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.00 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=199.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe-----cCce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH-----EGNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~ 429 (669)
.+|.|.| |.|..+.. .|+.||||++.. +..+|+++|+.++|+||+.+.+++.. -...
T Consensus 29 ~iG~GAy-------GvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 29 PIGRGAY-------GVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred cccCcce-------eeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4899999 99999988 488999999863 34579999999999999999999875 2467
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
|+|+|+|+. +|...++.+ ..|+......+++|+++||.|+|+.+ ++||||||+|+|++.+..+||+|||+|
T Consensus 102 YiV~elMet-DL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 102 YLVFELMET-DLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred EEehhHHhh-HHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 999999964 999999764 35999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
|...... . ....+..+.|.+|.|||.+.. ..||...||||.||++.||++|+..|.|.+..+ ....+..+
T Consensus 173 R~~~~~~-~-----~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~---Ql~lI~~~ 243 (359)
T KOG0660|consen 173 RYLDKFF-E-----DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH---QLQLILEL 243 (359)
T ss_pred eeccccC-c-----ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH---HHHHHHHh
Confidence 9886431 1 112344677999999999864 789999999999999999999999999865432 22222222
Q ss_pred Hhhhh-----------HHhhhhcccC---CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhc
Q 005923 589 LEESN-----------VREKLRGFID---PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIWS 648 (669)
Q Consensus 589 ~~~~~-----------~~~~l~~~~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~ 648 (669)
+..+. .+..++.+.. ..+...+| .......+|+.+||..||.+|+|++|.+++ |+....
T Consensus 244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 22211 1111111110 01111122 345568899999999999999999999987 555544
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.28 Aligned_cols=227 Identities=26% Similarity=0.388 Sum_probs=183.3
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHH-HHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEI-NILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++.. +++.+|+|+++.. +..|. .+++.++||||+++++++.+.+..++||
T Consensus 3 lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 3 IGKGSF-------GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred eeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 789999 99999998 4778999998531 23344 3578899999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 76 DYVNGGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 999999999998653 35888999999999999999999999 9999999999999999999999999987532
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+.+... ... ...
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~---- 209 (321)
T cd05603 148 EPE--------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD---NIL---- 209 (321)
T ss_pred CCC--------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH---HHh----
Confidence 211 11234578999999999999999999999999999999999999998654211 100 010
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 637 (669)
... ...+......+.+++.+||+.||.+||+..
T Consensus 210 ---------~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 ---------HKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---------cCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 000 122333455789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.90 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=190.8
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++.. .|+.||||+++. .+.+|+++|++++||||+++++++.+++..++|||
T Consensus 9 lG~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 9 IGRGAF-------GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred EEecCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 899999 99999998 478899999863 24579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 82 YLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999754 35899999999999999999999999 99999999999999999999999999976532
Q ss_pred CccccCCc------------------------------ccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 005923 515 DEHEQGGY------------------------------GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564 (669)
Q Consensus 515 ~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ell 564 (669)
........ .........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21100000 000111246999999999999999999999999999999999
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 005923 565 SGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS---ISEVFV 641 (669)
Q Consensus 565 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~ 641 (669)
+|..||.+....+. ...... . ...+..+........+.+++.+|+. +|.+|++ +.|++.
T Consensus 234 ~G~~Pf~~~~~~~~------~~~i~~----------~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQET------YRKIIN----------W-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHH------HHHHHc----------C-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999986543211 111110 0 0011111111234568899999996 9999998 888876
Q ss_pred H
Q 005923 642 T 642 (669)
Q Consensus 642 ~ 642 (669)
+
T Consensus 296 h 296 (364)
T cd05599 296 H 296 (364)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.21 Aligned_cols=243 Identities=21% Similarity=0.304 Sum_probs=192.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+ .+|.|+| |.||++... ++.+|+|.++. .+..|+.+++.++||||+++++++.++
T Consensus 44 ~y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 44 DFDVIK-VIGRGAF-------GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred HcEEEE-EEeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 344444 3899999 999999874 77899999853 255799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++++. .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEec
Confidence 9999999999999999999753 3788889999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG----VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+..... .
T Consensus 187 G~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~- 255 (370)
T cd05596 187 GTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T- 255 (370)
T ss_pred cceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---H-
Confidence 99986543221 112235789999999998653 47899999999999999999999998654321 0
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA--RPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 642 (669)
...+... . ..+..+.....+..+.+++.+||+.+|.+ ||++.|++.+
T Consensus 256 --~~~i~~~------~-----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 --YSKIMDH------K-----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --HHHHHcC------C-----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111110 0 00111111134567899999999999987 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.60 Aligned_cols=242 Identities=24% Similarity=0.399 Sum_probs=205.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|.+-+ ++|+|.| |.++..+. ++..+++|.+.- ...+|+.++++++|||||.+.+.+.+++
T Consensus 5 ~Ye~~~-~iG~Gaf-------G~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 5 NYEVLR-QVGRGAF-------GSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred hhhhhh-hcCcccc-------chhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 345545 4999999 87765554 577899998852 4578999999999999999999999999
Q ss_pred c-eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 428 N-TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 428 ~-~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
. .++||+|++||+|.+.+.+.+ ...+.++++..|+.|++.|++|||++. |+|||||+.|||++.+..+||+||
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecch
Confidence 8 899999999999999998764 456899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+|+.+.... ......+||+.||+||.+.+..|..|+|+|||||++|||++-+.+|.+.+-. .+...
T Consensus 151 GlaK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~k-- 217 (426)
T KOG0589|consen 151 GLAKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILK-- 217 (426)
T ss_pred hhhhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHH--
Confidence 9999987653 2345689999999999999999999999999999999999999999865421 11111
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. .+. ...+.|.....++..|+..|++.+|..||++.+++..
T Consensus 218 -i---------~~~-----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 -I---------NRG-----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -H---------hhc-----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 111 1234566677789999999999999999999999976
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=332.89 Aligned_cols=268 Identities=21% Similarity=0.308 Sum_probs=206.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
|.+.+ ++|.|+| |.||+|.. .|+.||+|+++. ++.+|++++++++||||+++++++.+++
T Consensus 4 YeIi~-~LGkGgf-------G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 4 YDIIR-LIGKGGM-------GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred eEEEE-EEecCCC-------EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 44434 3899999 99999987 478999999853 3668999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 428 NTYLVYEFADNGALSDWLHSNRY------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
..++||||+++|+|.+++..... .....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~v 152 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEV 152 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCE
Confidence 99999999999999999975311 11234678889999999999999999998 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCC----------cccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 005923 502 KITNFGLARSAESDEHEQGG----------YGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~ 571 (669)
||+|||+++........... ..........||..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 99999999876321110000 00011223579999999999999999999999999999999999999997
Q ss_pred CCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhcCC
Q 005923 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-SISEVFVTLSKIWSSS 650 (669)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~~ 650 (669)
......... ... ..++.- .....+.+..+.+++.+||+.||.+|| +++++.+.|+...+..
T Consensus 233 ~~~~~ki~~--------------~~~---i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 233 RKKGRKISY--------------RDV---ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred Ccchhhhhh--------------hhh---ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 643211000 000 011100 000123456688999999999999995 7888999999998888
Q ss_pred CCCCCC
Q 005923 651 SDWDPS 656 (669)
Q Consensus 651 ~~~~~~ 656 (669)
.+|.+.
T Consensus 295 p~w~~~ 300 (932)
T PRK13184 295 PEWTVK 300 (932)
T ss_pred cccccc
Confidence 888764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.95 Aligned_cols=240 Identities=29% Similarity=0.493 Sum_probs=193.9
Q ss_pred HHhCCCCcccceeeEEEEEEEC---CC--eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK---GD--DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~---g~--~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||+|.+. +. .+|+|.++. ++.+|+.++++++|+||+++++++.. ...++||
T Consensus 3 ig~g~~-------~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 3 LGDGSF-------GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CCccCc-------ccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 688999 999999873 22 589999864 35679999999999999999999987 8899999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+.. . ..++|..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++...
T Consensus 75 e~~~~~~L~~~l~~~~--~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--L-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred EecCCCcHHHHHHhcc--c-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccc
Confidence 9999999999998652 1 46899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
..... ........++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ ....+.
T Consensus 149 ~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~------ 214 (257)
T cd05040 149 QNEDH-----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKID------ 214 (257)
T ss_pred ccccc-----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH------
Confidence 43211 111223457788999999999999999999999999999999 999987543221 111110
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
. .......+...+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus 215 -------~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 215 -------K---EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------h---cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 00111223345567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=309.67 Aligned_cols=233 Identities=22% Similarity=0.345 Sum_probs=186.1
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++.. ++..+|+|+++.+ +..|+.++.++ +||||+++++++...+..++||
T Consensus 3 lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 3 IGRGSY-------AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred eeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 789999 99999987 4678999999642 45788888888 6999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... +.+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 76 EYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 999999999998654 35999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 148 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~----- 214 (327)
T cd05617 148 GPG--------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----- 214 (327)
T ss_pred CCC--------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-----
Confidence 211 1123457899999999999999999999999999999999999999642211100000011000
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
+.... ...|...+..+.+++.+||+.||.+|+++
T Consensus 215 -------~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 215 -------ILEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -------HHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 01111 12344455678999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=309.51 Aligned_cols=226 Identities=26% Similarity=0.412 Sum_probs=185.1
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhcCCC-CceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKINHS-NIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 433 (669)
+|+|+| |.||+|..+ ++.+|+|+++.+ +..|.+++..++|+ +|+++.+++...+..++||
T Consensus 8 lg~G~~-------g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 8 LGKGSF-------GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred EeeccC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 899999 999999985 568999998632 44688888888765 6888999998889999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||.+....+ .... .
T Consensus 153 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~---i----- 213 (324)
T cd05587 153 FGG--------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQS---I----- 213 (324)
T ss_pred CCC--------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH---H-----
Confidence 211 12334578999999999999999999999999999999999999998654321 1111 0
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
... ...++......+.+++.+||+.||.+|++.
T Consensus 214 --------~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 214 --------MEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --------HcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 122344455678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.65 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=191.8
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|.| |.||++.. +|+.+|+|+++. .+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 8 ~lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 8 LVGRGHF-------GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred EEEeccC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3899999 99999987 478899999864 2567899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+.+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999997642 45899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCccccCCcccceeeecccccccccccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIE------NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
.... .......||..|+|||++. ...++.++|||||||++|||++|+.||........ ...
T Consensus 154 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~ 220 (330)
T cd05601 154 ANKM-------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNN 220 (330)
T ss_pred CCCc-------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHH
Confidence 3321 1223357899999999987 46678999999999999999999999986543211 111
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
++.. ... +..+.....+..+.+|+.+||+ ||.+||++.+++.+
T Consensus 221 i~~~-------~~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 221 IMNF-------QRF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHcC-------CCc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1110 000 1111112345668899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.56 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=189.8
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||+|.. .+..+|+|+++. .+..|++++++++|+||+++++++.+++..++||
T Consensus 8 ~LG~G~~-------g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 8 TLGIGAF-------GEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred EEeecCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3899999 99999988 467899999853 2567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 81 DYIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999999754 35889999999999999999999999 9999999999999999999999999986432
Q ss_pred CCccccC---------------------------------------CcccceeeecccccccccccccccCCCCchhhHH
Q 005923 514 SDEHEQG---------------------------------------GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVF 554 (669)
Q Consensus 514 ~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~ 554 (669)
....... ...........||..|+|||.+.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1100000 0000011235799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHH--hcccCCCC
Q 005923 555 AFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKN--CTAHDLNA 632 (669)
Q Consensus 555 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~ 632 (669)
||||++|||++|+.||......+... .... . ...+..+.......++.+++.+ |+..++..
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~~------~i~~----------~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQL------KVIN----------W-ENTLHIPPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHHH------HHHc----------c-ccccCCCCCCCCCHHHHHHHHHHccCcccccC
Confidence 99999999999999998654321110 0000 0 0011111112344567888887 55667777
Q ss_pred CCCHHHHHHH
Q 005923 633 RPSISEVFVT 642 (669)
Q Consensus 633 RPt~~evl~~ 642 (669)
||++.|++.+
T Consensus 296 R~~~~~~l~h 305 (381)
T cd05626 296 RNGADDIKAH 305 (381)
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.04 Aligned_cols=245 Identities=27% Similarity=0.504 Sum_probs=196.0
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|++.+ ++|.|+| |.||++..+ +..+++|.++. .+.+|++++++++|+||+++.+++.+ ...+++
T Consensus 8 ~~~~~-~lg~g~~-------~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 8 LKLEK-KLGAGQF-------GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred eeEEe-EecCccc-------eEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 34444 4899999 999999874 56789998753 46689999999999999999999877 778999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 79 TEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEeCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence 9999999999999764 2346899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||++....++.++|+||||++++|+++ |+.||.+...... ... ..
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~- 217 (260)
T cd05073 153 EDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRA----LE- 217 (260)
T ss_pred cCCCc-------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----Hh-
Confidence 43221 11122345678999999999999999999999999999999 8888876443211 000 00
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
.....+.+...+.++.+++.+||+.+|.+||++.++++.|+.+
T Consensus 218 ------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 218 ------------RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ------------CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0111122234456789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=284.45 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=202.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecC-
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEG- 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~- 427 (669)
.+|.+.+. +|+|+| ..||.++. +++.+|+|++.- ...+|++..++++||||+++++++..+.
T Consensus 21 ~Ryri~~~-LgeGGf-------sfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 21 KRYRIQRL-LGEGGF-------SFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred ceEEEeee-ecCCCc-------eeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 46777774 999999 88988874 688899998842 3568999999999999999999987544
Q ss_pred ----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 428 ----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 428 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
..||+++|...|+|.+.+...+ ..+..+++.++++|+.+|++||++||+.. ||++||||||.|||+.+.+.+++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEE
Confidence 4899999999999999998764 34457999999999999999999999986 78999999999999999999999
Q ss_pred cccCCccccCCCccccCC-cccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 504 TNFGLARSAESDEHEQGG-YGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.|||.+....-....+.. ...+--.....|.-|+|||.+. +...++++|||||||+||+|+.|..||...-...
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-- 248 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-- 248 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--
Confidence 999999865432111100 0011112235788999999985 5678999999999999999999999996311000
Q ss_pred HHHHHHHHHHhhhhHHhhhh-cccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 580 LLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~-~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
+.+. ......+.-+.....+..+.+++++|++.||.+||+..|++..++.+.
T Consensus 249 ----------------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ----------------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 111222222222235667899999999999999999999999998764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=313.46 Aligned_cols=245 Identities=23% Similarity=0.360 Sum_probs=187.6
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|.| |.||++.. .++.+|+|+++. .+..|+.++.+++|+||+++++.+.++...++||
T Consensus 8 ~LG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 8 VIGRGAF-------GEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred EEEeCCC-------EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3899999 99999987 478899999863 2557999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+. +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999754 45899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCcccc---C------------------------CcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcC
Q 005923 514 SDEHEQ---G------------------------GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566 (669)
Q Consensus 514 ~~~~~~---~------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg 566 (669)
...... . ...........||..|+|||.+.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 211000 0 0000111235799999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 005923 567 REAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTA--HDLNARPSISEVFVT 642 (669)
Q Consensus 567 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~--~dP~~RPt~~evl~~ 642 (669)
+.||.+....+. ... +... ...+..+ .. .....++.+++.+++. .++..||+++||+++
T Consensus 233 ~~Pf~~~~~~~~---~~~---i~~~------~~~~~~p---~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 233 YPPFCSETPQET---YKK---VMNW------KETLIFP---PE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCCHHHH---HHH---HHcC------cCcccCC---Cc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999986543211 111 1100 0000001 11 1123456777777443 344567999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=297.46 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=197.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|++.+ .+|.|+| |.||+|... |. .+|+|.++. ++.+|+.++++++|+||++++++|..
T Consensus 9 ~~~~~-~ig~g~~-------g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 9 LEKIK-VLGSGAF-------GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred cEEcc-eecCCCC-------ccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 33333 4899999 999999873 32 488998753 35679999999999999999999976
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECC
Confidence 78899999999999999997642 35899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++........ .......++..|+|||.+....++.++|+||||+++||+++ |+.||.+....+
T Consensus 153 fg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------- 219 (279)
T cd05057 153 FGLAKLLDVDEKE------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------- 219 (279)
T ss_pred CcccccccCcccc------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------
Confidence 9999876532210 00111223568999999998999999999999999999999 999987643211
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSS 651 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 651 (669)
+...+. .......+..+...+.+++.+||..||.+||++.++++.|.++.....
T Consensus 220 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 220 IPDLLE-------------KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHHHHh-------------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 000110 011112233344568899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.67 Aligned_cols=235 Identities=23% Similarity=0.436 Sum_probs=193.1
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|.| |.||+|.. ++..+++|.+.. .+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 27 ~lg~g~~-------~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 27 KIGQGAS-------GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred EecCCCC-------eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3899999 99999986 578899998853 3667999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++++|.+++... .+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999643 4889999999999999999999999 9999999999999999999999999988654322
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
. ......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .... .
T Consensus 171 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~----~-------- 228 (296)
T cd06654 171 S--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL----I-------- 228 (296)
T ss_pred c--------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH----H--------
Confidence 1 1123467889999999999999999999999999999999999997654311 0000 0
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. .........+......+.+++.+||..||.+||++.|++..
T Consensus 229 -~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 229 -A---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -h---cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 00111112234455678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.90 Aligned_cols=198 Identities=27% Similarity=0.485 Sum_probs=161.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEe--cCc
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVH--EGN 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~--~~~ 428 (669)
|+++..++|.|.| |.||+|... +..+|+|.++. .+.+|+.+|++++||||+++++++.. +..
T Consensus 2 ~~~~~~~lG~G~~-------g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (317)
T cd07868 2 FEYEGCKVGRGTY-------GHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK 74 (317)
T ss_pred ccccccccccCCC-------eEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcE
Confidence 5566668999999 999999863 46799998864 46789999999999999999999864 346
Q ss_pred eeEEEEecCCCCHHHHHhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee----cCCCc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQ----TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLR 500 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl----~~~~~ 500 (669)
.++||||+. ++|.+++...+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~ 150 (317)
T cd07868 75 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 150 (317)
T ss_pred EEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCc
Confidence 789999996 4898888643211 1235899999999999999999999999 9999999999999 45678
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
+||+|||+++........ ........||..|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 151 ~kl~DfG~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 151 VKIADMGFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EEEeecCceeccCCCCcc-----ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999999999876432211 112234578999999999977 45899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.25 Aligned_cols=245 Identities=25% Similarity=0.416 Sum_probs=192.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.. ++|.|.| |.||+|.. +++.+|+|+.+. .+.+|+.++++++||||+++++++..++..
T Consensus 10 ~y~~~~-~lg~g~~-------g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 10 DYELIQ-RVGSGTY-------GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hcchhh-eeecCCC-------eEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 344444 4899999 99999997 577899998853 256799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++|+|.++++.. ..+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999999753 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+....... ......++..|+|||.+. ...++.++||||||+++|||++|+.|+......+...
T Consensus 154 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------ 219 (267)
T cd06646 154 AKITATIA--------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------ 219 (267)
T ss_pred eeeccccc--------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------
Confidence 86643211 112346788999999984 4557889999999999999999999986433211000
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
.. ....+..+... .....+..+.+++.+||+.||.+||+++++++.|
T Consensus 220 -~~-------~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 220 -LM-------SKSNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -ee-------ecCCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 00001111111 1123456789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.44 Aligned_cols=236 Identities=24% Similarity=0.366 Sum_probs=193.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++|.|.| |.||++.. .+..+++|.++. ++..|+.++++++|+||+++++.+..++..++||||
T Consensus 7 ~lg~g~~-------g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 7 VVGEGSF-------GRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred EeeccCC-------eEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 3899999 99999987 478899998742 356799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++|+|.+++...+ ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999987532 345889999999999999999999999 999999999999999999999999999866432
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ......
T Consensus 154 ~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~----- 214 (255)
T cd08219 154 GA--------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQ----- 214 (255)
T ss_pred cc--------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHhc-----
Confidence 21 12234688899999999999999999999999999999999999976432110 000000
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
......+...+..+.+++.+||+.||.+||++.|++..
T Consensus 215 ---------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ---------GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00112233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.57 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=192.2
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++|.|+| |.||++... +..+|+|.++. ++.+|++++++++||||++++++|..++..++||||
T Consensus 8 ~lg~G~~-------g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 8 ELGAGNG-------GVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred eccCCCC-------eEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3899999 999999874 67788888753 366899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
+++|+|.+++++. ..+++..+..++.|++.||.|||+ .+ ++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999754 458999999999999999999997 46 99999999999999999999999999876532
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh--
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES-- 592 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 592 (669)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 153 ~~----------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 153 SM----------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222 (308)
T ss_pred cc----------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCC
Confidence 21 223468899999999998889999999999999999999999987543211110000000000000
Q ss_pred ---------------hHHhhhhcccCCccCCCCc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 593 ---------------NVREKLRGFIDPSLRNEYP-LDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 593 ---------------~~~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
...+..+..+... ....| ......+.+++.+||+.||.+|||+.||+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000111000 00111 12445689999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.93 Aligned_cols=258 Identities=24% Similarity=0.446 Sum_probs=198.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe--cCce
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH--EGNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 429 (669)
.+|.|.| |.||++.++ +..+|||.++. ++.+|++++++++|+||+++++++.. +...
T Consensus 11 ~ig~g~~-------~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 11 QLGEGHF-------GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred eeccCCC-------eeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4899999 999999874 56899998852 36789999999999999999999877 5578
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|.+++...+ ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999997642 35999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
......... ........++..|++||.+.+..++.++||||||+++|||++|+.|+............. .
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-----~ 226 (284)
T cd05038 157 KVLPEDKDY-----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-----A 226 (284)
T ss_pred cccccCCcc-----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-----c
Confidence 877532210 111122345567999999999999999999999999999999999886432211000000 0
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
........+...+....+...+..++.++.+++.+||+.+|.+|||+.||+++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0000011111111122222334455578999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.33 Aligned_cols=226 Identities=26% Similarity=0.409 Sum_probs=185.3
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| |.||++... +..+|+|.++.+ +..|..++..+ +|++|+++.+++...+..++||
T Consensus 8 lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 8 LGKGSF-------GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred EeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 899999 999999885 568999998642 34567777776 5899999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999999754 35899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||.+....+ .... +
T Consensus 153 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~---i----- 213 (323)
T cd05616 153 WDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQS---I----- 213 (323)
T ss_pred CCC--------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHH---H-----
Confidence 221 11234578999999999999999999999999999999999999998654321 1111 1
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
.+.. ..+|.....++.+++.+||+.||.+|++.
T Consensus 214 --------~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 214 --------MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --------HhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111 12344456678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.90 Aligned_cols=238 Identities=24% Similarity=0.400 Sum_probs=194.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|+..+ .++.|.| |.||+|.. .+..+|+|..+. ++.+|++++++++||||+++++++..+...
T Consensus 6 y~~~~-~l~~g~~-------~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 6 FTKLE-RIGKGSF-------GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHH-HhcCCCC-------eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence 44444 3899999 99999987 467899998752 367899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccc
Confidence 999999999999999864 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~------ 211 (277)
T cd06642 149 GQLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F------ 211 (277)
T ss_pred ccccCcch--------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h------
Confidence 86643221 112245788999999999999999999999999999999999998643321100 0
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. +........+...+..+.+++.+||+.+|.+||++.|++.+
T Consensus 212 -------~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 -------L----IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -------h----hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 01111112233455678999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.15 Aligned_cols=242 Identities=24% Similarity=0.461 Sum_probs=190.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeEEEec---
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGFCVHE--- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~~~~~--- 426 (669)
.|++.+ .+|.|.| |.||+|.. .++.+|+|.++. ++..|+.+++++ +|+||+++++++...
T Consensus 7 ~y~~~~-~lg~g~~-------g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 7 IFELVE-LVGNGTY-------GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhHHH-heeecCC-------eEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 355554 4899999 99999988 467899999853 467899999998 799999999998753
Q ss_pred ---CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 427 ---GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 427 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
...++||||+++|+|.+++...+ ...++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l 152 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 152 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEE
Confidence 35799999999999999997642 346899999999999999999999998 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
+|||+++...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 153 ~Dfg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~ 224 (272)
T cd06637 153 VDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224 (272)
T ss_pred ccCCCceeccccc--------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 9999998654321 1123356888999999986 34688899999999999999999999864332111
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. .. .....+ ...+..++..+.+++.+||..||.+|||+.|+++
T Consensus 225 ~~------~~----------~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LF------LI----------PRNPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HH------HH----------hcCCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 00 000001 1112234457899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.50 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=196.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc--cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG--DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
|.+.. .+|.|.| |.||++... +..|++|.+.. ...+|+++|++++||||+++++++..+...++||
T Consensus 94 y~i~~-~Lg~G~~-------g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 94 YNILS-SLTPGSE-------GEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred eEEEE-eecCCCC-------eEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 44444 4899999 999999764 45689998864 4678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
|++. ++|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9996 6899998432 46999999999999999999999999 9999999999999999999999999998664
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
.... ........||..|+|||.+.+..++.++|||||||++|||++|+.||.+............+.+.+....
T Consensus 237 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 237 AHPD------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred cccc------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 4321 1122346799999999999999999999999999999999999999986543221111122222111100
Q ss_pred H----------HhhhhcccCCccCCCCc-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 V----------REKLRGFIDPSLRNEYP-------LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~----------~~~l~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ...+..+. ...+..++ ......+.+++++||+.||.+|||+.|++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYA-IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhc-ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00011100 01111111 1234567899999999999999999999876
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=290.22 Aligned_cols=242 Identities=26% Similarity=0.472 Sum_probs=197.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ .++.|.| |.||+|... +..+++|.++. ++.+|++++++++|+||+++++++..+...++
T Consensus 4 ~y~~~~-~i~~g~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 4 VFDILE-KLGEGSY-------GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cchhhh-hhcCCCC-------eEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 455555 4899999 999999985 67899999863 47789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..
T Consensus 76 ~~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 76 VMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred EEecCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence 99999999999999753 246899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........
T Consensus 149 ~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----------- 209 (256)
T cd06612 149 LTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----------- 209 (256)
T ss_pred cccCcc--------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----------
Confidence 644321 1223457889999999999999999999999999999999999997543211000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.......+. ...+......+.+++.+||+.||.+|||+.||++
T Consensus 210 -----~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 -----MIPNKPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -----hhccCCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000000111 1223344567899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=309.98 Aligned_cols=230 Identities=27% Similarity=0.380 Sum_probs=184.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHH-HHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEIN-ILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.|+| |.||++.. +|+.+|+|+++.. +..|.. +++.++||||+++++++..++..++|
T Consensus 2 ~lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv 74 (325)
T cd05604 2 VIGKGSF-------GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV 74 (325)
T ss_pred ceeeCCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence 3789999 99999987 4789999998532 233443 46778999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 75 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 75 LDFVNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999998754 45899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+. ......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~-- 210 (325)
T cd05604 147 IAQS--------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILH-- 210 (325)
T ss_pred CCCC--------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHc--
Confidence 3211 112345789999999999999999999999999999999999999986543210 011110
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 639 (669)
. .+ ..+......+.+++.+|++.||.+||++.+.
T Consensus 211 -------~----~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 211 -------K----PL--VLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred -------C----Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 0 00 1111234567899999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=296.97 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=190.6
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.+|.|.| |.||+|.. ++..+|+|.++. .+.+|+.++++++||||+++++++.+++..++|||
T Consensus 7 ~l~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 7 KIGEGTY-------GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred EecccCc-------eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 3789999 99999988 478899998752 36789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|++ ++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||+|+|||+++++.+||+|||+++....
T Consensus 80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 80 FLS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred cCC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 997 69999987542 2356899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH---h
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL---E 590 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~ 590 (669)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+...... ......... .
T Consensus 154 ~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~ 223 (285)
T cd07861 154 PV--------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTE 223 (285)
T ss_pred Cc--------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 21 11223456889999998865 4578999999999999999999999986543211 111100000 0
Q ss_pred h--------hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 591 E--------SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 591 ~--------~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. .........+..... .........++.+++.+||+.||.+|||+.||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000000001111111 0111224567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=293.94 Aligned_cols=239 Identities=26% Similarity=0.438 Sum_probs=193.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.++.|.| |.||+|.. .++.+|+|.++. .+.+|++++++++||||+++++++.+++
T Consensus 7 ~ig~g~~-------~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 7 LIGSGSF-------GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred eeecCCC-------eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 3788999 99999987 467899997742 3567999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 999999999999999999754 35889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++........... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .+.
T Consensus 152 ~~~~~~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~- 222 (267)
T cd06628 152 ISKKLEANSLSTKT--NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIF- 222 (267)
T ss_pred CCcccccccccCCc--cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHH-
Confidence 99876532211000 011123457889999999999999999999999999999999999997643211 000
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+... .....+...+..+.+++.+||+.||.+||++.|+++
T Consensus 223 ---------~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ---------KIGEN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------HHhcc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00011 112233445667899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.49 Aligned_cols=244 Identities=28% Similarity=0.486 Sum_probs=193.5
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|.|+| |.||+|.. .|. .+|+|.++. ++.+|+.++++++||||++++|+|.. ...++
T Consensus 14 ~lg~G~~-------g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~ 85 (303)
T cd05110 14 VLGSGAF-------GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL 85 (303)
T ss_pred ccccCCC-------ccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence 4899999 99999987 344 468887753 35679999999999999999999865 45789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999754 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ...+.
T Consensus 159 ~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~ 225 (303)
T cd05110 159 LEGDEKE------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLE 225 (303)
T ss_pred ccCcccc------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHH
Confidence 6432211 11122345678999999999999999999999999999997 8888875432111 11111
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
. ......+..++..+.+++.+||..+|++||+++|+++.|.++....
T Consensus 226 ~-------------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 226 K-------------GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C-------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 0011112234457899999999999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=314.52 Aligned_cols=242 Identities=21% Similarity=0.296 Sum_probs=190.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
|++.+ .+|.|+| |.||++... ++.+|+|.++. .+.+|+.+++.++||||+++++++..++
T Consensus 45 y~~~~-~lG~G~f-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 45 YDVVK-VIGRGAF-------GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred CeEEE-EEEecCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 44433 3899999 999999984 67899998853 2557999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999999999653 3788999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG----VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+++....... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+.
T Consensus 188 ~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~----- 255 (370)
T cd05621 188 TCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT----- 255 (370)
T ss_pred cceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----
Confidence 9987643221 112345799999999999764 378899999999999999999999986543211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA--RPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 642 (669)
...+... . ..+..+........+.+++.+|+..++.+ |+++.|++++
T Consensus 256 -~~~i~~~---------~--~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 -YSKIMDH---------K--NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHhC---------C--cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111100 0 01111111234567889999999855543 8999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=315.59 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=188.1
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||++.. +++.+|||++.. .+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~lG~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 8 VIGKGAF-------GEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred EEeecCC-------EEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3899999 99999987 578899998843 2567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999754 45889999999999999999999999 9999999999999999999999999997432
Q ss_pred CCcccc-------C-Ccc-------------------------------cceeeecccccccccccccccCCCCchhhHH
Q 005923 514 SDEHEQ-------G-GYG-------------------------------LQLTRHVVGTYGYMAPEYIENGVITPKLDVF 554 (669)
Q Consensus 514 ~~~~~~-------~-~~~-------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~ 554 (669)
...... . ... ........||..|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 110000 0 000 0001124699999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCC-
Q 005923 555 AFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR- 633 (669)
Q Consensus 555 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R- 633 (669)
||||++|||++|+.||.+....+. ...+ .. +. ..+..+.......++.+++.+|+. +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~---~~~i---~~----------~~-~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHET---YRKI---IN----------WR-ETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHH---HHHH---Hc----------cC-CccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999999999986543211 1111 00 00 001101111234568899999997 66665
Q ss_pred --CCHHHHHHH
Q 005923 634 --PSISEVFVT 642 (669)
Q Consensus 634 --Pt~~evl~~ 642 (669)
+++.|++.+
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.11 Aligned_cols=233 Identities=22% Similarity=0.407 Sum_probs=194.4
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++|.|.| |.||+|.. .+..+|+|..+. ++.+|++++++++|+||+++++++.++...++||||
T Consensus 11 ~lg~g~~-------~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 11 RIGKGSF-------GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hcccCCC-------eEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3899999 99999987 467899998752 366799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++|+|.+++... .+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 9999999998643 4889999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........
T Consensus 155 ~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------- 210 (277)
T cd06640 155 QI--------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------------- 210 (277)
T ss_pred cc--------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------
Confidence 21 122346788999999999999999999999999999999999998754321100
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. .+........+..++..+.+++.+||+.+|.+||++.+++..
T Consensus 211 ~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 F----LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred h----hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0 001111223445667789999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=305.68 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=190.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec-ccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
|++.+ .+|.|.| |.||+|... ++.||+|... .....|+.++++++|+||+++++++..++..++|||++
T Consensus 68 y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 68 YTVIK-TLTPGSE-------GRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cEEEE-EecCCCC-------eEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 44444 4899999 999999985 5689999864 34678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
. |+|.+++... ...++|..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 140 ~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 140 S-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred C-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 5 6999998653 246899999999999999999999999 9999999999999999999999999997543221
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH----HHHHHHHhhh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY----ASISRVLEES 592 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~----~~~~~~~~~~ 592 (669)
......||..|+|||++.+..++.++|||||||++|||+++..++............ ..+...+...
T Consensus 212 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~ 282 (357)
T PHA03209 212 ---------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282 (357)
T ss_pred ---------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence 112346899999999999999999999999999999999976666432221111100 0111111100
Q ss_pred h----------HHhhhhcccCCc--cCCCCc-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 593 N----------VREKLRGFIDPS--LRNEYP-------LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 593 ~----------~~~~l~~~~d~~--l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. .......+++.. .+..+. ...+..+.+|+.+||+.||.+|||+.|++.+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 000011111100 000000 1223456679999999999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=293.90 Aligned_cols=240 Identities=25% Similarity=0.423 Sum_probs=192.3
Q ss_pred HHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc-------------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG-------------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~-------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
+|.|.| |.||+|.. +++.+|+|.++. .+.+|++++++++|+||++++++|.+.+..++|
T Consensus 8 ig~g~~-------~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 8 LGKGAY-------GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred EeccCC-------eEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 899999 99999987 577899998752 256799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999754 35889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
....... ..........++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...
T Consensus 153 ~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~--- 221 (265)
T cd06631 153 AWVGLHG--THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF------YIG--- 221 (265)
T ss_pred hhccccc--cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH------Hhh---
Confidence 3211100 00112234568899999999999999999999999999999999999997543211100 000
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.... .....+......+.+++.+||+.+|.+||++.|++.
T Consensus 222 ----~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 222 ----AHRG-----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----hccC-----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 011223344567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.21 Aligned_cols=198 Identities=27% Similarity=0.489 Sum_probs=161.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEe--cCc
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVH--EGN 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~--~~~ 428 (669)
|.++.-++|.|+| |.||+|... +..+|+|.++. .+.+|++++++++||||+++++++.. +..
T Consensus 2 ~~~~g~~lG~G~~-------g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (317)
T cd07867 2 FEYEGCKVGRGTY-------GHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRK 74 (317)
T ss_pred cceeceEeccCCC-------eeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe
Confidence 4455557999999 999999873 35789998864 46789999999999999999999864 456
Q ss_pred eeEEEEecCCCCHHHHHhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee----cCCCc
Q 005923 429 TYLVYEFADNGALSDWLHSNRY----QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLR 500 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl----~~~~~ 500 (669)
.++||||+.+ +|.+++...+. .....+++..+..++.||+.||.|||+.+ ++||||||+|||+ ++++.
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 150 (317)
T cd07867 75 VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 150 (317)
T ss_pred EEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCc
Confidence 7999999875 88888754321 12235899999999999999999999999 9999999999999 56689
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
+||+|||+++........ ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 151 ~kl~DfG~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 151 VKIADMGFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EEEeeccceeccCCCccc-----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999999999876443211 111234568899999999876 45899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.80 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=190.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC-----ce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG-----NT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 429 (669)
.+|.|+| |.||++.. +|+.||+|.+.. .+.+|+++++.++|+||+++++++...+ ..
T Consensus 7 ~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 7 PIGYGAF-------GVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred eeeeCCC-------EEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4899999 99999986 588999998853 3567999999999999999999998766 78
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 80 ~lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccce
Confidence 99999997 5888888643 46999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
+....... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+ ....+...
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~ 220 (372)
T cd07853 151 RVEEPDES-------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDL 220 (372)
T ss_pred eecccCcc-------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHH
Confidence 86543221 112234678899999999874 57999999999999999999999998654322 11222211
Q ss_pred HhhhhH----------Hhhh-hcccCCc-cC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNV----------REKL-RGFIDPS-LR--NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~----------~~~l-~~~~d~~-l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+..... ...+ .....+. .. .........++.+|+.+||+.||.+|||+.|++.+
T Consensus 221 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 221 LGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred cCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 111100 0000 0000000 00 01112234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.43 Aligned_cols=231 Identities=21% Similarity=0.422 Sum_probs=182.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.+|.|+| |.||+|... ...+++|.+.. .+..|+.++++++||||+++++++..++..
T Consensus 2 ~lg~G~~-------~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 2 SLGQGTF-------TKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCcccc-------hhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence 3789999 999999863 22478887743 356789999999999999999999998999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc--------E
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR--------A 501 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~--------~ 501 (669)
++||||+++|+|.++++..+ ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++. +
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceE
Confidence 99999999999999997642 35899999999999999999999999 999999999999987765 6
Q ss_pred EEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+++|||++...... ....++..|+|||++.+ ..++.++||||||+++|||++|..++..........
T Consensus 148 ~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~ 215 (258)
T cd05078 148 KLSDPGISITVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL 215 (258)
T ss_pred EecccccccccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH
Confidence 99999998754322 12356788999999987 457999999999999999999964443222111000
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
.... . +...|.....++.+++.+||+.||.+|||++++++.|
T Consensus 216 ------~~~~-------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 216 ------QFYE-------------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------HHHH-------------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 0 1122333345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=293.23 Aligned_cols=242 Identities=29% Similarity=0.461 Sum_probs=194.2
Q ss_pred HHHhCCCCcccceeeEEEEEEECC-----CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG-----DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.|.| |.||+|...+ ..+++|..+. .+.+|+.++++++||||+++++++.. +..++|
T Consensus 13 ~lg~g~~-------g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 13 CIGEGQF-------GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred eeCCccc-------eeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4899999 9999998732 3588998753 36679999999999999999999864 567899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999997542 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... ......++..|+|||.+....++.++||||||+++|||++ |..||.+....+.. ..+ .
T Consensus 158 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~- 222 (270)
T cd05056 158 EDESYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----E- 222 (270)
T ss_pred ccccce-------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----H-
Confidence 443210 1112234567999999998899999999999999999996 99999765432110 000 0
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. ..+...+..++..+.+++.+||..+|.+|||+.|+++.|+++...
T Consensus 223 --------~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 223 --------N----GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------c----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 001122344566899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=300.87 Aligned_cols=261 Identities=19% Similarity=0.331 Sum_probs=189.4
Q ss_pred HHHhC--CCCcccceeeEEEEEEE--CCCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATG--SFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g--~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.| +| |+||++.. +|+.||+|.++.+ +..|+++++.++||||++++++|..++..++|
T Consensus 5 ~ig~G~~~~-------~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 5 VIGRGFEDL-------MTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hccccccce-------EEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 37777 56 89999987 4788999998632 45699999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++..+. ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++++||+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 78 TSFMAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred EeccCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999999999997542 235899999999999999999999999 999999999999999999999999876544
Q ss_pred CCCccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
........ ..........++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~ 228 (327)
T cd08227 152 INHGQRLR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVP 228 (327)
T ss_pred cccccccc-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcc
Confidence 22111000 00011122356778999999976 468999999999999999999999997543211 11111100000
Q ss_pred h----hh-HHhhhh-----cccCC-----------------ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 E----SN-VREKLR-----GFIDP-----------------SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~----~~-~~~~l~-----~~~d~-----------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. .. ..+.+. ...+. ....+........+.+++.+||+.||.+|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 00 000000 00000 00011222345678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=297.33 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=189.9
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++.|.| |.||++.. .|+.+++|.++. .+.+|++++++++|+||+++++++.+....++|+||
T Consensus 8 l~~g~~-------~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 8 IGEGTY-------GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ecccCC-------eEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 789999 99999998 478899998852 356899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
++ ++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 5898888653 245899999999999999999999999 999999999999999999999999999865432
Q ss_pred ccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
. .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+.+. ....+...+.....
T Consensus 153 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 222 (284)
T cd07839 153 V--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTE 222 (284)
T ss_pred C--------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence 1 112234578899999998764 479999999999999999999998764333221 11222221111100
Q ss_pred --HhhhhcccCCccCC---------CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 595 --REKLRGFIDPSLRN---------EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 595 --~~~l~~~~d~~l~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
...+....+..... .....+..++.+++.+||+.||.+|||++|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00011111110000 111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=295.94 Aligned_cols=234 Identities=26% Similarity=0.364 Sum_probs=186.9
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
+|.|.| |.||+|.. .+..+|+|.... ++.+|++++++++||||+++++++..++..++||||+
T Consensus 9 lg~g~~-------~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 9 LGHGNG-------GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred eccCCC-------eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 899999 99999987 578899998743 3667999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++|+|..+. .+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 999997653 3678899999999999999999999 9999999999999999999999999998654321
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH-HHHHHHHHHhhhhHH
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL-LYASISRVLEESNVR 595 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 595 (669)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......+... .....
T Consensus 150 ----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 209 (279)
T cd06619 150 ----------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL---------- 209 (279)
T ss_pred ----------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------
Confidence 123468889999999999999999999999999999999999997432211100 00000
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+.....+.+ .......++.+++.+||+.||.+||+++|+++.
T Consensus 210 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000011111 111234568999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.64 Aligned_cols=256 Identities=21% Similarity=0.376 Sum_probs=193.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|...+ ++|.|+| |.||+|.. .++.+|+|.++. .+.+|+.++++++||||+++++++..++..
T Consensus 8 y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 8 YIKLE-KLGEGTY-------ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred eEEEE-EecccCC-------EEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 44433 4899999 99999987 467899998862 356899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 80 ~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEEeCCCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccc
Confidence 999999985 899988654 245889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
+....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+.. ..+...
T Consensus 152 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~~~~~~ 220 (309)
T cd07872 152 RAKSVPTK--------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL---HLIFRL 220 (309)
T ss_pred eecCCCcc--------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHH
Confidence 76533221 1123457889999999865 56899999999999999999999999865432211 111111
Q ss_pred HhhhhHH--h------hhhcccCCccCC----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVR--E------KLRGFIDPSLRN----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~--~------~l~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+...... . .....-.+.... .....+..++.+|+.+||+.||.+|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 1110000 0 000000011000 0011245568899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=295.88 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=195.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|++.+ .+|.|.| |+||++... |..+|+|++.. .+.+|+++++.++||||+++++++...+..
T Consensus 7 ~~~~~-~ig~g~~-------g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 7 LETIS-DLGAGNG-------GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHH-HcCCCCC-------eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 44444 4899999 999999985 78899997642 366899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
++||||+++|+|.+++... +.+++..+..++.+++.||.|||+ .+ ++||||+|+||++++++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999998753 358999999999999999999997 46 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH-HHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE-LLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~ 587 (669)
++...... .....|+..|+|||.+.++.++.++|||||||++|||++|+.||......+.. .....+.
T Consensus 151 ~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~- 219 (284)
T cd06620 151 SGELINSI----------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL- 219 (284)
T ss_pred ccchhhhc----------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-
Confidence 87543211 12346889999999999889999999999999999999999999854321100 0000000
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+.+..++...........++..+.+++.+||+.||.+|||+.|++++.
T Consensus 220 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 220 --------DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --------HHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111111111111111123556789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=294.20 Aligned_cols=237 Identities=26% Similarity=0.410 Sum_probs=189.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|+| |.||+|..+ +..+++|.+.. .+.+|+++++.++|+|++++++++..++..++||||+
T Consensus 12 ~lg~g~~-------g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 12 ELGDGAF-------GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred hcccCCC-------eEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 4899999 999999985 56778888742 3567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++|+|.+++.+. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999988653 246999999999999999999999999 9999999999999999999999999987653321
Q ss_pred cccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
.......++..|+|||++. +..++.++|||||||++|||++|+.||......+. .......
T Consensus 158 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~ 223 (282)
T cd06643 158 --------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS 223 (282)
T ss_pred --------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhc
Confidence 1122346888999999984 45678899999999999999999999875432110 0000000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+. ...+...+.++.+++.+||+.||.+||++.++++.
T Consensus 224 ----------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 224 ----------EPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----------CCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 11233345678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.33 Aligned_cols=246 Identities=21% Similarity=0.373 Sum_probs=184.2
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-CC---eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-GD---DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-g~---~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|.| |.||+|... +. .+++|.++. .+.+|+.+++.++||||+++++.|......++||
T Consensus 2 ~lg~G~~-------g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWF-------GKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcC-------ceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 3789999 999999763 22 355666542 4677889999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++++.+. ....+.+..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 75 EYCELGDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred ecCCCCcHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999986531 2345777888999999999999999998 9999999999999999999999999986532
Q ss_pred CCccccCCcccceeeeccccccccccccccc-------CCCCchhhHHHHHHHHHHHHcC-CCCCCCCchhHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-------GVITPKLDVFAFGVVVLELLSG-REAVTGDQNCEAELLYASI 585 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~ 585 (669)
.... ........++..|+|||++.. ..++.++||||||+++|||+++ ..|+......+ .+
T Consensus 151 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~ 218 (268)
T cd05086 151 KEDY------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VL 218 (268)
T ss_pred cchh------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence 2111 011123467889999999853 3457899999999999999974 56665433211 11
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
...+. +....+.++.+... ....+.+++..|| .+|.+||+++||++.|.
T Consensus 219 ~~~~~-----~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 219 NHVIK-----DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHh-----hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 11122233333222 3456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=292.26 Aligned_cols=245 Identities=26% Similarity=0.440 Sum_probs=193.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC---CCeeEEEEecc-----------------cHHHHHHHHHh-cCCCCcee
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK---GDDAAVKVMKG-----------------DVSSEINILKK-INHSNIIR 418 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---g~~vavK~~~~-----------------~~~~E~~~l~~-l~H~niv~ 418 (669)
|++.+ .+|.|.| |.||+|..+ ++.+|+|.++. ++..|+.++.+ ++||||++
T Consensus 2 y~~~~-~ig~G~~-------~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~ 73 (269)
T cd08528 2 YAVLE-HLGSGAF-------GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVR 73 (269)
T ss_pred chhhh-hhcCCCC-------ceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeee
Confidence 34444 4899999 999999985 46789997641 24568887765 79999999
Q ss_pred EeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecC
Q 005923 419 LSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 419 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~ 497 (669)
+++++.+++..++||||+++++|.+++...+ .....+++..+++++.|++.||.|||+ .+ ++|+||+|+|||+++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~ 149 (269)
T cd08528 74 YYKTFLENDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE 149 (269)
T ss_pred EEeeEccCCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence 9999999999999999999999999986432 123468999999999999999999996 56 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
++.+||+|||++....... ......++..|+|||.+.++.++.++||||||+++|||++|+.||.......
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~ 220 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220 (269)
T ss_pred CCcEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence 9999999999998754322 1223567889999999999999999999999999999999999987543211
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
..... .+..............+.+++.+||+.||.+||++.|+..+|+
T Consensus 221 ------~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 ------LATKI-------------VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------HHHHH-------------hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000 0011111111123457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.70 Aligned_cols=237 Identities=25% Similarity=0.352 Sum_probs=191.5
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++... ++.+|+|.+.. .+..|+.++++++|+|++.+++.+..++..++|||
T Consensus 8 ig~G~~-------g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 8 LGKGGF-------GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred eecCCC-------eEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 799999 999999984 67899998743 24579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999996532 245899999999999999999999998 99999999999999999999999999876543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .........
T Consensus 155 ~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~--- 219 (285)
T cd05630 155 GQT---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE--- 219 (285)
T ss_pred Ccc---------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhh---
Confidence 211 12346899999999999999999999999999999999999999854321100 000000000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
....++......+.+|+.+||+.||.+||| +.|++++
T Consensus 220 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 -----------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -----------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001123334556899999999999999999 7888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=295.23 Aligned_cols=237 Identities=24% Similarity=0.341 Sum_probs=191.7
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |+||++... ++.+|+|.++. .+.+|+++|++++|+|++.+.+++..++..++|||
T Consensus 8 lg~G~~-------g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 8 LGKGGF-------GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred EecCCC-------eEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 899999 999999984 77899998752 24579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 81 IMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred eccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 99999999998753 2246999999999999999999999999 99999999999999999999999999976543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. ......|+..|+|||++.+..++.++|+||||+++|||++|+.||.+....... ..+..
T Consensus 155 ~~---------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~------- 215 (285)
T cd05632 155 GE---------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDR------- 215 (285)
T ss_pred CC---------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHH-------
Confidence 21 112346899999999999999999999999999999999999999864432110 11100
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
.+... ...++......+.+|+.+||+.||.+||+ ++|++..
T Consensus 216 --~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 216 --RVLET-----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --hhhcc-----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01000 01223344556889999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=292.31 Aligned_cols=245 Identities=26% Similarity=0.428 Sum_probs=191.4
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC----
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG---- 427 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 427 (669)
.+|.|+| |.||+|.+. +..+|||.++. ++.+|++++++++||||+++++++....
T Consensus 6 ~ig~g~~-------g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 6 MLGKGEF-------GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred cccCCCC-------CCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 3899999 999999863 56799998864 2567999999999999999999987542
Q ss_pred --ceeEEEEecCCCCHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 428 --NTYLVYEFADNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 428 --~~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
..++++||+++|+|.+++...+.. ....+++..+++++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEEC
Confidence 237899999999999998643211 2235899999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++........ .......++..|++||.+....++.++||||||+++|||++ |+.|+.+....+ ...
T Consensus 156 dfg~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~ 226 (273)
T cd05074 156 DFGLSKKIYSGDYY------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYN 226 (273)
T ss_pred cccccccccCCcce------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHH
Confidence 99999876433211 01112334568999999999999999999999999999999 888876543211 100
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
. ... .. ....+......+.+++.+||+.+|.+||++.|+++.|+++
T Consensus 227 ~----~~~---------~~----~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 Y----LIK---------GN----RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H----HHc---------CC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 000 00 0111223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.68 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=188.4
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|.| |.||+|.. .++.+|+|.++. .+.+|++++++++|+||+++++.+.+++..++||
T Consensus 8 ~LG~G~~-------g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 8 TLGIGAF-------GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred EEEeCCC-------EEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 3899999 99999987 477899999853 3567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+. +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 81 DYIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999999754 35889999999999999999999999 9999999999999999999999999986432
Q ss_pred CCcccc---C------------------------------------CcccceeeecccccccccccccccCCCCchhhHH
Q 005923 514 SDEHEQ---G------------------------------------GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVF 554 (669)
Q Consensus 514 ~~~~~~---~------------------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~ 554 (669)
...... . ...........||..|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 110000 0 0000011235799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC
Q 005923 555 AFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634 (669)
Q Consensus 555 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 634 (669)
||||++|||++|+.||.+....+... ... .. ...+..+.......++.+++.+|+ .+|.+|+
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~------~i~----------~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLETQM------KVI----------NW-QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHHHH------HHH----------cc-CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 99999999999999998654322110 000 00 011111111233456778888876 5999999
Q ss_pred C---HHHHHHH
Q 005923 635 S---ISEVFVT 642 (669)
Q Consensus 635 t---~~evl~~ 642 (669)
+ +.|++.+
T Consensus 295 ~~~~~~ei~~h 305 (382)
T cd05625 295 GKNGADEIKAH 305 (382)
T ss_pred CCCCHHHHhcC
Confidence 7 8877653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=291.42 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=189.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|+..+ .+|+|.| |.||++.. .+..+++|.++. .+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~-~lg~g~~-------g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (266)
T cd06651 4 WRRGK-LLGQGAF-------GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD 75 (266)
T ss_pred ccccc-eecCCCC-------EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence 34444 3899999 99999987 477899998742 25679999999999999999999875
Q ss_pred c--CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 E--GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
. ...++++||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l 147 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKL 147 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEE
Confidence 3 5678999999999999999754 34899999999999999999999998 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 148 ~dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------ 216 (266)
T cd06651 148 GDFGASKRLQTICMSG-----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------ 216 (266)
T ss_pred ccCCCccccccccccC-----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------
Confidence 9999998654321110 11123457889999999999999999999999999999999999997533211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+. ...........+......+.+++ +||..+|.+||+++||+.
T Consensus 217 ~~~-------------~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 217 AIF-------------KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHH-------------HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 00001111233444555677777 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.28 Aligned_cols=240 Identities=23% Similarity=0.421 Sum_probs=195.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
|.+.+ +++.|.| |.||+|.. +++.+++|.+.. .+.+|+.++++++|+|++++++++..++..+
T Consensus 21 y~~~~-~lg~g~~-------g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 21 YTRYE-KIGQGAS-------GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred EEEEE-EEecCCC-------eEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 44333 3899999 99999986 578999998743 3567999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+|+||+++++|.+++... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEEecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccch
Confidence 999999999999998643 4899999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.+........ ....
T Consensus 164 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~ 229 (296)
T cd06655 164 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT 229 (296)
T ss_pred hcccccc--------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh
Confidence 6543321 1123467889999999999999999999999999999999999998654321100 0000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
........+...+..+.+++.+||..||.+||++.+++..
T Consensus 230 ------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 230 ------------NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ------------cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000112233455678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=303.24 Aligned_cols=226 Identities=26% Similarity=0.419 Sum_probs=184.9
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHHHhcC-CCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|.| |.||++.. +|+.||+|+++.+ +..|..++..+. |++|+++.+++..++..++||
T Consensus 8 lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 8 LGKGSF-------GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred EEecCC-------eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 899999 99999987 4778999998642 445788888875 577888999998888999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999999754 35999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......||..|+|||++.+..++.++|||||||++|||++|+.||.+..... .. .....
T Consensus 153 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~---~~i~~--- 215 (323)
T cd05615 153 VDG--------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LF---QSIME--- 215 (323)
T ss_pred CCC--------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHHHh---
Confidence 221 11234568999999999999999999999999999999999999998654311 11 11111
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
. ...+|......+.+++.+||+.||.+|++.
T Consensus 216 ----------~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 ----------H--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----------C--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 112334455678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.14 Aligned_cols=243 Identities=26% Similarity=0.427 Sum_probs=193.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ ++|.|.| |.||++.. +++.+|+|.++. .+.+|+.+++.++||||+++++++..++..
T Consensus 10 ~~~~~~-~lg~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 10 DFELIQ-RIGSGTY-------GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHH-HhCCCCC-------eEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 466655 4899999 99999987 478899999863 256799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|.+++... +.+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999998754 35899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
....... .......|+..|+|||.+. .+.++.++|||||||++|||++|+.|+.......... .
T Consensus 154 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~--- 220 (267)
T cd06645 154 AQITATI--------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L--- 220 (267)
T ss_pred eEccCcc--------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--h---
Confidence 7654321 1122346889999999985 4568899999999999999999999987543211100 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. ...+..+.... ....+..+.+++.+||+.||++||++++|++
T Consensus 221 -~~--------~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 221 -MT--------KSNFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -hh--------ccCCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 00111111111 1123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=296.70 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=195.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|.+.+ ++|.|.| |.||++.. .++.+|+|.+.. .+.+|+.++++++|+||+++++++..++..
T Consensus 20 ~y~~~~-~lg~g~~-------g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 20 KYTRFE-KIGQGAS-------GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hceeee-eeccCCC-------eEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 444444 3899999 99999986 588999998853 356799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred EEeecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999999643 4889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
........ ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.+...... .
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~--------- 224 (297)
T cd06656 163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L--------- 224 (297)
T ss_pred eEccCCcc--------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-e---------
Confidence 86543321 11234678899999999999999999999999999999999999975432110 0
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.............+...+..+.+++.+||+.||.+||++.|+++.
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 225 --------YLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --------eeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000011112334455678999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.72 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=190.7
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.++.|.| |.||+|... |+.+|+|++.. .+.+|++++++++|+|++++++++..+...++|||
T Consensus 8 ~l~~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 8 KIGEGSY-------GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred eecccCC-------eEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 3799999 999999984 78899998742 25689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|++++.|..++... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99998888877543 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH-HHHhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS-RVLEES 592 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~ 592 (669)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+......... ......
T Consensus 153 ~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 153 PGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred Ccc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 321 1122456788999999876 557899999999999999999999998655432211111000 000000
Q ss_pred hH----HhhhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 593 NV----REKLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 593 ~~----~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. ......+..+......+ ...+..+.+++.+||+.||.+||++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00000111111111111 123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=307.11 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=190.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.+ .+|.|+| |.||++.. .|..+|+|.++. .+.+|+.+++.++||||+++++++...
T Consensus 21 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 21 KRYQQLK-PIGSGAQ-------GIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hceEEEE-EeecCCC-------EEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 4555555 4999999 99999987 478899999853 356799999999999999999998654
Q ss_pred C------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 G------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
+ ..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 93 KSLEEFQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred CCccccceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCC
Confidence 3 46999999975 67777643 3788999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+.+..+.
T Consensus 162 ~kl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-- 230 (359)
T cd07876 162 LKILDFGLARTACTNF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-- 230 (359)
T ss_pred EEEecCCCccccccCc---------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 9999999998643321 12335688999999999999999999999999999999999999986543211
Q ss_pred HHHHHHHHHhhhh------HHhhhhcccC--CccC----------------CCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 581 LYASISRVLEESN------VREKLRGFID--PSLR----------------NEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 581 ~~~~~~~~~~~~~------~~~~l~~~~d--~~l~----------------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
+..+...+.... ....+..+.. +... ..........+.+|+.+||+.||.+|||+
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 309 (359)
T cd07876 231 -WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309 (359)
T ss_pred -HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH
Confidence 111111110000 0000000000 0000 00111224568999999999999999999
Q ss_pred HHHHHH
Q 005923 637 SEVFVT 642 (669)
Q Consensus 637 ~evl~~ 642 (669)
.|++.+
T Consensus 310 ~e~l~h 315 (359)
T cd07876 310 DEALRH 315 (359)
T ss_pred HHHhcC
Confidence 999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=303.52 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=188.1
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||++..+ ++.+|+|.+.. .+..|+.++..++|+||+++++++.+++..++||
T Consensus 8 ~lG~G~f-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 8 VIGRGAF-------GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred EEEeCCC-------eEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3899999 999999985 56789999853 2567899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999999763 235899999999999999999999999 9999999999999999999999999997653
Q ss_pred CCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
.... .......||..|+|||++. ...++.++|||||||++|||++|+.||......+. ....
T Consensus 154 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i 220 (332)
T cd05623 154 EDGT-------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKI 220 (332)
T ss_pred cCCc-------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHH
Confidence 3221 1122357899999999986 35688999999999999999999999986543211 1111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL--NARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP--~~RPt~~evl~~ 642 (669)
.... ..+ .+ ......+...+.+|+++|+..++ ..|+++.|++++
T Consensus 221 ~~~~------~~~---~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 221 MNHK------ERF---QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred hCCC------ccc---cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1100 000 00 11122345678899999885544 447899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.85 Aligned_cols=229 Identities=26% Similarity=0.484 Sum_probs=182.8
Q ss_pred HHHhCCCCcccceeeEEEEEEECCC------------eeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGD------------DAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~------------~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.+|.|+| |.||+|...+. .+++|.++. .+.+|+.++++++||||+++++++.. +
T Consensus 2 ~lg~G~~-------~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 2 HLGQGTF-------TNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred ccccccc-------ceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 3789999 99999998533 377887643 36689999999999999999999988 7
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-------c
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-------R 500 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-------~ 500 (669)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ ++||||||+|||++.++ .
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~ 146 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPF 146 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCcee
Confidence 8899999999999999998642 26899999999999999999999998 99999999999999887 7
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccC--CCCchhhHHHHHHHHHHHHcC-CCCCCCCchhH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG--VITPKLDVFAFGVVVLELLSG-REAVTGDQNCE 577 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDV~S~Gvvl~elltg-~~p~~~~~~~~ 577 (669)
+||+|||+++..... ....++..|+|||++.+. .++.++||||||+++|||++| ..|+......+
T Consensus 147 ~kl~Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 147 IKLSDPGIPITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred EEeCCCCcccccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 999999999865431 123456789999999876 789999999999999999994 66665432111
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
... ... ... ..+......+.+++.+||..+|.+|||+.||++.|
T Consensus 215 ~~~-------~~~------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 215 KER-------FYQ------------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHH-------HHh------------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 000 000 00111115789999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.27 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=189.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||++... ++.+|||.++. .+.+|+++|++++|+||+++++.+.+++..++||
T Consensus 8 ~lG~G~~-------g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 8 TIGIGAF-------GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred EEEeCCC-------eEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4899999 999999874 78899999853 2567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 999999999999754 35888999999999999999999999 9999999999999999999999999985332
Q ss_pred CCcccc-------------------C----------------CcccceeeecccccccccccccccCCCCchhhHHHHHH
Q 005923 514 SDEHEQ-------------------G----------------GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGV 558 (669)
Q Consensus 514 ~~~~~~-------------------~----------------~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gv 558 (669)
...... . ...........||..|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 100000 0 00000112357999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC---C
Q 005923 559 VVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP---S 635 (669)
Q Consensus 559 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t 635 (669)
++|||++|+.||.+....+... .... . ...+.......+...+.+++.+|+ .+|.+|+ +
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~------~i~~----------~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQL------KVIN----------W-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHH------HHhc----------c-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 9999999999998655322110 0000 0 001111111234456788888876 5999999 8
Q ss_pred HHHHHHH
Q 005923 636 ISEVFVT 642 (669)
Q Consensus 636 ~~evl~~ 642 (669)
+.|++.+
T Consensus 295 ~~ell~h 301 (376)
T cd05598 295 ADEIKAH 301 (376)
T ss_pred HHHHhCC
Confidence 8998866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.93 Aligned_cols=239 Identities=25% Similarity=0.414 Sum_probs=194.0
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|++.. .++.|.| |.||+|.. +++.+++|.+.. .+.+|++++++++|+|++++.+++.++...
T Consensus 3 y~~~~-~lg~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 3 FTLLE-CIGKGSF-------GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74 (274)
T ss_pred hhhhh-hhcCCCC-------eEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence 33333 4899999 99999998 477899998753 356899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999753 5899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ..
T Consensus 146 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~----~~--- 208 (274)
T cd06609 146 GQLTSTMS--------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--V----LF--- 208 (274)
T ss_pred eeeccccc--------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--H----HH---
Confidence 87754321 1123467888999999999899999999999999999999999997543211 0 00
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.....+.+... ..+..+.+++.+||..||.+|||+++++..
T Consensus 209 -------~~~~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 209 -------LIPKNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -------HhhhcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0001111111111 144568899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.86 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=199.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc------HHHHHHHHHhcC-C-----CCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD------VSSEINILKKIN-H-----SNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~------~~~E~~~l~~l~-H-----~niv~l~g~~~ 424 (669)
.|.+.|+ +|.|.| |.|-++.. .++.||||++|.+ ...|+.+|..|+ | -|+|+++++|.
T Consensus 187 rY~V~e~-LGkGtF-------GQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 187 RYEVLEV-LGKGSF-------GQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEE-eccccc-------ceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 4555665 999999 99999988 4789999999864 346999999997 4 48999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC--CcEE
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN--LRAK 502 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~--~~~k 502 (669)
..+++|||+|.+.. +|.++|+.++. ..|+...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+|
T Consensus 259 fr~HlciVfELL~~-NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 259 FRNHLCIVFELLST-NLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cccceeeeehhhhh-hHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCcee
Confidence 99999999999975 99999998753 35999999999999999999999999 9999999999999653 4799
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+|||.|....... .....+..|+|||++.+..|+.+.|+||||||+.||++|...|.|++..+. .
T Consensus 332 VIDFGSSc~~~q~v-----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ---l 397 (586)
T KOG0667|consen 332 VIDFGSSCFESQRV-----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ---L 397 (586)
T ss_pred EEecccccccCCcc-----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH---H
Confidence 99999998764322 245678899999999999999999999999999999999888888764322 2
Q ss_pred HHHHHHHhhhhH-----HhhhhcccCC-----------------------------ccCCCCc-----------HHHHHH
Q 005923 583 ASISRVLEESNV-----REKLRGFIDP-----------------------------SLRNEYP-----------LDLAFS 617 (669)
Q Consensus 583 ~~~~~~~~~~~~-----~~~l~~~~d~-----------------------------~l~~~~~-----------~~~~~~ 617 (669)
..+.+++.-+.. ..+...+++. ......| ......
T Consensus 398 ~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~ 477 (586)
T KOG0667|consen 398 ARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKL 477 (586)
T ss_pred HHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHH
Confidence 223322221110 0011111111 0000011 123345
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 618 MAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 618 l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.+++++||..||.+|+|..|.+.+
T Consensus 478 F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 478 FIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHHHHHHHhccCchhcCCHHHHhcC
Confidence 8999999999999999999999876
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=297.19 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=194.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
..|.+.+ ++|.|+| |.||+|... +..||+|.++. .+.+|+.++++++|+||+++++++..++
T Consensus 6 ~~y~~~~-~lg~g~~-------g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 6 ETYIKLD-KLGEGTY-------ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred cceEEee-EeccCcC-------EEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 3455544 4899999 999999874 77899998752 3568999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 149 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFG 149 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCc
Confidence 9999999997 5999998754 245889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+ ....+.
T Consensus 150 ~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~ 218 (301)
T cd07873 150 LARAKSIPTK--------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIF 218 (301)
T ss_pred chhccCCCCC--------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 9976533211 1122356889999999865 457899999999999999999999998654321 112222
Q ss_pred HHHhhhhHHhhhhccc---------CCccCCC----CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFI---------DPSLRNE----YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~---------d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+..... .....++ .+..... ....+...+.+|+.+||+.||.+|||+.|++++
T Consensus 219 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 219 RILGTPTE-ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred HHcCCCCh-hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 22111100 0011110 0111111 112345568899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.94 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=188.7
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
.+|.|.| |.||+|... +..+++|.... .+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 15 ~lg~g~~-------g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 15 VLGKGTY-------GIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred EEecCCc-------eEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 4899999 999999874 56799998753 3678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEEcccCCccccC
Q 005923 437 DNGALSDWLHSNRYQTSDNL--TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGLARSAE 513 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DfGla~~~~ 513 (669)
++++|.++++... ..+ ++..+..++.|++.||+|||+.+ ++||||||+||+++. ++.+||+|||++....
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 88 PGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred CCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999997642 234 78889999999999999999998 999999999999986 6799999999997654
Q ss_pred CCccccCCcccceeeecccccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
.... ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+.......... .. .
T Consensus 161 ~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-~~--~----- 224 (268)
T cd06624 161 GINP--------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-FK--V----- 224 (268)
T ss_pred cCCC--------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-hh--h-----
Confidence 3211 112235788999999987644 7899999999999999999999987433211100 00 0
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .......+.....++.+++.+||+.+|.+|||+.|++..
T Consensus 225 --------~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 --------GM--FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------hh--hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 011123344556678999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.74 Aligned_cols=241 Identities=25% Similarity=0.433 Sum_probs=191.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-----------------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-----------------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-----------------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.+|.|+| |.||+|.. +|+.+|+|.++. .+.+|+.++++++|+|++++++++...
T Consensus 8 ~lg~g~~-------~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 8 LIGKGTY-------GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred eecccCc-------eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 3899999 99999986 578899998742 256799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++++. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence 9999999999999999999754 46899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|+++....... ........++..|+|||.+.... ++.++|+||||+++||+++|..|+......+.
T Consensus 153 ~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------ 220 (272)
T cd06629 153 GISKKSDDIYD------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------ 220 (272)
T ss_pred ccccccccccc------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------
Confidence 99986543211 11123456788999999987754 89999999999999999999999864332110
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...... ......+.+ .....++..+.+++.+||+.||.+||++++|+++
T Consensus 221 ~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 221 MFKLGN-----KRSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHhhc-----cccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000 001111111 1112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.59 Aligned_cols=235 Identities=27% Similarity=0.422 Sum_probs=190.1
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec-CceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE-GNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e 434 (669)
++.|.| |.||++.. +++.+++|.+.. .+..|++++++++|+|++++.+.+... ...++|||
T Consensus 8 lg~g~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 8 VGKGSY-------GEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ecCCCC-------eEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 788999 99999987 467899998742 356799999999999999999987644 45789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++...+ ...+++.++..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999997642 345899999999999999999999999 99999999999999999999999999986643
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... ......++..|+|||.+.+..++.++||||||++++||++|+.||....... . .....
T Consensus 155 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~----~~~~~----- 215 (257)
T cd08223 155 QCD--------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--L----VYRII----- 215 (257)
T ss_pred cCC--------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--H----HHHHH-----
Confidence 221 1223467889999999999999999999999999999999999987543211 0 00000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... ....+......+.+++.+||+.||.+||++.|++++
T Consensus 216 ----~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 ----EGK-----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----hcC-----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011 112233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.15 Aligned_cols=232 Identities=26% Similarity=0.349 Sum_probs=182.8
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc---CCCCceeEeeEEEecCceeE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI---NHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~l 431 (669)
+|.|+| |.||+|... +..+|+|++... +..|..++.+. +||||+++++++..+...++
T Consensus 1 lG~G~~-------g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~l 73 (330)
T cd05586 1 IGKGTF-------GQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYL 73 (330)
T ss_pred CCCCCc-------eEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEE
Confidence 478999 999999874 789999998531 23456666655 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 74 v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 74 VTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred EEcCCCCChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999999999999754 45899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
..... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+. ... ...
T Consensus 146 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~~---i~~ 211 (330)
T cd05586 146 NLTDN--------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YRN---IAF 211 (330)
T ss_pred CCCCC--------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HHH---HHc
Confidence 43221 112345789999999998764 479999999999999999999999986543210 000 000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP----SISEVFV 641 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP----t~~evl~ 641 (669)
. +..+. .......+.+++.+||+.||.+|| ++.|+++
T Consensus 212 -----~------~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 212 -----G------KVRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----C------CCCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 00110 012345678999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.08 Aligned_cols=238 Identities=30% Similarity=0.524 Sum_probs=190.8
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|.|+| |+||++... ++.+|+|.+... ..+|+.++++++||||+++++++.++...++||||
T Consensus 7 lg~G~~-------g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 7 LGSGGF-------GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEESS-------EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred EEeCCC-------EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 899999 999999995 457999998642 23489999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 80 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp ETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999833 45899999999999999999999999 999999999999999999999999999864111
Q ss_pred ccccCCcccceeeecccccccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIE-NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
........++..|+|||.+. +..++.++||||+|+++|+|++|..|+........... +.........
T Consensus 152 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~ 220 (260)
T PF00069_consen 152 --------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKRPLP 220 (260)
T ss_dssp --------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHTHHH
T ss_pred --------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhccccccc
Confidence 12234467889999999998 88999999999999999999999999986522111111 1111110000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. . .........+.+++.+||+.||.+||++.++++
T Consensus 221 ~~-~----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SS-S----------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HH-T----------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc-c----------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 000111267999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=295.26 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=187.1
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhc---CCCCceeEeeEEEec-----
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKI---NHSNIIRLSGFCVHE----- 426 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l---~H~niv~l~g~~~~~----- 426 (669)
++|.|+| |.||++.. +++.+|+|.++. .+.+|+.+++++ +||||+++++++...
T Consensus 7 ~lg~g~~-------g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 7 EIGVGAY-------GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred EEeecCC-------eEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4899999 99999988 477899998853 245688877766 699999999998642
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
...++||||+.+ +|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 357999999984 899998754 2245899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.+|.+....+ ....+.
T Consensus 153 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~ 220 (288)
T cd07863 153 GLARIYSCQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIF 220 (288)
T ss_pred CccccccCcc---------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHH
Confidence 9998764321 1123467889999999999999999999999999999999999987654321 111111
Q ss_pred HHHhhhhHHhh---h---hcccCCccC---CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 587 RVLEESNVREK---L---RGFIDPSLR---NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 587 ~~~~~~~~~~~---l---~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
........... . .....+... .....+....+.+++.+||+.||.+|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111000000 0 000000000 0011234556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=278.78 Aligned_cols=233 Identities=30% Similarity=0.449 Sum_probs=188.7
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------------cHHHHHHHHHhc-CCCCceeEeeEEEecCc
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------------DVSSEINILKKI-NHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 428 (669)
+|.|.- ..|-+... .|++.|+|++.. .-.+|+.+|+++ .||+|+.+.++++.+..
T Consensus 25 lgrgvs-------s~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 25 LGRGVS-------SVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcccch-------hhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 555554 33444433 367788887731 245799999998 59999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++|+|.|+.|.|.|+|... -.++++...+|+.|+++|++|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 98 ~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999754 46999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN------GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
+..+..+. ..+..+||++|+|||.+.. ..|+...|.|+.||+||-|+.|+.||..... +
T Consensus 170 a~~l~~Ge---------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----m-- 234 (411)
T KOG0599|consen 170 ACQLEPGE---------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----M-- 234 (411)
T ss_pred eeccCCch---------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----H--
Confidence 99887654 2456899999999999853 4578899999999999999999999975321 1
Q ss_pred HHHHHHHhhhhHHhhhhcccCCcc--CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSL--RNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
-.++-++...+ +.+.-.+......+|+.+||+.||.+|.|++|++.+
T Consensus 235 -------------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 235 -------------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -------------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11122222222 222224666778999999999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.40 Aligned_cols=243 Identities=25% Similarity=0.463 Sum_probs=192.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.+|.|+| |.||+|..+ ...+++|.+.. ++.+|++++++++|+||+++++++.+.+..+
T Consensus 12 ~lg~g~~-------g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 12 TLGRGEF-------GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred eecccce-------eEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 3899999 999999863 35689998742 4678999999999999999999999888999
Q ss_pred EEEEecCCCCHHHHHhcCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 431 LVYEFADNGALSDWLHSNRYQT----SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+||||+++|+|.++++..+... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997653111 126899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... . ...
T Consensus 162 ~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~-~~~- 230 (275)
T cd05046 162 SLSKDVYNSEY-------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--V-LNR- 230 (275)
T ss_pred ccccccCcccc-------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--H-HHH-
Confidence 99875533221 11223356778999999998889999999999999999999 777876433211 0 000
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
. . ...+....+..++..+.+++.+||+.||.+||++.|++..|+
T Consensus 231 --~-~------------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 --L-Q------------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --H-H------------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 0 001111122344567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.88 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=190.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+ .+|.|+| |.||++..+ ++.+|+|+++. .+.+|+.+++.++||||+++++++..
T Consensus 43 ~~y~i~~-~lG~G~f-------g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 43 EDYEVVK-VIGRGAF-------GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred hhcEEEE-EEeecCC-------eEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455444 3899999 999999984 67899999852 24578999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.++++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999753 3788899999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG----VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
||+++....... .......||..|+|||++.+. .++.++|||||||++|||++|+.||.+......
T Consensus 186 fG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--- 255 (371)
T cd05622 186 FGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--- 255 (371)
T ss_pred CCceeEcCcCCc-------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---
Confidence 999987643221 112345799999999999754 378999999999999999999999986543211
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA--RPSISEVFVTL 643 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 643 (669)
...++.. . ..+..+........+.+++.+|+..++.+ ||++.|++++.
T Consensus 256 ---~~~i~~~----------~-~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 256 ---YSKIMNH----------K-NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---HHHHHcC----------C-CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111110 0 00111112234567889999999844433 78899888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.94 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=190.6
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|++.++ ++.|.| |.||+|.. .+..|++|.++. .+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~~~-l~~g~~-------g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 75 (265)
T cd06652 4 WRLGKL-LGQGAF-------GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD 75 (265)
T ss_pred ceEeeE-EecCCc-------eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence 444443 889999 99999987 478899998741 25579999999999999999998866
Q ss_pred c--CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 E--GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
. ...++||||+++|+|.+++... ..+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l 147 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKL 147 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEE
Confidence 4 4578999999999999999754 34889999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++........ ........++..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 148 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------ 216 (265)
T cd06652 148 GDFGASKRLQTICLS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------ 216 (265)
T ss_pred CcCcccccccccccc-----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------
Confidence 999999865432110 011233468889999999999899999999999999999999999987532211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+... .........|......+.+++.+||. +|.+||+++||++.
T Consensus 217 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 217 AIFKI-------------ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHH-------------hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00000 00011223455566678899999995 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.48 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=185.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhcCC------CCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKINH------SNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H------~niv~l~g~~~ 424 (669)
.|++.+ ++|.|+| |+||++.. .++.||||+++. ++..|++++++++| .+++++++++.
T Consensus 130 ~y~i~~-~lG~G~f-------g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 130 RFKILS-LLGEGTF-------GKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cEEEEE-EEEeccC-------EEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 455555 3899999 99999987 467899999863 34568888888765 45888999887
Q ss_pred ec-CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCC---
Q 005923 425 HE-GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNL--- 499 (669)
Q Consensus 425 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~--- 499 (669)
.+ ++.++|||++ +++|.+++.+. +.+++..+..|+.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 54 4678999988 67999998754 359999999999999999999998 48 99999999999998765
Q ss_pred -------------cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcC
Q 005923 500 -------------RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566 (669)
Q Consensus 500 -------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg 566 (669)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERHS-----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCccc-----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 4999999987643221 2235789999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHhhh---hH----Hhhhhccc------CCccCC-----------CCcHHHHHHHHHHH
Q 005923 567 REAVTGDQNCEAELLYASISRVLEES---NV----REKLRGFI------DPSLRN-----------EYPLDLAFSMAQLA 622 (669)
Q Consensus 567 ~~p~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~l~~~~------d~~l~~-----------~~~~~~~~~l~~li 622 (669)
+.||.+....+.... +...+... .. ....+.+. ++.... .........+.+|+
T Consensus 342 ~~pf~~~~~~~~~~~---i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 342 KLLYDTHDNLEHLHL---MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred CCCCCCCChHHHHHH---HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 999987554322111 11111100 00 00000000 000000 00001134578999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 005923 623 KNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 623 ~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+||+.||.+|||++|++++
T Consensus 419 ~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 419 YGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHhCCcChhhCCCHHHHhcC
Confidence 99999999999999999974
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.07 Aligned_cols=236 Identities=23% Similarity=0.343 Sum_probs=192.6
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|.|.| |.||.+.. +++.+++|.+.. ++.+|++++++++|+||+++++++.+++..+++|||
T Consensus 8 ig~g~~-------g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 8 LGKGAF-------GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ecccCC-------ceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 799999 87776665 578899998642 367899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++|+|.+++...+ ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999997642 346899999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ......++..|+|||.+.+..++.++||||||+++|||++|..||......+ ......
T Consensus 155 ~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~------ 214 (256)
T cd08221 155 YS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV------ 214 (256)
T ss_pred cc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH------
Confidence 21 1223568899999999998889999999999999999999999987543211 000010
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
...+ ...+...+.++.+++.+||+.+|.+||++.|+++.+
T Consensus 215 -------~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 215 -------QGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -------cCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0011 112234456789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.21 Aligned_cols=243 Identities=27% Similarity=0.438 Sum_probs=194.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|.+.+ +++.|.| |.||++..+ +..+|+|..+. ++..|++++++++|+||+++++++..++..
T Consensus 6 ~~~i~~-~l~~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 6 IWEIIG-ELGDGAF-------GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred HHHHHH-HhcCCCC-------ceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 355555 4899999 999999984 77899998853 366799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 78 WILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEEeeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccc
Confidence 9999999999999998754 245999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
....... .......++..|+|||.+. ...++.++||||||+++|||++|+.||....... .
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~ 216 (280)
T cd06611 151 AKNKSTL--------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------V 216 (280)
T ss_pred hhhcccc--------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------H
Confidence 7654321 1122346888999999985 3457789999999999999999999997543211 0
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+... .....+. ...+......+.+++.+||+.||.+||++.++++.
T Consensus 217 ~~~~----------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 LLKI----------LKSEPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHH----------hcCCCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000 0000011 11233445678999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=285.93 Aligned_cols=243 Identities=25% Similarity=0.427 Sum_probs=194.6
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
|++.+ .++.|.| |.||++... ++.+++|.++. .+.+|++++++++||||+++++++..++..+
T Consensus 5 ~~~~~-~l~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 5 YELIQ-RIGSGTY-------GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred eEEEE-EecCCCc-------eEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 44444 3899999 999999873 67899998753 3678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
++|||+++++|.+++...+ ..+++.++..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++.
T Consensus 77 l~~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccch
Confidence 9999999999999987542 45899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG---VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......... .
T Consensus 150 ~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~---- 215 (262)
T cd06613 150 QLTATI--------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--L---- 215 (262)
T ss_pred hhhhhh--------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----
Confidence 654321 112234678899999999877 88999999999999999999999997644321100 0
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. ....+..+.+ ..+...+.++.+++.+||..||.+|||+.+|+.
T Consensus 216 ~--------~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 I--------SKSNFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred H--------HhccCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000111111 123344567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=290.29 Aligned_cols=243 Identities=25% Similarity=0.410 Sum_probs=192.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ ++|.|.| |.||+|..+ +..+++|.++. ++.+|+.++++++|+||+++++++..++..
T Consensus 13 ~y~i~~-~lg~g~~-------g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 13 VWEIIG-ELGDGAF-------GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred hhhhhh-eecCCCC-------eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 455544 4899999 999999984 67899999853 356799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|..++.+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EEEEecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999999888643 245899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
....... .......++..|+|||.+. ...++.++|||||||++|||++|+.|+....... .
T Consensus 158 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~ 223 (292)
T cd06644 158 AKNVKTL--------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------V 223 (292)
T ss_pred eeccccc--------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------H
Confidence 7643221 1112345788999999985 3457889999999999999999999987543211 0
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... .....+. ...+.....++.+++.+||+.||.+||++.|+++.
T Consensus 224 ~~~~----------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 224 LLKI----------AKSEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHH----------hcCCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0001111 11233445578999999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.82 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=190.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+ .+|.|+| |.||++.. .++.+|||+++. ++.+|+.+++.++||||+++++++...
T Consensus 24 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 24 KRYQNLK-PIGSGAQ-------GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred cceeEEE-EeecCCC-------eEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 4555555 3899999 99999987 477899999853 355799999999999999999987643
Q ss_pred ------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 ------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 96 KSLEEFQDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred ccccccCeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCc
Confidence 356999999975 78888753 3889999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+||+|||+++...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||.+....+..
T Consensus 165 ~kL~DfG~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~- 234 (364)
T cd07875 165 LKILDFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW- 234 (364)
T ss_pred EEEEeCCCccccCCCC---------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 9999999998654321 123356899999999999999999999999999999999999999865532211
Q ss_pred HHHHHHHHHhhhh--H----HhhhhcccC--C------------cc----CCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 581 LYASISRVLEESN--V----REKLRGFID--P------------SL----RNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 581 ~~~~~~~~~~~~~--~----~~~l~~~~d--~------------~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
..+...+.... . ...+...+. + .. ...........+.+|+.+||+.||.+|||+
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~ 312 (364)
T cd07875 235 --NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312 (364)
T ss_pred --HHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence 11111100000 0 000000000 0 00 001111123467899999999999999999
Q ss_pred HHHHHH
Q 005923 637 SEVFVT 642 (669)
Q Consensus 637 ~evl~~ 642 (669)
.|++++
T Consensus 313 ~e~L~h 318 (364)
T cd07875 313 DEALQH 318 (364)
T ss_pred HHHhcC
Confidence 999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.42 Aligned_cols=236 Identities=25% Similarity=0.417 Sum_probs=194.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.+|.|.| |.+|++.. +|..+++|.++. ++.+|+.++++++|+||+++++++..++..++|||
T Consensus 7 ~lg~g~~-------g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 7 KIGEGSF-------GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred EeccCCc-------eEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 3899999 99999887 578899998742 46789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++.... ...+++.++++++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 80 YCEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred cCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 999999999997542 235889999999999999999999998 99999999999999999999999999986643
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... ......|+..|+|||.+.++.++.++|+||||++++||++|+.|+......+ . ...
T Consensus 154 ~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~----~~~------- 212 (256)
T cd08218 154 TVE--------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN--L----VLK------- 212 (256)
T ss_pred chh--------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH--H----HHH-------
Confidence 221 1223457889999999999999999999999999999999999987543211 0 000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+... ....+......+.+++.+||+.+|.+||++.||+++
T Consensus 213 --~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 213 --IIRGS-----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HhcCC-----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01111 112334556678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.30 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=187.3
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++.. .++.+|+|+++. .+..|+.++.+++|+||+++++.+.+++..++|||
T Consensus 9 lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 9 IGRGAF-------GEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred EeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 899999 99999988 478899999853 25579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 82 FLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred CCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999754 35899999999999999999999999 99999999999999999999999999875532
Q ss_pred CccccC---------------------------CcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCC
Q 005923 515 DEHEQG---------------------------GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567 (669)
Q Consensus 515 ~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~ 567 (669)
...... ...........||..|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110000 00001122357999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005923 568 EAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS---ISEVFVT 642 (669)
Q Consensus 568 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 642 (669)
.||.+....+. .. .+.. . ...+..+.......++.+++.+|+. ||.+|++ +.|++++
T Consensus 234 ~Pf~~~~~~~~---~~---~i~~----------~-~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQET---YR---KVMN----------W-KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHHHH---HH---HHHc----------C-CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99986543211 00 0100 0 0000000011234567888888774 9999996 5565544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=305.25 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=190.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.+ .+|.|+| |.||++.. .++.+|||.++. .+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 17 KRYQNLK-PIGSGAQ-------GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hceeEEE-EeeecCC-------EEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 4455544 3899999 99999986 478899998853 345799999999999999999998644
Q ss_pred C------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 G------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
. ..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~ 157 (355)
T cd07874 89 KSLEEFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred ccccccceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCC
Confidence 2 46999999975 78777753 3889999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+..
T Consensus 158 ~kl~Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~- 227 (355)
T cd07874 158 LKILDFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW- 227 (355)
T ss_pred EEEeeCcccccCCCcc---------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 9999999998654321 122356899999999999999999999999999999999999999865432211
Q ss_pred HHHHHHHHHhhhh------HHhhhhcccC----------Cc-----c---CCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 581 LYASISRVLEESN------VREKLRGFID----------PS-----L---RNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 581 ~~~~~~~~~~~~~------~~~~l~~~~d----------~~-----l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
..+...+.... ....+..+++ +. + ....+......+.+|+.+||+.||.+|||+
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~ 305 (355)
T cd07874 228 --NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_pred --HHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence 11111100000 0000000000 00 0 001112234568999999999999999999
Q ss_pred HHHHHH
Q 005923 637 SEVFVT 642 (669)
Q Consensus 637 ~evl~~ 642 (669)
.|++++
T Consensus 306 ~ell~h 311 (355)
T cd07874 306 DEALQH 311 (355)
T ss_pred HHHhcC
Confidence 999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.28 Aligned_cols=247 Identities=25% Similarity=0.441 Sum_probs=191.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeEEEe----
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGFCVH---- 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~~~~---- 425 (669)
.|++.+ .+++|+| |.||++.. .++.+|+|..+. ++..|+.+++++ +|+||+++++++..
T Consensus 19 ~~~~~~-~lg~g~~-------~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 19 TWEIIE-TIGKGTY-------GKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ceeeee-eeccCCC-------cEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 455555 4899999 99999987 477899998753 466799999999 69999999999853
Q ss_pred -cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 426 -EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 426 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++..++||||+++|+|.++++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 346899999999999999986432 22356899999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
|||+++....... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.|+........
T Consensus 167 dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~- 237 (286)
T cd06638 167 DFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA- 237 (286)
T ss_pred cCCceeecccCCC--------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence 9999986643211 1123468899999999853 4578899999999999999999999875432110
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+. .......+.+ ..+......+.+++.+||+.||.+|||+.|+++.+
T Consensus 238 -----~~----------~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 -----LF----------KIPRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----Hh----------hccccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0000000111 11222345689999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=287.49 Aligned_cols=238 Identities=26% Similarity=0.411 Sum_probs=192.5
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe--cCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH--EGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 432 (669)
.++.|+| |.||++.. .+..+++|.++. .+..|++++++++|+||+++++++.. +...+++
T Consensus 7 ~lg~g~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 7 TIGKGSF-------GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred eeccCCC-------eEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 3789999 99999987 467899998752 35679999999999999999998764 3457999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH-----KYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH-----~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
|||+++++|.+++...+ .....+++..++.++.|++.||+||| +.+ ++|+||+|+||++++++.+||+|||
T Consensus 80 ~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 80 MEYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred ehhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccc
Confidence 99999999999997642 23457999999999999999999999 666 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......+ ...
T Consensus 156 ~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---- 220 (265)
T cd08217 156 LAKILGHDSS--------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS---- 220 (265)
T ss_pred ccccccCCcc--------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH----
Confidence 9987654321 1233468899999999999999999999999999999999999998644211 100
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.. ......+...+..+.+++.+||+.+|.+||++.+|+++
T Consensus 221 ---------~~~~----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 ---------KIKE----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------HHhc----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111 11122344456678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.68 Aligned_cols=235 Identities=24% Similarity=0.431 Sum_probs=192.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|+| |.||++.. ++..+|||.++. .+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 29 ~lg~g~~-------g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 29 KIGEGST-------GIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred cccCCCC-------eEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 5899999 99999987 478899998753 3668999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++++|.+++... .+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 102 EGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999999998543 4889999999999999999999998 9999999999999999999999999987653322
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ +.
T Consensus 173 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~---------- 228 (292)
T cd06658 173 P--------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MR---------- 228 (292)
T ss_pred c--------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH----------
Confidence 1 12234688999999999998999999999999999999999999986443211 00
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+...+.+.... .......+.+++.+||..||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 229 RIRDNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHhcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011111111111 11234568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.21 Aligned_cols=241 Identities=22% Similarity=0.401 Sum_probs=194.0
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.+|+|.| |.||++.. +++.+|+|.++. ++..|++++++++|+||+++++++.+.+..+
T Consensus 7 ~lg~g~~-------~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 7 QLGTGAF-------SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred eecCcCc-------eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 3899999 99999986 578899998852 3667999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccCCc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLA 509 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfGla 509 (669)
+||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++
T Consensus 80 ~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred EEEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 999999999999999754 35899999999999999999999999 99999999999998775 6999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
.......... ........++..|+|||.+.+..++.++||||+|++++||++|+.||.......... .+
T Consensus 152 ~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~---- 220 (268)
T cd06630 152 ARLAAKGTGA----GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LI---- 220 (268)
T ss_pred cccccccccC----CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HH----
Confidence 8765432110 111233568889999999998899999999999999999999999987433211000 00
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
............+......+.+++.+||+.+|.+||++.|++.
T Consensus 221 ---------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 ---------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000011123345556678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=289.91 Aligned_cols=238 Identities=24% Similarity=0.462 Sum_probs=191.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
.+|.|+| |.||++..+ +..+|+|.++. .+.+|++++++++|+||+++++.+..++..++||||
T Consensus 8 ~ig~g~~-------g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 8 ELGKGNY-------GSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhcccCC-------eEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4899999 999999985 78899998753 366799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
+++++|.++++... ....+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999999987541 23468999999999999999999997 46 99999999999999999999999999976532
Q ss_pred CccccCCcccceeeecccccccccccccccCC------CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV------ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
.. .....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||....... ....
T Consensus 156 ~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~---- 218 (286)
T cd06622 156 SL----------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQ---- 218 (286)
T ss_pred Cc----------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHH----
Confidence 21 22345788999999986543 4889999999999999999999997533211 0011
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+..+.+. .....+.++...+.+++.+||+.+|.+||++.+++..
T Consensus 219 ---------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 219 ---------LSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---------HHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111111 1122344566778999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=278.52 Aligned_cols=241 Identities=25% Similarity=0.391 Sum_probs=191.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec---------ccHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK---------GDVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|.+.|. +|.|.| ..|++... .|+.+|+|++. +++.+|+.|.+.++|||||+|.....+++
T Consensus 12 ~y~l~e~-igkG~F-------SvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 12 NYDVKEE-LGKGAF-------SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred hhhHHHH-HccCch-------HHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 5666674 999999 55555544 46777777653 35778999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~ 504 (669)
..|||+|+|.||+|..-+-.+ ...++...-+.+.||+++|.|+|.++ |||||+||+|+|+.+ .--+|++
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred eeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence 999999999999997766433 34778888999999999999999999 999999999999954 3458999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+|..+..+. .-....||++|||||++...+|+..+|||+.||+||-|+.|..||.++... .+++.
T Consensus 156 ~FGvAi~l~~g~---------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~ 223 (355)
T KOG0033|consen 156 DFGLAIEVNDGE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQ 223 (355)
T ss_pred ccceEEEeCCcc---------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHH
Confidence 999999887332 223468999999999999999999999999999999999999999985432 22222
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+. ..-.| +..++-....++..+|+++||..||.+|.|+.|.+.
T Consensus 224 I~------------~g~yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 224 IK------------AGAYD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred Hh------------ccccC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 21 11111 112222345567899999999999999999998764
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=290.93 Aligned_cols=246 Identities=26% Similarity=0.451 Sum_probs=191.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeEEEec---
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGFCVHE--- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~~~~~--- 426 (669)
.|.+.+ .++.|.| |.||++.. .++.+|+|.+.. .+.+|+.++.++ +|||++++++++...
T Consensus 23 ~y~~~~-~l~~g~~-------~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 23 TWEIIE-TIGKGTY-------GKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CeEEEE-EeecCCC-------eEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 455555 4899999 99999988 477899998853 356799999999 899999999998754
Q ss_pred --CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 427 --GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 427 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+..++||||+++|+|.++++... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 35799999999999999987532 22356899999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-----VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
|||+++....... ......++..|+|||.+... .++.++|||||||++|||++|+.|+......+.
T Consensus 171 dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~- 241 (291)
T cd06639 171 DFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT- 241 (291)
T ss_pred ecccchhcccccc--------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence 9999987643221 11224578899999998653 368899999999999999999999975432111
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.... ....+.+ ..+......+.+++.+||+.||.+||++.|++++
T Consensus 242 -----~~~~~----------~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 -----LFKIP----------RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----HHHHh----------cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00000 0000111 1223344578999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=284.91 Aligned_cols=238 Identities=33% Similarity=0.593 Sum_probs=192.5
Q ss_pred HHHhCCCCcccceeeEEEEEEECC------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKG------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|.|+| |.||++.... ..+|+|.++. .+..|+.++++++|+||+++++++.+.+..++
T Consensus 6 ~lg~g~~-------g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 6 KLGEGAF-------GEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred eeccCCC-------cceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 4899999 9999999864 7799999863 35679999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
+|||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 79 i~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred EEeccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence 999999999999997642 122899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
........ .....++..|+|||.+.+..++.++||||+|++++||++ |..|+....... ....
T Consensus 153 ~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~------ 216 (258)
T smart00219 153 LYDDDYYK-------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY------ 216 (258)
T ss_pred cccccccc-------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH------
Confidence 65432111 112336789999999988899999999999999999998 777776533211 0000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+.. ......+...+.++.+++.+||..||.+|||+.|+++.|
T Consensus 217 -------~~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 -------LKK----GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------Hhc----CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 001122233566789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.63 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=187.3
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||+++.. ++.+|+|.++. .+..|..++..++|+||+++++++.+++..|+||
T Consensus 8 ~lG~G~f-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 8 VIGRGAF-------GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred EEeeCCC-------eEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4899999 999999874 67899998853 2567889999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.++++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999763 245899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
.... .......||..|+|||++.+ +.++.++||||||+++|||++|+.||......+. ....
T Consensus 154 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i 220 (331)
T cd05624 154 QDGT-------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKI 220 (331)
T ss_pred CCCc-------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHH
Confidence 3321 11223568999999999875 5688999999999999999999999986543211 1111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA--RPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 642 (669)
.... . .+ .+ .....+.+..+.+++.+|+..++.+ |+++++++++
T Consensus 221 ~~~~-----~-~~---~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 221 MNHE-----E-RF---QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HcCC-----C-cc---cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1000 0 00 00 0111234567889999999865544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.53 Aligned_cols=234 Identities=25% Similarity=0.371 Sum_probs=190.9
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|.|.| |.||++.. .++.+++|.+.. .+.+|++++++++|||++++++.+..++..++||||
T Consensus 8 lg~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 8 VGRGAF-------GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred ecccCc-------eEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 789999 99999887 477899998742 367899999999999999999999988999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DfGla~~~~~ 514 (669)
+++++|.+++.... ...+++..+.+++.+++.||+|||+++ ++|+||+|+||+++++ +.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999997642 345899999999999999999999999 9999999999999865 5689999999987643
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... . .....
T Consensus 155 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~----~~~~~----- 214 (256)
T cd08220 155 KSK---------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--L----VLKIM----- 214 (256)
T ss_pred Ccc---------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--H----HHHHH-----
Confidence 321 122467889999999999999999999999999999999999987543211 0 00000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ......+......+.+++.+||+.||.+|||++|++..
T Consensus 215 ----~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 215 ----S-----GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----h-----cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 00112233455678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=303.69 Aligned_cols=241 Identities=27% Similarity=0.443 Sum_probs=191.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEE---EE---ec-----ccHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAV---KV---MK-----GDVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vav---K~---~~-----~~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
+..+|.+ .+|.|.| -+||||... |-+||- |. .+ ..|..|+.+|+.|+|+||++++.++.
T Consensus 40 Ry~k~~e-vLGrGaf-------KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 40 RYLKFDE-VLGRGAF-------KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ceeehhh-hcccccc-------eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 4456666 4999999 899999985 555552 21 11 35778999999999999999999998
Q ss_pred ecCc--eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcE
Q 005923 425 HEGN--TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRA 501 (669)
Q Consensus 425 ~~~~--~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~ 501 (669)
+... .-+|.|.+..|+|+.|+++.+ .++.+.+..|++||++||.|||++ .|||+|||||..||||+.+ |.+
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~V 185 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEV 185 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCce
Confidence 7655 788999999999999998873 588899999999999999999998 5999999999999999765 899
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
||+|+|||....... ..++.||+.|||||..+ ..|....||||||+.|+||.|+..||..-.+. +
T Consensus 186 KIGDLGLAtl~r~s~----------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-A--- 250 (632)
T KOG0584|consen 186 KIGDLGLATLLRKSH----------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-A--- 250 (632)
T ss_pred eecchhHHHHhhccc----------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-H---
Confidence 999999999876543 24589999999999998 78999999999999999999999999732221 1
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+...++..+. ..+.+..+- ..+++++|.+|+.. ..+|||+.|++..
T Consensus 251 -QIYKKV~SGi-KP~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 251 -QIYKKVTSGI-KPAALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -HHHHHHHcCC-CHHHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1111121111 011122221 23689999999999 9999999999864
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.21 Aligned_cols=240 Identities=23% Similarity=0.339 Sum_probs=186.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|+| |.||++... ++.+|+|+++. .+.+|+.++..++|+||+++++++.+++..++||
T Consensus 8 ~lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 8 VIGRGAF-------GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred EEEecCC-------eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3899999 999999974 77899999853 2567899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999999753 245899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
.... .......||..|+|||++.. ..++.++|||||||++|||++|+.||.+....+. ....
T Consensus 154 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i 220 (331)
T cd05597 154 ADGT-------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKI 220 (331)
T ss_pred CCCC-------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHH
Confidence 3221 11122468999999999863 4578899999999999999999999976442111 1111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAH--DLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPt~~evl~~ 642 (669)
.... ... .+ .......+..+.+++++|+.. ++..||++.+++.+
T Consensus 221 ~~~~-------~~~--~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 221 MNHK-------EHF--QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HcCC-------Ccc--cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1100 000 00 011112455678888887754 33448899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=288.85 Aligned_cols=233 Identities=23% Similarity=0.418 Sum_probs=191.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++|.|.| |.||+|.. ++..+|+|.... ++.+|++++++++||||+++++++..+...++||||
T Consensus 11 ~ig~G~~-------~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 11 KIGKGSF-------GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred eEeecCC-------eEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3899999 99999987 467899998752 466899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 84 LGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999999998643 4899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ......++..|+|||.+.+..++.++|+||||+++|||++|..|+....... ....
T Consensus 155 ~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~----------- 212 (277)
T cd06641 155 QI--------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFL----------- 212 (277)
T ss_pred hh--------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHH-----------
Confidence 11 1122457889999999999899999999999999999999999987533211 0000
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.. ......+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 213 --~~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 --IPK----NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --Hhc----CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 00112233445678999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=285.69 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=196.2
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|.| |.||++..+ +..+++|.+.. .+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 lg~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGF-------GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCc-------eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEe
Confidence 467888 999999996 78999998752 36679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 74 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 74 YCLGGELWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 99999999999764 34899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. ......++..|++||.+.+..++.++|+||||+++|||++|..|+..........
T Consensus 146 ~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------- 202 (262)
T cd05572 146 GQ---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-------------- 202 (262)
T ss_pred cc---------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH--------------
Confidence 32 1123467889999999998889999999999999999999999998654211110
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHhhcCCCCCC
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L~~i~~~~~~~~ 654 (669)
...+.+......+|...+..+.+++.+||+.||.+||+ +.|+++. -+-...+|+
T Consensus 203 ---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~---~~~~~~~~~ 261 (262)
T cd05572 203 ---YNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH---KWFNGFDWE 261 (262)
T ss_pred ---HHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC---hhhhCCCCC
Confidence 11111111123344445678999999999999999999 5665542 222345665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=292.74 Aligned_cols=236 Identities=25% Similarity=0.407 Sum_probs=192.3
Q ss_pred HHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 365 LKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 365 l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
.++|.|+| |.||++.. .+..+|+|.++. .+.+|+.+++.++||||+++++++..++..++||||
T Consensus 27 ~~ig~g~~-------g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 27 IKIGEGST-------GIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhcCCCCc-------eeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 36899999 99999987 478899999742 366899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 100 LQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred CCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 999999998854 24899999999999999999999999 999999999999999999999999998765432
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. . .+.
T Consensus 171 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~-~~~----- 230 (297)
T cd06659 171 VP--------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------K-RLR----- 230 (297)
T ss_pred cc--------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-HHh-----
Confidence 21 122356889999999999989999999999999999999999999854432110 0 000
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+.. .........+.+++.+||+.+|.+||++.|+++.
T Consensus 231 ----~~~~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 231 ----DSPPPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----ccCCCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000111 1112234568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=287.26 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=197.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
++.|+| |.||++... |+.+++|.++. .+.+|++++++++|+||+++++.+..+...++|||
T Consensus 1 lg~g~~-------~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAY-------GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCc-------eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEe
Confidence 367888 999999985 88999998853 35678999999999999999999998999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++++. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 74 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 74 YLPGGDLASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99999999999764 25899999999999999999999999 99999999999999999999999999886543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.................++..|++||.+.....+.++||||||+++|||++|+.||......+. ... .
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~---~------ 213 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQN---I------ 213 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---H------
Confidence 2110000001122335678899999999988899999999999999999999999975442210 000 0
Q ss_pred HhhhhcccCCccCCCCcHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 005923 595 REKLRGFIDPSLRNEYPLD--LAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDW 653 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~--~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 653 (669)
..... ..+.. .+..+.+++.+||+.+|.+|||+.++.+.|+.-+-...+|
T Consensus 214 -------~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 214 -------LNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred -------hcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 00000 11222 2567899999999999999999977777776554445555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=289.20 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=191.4
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|+|.| |.||+|..+ ++.|++|.++. .+.+|++++++++|+||+++++++..++..++||||
T Consensus 9 i~~g~~-------~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 9 VGEGAY-------GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ecccCC-------eeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 799999 999999884 67899998752 467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
++++.|..+.... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9987776655432 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......++..|+|||++.+. .++.++||||||+++|||++|+.||.+....+.... +...+.....
T Consensus 154 ~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~ 223 (288)
T cd07833 154 PA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL---IQKCLGPLPP 223 (288)
T ss_pred cc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCH
Confidence 21 012234678889999999888 889999999999999999999999876543221111 1111110000
Q ss_pred H-hh-------hh--cccCC----ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 595 R-EK-------LR--GFIDP----SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 595 ~-~~-------l~--~~~d~----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. .. .. .+.+. .+...++..++.++.+++++||..+|.+||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00 00 00000 0001123334678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=284.05 Aligned_cols=232 Identities=28% Similarity=0.432 Sum_probs=190.6
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
+|.|+| |.||+|.. +++.+++|.+.. .+.+|++++++++|+||+++++++..+...++|
T Consensus 8 ig~g~~-------~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 8 LGSGSF-------GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred eeecCC-------ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 899999 99999998 478899998642 256799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999999754 35889999999999999999999999 999999999999999999999999998875
Q ss_pred CCCccccCCcccceeeecccccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
.... ......++..|++||.+.... ++.++|+||||+++|||++|+.||....... ... ..
T Consensus 153 ~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~----~~--- 214 (258)
T cd06632 153 VEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVF----KI--- 214 (258)
T ss_pred cccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHH----HH---
Confidence 4322 123346788999999998776 8999999999999999999999987543211 100 00
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
... ......+......+.+++.+||+.+|.+||++.+++.
T Consensus 215 -------~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 215 -------GRS---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------Hhc---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000 0011223345567899999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=292.81 Aligned_cols=244 Identities=24% Similarity=0.314 Sum_probs=192.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|+| |.||++... ++.+|+|.+.. .+..|++++++++|+||+++++.+..+...++||
T Consensus 8 ~ig~g~~-------g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 8 LLGKGDV-------GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred eecCCcc-------EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3899999 999999984 68899998853 2567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999999754 2356899999999999999999999998 9999999999999999999999999987653
Q ss_pred CCccccC---------------------CcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 005923 514 SDEHEQG---------------------GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTG 572 (669)
Q Consensus 514 ~~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~ 572 (669)
....... ...........|+..|+|||.+.+..++.++||||||+++|||++|+.||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 3211000 0000112235788999999999999999999999999999999999999976
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS----ISEVFV 641 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~evl~ 641 (669)
...... .. .+.+...........+..+.+++.+||+.||.+||+ +.|++.
T Consensus 235 ~~~~~~------~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDET------FS-------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHH------HH-------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 543211 00 011111111111125667999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=291.60 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=191.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc------------HHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD------------VSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~------------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.+|.|.| |.||+|.. +|+.+++|.++.. +..|++++++++|+||+++++++.+++..++
T Consensus 7 ~lg~g~~-------~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 7 KLGEGTY-------AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred eeeeccc-------cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 3899999 99999997 4789999998532 3469999999999999999999999889999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+ +|+|.+++.... ..+++..++.++.||++||.|||+++ ++|+||+|+|||++.++.+||+|||+++.
T Consensus 80 v~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 99999 899999997542 36999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|..+|.+..+.+ . ...+...+.
T Consensus 152 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~-~~~~~~~~~ 220 (298)
T cd07841 152 FGSPNR--------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--Q-LGKIFEALG 220 (298)
T ss_pred ccCCCc--------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--H-HHHHHHHcC
Confidence 654321 1122345778999999865 467899999999999999999977776544321 1 111111111
Q ss_pred hhhH-----HhhhhcccCCccCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNV-----REKLRGFIDPSLRNEY-----PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~-----~~~l~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... ...+............ .......+.+++.+||+.||.+|||+.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1000 0011111111111111 12335678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=290.49 Aligned_cols=236 Identities=28% Similarity=0.424 Sum_probs=189.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
|...+ .++.|.| |.||+|.. +++.||+|.+.. ++.+|++++++++||||+++.++|..++
T Consensus 17 y~~~~-~lg~g~~-------g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 17 FTDLR-EIGHGSF-------GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred hhhhe-eecCCCC-------eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 44444 4899999 99999987 478899998742 3668999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecC
Confidence 9999999997 58888876432 35899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
++...... ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+.+...... ..
T Consensus 161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~-- 224 (307)
T cd06607 161 SASLVSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY-- 224 (307)
T ss_pred cceecCCC------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HH--
Confidence 98765322 1235678899999884 46688999999999999999999999876443211 00
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... ....+. ..+...+..+.+++.+||+.||.+||++.+|+..
T Consensus 225 --~~~----------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 --HIA----------QNDSPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --HHh----------cCCCCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000011 1122355678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=284.86 Aligned_cols=243 Identities=24% Similarity=0.439 Sum_probs=194.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|++.+ .+|.|.| |.||++..+ ++.+++|.+.. ++.+|++++++++||||+++++++..++..
T Consensus 3 ~~~~~-~ig~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 3 LEYLG-ELGAGNS-------GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74 (265)
T ss_pred chHHH-HhcCCCC-------eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence 34444 4899999 999999985 78899998753 366799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
++++||+++++|.+++...+ ..+++..+.+++.|++.||+|||+ .+ ++|+||+|+||++++++.+||+|||.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999997642 468999999999999999999999 88 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
+....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......+...
T Consensus 148 ~~~~~~~~----------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~ 216 (265)
T cd06605 148 SGQLVNSL----------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYI 216 (265)
T ss_pred chhhHHHH----------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHH
Confidence 87653321 111567889999999999999999999999999999999999997542110 0111111111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLD-LAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+... ....+.. ....+.+++.+||..||.+|||+.|++..
T Consensus 217 -------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 217 -------------VNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -------------hcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1110 1111222 55678999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=294.19 Aligned_cols=242 Identities=29% Similarity=0.462 Sum_probs=203.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcC-CCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKIN-HSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~-H~niv~l~g~~~ 424 (669)
..|++.+ ++|.|.| |.||+++.+ |+.+|+|.++. ++.+|+.+|+++. |||||.+.++++
T Consensus 35 ~~Y~l~~-~lG~G~F-------g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 35 EKYELGR-ELGRGQF-------GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred ccEEehh-hhCCCCc-------eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 3466665 5999999 999999883 88999999842 4678999999998 999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC----Cc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN----LR 500 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~----~~ 500 (669)
.....++|||++.||.|.+.+... .+++.....++.|++.+++|||+.+ ++||||||+|+|+... +.
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCc
Confidence 999999999999999999999754 2999999999999999999999999 9999999999999543 57
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+|++|||++...... ......+||+.|+|||++....|+...||||+||++|.|++|..||.+....+...
T Consensus 178 ik~~DFGla~~~~~~---------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPG---------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred EEEeeCCCceEccCC---------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 999999999987652 23556899999999999999999999999999999999999999999876432211
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+... +..+..+.-.+....+.++++.|+..||..|+|+.+++++
T Consensus 249 ------~i~~~-----------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ------AILRG-----------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------HHHcC-----------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 1122223334556778999999999999999999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=290.09 Aligned_cols=239 Identities=24% Similarity=0.444 Sum_probs=205.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEE--ECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGS--FKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~--~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+++ .+|.|-| ..|-.++ +.|+.||||++.. .+.+|++.|+.++|||||+|+.+....
T Consensus 18 GLYDLek-TlG~GHF-------AVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 18 GLYDLEK-TLGRGHF-------AVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ 89 (864)
T ss_pred eeehhhh-hhcCCce-------ehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence 4677766 4999999 6666664 5899999999853 467899999999999999999999888
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-CCCcEEEcc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-TNLRAKITN 505 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~D 505 (669)
..+|||+|.-++|+|.||+.++. ..|.+....+++.||..|+.|+|+.+ +|||||||+||.+- +-|-+|+.|
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeee
Confidence 89999999999999999998763 45999999999999999999999999 99999999999875 458899999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVIT-PKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||++-.+..+. .....+|...|-|||.+.+..|. ++.||||+||+||-|++|+.||...++.
T Consensus 163 FGFSNkf~PG~---------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------- 225 (864)
T KOG4717|consen 163 FGFSNKFQPGK---------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------- 225 (864)
T ss_pred ccccccCCCcc---------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------
Confidence 99998876543 23457899999999999998885 6799999999999999999999865543
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+.+..++|..+ ..|..+..+..+||..||..||.+|-+.+||+.
T Consensus 226 -----------ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 226 -----------ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----------hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 33555666654 467778888999999999999999999999874
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=287.14 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=189.3
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++.|.| |.||+|.. +|..++||.++. .+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 l~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 8 IGEGTY-------GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ecCCCc-------eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 788999 99999987 478899998752 367899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 6899998754 2356899999999999999999999998 999999999999999999999999998865432
Q ss_pred ccccCCcccceeeecccccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh-
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN- 593 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 593 (669)
.. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||.+....+ ...... ..+....
T Consensus 154 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~ 222 (284)
T cd07860 154 VR--------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDE 222 (284)
T ss_pred cc--------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCCh
Confidence 11 112235678899999887644 5889999999999999999999998654321 111111 1110000
Q ss_pred -----------HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 -----------VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 -----------~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
............+. .........+.+++.+||+.||.+|||++|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 223 VVWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000 0011234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=292.37 Aligned_cols=257 Identities=24% Similarity=0.319 Sum_probs=198.3
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.++.|.| |.||++... ++.|++|.++. .+.+|+++++.++||||+++++.+..++..++||
T Consensus 8 ~l~~g~~-------~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 8 LISNGAY-------GAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred EeecCCC-------eeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3789999 999999884 67899998753 2457999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.+++... +.+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 999999999999754 35899999999999999999999998 9999999999999999999999999987422
Q ss_pred CCcccc-------CCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 514 SDEHEQ-------GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 514 ~~~~~~-------~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
...... ............++..|+|||.+.+..++.++|+||||+++|||++|+.||.+....+ .. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~----~ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LF----G 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----H
Confidence 111000 0000011122457889999999999999999999999999999999999998654321 10 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDP 655 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 655 (669)
.... .....+.. +...+..+.+++.+||+.||.+||++.++.+.|+.-+-...+|..
T Consensus 227 ~~~~--------~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 227 QVIS--------DDIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred HHHh--------cccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 0000 00111111 113445689999999999999999988888877776555566654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.04 Aligned_cols=238 Identities=26% Similarity=0.411 Sum_probs=200.5
Q ss_pred HHHHhCCCCcccceeeEEEEEEECCC--eeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 365 LKIATGSFSEENRIQGSVYRGSFKGD--DAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 365 l~~~~g~f~~~~~~~G~Vy~g~~~g~--~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+.+|.|.| |+||.|+.... .+|||-+.. -+..|+.+-++++|.|||+++|.|-+++..-+.||-
T Consensus 581 vVLGKGTY-------G~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTY-------GTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EEeecCce-------eEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 45899999 99999998544 568998743 266899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEEcccCCcccc
Q 005923 436 ADNGALSDWLHSNRYQTSDNL--TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGLARSA 512 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DfGla~~~ 512 (669)
++||||.+.|+.. .++| .+..+-.+..||++||.|||++. |||||||-.|||++. .|.+||+|||-++.+
T Consensus 654 VPGGSLSsLLrsk----WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSK----WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred CCCCcHHHHHHhc----cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhh
Confidence 9999999999753 5667 78888899999999999999999 999999999999965 789999999999877
Q ss_pred CCCccccCCcccceeeecccccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG--VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
..- ...+....||.-|||||++..+ .|..++|||||||++.||.||+.||.......+.+ .++
T Consensus 727 Agi--------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-----FkV-- 791 (1226)
T KOG4279|consen 727 AGI--------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-----FKV-- 791 (1226)
T ss_pred ccC--------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-----hhh--
Confidence 542 2456778999999999999874 58899999999999999999999998543322111 000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
++ -..+.+.|+++..+...++.+|+..||.+||++.++++-
T Consensus 792 ---------Gm--yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 792 ---------GM--YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ---------cc--eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 01 133578899999999999999999999999999999863
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.61 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=190.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
++|.|.| |.||++..+ ++.+|+|.+.. .+.+|++++++++||||+++++++..++..++|||
T Consensus 8 ~lg~g~~-------~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 8 LVGEGSY-------GMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred eeccCCC-------eEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4899999 999999984 78899998642 35689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.++.... ..++|.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999998877543 34899999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.+|......+ ....+........
T Consensus 153 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~ 221 (286)
T cd07846 153 PGE--------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLI 221 (286)
T ss_pred Ccc--------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCc
Confidence 321 1223457889999999875 457889999999999999999998887544321 1111111111100
Q ss_pred HH--h------hhhcccCCccCCC-----CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 VR--E------KLRGFIDPSLRNE-----YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~~--~------~l~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. + .......+..... .....+..+.+++.+||+.||.+||++.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 0 0000001111000 012345678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.49 Aligned_cols=239 Identities=24% Similarity=0.451 Sum_probs=191.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcC---CCCceeEeeEEEec
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKIN---HSNIIRLSGFCVHE 426 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~---H~niv~l~g~~~~~ 426 (669)
|+..+ .++.|.| |.||+|.. .+..+++|.++. ++.+|+.++++++ |||++++++++..+
T Consensus 3 y~~~~-~l~~g~~-------g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 3 YQRLE-LIGRGAY-------GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhh-heeccCC-------ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 44444 4899999 99999997 478899998742 3667999999997 99999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
...++||||+++++|.++++.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccC
Confidence 9999999999999999998643 5899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
|++........ ......|+..|+|||.+.++ .++.++||||||+++|||++|+.||.+...... .
T Consensus 146 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~ 211 (277)
T cd06917 146 GVAALLNQNSS--------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M 211 (277)
T ss_pred CceeecCCCcc--------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h
Confidence 99987654321 11234688899999998754 468999999999999999999999975432110 0
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+.....+.+.. ...+.++.+++.+||+.||.+||++.|++..
T Consensus 212 ----------~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 212 ----------MLIPKSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----------hccccCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0010111111111 1144578999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=287.52 Aligned_cols=243 Identities=24% Similarity=0.452 Sum_probs=190.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeEEEe---
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGFCVH--- 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~~~~--- 425 (669)
..|++.+ .+|+|.| |.||+|.. .++.+|+|.+.. ++..|+.+++++ +|+||+++++++..
T Consensus 16 ~~~~~~~-~lg~g~~-------~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 16 GIFELVE-VVGNGTY-------GQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhe-eeccCCC-------eEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 3555555 4899999 99999998 467899998742 456788999998 79999999999863
Q ss_pred ---cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 426 ---EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 426 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
....+++|||+++|+|.+++...+ ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 356799999999999999997643 345889999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
|+|||+++....... ......|+..|+|||.+. ...++.++||||||+++|||++|+.||.......
T Consensus 162 l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 162 LVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred EeeCcchhhhhcccc--------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999886532211 112346888999999986 3567889999999999999999999997543211
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. .. +.....+.. .....+..+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~------~~----------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 AL------FL----------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hh------hh----------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00 000011111 11234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.77 Aligned_cols=267 Identities=18% Similarity=0.303 Sum_probs=193.7
Q ss_pred HHHhC--CCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 366 KIATG--SFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g--~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
++|.| +| |+||++.. .|+.||+|.++. .+.+|+.+++.++||||++++++|..++..++|
T Consensus 5 ~ig~g~~~~-------~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 5 EIGRGFCNL-------TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HhCCcccCc-------eeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence 46666 77 89999987 589999999752 256788999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+.+|+|.+++.+.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++||+.+...
T Consensus 78 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 78 SPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999999999997642 235899999999999999999999998 999999999999999999999999866543
Q ss_pred CCCccccCCcccceeeecccccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH--
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG--VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV-- 588 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-- 588 (669)
........ ..........++..|+|||++.+. .++.++||||||+++|||++|+.||......... ...+...
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~ 228 (328)
T cd08226 152 VRNGQKAK-VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPY 228 (328)
T ss_pred hccCcccc-ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCC
Confidence 22111000 000011112356679999999763 4789999999999999999999999754322111 0000000
Q ss_pred --------------Hhhh--hH-----Hhh-----hhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 --------------LEES--NV-----REK-----LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 --------------~~~~--~~-----~~~-----l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... .. ... .....+..++...+..+...+.+|+++||+.||.+|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 00 000 001111222333345567789999999999999999999999754
Q ss_pred --HHHhhc
Q 005923 643 --LSKIWS 648 (669)
Q Consensus 643 --L~~i~~ 648 (669)
+..+..
T Consensus 309 ~~~~~~~~ 316 (328)
T cd08226 309 AFFKQVKE 316 (328)
T ss_pred HHHHHHHH
Confidence 455544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.60 Aligned_cols=244 Identities=24% Similarity=0.392 Sum_probs=194.8
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
+|+|+| |.||+|.. ++..+++|++.. ++.+|+++++.++|+|++++++.+..++..++|||++
T Consensus 9 lg~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 9 IGVGAT-------AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred ecCCCC-------eEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 899999 99999987 567899998752 3678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++++|.++++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 82 SGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999997642 2246899999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
... ........|+..|+|||.+... .++.++|+||||+++|||++|+.||....... ........
T Consensus 157 ~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~---- 222 (267)
T cd06610 157 DRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN---- 222 (267)
T ss_pred ccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC----
Confidence 210 0122334688899999999877 78999999999999999999999997543211 01111110
Q ss_pred hhhhcccCCccCCCC-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEY-PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+.+.... ....+..+.+++.+||+.||.+||++.|+++.
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 ------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111111 12445678999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.52 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=189.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|...+ .+|.|+| |.||++.. .+..||||.++. .+.+|++++++++||||+++++++...
T Consensus 15 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 15 ERYQNLT-PVGSGAY-------GSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhe-ecccCCC-------eEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 3455544 4899999 99999987 467899999853 245799999999999999999987543
Q ss_pred ------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 ------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~ 156 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCE 156 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCC
Confidence 3468999988 6799988854 24899999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.
T Consensus 157 ~kl~Dfg~~~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~- 224 (343)
T cd07878 157 LRILDFGLARQADDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ- 224 (343)
T ss_pred EEEcCCccceecCCCc-----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-
Confidence 9999999998654321 22468899999999877 5689999999999999999999999976443211
Q ss_pred HHHHHHHHHHhhhhH-------HhhhhcccCC--ccCC----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HH
Q 005923 580 LLYASISRVLEESNV-------REKLRGFIDP--SLRN----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LS 644 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~-------~~~l~~~~d~--~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~ 644 (669)
...+......... .+..+.++.. .... .........+.+|+.+||+.||.+|||+.|++.+ +.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 225 --LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred --HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 1111111110000 0000000000 0000 0001123457899999999999999999999965 44
Q ss_pred Hh
Q 005923 645 KI 646 (669)
Q Consensus 645 ~i 646 (669)
+.
T Consensus 303 ~~ 304 (343)
T cd07878 303 QY 304 (343)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.74 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=193.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+ .+|.|.| |.||+|..+ +..+++|.++. .+.+|++++++++||||+++++++..+
T Consensus 5 ~~y~~~~-~lg~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 5 DEYEKLN-RIEEGTY-------GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhh-hhcCCCC-------eEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 3455544 4899999 999999985 67899998852 245799999999999999999999877
Q ss_pred --CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 427 --GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 427 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+..++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+
T Consensus 77 ~~~~~~lv~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 77 NLDKIYMVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred CCCcEEEEehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEe
Confidence 78999999997 49999987642 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|||+++....... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+. ..
T Consensus 149 d~g~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~ 217 (293)
T cd07843 149 DFGLAREYGSPLK--------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LN 217 (293)
T ss_pred ecCceeeccCCcc--------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HH
Confidence 9999987654321 11223567889999998764 468999999999999999999999986543211 11
Q ss_pred HHHHHHhhhhH--H-----------hhhhcccCCccCCCCcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 584 SISRVLEESNV--R-----------EKLRGFIDPSLRNEYPLD-LAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 584 ~~~~~~~~~~~--~-----------~~l~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+...+..... . ..........+...++.. ....+.+++.+||+.||++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 218 KIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111110000 0 000000111112222222 4567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=287.98 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=190.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|.+.+ .+|.|.| |.||+|.. +++.+|+|.++. .+.+|++++++++|+||+++++++..++.
T Consensus 6 ~y~~~~-~lg~g~~-------~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 6 TYKKLD-KLGEGSY-------ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT 77 (291)
T ss_pred ceeEEE-EEeecCC-------eEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCe
Confidence 344444 3899999 99999987 478899998853 24679999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+.+ +|.+++.+.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccc
Confidence 9999999985 9999987542 36899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....... ...+..
T Consensus 150 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~ 219 (291)
T cd07844 150 ARAKSVPSK--------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFR 219 (291)
T ss_pred ccccCCCCc--------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHH
Confidence 876432211 1112346788999999875 55899999999999999999999999754421111 111111
Q ss_pred HHhhhhHHh-----hhhcccC--------CccCCCC-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVRE-----KLRGFID--------PSLRNEY-PLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~~-----~l~~~~d--------~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+....... ....... ..+.... .......+.+++.+||+.||.+|||+.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 220 VLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 111100000 0000000 0000000 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=321.27 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=189.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec-
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~- 426 (669)
.|.+.+ ++|.|.| |.||++... +..+|+|.++. .+..|+.+|++++|||||+++++|...
T Consensus 14 ~YeIl~-kLG~GgF-------GtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 14 EYEVIK-KIGNGRF-------GEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CEEEEE-EEecCCC-------eEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 455555 3899999 999999984 66789998752 366899999999999999999988654
Q ss_pred -CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeeCCCCCCeeecCC---
Q 005923 427 -GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN----PPYVHKNLKTSNILLDTN--- 498 (669)
Q Consensus 427 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~ivHrDik~~NILl~~~--- 498 (669)
...||||||+++|+|.++|.... .....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 46899999999999999997532 223469999999999999999999998542 349999999999999642
Q ss_pred --------------CcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHH
Q 005923 499 --------------LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLE 562 (669)
Q Consensus 499 --------------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~e 562 (669)
..+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc---------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 358999999998664321 1233578999999999864 458999999999999999
Q ss_pred HHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 563 LLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 563 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
|++|+.||........ . + .. +... +.+. ....+..+.+||..||+.+|.+||++.|++.
T Consensus 236 LLTGk~PF~~~~~~~q--l---i-~~---------lk~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 236 LCSGKTPFHKANNFSQ--L---I-SE---------LKRG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHCCCCCCcCCcHHH--H---H-HH---------HhcC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999975443211 0 0 00 1000 0110 0123456899999999999999999999984
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=286.39 Aligned_cols=252 Identities=27% Similarity=0.372 Sum_probs=192.4
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.+|.|.| |.||+|.. +|+.+++|+++. ++.+|+.++++++|+||+++++++..+...++|||
T Consensus 7 ~l~~g~~-------~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 7 RIGEGAH-------GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred ecccCCC-------cEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 3899999 99999997 478899999852 36689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+ +++|.+++.... ..+++.+++.++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 80 ~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 80 YM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred cc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 99 999999997542 56999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .......++..|+|||.+.+. .++.++||||+|++++||++|..+|.+..+.+. ...+...+....
T Consensus 152 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~ 221 (286)
T cd07832 152 EEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPN 221 (286)
T ss_pred CCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCC
Confidence 321 112335688899999998654 468999999999999999999877765443211 111111111100
Q ss_pred H--Hhhhh------cccCCccC----CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 V--REKLR------GFIDPSLR----NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~--~~~l~------~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ...+. ....+... .....+....+.+++.+||+.||.+||++++++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000 00000000 00111334778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=288.88 Aligned_cols=237 Identities=27% Similarity=0.424 Sum_probs=190.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.++.|+| |.||++.. ++..+|+|.+.. ++.+|++++++++|+|++++++++.++...++||
T Consensus 32 ~lg~G~~-------~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 32 EIGHGSF-------GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred eeccCCC-------eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4899999 99999987 477899998752 3667999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+. |+|.+++... ...++|.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 105 EYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred eCCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 9997 5888888653 245899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
.. ....++..|+|||.+. .+.++.++||||||+++|||++|+.||........ ... ...
T Consensus 177 ~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~~~ 238 (317)
T cd06635 177 PA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH----IAQ 238 (317)
T ss_pred Cc------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHH----HHh
Confidence 22 1235788899999974 46789999999999999999999999876432111 000 000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
.......+......+.+++.+||+.+|.+||++.+++..+-.+..
T Consensus 239 -------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 239 -------------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 000011122344568999999999999999999999987654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=298.51 Aligned_cols=234 Identities=29% Similarity=0.458 Sum_probs=195.4
Q ss_pred hhHH-HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec----------ccHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 362 FQDL-KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK----------GDVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 362 ~~~l-~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
|.++ +||.|+| |.||.+.. +.+.||||+|. .|+.+|+..|.+++|||.+.+-|+|..+..
T Consensus 28 f~dLrEIGHGSF-------GAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHhcCCcc-------ceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence 3344 5999999 99999987 57789999994 368899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.|||||||- ||-.|.|.-++ ++|.+..+..|+.+.+.||+|||+++ .||||||+.|||+.+.|.+|++|||.
T Consensus 101 aWLVMEYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 101 AWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred HHHHHHHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccc
Confidence 999999996 58888886543 56999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
|...... +.++||+.|||||++. .+.|+-++||||+|++..||.-.+.|++..+... .++..
T Consensus 173 Asi~~PA------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYHI- 237 (948)
T KOG0577|consen 173 ASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI- 237 (948)
T ss_pred hhhcCch------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHHH-
Confidence 9876543 3478999999999985 5889999999999999999999999998765421 11111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
...-.|.+. ..+-...++.++..||++-|.+|||.++++.
T Consensus 238 -------------AQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 238 -------------AQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -------------HhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111122222 2244567899999999999999999998765
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=284.23 Aligned_cols=245 Identities=26% Similarity=0.486 Sum_probs=191.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeEEEecC--
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGFCVHEG-- 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~~~~~~-- 427 (669)
.|++.+ .++.|.| |.||+|..+ ++.+++|.++. ++.+|+.+++++ +|+||+++++++....
T Consensus 7 ~y~~~~-~l~~g~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 7 IFELVE-VIGEGTY-------GKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred heehee-eecCCCC-------eEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 355544 3899999 999999984 67899998753 477899999999 7999999999997654
Q ss_pred ----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 428 ----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 428 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
..++||||+++++|.+++...+ .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEE
Confidence 4799999999999999987532 12356899999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
+|||++........ ......++..|+|||.+.. ..++.++||||||++++||++|+.||.......
T Consensus 155 ~d~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~- 225 (275)
T cd06608 155 VDFGVSAQLDSTLG--------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR- 225 (275)
T ss_pred CCCccceecccchh--------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-
Confidence 99999976543221 1123467889999998853 346789999999999999999999997533211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. ... ... ..+. ...+......+.+++.+||..||.+|||+.|+++
T Consensus 226 -~~----~~~---------~~~-~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 -AL----FKI---------PRN-PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -HH----HHh---------hcc-CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 000 000 0011 1222335567899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.97 Aligned_cols=240 Identities=28% Similarity=0.483 Sum_probs=191.1
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.+++|.| |.||+|.. ++..+++|.++. .+.+|++++++++|+||+++++++...+..++|+|
T Consensus 7 ~lg~G~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 7 KIGGGTF-------GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred EeecCCC-------cEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 3899999 99999987 477899999753 35679999999999999999999998999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 80 YCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred cCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999999754 34889999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeecccccccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV---ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ..... .
T Consensus 152 ~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~----~--- 219 (264)
T cd06626 152 NTTTMG----EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFH----V--- 219 (264)
T ss_pred CCCccc----ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHH----H---
Confidence 332110 1122346788999999998766 8999999999999999999999997543211 11000 0
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.....+.+ +........+.+++.+||+.||.+||++.|++.
T Consensus 220 -------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 -------GAGHKPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -------hcCCCCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111 111123567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.11 Aligned_cols=233 Identities=23% Similarity=0.333 Sum_probs=183.6
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHHHh---cCCCCceeEeeEEEecCceeE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINILKK---INHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~l 431 (669)
+|.|+| |.||++.. ++..+|+|.++.. +..|..+++. .+|+|++.+++++..++..++
T Consensus 2 lg~G~~-------g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (279)
T cd05633 2 IGRGGF-------GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF 74 (279)
T ss_pred cccCCC-------eEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence 688999 99999987 4788999987531 2234333333 479999999999998899999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++..+ +.+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 75 v~e~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 75 ILDLMNGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999999754 35999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
..... .....|+..|+|||.+.+ ..++.++||||||++++||++|..||........... ...
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~-- 210 (279)
T cd05633 147 FSKKK----------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRM-- 210 (279)
T ss_pred ccccC----------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHH--
Confidence 53221 122468999999999864 5689999999999999999999999975432111110 000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
.. ......+...+.++.+++.+||+.||.+|| ++.|++++
T Consensus 211 --------~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 211 --------TL----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --------hh----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00 111223444566789999999999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.31 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=190.1
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|.|.+ |.||+|.. +|..+++|+++. .+.+|++++++++|+|++++++++.+++..+++|||
T Consensus 7 l~~g~~-------~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 7 IGEGTY-------GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred ecCCCC-------eEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 788999 99999987 588999998752 366899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
++ ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 80 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 80 LD-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred cC-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 95 69999997642 246899999999999999999999998 999999999999999999999999999765332
Q ss_pred ccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh--
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES-- 592 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 592 (669)
.. ...+..++..|+|||++.+. .++.++||||||+++|||++|+.||.+...... ... +.......
T Consensus 153 ~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~ 221 (283)
T cd07835 153 VR--------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDE 221 (283)
T ss_pred cc--------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCh
Confidence 11 11223567899999988764 578999999999999999999999986543221 111 11110000
Q ss_pred ----------hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 593 ----------NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 593 ----------~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.............. ..........+.+++.+||+.||.+|||++|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHhhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000111110111 11122334578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.59 Aligned_cols=241 Identities=24% Similarity=0.416 Sum_probs=194.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ .+|.|.| |.||++.. +++.+++|.+.. .+.+|+.++++++||||+++++++..++..
T Consensus 20 ~~~~~~-~lg~g~~-------g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 20 KYTRFE-KIGQGAS-------GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hceeee-EecCCCC-------eEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 344443 3899999 99999986 577899998753 356799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++|+||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred EEEEecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcce
Confidence 9999999999999999753 4789999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
........ ......++..|+|||.+.+..++.++||||||+++||+++|+.||......+... .
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~-- 226 (293)
T cd06647 163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------L-- 226 (293)
T ss_pred eccccccc--------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------e--
Confidence 76543221 1123467889999999999899999999999999999999999997543211000 0
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+ ...+......+......+.+++.+||+.+|.+||++++++.+
T Consensus 227 --------~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 227 --------I--ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --------h--hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000111111233445678999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.75 Aligned_cols=235 Identities=29% Similarity=0.457 Sum_probs=192.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
|.+.+ .++.|+| |.||++.. .++.+|+|.++. .+.+|++++++++||||+++++++.+++
T Consensus 3 y~~~~-~ig~g~~-------~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (290)
T cd05580 3 FEFIK-TLGTGSF-------GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS 74 (290)
T ss_pred eEEEE-EeecCCC-------eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence 33433 3899999 99999998 478899998853 2567999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+|||+++++.+||+|||
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999999754 46899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++..... .....++..|+|||.+.+...+.++||||||+++|||++|+.||....... ....
T Consensus 147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~--- 209 (290)
T cd05580 147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEK--- 209 (290)
T ss_pred CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---
Confidence 99876432 123467889999999998889999999999999999999999997544211 0000
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
. ... ....+......+.+++.+||..||.+|+ +++|++..
T Consensus 210 ~-------------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 I-------------LEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred H-------------hcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 000 1123334456789999999999999999 77777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=291.15 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=190.8
Q ss_pred HHhCCCCcccceeeEEEEEEE----CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec--Ccee
Q 005923 367 IATGSFSEENRIQGSVYRGSF----KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE--GNTY 430 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~----~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 430 (669)
+|.|.| |.||+|.. .+..+|+|.++. .+.+|+.++++++||||+++++++... +..+
T Consensus 8 ig~g~~-------g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 8 IGRGTY-------GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred eccCCc-------EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 889999 99999998 457899999865 356799999999999999999999987 7899
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC----CCcEEEccc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT----NLRAKITNF 506 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~----~~~~kl~Df 506 (669)
+||||+++ +|.+++..........+++..++.++.|++.||+|||+.+ ++||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7888876543333347899999999999999999999999 999999999999999 999999999
Q ss_pred CCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH------HH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCE------AE 579 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~------~~ 579 (669)
|+++........ ........++..|+|||.+.+ ..++.++||||||++++||++|+.||.+..... ..
T Consensus 157 g~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 157 GLARLFNAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred ccccccCCCccc-----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 999876433210 111223467889999998876 457999999999999999999999997543321 00
Q ss_pred HHHHHHHHHHhhhhHH--h------hhhcccCCccCCCCc---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005923 580 LLYASISRVLEESNVR--E------KLRGFIDPSLRNEYP---------L--DLAFSMAQLAKNCTAHDLNARPSISEVF 640 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~--~------~l~~~~d~~l~~~~~---------~--~~~~~l~~li~~Cl~~dP~~RPt~~evl 640 (669)
.....+...+...... . ......+......++ . .....+.+++.+||+.||.+|||+.|++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0111111111100000 0 000000000001111 1 2345688999999999999999999998
Q ss_pred HH
Q 005923 641 VT 642 (669)
Q Consensus 641 ~~ 642 (669)
.+
T Consensus 312 ~~ 313 (316)
T cd07842 312 EH 313 (316)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=281.02 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=191.8
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHH-HhcCCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINIL-KKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++.|.| |.||+|.. .|+.+|+|.++.. +..|..++ ...+|+|++++++++..++..++|+
T Consensus 4 l~~g~~-------~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 4 ISKGAF-------GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred CCcCCC-------eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 788999 99999988 4789999998531 22343333 3458999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 77 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999999999754 35899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
.. ....++..|+|||.+.+..++.++||||||+++|||++|..||........ ... ...
T Consensus 149 ~~------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~---~~~--- 207 (260)
T cd05611 149 EN------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDN---ILS--- 207 (260)
T ss_pred cc------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHH---HHh---
Confidence 21 123577889999999988899999999999999999999999976543211 100 000
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 654 (669)
.. . .........++..+.+++.+||+.||.+||++.++.+.|+.-+-...+||
T Consensus 208 --~~----~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 208 --RR----I--NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred --cc----c--CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 00 0 01111222345678999999999999999988777766665555666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=282.80 Aligned_cols=235 Identities=24% Similarity=0.428 Sum_probs=190.4
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++.|+| |.||+|..+ |..+|+|.+.. .+.+|++++++++|+||+++++.+..++..++|+||
T Consensus 8 l~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 8 IGEGSF-------GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ecCCCc-------ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 788999 999999984 67899998742 356899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfGla~~~~~ 514 (669)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999997542 235899999999999999999999999 99999999999998885 569999999987643
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+......+ .+...
T Consensus 155 ~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~------ 214 (257)
T cd08225 155 SM--------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKI------ 214 (257)
T ss_pred Cc--------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH------
Confidence 22 11223468889999999998899999999999999999999999987543211 11111
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...... ..+...+..+.+++.+||+.+|.+|||+.|++..
T Consensus 215 ---~~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 ---CQGYFA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---hcccCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111111 1112334568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=283.43 Aligned_cols=243 Identities=28% Similarity=0.466 Sum_probs=196.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.|+... .+++|.| |.||+|..+ +..+++|+++. .+.+|++++++++|+|++++++++..++..+
T Consensus 20 ~~~~~~-~l~~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 20 LYKNLE-KIGEGAS-------GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred cchHhH-hccCCCC-------eEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 355554 4899999 999999985 78899999863 4678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 9999999999999998652 36999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
....... ......++..|++||.+.+..++.++||||||+++|||++|+.|+.......... ....
T Consensus 165 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~~~ 230 (286)
T cd06614 165 QLTKEKS--------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LITT 230 (286)
T ss_pred hhccchh--------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh
Confidence 6543221 1122457789999999999899999999999999999999999987544321100 0000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... + ....+..++..+.+++.+||+.+|.+||++.++++.
T Consensus 231 ---------~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 231 ---------KGI-P--PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---------cCC-C--CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0 011122245678999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=285.09 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=189.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|.+.+ ++|.|.| |.||+|.. ++..+++|.++. .+.+|++++++++|+||+++.+++..++.
T Consensus 6 ~y~~~~-~ig~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 6 SYLNLE-KLGEGSY-------ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET 77 (291)
T ss_pred eeEEEE-EEEecCC-------EEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence 344444 3899999 99999987 478999998853 35689999999999999999999998889
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+. ++|.+++... ...+.+.++..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccc
Confidence 999999996 6888887643 235788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.+..+.. +.+ ..+..
T Consensus 150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~-~~~~~ 219 (291)
T cd07870 150 ARAKSIPSQ--------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQL-EKIWT 219 (291)
T ss_pred ccccCCCCC--------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHH-HHHHH
Confidence 986533211 11223568899999998764 57899999999999999999999997544321 111 11111
Q ss_pred HHhhhh--H---HhhhhcccCCccCCCCc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESN--V---REKLRGFIDPSLRNEYP---------LDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~--~---~~~l~~~~d~~l~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+.... . ...+............+ ......+.+++.+|++.||.+|||+.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 110000 0 00000000000000000 012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.76 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=188.1
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcC-CCCceeEeeEEEecCc-----e
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKIN-HSNIIRLSGFCVHEGN-----T 429 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----~ 429 (669)
+|.|.| |.||+|.. +++.||+|..+. .+.+|+.++++++ |+||+++++++...+. .
T Consensus 9 lg~g~~-------g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 9 IGEGTY-------GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred ecccCC-------eEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 899999 99999998 478899998752 3567999999995 6999999999987665 7
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEEcccCC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGL 508 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DfGl 508 (669)
++||||+++ +|.+++..........+++..++.++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 8999987653222456899999999999999999999998 999999999999998 89999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|..||.+....+. .. .+..
T Consensus 158 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~-~~~~ 226 (295)
T cd07837 158 GRAFSIPVK--------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LL-HIFK 226 (295)
T ss_pred ceecCCCcc--------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH-HHHH
Confidence 986533211 1122356788999998865 4579999999999999999999999986543221 11 1111
Q ss_pred HHhhhhHH-----hhhhcccC-CccCC----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVR-----EKLRGFID-PSLRN----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~-----~~l~~~~d-~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+...... ..+..... +.... ........++.+++.+||+.||.+||+++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11100000 00000000 00000 001134567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=279.00 Aligned_cols=272 Identities=25% Similarity=0.356 Sum_probs=201.7
Q ss_pred cccccccchhHHHHHhCCCCcccceeeEEEEEEEC------CCeeEEEEeccc---------HHHHHHHHHhcCCCCcee
Q 005923 354 VESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK------GDDAAVKVMKGD---------VSSEINILKKINHSNIIR 418 (669)
Q Consensus 354 ~~~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~------g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~ 418 (669)
++.+..|+.-. ++|.|.| |.||+++-. ...+|+|.++.+ ..+|+.+++.++||||+.
T Consensus 20 ve~l~~ye~ig-~Ig~GTY-------G~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~ 91 (438)
T KOG0666|consen 20 VEDLFEYEGIG-KIGRGTY-------GKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVIS 91 (438)
T ss_pred HHHHHHhhccc-eeccccc-------ceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchh
Confidence 44444443322 3899999 999999652 236899998754 568999999999999999
Q ss_pred EeeEEEe-cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 419 LSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 419 l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
|..++.. +...+|++||+++ +|...++.++....+.++...+..|++||++|+.|||++- |+||||||.|||+..
T Consensus 92 Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmg 167 (438)
T KOG0666|consen 92 LVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMG 167 (438)
T ss_pred HHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEec
Confidence 9999987 7789999999998 9999998887666678999999999999999999999998 999999999999987
Q ss_pred C----CcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 005923 498 N----LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTG 572 (669)
Q Consensus 498 ~----~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~ 572 (669)
+ |++||+|||++|.+...-.. ......++-|.+|+|||.+.+ ..||++.|||+.||++.||++-+..|.+
T Consensus 168 dgperG~VKIaDlGlaR~~~~plkp-----l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 168 DGPERGRVKIADLGLARLFNNPLKP-----LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cCCccCeeEeecccHHHHhhccccc-----cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 7 99999999999987654321 112344678999999999988 5699999999999999999999888876
Q ss_pred CchhH------HHHHHHHHHHHHhhhhHH--hhhhcccCC---------ccCCCCc--------HHHHHHHHHHHHHhcc
Q 005923 573 DQNCE------AELLYASISRVLEESNVR--EKLRGFIDP---------SLRNEYP--------LDLAFSMAQLAKNCTA 627 (669)
Q Consensus 573 ~~~~~------~~~~~~~~~~~~~~~~~~--~~l~~~~d~---------~l~~~~~--------~~~~~~l~~li~~Cl~ 627 (669)
....- .......+..++..+... ..++.+-+- ....... ..-....++|+.++|.
T Consensus 243 ~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~ 322 (438)
T KOG0666|consen 243 REEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT 322 (438)
T ss_pred hhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc
Confidence 43210 011223333333322211 111111110 0000000 0001226799999999
Q ss_pred cCCCCCCCHHHHHHH
Q 005923 628 HDLNARPSISEVFVT 642 (669)
Q Consensus 628 ~dP~~RPt~~evl~~ 642 (669)
.||.+|.|+++.++.
T Consensus 323 yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 323 YDPIKRITAEQALEH 337 (438)
T ss_pred cCchhhccHHHHhcc
Confidence 999999999998865
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=283.77 Aligned_cols=234 Identities=25% Similarity=0.432 Sum_probs=191.0
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
.+|.|.| |.||++.. .+..+++|.++. .+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 26 ~lg~g~~-------g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 26 KIGEGST-------GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred EeccCCC-------eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 4899999 99999986 467899998742 3567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++++|.+++... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 99 EGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred CCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999999752 4899999999999999999999999 9999999999999999999999999987654322
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. ...
T Consensus 170 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~--------- 226 (285)
T cd06648 170 P--------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKR--------- 226 (285)
T ss_pred c--------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHH---------
Confidence 1 11234678899999999988899999999999999999999999876442111 100
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+.....+.+. .+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 227 -~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 227 -IRDNLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -HHhcCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1111111111 11224467899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=285.16 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=187.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 434 (669)
++|.|+| |.||++.. .+..+|+|.++. .+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 11 ~lg~G~~-------g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 11 EIGRGAF-------GTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhCCCCc-------eEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4899999 99999998 478899998853 3567999999996 9999999999998889999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
|+.. +|.++...........+++..+.+++.|++.||+|||+. + ++||||||+||++++++.+||+|||+++...
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 665544221001235699999999999999999999974 7 9999999999999999999999999997654
Q ss_pred CCccccCCcccceeeecccccccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG---VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
.... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ....+....
T Consensus 160 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~- 224 (288)
T cd06616 160 DSIA---------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV- 224 (288)
T ss_pred cCCc---------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-
Confidence 3211 1223578899999999876 689999999999999999999999874321 001111110
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+.+....+...+.++.+|+.+||+.||.+|||++||+..
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 ---------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111222222233456679999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=282.42 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=190.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec--CceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE--GNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 433 (669)
++|.|.| |.||++.. .++.+|+|.+.. ++.+|++++++++||||++++++|... +..++||
T Consensus 8 ~lg~g~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 8 RLGEGAG-------GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred EeccCCc-------eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3789999 99999998 467899998753 367899999999999999999998654 3689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999886532 23356899999999999999999999999 9999999999999999999999999987653
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+......
T Consensus 157 ~~~----------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---- 221 (287)
T cd06621 157 NSL----------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIV---- 221 (287)
T ss_pred ccc----------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHh----
Confidence 321 112356788999999999999999999999999999999999997542100 00001110000
Q ss_pred HHhhhhcccCCccCCCCc--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYP--LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..-.+.+....+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 222 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 222 ------NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ------cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000011111111 2345678999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=282.04 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=190.0
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+++.|.| |.||+|.. +|..+|+|.++. .+.+|++++++++|+||+++++++...+..++||||
T Consensus 7 ~l~~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 7 KLGEGTY-------ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred eeccCCc-------eEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4789999 99999998 478899998753 345799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++ +|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 80 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 985 8999987542 2346899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh-
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN- 593 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 593 (669)
.. ......++..|++||.+.+ ..++.++||||||+++|||++|+.||.+....+. ...+........
T Consensus 154 ~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~ 222 (284)
T cd07836 154 VN--------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTE 222 (284)
T ss_pred cc--------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCh
Confidence 11 1122456888999999866 4578999999999999999999999986543221 111111110000
Q ss_pred -HHhhhhcccCCccCCC-----------CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 594 -VREKLRGFIDPSLRNE-----------YPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 594 -~~~~l~~~~d~~l~~~-----------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
..+.+... +.+... .....+..+.+++.+||+.||.+||++.|+++
T Consensus 223 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 223 STWPGISQL--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhHHHHhcC--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111100 000011 11123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.05 Aligned_cols=238 Identities=22% Similarity=0.390 Sum_probs=184.2
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc--------HHHHHHH-HHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------VSSEINI-LKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~--------~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.+|.|+| |.||++... |+.||+|.++.. +..|+.+ ++.++||||+++++++..++..++|||
T Consensus 8 ~ig~g~~-------g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 8 ELGRGAY-------GVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred EecccCC-------eEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3899999 999999984 789999988642 3345554 556789999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
|++ |+|.+++.... .....+++..++.++.|++.||+|||++ + ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 68998887542 2235699999999999999999999986 7 9999999999999999999999999998653
Q ss_pred CCccccCCcccceeeeccccccccccccccc----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... .......
T Consensus 156 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~ 221 (283)
T cd06617 156 DSV---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVV 221 (283)
T ss_pred ccc---------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHH
Confidence 321 1122467889999999865 456889999999999999999999986422111 0011111
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ...+.+. ....+..+.+++.+||..+|.+||++.++++.
T Consensus 222 ~----------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 222 E----------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred h----------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0011110 11234578999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.86 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=200.7
Q ss_pred HHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc-----------cHHHHHHHHHhc-CCCCceeEeeEEEecCce
Q 005923 367 IATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG-----------DVSSEINILKKI-NHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 429 (669)
+|.|+| |.||++.. +++.+|||.++. .+..|++++.++ +|+||+++++.+..+...
T Consensus 8 ig~G~~-------~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 8 LGTGAY-------GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred eccCCC-------ceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 899999 99999875 356799998853 255799999999 599999999999988899
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999999753 35899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+....... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... .. ..+..
T Consensus 153 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~-~~~~~ 222 (288)
T cd05583 153 KEFLAEEE-------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQ-SEISR 222 (288)
T ss_pred cccccccc-------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hH-HHHHH
Confidence 87543321 1122346788999999987765 7889999999999999999999986432110 00 00000
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDP 655 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 655 (669)
. .... ....+..+...+.+++.+||+.||.+|||+.++.+.|...+-...+|+.
T Consensus 223 ~--------~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 223 R--------ILKS------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred H--------HHcc------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 0 0000 1123334556789999999999999999999999999999888889975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=305.92 Aligned_cols=266 Identities=23% Similarity=0.382 Sum_probs=185.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECC---CeeEE------------------EEec------ccHHHHHHHHHh
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKG---DDAAV------------------KVMK------GDVSSEINILKK 410 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g---~~vav------------------K~~~------~~~~~E~~~l~~ 410 (669)
..|++.+ ++|.|+| |+||++..+. ...++ |.++ ..+.+|+++|++
T Consensus 148 ~~Y~ii~-~LG~G~f-------G~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~ 219 (501)
T PHA03210 148 AHFRVID-DLPAGAF-------GKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR 219 (501)
T ss_pred hccEEEe-EecCCCC-------cceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh
Confidence 3455555 4899999 9999987531 11111 1111 236789999999
Q ss_pred cCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 005923 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490 (669)
Q Consensus 411 l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~ 490 (669)
++|+||+++++++...+..++|+|++. ++|.+++..............++..|+.||+.||+|||+++ |+||||||
T Consensus 220 l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP 295 (501)
T PHA03210 220 LNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKL 295 (501)
T ss_pred CCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 999999999999999999999999995 58888876543222233456678899999999999999999 99999999
Q ss_pred CCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 005923 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV 570 (669)
Q Consensus 491 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~ 570 (669)
+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999987643321 1123357899999999999999999999999999999999988654
Q ss_pred CC-CchhHHHHHHHHHHHHH--hhh--hHHhhhhcccCCc-c---CCCCc-----HHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 571 TG-DQNCEAELLYASISRVL--EES--NVREKLRGFIDPS-L---RNEYP-----LDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 571 ~~-~~~~~~~~~~~~~~~~~--~~~--~~~~~l~~~~d~~-l---~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
.+ ........+...+.... ... .....+..+++.. + ....+ ...+..+.+++.+||+.||.+|||+
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa 448 (501)
T PHA03210 369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA 448 (501)
T ss_pred ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH
Confidence 42 22211122212111110 000 0000111111100 0 00000 1123456788999999999999999
Q ss_pred HHHHHH
Q 005923 637 SEVFVT 642 (669)
Q Consensus 637 ~evl~~ 642 (669)
.|++.+
T Consensus 449 ~elL~h 454 (501)
T PHA03210 449 AELLAL 454 (501)
T ss_pred HHHhhC
Confidence 999864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=286.98 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=187.9
Q ss_pred eEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCC
Q 005923 380 GSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRY 450 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~ 450 (669)
+.||++..+++.+|||+++. .+.+|++++++++|+||+++++++..++..+++|||+++|+|.+++....
T Consensus 16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~- 94 (314)
T cd08216 16 VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF- 94 (314)
T ss_pred EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc-
Confidence 56677777899999999753 36689999999999999999999999999999999999999999998642
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeec
Q 005923 451 QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530 (669)
Q Consensus 451 ~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 530 (669)
...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+........... .........
T Consensus 95 --~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~-~~~~~~~~~ 168 (314)
T cd08216 95 --PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR-VVHDFPKSS 168 (314)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc-ccccccccc
Confidence 235889999999999999999999999 99999999999999999999999999876543221100 001122345
Q ss_pred cccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH----hhhhH---Hhhhh--
Q 005923 531 VGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL----EESNV---REKLR-- 599 (669)
Q Consensus 531 ~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~l~-- 599 (669)
.++..|+|||.+.. ..++.++|+||||+++|||++|+.||....... ...+...... ..... .....
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcc
Confidence 67788999999876 458899999999999999999999998543221 1111111000 00000 00000
Q ss_pred --cccCCc----cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 600 --GFIDPS----LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 600 --~~~d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...++. ...........++.+++.+||+.||.+|||+++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 011111 1112233445678999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=277.79 Aligned_cols=237 Identities=24% Similarity=0.400 Sum_probs=194.0
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
.++.|+| |.||++... ++.+++|.++. .+.+|+..+.+++|+|++++++++..++..++||||
T Consensus 8 ~i~~g~~-------~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 8 VLGQGSS-------GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred eeeecCC-------eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3889999 999999984 78899998753 366899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
+++++|.+++... ..+++..++.++.|++.||+|||+ .+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999754 468999999999999999999999 88 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+........... ..
T Consensus 153 ~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~-------- 213 (264)
T cd06623 153 TLD--------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQ-------- 213 (264)
T ss_pred CCC--------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HH--------
Confidence 321 11234578899999999999999999999999999999999999975432110010 00
Q ss_pred HhhhhcccCCccCCCCcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLD-LAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+..... ...+.. .+..+.+++.+||+.+|.+||++.|+++.
T Consensus 214 --~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 --AICDGPP----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --HHhcCCC----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111111 112223 55678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=279.29 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=187.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc--------HHHHHHHHHhcC-CCCceeEeeEEEec--CceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD--------VSSEINILKKIN-HSNIIRLSGFCVHE--GNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~--------~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV 432 (669)
++|.|.| |.||+|.. ++..+|+|.++.. ..+|+.++.++. |+|++++++++.++ +..++|
T Consensus 6 ~lg~g~~-------~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 6 KIGEGTF-------SEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ecccccc-------ceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 3789999 99999987 4788999988642 236888899885 99999999999887 889999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||++ |+|.+++...+ ..++|..+..++.|++.||+|||+.+ ++||||+|+||++++ +.+||+|||+++..
T Consensus 79 ~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 79 FELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred EecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 99997 58988887542 46899999999999999999999999 999999999999999 99999999999876
Q ss_pred CCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .....++..|+|||.+.. +.++.++|||||||++|||++|+.||.+.+..+. ...+......
T Consensus 150 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~ 217 (282)
T cd07831 150 YSKPP---------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGT 217 (282)
T ss_pred ccCCC---------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCC
Confidence 43221 112357889999997654 5678999999999999999999999986543221 1122111111
Q ss_pred hhH--Hhhh-----hcccCCccCC----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNV--REKL-----RGFIDPSLRN----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~--~~~l-----~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... .... ..+..+.... ......+..+.+++.+||+.||.+||+++|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000 0000 0000000000 0012346789999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=279.31 Aligned_cols=236 Identities=23% Similarity=0.346 Sum_probs=194.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+++.|.| |.||++.. +++.+++|.++. ++.+|++++++++|+||+++.+++..+...++|||
T Consensus 7 ~i~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 7 KLGKGSY-------GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred eecCCCc-------eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 3788999 99999987 467899998753 35679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++.+.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++|||+++....
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 80 YAPFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hcCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999999997632 22356899999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .....++..|++||.+.+..++.++|+||||+++|||++|+.||......+. ..
T Consensus 156 ~~----------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~----------- 211 (256)
T cd08530 156 NM----------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RY----------- 211 (256)
T ss_pred CC----------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-----------
Confidence 31 1224578899999999999999999999999999999999999976542110 00
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. ........+......+.+++.+||+.+|++||++.|+++.
T Consensus 212 --~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 212 --KV----QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --HH----hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0011122334556779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=278.18 Aligned_cols=241 Identities=22% Similarity=0.327 Sum_probs=191.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|.+.+ .++.|.| |.||+|.. ++..+++|.+.. .+.+|++++++++|+||+++++++.+
T Consensus 4 ~~~~~-~lg~g~~-------g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 75 (264)
T cd06653 4 WRLGK-LLGRGAF-------GEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD 75 (264)
T ss_pred eeeee-eEccCCC-------eEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence 44444 3899999 99999987 478899998631 35679999999999999999999876
Q ss_pred c--CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 E--GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
. ...++|+||+++++|.+++... ..+++..+++++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l 147 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKL 147 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 4 4578999999999999999753 34889999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++........ ........++..|+|||.+.+..++.++|+||||+++|||++|+.||......+
T Consensus 148 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------ 216 (264)
T cd06653 148 GDFGASKRIQTICMS-----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------ 216 (264)
T ss_pred Ccccccccccccccc-----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------
Confidence 999999875432110 011223568899999999999889999999999999999999999997533211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+. ...........|......+.+++.+||. +|..||+..+++.
T Consensus 217 ~~~-------------~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 217 AIF-------------KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHH-------------HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000 1111112233455666789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=282.17 Aligned_cols=236 Identities=25% Similarity=0.420 Sum_probs=191.6
Q ss_pred HHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 365 LKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 365 l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
.++|.|.| |.||++.. +++.+|+|.+.. .+.+|+.++++++|+|++++++++..++..++||||
T Consensus 26 ~~lg~g~~-------g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 26 IKIGEGST-------GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHcCCCCC-------eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 36899999 99999988 478899998742 366799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 99 LEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 9999999988543 4899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. ......++..|+|||.+.+..++.++|+||||+++|||++|..||.+....+. ...
T Consensus 170 ~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~----------- 227 (292)
T cd06657 170 VP--------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKM----------- 227 (292)
T ss_pred cc--------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-----------
Confidence 21 11234678899999999888899999999999999999999999976443211 000
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.....+.+. .....+..+.+++.+||+.||.+||++.+++..
T Consensus 228 --~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 228 --IRDNLPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --HHhhCCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0111111111 111234567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=276.34 Aligned_cols=237 Identities=30% Similarity=0.474 Sum_probs=195.6
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
++.|+| |.||++... +..+++|.+.. .+.+|++++++++|+|++++.+.+..++..++|+||
T Consensus 8 l~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 8 IGKGSF-------GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred eccCCC-------eEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 789999 999999985 78899999853 266799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.+++.... .....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999998642 12367999999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
. .......++..|+|||.+.+..++.++|+||||+++++|++|+.|+......+ .....
T Consensus 157 ~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~------- 215 (258)
T cd08215 157 V--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKI------- 215 (258)
T ss_pred c--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHH-------
Confidence 2 12233467889999999999999999999999999999999999987543211 00000
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... . ....+......+.+++.+||..+|.+|||+.|+++.
T Consensus 216 --~~~----~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 216 --LKG----Q-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --hcC----C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 122333455678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=282.52 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=190.3
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEec--CceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVHE--GNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 432 (669)
++|.|.| |.||+|... ++.+++|.++.. +.+|++++++++|+|++++++++..+ +..++|
T Consensus 6 ~l~~g~~-------~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 6 QIGEGTY-------GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred EeccCCC-------eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 3788999 999999984 688999998643 66799999999999999999999888 789999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 79 ~e~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 79 FEYMDH-DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred eccccc-cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 999985 899998654 146899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+......
T Consensus 151 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~ 220 (287)
T cd07840 151 TKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGS 220 (287)
T ss_pred cCCCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence 54321 11223456788999998765 467999999999999999999999997654321 11111111111
Q ss_pred hhHH--hhhhc-----------ccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVR--EKLRG-----------FIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~--~~l~~-----------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... ..... .....+.......++..+.+++++||+.||.+||+++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 00000 000000011111125678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=281.20 Aligned_cols=236 Identities=24% Similarity=0.358 Sum_probs=188.2
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |+||++.. +|+.+++|.+.. .+..|++++++++||||+++++++...+..++|||
T Consensus 1 lg~g~~-------g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGF-------GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCc-------eeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEe
Confidence 467889 99999987 478899998742 24579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++.+.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 74 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 74 LMNGGDLKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred cCCCCcHHHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999999999997642 246899999999999999999999999 99999999999999999999999999886543
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
... .....++..|+|||.+.++.++.++||||||++++||++|+.||......... ..+ .
T Consensus 148 ~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~---- 207 (277)
T cd05577 148 GKK---------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EEL----K---- 207 (277)
T ss_pred CCc---------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHH----H----
Confidence 211 12245778899999999888999999999999999999999999754321000 000 0
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFV 641 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 641 (669)
.. ... .....+......+.+++.+||+.||.+|| ++.+++.
T Consensus 208 -~~---~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 208 -RR---TLE--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -hc---ccc--ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00 000 11223334466789999999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=289.06 Aligned_cols=243 Identities=28% Similarity=0.397 Sum_probs=194.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc---------cHHHHHHHHHhcC-CCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG---------DVSSEINILKKIN-HSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~---------~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+- .+||++...+ +.+|+|+... -+..|+..|.+|+ |.+||+|++|-..++
T Consensus 362 ~Yeilk-~iG~GGS-------SkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 362 EYEILK-QIGSGGS-------SKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred hhhHHH-hhcCCCc-------ceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 455544 5899998 7899999854 4567776532 3778999999995 899999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
.+||||||-+. +|..+|++.. .....| .++.+..|++.++.++|+++ |||.||||.|+|+- +|++||+|||
T Consensus 434 ~lYmvmE~Gd~-DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 434 YLYMVMECGDI-DLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred eEEEEeecccc-cHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeec
Confidence 99999999865 9999998753 122335 78889999999999999999 99999999999986 5799999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCchh
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-----------VITPKLDVFAFGVVVLELLSGREAVTGDQNC 576 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~ 576 (669)
+|..+..+.. .......+||..||+||.+... +.+.++||||+||+||+|+.|+.||..-.+
T Consensus 505 IA~aI~~DTT------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n- 577 (677)
T KOG0596|consen 505 IANAIQPDTT------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN- 577 (677)
T ss_pred hhcccCcccc------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-
Confidence 9998876543 2334567999999999999532 256789999999999999999999863221
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDL-AFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...++..++||...-+||.-- ..++.++|+.||+.||.+||+..|+++.
T Consensus 578 -----------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 -----------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 124566778886544555322 2238999999999999999999999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=274.53 Aligned_cols=237 Identities=29% Similarity=0.402 Sum_probs=196.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec--CceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE--GNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 433 (669)
++.|+| |.||+|... +..+++|.++. .+.+|++++++++|+||+++++.+... ...++|+
T Consensus 8 i~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 8 LGRGSF-------GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeecCc-------eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 788999 999999985 78899998753 356899999999999999999999888 7899999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999764 26999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
..... .......++..|+|||.+.+...+.++||||||++++||++|+.||....+.. ..
T Consensus 153 ~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~------------- 212 (260)
T cd06606 153 DIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AA------------- 212 (260)
T ss_pred ccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HH-------------
Confidence 54310 01233567889999999999889999999999999999999999998644211 00
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+............+...+..+.+++.+||+.||.+||++.|++..
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 213 ----LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ----HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 001111112233445557789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=290.12 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=191.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|+..+ .+|.|.| |.||++.. .++.+|+|.++. .+.+|+.++++++|+||+++++++...
T Consensus 16 ~~y~~~~-~lg~g~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 16 KRYQNLK-PIGSGAQ-------GIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred cceEEEE-EeccCCC-------EEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 3455444 4899999 99999987 578999999853 345799999999999999999998643
Q ss_pred ------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 ------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
...++||||+. ++|.+++... +++..+..++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 88 KSLEEFQDVYLVMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred CCccccCcEEEEEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCC
Confidence 34699999996 5898888532 889999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 157 ~kL~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-- 225 (353)
T cd07850 157 LKILDFGLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-- 225 (353)
T ss_pred EEEccCccceeCCCCCC---------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH--
Confidence 99999999986543211 1234578899999999999999999999999999999999999986543211
Q ss_pred HHHHHHHHHhhhhH--H----hhhh---------------cccCC----ccCCCCcHHHHHHHHHHHHHhcccCCCCCCC
Q 005923 581 LYASISRVLEESNV--R----EKLR---------------GFIDP----SLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635 (669)
Q Consensus 581 ~~~~~~~~~~~~~~--~----~~l~---------------~~~d~----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 635 (669)
+..+...+..... . ..+. ..... ......+...+..+.+++.+||+.||.+|||
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 304 (353)
T cd07850 226 -WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304 (353)
T ss_pred -HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC
Confidence 1111111110000 0 0000 00000 0001112234567889999999999999999
Q ss_pred HHHHHHH
Q 005923 636 ISEVFVT 642 (669)
Q Consensus 636 ~~evl~~ 642 (669)
+.|++..
T Consensus 305 ~~eiL~~ 311 (353)
T cd07850 305 VDDALQH 311 (353)
T ss_pred HHHHhcC
Confidence 9999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=286.72 Aligned_cols=263 Identities=26% Similarity=0.396 Sum_probs=194.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhc-CCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKI-NHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l-~H~niv~l~g~~~~~ 426 (669)
.|++.+ .+|.|.| |.||+|.. .++.+|+|++.. .+.+|+.+++++ +|+||++++++|...
T Consensus 8 ~y~~~~-~lg~g~~-------~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 8 KYEILQ-KLGKGAY-------GIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred HHHHhH-hhcCCCC-------eeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 456655 4899999 99999987 477899998742 255799999999 999999999998654
Q ss_pred --CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 427 --GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 427 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
...++||||++ ++|.+++... .++|..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 35799999997 5999998642 5889999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|||+++.......... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+.. .
T Consensus 150 d~g~~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~---~ 223 (337)
T cd07852 150 DFGLARSLSELEENPE---NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL---E 223 (337)
T ss_pred eccchhcccccccccc---CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH---H
Confidence 9999987654321100 112234568899999998865 56789999999999999999999999764432211 1
Q ss_pred HHHHHHh-----------hhhHHhhhhcccCC---ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 584 SISRVLE-----------ESNVREKLRGFIDP---SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 584 ~~~~~~~-----------~~~~~~~l~~~~d~---~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
.+..... .......+...... ......+ ..+.++.+++.+||+.||.+|||+.+++.. ++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhcc-CCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 1111100 00000111111110 0001111 245678999999999999999999999976 5554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=278.55 Aligned_cols=232 Identities=23% Similarity=0.351 Sum_probs=184.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecccHH--HHHHHHHhc-CCCCceeEeeEEEecCceeEEEEecCCCC
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGDVS--SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGA 440 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~~~--~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gs 440 (669)
++|.|.| |.||++.. .+..+|+|..+.... .|+.....+ +|+|++++++++..++..++||||+++|+
T Consensus 23 ~lg~g~~-------g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 23 KLIDGKF-------GKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred eecCCCc-------eEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 4799999 99999987 477889999865322 244333333 79999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccCCccccCCCcccc
Q 005923 441 LSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAESDEHEQ 519 (669)
Q Consensus 441 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 519 (669)
|.++++.. ..++|..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||+++......
T Consensus 96 L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--- 164 (267)
T PHA03390 96 LFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--- 164 (267)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---
Confidence 99999764 26999999999999999999999999 99999999999999988 99999999987654321
Q ss_pred CCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhh
Q 005923 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLR 599 (669)
Q Consensus 520 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 599 (669)
...++..|+|||++.+..++.++||||||+++|||++|+.||......+... .... ..
T Consensus 165 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~---------~~-- 222 (267)
T PHA03390 165 ---------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ESLL---------KR-- 222 (267)
T ss_pred ---------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HHHH---------Hh--
Confidence 1357889999999999999999999999999999999999998543221000 0000 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005923 600 GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-ISEVFV 641 (669)
Q Consensus 600 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 641 (669)
... ....+......+.+++.+||+.||.+||+ ++|+++
T Consensus 223 --~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 --QQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --hcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 11222345567899999999999999996 688874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=284.65 Aligned_cols=266 Identities=21% Similarity=0.348 Sum_probs=189.8
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
+..|+... ++|.|.| |.||++.. +++.+|||.+.. .+.+|++++++++||||++++++|..
T Consensus 11 ~~~y~~~~-~lg~g~~-------~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 11 VSKYEKLA-KIGQGTF-------GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hhheEEEE-EeecCCC-------EEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 34455544 4899999 99999997 478899998742 23579999999999999999999876
Q ss_pred cC--------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 426 EG--------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 426 ~~--------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
.+ ..++||||+.+ +|.+++... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~ 154 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITK 154 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECC
Confidence 54 34999999974 898888653 235899999999999999999999998 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~ 576 (669)
++.+||+|||++.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+.+....
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 155 DGILKLADFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred CCcEEECcCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999998764332110 0112334678899999998764 4788999999999999999999998765432
Q ss_pred HHHHHHHHHHHHHhhhh-----HHhhhhcccCCc-cCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 577 EAELLYASISRVLEESN-----VREKLRGFIDPS-LRNEY-----PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~-----~~~~l~~~~d~~-l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
........+........ .......+..+. ..... +......+.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 21111111110000000 000000000000 00000 00112356799999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=280.24 Aligned_cols=233 Identities=27% Similarity=0.346 Sum_probs=191.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.++.|+| |.||++..+ +..+|+|.+.. .+.+|++++++++||||+++++++.++...++|+
T Consensus 7 ~i~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 7 VIGKGAF-------GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred EeccCCC-------ceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 3789999 999999985 78999998852 3567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 80 DLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred eCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999999754 36899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
.... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+............
T Consensus 152 ~~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----------- 211 (258)
T cd05578 152 PDTL---------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----------- 211 (258)
T ss_pred CCcc---------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-----------
Confidence 4321 12345788999999999888999999999999999999999999865431111110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI--SEVF 640 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl 640 (669)
..... .....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 212 --~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 --AKQET-----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --HHhcc-----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00000 1123344455788999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=278.39 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=187.7
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHH---HHHhcCCCCceeEeeEEEecCceeE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEIN---ILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
+|.|+| |.||++.. .++.||+|.+... +..|.. .++..+||||+++.+++..++..++
T Consensus 2 ig~g~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 74 (278)
T cd05606 2 IGRGGF-------GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 74 (278)
T ss_pred cccCCC-------eEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence 688999 99999987 4788999987431 223333 3444579999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++... +.+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 75 v~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 75 ILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999998653 46999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
..... .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||...........
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--------- 207 (278)
T cd05606 147 FSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------- 207 (278)
T ss_pred cCccC----------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---------
Confidence 53321 1224688999999999754 689999999999999999999999975432111000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHhhcCCCCCCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVTLSKIWSSSSDWDP 655 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L~~i~~~~~~~~~ 655 (669)
...... .....+...+..+.+++.+||..||.+|| ++.|+++. -+-...+|+.
T Consensus 208 -----~~~~~~----~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~---~~~~~~~~~~ 265 (278)
T cd05606 208 -----DRMTLT----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH---PFFRSLDWQM 265 (278)
T ss_pred -----HHHhhc----cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC---ccccCCCchH
Confidence 000000 11223334456789999999999999999 88888753 2233455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=282.30 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=191.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+ .+|.|.| |.||+|.. .|+.||+|.++. .+.+|+.++++++|+||+++++++...
T Consensus 7 ~~y~~~~-~ig~g~~-------~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 7 TEFEKLN-RIGEGTY-------GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cceeEee-eeeecCC-------EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 3455444 3899999 99999998 478999999852 245799999999999999999998755
Q ss_pred --CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 427 --GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 427 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+..++||||+.+ +|.+++...+ ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 79 HLDSIFLVMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred CCCeEEEEEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEC
Confidence 467999999974 8999987542 46999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+. ..
T Consensus 151 dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~ 219 (309)
T cd07845 151 DFGLARTYGLPAK--------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LD 219 (309)
T ss_pred ccceeeecCCccC--------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 9999987653221 1112345778999999875 5578999999999999999999999986554221 11
Q ss_pred HHHHHHhhhhH--Hhhhh------cccCCccCCC----CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNV--REKLR------GFIDPSLRNE----YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~--~~~l~------~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+...+..... ...++ .+.-+.-... ........+.+++.+||+.||.+|||+.|++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11111111000 00000 0000000000 001134567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=281.32 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=188.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
|++.+ +++.|.| |.||+|..+ |+.+++|.++. .+.+|++++++++|+||+++++++..+..
T Consensus 4 y~~~~-~l~~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 4 YEKVE-KIGEGTY-------GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75 (294)
T ss_pred eEEEE-EecCCCC-------EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence 33333 4789999 999999974 77899998742 36689999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DfG 507 (669)
.++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ ++||||+|+||++++ ++.+||+|||
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEEeccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999996 5888888653 2234688899999999999999999998 999999999999985 5679999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+. ... +.
T Consensus 149 ~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~ 217 (294)
T PLN00009 149 LARAFGIPVR--------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IF 217 (294)
T ss_pred cccccCCCcc--------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HH
Confidence 9976543211 11234568899999998764 578999999999999999999999976543211 111 11
Q ss_pred HHHhhhhHHhhhh------cccC--CccCC----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLR------GFID--PSLRN----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~------~~~d--~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....... ..... .... +.... ........++.+++.+|++.||.+||++.++++.
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 218 RILGTPN-EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHhCCCC-hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110000 00000 0000 00000 0011234568899999999999999999999863
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=274.79 Aligned_cols=243 Identities=23% Similarity=0.399 Sum_probs=203.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
+|.+-+ ++|+|+| |+||++.. .|+.+|||.+.- ++.+|+.+|++...+++|+++|.+.....+|+
T Consensus 34 VFDi~~-KLGEGSY-------GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVG-KLGEGSY-------GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHH-HhcCCcc-------hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 455544 6999999 99999987 488999999853 46789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+-.|+..|.++-+ .++|++..+..++.+-+.||+|||... -+|||||+.|||++.+|.+|++|||.|..
T Consensus 106 VMEYCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred ehhhcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccch
Confidence 99999999999999865 367999999999999999999999988 89999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
+...- ...+.+.||+.|||||++..-.|..++||||+|+...||..|+.|+.+.....
T Consensus 179 LTDTM--------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------------- 236 (502)
T KOG0574|consen 179 LTDTM--------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------------- 236 (502)
T ss_pred hhhhH--------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------------
Confidence 64321 22456899999999999999999999999999999999999999997533210
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....--..|.--...|+.-..++-++++.||-++|++|-|+.+++++
T Consensus 237 ----AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 237 ----AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ----eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 00000011111224566777889999999999999999999988764
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=280.01 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=189.4
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc--------HHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD--------VSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~--------~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 434 (669)
.+|.|.| |.||+|.. .++.+++|.++.. ..+|+..+++++ |+|++++++++..++..++|||
T Consensus 6 ~ig~g~~-------g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 6 QLGDGTF-------GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred eeccCCc-------eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 3899999 99999998 4678999987542 346889999999 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+ +|+|.+++.... ...+++.++..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++.....
T Consensus 79 ~~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred cC-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 99 789999997642 246899999999999999999999999 99999999999999999999999999986543
Q ss_pred CccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||......+.. ..+...+....
T Consensus 152 ~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~ 219 (283)
T cd07830 152 RPP---------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL---YKICSVLGTPT 219 (283)
T ss_pred CCC---------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH---HHHHHhcCCCC
Confidence 221 122457889999998854 55799999999999999999999998765432211 11111111100
Q ss_pred H-----HhhhhcccCCccC-------CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 594 V-----REKLRGFIDPSLR-------NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 594 ~-----~~~l~~~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ...+...++..+. ..........+.+++++||+.||.+|||++|++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 0000001110000 00001114568999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=271.91 Aligned_cols=236 Identities=30% Similarity=0.514 Sum_probs=192.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
.++.|.| |.||++... +..+++|+.+. ++.+|++++++++|+|++++++++..+...++++||+
T Consensus 7 ~l~~g~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 7 KIGKGGF-------GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred eeccCCc-------eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3788999 999999985 78899998853 3668999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 80 SGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999997642 46899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
. .....++..|+|||.+.+..++.++||||||++++||++|+.|+.......... .
T Consensus 153 ~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~------------ 208 (253)
T cd05122 153 A---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF---K------------ 208 (253)
T ss_pred c---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH---H------------
Confidence 1 233567889999999998889999999999999999999999987543211100 0
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.....-+.+ ..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 209 -~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 209 -IATNGPPGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -HHhcCCCCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000011 1111224578999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=281.09 Aligned_cols=231 Identities=28% Similarity=0.451 Sum_probs=185.8
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||+|.. .++.+++|.+.. ++.+|++++++++|+|++++++++.++...++||
T Consensus 28 ~lg~g~~-------g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 28 EIGHGSF-------GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred eeccCCC-------eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 4899999 99999987 578899998752 3567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+. |+|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 101 e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 101 EYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred ecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 9996 5888888653 245899999999999999999999999 9999999999999999999999999986432
Q ss_pred CCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
.. ....|+..|+|||.+. .+.++.++||||||+++|||++|..|+.......... ....
T Consensus 173 ~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~ 234 (313)
T cd06633 173 PA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ 234 (313)
T ss_pred CC------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHh
Confidence 21 1246788999999984 4668899999999999999999999987654321100 0000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .+.. .....+..+.+++.+||+.+|.+||++.+++..
T Consensus 235 -----~~-----~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 -----ND-----SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----cC-----CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111 111233468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=276.97 Aligned_cols=242 Identities=23% Similarity=0.393 Sum_probs=190.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|.+.+ ++|.|+| |.||++... +..+++|.++. ++..|+.++++++||||+++++++.+
T Consensus 2 y~i~~-~ig~g~~-------g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (260)
T cd08222 2 YILQQ-RLGKGSF-------GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE 73 (260)
T ss_pred ceeee-eecCCCC-------ceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence 34444 4899999 999999874 34456666542 24568899999999999999999998
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
....++||||+++++|.+++...+ .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecc
Confidence 889999999999999999987532 23357999999999999999999999998 999999999999975 5699999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+....... ..
T Consensus 149 ~g~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~ 214 (260)
T cd08222 149 FGVSRLLMGSCD--------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VV 214 (260)
T ss_pred cCceeecCCCcc--------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HH
Confidence 999987643221 1223457889999999988889999999999999999999999986533211 11
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... . ......+...+.++.+++.+||+.||.+||++.|+++.
T Consensus 215 ~~~~----------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 215 LRIV----------E----GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHH----------c----CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1110 0 01122344556688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=289.09 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=192.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC--
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG-- 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 427 (669)
|++.+ .+|.|+| |.||+|.. .|+.||+|.++. .+.+|+.++++++|+||+++++++....
T Consensus 7 y~i~~-~lg~G~~-------g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 7 YQNLS-YIGEGAY-------GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred eEEEE-EEEecCC-------eEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 44444 3899999 99999987 478899998752 2567999999999999999999876443
Q ss_pred ---ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 428 ---NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 428 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
..++|+||+.+ +|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccceEEEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 47999999974 88888754 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|||+++......... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..... ...
T Consensus 149 dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~ 220 (336)
T cd07849 149 DFGLARIADPEHDHT-----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLN 220 (336)
T ss_pred cccceeecccccccc-----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 999998754322111 11233568899999998754 568999999999999999999999997644211 111
Q ss_pred HHHHHHhhhhHHhhhhcccCCcc---------CCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhh
Q 005923 584 SISRVLEESNVREKLRGFIDPSL---------RNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIW 647 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l---------~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~ 647 (669)
.+...+..... +.+..+.+... ....+ .....++.+++.+||+.||.+|||+.|+++. |+...
T Consensus 221 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 221 LILGVLGTPSQ-EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHcCCCCH-HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 11111111110 11111111000 00000 1224568899999999999999999999987 65544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=279.95 Aligned_cols=238 Identities=24% Similarity=0.367 Sum_probs=187.6
Q ss_pred HHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc-----------cHHHHHHHHHhc-CCCCceeEeeEEEecCc
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG-----------DVSSEINILKKI-NHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 428 (669)
.+|.|+| |.||++.. +|..+|+|+++. .+.+|+++++++ +|+||+++++++..+..
T Consensus 7 ~lg~G~~-------g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 7 VLGTGAY-------GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred eeccCCc-------ceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 3899999 99999886 578899998853 245799999999 59999999999998889
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 99999999999999999754 35889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG--VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
++....... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.|+.......... ....
T Consensus 152 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~ 222 (290)
T cd05613 152 SKEFHEDEV-------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA--EISR 222 (290)
T ss_pred ceecccccc-------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH--HHHH
Confidence 987543221 112235688899999998753 46889999999999999999999986432211000 0000
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
.+.. ...+++......+.+++.+||+.||.+|| ++.+++..
T Consensus 223 -------------~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 -------------RILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------------Hhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 01223444566789999999999999997 66666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=278.56 Aligned_cols=254 Identities=17% Similarity=0.228 Sum_probs=180.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCC-----eeEEEEecc---cHH---------------HHHHHHHhcCCCC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-----DAAVKVMKG---DVS---------------SEINILKKINHSN 415 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~-----~vavK~~~~---~~~---------------~E~~~l~~l~H~n 415 (669)
.|++.++ +|.|+| |.||+|...+. .+++|.... .+. .+...+..++|+|
T Consensus 13 ~y~i~~~-LG~G~f-------G~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 13 EWKIDKL-IGCGGF-------GCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ceEEeeE-EecCCC-------ceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 4666664 899999 99999998543 556665321 111 1223445568999
Q ss_pred ceeEeeEEEecC----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 005923 416 IIRLSGFCVHEG----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTS 491 (669)
Q Consensus 416 iv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~ 491 (669)
++++++++.... ..++++|++.. ++.+.+... ...++..+..|+.|++.||+|||+.+ ++||||||+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~ 155 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPE 155 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 999999876543 34678887753 777776543 23578889999999999999999998 999999999
Q ss_pred CeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 005923 492 NILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571 (669)
Q Consensus 492 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~ 571 (669)
|||++.++.+||+|||+++.......... ..........||..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999987643221100 00111223469999999999999999999999999999999999999998
Q ss_pred CCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+......... .... +.+..+..... ....++..+.+++..||..+|.+||++.++.+.|
T Consensus 235 ~~~~~~~~~~-~~~~---------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 235 GFGHNGNLIH-AAKC---------DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccccchHHHH-HhHH---------HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 6532211110 0000 01111111111 1122356789999999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=280.10 Aligned_cols=233 Identities=27% Similarity=0.416 Sum_probs=186.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.++.|.| |.||+|.. ++..+++|.+.. ++.+|++++++++|+|++++.+++..+...++||
T Consensus 22 ~lg~g~~-------g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 22 EIGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred heeeCCC-------EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4899999 99999997 467899998742 3567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+. |+|.+++.... ..+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 68888876432 35899999999999999999999998 9999999999999999999999999987653
Q ss_pred CCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
.. ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+......+. ... ..
T Consensus 167 ~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~- 227 (308)
T cd06634 167 PA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH----IA- 227 (308)
T ss_pred Cc------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHH----Hh-
Confidence 32 1235788999999974 35688899999999999999999999875432111 000 00
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
+. ..+. ..+......+.+++.+||+.+|.+||++.+++....
T Consensus 228 --------~~-~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 228 --------QN-ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --------hc-CCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 0011 112234566899999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=290.84 Aligned_cols=237 Identities=26% Similarity=0.427 Sum_probs=192.6
Q ss_pred HHHhCCCCcccceeeEEEEEEECCC--eeEEEEec-------ccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGD--DAAVKVMK-------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~--~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|.| |+||++..+.. ..|-|++. .|+.-|++||....||+||+|++.|..++.++++.|||
T Consensus 39 ELGDGAF-------GKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 39 ELGDGAF-------GKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred hhcCccc-------hhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 5899999 99999998643 34667763 36778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
.||-....+-. .+..|++.++.-+++|+++||.|||+++ |||||||+.|||++-+|.++|+|||.+.......
T Consensus 112 ~GGAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred CCchHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 99999887753 3467999999999999999999999999 9999999999999999999999999987654321
Q ss_pred cccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
+......||+.|||||+.. ...|..++||||||++|.||..+..|...-+.. ..+.++
T Consensus 185 --------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKi--- 247 (1187)
T KOG0579|consen 185 --------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI--- 247 (1187)
T ss_pred --------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHH---
Confidence 2234578999999999875 478999999999999999999999887643321 111111
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..--.|.+ -.|..-...+.+++.+||..||..||++.+++++
T Consensus 248 -------aKSePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 248 -------AKSEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------hhcCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11111222 2345556678999999999999999999998864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=281.91 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=190.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------------------cHHHHHHHHHhcCCCCceeEeeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------------------DVSSEINILKKINHSNIIRLSGF 422 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------------------~~~~E~~~l~~l~H~niv~l~g~ 422 (669)
.+|.|+| |.||+|.. .++.+|||.++. .+.+|++++++++|+||++++++
T Consensus 16 ~ig~G~~-------g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 16 HLGEGTY-------GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred cccCCCc-------eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 4899999 99999986 478899998753 25679999999999999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+..++..++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 999999999999997 6999998653 35899999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCC------cccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 503 ITNFGLARSAESDEHEQGG------YGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
|+|||+++........... ..........++..|+|||.+.+. .++.++||||||+++|||++|+.||.+..+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876522110000 000111223467889999998764 468999999999999999999999986554
Q ss_pred hHHHHHHHHHHHHHhhhhHHh-----hhh------cccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 576 CEAELLYASISRVLEESNVRE-----KLR------GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~-----~l~------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+ ....+...+....... .+. ....+... ........++.+++.+||+.||.+||+++|++..
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 22 1122222221111000 000 00000000 0011234568899999999999999999999964
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=279.97 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=189.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+ .++.|.| |.||+|.. +|+.+|+|.++. .+.+|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~-~lg~g~~-------g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 8 KFDIIG-QIGEGTY-------GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhheee-eecccCC-------EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 344444 4899999 99999998 478899999853 2567999999999999999999987654
Q ss_pred ----------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 428 ----------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 428 ----------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
..++|+||+++ +|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||+|+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~ 151 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNN 151 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 78999999986 787877643 246899999999999999999999998 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~ 576 (669)
++.+||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 152 KGQIKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred CCcEEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999987644321 11112345778999998865 45789999999999999999999998754332
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccC--------------CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 577 EAELLYASISRVLEESNVREKLRGFID--------------PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d--------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+ . ...+......... .....+.. ...+.. ....+..+.+++.+||+.||.+||++++++..
T Consensus 225 ~--~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 A--Q-LELISRLCGSPCP-AVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred H--H-HHHHHHHhCCCCh-hhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 1 1111111111100 00000000 001011 11235678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=280.68 Aligned_cols=241 Identities=23% Similarity=0.430 Sum_probs=185.4
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcC-CCCceeEeeEEEecCc
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKIN-HSNIIRLSGFCVHEGN 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 428 (669)
|++.+ .++.|.| |.||+|..+ ++.+|||.++. ++..|+.++.+.. |+||++++++|..+..
T Consensus 17 ~~~~~-~lg~g~~-------~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 17 LENLG-EIGSGTC-------GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred heeee-EeeccCC-------eEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 34434 4899999 999999996 88999999863 2345676666665 9999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
.++||||+. ++|.+++... ...+++..+.+++.|++.||+|||+ .+ ++||||+|+||++++++.+||+|||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred EEEEeeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccc
Confidence 999999985 4787777543 2369999999999999999999997 47 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV----ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
++........ .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+
T Consensus 161 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~ 226 (296)
T cd06618 161 ISGRLVDSKA---------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FE 226 (296)
T ss_pred cchhccCCCc---------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HH
Confidence 9876543221 11234678899999997654 789999999999999999999998643211 01
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.....+... .+.+ .....++.++.+++.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 227 VLTKILQEE----------PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHhcCC----------CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111110 0011 1111345678999999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=270.63 Aligned_cols=233 Identities=28% Similarity=0.480 Sum_probs=192.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.++.|.| |.||++.. .++.+++|.+.. .+.+|++++++++|+|++++++++.+++..++|||
T Consensus 7 ~l~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 7 LIGRGAF-------GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred EEcccCC-------eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 3789999 99999987 467899998753 35789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 80 YAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred cCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 99999999999754 46899999999999999999999998 99999999999999999999999999987754
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.... .....++..|+|||.+.+..++.++|||++|+++|||++|+.|+........ ... ..
T Consensus 152 ~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~----~~----- 212 (254)
T cd06627 152 VSKD--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFR----IV----- 212 (254)
T ss_pred Cccc--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHH----Hh-----
Confidence 3211 1234678899999999888899999999999999999999999875432111 000 00
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. ......+...+..+.+++.+||..+|++||++.|++.
T Consensus 213 -----~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 213 -----Q----DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----c----cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 0112233344567899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=275.41 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=188.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhc---CCCCceeEeeEEEecCc----
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKI---NHSNIIRLSGFCVHEGN---- 428 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l---~H~niv~l~g~~~~~~~---- 428 (669)
++.|.| |.||+|..+ +..+|+|.++. .+.+|+.+++++ +|+|++++++++...+.
T Consensus 7 l~~g~~-------~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 7 IGEGAY-------GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred ecccCc-------eEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 789999 999999984 78999999862 245688777766 59999999999988776
Q ss_pred -eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 429 -TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 429 -~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
.+++|||+. ++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccC
Confidence 899999997 48999987642 235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++........ .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.+....+ . ...+..
T Consensus 153 ~~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~-~~~~~~ 220 (287)
T cd07838 153 LARIYSFEMA---------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--Q-LDKIFD 220 (287)
T ss_pred cceeccCCcc---------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--H-HHHHHH
Confidence 9987643321 122346888999999999999999999999999999999998887654321 1 111111
Q ss_pred HHhhhhHHhhh------hcccCCccC---CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVREKL------RGFIDPSLR---NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~~~l------~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
........... ......... .....+....+.+++.+||+.||.+||++.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 11100000000 000000000 0111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-33 Score=316.51 Aligned_cols=239 Identities=28% Similarity=0.409 Sum_probs=194.5
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.+|.|.| |.||-+.. +|+-.|+|-++- .+.+|..+|..|+|||+|+.+|+-.+.+..++.||
T Consensus 1242 ~Ig~G~f-------G~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1242 FIGGGTF-------GKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred ccCCcce-------eeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 4677777 99999987 577888887752 46789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+.+...+ .+++.....+..|++.|+.|||+++ ||||||||.|||++.+|.+|++|||.|+.+..
T Consensus 1315 yC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999997653 3555556668899999999999999 99999999999999999999999999998866
Q ss_pred CccccCCcccceeeecccccccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV---ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... ..-..+..||+.|||||++.+.. -.-++||||+|||+.||+||+.||..-++. + +.+-.+.
T Consensus 1387 ~~~~~----~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~--aIMy~V~-- 1455 (1509)
T KOG4645|consen 1387 NAQTM----PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---W--AIMYHVA-- 1455 (1509)
T ss_pred chhcC----CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---h--HHHhHHh--
Confidence 53111 12245789999999999997643 456899999999999999999999854331 1 1111111
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+-.++.|..+..+-.+++.+||+.||.+|.++.|+++.
T Consensus 1456 ------------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 ------------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 112356777888889999999999999999998877754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=270.64 Aligned_cols=228 Identities=30% Similarity=0.429 Sum_probs=189.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|.|+| |.||++... ++.+++|.++. .+..|++++++++|+||+++++.+..++..++|||
T Consensus 1 lg~G~~-------~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 73 (250)
T cd05123 1 LGKGSF-------GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLE 73 (250)
T ss_pred CCCCCc-------eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEe
Confidence 478899 999999984 78899998753 36679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 74 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 74 YAPGGELFSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99999999999754 35899999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......++..|++||.+.+...+.++|+||||+++|||++|+.||....... ....
T Consensus 146 ~~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~---------- 204 (250)
T cd05123 146 EG--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEK---------- 204 (250)
T ss_pred CC--------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH----------
Confidence 31 11233567889999999998889999999999999999999999997543210 0000
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 638 (669)
+.. .....+...+..+.+++.+||..||.+||++.+
T Consensus 205 ------~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 205 ------ILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------Hhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 011 112334444677899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=288.22 Aligned_cols=238 Identities=27% Similarity=0.476 Sum_probs=198.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|.+.. .+|.|+| +.|..|.. .+..||+|.+.+ .+.+|+++|+.++|||||+++.+.....
T Consensus 57 ~y~i~~-tig~g~f-------~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 57 LYVIIK-TIGKGNF-------AKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred ceeeee-eecccee-------EEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 455544 5999999 99999987 589999999854 2568999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
.+|+||||+.+|.+.+||.++ +.+.......++.|+..|++|||+++ |||||||++||||+.+.++||+|||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 999999999999999999876 34666788899999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
++..+.... +.....|++-|.|||++.+..+ .+++|+||+|+++|-|+.|..||++..-.+
T Consensus 201 fS~~~~~~~---------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------- 262 (596)
T KOG0586|consen 201 FSTFFDYGL---------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------- 262 (596)
T ss_pred cceeecccc---------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------
Confidence 999876533 3456789999999999998766 689999999999999999999998754211
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+. ...+-..++- |.-...+..++++++|-.+|.+|++++++.+.
T Consensus 263 --Lr--------~rvl~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 --LR--------PRVLRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --cc--------chheeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 00 0111112222 22333456899999999999999999999876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=277.79 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=190.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+. +|.|.| |.||+|..+ ++.+++|.+.. .+.+|++++++++|+||+++++++...
T Consensus 8 ~~y~~~~~-lg~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 8 RDYEILGK-LGEGTF-------GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred ccEEEEEE-eccCCC-------EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecc
Confidence 34555443 899999 999999984 78899998742 356799999999999999999987644
Q ss_pred C--------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 427 G--------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 427 ~--------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
. ..++||||+.+ +|.+++... ...+++.++..++.|+++||+|||+.+ ++|+||||+||+++++
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~ 151 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQ 151 (311)
T ss_pred cccccccCceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 3 46999999975 788887643 246999999999999999999999999 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccCCc---ccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Q 005923 499 LRAKITNFGLARSAESDEHEQGGY---GLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQ 574 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~ 574 (669)
+.+||+|||+++............ .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999998654332111000 0112234567888999998865 457899999999999999999999997654
Q ss_pred hhHHHHHHHHHHHHHhhhh-----HHhhhhcccCCccCCCCc-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 575 NCEAELLYASISRVLEESN-----VREKLRGFIDPSLRNEYP-------LDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~-----~~~~l~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
..... +.+........ ....+....+.......+ ......+.+++.+||+.||.+|||+.|++.
T Consensus 232 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 232 DIDQL---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHH---HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 32211 11111111000 000111111100000111 122256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.40 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=191.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe---
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH--- 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~--- 425 (669)
|++.+ .+|.|+| |.||+|.. .|..+|+|++.. .+.+|+.+|++++||||+++.+++..
T Consensus 7 y~~~~-~lg~g~~-------g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 7 YKPIE-NIGSGAY-------GVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred eeeee-eeecCCC-------eEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 44444 3899999 99999987 488999998753 24579999999999999999998763
Q ss_pred -cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 426 -EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 426 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
....++||||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence 346799999996 6999998643 34899999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|||+++......... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+...... ..
T Consensus 150 dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~ 222 (334)
T cd07855 150 DFGMARGLSSSPTEH----KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LK 222 (334)
T ss_pred ccccceeecccCcCC----CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HH
Confidence 999998654322110 111223468889999999865 5689999999999999999999999976543211 11
Q ss_pred HHHHHHhhhhH-------HhhhhcccCC-ccCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNV-------REKLRGFIDP-SLRNEY-----PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~-------~~~l~~~~d~-~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+......... .+.+....+. ...... ....+..+.+++.+||+.||.+||++++++..
T Consensus 223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111110000 0001111100 000111 12245678999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.71 Aligned_cols=240 Identities=27% Similarity=0.447 Sum_probs=194.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 432 (669)
.+|.|+| |.||++.. ++..+++|+... .+..|.+++++++ |+||+++++++..++..++|
T Consensus 8 ~lg~g~~-------~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 8 IIGEGSF-------STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred eecCCCc-------eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3899999 99999998 578999998853 3567899999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++++|.+++.+. ..+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999999764 36999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCccccC------------CcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 513 ESDEHEQG------------GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 513 ~~~~~~~~------------~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
........ ...........++..|+|||.+....++.++|+||||++++|+++|+.|+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 229 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--- 229 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---
Confidence 54321100 000122234567899999999998889999999999999999999999998543211
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI----SEVFV 641 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~evl~ 641 (669)
...... ......+...+..+.+++.+||+.||.+||++ ++++.
T Consensus 230 ---~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ---TFQKIL---------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHH---------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000010 01123344446678999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=283.36 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=195.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec--
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE-- 426 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~-- 426 (669)
|+... .+|.|+| |.||++.. .+..||||.++. .+..|+.++++++|+||+++++++...
T Consensus 7 y~~~~-~lg~G~~-------~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 7 YVPIK-PIGRGAY-------GIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred eeEEE-EeccCCC-------eEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 44444 4899999 99999987 478899998753 245799999999999999999988644
Q ss_pred ---CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 427 ---GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 427 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
...++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 34799999996 6899998653 45999999999999999999999998 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
+|||+++...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.+....+ ..
T Consensus 150 ~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~ 218 (337)
T cd07858 150 CDFGLARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QL 218 (337)
T ss_pred CcCccccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HH
Confidence 9999998764321 11123457889999998865 568999999999999999999999997654221 11
Q ss_pred HHHHHHHhhhh-----------HHhhhhcc---cCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 583 ASISRVLEESN-----------VREKLRGF---IDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 583 ~~~~~~~~~~~-----------~~~~l~~~---~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
..+...+.... ....++.. .+.... ....++..++.+++++||+.||.+|||++|+++. |+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 219 KLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 11111111100 00001000 001110 0112345678999999999999999999999988 7766
Q ss_pred hcC
Q 005923 647 WSS 649 (669)
Q Consensus 647 ~~~ 649 (669)
...
T Consensus 298 ~~~ 300 (337)
T cd07858 298 HDP 300 (337)
T ss_pred cCc
Confidence 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=268.61 Aligned_cols=215 Identities=20% Similarity=0.195 Sum_probs=175.5
Q ss_pred eEEEEEEE--CCCeeEEEEecc--cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCC
Q 005923 380 GSVYRGSF--KGDDAAVKVMKG--DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN 455 (669)
Q Consensus 380 G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~ 455 (669)
|.||++.. +++.+|+|.++. .+..|...+....|||++++++++.+++..++||||+++|+|.+++... ..
T Consensus 7 ~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~ 81 (237)
T cd05576 7 DKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-----LN 81 (237)
T ss_pred ceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-----cC
Confidence 89999988 578899999975 3556666666778999999999999999999999999999999999754 34
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccc
Q 005923 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535 (669)
Q Consensus 456 l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~ 535 (669)
+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++....... ....++..
T Consensus 82 l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----------~~~~~~~~ 147 (237)
T cd05576 82 IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----------DGEAVENM 147 (237)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----------ccCCcCcc
Confidence 899999999999999999999998 9999999999999999999999999887654321 11234667
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHH
Q 005923 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLA 615 (669)
Q Consensus 536 y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 615 (669)
|+|||.+.+..++.++||||+|+++|||++|+.++...... .. .......|....
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------------~~----~~~~~~~~~~~~ 202 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------------IN----THTTLNIPEWVS 202 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------------cc----cccccCCcccCC
Confidence 99999998888999999999999999999999876532110 00 000112233345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHH
Q 005923 616 FSMAQLAKNCTAHDLNARPSISE 638 (669)
Q Consensus 616 ~~l~~li~~Cl~~dP~~RPt~~e 638 (669)
..+.+++.+||+.||.+||++.+
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCc
Confidence 67899999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=273.50 Aligned_cols=249 Identities=29% Similarity=0.414 Sum_probs=191.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.++.|.| |.||++.. +++.+++|.++. .+.+|++++++++|+||+++++++..++..++|||
T Consensus 6 ~i~~g~~-------~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 6 KIGEGTY-------GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred eeecCCC-------ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 3788999 99999987 478899998753 35679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++ +|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 79 ~~~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 79 FMDT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred ccCC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 9975 899988753 246899999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.+|......+. ...+...+....
T Consensus 151 ~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~ 219 (283)
T cd05118 151 PVR--------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPD 219 (283)
T ss_pred Ccc--------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCc
Confidence 321 11224577889999999876 789999999999999999999999876543221 111111111100
Q ss_pred HHhhhhcccC---------Cc----cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 594 VREKLRGFID---------PS----LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 594 ~~~~l~~~~d---------~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+....+.+ +. .......+...++.+++.+||+.||.+||++.|++.
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 220 -PEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred -hHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000001100 00 001112245678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=283.19 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=196.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC-----ce
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG-----NT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 429 (669)
.+|.|.| |.||++... ++.+++|.+.. .+.+|+.++++++|+||+++.+++...+ ..
T Consensus 7 ~ig~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 7 PIGSGAY-------GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred eecCCCC-------eEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4899999 999999974 78899998753 3667999999999999999999998765 78
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||++ ++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCce
Confidence 99999998 4899998754 36999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
......... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+....+. ...+...
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~ 222 (330)
T cd07834 151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEV 222 (330)
T ss_pred Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHh
Confidence 876543210 0112334678899999999887 889999999999999999999999986553221 1111111
Q ss_pred HhhhhHH-------hhhhcccC---CccC---CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhcC
Q 005923 589 LEESNVR-------EKLRGFID---PSLR---NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIWSS 649 (669)
Q Consensus 589 ~~~~~~~-------~~l~~~~d---~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~~ 649 (669)
....... .....++. .... .......+..+.+++.+||+.||.+||++.+++.. ++++...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 1100000 00000000 0000 00112245678999999999999999999999985 6666544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=273.79 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=190.7
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.++.|.| |.||+|... ++.+++|.++. .+..|+.++++++|+|++++++++...+..++|||
T Consensus 6 ~ig~g~~-------~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 6 KLGEGTY-------GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred cccccCc-------ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 4789999 999999984 78899998863 25679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|++ ++|.+++.... ..+++..+.+++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 79 ~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 79 YCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred CcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 998 59999997642 35999999999999999999999999 99999999999999999999999999987644
Q ss_pred CccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.+....+. ...+...+....
T Consensus 151 ~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 219 (282)
T cd07829 151 PLR--------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPT 219 (282)
T ss_pred Ccc--------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCc
Confidence 321 11223456789999998776 889999999999999999999999876543211 111111111100
Q ss_pred H--Hhhhhcc------c----CCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 594 V--REKLRGF------I----DPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 594 ~--~~~l~~~------~----d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. ......+ . ........+ .....+.+++++||+.||.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHhhcccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000 0 000001111 22557899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=278.07 Aligned_cols=233 Identities=24% Similarity=0.318 Sum_probs=194.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|+| |.||-... .|+-+|.|.+.. -...|-.+|++++.+.||.|--.+..++.++||+
T Consensus 192 vlGkGGF-------GEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 192 VLGKGGF-------GEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred EEecccc-------cceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 3899999 88887766 578888887632 2457999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
..|.||+|.-+|.+. ....+++..++-++.+|+.||++||..+ ||+||+||+|||+|+.|+++|+|+|||..+.
T Consensus 265 tlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999765 2357999999999999999999999999 9999999999999999999999999999886
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... ..+..+||.+|||||++.++.|+...|.||+||++|||+.|+.||...... ...
T Consensus 339 ~g~---------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~----------- 395 (591)
T KOG0986|consen 339 EGK---------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKR----------- 395 (591)
T ss_pred CCC---------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhH-----------
Confidence 543 344569999999999999999999999999999999999999999753321 111
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 637 (669)
+.++..+- .-..++++.+..+..++.+..|++||.+|...+
T Consensus 396 --eEvdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 396 --EEVDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --HHHHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11111110 012467788888999999999999999998554
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=275.10 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=188.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe-c
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH-E 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~-~ 426 (669)
.|.+.. .++.|+| |.||++.. .++.+|+|.+.. .+..|++++++++||||+++.+++.. +
T Consensus 11 ~y~~~~-~ig~g~~-------g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 11 RYVDLQ-PVGMGAF-------GLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ceEEEE-eecccCC-------eEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 344444 4899999 99999986 477899997632 46679999999999999999999875 4
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
...++|+||+ +++|.++++.. .+++..+..++.|++.||+|||+.+ ++||||+|+|||+++++.+||+||
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcc
Confidence 5789999998 56999888643 4788889999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..... ....+
T Consensus 153 g~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~---~~~~~ 218 (328)
T cd07856 153 GLARIQDPQM-----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN---QFSII 218 (328)
T ss_pred ccccccCCCc-----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence 9987543211 12356788999999866 568999999999999999999999997654311 11111
Q ss_pred HHHHhhhhH--------HhhhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNV--------REKLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~--------~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+..... ...++-+..-......+ ..++..+.+++.+||+.+|.+||++.|++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111000 00000000000111111 1234678999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=265.06 Aligned_cols=252 Identities=26% Similarity=0.380 Sum_probs=205.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecccH----------HHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGDV----------SSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~~----------~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|.|-.+ +|.|.| |+|-..+- .|+.+|+|+++.++ ..|-++|+..+||.+..|--.|..
T Consensus 168 ~dFdfLKv-LGkGTF-------GKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 168 EDFDFLKV-LGKGTF-------GKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred chhhHHHH-hcCCcc-------ceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34555554 899999 99988876 48889999998653 357889999999999999989999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.+.+|+||||+.||.|.-+|.+. +.+++.....+..+|..||.|||+.+ ||.||||.+|.|+|.||++||+|
T Consensus 240 ~drlCFVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred CceEEEEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeee
Confidence 99999999999999999999765 45888888889999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++.--.. ...+...+||+.|+|||++....|....|.|.+|||||||++|+.||...+.. .+++.+
T Consensus 312 FGLCKE~I~~--------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLI 380 (516)
T KOG0690|consen 312 FGLCKEEIKY--------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELI 380 (516)
T ss_pred cccchhcccc--------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHH
Confidence 9999864332 23567789999999999999999999999999999999999999999865432 122111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC--HHHHHHHHHHhhcCCCCCC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS--ISEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt--~~evl~~L~~i~~~~~~~~ 654 (669)
+- + .-.+|..+..+...|+...|.+||.+|.. .+++.+....=.-.+.+|+
T Consensus 381 ---l~-----e----------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 381 ---LM-----E----------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ---Hh-----h----------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 00 0 12467777788999999999999999963 3455554444455566665
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=289.02 Aligned_cols=263 Identities=28% Similarity=0.402 Sum_probs=196.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC------ce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG------NT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 429 (669)
.+|+|+| |.||+|+. .|+.||||.++. ..-+|+++|++++|+|||+++++-.... ..
T Consensus 20 ~LG~Ga~-------g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 20 RLGKGAF-------GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred hhcCCcc-------ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4999999 99999997 499999999865 2457999999999999999999865433 46
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec--CCC--cEEEcc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD--TNL--RAKITN 505 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~--~~~--~~kl~D 505 (669)
.+||||+.+|||...|.+- .+...|++.+.+.++.++..||.|||+++ |+||||||.||++- +++ .-||+|
T Consensus 93 vlvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eEEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeec
Confidence 8999999999999999865 46677999999999999999999999999 99999999999983 333 469999
Q ss_pred cCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchh--HHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNC--EAELLY 582 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~--~~~~~~ 582 (669)
||.||.+..+. ......||..|++||.++. ..|+..+|.|||||++||..||..||-..... ..+..+
T Consensus 168 fG~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 168 FGAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred ccccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 99999887643 4677899999999999995 88999999999999999999999999732211 111111
Q ss_pred HHHHHHHhhhh--HHhhhhcccCCccCCCCcH----HHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhhcC
Q 005923 583 ASISRVLEESN--VREKLRGFIDPSLRNEYPL----DLAFSMAQLAKNCTAHDLNARP--SISEVFVTLSKIWSS 649 (669)
Q Consensus 583 ~~~~~~~~~~~--~~~~l~~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RP--t~~evl~~L~~i~~~ 649 (669)
..+.+-..... ..+...+-++-....++|. .....+-..+..+|..+|++|- ...+....+..|...
T Consensus 239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11110000000 0000011111111122232 3334456777788889999998 888888777777643
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=276.34 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=184.8
Q ss_pred HHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc---------cHHHHHHHHHhc-CCCCceeEeeEEEec----Cc
Q 005923 367 IATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG---------DVSSEINILKKI-NHSNIIRLSGFCVHE----GN 428 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~---------~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 428 (669)
+|.|.| |.||++... +..+|+|.++. .+.+|+++++++ +||||+++++++... ..
T Consensus 8 lg~G~~-------g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 8 LGQGAY-------GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ccccCC-------eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 789999 999999984 55899998753 356799999999 599999999976533 34
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++++||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 688889886 6999998653 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++......... ........|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+....+ ....+..
T Consensus 152 a~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~ 224 (332)
T cd07857 152 ARGFSENPGEN----AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQ 224 (332)
T ss_pred ceecccccccc----cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHH
Confidence 98764322110 011223568899999998765 568999999999999999999999987644321 1111111
Q ss_pred HHhhhhHHhhhhcccCC-----------ccCCC---CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDP-----------SLRNE---YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~-----------~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.... .+.+..+.++ .-... ........+.+++.+||+.||.+|||+.|++..
T Consensus 225 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 225 VLGTPD-EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhCCCC-HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111000 0000000000 00000 001124578999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=279.47 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=189.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|...+ .+|.|+| |.||+|.. .|+.+|+|.++. .+.+|+.++++++|+||+++++++....
T Consensus 16 ~y~~~~-~ig~g~~-------g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 16 RYTSLK-QVGSGAY-------GSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred ceEEEE-EeeecCC-------eEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 344333 4899999 99999987 478999998853 2568999999999999999999987543
Q ss_pred ------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 428 ------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 428 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 45999999974 7877653 24899999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
||+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+......
T Consensus 157 kL~dfg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-- 223 (342)
T cd07879 157 KILDFGLARHADAEM-----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-- 223 (342)
T ss_pred EEeeCCCCcCCCCCC-----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 999999998653211 12356788999999876 5689999999999999999999999986542111
Q ss_pred HHHHHHHHHhhh--hHHhh---------hhc---ccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HH
Q 005923 581 LYASISRVLEES--NVREK---------LRG---FIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LS 644 (669)
Q Consensus 581 ~~~~~~~~~~~~--~~~~~---------l~~---~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~ 644 (669)
...+....... ...+. ... .....+...++ .....+.+++.+||+.||.+||++.|++.+ ++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 224 -LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred -HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 11111111000 00000 000 00000000001 234568899999999999999999999965 77
Q ss_pred HhhcC
Q 005923 645 KIWSS 649 (669)
Q Consensus 645 ~i~~~ 649 (669)
.+...
T Consensus 302 ~~~~~ 306 (342)
T cd07879 302 SFRDA 306 (342)
T ss_pred hcccc
Confidence 66543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=300.18 Aligned_cols=136 Identities=32% Similarity=0.463 Sum_probs=122.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|.+.+ ++|.|.| |.||+|... ++.||+|+++. .+..|+.+++.++|+||+++++++...
T Consensus 5 ~y~i~~-~LG~G~f-------g~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 5 EFVIVK-PISRGAF-------GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred CEEEEE-EEecCCC-------eEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 455444 4899999 999999986 88999999863 366799999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..+|||||+.+++|.++++.. +.+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeC
Confidence 9999999999999999999754 35889999999999999999999998 999999999999999999999999
Q ss_pred CCcc
Q 005923 507 GLAR 510 (669)
Q Consensus 507 Gla~ 510 (669)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=294.94 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=180.4
Q ss_pred chhHHH-HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc--------HHHHHHHHHhcCCCCceeEeeEEEec---
Q 005923 361 KFQDLK-IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD--------VSSEINILKKINHSNIIRLSGFCVHE--- 426 (669)
Q Consensus 361 ~~~~l~-~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~--------~~~E~~~l~~l~H~niv~l~g~~~~~--- 426 (669)
.|+|++ +|.|+| |.||+++. +|..+|||++.-. +.+|+.+|.+|+|||||+++..+.+.
T Consensus 480 DFEEL~lLGkGGF-------G~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 480 DFEELELLGKGGF-------GSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHHHHHhcCCCC-------ceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 466765 699999 99999986 7999999998644 67899999999999999987543210
Q ss_pred --------------------------------------------------------------------------------
Q 005923 427 -------------------------------------------------------------------------------- 426 (669)
Q Consensus 427 -------------------------------------------------------------------------------- 426 (669)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ------------------------------------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH
Q 005923 427 ------------------------------------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470 (669)
Q Consensus 427 ------------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~ 470 (669)
-.+|+=||||+.-.|.++++++.... .-...++++++|++
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILE 708 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHH
Confidence 01366788888877777776553110 35667899999999
Q ss_pred HHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC----C------CccccCCcccceeeeccccccccccc
Q 005923 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE----S------DEHEQGGYGLQLTRHVVGTYGYMAPE 540 (669)
Q Consensus 471 ~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~----~------~~~~~~~~~~~~~~~~~gt~~y~aPE 540 (669)
||.|+|+.+ +|||||||.|||+|++..+||+|||+|.... . ......+......+..+||.-|+|||
T Consensus 709 GLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 999999999 9999999999999999999999999998721 0 01111111122345578999999999
Q ss_pred ccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCC--CCcHHHH
Q 005923 541 YIENGV---ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRN--EYPLDLA 615 (669)
Q Consensus 541 ~l~~~~---~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~--~~~~~~~ 615 (669)
.+.+.. |+.|+|+||+|||++||+. ||..... ...+ ...++ +..+.. .+..+..
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~i---------L~~LR---~g~iP~~~~f~~~~~ 844 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASI---------LTNLR---KGSIPEPADFFDPEH 844 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHH------HHHH---------HHhcc---cCCCCCCcccccccc
Confidence 997754 9999999999999999985 3543211 0111 11122 222211 1223333
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 616 FSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 616 ~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
..-+++|++++++||.+|||+.|++.
T Consensus 845 ~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 845 PEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 44579999999999999999999874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=274.55 Aligned_cols=256 Identities=22% Similarity=0.390 Sum_probs=189.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC-
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG- 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~- 427 (669)
|+..+ .+|.|.| |.||++.. .+..||||.++. .+.+|++++++++|+||+++++++..+.
T Consensus 17 y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 17 YRDLK-QVGSGAY-------GTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred eEEEE-EeeecCC-------eEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 44333 3899999 99999987 478899998742 3567999999999999999999987553
Q ss_pred -----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 428 -----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 428 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 358999999 6799988864 24899999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
|+|||+++...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.......
T Consensus 159 l~dfg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-- 225 (343)
T cd07880 159 ILDFGLARQTDSEM-----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL-- 225 (343)
T ss_pred EeecccccccccCc-----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 99999998654321 12356888999999876 46889999999999999999999999865432111
Q ss_pred HHHHHHHH-----------hhhhHHhhhh---cccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHH
Q 005923 582 YASISRVL-----------EESNVREKLR---GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV--TLSK 645 (669)
Q Consensus 582 ~~~~~~~~-----------~~~~~~~~l~---~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~ 645 (669)
..+.... ........+. .+....+ ......+...+.+++.+|++.||.+|||+.+++. .++.
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 226 -MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred -HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 1111100 0000000000 0000000 0011233456889999999999999999999994 4555
Q ss_pred hhc
Q 005923 646 IWS 648 (669)
Q Consensus 646 i~~ 648 (669)
...
T Consensus 304 ~~~ 306 (343)
T cd07880 304 FHD 306 (343)
T ss_pred hcC
Confidence 543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=276.60 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=184.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEec----
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHE---- 426 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~---- 426 (669)
|.+.+ .+|.|+| |.||+|.. .|..|++|.+.. .+.+|++++++++||||+++++++...
T Consensus 7 y~~~~-~Lg~g~~-------g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 7 YMDLR-PLGCGSN-------GLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred eEEEE-EecCCCC-------EEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 44433 3899999 99999987 478899998743 367899999999999999999876543
Q ss_pred ----------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec
Q 005923 427 ----------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 427 ----------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~ 496 (669)
...++||||++ ++|.+++... .+++..++.++.||+.||+|||+.+ ++||||||+||+++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~ 148 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence 35789999997 5999888643 4889999999999999999999999 99999999999997
Q ss_pred -CCCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Q 005923 497 -TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQ 574 (669)
Q Consensus 497 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~ 574 (669)
+++.+|++|||+++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.+..
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHK-----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CCCceEEECCcccceecCCccccc-----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 45678999999998654321110 01122357888999998754 568889999999999999999999998654
Q ss_pred hhHHHHHHHHHHHH-Hhhh-hHHh---hhhcccC-CccCCC-----CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 575 NCEAELLYASISRV-LEES-NVRE---KLRGFID-PSLRNE-----YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 575 ~~~~~~~~~~~~~~-~~~~-~~~~---~l~~~~d-~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+.... ..... .... .... .+...+. ...... .......++.+++.+||+.||.+|||+.|++..
T Consensus 224 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 224 ELEQMQL--ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHH--HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 3221110 00000 0000 0000 0000000 000000 011234568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=260.40 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=196.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcC-CCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKIN-HSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 427 (669)
..|++.+-.+|+|.| +.|--.+. .|.++|||++.+ .+.+|++++.+.+ |+||++|+.+|+++.
T Consensus 77 d~YkLt~e~LGeGAy-------asVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAY-------ASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHhHHHHhcCccc-------eeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 457777777999999 77776553 789999999853 5778999999985 999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC---cEEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---RAKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~ 504 (669)
..|||||-|.||+|..+++++ ..+++....++..+|+.||.|||.++ |.|||+||+|||..+-. -+||+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred eEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999876 45899999999999999999999999 99999999999996543 48999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
||.|..-......-.... ..-....+|...|||||+.. ...|..+.|.||+|||||-|++|-.||.|.-+.+-.
T Consensus 222 DfDLgSg~k~~~~~spas-tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPAS-TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred ccccccccccCCCCCCCC-CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999987543322211111 11123468899999999874 356888999999999999999999999864332111
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPL----DLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
|-.....+.-++. ..+.+ -+. .-++|+ ....+..+++...+..|+.+|.++..++.
T Consensus 301 WdrGe~Cr~CQ~~-LFesI---QEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNK-LFESI---QEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHH-HHHHH---hcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111111110 00111 111 123443 34456789999999999999999998886
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=252.68 Aligned_cols=236 Identities=22% Similarity=0.447 Sum_probs=186.3
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc--------HHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------VSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~--------~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|.|.- |.|++.++. |...|||.|+.. +...++++.+-+ .|.||+.+|||..+...++.||.
T Consensus 100 lGsGtc-------G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 100 LGSGTC-------GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hcCCCc-------cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 788888 999999995 588899999642 334455554444 79999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
|.. .+..+|++-+ +++++.-+-++...+..||.||.+++ .|+|||+||+|||+|+.|++|+||||++..+-..
T Consensus 173 Ms~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 173 MST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 964 7777776542 56888888999999999999998764 3999999999999999999999999999876543
Q ss_pred ccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
. ......|-+.|||||.+. ...|.-++||||||+.++||.||+.||.+-+.+ ++.+..++.+.
T Consensus 246 k---------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~e 311 (391)
T KOG0983|consen 246 K---------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNEE 311 (391)
T ss_pred c---------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhcC
Confidence 2 123356888999999995 457888999999999999999999999864321 12223333221
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.|.+.+ ...+...+.+++..||++|+.+||...+++++
T Consensus 312 ----------PP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 ----------PPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ----------CCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 133322 22366778999999999999999999998875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=273.60 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=185.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec-
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~- 426 (669)
.|.+.+ .+|.|+| |.||++.. +++.||+|+++. .+.+|+.++++++|+||+++.+++...
T Consensus 18 ~y~~~~-~lg~G~~-------g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 18 RYQNLS-PVGSGAY-------GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred ceEEEE-EeeecCC-------eEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 344444 3899999 99999986 478899998853 245699999999999999999988643
Q ss_pred -----CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 427 -----GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 427 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3467888876 78999888643 4899999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
||+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 160 kl~dfg~~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-- 226 (345)
T cd07877 160 KILDFGLARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-- 226 (345)
T ss_pred EEecccccccccccc-----------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 999999988653221 22457889999999876 5688999999999999999999999975433211
Q ss_pred HHHHHHHHHh-----------hhhHHhh---hhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 581 LYASISRVLE-----------ESNVREK---LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 581 ~~~~~~~~~~-----------~~~~~~~---l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+..... ....... +.......+. ........++.+++.+|++.||.+||++.|++.+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 -LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred -HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 111111100 0000000 0000000000 0011234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=277.40 Aligned_cols=252 Identities=23% Similarity=0.404 Sum_probs=188.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|.+.. .+|.|.| |.||+|... +..+|+|+++. .+.+|+.++++++|+|++++.+++..++
T Consensus 16 ~y~~~~-~ig~g~~-------g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 16 RYQNLS-PVGSGAY-------GQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ceEEEE-EeccCCc-------eEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 344433 3899999 999999984 67899998753 2456999999999999999999887655
Q ss_pred c------eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 428 N------TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 428 ~------~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
. .++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 4 89999998 5699999864 35899999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+.
T Consensus 158 kL~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-- 224 (343)
T cd07851 158 KILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-- 224 (343)
T ss_pred EEcccccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--
Confidence 99999999865432 122356788999999865 4678999999999999999999999986543211
Q ss_pred HHHHHHHHHhhhh-------HHhhhhcccCC---ccCCCC---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 581 LYASISRVLEESN-------VREKLRGFIDP---SLRNEY---PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 581 ~~~~~~~~~~~~~-------~~~~l~~~~d~---~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+........ ..+....++.. ..+..+ ......++.+++.+||+.||.+|||+.||+.+
T Consensus 225 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 225 -LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred -HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 111111111000 00000011100 000000 01235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=265.16 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=195.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCC--C----CceeEeeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINH--S----NIIRLSGFC 423 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H--~----niv~l~g~~ 423 (669)
..|.+-++ +|+|.| |.|-....+ +..||||++|. ...-|+++|.++++ | -+|.+.++|
T Consensus 89 ~Ry~i~~~-lGeGtF-------GkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 89 NRYEIVDL-LGEGTF-------GKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cceehhhh-hcCCcc-------cceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 35666564 899999 888887764 67899999974 34569999999943 2 378899999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-------
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD------- 496 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~------- 496 (669)
...++.++|+|.+ |-|+.++|..+ ...+++..++..|++|++++++|||+.+ ++|.||||+|||+-
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 9999999999999 44999999876 3456889999999999999999999999 99999999999993
Q ss_pred -------------CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 005923 497 -------------TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563 (669)
Q Consensus 497 -------------~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~el 563 (669)
.+..+||+|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||.|+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 13458999999998754332 346789999999999999999999999999999999
Q ss_pred HcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH----hhhhc-----ccC---------------Ccc----CCCCcHHHH
Q 005923 564 LSGREAVTGDQNCEAELLYASISRVLEESNVR----EKLRG-----FID---------------PSL----RNEYPLDLA 615 (669)
Q Consensus 564 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~-----~~d---------------~~l----~~~~~~~~~ 615 (669)
.+|...|.+.++.|- + +.+.+++...... ....+ -+| +.. .......+.
T Consensus 303 ytG~~LFqtHen~EH--L-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 303 YTGETLFQTHENLEH--L-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred eccceecccCCcHHH--H-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 999999997765432 1 3334444321110 00000 011 000 001123445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 616 FSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 616 ~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.++.+|+++||..||.+|+|+.|++.+
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhcC
Confidence 669999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=278.21 Aligned_cols=234 Identities=25% Similarity=0.345 Sum_probs=190.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---HHHHHHHHHhc-CCCCceeEeeEEEecCceeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 432 (669)
.|.+.+ ++|.|.| +.|-++.. .++..+||++... ..+|+.++.+. +|||++++.+.+.++.+.|+|
T Consensus 323 ~y~~~~-~~~~gs~-------s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 323 SYEFRE-ELGEGSF-------SAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred hhcccc-ccCCCCc-------cceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 344433 4788888 77777766 4677899998654 77888887776 699999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee-cCCCcEEEcccCCccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL-DTNLRAKITNFGLARS 511 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl-~~~~~~kl~DfGla~~ 511 (669)
||.+.+|-|.+.+...+ .....+.+|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++.
T Consensus 395 ~e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred ehhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999998888887542 222778889999999999999999 9999999999999 6899999999999998
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
....- -+..-|..|.|||++....+++++|+||||++||+||+|+.||....+.. .+
T Consensus 466 ~~~~~-----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei------ 522 (612)
T KOG0603|consen 466 LERSC-----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EI------ 522 (612)
T ss_pred Cchhh-----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HH------
Confidence 76541 12345788999999999999999999999999999999999998654321 00
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+- .+.+........++|+.+||+.||.+||+|.++..+
T Consensus 523 ------~~~i~----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 523 ------HTRIQ----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------HHhhc----CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 01111 123335667789999999999999999999999865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=263.08 Aligned_cols=233 Identities=26% Similarity=0.407 Sum_probs=195.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCC--eeEEEEecccH----------HHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD--DAAVKVMKGDV----------SSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~--~vavK~~~~~~----------~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|.|-.+ +|.|+| |+|.++..+|. .+|||+++.++ ..|-++|..- +-|.+++|..++.
T Consensus 349 tDFnFl~V-lGKGSF-------GKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 349 TDFNFLMV-LGKGSF-------GKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred cccceEEE-eccCcc-------ceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 34555444 899999 99999998754 58999998753 2466666655 4678999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.-+.+|+||||+.+|+|.-+++.- +.+.+....-+|.+||-||-|||+++ |++||||..|||+|.+|++||+
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEee
Confidence 999999999999999999998753 45788889999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++..-.+ ...++...||+.|+|||.+..+.|+..+|+|||||+||||+.|+.||++++.. .+++.
T Consensus 493 DFGmcKEni~~--------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~a 561 (683)
T KOG0696|consen 493 DFGMCKENIFD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQA 561 (683)
T ss_pred ecccccccccC--------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH
Confidence 99999864332 35688899999999999999999999999999999999999999999987642 22222
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 635 (669)
+++.. -.||..+..+..++.+..+.++|.+|..
T Consensus 562 ----------------I~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 ----------------IMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----------------HHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 12221 3577788888999999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=253.80 Aligned_cols=227 Identities=34% Similarity=0.509 Sum_probs=185.8
Q ss_pred eEEEEEEEC--CCeeEEEEec--------ccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCC
Q 005923 380 GSVYRGSFK--GDDAAVKVMK--------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR 449 (669)
Q Consensus 380 G~Vy~g~~~--g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~ 449 (669)
|.||+|... |+.+++|+.. .++.+|++.+++++|+|++++++++..+...+++|||+++++|.+++....
T Consensus 3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~ 82 (244)
T smart00220 3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG 82 (244)
T ss_pred eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc
Confidence 899999985 5889999984 356789999999999999999999999899999999999999999997542
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeee
Q 005923 450 YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529 (669)
Q Consensus 450 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~ 529 (669)
.+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 83 -----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------~~~~ 145 (244)
T smart00220 83 -----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------LLTT 145 (244)
T ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---------cccc
Confidence 2899999999999999999999998 9999999999999999999999999998765432 1233
Q ss_pred cccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCC
Q 005923 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNE 609 (669)
Q Consensus 530 ~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~ 609 (669)
..++..|++||.+.+..++.++|||+||++++||++|..|+......+ .... .+. . ......
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~----~~~---------~---~~~~~~ 207 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFK----KIG---------K---PKPPFP 207 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH----HHh---------c---cCCCCc
Confidence 467889999999998899999999999999999999999987532211 1100 000 0 000000
Q ss_pred CcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 610 YPL-DLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 610 ~~~-~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
... ..+.++.+++.+||..+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000 14567899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=252.66 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=192.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--cHHHHHHHHHhc-CCCCceeEeeEEEe----cCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--DVSSEINILKKI-NHSNIIRLSGFCVH----EGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 429 (669)
.|++..-.+|-|-- |+|-.... .|+.+|+|++.+ ...+|+++--.. .|||||++++++.+ ...+
T Consensus 62 dY~is~qvLG~Gin-------GkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 62 DYSISWQVLGAGIN-------GKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hheehhhhhccccC-------CceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 35554445788877 88877766 488899999975 467888876655 59999999999864 3467
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEccc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNF 506 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~Df 506 (669)
.+|||+|+||.|...+..++ ...+++++...|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+||
T Consensus 135 LiVmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred EeeeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 89999999999999998763 456999999999999999999999999 999999999999954 567999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+|+...... ......-|+.|.|||++...+|....|+||+||+||-|++|-.||....... +.
T Consensus 209 GFAK~t~~~~---------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------is 272 (400)
T KOG0604|consen 209 GFAKETQEPG---------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------IS 272 (400)
T ss_pred ccccccCCCc---------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------CC
Confidence 9999765422 2344577999999999999999999999999999999999999998533210 00
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCc----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYP----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+ +.+....+ .+| ....+...++|+..|..+|.+|.|+.|++..
T Consensus 273 -----pgMk---~rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 -----PGMK---RRIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -----hhHH---hHhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0001 11111111 222 2445667899999999999999999999865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=230.27 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=195.2
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
++|+|.| |+||+|+.. ++.||+|..+- ...+|+-+|+.++|.|||+++++...+..+-||+|
T Consensus 9 kigegty-------gtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 9 KIGEGTY-------GTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred hhcCCcc-------eeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 6999999 999999874 67899999863 26789999999999999999999988999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+.. +|..|...- .+.++.+....++.|+++||.|+|+++ +.|||+||.|.|++.+|.+|++|||++|.++-
T Consensus 82 ~cdq-dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred HhhH-HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9975 899998653 356899999999999999999999999 99999999999999999999999999998764
Q ss_pred CccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
.- ......+-|.+|.+|.++.+ ..|+...|+||-||++.|+.. |+..|.+.+.. .....+.+.+...
T Consensus 154 pv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd---dqlkrif~~lg~p 222 (292)
T KOG0662|consen 154 PV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTP 222 (292)
T ss_pred ce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH---HHHHHHHHHhCCC
Confidence 32 12233467899999999987 458999999999999999987 55555554322 2223444444332
Q ss_pred hHH--hhhhcccCCccCCCCcH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 593 NVR--EKLRGFIDPSLRNEYPL---------DLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 593 ~~~--~~l~~~~d~~l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... ..+..+-|...-.-+|. .+...-++|+.+.+.-+|.+|.++++.++.
T Consensus 223 ~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 223 TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 221 22333334333333332 222234688999999999999999988753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=278.08 Aligned_cols=245 Identities=26% Similarity=0.409 Sum_probs=186.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc----HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~----~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 434 (669)
|.-+|+ +|.|+-+ +.||+|.++|+.||||++-.+ ..+|+..|+.- +|||||++++.-.++...|+..|
T Consensus 511 ~~~~ei-lG~Gs~G------t~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEI-LGYGSNG------TVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHH-cccCCCC------cEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 444554 6677652 579999999999999998654 45899999988 59999999999888889999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-----CCcEEEcccCCc
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-----NLRAKITNFGLA 509 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-----~~~~kl~DfGla 509 (669)
.+.. +|.|++.... .......-...+.+..|++.||+|||+.+ ||||||||.||||+. ..+++|+|||++
T Consensus 584 LC~~-sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred Hhhh-hHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 9976 9999998641 11111111345678899999999999999 999999999999965 257999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG-REAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
+.+..+... ........||-+|+|||.+....-+.++|+||+|||+|+.++| ..||......+.. +
T Consensus 659 Kkl~~~~sS-----~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------I 725 (903)
T KOG1027|consen 659 KKLAGGKSS-----FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------I 725 (903)
T ss_pred cccCCCcch-----hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------h
Confidence 998765421 2234557899999999999999999999999999999999996 7888653322111 1
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+... ..+. .+. ...++ +..+||.+|++.||..||++.+|+.
T Consensus 726 l~~~---~~L~-----~L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 726 LTGN---YTLV-----HLE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hcCc---ccee-----eec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1110 0000 011 11122 6789999999999999999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-31 Score=252.48 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=189.4
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec---------ccHHHHHHHHHhcCCCCceeEeeEEEec--------
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINILKKINHSNIIRLSGFCVHE-------- 426 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 426 (669)
++|.|.| |.||+++.+ |+.||+|+.- ....+|+++|..+.|+|++.++..|...
T Consensus 24 kigqGtf-------geVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 24 KIGQGTF-------GEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hcCCchH-------HHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 5899999 999999873 6778887642 1356899999999999999999998643
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
...||||+++++ +|.-.|.+.. ..++...+.+++.++.+||.|+|... |+|||+|+.|+||+.++.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 357999999997 8999987642 45899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
|++|.+........ . .....+-|..|++||.+.+ ..++++.|||.-||||.||+++...+.+...... ...+
T Consensus 169 Glar~fs~~~n~~k---p-rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq---l~~I 241 (376)
T KOG0669|consen 169 GLARAFSTSKNVVK---P-RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ---LHLI 241 (376)
T ss_pred ccccceecccccCC---C-CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH---HHHH
Confidence 99988755443221 1 1234567999999999987 6799999999999999999999988887654322 2233
Q ss_pred HHHHhhhhH--------Hhhhhcc------------cCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNV--------REKLRGF------------IDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~--------~~~l~~~------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+...-.. ......+ +..+++ ++ .-..+..+|+..++..||.+|+++++++.+
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k-p~--~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK-PY--VKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcc-cc--cCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 322221100 0001111 111111 00 012357899999999999999999887643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=260.40 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=193.9
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEec--c------------cHHHHHHHHHhcCCCCceeEeeEEEec-Cce
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK--G------------DVSSEINILKKINHSNIIRLSGFCVHE-GNT 429 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~--~------------~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~ 429 (669)
+|.|+| ..||++.. ..+.||||+-. . ...+|.+|-+.|.||.||++++|+.-+ +..
T Consensus 471 LGrGGF-------SEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 471 LGRGGF-------SEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred hccccH-------HHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 799999 77999976 57789999752 1 245799999999999999999998754 567
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEccc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNF 506 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~Df 506 (669)
|-|+||++|.+|.-||+.++ .++++....|+.||..||.||.+. +|||||-||||.|||+-+ -|.+||.||
T Consensus 544 CTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 99999999999999998763 589999999999999999999987 589999999999999954 478999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG----VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
||++.+..+.+. ...+..++....||.+|++||++.-+ +++.|.||||.||++|..+.|+.||.......
T Consensus 618 GLSKIMdddSy~-~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----- 691 (775)
T KOG1151|consen 618 GLSKIMDDDSYN-SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----- 691 (775)
T ss_pred chhhhccCCccC-cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-----
Confidence 999998766543 22345678889999999999998643 57899999999999999999999998654321
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.++++..+..... ...+....+..+...+|++||++.-++|....++..
T Consensus 692 ----dILqeNTIlkAtE------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 ----DILQENTILKATE------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----HHHhhhchhccee------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2233222111000 001111234456789999999999999988777653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=275.61 Aligned_cols=244 Identities=24% Similarity=0.461 Sum_probs=199.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeEEEe----
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGFCVH---- 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~~~~---- 425 (669)
.|.+.|. +|.|.+ |.||+++. +++.+|+|++.. +++.|.++|+.. +|||++.++|++..
T Consensus 20 ~~ei~ev-ig~Gty-------gkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 20 IFEIIEV-IGNGTY-------GKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred ccEEEEE-Eeeccc-------eeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3455553 888888 88887765 688899998853 456677888887 69999999999874
Q ss_pred -cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 426 -EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 426 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++.+|||||||.+||..|++++.+ +..+.|..+..|++.++.||.|||... ++|||||-.|||++.++.+|+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 468999999999999999998764 678999999999999999999999998 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
|||.+..+...- .......||+.|||||++.. ..|+.++|+||+|++..||--|..|+.+.....
T Consensus 166 DFGvSaQldsT~--------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-- 235 (953)
T KOG0587|consen 166 DFGVSAQLDSTV--------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-- 235 (953)
T ss_pred eeeeeeeeeccc--------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--
Confidence 999998775432 22455789999999999964 457789999999999999999999987643211
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+.-.-+|......|..-..++-++|..||.+|-.+||++.+++++
T Consensus 236 ----------------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ----------------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11112223444445567778889999999999999999999988753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=265.83 Aligned_cols=237 Identities=27% Similarity=0.452 Sum_probs=192.2
Q ss_pred hHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 363 QDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 363 ~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|..+|.|.| |+||-|+. .|+.||||++.+ .+..|+.||++++||.||.|-..|+..+..++
T Consensus 568 ~devLGSGQF-------G~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 568 ADEVLGSGQF-------GTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred hHhhccCCcc-------eeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 4456899999 99999988 599999999843 36789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC---CcEEEcccCC
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN---LRAKITNFGL 508 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~DfGl 508 (669)
|||-+. |++.+.+-.. ..++|++..-..++.||+.||.|||.++ |+|+||||+|||+.+. -++||||||+
T Consensus 641 VMEKl~-GDMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 641 VMEKLH-GDMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred Eehhhc-chHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccc
Confidence 999995 5777766543 3467999998999999999999999999 9999999999999653 4799999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
||.++... ..+.++||+.|+|||++.+..|....|+||.||++|--++|..||..+.+-. ..
T Consensus 714 ARiIgEks---------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQ 775 (888)
T KOG4236|consen 714 ARIIGEKS---------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQ 775 (888)
T ss_pred eeecchhh---------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HH
Confidence 99987542 4567899999999999999999999999999999999999999998544311 11
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
++. ..|+-|. ..-.+......+||...|+..-.+|-|.+.-+.
T Consensus 776 IQN-------AaFMyPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 776 IQN-------AAFMYPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhc-------cccccCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111 0112111 111244556789999999998888988876554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-31 Score=252.78 Aligned_cols=243 Identities=24% Similarity=0.377 Sum_probs=185.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 434 (669)
++|.|.| |+|+|-..+ |+..|||+++. ++..|.+...+- +.||||+++|.+..++..|+.||
T Consensus 71 ~iG~G~f-------G~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 71 EIGNGAF-------GTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HhcCCcc-------hhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 5899999 999999885 88899999974 244566554443 68999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
.|+- ||..+-+.-.......+++.-+-+|.....+||+||...-+ |+|||+||+|||+|..|.+|+||||++..+..
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9974 77766543211223468888889999999999999986542 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
+- ......|-..|||||.+.. ..|.-++||||+|++|+|+.||+.|+.+=++ .++.+..+..+.
T Consensus 221 Si---------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gd 286 (361)
T KOG1006|consen 221 SI---------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGD 286 (361)
T ss_pred HH---------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCC
Confidence 32 1233567888999999964 3488999999999999999999999875221 222233332221
Q ss_pred hHHhhhhcccCCccCCC-CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 593 NVREKLRGFIDPSLRNE-YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. |.+..+ ........|..++.-|+.+|-.+||...++.++
T Consensus 287 p----------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 287 P----------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred C----------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 111111 113356679999999999999999999998765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=279.96 Aligned_cols=259 Identities=18% Similarity=0.231 Sum_probs=169.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC------CCeeEEEEecccHHHHHHHHHhcCC---CCceeEeeE------
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK------GDDAAVKVMKGDVSSEINILKKINH---SNIIRLSGF------ 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~------g~~vavK~~~~~~~~E~~~l~~l~H---~niv~l~g~------ 422 (669)
..|.+.+ ++|.|+| |.||+|.+. +..+|+|+++.....|..+..+++| .+++.++..
T Consensus 132 ~~y~l~~-~LG~G~F-------G~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 132 DDFVLGK-KLGEGAF-------GVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred CCeEEeE-EEeeCCC-------eEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccc
Confidence 3455555 3999999 999999984 5689999987655555555444432 233322221
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQ---------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrD 487 (669)
+..+...++||||+.+++|.++++..... ......+..+..|+.||+.||+|||+.+ |+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCc
Confidence 23566789999999999999999754210 0011223456789999999999999998 99999
Q ss_pred CCCCCeeecC-CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC---------------------
Q 005923 488 LKTSNILLDT-NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG--------------------- 545 (669)
Q Consensus 488 ik~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------------------- 545 (669)
|||+|||+++ ++.+||+|||+++....... .......+++.|+|||.+...
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccc-------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 9999999986 58999999999986543221 122345788999999966432
Q ss_pred -CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh-HHhhhhcccCCccCCC----C--cHHHHHH
Q 005923 546 -VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN-VREKLRGFIDPSLRNE----Y--PLDLAFS 617 (669)
Q Consensus 546 -~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~d~~l~~~----~--~~~~~~~ 617 (669)
.++.++|||||||+||||+++..+..... .. ....+.... ........+.+....+ + .......
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~----~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNL----IQ----FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchHH----HH----HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 23456799999999999998765543211 00 111111100 0011111111111000 0 0011223
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 618 MAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 618 l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+|+.+||+.||.+|||+.|++++
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCC
Confidence 5689999999999999999999975
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=281.44 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=196.2
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
||.|.| |.|...+.+ ++.+|.|++.. -|..|-++|..-+.+-|++|.-.|.++.++|||||
T Consensus 83 IGrGaF-------GEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 83 IGRGAF-------GEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hccccc-------ceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 899999 999988874 66789998753 37789999998899999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
||+||+|..+|.+. ..+++.....++..|..||.-||+.| +|||||||.|||+|..|++||+|||-+-.+..
T Consensus 156 Y~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999764 36999999999999999999999999 99999999999999999999999999988765
Q ss_pred CccccCCcccceeeecccccccccccccc----c-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIE----N-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
++. ......+||+.|++||++. + +.|++.+|+||+||++|||+.|..||..+.- ..-
T Consensus 228 dG~-------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veT----- 289 (1317)
T KOG0612|consen 228 DGT-------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VET----- 289 (1317)
T ss_pred CCc-------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHH-----
Confidence 442 3344579999999999995 3 6799999999999999999999999985432 111
Q ss_pred hhhhHHhhhhcccCCccCCCCc--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHHhhcCCCCCC
Q 005923 590 EESNVREKLRGFIDPSLRNEYP--LDLAFSMAQLAKNCTAHDLNARPS---ISEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~L~~i~~~~~~~~ 654 (669)
...+++-.-...+| .+.+.+..+||++.+. +|..|.. ++++..+ -+-.-.||+
T Consensus 290 --------Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H---pFF~g~~W~ 347 (1317)
T KOG0612|consen 290 --------YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH---PFFEGIDWD 347 (1317)
T ss_pred --------HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC---ccccCCChh
Confidence 22222221122333 4567788999988774 6778887 7776654 234445564
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=263.11 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=204.4
Q ss_pred HHhCCCCcccceeeEEEEEEECCCe--eEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~--vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|-|+| |.|-....+++. .|+|.++. .+..|-.+|.+.+.|.||+|+..|.+....||+||
T Consensus 428 LGvGgF-------GRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 428 LGVGGF-------GRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred cccCcc-------ceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 699999 999999988766 68888864 35679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
-+-||.|...|+++ +.++......++..+.+|++|||+++ ||+|||||+|.++|.+|.+||.|||+|+.+..
T Consensus 501 aClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999875 45778888889999999999999999 99999999999999999999999999999876
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
+. .+....||+.|.|||.+.+.....++|.||+|++++||++|..||.+.+....+. .+.+.++
T Consensus 573 g~---------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn---~ILkGid---- 636 (732)
T KOG0614|consen 573 GR---------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN---LILKGID---- 636 (732)
T ss_pred CC---------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH---HHHhhhh----
Confidence 43 4778999999999999999999999999999999999999999999866532222 1211111
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC--HHHHHHHHHHhhcCCCCCCC
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS--ISEVFVTLSKIWSSSSDWDP 655 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt--~~evl~~L~~i~~~~~~~~~ 655 (669)
.-.+|........+|+++....+|.+|.. ...|-+.=.-.+-...||+-
T Consensus 637 ------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 637 ------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred ------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 12456666777889999999999999986 33333333334566677763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=265.99 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=176.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE------------------CCCeeEEEEecc-------cH-----------
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF------------------KGDDAAVKVMKG-------DV----------- 401 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~------------------~g~~vavK~~~~-------~~----------- 401 (669)
..|++.+ ++|+|+| |.||+|.+ ++..||||+++. +|
T Consensus 145 d~F~i~~-~LG~GgF-------G~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~ 216 (507)
T PLN03224 145 DDFQLRD-KLGGGNF-------GITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSA 216 (507)
T ss_pred cCceEee-EeecCCC-------eEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhccc
Confidence 3455554 4899999 99999964 245799999753 12
Q ss_pred ---HHHHHHHHhcCCCCc-----eeEeeEEEe--------cCceeEEEEecCCCCHHHHHhcCCC---------------
Q 005923 402 ---SSEINILKKINHSNI-----IRLSGFCVH--------EGNTYLVYEFADNGALSDWLHSNRY--------------- 450 (669)
Q Consensus 402 ---~~E~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------- 450 (669)
..|+.++.+++|.++ ++++++|.. ++..+|||||+++|+|.++|+....
T Consensus 217 e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~ 296 (507)
T PLN03224 217 ETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK 296 (507)
T ss_pred chhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence 236777777766554 778888763 3568999999999999999975311
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccce
Q 005923 451 ----QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526 (669)
Q Consensus 451 ----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 526 (669)
.....++|..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++........ .
T Consensus 297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-------~ 366 (507)
T PLN03224 297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-------N 366 (507)
T ss_pred hhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-------C
Confidence 01124678899999999999999999998 999999999999999999999999999765432210 1
Q ss_pred eeecccccccccccccccCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCchhHHHHHHH
Q 005923 527 TRHVVGTYGYMAPEYIENGVI----------------------TPKLDVFAFGVVVLELLSGRE-AVTGDQNCEAELLYA 583 (669)
Q Consensus 527 ~~~~~gt~~y~aPE~l~~~~~----------------------s~~sDV~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~ 583 (669)
.....+++.|+|||.+..... ..+.||||+||+++||++|.. |+.+......+.
T Consensus 367 ~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~--- 443 (507)
T PLN03224 367 PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL--- 443 (507)
T ss_pred ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH---
Confidence 112344789999998864321 234799999999999999875 554321111000
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL---NARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~evl~~ 642 (669)
.. ........+....................+|+.++|..+| .+|+|++|++.+
T Consensus 444 --~~---~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 444 --RQ---YDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --hh---ccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 0000000111111111111122334568899999999866 689999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=238.04 Aligned_cols=228 Identities=25% Similarity=0.423 Sum_probs=186.2
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
+|.|+| .+|..+++. .+.+|+|++|.+ +..|-.+..+- +||.+|-|..+|..+..+++|.
T Consensus 258 igrgsy-------akvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 258 IGRGSY-------AKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred ecCcch-------hhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 899999 788888774 567899998764 34566666665 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|.-++++. +.|+++....+..+|..||.|||+.+ |+.||||..|||+|..|++|+.|+|+++..-
T Consensus 331 eyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999888765 45999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCC--CCchhH---HHHHHHHHHHH
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT--GDQNCE---AELLYASISRV 588 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~--~~~~~~---~~~~~~~~~~~ 588 (669)
.+ ..++....||+.|+|||.+.+..|....|.|++||+|+||+.|+.||+ +.++.+ +..+++.+
T Consensus 403 ~~--------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--- 471 (593)
T KOG0695|consen 403 GP--------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--- 471 (593)
T ss_pred CC--------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH---
Confidence 33 245677899999999999999999999999999999999999999998 333221 12222221
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 635 (669)
++..+ ..|..+..+...+++.-|.+||.+|..
T Consensus 472 -------------lekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 472 -------------LEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------------hhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11112 234455556778899999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=240.72 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=190.2
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec-----Cce
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE-----GNT 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 429 (669)
-||-|.| |.||.... +|+.||+|++.. .+.+|+++|.-++|.|++..++...-. .+.
T Consensus 60 PIGYGAF-------GVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 60 PIGYGAF-------GVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cccccce-------eEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3899999 99999887 689999999853 466899999999999999998876432 357
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
|++.|.|.. +|.+.+- ....|+-..+.-+.+||++||.|||+.+ |.||||||.|.|+++|..+||+|||++
T Consensus 133 YV~TELmQS-DLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHh-hhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccc
Confidence 889999865 7877774 3457888999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
|..+.++. .-..+.+-|..|.|||.+.+ ..|+.+.||||.||++.||+..+..|.....-+. .+.+..+
T Consensus 204 Rvee~d~~-------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ---L~lItdL 273 (449)
T KOG0664|consen 204 RTWDQRDR-------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ---LQMIIDL 273 (449)
T ss_pred cccchhhh-------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH---HHHHHHH
Confidence 98765432 11234566899999999987 5699999999999999999998888875544322 1223333
Q ss_pred HhhhhH-----------Hhhhhccc-CCccCC----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 589 LEESNV-----------REKLRGFI-DPSLRN----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 589 ~~~~~~-----------~~~l~~~~-d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+..+.. ...++.-. .|.+.- ..+.+-..+...+...++..||+.|.+..+.+..+
T Consensus 274 LGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 274 LGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 322211 11122211 111111 11123334567888899999999999999988764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=250.90 Aligned_cols=196 Identities=26% Similarity=0.376 Sum_probs=161.8
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
||-|.| |.|.++.-. ...+|.|.+++ .+..|-+||..-..+-||+|+-.|.+++.+|+|||
T Consensus 637 iGvGAF-------GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 637 IGVGAF-------GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred eccccc-------ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 577888 888887653 34568888753 25679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|++||++..+|-+. +.+.+.....++.++..|+++.|..| +|||||||.|||||.+|++||.||||+.-+..
T Consensus 710 YIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999765 45788888889999999999999999 99999999999999999999999999864321
Q ss_pred Cc---cccCC-------c------------------------ccceeeecccccccccccccccCCCCchhhHHHHHHHH
Q 005923 515 DE---HEQGG-------Y------------------------GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560 (669)
Q Consensus 515 ~~---~~~~~-------~------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl 560 (669)
.. +...+ + ...+....+||..|+|||++....++..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 10 00000 0 00112245899999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCchhH
Q 005923 561 LELLSGREAVTGDQNCE 577 (669)
Q Consensus 561 ~elltg~~p~~~~~~~~ 577 (669)
+||+.|+.||..+...+
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999998766544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=224.41 Aligned_cols=203 Identities=37% Similarity=0.649 Sum_probs=178.0
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc--------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~--------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
+++|.+ |.||++... ++.+++|+.... +.+|++.+++++|++++++++++......++++||+
T Consensus 1 l~~g~~-------~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGF-------GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCc-------eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 367888 999999997 889999998643 778999999999999999999999989999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEEcccCCccccCCC
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGLARSAESD 515 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DfGla~~~~~~ 515 (669)
.+++|.+++.... ..+++..+..++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 74 ~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 74 EGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 9999999997541 35899999999999999999999998 999999999999999 899999999999876543
Q ss_pred ccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. ......+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 147 ~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------- 187 (215)
T cd00180 147 KS--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------- 187 (215)
T ss_pred cc--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence 21 12234567889999999887 889999999999999998
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
..+.+++.+|++.||.+||++.++++.|
T Consensus 188 ---------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2478999999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=246.83 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=193.4
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc------HHHHHHHHHhcCC------CCceeEeeEEEecCceeEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD------VSSEINILKKINH------SNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~------~~~E~~~l~~l~H------~niv~l~g~~~~~~~~~lV 432 (669)
.|.|-| ++|.+|.. .|..||||+++.. =..|+++|++|+. -|.++|+..|.+.+++|||
T Consensus 440 ~GkGvF-------s~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV 512 (752)
T KOG0670|consen 440 TGKGVF-------STVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV 512 (752)
T ss_pred ccccee-------eeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence 578888 88999987 4889999999753 2479999999963 4899999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEcccCCccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARS 511 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DfGla~~ 511 (669)
||-+. -+|.+.|++-. ..-.|....+..++.|++.||.+|..++ |+|.||||.|||+++. ..+||||||.|..
T Consensus 513 FE~Ls-lNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 513 FEPLS-LNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred ehhhh-chHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccc
Confidence 99996 49999998753 3345888999999999999999999999 9999999999999875 5689999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... .....-...|.|||.+.+-.|+...|+||.||.||||.||+..|.|..+....-+...+..-+..
T Consensus 587 ~~ene----------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 587 ASENE----------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred ccccc----------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 65433 12234466899999999999999999999999999999999999987765433332222211111
Q ss_pred hhHHh--h--------------------------hhcccCC------ccC--CCCc---HHHHHHHHHHHHHhcccCCCC
Q 005923 592 SNVRE--K--------------------------LRGFIDP------SLR--NEYP---LDLAFSMAQLAKNCTAHDLNA 632 (669)
Q Consensus 592 ~~~~~--~--------------------------l~~~~d~------~l~--~~~~---~~~~~~l~~li~~Cl~~dP~~ 632 (669)
...+. . +...+.| .+. ..+| ......+.+|+..|+..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 11000 0 0001111 000 1122 234566889999999999999
Q ss_pred CCCHHHHHHH
Q 005923 633 RPSISEVFVT 642 (669)
Q Consensus 633 RPt~~evl~~ 642 (669)
|.|..+.+++
T Consensus 737 Rit~nqAL~H 746 (752)
T KOG0670|consen 737 RITVNQALKH 746 (752)
T ss_pred cCCHHHHhcC
Confidence 9999998864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=217.58 Aligned_cols=255 Identities=19% Similarity=0.347 Sum_probs=191.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----cHHHHHHHHHhcC-CCCceeEeeEEEec--Cc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----DVSSEINILKKIN-HSNIIRLSGFCVHE--GN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~ 428 (669)
..|.+.. ++|.|.| ..||.|.. +.+.++||++|. .+.+|+.+|..+. ||||+.|+++..+. ..
T Consensus 38 ddYeivr-k~GRGKY-------SEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 38 DDYEIVR-KVGRGKY-------SEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred chHHHHH-HHcCccH-------hhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3455544 6899999 67999984 678899999964 6889999999997 99999999998754 45
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DfG 507 (669)
..||+||+.+.+..... ..|+...+..++.+++.||.|+|+.| |+|||+||.|+++|.. -.++|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred chhHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecc
Confidence 68999999998877665 34788889999999999999999999 9999999999999865 569999999
Q ss_pred CccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+|........ -+-.+.+..|.-||.+-. ..|....|+|||||++.+|+..++||..+.+... ..-.+.
T Consensus 179 LAEFYHp~~e---------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D--QLVkIa 247 (338)
T KOG0668|consen 179 LAEFYHPGKE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVKIA 247 (338)
T ss_pred hHhhcCCCce---------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH--HHHHHH
Confidence 9988755432 122456677889999854 7789999999999999999999999984433221 122334
Q ss_pred HHHhhhhHHhhhh---cccCCccCC--------C--------CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLR---GFIDPSLRN--------E--------YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~---~~~d~~l~~--------~--------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+++......+-+. --+||.+.. . ...-...+..+++.+.|..|-.+|||+.|.+.+
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 4444333221111 112222111 0 001123568899999999999999999998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=217.39 Aligned_cols=187 Identities=24% Similarity=0.392 Sum_probs=153.5
Q ss_pred HHHhCCCCcccceeeE--EEEEEECCCeeEEEEeccc--------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGS--VYRGSFKGDDAAVKVMKGD--------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~--Vy~g~~~g~~vavK~~~~~--------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 434 (669)
++|.|+| |. +|+-..+|.-.|+|.++.. ...|+++..+- ..|.+|.++|....++..++.||
T Consensus 53 elGrGay-------G~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 53 ELGRGAY-------GVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhcCCcc-------chhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4899999 65 4555668999999998753 34566655443 58999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
.|+- ||..|-++- ...+..+++.-+-+|+..+..||.|||++-+ ++|||+||+|||++.+|++|+||||++..+.+
T Consensus 126 ~M~t-Sldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred Hhhh-hHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9975 888876543 2345678999999999999999999998753 99999999999999999999999999987754
Q ss_pred CccccCCcccceeeeccccccccccccccc----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN----GVITPKLDVFAFGVVVLELLSGREAVTG 572 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~~sDV~S~Gvvl~elltg~~p~~~ 572 (669)
+-. ..-..|-.-|||||.+.. ..|+-|+||||+|+.+.||.+++.|+..
T Consensus 202 SiA---------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SIA---------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhH---------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 321 122456778999999854 4689999999999999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=229.07 Aligned_cols=232 Identities=25% Similarity=0.336 Sum_probs=175.5
Q ss_pred CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec------CceeEEEEecCCCCHHHHHhcCCCCC
Q 005923 388 KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE------GNTYLVYEFADNGALSDWLHSNRYQT 452 (669)
Q Consensus 388 ~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~ 452 (669)
.+..||+|++.. ...+|..++..++|+|+++++.+++-. .+.|+|||+|.. +|...++..
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e---- 114 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILME---- 114 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHh----
Confidence 478899988743 345799999999999999999999743 367999999975 999988732
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeeccc
Q 005923 453 SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532 (669)
Q Consensus 453 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~g 532 (669)
++-..+..|..|++.|++|||+.+ |+||||||+||++..++.+||.|||+|+....+ ......+.
T Consensus 115 ---lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---------~~mtpyVv 179 (369)
T KOG0665|consen 115 ---LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---------FMMTPYVV 179 (369)
T ss_pred ---cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---------cccCchhh
Confidence 677888999999999999999999 999999999999999999999999999975443 12344678
Q ss_pred ccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH--Hhh-------------
Q 005923 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV--REK------------- 597 (669)
Q Consensus 533 t~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------------- 597 (669)
|..|.|||++.+..+.+.+||||.||++.||++|+..|.|.+.-+ .+..+...++.... ...
T Consensus 180 tRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id---Q~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~ 256 (369)
T KOG0665|consen 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID---QWNKIIEQLGTPDPSFMKQLQPTVRNYVENRP 256 (369)
T ss_pred eeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH---HHHHHHHHhcCCCHHHHHHhhHHHHHHhhcCh
Confidence 899999999999889999999999999999999999988654321 11122222221110 000
Q ss_pred -------hhcccCCccCC--CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 598 -------LRGFIDPSLRN--EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 598 -------l~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
-+.+-|..+.. +.+.-....+.+++.+||-.||++|.++++++.+
T Consensus 257 ~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 257 QYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00111111111 1111122347899999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=232.96 Aligned_cols=122 Identities=25% Similarity=0.409 Sum_probs=103.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc------HHHHHHHHHhcC-----C---CCceeEeeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD------VSSEINILKKIN-----H---SNIIRLSGFC 423 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~------~~~E~~~l~~l~-----H---~niv~l~g~~ 423 (669)
|.... ++|.|-| .+||++.. ..+.||+|+.|.. ...||++|++++ | ..||+|++.|
T Consensus 80 Y~v~r-KLGWGHF-------STVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 80 YHVQR-KLGWGHF-------STVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred EEEEE-ecccccc-------ceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 44333 6999999 89999987 4678999999853 568999999984 3 3699999999
Q ss_pred Eec----CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee
Q 005923 424 VHE----GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL 495 (669)
Q Consensus 424 ~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl 495 (669)
... .+.+||+|++ |.+|..++... ..+.++...+.+|++||+.||.|||... .|||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 864 4789999999 56999999875 3467999999999999999999999764 39999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=268.49 Aligned_cols=205 Identities=17% Similarity=0.202 Sum_probs=141.8
Q ss_pred HHhcCC-CCceeEeeEE-------EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005923 408 LKKINH-SNIIRLSGFC-------VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT 479 (669)
Q Consensus 408 l~~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~ 479 (669)
.+.++| .||++++++| .+.+..++++||+ +++|.++|+.. ...+++.+++.++.||+.||+|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 345566 6888898887 3334678889988 45999999743 245999999999999999999999999
Q ss_pred CCCeEeeCCCCCCeeecCC-------------------CcEEEcccCCccccCCCccc-------cCCcc-cceeeeccc
Q 005923 480 NPPYVHKNLKTSNILLDTN-------------------LRAKITNFGLARSAESDEHE-------QGGYG-LQLTRHVVG 532 (669)
Q Consensus 480 ~~~ivHrDik~~NILl~~~-------------------~~~kl~DfGla~~~~~~~~~-------~~~~~-~~~~~~~~g 532 (669)
|+||||||+||||+.. +.+|++|||+++........ ..+.. ........|
T Consensus 101 ---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 101 ---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred ---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 9999999999999654 44556666666542110000 00000 000112457
Q ss_pred ccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcH
Q 005923 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPL 612 (669)
Q Consensus 533 t~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~ 612 (669)
|..|||||++.+..++.++|||||||+||||++|..|+..... . ...+ . ...+.+.. .
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~-~~~~----~--------~~~~~~~~-----~ 235 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----T-MSSL----R--------HRVLPPQI-----L 235 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----H-HHHH----H--------HhhcChhh-----h
Confidence 8899999999999999999999999999999998877542110 0 0000 0 00111111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 613 DLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 613 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.......+++.+||+.||.+||+|.|++++
T Consensus 236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 236 LNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 112345688999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=237.87 Aligned_cols=181 Identities=26% Similarity=0.409 Sum_probs=158.7
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc---------------HHHHHHHHHhcC---CCCceeEeeEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD---------------VSSEINILKKIN---HSNIIRLSGFCVH 425 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~---------------~~~E~~~l~~l~---H~niv~l~g~~~~ 425 (669)
++|.|.| |.|+.+.++ ...|+||.+.++ +-.|+.||..++ |+||++++.+|++
T Consensus 568 ~lG~GAy-------GkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 568 PLGEGAY-------GKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ecccccc-------ceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4799999 999999985 557889987532 446999999997 9999999999999
Q ss_pred cCceeEEEEecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 426 EGNTYLVYEFADN-GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 426 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++.+||+||-.-- -+|.+++..+ ..+++....-|+.||+.|+++||+++ |||||||-+||.++.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 9999999998644 4999999654 56999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVT 571 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~ 571 (669)
|||.+.....+. ....+||..|.|||++.+..| ...-|||++|++||-++....||.
T Consensus 713 dfgsaa~~ksgp----------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGP----------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCC----------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998766543 234689999999999999887 456899999999999998888875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=210.87 Aligned_cols=169 Identities=20% Similarity=0.247 Sum_probs=128.5
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccc
Q 005923 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518 (669)
Q Consensus 439 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~ 518 (669)
|+|.++++.. ...++|.+++.|+.|++.||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 7899999754 246999999999999999999999876 999999999999999 99988654321
Q ss_pred cCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhh
Q 005923 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKL 598 (669)
Q Consensus 519 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 598 (669)
..||..|||||++.+..++.++|||||||++|||++|+.||....... . ........ .
T Consensus 64 -----------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~---~~~~~~~~------~ 121 (176)
T smart00750 64 -----------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--A---ILEILLNG------M 121 (176)
T ss_pred -----------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--H---HHHHHHHH------h
Confidence 257899999999999999999999999999999999999987533211 0 01111100 0
Q ss_pred hcccCCccCCCCcHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 599 RGFIDPSLRNEYPLDLAF--SMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~--~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
... ++.. ...+..... .+.+++.+||+.||.+||++.|+++++..+..
T Consensus 122 ~~~-~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 122 PAD-DPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccC-Cccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 000 0000 011223333 68999999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=212.09 Aligned_cols=186 Identities=38% Similarity=0.585 Sum_probs=161.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEe
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 435 (669)
.++.|.| |.||++... ++.+++|.... .+.+|++.+++++|+|++++++++......++++||
T Consensus 6 ~i~~g~~-------~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 6 KLGEGAF-------GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred EeecCCC-------eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 3788889 999999985 58899998853 456799999999999999999999988999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+++++|.+++...+ ..+++..+..++.+++.++.|||+.+ ++|+||++.||+++.++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 79 CEGGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999999997642 11889999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccCCcccceeeeccccccccccccc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSGREAVTG 572 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~~sDV~S~Gvvl~elltg~~p~~~ 572 (669)
.. .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 152 ~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LA-------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cc-------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 20 012334677889999998 777888899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-24 Score=233.53 Aligned_cols=171 Identities=16% Similarity=0.156 Sum_probs=134.5
Q ss_pred eeeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeecccCCCC--------CC----cceeeee
Q 005923 61 YLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGG--------DG----DYYQFNT 128 (669)
Q Consensus 61 ~~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c~~~~--------~~----~~~~~~~ 128 (669)
+..|+|++ ||||+.||+.|| +++.+|+++|++. .+.|.+||.|.||..-.-.... .. .......
T Consensus 405 ~~~ytVk~-GDTL~sIA~kyg-VSv~~L~~~N~l~--s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~ 480 (592)
T PRK06347 405 AKVYTVVK-GDSLWRIANNNK-VTIANLKSWNNLK--SDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAK 480 (592)
T ss_pred ceeEEecC-CCCHHHHHHHhC-CCHHHHHHHhCCC--cceeccCcEEEEecCCcccccccccccccccccccccccccce
Confidence 56799998 999999999999 9999999999984 5689999999999753210000 00 0011225
Q ss_pred EEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEeeecCCCCccc-----ccCCceEEEEEEcCCCC
Q 005923 129 TYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQ-----AASGFNHLLTYMVTWGD 203 (669)
Q Consensus 129 ~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~~c~c~~~~~-----~~~~~~~~~tY~v~~GD 203 (669)
.|+|+ +|||||+|| ++|+ +++++|+++|++.++.|++||+|.||....-..... .........+|+|++||
T Consensus 481 ~YtVk-~GDTL~sIA-kkyg--VSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GD 556 (592)
T PRK06347 481 VYTVA-KGDSLWRIA-NNNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGD 556 (592)
T ss_pred eeeec-CCCCHHHHH-HHHC--CCHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCC
Confidence 79999 999999999 7888 999999999998877999999999998643211000 00011124689999999
Q ss_pred CHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccc
Q 005923 204 SISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVP 240 (669)
Q Consensus 204 tl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP 240 (669)
|||+||+||||++++|++||+|. .+.|+|||.|.|+
T Consensus 557 TL~sIA~KygvSv~~L~~~N~L~-~~~L~~GQ~L~I~ 592 (592)
T PRK06347 557 SLWAISRQYKTTVDNIKAWNKLT-SNMIHVGQKLTIK 592 (592)
T ss_pred cHHHHHHHhCCCHHHHHHhcCCC-cccCCCCCEEecC
Confidence 99999999999999999999996 5679999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-25 Score=235.36 Aligned_cols=236 Identities=24% Similarity=0.439 Sum_probs=189.5
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc-------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD-------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~-------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|.| |.|||++. .++.+|||++|-+ +++|+-+++.-+|||||.++|.+...+..++.|||+
T Consensus 22 rvgsgTy-------gdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 22 RVGSGTY-------GDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred eecCCcc-------cchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 4899999 99999987 5889999998742 568999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
.+|+|.+.-+. .+.|++.++..++++.+.||+|||+.+ =+|||||-.|||+++.+.+|++|||.+..+...
T Consensus 95 gggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 95 GGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred CCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 99999998764 367999999999999999999999999 899999999999999999999999998765432
Q ss_pred cccCCcccceeeeccccccccccccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
........||+.|||||+- ..+.|..++|||+.|+...|+---+.|...-.... .++ +
T Consensus 166 -------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~-----L----- 226 (829)
T KOG0576|consen 166 -------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALF-----L----- 226 (829)
T ss_pred -------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHH-----H-----
Confidence 2234557899999999986 45789999999999999999977776655322110 000 0
Q ss_pred HHhhhhcccC-CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 594 VREKLRGFID-PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 594 ~~~~l~~~~d-~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.-+...+ +.+++ +..-...+-++++.|+..+|++||+++.++.
T Consensus 227 ---mTkS~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 227 ---MTKSGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---hhccCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111122 22221 2233446789999999999999999986543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=209.14 Aligned_cols=230 Identities=23% Similarity=0.406 Sum_probs=185.6
Q ss_pred eEEEEEEECCCeeEEEEec---------ccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCC
Q 005923 380 GSVYRGSFKGDDAAVKVMK---------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRY 450 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~ 450 (669)
|..|+|+|.|..+++|+++ .+|..|.-.|+-+.||||+.++|.|....+..++..||+.|||...||..
T Consensus 204 gelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~-- 281 (448)
T KOG0195|consen 204 GELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ-- 281 (448)
T ss_pred cccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC--
Confidence 8999999999999888874 46888999999999999999999999999999999999999999999874
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc--ccCCccccCCCccccCCcccceee
Q 005923 451 QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT--NFGLARSAESDEHEQGGYGLQLTR 528 (669)
Q Consensus 451 ~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~~ 528 (669)
..-..+-.+.++++.++|+||+|||+.. |-|.---|.+..+++|++.+++|+ |--++. .. .
T Consensus 282 -t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--qe-------------~ 344 (448)
T KOG0195|consen 282 -TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE-------------V 344 (448)
T ss_pred -ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--ec-------------c
Confidence 3445778899999999999999999975 334455789999999999998875 322211 11 0
Q ss_pred ecccccccccccccccCCC---CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCc
Q 005923 529 HVVGTYGYMAPEYIENGVI---TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPS 605 (669)
Q Consensus 529 ~~~gt~~y~aPE~l~~~~~---s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~ 605 (669)
...-.+.||+||.+....- -.++|+|||.+++|||.|...||..-.+.+..+ ++.-++
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------------------kialeg 405 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------------------KIALEG 405 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------------------hhhhcc
Confidence 1233578999999976443 347999999999999999999998644432211 111234
Q ss_pred cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 606 LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 606 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
++...|......+.+||.-|+..||.+||.++.|+-.|+++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 566677778889999999999999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=203.89 Aligned_cols=244 Identities=20% Similarity=0.336 Sum_probs=172.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeE-EEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGF-CVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~-~~~~~ 427 (669)
..|.+.. .+|+|.| |.+.++..+ .+.+++|.+.. +|.+|..---.| .|.||+.-+++ |...+
T Consensus 24 d~y~I~k-~lgeG~F-------gkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 24 DVYTINK-QLGEGRF-------GKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhHHH-Hhcccce-------eeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 3466555 4999999 999999986 45789998865 455554433333 58999988765 45566
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee-cC-CCcEEEcc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL-DT-NLRAKITN 505 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl-~~-~~~~kl~D 505 (669)
.+.+++||++.|+|..-+.. ..+-+..-.+++.|++.|+.|||+++ +||||||.+|||| +. ..++|+||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred eEEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeee
Confidence 78899999999999987754 34778888999999999999999999 9999999999999 33 45899999
Q ss_pred cCCccccCCCccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchh-HHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNC-EAE 579 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~-~~~ 579 (669)
||+.+..+.- .....-+..|.+||.... -...+.+|+|.||++++.++||+.|+...... ..+
T Consensus 167 FG~t~k~g~t-----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y 235 (378)
T KOG1345|consen 167 FGLTRKVGTT-----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY 235 (378)
T ss_pred cccccccCce-----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH
Confidence 9999876432 223344567999998753 23467899999999999999999999832211 111
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+.+ . . .... ..+.+...+ ..+...+.++.++-+..++++|=-..++.+.-
T Consensus 236 ~~~--~-~---------w~~r-k~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 236 WEW--E-Q---------WLKR-KNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHH--H-H---------Hhcc-cCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111 0 0 0101 111111111 12334577888999999999995545544443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=216.46 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=186.8
Q ss_pred HHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEec-----ccHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMK-----GDVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~-----~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 434 (669)
++|.|.| ++||++.+ .+..||+|.+. ..+..|+++|..+. +.||+++.+++..++...+|+|
T Consensus 43 kigeGsF-------ssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 43 KIGEGSF-------SSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred cccccch-------hhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 5999999 89999976 35679999885 35789999999995 8999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEcccCCccccC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAE 513 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DfGla~~~~ 513 (669)
|+++-...+++.. ++...+..+++.++.||.|+|.+| ||||||||+|+|.+.. ++-.|.|||+|....
T Consensus 116 ~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred ccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999999863 778899999999999999999999 9999999999999864 678899999997211
Q ss_pred CCc------c-------c----------------cC-------Ccccceeeeccccccccccccccc-CCCCchhhHHHH
Q 005923 514 SDE------H-------E----------------QG-------GYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAF 556 (669)
Q Consensus 514 ~~~------~-------~----------------~~-------~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~ 556 (669)
... . . .. ...........||++|.|||++.. ...++++||||-
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 0 00 000011123579999999999865 667999999999
Q ss_pred HHHHHHHHcCCCCCCCCch-hHHHHHHH------HHHHH---Hhh------hh---HHhh---hhcc-cCCccC------
Q 005923 557 GVVVLELLSGREAVTGDQN-CEAELLYA------SISRV---LEE------SN---VREK---LRGF-IDPSLR------ 607 (669)
Q Consensus 557 Gvvl~elltg~~p~~~~~~-~~~~~~~~------~~~~~---~~~------~~---~~~~---l~~~-~d~~l~------ 607 (669)
||+++-+++++.||....+ .++-.... .+.+. ... .. ..+. .+.+ +.....
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999984322 11111110 11100 000 00 0000 1111 010011
Q ss_pred --CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 608 --NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 608 --~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+..+..+++|+.+|++.||.+|.|++|.+++
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11112233468999999999999999999998865
|
|
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=226.22 Aligned_cols=175 Identities=18% Similarity=0.164 Sum_probs=137.2
Q ss_pred eeeeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeecccCC------CCC-------Ccceee
Q 005923 60 AYLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSG------GGD-------GDYYQF 126 (669)
Q Consensus 60 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c~~------~~~-------~~~~~~ 126 (669)
.+..|+|+. ||||+.||+.|| +++++|+++|++ ..+.|.+||.|+||..-.-.. ... ......
T Consensus 329 ~~~~Y~V~s-GDTL~~IA~ryg-vSv~eL~~~N~l--~~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~ 404 (592)
T PRK06347 329 NAKIYTVVK-GDSLWRIANNHK-VTVANLKAWNNL--KSDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTN 404 (592)
T ss_pred CceEEEeCC-CCCHHHHHHHhC-CCHHHHHHHhCC--CccccccCcEEEEeccccccccccccccccccccccccccccC
Confidence 577899998 999999999999 999999999998 467999999999997421100 000 000112
Q ss_pred eeEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEeeecCC------CCccc-----ccCCceEEE
Q 005923 127 NTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCAC------PSRDQ-----AASGFNHLL 195 (669)
Q Consensus 127 ~~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~~c~c------~~~~~-----~~~~~~~~~ 195 (669)
...|+|+ +|||++.|| ++|+ ++..+|+++|++..+.|.+||.|.||..-.- +.... .+....-..
T Consensus 405 ~~~ytVk-~GDTL~sIA-~kyg--VSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~ 480 (592)
T PRK06347 405 AKVYTVV-KGDSLWRIA-NNNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAK 480 (592)
T ss_pred ceeEEec-CCCCHHHHH-HHhC--CCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccce
Confidence 3579999 999999999 7888 8899999999987778999999999974211 10000 000111235
Q ss_pred EEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCC
Q 005923 196 TYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKT 243 (669)
Q Consensus 196 tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~ 243 (669)
+|+|+.|||||+||+||||++++|++||++. .+.|+|||.|.||...
T Consensus 481 ~YtVk~GDTL~sIAkkygVSv~~L~~~N~l~-s~~L~~GQ~L~Ip~~~ 527 (592)
T PRK06347 481 VYTVAKGDSLWRIANNNKVTIANLKSWNNLK-SDFIYPGQKLKVSAGS 527 (592)
T ss_pred eeeecCCCCHHHHHHHHCCCHHHHHHhcCCC-cccccCCcEEEEecCc
Confidence 8999999999999999999999999999996 4689999999999865
|
|
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=205.21 Aligned_cols=168 Identities=15% Similarity=0.162 Sum_probs=128.2
Q ss_pred eecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCC-CC-CcEEEeeecccC-------C----CCCC----cceee
Q 005923 64 FRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLP-TD-TPVLIPVNCSCS-------G----GGDG----DYYQF 126 (669)
Q Consensus 64 y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~-~g-q~l~IP~~c~c~-------~----~~~~----~~~~~ 126 (669)
..+.. +.+|..||+++| ++.++|+++|... +...+. .| +.|+||....-. + ..++ .....
T Consensus 266 V~v~~-~i~L~~iA~~~g-vs~~eL~~LNP~~-kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~ 342 (456)
T PRK10783 266 VDLGQ-QIELAQAAEMAG-MSLTKLKTFNAGY-KRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLN 342 (456)
T ss_pred EecCC-CcCHHHHHHHcC-CCHHHHHHhCccc-cCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCC
Confidence 34433 779999999999 9999999999543 334333 34 678888753210 0 0000 00012
Q ss_pred eeEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEeeecCCCCcccccCCceEEEEEEcCCCCCHH
Q 005923 127 NTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSIS 206 (669)
Q Consensus 127 ~~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~~c~c~~~~~~~~~~~~~~tY~v~~GDtl~ 206 (669)
..+|+|+ +|||+++|| ++|+ ++.++|+++|++..+.|.+||+|.||..|.|.. .......++|+|++||||+
T Consensus 343 ~~~y~Vk-~GDTL~sIA-~r~g--vs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~----~~~~~~~~~Y~Vr~GDTL~ 414 (456)
T PRK10783 343 SRSYKVR-SGDTLSGIA-SRLN--VSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQR----LANNSDSITYRVRKGDSLS 414 (456)
T ss_pred ceEEEEC-CCCcHHHHH-HHHC--cCHHHHHHHcCCCcccCCCCCEEEecCCccccc----ccccccceeEEeCCCCCHH
Confidence 3579999 999999999 6776 778999999998777899999999998766532 1122335799999999999
Q ss_pred HHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCC
Q 005923 207 AIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKT 243 (669)
Q Consensus 207 ~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~ 243 (669)
+||+||||++++|++||++..+ .|+|||+|.|++..
T Consensus 415 sIA~kygVtv~~L~~~N~l~~~-~L~pGq~L~l~v~~ 450 (456)
T PRK10783 415 SIAKRHGVNIKDVMRWNSDTAK-NLQPGDKLTLFVKN 450 (456)
T ss_pred HHHHHhCCCHHHHHHhcCCCCC-cCCCCCEEEEecCC
Confidence 9999999999999999998655 99999999998765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-19 Score=191.30 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=192.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCC---eeEEEEecc-------cHHHHHHHHHhcCC----CCceeEeeEE-
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGD---DAAVKVMKG-------DVSSEINILKKINH----SNIIRLSGFC- 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~---~vavK~~~~-------~~~~E~~~l~~l~H----~niv~l~g~~- 423 (669)
.|++.. ++|.|.| |.||.+..... .+|+|.... .+..|..++..+.+ +++..+++..
T Consensus 19 ~~~i~~-~iG~G~f-------G~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGK-KIGEGGF-------GAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEee-eccccCC-------ceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 455555 5999999 99999998543 588888753 36789999999973 5888888888
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-----
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN----- 498 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~----- 498 (669)
..++..++||+.+ |.+|.++.... ..+.++....++|+.|++.+|++||+.+ ++||||||.|+++...
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~ 163 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEV 163 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCccc
Confidence 4677889999988 67999988654 2467999999999999999999999999 9999999999999764
Q ss_pred CcEEEcccCCccccC--CCccccCCcccce-eeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 499 LRAKITNFGLARSAE--SDEHEQGGYGLQL-TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 499 ~~~kl~DfGla~~~~--~~~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
..+.|.|||+++... ....... ..... .....||.+|+++.+..+...+.+.|+||++.++.|++.|..|+.+...
T Consensus 164 ~~~~llDfGlar~~~~~~~~~~~~-~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 164 RTLYLLDFGLARRFKYVGDSGGNL-RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ceEEEEecCCCccccccCCCCccc-ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 468999999999332 2211100 00011 1235699999999999999999999999999999999999999875432
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
..... ....... ...... .....+.++.+++..+-..+..++|....+...|+.+....
T Consensus 243 ~~~~~---~~~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 243 TDLKS---KFEKDPR--------KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred cchHH---HHHHHhh--------hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 21111 1100000 000110 12223345667777777799999999999999998887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=179.78 Aligned_cols=254 Identities=18% Similarity=0.240 Sum_probs=196.1
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec-----ccHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK-----GDVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
+||+|+| |..+.|+. +++.||||... ..+..|.+..+.|. .++|...+-+-.++.+-.||+|.+
T Consensus 35 KIGeGsF-------G~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 35 KIGEGSF-------GVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccccCcc-------eeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 7999999 99999975 89999999863 24788999999885 689999888877788889999998
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-----CcEEEcccCCcccc
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-----LRAKITNFGLARSA 512 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-----~~~kl~DfGla~~~ 512 (669)
|.||.|++.-. ++.++.+.+..||.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+..
T Consensus 107 GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 67999988643 467999999999999999999999999 9999999999999643 45889999999987
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
.+.....+. ...-.....||.+||+--...+...+.+.|+-|+|.|++..|-|..||.|-........++.|..-....
T Consensus 180 rDp~TkqHI-PYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHI-PYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccC-ccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 655443331 1233445789999999999999999999999999999999999999999754332233333332111111
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
.+ . ...+..+.++...++..=..+-.+-|..+-+...+..++.
T Consensus 259 ~i----~---------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 259 PI----E---------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred CH----H---------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11 1 1112345567777777777888888998877776666653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=195.87 Aligned_cols=160 Identities=21% Similarity=0.214 Sum_probs=120.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE---CCCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF---KGDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~---~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|.+.+. +|.|.| |+||+|.. .+..+|||+... .+.+|+++|++++|+|++..+..
T Consensus 19 ~Y~~~~~-IG~G~f-------g~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 19 RFVETAV-LKRDVF-------STVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred CceEccE-EeecCc-------EEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 4555553 899999 99999987 356679998531 26789999999999999853322
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC-CCCCeeecCCCcEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNL-KTSNILLDTNLRAK 502 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDi-k~~NILl~~~~~~k 502 (669)
.+..+|||||+++++|.. +... . ...++.+++.+|.|||+.+ |+|||| ||+|||++.++.+|
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~~~-----~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-ARPH-----G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hCcc-----c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 256899999999999963 2110 1 1467889999999999999 999999 99999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeeccccccccccccccc
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN 544 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 544 (669)
|+|||+++.................+...++..|+|||.+.-
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999997754321110000011245778889999999854
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-18 Score=180.26 Aligned_cols=252 Identities=31% Similarity=0.456 Sum_probs=188.3
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecc----------cHHHHHHHHHhcCCC-CceeEeeEEEecCceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG----------DVSSEINILKKINHS-NIIRLSGFCVHEGNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~----------~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~ 435 (669)
+|.|.| |.||++... ..+++|.+.. .+.+|+.++..+.|+ +++++..++......++++++
T Consensus 8 l~~g~~-------~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 8 LGEGSF-------GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ecCCCC-------eEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 678999 999999988 7788888753 366889999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfGla~~~~~ 514 (669)
+.+++|.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||+++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999777654211 36889999999999999999999999 99999999999999988 799999999986544
Q ss_pred CccccCCcccceeeeccccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCchh-HHHHHHHHHHHHHh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQNC-EAELLYASISRVLE 590 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~ 590 (669)
....... ........|+..|++||.+.+ ...+...|+|++|++++++++|..|+...... ..... ...+.
T Consensus 155 ~~~~~~~--~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~----~~~~~ 228 (384)
T COG0515 155 PGSTSSI--PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT----LKIIL 228 (384)
T ss_pred CCccccc--cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH----HHHHH
Confidence 3211000 012456789999999999988 68899999999999999999999997654321 00000 00110
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .............+......+.+++..|+..+|..|.++.+....
T Consensus 229 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 EL-----PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hc-----CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000011111112223567899999999999999999988875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=170.01 Aligned_cols=253 Identities=19% Similarity=0.295 Sum_probs=193.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-----cHHHHHHHHHhcCC-CCceeEeeEEEecCceeEEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-----DVSSEINILKKINH-SNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
++|.|+| |.+|.|.. +|+.||||..+. .+..|..+...++| ..|..+..|..++..-.||||.+
T Consensus 22 kiGsGSF-------GdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 22 KIGSGSF-------GDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred eecCCch-------hheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 5999999 99999987 799999999865 46789999999975 67788888888888999999998
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC---CcEEEcccCCccccCC
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN---LRAKITNFGLARSAES 514 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~DfGla~~~~~ 514 (669)
|.||.+.+.-. .+.++-+.++.++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.++|||+|+...+
T Consensus 94 GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 94 GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 67999988643 456899999999999999999999999 9999999999998644 4578999999998755
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.....+ -.....+...||.+|.+--...+-..+.+.|+-|+|.||..+.-|..||.+-........++.+ .+..
T Consensus 167 ~~t~~H-Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---~EkK-- 240 (341)
T KOG1163|consen 167 IRTRQH-IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---SEKK-- 240 (341)
T ss_pred cccccc-CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---HHhh--
Confidence 433322 1123345678999999999988888899999999999999999999999976543222222222 1110
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
+.. ..+......+.++.-.+..|=..--++-|...-+-+.+.-+.
T Consensus 241 ---~s~-----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 241 ---MST-----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred ---cCC-----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 000 001111233456777888888888888898877666655443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=210.91 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=180.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc--------cHHH---HHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG--------DVSS---EINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~--------~~~~---E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.+.+.+ .+|.++| -+|.+++.+...|+||++-. .+.+ |++ ...++|||.+.+.-+-..+.
T Consensus 24 e~~~~~-~LGstRF-------lKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k 94 (1431)
T KOG1240|consen 24 ECHYVE-NLGSTRF-------LKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK 94 (1431)
T ss_pred ceeeec-ccCchhh-------hhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence 344545 4899999 78999998777799999832 2333 444 45568999999998877777
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..|||-+|+.+ +|.|.|..+ ..|...+.+-|+.|++.||..+|..+ |+|||||.+||||+.-..+.|+||.
T Consensus 95 AAylvRqyvkh-nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhccc
Confidence 88999999977 999999754 56778888889999999999999999 9999999999999999999999998
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC-----------CCCchhhHHHHHHHHHHHHc-CCCCCCCCch
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-----------VITPKLDVFAFGVVVLELLS-GREAVTGDQN 575 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~ 575 (669)
-.+...-.++..+.+.....+... -..|+|||.+-.. ..+++.||||.|||+.||++ |+.+|.-.
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrR-RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-- 242 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRR-RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-- 242 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCc-eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence 887654444333334333333322 2379999988531 26789999999999999998 56666421
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
.+.+.... +.......++++-|. .++.|+..|++.||.+|.++++.++.-
T Consensus 243 ----QL~aYr~~--~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 243 ----QLLAYRSG--NADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ----HHHhHhcc--CccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11111100 011112223333333 367999999999999999999999873
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=195.75 Aligned_cols=221 Identities=24% Similarity=0.360 Sum_probs=164.8
Q ss_pred HHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 005923 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487 (669)
Q Consensus 408 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrD 487 (669)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+... ...++|.-...+.++|+.||+|||... -..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence 46789999999999999999999999999999999999864 345899999999999999999999754 239999
Q ss_pred CCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-------CCCchhhHHHHHHHH
Q 005923 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-------VITPKLDVFAFGVVV 560 (669)
Q Consensus 488 ik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~s~~sDV~S~Gvvl 560 (669)
++++|+++|..+.+|++|||+.......... .......-...|.|||.+.+. ..+.+.||||||+++
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~------~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEP------EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccc------cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 9999999999999999999999876431100 001112234579999999763 147789999999999
Q ss_pred HHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005923 561 LELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640 (669)
Q Consensus 561 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 640 (669)
+|+++.+.||......+.. .+.+..+.. .-...+.|.+.... +...++..++.+||..+|.+||+++.|-
T Consensus 149 ~ei~~r~~~~~~~~~~~~~--~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 149 YEILFRSGPFDLRNLVEDP--DEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHHhccCccccccccCCh--HHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 9999999999853221111 111111111 01111112221111 3444789999999999999999999999
Q ss_pred HHHHHhhcCC
Q 005923 641 VTLSKIWSSS 650 (669)
Q Consensus 641 ~~L~~i~~~~ 650 (669)
..++.+....
T Consensus 219 ~~~~~~~~~~ 228 (484)
T KOG1023|consen 219 SKLLTINKGG 228 (484)
T ss_pred hhhhhhcccc
Confidence 9998887643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-20 Score=208.14 Aligned_cols=217 Identities=20% Similarity=0.238 Sum_probs=165.0
Q ss_pred HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005923 401 VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480 (669)
Q Consensus 401 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 480 (669)
+..|+-+-..++|+|++..+..+.+....+-+|||+++ +|..++... ..++...+-.++.|++.|++|||+.+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC-
Confidence 34466666678999999888887777666666999999 999999754 35888889999999999999999999
Q ss_pred CCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCch-hhHHHHHHH
Q 005923 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK-LDVFAFGVV 559 (669)
Q Consensus 481 ~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~-sDV~S~Gvv 559 (669)
+.|||+|++|+++..++.+||+|||.+.....+.... ........|.-.|+|||.+.+..|.+. .||||.|++
T Consensus 441 --iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~----~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii 514 (601)
T KOG0590|consen 441 --LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN----IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGII 514 (601)
T ss_pred --ceeccCccccEEEecCCceEEeecCcceeeccCcchh----hhhhcCcccCCcCcCcccccccccCcchhhhhhccce
Confidence 9999999999999999999999999998775543211 133445788999999999999999775 799999999
Q ss_pred HHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005923 560 VLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639 (669)
Q Consensus 560 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 639 (669)
+..|++|+.||......+... ... .....+-........-..++.+...++.++|+.||.+|.|+++|
T Consensus 515 ~~~m~~~~~~Wk~a~~~~~~~--------~~~----~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i 582 (601)
T KOG0590|consen 515 YICMILGRFPWKVAKKSDNSF--------KTN----NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQI 582 (601)
T ss_pred EEEEecCCCccccccccccch--------hhh----ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHH
Confidence 999999999987432211100 000 00000000011112224566778899999999999999999999
Q ss_pred HHH
Q 005923 640 FVT 642 (669)
Q Consensus 640 l~~ 642 (669)
++.
T Consensus 583 ~~d 585 (601)
T KOG0590|consen 583 LND 585 (601)
T ss_pred hhC
Confidence 863
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-18 Score=164.96 Aligned_cols=130 Identities=20% Similarity=0.273 Sum_probs=103.8
Q ss_pred HHHhCCCCcccceeeEEEEEEE-CCCeeEEEEeccc----------------H-----------------HHHHHHHHhc
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKGD----------------V-----------------SSEINILKKI 411 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~~----------------~-----------------~~E~~~l~~l 411 (669)
.+|+|+| |.||+|.. +|+.||||+++.+ | ..|++.+.++
T Consensus 4 ~ig~G~~-------~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05147 4 CISTGKE-------ANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL 76 (190)
T ss_pred ccccccc-------eEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4899999 99999997 5889999998642 1 1389999999
Q ss_pred CCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeeCCCC
Q 005923 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL-HKYTNPPYVHKNLKT 490 (669)
Q Consensus 412 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivHrDik~ 490 (669)
.|+++.....+. ....+|||||+++++|....... ..+++....+++.|++.+|.|| |+.+ |+||||||
T Consensus 77 ~~~~v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP 146 (190)
T cd05147 77 VTAGIPCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSE 146 (190)
T ss_pred HHCCCCCCcEEE--ecCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCH
Confidence 887764333222 22348999999988776553222 3588999999999999999999 6888 99999999
Q ss_pred CCeeecCCCcEEEcccCCccccC
Q 005923 491 SNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 491 ~NILl~~~~~~kl~DfGla~~~~ 513 (669)
+|||++ ++.++|+|||+|....
T Consensus 147 ~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 147 YNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HHEEEE-CCcEEEEEccccccCC
Confidence 999998 4789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=161.09 Aligned_cols=130 Identities=22% Similarity=0.273 Sum_probs=105.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-CCeeEEEEeccc---------------------------------HHHHHHHHHhc
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKGD---------------------------------VSSEINILKKI 411 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~~---------------------------------~~~E~~~l~~l 411 (669)
.+|.|+| |.||+|... |+.||||+++.. +..|.+.+.++
T Consensus 4 ~ig~G~~-------~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05145 4 CISTGKE-------ANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL 76 (190)
T ss_pred eeecCCC-------cEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 3789999 999999984 999999998642 13578899999
Q ss_pred CCCCceeEeeEEEecCceeEEEEecCCCCHHHH-HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCC
Q 005923 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW-LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLK 489 (669)
Q Consensus 412 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik 489 (669)
.|+++.....+... ..+|||||++++++... +.. ..++.....+++.|++.++.+||+ .+ |+|||||
T Consensus 77 ~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 77 YEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred HhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 99987544443322 34899999998855443 432 247788999999999999999999 88 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+|||++ ++.++|+|||+++....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999999 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-18 Score=187.18 Aligned_cols=220 Identities=28% Similarity=0.375 Sum_probs=179.4
Q ss_pred CCCeeEEEEecc---------cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCC
Q 005923 388 KGDDAAVKVMKG---------DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLT 457 (669)
Q Consensus 388 ~g~~vavK~~~~---------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~ 457 (669)
.|.-+|.|+.+. ....|..++..++ ||.+|++.-.+..+...+++++|..+|.|...+.+. ..++
T Consensus 21 a~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~-----~~f~ 95 (612)
T KOG0603|consen 21 AGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE-----VMFD 95 (612)
T ss_pred ccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccC-----CchH
Confidence 345556655532 2446888899887 999999999999999999999999999999888654 4577
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccc
Q 005923 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYM 537 (669)
Q Consensus 458 ~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 537 (669)
......+...++-+++++|+.+ ++|||+|++||+++.+|++|+.|||+++..-.... .+||..||
T Consensus 96 ~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------------~cgt~eym 160 (612)
T KOG0603|consen 96 ELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------------ACGTYEYR 160 (612)
T ss_pred HHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh------------cccchhhh
Confidence 7778888999999999999999 99999999999999999999999999997654321 17899999
Q ss_pred cccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHH
Q 005923 538 APEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFS 617 (669)
Q Consensus 538 aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~ 617 (669)
|||++. ......|.||||++++||++|..||.++. ...++ ......|......
T Consensus 161 ApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----------~~~Il---------------~~~~~~p~~l~~~ 213 (612)
T KOG0603|consen 161 APEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----------MKRIL---------------KAELEMPRELSAE 213 (612)
T ss_pred hhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----------HHHHh---------------hhccCCchhhhHH
Confidence 999998 55778999999999999999999997611 11111 1124567788888
Q ss_pred HHHHHHHhcccCCCCCCCH--HHHHHHHHHhhcCCCCCC
Q 005923 618 MAQLAKNCTAHDLNARPSI--SEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 618 l~~li~~Cl~~dP~~RPt~--~evl~~L~~i~~~~~~~~ 654 (669)
+.+++..+...+|..|.-. ..+.+.++--.-...+|+
T Consensus 214 a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 214 ARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 9999999999999999866 577777777777778887
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=159.58 Aligned_cols=183 Identities=15% Similarity=0.122 Sum_probs=134.9
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----------cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----------DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 433 (669)
.++.|.| |+||.....+..++.+.+.. .+.+|+++|++++ |+++++++++ +..+++|
T Consensus 9 ~l~~~~f-------~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 9 PLKSDTF-------GRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred eecCCCc-------ceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3788999 99998877788888776642 2678999999995 5889999886 3569999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC-CCCCeeecCCCcEEEcccCCcccc
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNL-KTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDi-k~~NILl~~~~~~kl~DfGla~~~ 512 (669)
||+.|.+|.+.+.. ....++.|++.+|+++|+++ |+|||| ||.|||+++++.++|+|||++...
T Consensus 78 eyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 78 SYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred eeecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 99999998654321 11357789999999999999 999999 799999999999999999999865
Q ss_pred CCCccc-----cCCcccceeeeccccccccccccccc-CCCC-chhhHHHHHHHHHHHHcCCCCCCCCc
Q 005923 513 ESDEHE-----QGGYGLQLTRHVVGTYGYMAPEYIEN-GVIT-PKLDVFAFGVVVLELLSGREAVTGDQ 574 (669)
Q Consensus 513 ~~~~~~-----~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s-~~sDV~S~Gvvl~elltg~~p~~~~~ 574 (669)
...... ..........-...++.|+.|+-..- ...+ ...+.++-|.-+|.++|++.+..++.
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 432210 00000000111235666777765432 2333 57899999999999999998887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=166.08 Aligned_cols=201 Identities=22% Similarity=0.306 Sum_probs=143.0
Q ss_pred CCCCceeEeeEEEe---------------------------cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHH
Q 005923 412 NHSNIIRLSGFCVH---------------------------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464 (669)
Q Consensus 412 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 464 (669)
+|||||++.++|.+ ...+|+||...+. +|.++|..+ ..+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHHH
Confidence 69999999988763 2357999999876 999999754 3666777789
Q ss_pred HHHHHHHHHHHHhCCCCCeEeeCCCCCCeee--cCCC--cEEEcccCCccccCCCccccCCcccceeeeccccccccccc
Q 005923 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILL--DTNL--RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540 (669)
Q Consensus 465 ~~qia~~L~yLH~~~~~~ivHrDik~~NILl--~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 540 (669)
+.|+++|+.|||.++ +.|||+|++|||+ |+|. .+.|+|||.+-.-....-.. .+. ...-..-|....||||
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlql-py~-S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQL-PYE-SDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecccccccc-ccc-cccccCCCcceecchh
Confidence 999999999999999 9999999999999 4443 46889999886433211000 000 0011234677899999
Q ss_pred ccccCCC------CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHH
Q 005923 541 YIENGVI------TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDL 614 (669)
Q Consensus 541 ~l~~~~~------s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 614 (669)
+.....- -.|+|.|+.|.+.||++....||.+... ..... +..-+..+ ...|+.+
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe----m~L~~--------------r~Yqe~qL-Palp~~v 482 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE----MLLDT--------------RTYQESQL-PALPSRV 482 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch----heech--------------hhhhhhhC-CCCcccC
Confidence 8864321 2489999999999999999999986432 11000 00000111 3446677
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 615 AFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 615 ~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+..+.+|+...|+.||.+|++.+-..-.|
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 77889999999999999999977555444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=162.49 Aligned_cols=154 Identities=12% Similarity=0.117 Sum_probs=121.6
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEeccc----------------HHHHHHHHHhcCCCCceeEeeEEEec----
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----------------VSSEINILKKINHSNIIRLSGFCVHE---- 426 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~----------------~~~E~~~l~~l~H~niv~l~g~~~~~---- 426 (669)
++.|.| |.||....++..+|||.++.. +++|++.+.+++|++|..+..++...
T Consensus 39 l~~~~f-------~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 39 FRNIDD-------TKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred ecCCCc-------eEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 578888 999998777889999999631 46889999999999999998886533
Q ss_pred ----CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 427 ----GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 427 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+..+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||++|+||++++++ ++
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EE
Confidence 35799999999999988742 222 24569999999999999 99999999999999988 99
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ell 564 (669)
|+|||..+........ ..++....+..++|+|+||+.+.-+.
T Consensus 175 liDfg~~~~~~e~~a~--------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH--------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999998766332110 01334445567899999999877553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=183.71 Aligned_cols=182 Identities=23% Similarity=0.300 Sum_probs=148.8
Q ss_pred HHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecccHHHHHH----HHHhcC---CCCceeEeeEEEecCceeEEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKGDVSSEIN----ILKKIN---HSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~~~~~E~~----~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
++|.|+| |+||+|.. +|+.||+|+-+.--..|+. ++.||+ -+.|..+...+...+..+||+||.+
T Consensus 705 e~G~g~y-------~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 705 EIGEGSY-------GSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred eeccccc-------eEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 4899999 99999987 6889999999875555544 344444 2334444444555677899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-------CCCcEEEcccCCcc
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-------TNLRAKITNFGLAR 510 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~-------~~~~~kl~DfGla~ 510 (669)
.|+|.+++... +.++|..++.++.|+++-+++||..+ |||+||||+|+||. +...++|+|||.+.
T Consensus 778 ~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 778 YGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred cccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999999744 56899999999999999999999999 99999999999993 23468999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE 568 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~ 568 (669)
.+.--.. .......++|-.+-++|...|..++.+.|.|.+..+++-||.|+.
T Consensus 850 Dm~lfp~------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPD------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCC------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 7643221 234566789999999999999999999999999999999998864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=159.77 Aligned_cols=219 Identities=21% Similarity=0.268 Sum_probs=139.1
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcC----------CCCceeEeeEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKIN----------HSNIIRLSGFCV 424 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~----------H~niv~l~g~~~ 424 (669)
++.|.| +.||.++.. +++.|||+... ++.+|.-....+. |-.++--++...
T Consensus 20 i~~g~~-------~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 20 IGKGGF-------SIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEETT-------EEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred cccCCc-------eEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 888999 999999995 58999998731 2333333333321 211211111111
Q ss_pred ---------ecC--------ceeEEEEecCCCCHHHHHh---cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005923 425 ---------HEG--------NTYLVYEFADNGALSDWLH---SNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484 (669)
Q Consensus 425 ---------~~~--------~~~lV~e~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv 484 (669)
... +.+++|+-+. ++|.+++. ... .....+....++.+..|+++.+++||+++ +|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~-~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRA-QTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcc-cccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 111 3477888885 58888754 221 11233556677888899999999999999 99
Q ss_pred eeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc--------CCCCchhhHHHH
Q 005923 485 HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--------GVITPKLDVFAF 556 (669)
Q Consensus 485 HrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDV~S~ 556 (669)
|+||+++|+|++.+|.++|+||+.....+... .....+..|.+||.... -.++.+.|.|++
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCcee-----------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 99999999999999999999998876554321 11344578999997754 247889999999
Q ss_pred HHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCC
Q 005923 557 GVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633 (669)
Q Consensus 557 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 633 (669)
|+++|.|+++..||......... + .. -..+. +.+..+.+||..+|+.||.+|
T Consensus 237 G~~ly~lWC~~lPf~~~~~~~~~----------------~-------~~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 237 GITLYSLWCGRLPFGLSSPEADP----------------E-------WD-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHSS-STCCCGGGSTS----------------G-------GG-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCCCCCCccccc----------------c-------cc-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999854321100 0 01 12444 778889999999999999988
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-17 Score=174.50 Aligned_cols=180 Identities=29% Similarity=0.454 Sum_probs=135.4
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
...|+.|+++..++|.+||.+.+ .....+|...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence 35789999999999999998664 44567889999999999999999 67 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
|+........... ..........||..||+||.+.+..|+.|+||||+|++|+|++. -...+....
T Consensus 401 gl~ts~~~~~~~~--~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------- 467 (516)
T KOG1033|consen 401 GLVTSQDKDETVA--PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------- 467 (516)
T ss_pred hheeecccCCccc--chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------
Confidence 9998775543110 11233455789999999999999999999999999999999997 222221100
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 639 (669)
.+ .+.-...++|....++|. =+.|+.+++...|.+||++.++
T Consensus 468 --t~-----~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 --TL-----TDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --hh-----hhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 00 011122333333334443 3589999999999999955443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.7e-16 Score=152.08 Aligned_cols=126 Identities=17% Similarity=0.218 Sum_probs=98.9
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-------cHHHHHHHHHhc-----CCCCceeEeeEEEecC---c-e
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-------DVSSEINILKKI-----NHSNIIRLSGFCVHEG---N-T 429 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~ 429 (669)
.+|+|+| |.||.....+.. +||++.. ++.+|+++++++ +||||++++|++..+. . .
T Consensus 9 ~LG~G~~-------~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 9 PLGTGRH-------RKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred eecCCCc-------eEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4899999 999973323333 6888753 478899999999 5799999999998763 3 3
Q ss_pred eEEEEe--cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeeCCCCCCeeecC----CCcEE
Q 005923 430 YLVYEF--ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL-NYLHKYTNPPYVHKNLKTSNILLDT----NLRAK 502 (669)
Q Consensus 430 ~lV~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~ivHrDik~~NILl~~----~~~~k 502 (669)
.+|+|| ..+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +++++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEE
Confidence 378999 5579999999653 25554 35678888887 9999999 999999999999974 34899
Q ss_pred EcccCCcc
Q 005923 503 ITNFGLAR 510 (669)
Q Consensus 503 l~DfGla~ 510 (669)
|+||+.++
T Consensus 150 LiDg~G~~ 157 (210)
T PRK10345 150 VCDNIGES 157 (210)
T ss_pred EEECCCCc
Confidence 99955544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=151.67 Aligned_cols=126 Identities=24% Similarity=0.392 Sum_probs=110.7
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.+|+|.+ |.||+|.+.|..+++|..+. .+.+|+.++.+++|+++.....++...+..+
T Consensus 3 ~l~~G~~-------~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 3 LIKRGAE-------AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI 75 (211)
T ss_pred ccccCce-------EEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence 3789999 99999999999999997542 2457899999999999888777777778889
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++
T Consensus 76 lv~e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEEEEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999999999998643 12 78899999999999999999 99999999999999 7899999999987
Q ss_pred c
Q 005923 511 S 511 (669)
Q Consensus 511 ~ 511 (669)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 5
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=149.11 Aligned_cols=123 Identities=24% Similarity=0.387 Sum_probs=104.3
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
+|.|+| |.||+|.++|..+++|.... .+.+|++++..++|+++.....++......++
T Consensus 2 ig~G~~-------~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 2 IAKGAE-------AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCce-------EEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEE
Confidence 678999 99999999999999998532 23469999999998876555555556777899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||+++.
T Consensus 75 v~e~~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEECCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999999886431 0 78999999999999999 99999999999999 89999999999876
Q ss_pred c
Q 005923 512 A 512 (669)
Q Consensus 512 ~ 512 (669)
.
T Consensus 139 ~ 139 (199)
T TIGR03724 139 S 139 (199)
T ss_pred C
Confidence 4
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.7e-15 Score=166.47 Aligned_cols=123 Identities=24% Similarity=0.363 Sum_probs=106.9
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEec---------------ccHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK---------------GDVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.+|.|.| |.||+|.+.+..+++|+.. ..+.+|++++++++|++++....++......+
T Consensus 340 ~iG~G~~-------g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 340 LIGKGAE-------ADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred eeccCCc-------EEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 5899999 9999999987776665431 12567999999999999998888887777889
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 413 lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 9999999999999884 34678999999999999999 9999999999999 67899999999998
Q ss_pred cc
Q 005923 511 SA 512 (669)
Q Consensus 511 ~~ 512 (669)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.7e-15 Score=147.95 Aligned_cols=134 Identities=19% Similarity=0.248 Sum_probs=105.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEE---ECCCeeEEEEeccc-------------------------------HHHHH
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGS---FKGDDAAVKVMKGD-------------------------------VSSEI 405 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~---~~g~~vavK~~~~~-------------------------------~~~E~ 405 (669)
|.+.+ .+|+|+| |.||+|. .+|..||+|.++.. +..|+
T Consensus 30 ~~i~~-~Lg~G~~-------g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 30 SAIGG-CISTGKE-------ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHhCC-eeccCcc-------eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 44555 4899999 9999998 36899999988631 34699
Q ss_pred HHHHhcCCC--CceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005923 406 NILKKINHS--NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPY 483 (669)
Q Consensus 406 ~~l~~l~H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 483 (669)
+.++++.+. .+.+++++ ...++||||+++++|..+.... ..+.......++.|++.++.+||+.+ .+
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g--~i 170 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG--EL 170 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC--CE
Confidence 999999753 34444443 2458999999998887765322 23556677899999999999999876 39
Q ss_pred EeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 484 VHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 484 vHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
+||||||+||+++ ++.++|+|||.+....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.2e-15 Score=170.25 Aligned_cols=225 Identities=25% Similarity=0.371 Sum_probs=149.4
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHH
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 444 (669)
+..|.| |.||..+.+ .+..|.|.-++.+.-. .++.....|.+| |+=.+.
T Consensus 91 isngAy-------gavylvrh~~trqrfa~kiNkq~lilR-nilt~a~npfvv---------------------gDc~tl 141 (1205)
T KOG0606|consen 91 ISNGAY-------GAVYLVRHKETRQRFAMKINKQNLILR-NILTFAGNPFVV---------------------GDCATL 141 (1205)
T ss_pred eccCCC-------Cceeeeeccccccchhhcccccchhhh-ccccccCCccee---------------------chhhhh
Confidence 678888 999999775 5667776544332100 022222333333 444445
Q ss_pred HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccc--cC--
Q 005923 445 LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE--QG-- 520 (669)
Q Consensus 445 l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~--~~-- 520 (669)
++.. +.+.- +++.+++|||+.+ |+|||+||.|.+|+.-|++|+.|||+++........ ..
T Consensus 142 lk~~-----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 142 LKNI-----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred cccC-----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 5432 33433 2378999999999 999999999999999999999999999854221100 00
Q ss_pred ---CcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhh
Q 005923 521 ---GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREK 597 (669)
Q Consensus 521 ---~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (669)
.......+.+.||+.|+|||++....|...+|+|++|+++||.+-|+.||+++..++ ++. .++.+.
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg---~visd~----- 274 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG---QVISDD----- 274 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHh---hhhhhh-----
Confidence 001122345789999999999999999999999999999999999999999986532 111 111110
Q ss_pred hhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 005923 598 LRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 598 l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~ 654 (669)
..+ .+..+..+.++.+++.+.|+.+|..|---...++.-+.=+-..+||.
T Consensus 275 -i~w------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 275 -IEW------PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -ccc------cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 011 11133445678999999999999999654444444333334456666
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=140.70 Aligned_cols=124 Identities=19% Similarity=0.205 Sum_probs=100.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc-----------------------------cHHHHHHHHHhcCCC-
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG-----------------------------DVSSEINILKKINHS- 414 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~-----------------------------~~~~E~~~l~~l~H~- 414 (669)
.++.|.| |.||++.. +|+.+|||+++. .+..|..++.++.|+
T Consensus 22 ~i~~G~~-------g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 22 QIGVGKE-------SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred ccccCcc-------eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4899999 99999988 588999997542 145688889989887
Q ss_pred -CceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 415 -NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 415 -niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
.+...++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ ++||||+|+||
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Ni 156 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNI 156 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccE
Confidence 4444443 2456899999999998765421 234578899999999999998 99999999999
Q ss_pred eecCCCcEEEcccCCccccCC
Q 005923 494 LLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~ 514 (669)
++++++.++|+|||++.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=127.14 Aligned_cols=127 Identities=23% Similarity=0.310 Sum_probs=109.6
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCC--CCceeEeeEEEecCceeEEEEecCCC
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINH--SNIIRLSGFCVHEGNTYLVYEFADNG 439 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g 439 (669)
++.|.+ +.||++..++..+++|..+. ++..|+.+++.++| .++++++++...++..+++|||++++
T Consensus 6 i~~g~~-------~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 6 LKGGLT-------NRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cccccc-------cceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 678888 89999999888999999864 37889999999976 58999999988778899999999987
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 440 ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 440 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
.+..+ ++.....++.+++.+|++||.....+++|+|++|+||++++++.+++.|||.++..
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 66432 45667788999999999999865456999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=9e-14 Score=151.64 Aligned_cols=107 Identities=15% Similarity=0.143 Sum_probs=92.3
Q ss_pred eeeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeecccCCCCCCcceeeeeEEEEecCCcchh
Q 005923 61 YLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYL 140 (669)
Q Consensus 61 ~~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c~~~~~~~~~~~~~~y~V~~~gdT~~ 140 (669)
...|+|++ |||+++||+.|| ++..+|+++|++. . +.|.+||.|.||.++.|.... ......+|+|+ +|||+|
T Consensus 343 ~~~y~Vk~-GDTL~sIA~r~g-vs~~~L~~~N~l~-~-~~L~~Gq~L~Ip~~~~~~~~~---~~~~~~~Y~Vr-~GDTL~ 414 (456)
T PRK10783 343 SRSYKVRS-GDTLSGIASRLN-VSTKDLQQWNNLR-G-SKLKVGQTLTIGAGSSAQRLA---NNSDSITYRVR-KGDSLS 414 (456)
T ss_pred ceEEEECC-CCcHHHHHHHHC-cCHHHHHHHcCCC-c-ccCCCCCEEEecCCccccccc---ccccceeEEeC-CCCCHH
Confidence 56799999 999999999999 9999999999995 3 889999999999887764221 11233689999 999999
Q ss_pred hhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEeee
Q 005923 141 SVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLR 178 (669)
Q Consensus 141 ~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~~ 178 (669)
+|| ++|+ ++.++|+++|+...+.|++||+|.|++.
T Consensus 415 sIA-~kyg--Vtv~~L~~~N~l~~~~L~pGq~L~l~v~ 449 (456)
T PRK10783 415 SIA-KRHG--VNIKDVMRWNSDTAKNLQPGDKLTLFVK 449 (456)
T ss_pred HHH-HHhC--CCHHHHHHhcCCCCCcCCCCCEEEEecC
Confidence 999 7898 9999999999976559999999999875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.8e-13 Score=135.86 Aligned_cols=120 Identities=16% Similarity=0.191 Sum_probs=97.4
Q ss_pred eEEEEEEECCCeeEEEEecc--------------------cHHHHHHHHHhcCCCCc--eeEeeEEEecCc----eeEEE
Q 005923 380 GSVYRGSFKGDDAAVKVMKG--------------------DVSSEINILKKINHSNI--IRLSGFCVHEGN----TYLVY 433 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~--------------------~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~----~~lV~ 433 (669)
|+||+....+..++||..+. .+.+|++++.+++|+++ ++.+++...+.. .++||
T Consensus 46 gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~ 125 (239)
T PRK01723 46 GTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI 125 (239)
T ss_pred ccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence 89999999899999987631 24569999999998874 777877554332 25999
Q ss_pred EecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 434 EFADN-GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 434 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|++++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|+|||.++..
T Consensus 126 e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 126 ERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 99997 6999998642 34443 3578999999999999 999999999999999899999999998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=137.74 Aligned_cols=207 Identities=22% Similarity=0.350 Sum_probs=143.1
Q ss_pred HHHHhcCCCCceeEeeEEEecC-----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005923 406 NILKKINHSNIIRLSGFCVHEG-----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480 (669)
Q Consensus 406 ~~l~~l~H~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 480 (669)
+-|-++.|.|||++..|+.+.. ...++.|||..|+|..+|++.+ .....+......+|+.||+.||.|||+. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3455567999999999987543 4689999999999999999875 3445688888899999999999999998 5
Q ss_pred CCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHH
Q 005923 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560 (669)
Q Consensus 481 ~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl 560 (669)
||++|+++..+-|++..++-+|+.--.-........... ..-+..-.+-++|.+||+-.....+..+|||+||+-.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~----~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTR----EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhh----HhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 999999999999999999989975321111100000000 0001112356789999998888888899999999999
Q ss_pred HHHHcCCCCCCCCc-hhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005923 561 LELLSGREAVTGDQ-NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639 (669)
Q Consensus 561 ~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 639 (669)
+||.-+..--.... ..+.+. .+. ..+... ...+ -++++.+|++-+|..||+|+++
T Consensus 273 lemailEiq~tnseS~~~~ee---~ia---------~~i~~l-en~l-----------qr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEE---NIA---------NVIIGL-ENGL-----------QRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred HHHHHheeccCCCcceeehhh---hhh---------hheeec-cCcc-----------ccCcCcccccCCCCCCcchhhh
Confidence 99987664422111 100000 000 001010 1111 1467899999999999999988
Q ss_pred HHH
Q 005923 640 FVT 642 (669)
Q Consensus 640 l~~ 642 (669)
+.+
T Consensus 329 lfH 331 (458)
T KOG1266|consen 329 LFH 331 (458)
T ss_pred hcC
Confidence 754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=9e-13 Score=128.03 Aligned_cols=127 Identities=22% Similarity=0.285 Sum_probs=93.0
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecccH-------------------------------HHHHHHHHhcCC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKGDV-------------------------------SSEINILKKINH 413 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~~~-------------------------------~~E~~~l~~l~H 413 (669)
.++.|+| |.||+|... |+.||||+++... ..|.+.+.++++
T Consensus 4 ~lg~G~~-------g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 76 (187)
T cd05119 4 PIGTGKE-------ADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE 76 (187)
T ss_pred ccccccc-------eeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence 3789999 999999986 8899999876421 234445555543
Q ss_pred CC--ceeEeeEEEecCceeEEEEecCCCCHHHH-HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCC
Q 005923 414 SN--IIRLSGFCVHEGNTYLVYEFADNGALSDW-LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLK 489 (669)
Q Consensus 414 ~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik 489 (669)
.. +.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|. .+ ++|||||
T Consensus 77 ~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~ 142 (187)
T cd05119 77 AGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREAG---LVHGDLS 142 (187)
T ss_pred cCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCC
Confidence 32 3444433 246899999999544321 1111 011 5677899999999999999 88 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+||+++ ++.++++|||.++....
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hhhEEEE-CCcEEEEECcccccccC
Confidence 9999999 99999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.8e-12 Score=138.67 Aligned_cols=174 Identities=14% Similarity=0.104 Sum_probs=98.4
Q ss_pred eeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeecccCCCCC-----------CcceeeeeEE
Q 005923 62 LTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGD-----------GDYYQFNTTY 130 (669)
Q Consensus 62 ~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c~~~~~-----------~~~~~~~~~y 130 (669)
-.|.|++ |||||.||++|| +++++|+++|++ ..+.|.+||.|.||-...-....+ ....+....-
T Consensus 28 ~tytVq~-GDTLw~IA~~yg-vtv~~I~~~N~l--~~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIg 103 (481)
T PRK13914 28 STVVVEA-GDTLWGIAQSKG-TTVDAIKKANNL--TTDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIIT 103 (481)
T ss_pred ceEEECC-CCCHHHHHHHHC-CCHHHHHHHhCC--CcccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceee
Confidence 3489999 999999999999 999999999999 567899999999996542110000 0001111223
Q ss_pred EEecCCcchhhhHhh---h----hc-Cc---hhHHHHHhcCCCCCCCCCCCceEEE--------eee----------cC-
Q 005923 131 TIQNHVETYLSVANN---T----YQ-GL---TTCQAMMSQNPVDSRNLTVGLDLFV--------PLR----------CA- 180 (669)
Q Consensus 131 ~V~~~gdT~~~IA~~---~----~~-~l---t~~~~l~~~N~~~~~~l~~G~~L~i--------p~~----------c~- 180 (669)
.+. .|+.+-.+... - |. |. +.-+-|...=.. ..+..-|++.= |.. .+
T Consensus 104 sl~-~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (481)
T PRK13914 104 SIK-GGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTS--TPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQAT 180 (481)
T ss_pred eec-CCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCcc--CccccchhhhhccccccccchhcccchhccCCccc
Confidence 334 44443332100 0 11 10 000000000000 00000011100 000 00
Q ss_pred CCCcc--cccCC---ceEEEEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCC
Q 005923 181 CPSRD--QAASG---FNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKT 243 (669)
Q Consensus 181 c~~~~--~~~~~---~~~~~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~ 243 (669)
.|... ....+ ..-..+|.|++||+||.||++||+++++|++||++.. ..|+|||.|.||...
T Consensus 181 ~~~~~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s-~~L~pGQ~L~Ip~sa 247 (481)
T PRK13914 181 TPAPKVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSS-SSIYVGQKLAIKQTA 247 (481)
T ss_pred CCcccccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCc-cccCCCCEEEecCCC
Confidence 00000 00000 0013589999999999999999999999999999954 679999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=136.15 Aligned_cols=134 Identities=21% Similarity=0.307 Sum_probs=96.5
Q ss_pred HHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEeccc------------------------------------------
Q 005923 364 DLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKGD------------------------------------------ 400 (669)
Q Consensus 364 ~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~~------------------------------------------ 400 (669)
+.-+|.|++ |.||+|++ +|+.||||+.+..
T Consensus 122 ~~plasaSi-------gQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l 194 (437)
T TIGR01982 122 EKPLAAASI-------AQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL 194 (437)
T ss_pred Ccceeeeeh-------hheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence 345899999 99999998 6899999998542
Q ss_pred -----HHHHHHHHHhc----CCCCceeEeeEEE-ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH
Q 005923 401 -----VSSEINILKKI----NHSNIIRLSGFCV-HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470 (669)
Q Consensus 401 -----~~~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~ 470 (669)
+..|+..+.++ +|.+-+.+-.++. .....+|||||++|++|.++..... ..+ .+.+++..++.
T Consensus 195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~ 267 (437)
T TIGR01982 195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLAR 267 (437)
T ss_pred HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHH
Confidence 22244444443 2333333333332 2345799999999999998875321 112 23456777666
Q ss_pred -HHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 471 -ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 471 -~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
.+..+|..+ ++|+|++|.||+++++++++++|||++.....
T Consensus 268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 478899988 99999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.6e-13 Score=150.22 Aligned_cols=209 Identities=23% Similarity=0.318 Sum_probs=159.8
Q ss_pred HHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCCCCHHHHH-hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCC
Q 005923 403 SEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL-HSNRYQTSDNLTWKQRVQIAYDVANALNYLH-KYT 479 (669)
Q Consensus 403 ~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~ 479 (669)
.|..+-+.+. |+|++.+++...+.+..+++.+|..+|++.+.+ +.. ....+....-.++.|+..++.|+| ..+
T Consensus 69 ~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~~~ 144 (601)
T KOG0590|consen 69 TETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPENG 144 (601)
T ss_pred ccccccccccccccccccCCccCCCcccccccCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCcccc
Confidence 4677777776 999999999999999999999999999998888 432 113455566678999999999999 888
Q ss_pred CCCeEeeCCCCCCeeecCCC-cEEEcccCCccccCC-CccccCCcccceeeeccc-cccccccccccc-CCCCchhhHHH
Q 005923 480 NPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAES-DEHEQGGYGLQLTRHVVG-TYGYMAPEYIEN-GVITPKLDVFA 555 (669)
Q Consensus 480 ~~~ivHrDik~~NILl~~~~-~~kl~DfGla~~~~~-~~~~~~~~~~~~~~~~~g-t~~y~aPE~l~~-~~~s~~sDV~S 555 (669)
+.||||||+|.+++..+ ..|++|||+|..... ... ........| ++.|+|||...+ ....+..|+||
T Consensus 145 ---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S 215 (601)
T KOG0590|consen 145 ---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWS 215 (601)
T ss_pred ---cccCCCCCccchhccCCCcccCCCchhhccccccCCc------ceeeecccCCCCCCCCcccccchhhcCCCccccc
Confidence 99999999999999999 999999999988765 221 233455677 999999999988 45577899999
Q ss_pred HHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccC--CCCcHHHHHHHHHHHHHhcccCCCCC
Q 005923 556 FGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLR--NEYPLDLAFSMAQLAKNCTAHDLNAR 633 (669)
Q Consensus 556 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~R 633 (669)
.|+++.-+++|..|+....... .....+++...+ ............++..+++..+|..|
T Consensus 216 ~g~~l~~~~~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r 277 (601)
T KOG0590|consen 216 LGIVLSAMLTGELPWDFPSRKD------------------GRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNR 277 (601)
T ss_pred ccccccccccCCCCcccccccc------------------ccceeecccccccccCccccCChhhhhcccccccCCchhc
Confidence 9999999999999987433211 111112221111 11222334457788999999999999
Q ss_pred CCHHHHHHH
Q 005923 634 PSISEVFVT 642 (669)
Q Consensus 634 Pt~~evl~~ 642 (669)
.+.+++...
T Consensus 278 ~s~~~~~~d 286 (601)
T KOG0590|consen 278 LSIEELKLD 286 (601)
T ss_pred ccccccccc
Confidence 999988643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-10 Score=111.34 Aligned_cols=122 Identities=20% Similarity=0.201 Sum_probs=93.1
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecc------cHHHHHHHHHhcCCCCce-eEeeEEEecCceeEEEEecCCC
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG------DVSSEINILKKINHSNII-RLSGFCVHEGNTYLVYEFADNG 439 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~------~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~g 439 (669)
++.|.+ +.||+....+..+++|.... ++..|+.+++.+.+.+++ +++.+. ....++||||+++.
T Consensus 6 l~~G~~-------~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 6 LKGGMT-------NKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred cCCccc-------CceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 456666 88999999999999998743 357899999999765554 444443 34568999999998
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 440 ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT--NPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 440 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
++.+.- . ....++.+++.+|+.||+.+ ...++|+|+++.||+++ ++.++++|||.+..
T Consensus 77 ~l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 775430 0 11245678999999999886 23369999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.1e-11 Score=86.62 Aligned_cols=43 Identities=23% Similarity=0.519 Sum_probs=36.0
Q ss_pred EEcCCCCCHHHHHHHhCCCHHhHHHhc-CCCCCCCCCCCcccccc
Q 005923 197 YMVTWGDSISAIAQLFNVDERSVLDAN-KLSQDDLIFPFTPILVP 240 (669)
Q Consensus 197 Y~v~~GDtl~~Ia~~f~v~~~~l~~~N-~l~~~~~l~p~~~l~iP 240 (669)
|+|++|||+++||++||++.++|++|| ++.... |+|||.|.||
T Consensus 1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~-l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDN-LQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCccc-CCCCCEEEeC
Confidence 899999999999999999999999999 775545 9999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-10 Score=125.24 Aligned_cols=236 Identities=24% Similarity=0.288 Sum_probs=170.9
Q ss_pred HHh--CCCCcccceeeEEEEEEE----CCCeeEEEEeccc---------HHHHHHHHHhcC-CCCceeEeeEEEecCcee
Q 005923 367 IAT--GSFSEENRIQGSVYRGSF----KGDDAAVKVMKGD---------VSSEINILKKIN-HSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 367 ~~~--g~f~~~~~~~G~Vy~g~~----~g~~vavK~~~~~---------~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 430 (669)
+|. |.+ |.||.+.. .+..+|+|.-+.- -.+|+...++++ |+|.++....+...+..+
T Consensus 122 ~g~~~g~~-------~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 122 TGSLPGSK-------GSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred cccCCCCC-------ceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 566 888 99999877 4677899885432 235777777774 999999888888889999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN----ALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITN 505 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~D 505 (669)
+=.|++. .+|.++.+.. ...+....++.+..+... ||.++|+.+ ++|-|+||.||+..++ ..+++.|
T Consensus 195 iqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999986 6888888753 334555666666777777 999999998 9999999999999999 8899999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+...+........ ........|...|++||.+. +.++...|+|++|.++.|...+......+....
T Consensus 267 f~~v~~i~~~~~~~~---~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------- 334 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSV---FKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------- 334 (524)
T ss_pred cceeEEccCCccccc---eeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------
Confidence 999998876542211 12223346788899999876 567889999999999999988876665331100
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
...++... +..++-.....++...+..|++.+|..|++..++..
T Consensus 335 ---------W~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ---------WSQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---------cccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 01111111 111222222344556889999999999999887764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.04 E-value=7e-10 Score=123.43 Aligned_cols=136 Identities=20% Similarity=0.256 Sum_probs=88.4
Q ss_pred hhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc---------------------------------------
Q 005923 362 FQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------------------------------------- 400 (669)
Q Consensus 362 ~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~--------------------------------------- 400 (669)
|++.-+|.|++ |.||+|++. |+.||||+.+..
T Consensus 122 fd~~PlasaSi-------aQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 122 FDIKPLASASI-------AQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred cChhhhcCCCc-------cEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 34456899999 999999983 899999998632
Q ss_pred --------HHHHHHHHHhcC----CCCceeEeeEEEe-cCceeEEEEecCCCCHHHH--HhcCCCCCCCCCCHHHHHHHH
Q 005923 401 --------VSSEINILKKIN----HSNIIRLSGFCVH-EGNTYLVYEFADNGALSDW--LHSNRYQTSDNLTWKQRVQIA 465 (669)
Q Consensus 401 --------~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~ 465 (669)
+.+|+.-+.+++ +.+.+.+=.++.+ ....+|||||++|+.+.++ +.... .....+....+..++
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~ 273 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHH
Confidence 122333333331 3333333333322 3456899999999999875 32211 001123333333333
Q ss_pred HHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC----cEEEcccCCccccCCC
Q 005923 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL----RAKITNFGLARSAESD 515 (669)
Q Consensus 466 ~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~----~~kl~DfGla~~~~~~ 515 (669)
.|+ ...+ ++|+|++|.||+++.++ ++++.|||++..+...
T Consensus 274 ~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 333 4567 99999999999999888 9999999999877554
|
|
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-10 Score=103.61 Aligned_cols=112 Identities=23% Similarity=0.296 Sum_probs=89.8
Q ss_pred HHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeecccCCCCCCcceeeeeEEEEecCCcchhhhHhhhhcCchhHHH
Q 005923 76 IDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLSVANNTYQGLTTCQA 155 (669)
Q Consensus 76 Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c~~~~~~~~~~~~~~y~V~~~gdT~~~IA~~~~~~lt~~~~ 155 (669)
||..|+ +++.+|+.+|.+....+.+.+||.|.+|.. ..+.+. .|++.+..++..+. ...
T Consensus 1 ia~~~~-~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~---------------~~~~~~-~~~~~~~~~~~~~~--~~~-- 59 (124)
T COG1388 1 IASKYG-VSVKALKKANALTGKSDAIKPGQVLKIPGD---------------ISSTVN-AGQTLSSLSNKVSD--SSS-- 59 (124)
T ss_pred Cccccc-ccHHHHHHHhcccCCCCccccCceEEccCC---------------cccccc-cccccccccceeec--ccc--
Confidence 578899 999999999998422899999999999865 236677 89999999943333 110
Q ss_pred HHhcCCCCCCCCCCCceEEEeeecCCCCcccccCCceEEEEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCc
Q 005923 156 MMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFT 235 (669)
Q Consensus 156 l~~~N~~~~~~l~~G~~L~ip~~c~c~~~~~~~~~~~~~~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~ 235 (669)
+....+..+|+|+.||+|+.||++|++++..|+++|++..+ .+++||
T Consensus 60 --------------------------------~~~~~~~~~~~V~~gdtL~~Ia~~~~~tv~~l~~~n~l~~~-~i~~gq 106 (124)
T COG1388 60 --------------------------------ASKAPPVVTYTVKKGDTLSKIARKYGVTVAELKQLNNLSSD-KIKVGQ 106 (124)
T ss_pred --------------------------------ccccCCCceEEEecCCCHHHHHHHhCCCHHHHHHHhccCCC-ceecCc
Confidence 00111235899999999999999999999999999999655 999999
Q ss_pred cccccc
Q 005923 236 PILVPL 241 (669)
Q Consensus 236 ~l~iP~ 241 (669)
.|.+|.
T Consensus 107 ~l~~~~ 112 (124)
T COG1388 107 KLKLPV 112 (124)
T ss_pred EEEEec
Confidence 999987
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.4e-09 Score=102.80 Aligned_cols=98 Identities=16% Similarity=0.228 Sum_probs=75.4
Q ss_pred HHHHHHHhcCC--CCceeEeeEEEecCceeEEEEecCCCCHHH-HHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhC
Q 005923 403 SEINILKKINH--SNIIRLSGFCVHEGNTYLVYEFADNGALSD-WLHSNRYQTSDNLTWKQRVQIAYDVANALNYL-HKY 478 (669)
Q Consensus 403 ~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~ 478 (669)
+|...|+++.. -++.+.+++ ...+|||||+.++.+.. .|++ ..++..+...+..+++.+|..| |..
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhC
Confidence 69999999853 466667754 46789999998654422 2222 1245566778889999999999 888
Q ss_pred CCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 479 ~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
+ +||+||++.|||++ ++.+.|+|||.+.....
T Consensus 145 g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 145 N---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred C---eecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 8 99999999999997 46899999999886643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.7e-09 Score=112.80 Aligned_cols=157 Identities=23% Similarity=0.323 Sum_probs=117.3
Q ss_pred CCCeeEEEEeccc-------HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHH
Q 005923 388 KGDDAAVKVMKGD-------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460 (669)
Q Consensus 388 ~g~~vavK~~~~~-------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~ 460 (669)
.+.+|.|...+.. ..+-++.|+.++||||++++.....++..|||.|-+. -|..++.. +....
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHHHH
Confidence 3556666555421 4456788999999999999999999999999999985 78888864 33555
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeeccccccccccc
Q 005923 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPE 540 (669)
Q Consensus 461 ~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 540 (669)
+.-.+.||+.||.|||+.++ ++|++|.-..|+|++.|..||++|.++........ ..+...--..|..|+
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--------ccccchhhhcccChh
Confidence 66688999999999985442 99999999999999999999999998876543221 001111222456666
Q ss_pred ccccCCCCchhhHHHHHHHHHHHHcC
Q 005923 541 YIENGVITPKLDVFAFGVVVLELLSG 566 (669)
Q Consensus 541 ~l~~~~~s~~sDV~S~Gvvl~elltg 566 (669)
.+.... -..|.|-||+++||++.|
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCc
Confidence 543222 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-08 Score=101.46 Aligned_cols=133 Identities=22% Similarity=0.344 Sum_probs=103.5
Q ss_pred HHhCCCCcccceeeEEEEEEECC-CeeEEEEecc--------cHHHHHHHHHhcCC--CCceeEeeEEEec---CceeEE
Q 005923 367 IATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG--------DVSSEINILKKINH--SNIIRLSGFCVHE---GNTYLV 432 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~--------~~~~E~~~l~~l~H--~niv~l~g~~~~~---~~~~lV 432 (669)
++.|.+ +.||+....+ ..+++|.... ++..|.++++.+++ .++.+++.+.... +..++|
T Consensus 6 l~~G~~-------n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 6 LSGGQS-------NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred cCCCcc-------ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 567777 8899998865 8899998643 46789999999976 4467788877654 256899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT--------------------------------- 479 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------- 479 (669)
|||+++++|.+.+.. ..++..++..++.+++.+|..||+..
T Consensus 79 ~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 79 MERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred EEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 999999888765421 24677788888888888888888531
Q ss_pred --------------------CCCeEeeCCCCCCeeecC--CCcEEEcccCCcccc
Q 005923 480 --------------------NPPYVHKNLKTSNILLDT--NLRAKITNFGLARSA 512 (669)
Q Consensus 480 --------------------~~~ivHrDik~~NILl~~--~~~~kl~DfGla~~~ 512 (669)
...++|+|+.+.||+++. +..+.|+||+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245899999999999998 566899999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-07 Score=101.38 Aligned_cols=162 Identities=22% Similarity=0.331 Sum_probs=126.8
Q ss_pred eEEEEEEE--CCCeeEEEEeccc-------HHHHHHHHHhcCCCCceeEeeEEE----ecCceeEEEEecCC-CCHHHHH
Q 005923 380 GSVYRGSF--KGDDAAVKVMKGD-------VSSEINILKKINHSNIIRLSGFCV----HEGNTYLVYEFADN-GALSDWL 445 (669)
Q Consensus 380 G~Vy~g~~--~g~~vavK~~~~~-------~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~l 445 (669)
-+.||+.- +|..+.+|++..+ -..-+++++++.|.|+|++..++. .+..++|||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57888876 6889999999432 234688999999999999998876 34567999999997 5777765
Q ss_pred hcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 446 HSNR----------YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 446 ~~~~----------~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
.... ......+++..++.++.|+..||.++|+.| +..+-|.+++||++.+.+++|+..|..-....+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 112235788999999999999999999999 999999999999999999999998887766543
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p 569 (669)
.. |-+++ -.+-|.=.||.+++.|.+|.+-
T Consensus 447 ~~----------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT----------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC----------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 20 11211 2367999999999999999765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.7e-08 Score=93.55 Aligned_cols=118 Identities=28% Similarity=0.351 Sum_probs=90.9
Q ss_pred eEEEEEEECCCeeEEEEec---------------ccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHH
Q 005923 380 GSVYRGSFKGDDAAVKVMK---------------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 444 (669)
..+|.+.+-|.++.+|.=. ....+|+.++.+++--.|..-+=+..+.+...++|||+++..|.+.
T Consensus 10 a~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~ 89 (204)
T COG3642 10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDA 89 (204)
T ss_pred eeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHH
Confidence 6788888888777776421 1245699999998655544444445577888999999999999999
Q ss_pred HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 445 LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 445 l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+....
T Consensus 90 l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 90 LEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred HHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 8643 2456677777778899999 99999999999998655 9999999998543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.9e-09 Score=123.04 Aligned_cols=222 Identities=19% Similarity=0.252 Sum_probs=152.7
Q ss_pred HHHhcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 005923 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486 (669)
Q Consensus 407 ~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHr 486 (669)
++-..+||-+++..--+.-....+||++|+.+++|...|++.. .++..-.......+..+++|||... +.||
T Consensus 857 ~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~ 928 (1205)
T KOG0606|consen 857 ILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHR 928 (1205)
T ss_pred ccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcc
Confidence 3333456777766655556778899999999999999998652 3444445556777888999999987 8999
Q ss_pred CCCCCCeeecCCCcEEEcccCCccccCCC---------------------cc-ccC-Ccccceeeecccccccccccccc
Q 005923 487 NLKTSNILLDTNLRAKITNFGLARSAESD---------------------EH-EQG-GYGLQLTRHVVGTYGYMAPEYIE 543 (669)
Q Consensus 487 Dik~~NILl~~~~~~kl~DfGla~~~~~~---------------------~~-~~~-~~~~~~~~~~~gt~~y~aPE~l~ 543 (669)
|++|.|.|...++..+++|||.......- .. ... ...........+|..|.+||.+.
T Consensus 929 ~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen 929 DLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred cccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc
Confidence 99999999999999999999843321110 00 000 00011233467899999999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccC-CCCcHHHHHHHHHHH
Q 005923 544 NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLR-NEYPLDLAFSMAQLA 622 (669)
Q Consensus 544 ~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li 622 (669)
+......+|+|++|++++|.++|..||....... + .+.+...... ...+......+.+++
T Consensus 1009 g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~----------~---------f~ni~~~~~~~p~g~~~~s~~aq~~~ 1069 (1205)
T KOG0606|consen 1009 GRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ----------I---------FENILNRDIPWPEGPEEGSYEAQDLI 1069 (1205)
T ss_pred cccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh----------h---------hhccccCCCCCCCCccccChhhhhhh
Confidence 9999999999999999999999999998654321 0 1111111111 233455566788999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 005923 623 KNCTAHDLNARPSISEVFVTLSKIWSSSSDWDP 655 (669)
Q Consensus 623 ~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 655 (669)
.+.+..+|.+|-.|.--.+.=.--.....+|+.
T Consensus 1070 ~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1070 NRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhccCchhccCcccccccccCCccCCCCccc
Confidence 999999999998887333322222333455553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.2e-08 Score=92.58 Aligned_cols=128 Identities=25% Similarity=0.354 Sum_probs=95.0
Q ss_pred eEEEEEEECCCeeEEEEe---------------cccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecCC-CCHHH
Q 005923 380 GSVYRGSFKGDDAAVKVM---------------KGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADN-GALSD 443 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~---------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~-gsL~~ 443 (669)
+.|+++.+.|+...||.- +....+|+++|.+++--.|.--.=++.+...-.++|||+++ .++.+
T Consensus 21 Arv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~ 100 (229)
T KOG3087|consen 21 ARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKD 100 (229)
T ss_pred eeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHH
Confidence 789999999999888752 12355799999988644443333344466677899999976 48889
Q ss_pred HHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC---cEEEcccCCccccC
Q 005923 444 WLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---RAKITNFGLARSAE 513 (669)
Q Consensus 444 ~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~DfGla~~~~ 513 (669)
++...- ...-.......++..|-..+.-||..+ ++|+||.++||++..++ .+.++|||++....
T Consensus 101 ~i~~~~---~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 101 FILSTM---EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred HHHHHc---cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhccc
Confidence 887652 122223334678888999999999999 99999999999996554 45899999987653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.2e-08 Score=100.44 Aligned_cols=126 Identities=13% Similarity=0.196 Sum_probs=96.9
Q ss_pred eEEEEEEECCCeeEEEEecc------------------cHHHHHHHHHhcCCC--CceeEeeEEEe-----cCceeEEEE
Q 005923 380 GSVYRGSFKGDDAAVKVMKG------------------DVSSEINILKKINHS--NIIRLSGFCVH-----EGNTYLVYE 434 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~------------------~~~~E~~~l~~l~H~--niv~l~g~~~~-----~~~~~lV~e 434 (669)
..|++..++|+.+.||.... .+.+|...+.++... .....+++... ....+||+|
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 34668888899999996521 256899999888533 34455666543 234689999
Q ss_pred ecCCC-CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-------CCcEEEccc
Q 005923 435 FADNG-ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-------NLRAKITNF 506 (669)
Q Consensus 435 ~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-------~~~~kl~Df 506 (669)
++++- +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+.++||
T Consensus 116 ~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 116 DLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 99986 8999985421 123456677899999999999999999 999999999999975 468899999
Q ss_pred CCccc
Q 005923 507 GLARS 511 (669)
Q Consensus 507 Gla~~ 511 (669)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 99864
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-08 Score=73.91 Aligned_cols=43 Identities=37% Similarity=0.555 Sum_probs=38.7
Q ss_pred cCCCCCHHHHHHHhCCCHHhHHHhcC-CCCCCCCCCCccccccc
Q 005923 199 VTWGDSISAIAQLFNVDERSVLDANK-LSQDDLIFPFTPILVPL 241 (669)
Q Consensus 199 v~~GDtl~~Ia~~f~v~~~~l~~~N~-l~~~~~l~p~~~l~iP~ 241 (669)
|++|||||+||++||++.++|.++|+ +.++..+++||+|.||.
T Consensus 1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip~ 44 (44)
T TIGR02899 1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIPS 44 (44)
T ss_pred CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecCC
Confidence 68999999999999999999999997 54567899999999973
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.6e-09 Score=75.40 Aligned_cols=43 Identities=37% Similarity=0.596 Sum_probs=34.8
Q ss_pred EEEecCCcchhhhHhhhhcCchhHHHHHhcC-CCCCCCCCCCceEEEe
Q 005923 130 YTIQNHVETYLSVANNTYQGLTTCQAMMSQN-PVDSRNLTVGLDLFVP 176 (669)
Q Consensus 130 y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N-~~~~~~l~~G~~L~ip 176 (669)
|+|+ +|||+|+|| ++|+ ++.++|+++| .+....|.+||+|.||
T Consensus 1 y~V~-~gDtl~~IA-~~~~--~~~~~l~~~N~~~~~~~l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQ-PGDTLWSIA-KRYG--ISVDELMELNPNIDSDNLQPGQKLCIP 44 (44)
T ss_dssp EEE--TT--HHHHH-HHTT--S-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred CEEC-cCCcHHHHH-hhhh--hhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence 8999 999999999 7787 8899999999 5555579999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.7e-08 Score=93.02 Aligned_cols=118 Identities=23% Similarity=0.351 Sum_probs=80.6
Q ss_pred EEEEEEE-CCCeeEEEEecc---------------------------------cHHHHHHHHHhcCCC--CceeEeeEEE
Q 005923 381 SVYRGSF-KGDDAAVKVMKG---------------------------------DVSSEINILKKINHS--NIIRLSGFCV 424 (669)
Q Consensus 381 ~Vy~g~~-~g~~vavK~~~~---------------------------------~~~~E~~~l~~l~H~--niv~l~g~~~ 424 (669)
.||.|.. +|..+|||+.+. ...+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3888886 678899998641 134699999999765 566676552
Q ss_pred ecCceeEEEEecC--CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 425 HEGNTYLVYEFAD--NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY-LHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 425 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~y-LH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
...|||||++ +..+..+.... ++......++.+++..+.. +|..+ ++|+||.+.|||++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 5689999998 54554433221 2234456778888886666 57888 9999999999999988 99
Q ss_pred EEcccCCccccC
Q 005923 502 KITNFGLARSAE 513 (669)
Q Consensus 502 kl~DfGla~~~~ 513 (669)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.2e-08 Score=86.12 Aligned_cols=51 Identities=22% Similarity=0.255 Sum_probs=43.4
Q ss_pred EEEEEcCCCCCHHHHHHHhCCC--------HHhHHHhcCCCCCCCCCCCcccccccCCCC
Q 005923 194 LLTYMVTWGDSISAIAQLFNVD--------ERSVLDANKLSQDDLIFPFTPILVPLKTAP 245 (669)
Q Consensus 194 ~~tY~v~~GDtl~~Ia~~f~v~--------~~~l~~~N~l~~~~~l~p~~~l~iP~~~~P 245 (669)
..+|+|++|||||+||++|+.+ ++.|++.|++.+ +.|+|||.|.||....-
T Consensus 36 ~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~-~~I~~Gq~L~IP~~~~~ 94 (103)
T PRK14125 36 YVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPS-GHIKAGDKLVIPVLKSK 94 (103)
T ss_pred cEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCC-CcCCCCCEEEEecCCCC
Confidence 3689999999999999999876 567788899954 57999999999987644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.5e-09 Score=112.66 Aligned_cols=233 Identities=22% Similarity=0.229 Sum_probs=162.4
Q ss_pred HHHhCCCCcccceeeEEEEEEE---CCCeeEEEEeccc---------HHHHHHHHHhc-CCCCceeEeeEEEecCceeEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF---KGDDAAVKVMKGD---------VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~---~g~~vavK~~~~~---------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 432 (669)
+++.|.| +.|+.... ++..+++|.+... -..|+.+...+ .|.++++....+......|+=
T Consensus 272 ~i~~~~~-------~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 272 KISDGNF-------SSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred EccCCcc-------ccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 3677777 56666554 3556777766432 12466565555 488889888888788888899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEcccCCccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARS 511 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DfGla~~ 511 (669)
-||++++++.....- ...+....++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||....
T Consensus 345 ~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred hhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999988877632 234777888999999999999999988 9999999999999876 8889999999875
Q ss_pred cCCCccccCCcccceeeeccccccc-ccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGY-MAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
+..... -....+..| .+++..+...+-.+.|+||||.-+.|.+++...-.....
T Consensus 417 ~~~~~~----------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------------- 471 (524)
T KOG0601|consen 417 LAFSSG----------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------------- 471 (524)
T ss_pred cceecc----------cccccccccccchhhccccccccccccccccccccccccCcccCccccc---------------
Confidence 322110 001122233 366666778888999999999999999988654332110
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
...+....+ ...+... ..+..+.+.++..++..||.+.++........
T Consensus 472 -------~~~i~~~~~-p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 472 -------SLTIRSGDT-PNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred -------ceeeecccc-cCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 000000000 1112222 56778889999999999999998877655443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-08 Score=112.32 Aligned_cols=157 Identities=22% Similarity=0.348 Sum_probs=108.0
Q ss_pred HHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcc-ccCCcccceeeeccccccccccccccc
Q 005923 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH-EQGGYGLQLTRHVVGTYGYMAPEYIEN 544 (669)
Q Consensus 466 ~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~l~~ 544 (669)
.++++||.|+|.. +.+||++|.|++|.++.++..||+.|+.+........ ....++..+.--..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999975 4599999999999999999999999998876544211 111111122222344567999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHH
Q 005923 545 GVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAK 623 (669)
Q Consensus 545 ~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~ 623 (669)
...+.++|+||+|++++.+.. |+..+......... .. ....+..-...++.+++.++.+-+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~~-------------~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----SF-------------SRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh----hh-------------hhcccccccccccccCcHHHHHHHH
Confidence 889999999999999999994 55544433221111 11 1111111112344667788999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 005923 624 NCTAHDLNARPSISEVFV 641 (669)
Q Consensus 624 ~Cl~~dP~~RPt~~evl~ 641 (669)
+++..++..||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999998887654
|
|
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=98.61 E-value=6e-08 Score=70.08 Aligned_cols=45 Identities=33% Similarity=0.469 Sum_probs=42.3
Q ss_pred EEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccc
Q 005923 196 TYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVP 240 (669)
Q Consensus 196 tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP 240 (669)
+|+|++|||+++||++|+++..+|.++|+......+.+|+.+.||
T Consensus 2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence 699999999999999999999999999998667889999999887
|
This domain may have a general peptidoglycan binding function. |
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.5e-07 Score=79.62 Aligned_cols=54 Identities=13% Similarity=0.221 Sum_probs=46.1
Q ss_pred cceeeeeecCCCCCCHHHHHHhhCCCC--------hHHHhhhcCCCCCCCCCCCCCcEEEeeeccc
Q 005923 58 CQAYLTFRSNPSYNTPVTIDYLFKTSH--------PNLIASINSITNVTATLPTDTPVLIPVNCSC 115 (669)
Q Consensus 58 c~~~~~y~~~~~g~tl~~Ia~~~~~~~--------~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c 115 (669)
+..|..|+|++ |||||+||+.|+ .+ +..|++.|++. ++.|.+||.|.||+.-+-
T Consensus 33 ~~~~~~~tV~~-GDTLW~IA~~y~-~~~~l~~~~~v~~I~~~N~l~--~~~I~~Gq~L~IP~~~~~ 94 (103)
T PRK14125 33 KNQYVEITVQE-GDTLWALADQYA-GKHHMAKNEFIEWVEDVNNLP--SGHIKAGDKLVIPVLKSK 94 (103)
T ss_pred CCCcEEEEECC-CCCHHHHHHHhC-CCcCCCHHHHHHHHHHhcCCC--CCcCCCCCEEEEecCCCC
Confidence 45688899999 999999999998 65 57888999994 567999999999987653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.1e-06 Score=89.69 Aligned_cols=205 Identities=17% Similarity=0.222 Sum_probs=133.0
Q ss_pred eeEEEEecCCC-CHHHHHh-cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 429 TYLVYEFADNG-ALSDWLH-SNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 429 ~~lV~e~~~~g-sL~~~l~-~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
.-++|..+.+. -...+++ ..|.+......|...+++++.+|.+.+-||..| .+-+|+.++|+|+.+++.+.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 56777777764 2223322 123345567899999999999999999999999 999999999999999999999874
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcC-CCCCCCCchhH-HH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSG-REAVTGDQNCE-AE 579 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg-~~p~~~~~~~~-~~ 579 (669)
........ .......+|...|.+||.-. +..-+...|-|.+|+++++++.| +.||.|..-.. +-
T Consensus 162 Dsfqi~~n---------g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 162 DSFQINAN---------GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred cceeeccC---------CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 43332221 12345568899999999765 34557789999999999999886 89997532110 00
Q ss_pred HHHH-HHH-HHHhhhhHHhhhhcccCCccCCCCc-HHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhhcC
Q 005923 580 LLYA-SIS-RVLEESNVREKLRGFIDPSLRNEYP-LDLAFSMAQLAKNCTAHD--LNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 580 ~~~~-~~~-~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~d--P~~RPt~~evl~~L~~i~~~ 649 (669)
...+ .|. ..+.... +.-.....+ - ...| .-++..+..|..+|+... +.-|||.+--+..|..+.++
T Consensus 233 ~p~E~~Ia~g~f~ya~--~~~~g~~p~-P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 233 NPLETDIAHGRFAYAS--DQRRGLKPP-P-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred Ccchhhhhcceeeech--hccCCCCCC-C-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0000 110 0000000 000011111 0 1122 234566778888998653 56899999988888777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.3e-06 Score=83.42 Aligned_cols=106 Identities=22% Similarity=0.245 Sum_probs=84.9
Q ss_pred cHHHHHHHHHhcC--CCCceeEeeEEEecC----ceeEEEEecCCC-CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 005923 400 DVSSEINILKKIN--HSNIIRLSGFCVHEG----NTYLVYEFADNG-ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472 (669)
Q Consensus 400 ~~~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L 472 (669)
...+|...+.++. .-.+.+.+++..... ..+||+|++++- +|.+++.... .++......++.+++..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHHH
Confidence 4667888888885 344566777766532 358999999984 8999997631 255667889999999999
Q ss_pred HHHHhCCCCCeEeeCCCCCCeeecCCC---cEEEcccCCccccC
Q 005923 473 NYLHKYTNPPYVHKNLKTSNILLDTNL---RAKITNFGLARSAE 513 (669)
Q Consensus 473 ~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~DfGla~~~~ 513 (669)
.-||+.+ |+|+|+++.|||++.+. .+.++||+.++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 99999999999998887 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.7e-07 Score=93.79 Aligned_cols=46 Identities=24% Similarity=0.357 Sum_probs=43.4
Q ss_pred EEEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccc
Q 005923 194 LLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVP 240 (669)
Q Consensus 194 ~~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP 240 (669)
..+|+|++|||||+||+|||++++.|+++|++. ++.|++|+.|+||
T Consensus 293 ~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~-~~~L~~GQ~L~IP 338 (338)
T TIGR02907 293 LRMCIVQEGDTIETIAERYEISVSQLIRHNQLE-DFEVNEGQILYIP 338 (338)
T ss_pred cEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence 458999999999999999999999999999996 7899999999997
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.4e-07 Score=95.42 Aligned_cols=48 Identities=23% Similarity=0.178 Sum_probs=45.7
Q ss_pred EEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCC
Q 005923 196 TYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKT 243 (669)
Q Consensus 196 tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~ 243 (669)
+|+|++|||||.||.+||++..+|.+||+|.++..|++||.|.+|...
T Consensus 62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~~ 109 (319)
T PRK10871 62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNAS 109 (319)
T ss_pred ceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCCC
Confidence 799999999999999999999999999999999999999999998654
|
|
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.4e-07 Score=94.76 Aligned_cols=98 Identities=18% Similarity=0.161 Sum_probs=81.5
Q ss_pred EEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEeeecCCCCcccccCCceEEEEEEcCCCCCHHHH
Q 005923 129 TYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSISAI 208 (669)
Q Consensus 129 ~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~~c~c~~~~~~~~~~~~~~tY~v~~GDtl~~I 208 (669)
.|.|+ +||+.+.|| .+|. .+...|...|.+..+.|.+||.+.||.. -..|.|++||++++|
T Consensus 3 i~~~~-pg~~~~~i~-~~~~--~~~~~i~~~~~~~~d~~~~~q~~~v~~~---------------~~~y~~~~~d~~~Si 63 (423)
T COG3858 3 IHLVG-PGDSRLIIA-VYFP--YTNNRIVNGNDYTNDDLVDGQTFVVPPS---------------GHFYDVGPGDTLTSI 63 (423)
T ss_pred EEEcc-CCceeeeeh-hhcc--ccccccccccccccccccCceeEEECCc---------------ceEEEecCCcchhhh
Confidence 58899 999999999 5666 4445554555444468999999999963 248999999999999
Q ss_pred HHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCCCC
Q 005923 209 AQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAP 245 (669)
Q Consensus 209 a~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~~P 245 (669)
|++|+|+.+.+...|....+..+++|-.+.+|-....
T Consensus 64 a~~~~vt~~~~~~m~~~~~~~~l~~~~~l~~P~~~~~ 100 (423)
T COG3858 64 ARTVGVTQDSAAIMNFVICPGYLQYGLNLYIPSARKT 100 (423)
T ss_pred hhhhcCCHHHHHhhcccccccceeeeeEEeccCCCCC
Confidence 9999999999999998877888999999999877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=1e-05 Score=78.92 Aligned_cols=127 Identities=17% Similarity=0.161 Sum_probs=97.2
Q ss_pred eEEEEEEECCCeeEEEEec-------------ccHHHHHHHHHhcCC--CCceeEeeEEEecC----ceeEEEEecCC-C
Q 005923 380 GSVYRGSFKGDDAAVKVMK-------------GDVSSEINILKKINH--SNIIRLSGFCVHEG----NTYLVYEFADN-G 439 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~-------------~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~e~~~~-g 439 (669)
.-|++-.++|+.+-+|... ..|.+|+..|.++.. -.+.+.+....... ..+||+|-+.+ -
T Consensus 32 SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~ 111 (216)
T PRK09902 32 SGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFI 111 (216)
T ss_pred ceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCc
Confidence 5688888888888888764 247789999999853 33555552222221 35899998764 4
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc--EEEcccCCcccc
Q 005923 440 ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR--AKITNFGLARSA 512 (669)
Q Consensus 440 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~--~kl~DfGla~~~ 512 (669)
+|.+++... .....+...+..+..+++..+.-||+.+ +.|+|+.+.|||++.++. ++++||--++..
T Consensus 112 ~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 112 SIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred cHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 999998653 2234677788899999999999999999 999999999999986666 999999877653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.6e-06 Score=94.52 Aligned_cols=133 Identities=23% Similarity=0.304 Sum_probs=88.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc---------------------------------------------
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG--------------------------------------------- 399 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~--------------------------------------------- 399 (669)
-+|.++- |.||+|++. |+.||||+.+.
T Consensus 132 PiAsASI-------aQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 132 PIASASI-------AQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred chhhhhH-------hhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 4666666 999999996 99999999752
Q ss_pred --cHHHHHHHHHhcC----CCCceeEeeEEE-ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHH-
Q 005923 400 --DVSSEINILKKIN----HSNIIRLSGFCV-HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA- 471 (669)
Q Consensus 400 --~~~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~- 471 (669)
|+..|..-+.+++ +..-+++=.+++ ..+...|+|||++|-.+.+...... ..++.+ .++..++.+
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k---~ia~~~~~~f 277 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRK---ELAELLVRAF 277 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHH---HHHHHHHHHH
Confidence 1233555555542 222233333333 3467799999999998888843221 224433 333333333
Q ss_pred HHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCC
Q 005923 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 472 L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~ 515 (669)
+..+=..+ ++|.|..|.||+++.++++.+.|||+.......
T Consensus 278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 22233356 999999999999999999999999999877654
|
|
| >smart00257 LysM Lysin motif | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-06 Score=62.47 Aligned_cols=44 Identities=25% Similarity=0.400 Sum_probs=39.5
Q ss_pred EEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCccccc
Q 005923 196 TYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILV 239 (669)
Q Consensus 196 tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~i 239 (669)
+|.|++|||+++||++|+++..++.++|+......+.+|+.+.+
T Consensus 1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~i 44 (44)
T smart00257 1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44 (44)
T ss_pred CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEeC
Confidence 48999999999999999999999999999656678999998754
|
|
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.7e-06 Score=90.36 Aligned_cols=94 Identities=23% Similarity=0.250 Sum_probs=82.0
Q ss_pred eeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeecccCCCCCCcceeeeeEEEEecCCcchhh
Q 005923 62 LTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQFNTTYTIQNHVETYLS 141 (669)
Q Consensus 62 ~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c~~~~~~~~~~~~~~y~V~~~gdT~~~ 141 (669)
.+|.++| ||++..|+.+|+ .+..+|...|.+. . +.+.+||.++||..- ..|.|+ +|||+++
T Consensus 2 ~i~~~~p-g~~~~~i~~~~~-~~~~~i~~~~~~~-~-d~~~~~q~~~v~~~~--------------~~y~~~-~~d~~~S 62 (423)
T COG3858 2 SIHLVGP-GDSRLIIAVYFP-YTNNRIVNGNDYT-N-DDLVDGQTFVVPPSG--------------HFYDVG-PGDTLTS 62 (423)
T ss_pred EEEEccC-Cceeeeehhhcc-ccccccccccccc-c-ccccCceeEEECCcc--------------eEEEec-CCcchhh
Confidence 4688888 999999999999 9999998888886 4 999999999999543 479999 9999999
Q ss_pred hHhhhhcCchhHHHHHhcCCCC-CCCCCCCceEEEee
Q 005923 142 VANNTYQGLTTCQAMMSQNPVD-SRNLTVGLDLFVPL 177 (669)
Q Consensus 142 IA~~~~~~lt~~~~l~~~N~~~-~~~l~~G~~L~ip~ 177 (669)
|| .++. +|.+.+...|... +..|.+|-.|.+|-
T Consensus 63 ia-~~~~--vt~~~~~~m~~~~~~~~l~~~~~l~~P~ 96 (423)
T COG3858 63 IA-RTVG--VTQDSAAIMNFVICPGYLQYGLNLYIPS 96 (423)
T ss_pred hh-hhhc--CCHHHHHhhcccccccceeeeeEEeccC
Confidence 99 7777 8888898888765 45899999999984
|
|
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.4e-06 Score=92.11 Aligned_cols=47 Identities=30% Similarity=0.291 Sum_probs=43.5
Q ss_pred EEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCC
Q 005923 196 TYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKT 243 (669)
Q Consensus 196 tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~ 243 (669)
+|.|++|||||.||++||+++++|+++|++. ++.|+|||.|.||...
T Consensus 29 tytVq~GDTLw~IA~~ygvtv~~I~~~N~l~-~~~I~~Gq~L~Ip~~~ 75 (481)
T PRK13914 29 TVVVEAGDTLWGIAQSKGTTVDAIKKANNLT-TDKIVPGQKLQVNEVA 75 (481)
T ss_pred eEEECCCCCHHHHHHHHCCCHHHHHHHhCCC-cccccCCCEEEeCCCC
Confidence 6999999999999999999999999999994 6789999999999654
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.9e-06 Score=60.50 Aligned_cols=43 Identities=12% Similarity=0.080 Sum_probs=37.4
Q ss_pred cCCCCCCHHHHHHhhCCCChHHHhhhcC-CCCCCCCCCCCCcEEEee
Q 005923 66 SNPSYNTPVTIDYLFKTSHPNLIASINS-ITNVTATLPTDTPVLIPV 111 (669)
Q Consensus 66 ~~~~g~tl~~Ia~~~~~~~~~~i~~~N~-~~~~~~~l~~gq~l~IP~ 111 (669)
|++ ||||++||+.|| ++..+|+++|+ +. +...+.+||.|.||.
T Consensus 1 v~~-gdtl~~IA~~~~-~~~~~l~~~N~~~~-~~~~~~~g~~l~ip~ 44 (44)
T TIGR02899 1 VQK-GDTLWKIAKKYG-VDFDELIQANPQLS-NPNLIYPGMKIKIPS 44 (44)
T ss_pred CCC-CCCHHHHHHHHC-cCHHHHHHHhhcCC-CCCCcCCCCEEecCC
Confidence 455 999999999999 99999999996 53 457899999999983
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.2e-05 Score=77.91 Aligned_cols=105 Identities=18% Similarity=0.265 Sum_probs=83.0
Q ss_pred HHHHHHHhcCC-CCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005923 403 SEINILKKINH-SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNP 481 (669)
Q Consensus 403 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~ 481 (669)
.|.-+|+.+++ +++.+++|+| ..++|.||...+++...-.. ....-.-+|..|.+||.++++.+++|++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888998976 6999999999 45789999987765421000 00112368999999999999999999986555
Q ss_pred CeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 482 PYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 482 ~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
.+...|++++|+-+++++++|+.|...+....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 58899999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.8e-05 Score=79.04 Aligned_cols=118 Identities=18% Similarity=0.208 Sum_probs=86.9
Q ss_pred eEEEEEEE-CCCeeEEEEecc-----------------------------cHHHHHHHHHhcCCC--CceeEeeEEEecC
Q 005923 380 GSVYRGSF-KGDDAAVKVMKG-----------------------------DVSSEINILKKINHS--NIIRLSGFCVHEG 427 (669)
Q Consensus 380 G~Vy~g~~-~g~~vavK~~~~-----------------------------~~~~E~~~l~~l~H~--niv~l~g~~~~~~ 427 (669)
+.||.|.. +|.++|||.=+. ...+|.++|.++.-. .|.+.+++ +
T Consensus 105 sdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----n 180 (304)
T COG0478 105 SDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----N 180 (304)
T ss_pred ceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----c
Confidence 78999998 599999996431 134799999998654 67777654 4
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
...+||||+++--|...- ++-...-.|+..|+.-+.-+-..| +||+|+..-||++++||.+.++||-
T Consensus 181 RHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 181 RHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred cceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCc
Confidence 678999999985554321 123334455566666666666778 9999999999999999999999997
Q ss_pred CccccCC
Q 005923 508 LARSAES 514 (669)
Q Consensus 508 la~~~~~ 514 (669)
-+.....
T Consensus 248 Q~v~~~h 254 (304)
T COG0478 248 QAVPISH 254 (304)
T ss_pred ccccCCC
Confidence 7765543
|
|
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.3e-05 Score=82.80 Aligned_cols=47 Identities=15% Similarity=0.130 Sum_probs=44.3
Q ss_pred eeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeee
Q 005923 63 TFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVN 112 (669)
Q Consensus 63 ~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~ 112 (669)
.|+|++ ||||+.||..|| +++.+|+++|+|. ++..|.+||.|.||.+
T Consensus 62 ~y~Vk~-GDTL~~IA~~~g-~~~~~La~~N~l~-~p~~I~~GQ~L~i~~~ 108 (319)
T PRK10871 62 TYTVKK-GDTLFYIAWITG-NDFRDLAQRNNIQ-APYSLNVGQTLQVGNA 108 (319)
T ss_pred ceEECC-CCHHHHHHHHHC-cCHHHHHHhcCCC-CCccccCCCEEEeCCC
Confidence 599999 999999999999 9999999999997 7899999999999854
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.3e-05 Score=76.86 Aligned_cols=131 Identities=14% Similarity=0.158 Sum_probs=83.9
Q ss_pred eEEEEEEECCCeeEEEEecc----cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCCCCHHHHH---------
Q 005923 380 GSVYRGSFKGDDAAVKVMKG----DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL--------- 445 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l--------- 445 (669)
..||+...++..+.||.... ++.+|+++++.+. +--+.+++++...++..++|||+++|.+|.+..
T Consensus 13 ~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~ 92 (244)
T cd05150 13 ATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLV 92 (244)
T ss_pred CeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHH
Confidence 57999988777888998865 4889999999884 444667788776666789999999987776432
Q ss_pred ----------hcCCCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----CCCCCeEeeCCC
Q 005923 446 ----------HSNRYQTSDNLT--WKQRVQIAY--------------------DVANALNYLHK----YTNPPYVHKNLK 489 (669)
Q Consensus 446 ----------~~~~~~~~~~l~--~~~~~~i~~--------------------qia~~L~yLH~----~~~~~ivHrDik 489 (669)
|.-. .....+. ......... .+...+..|-. ...+.++|+|+.
T Consensus 93 ~~l~~~l~~lH~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~ 171 (244)
T cd05150 93 DALAEALRRLHALP-VADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDAC 171 (244)
T ss_pred HHHHHHHHHHhcCC-cccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCC
Confidence 1110 0000111 001110000 01111222211 123569999999
Q ss_pred CCCeeecCCCcEEEcccCCccc
Q 005923 490 TSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~ 511 (669)
+.|||++++....|+||+.+..
T Consensus 172 ~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 172 LPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CccEEEeCCcEEEEEEcccccc
Confidence 9999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.8e-05 Score=75.12 Aligned_cols=132 Identities=17% Similarity=0.238 Sum_probs=81.0
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCCC--ceeEeeEEEecCceeEEEEecCCC
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHSN--IIRLSGFCVHEGNTYLVYEFADNG 439 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~g 439 (669)
++.|.- +.||+. .|...++|.... +..+|.++++.+..-. +.+.++++...+...+|||+++|.
T Consensus 9 i~~G~t-------~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 9 TGEGGN-------GESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred ecCCCC-------cceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 566766 788983 355677888654 4778999999986443 467788877777788999999986
Q ss_pred C-HHHHH---------------------hcCCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeE
Q 005923 440 A-LSDWL---------------------HSNRYQTSDNLTWKQRV-QIAY----------DVAN-ALNYLHKY-TNPPYV 484 (669)
Q Consensus 440 s-L~~~l---------------------~~~~~~~~~~l~~~~~~-~i~~----------qia~-~L~yLH~~-~~~~iv 484 (669)
. +...+ |.-. .......... ++.. ++.. ...+|... ..+.++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~---~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTK---CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCC---CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 3 22111 1110 0011111100 0100 0111 12223221 234589
Q ss_pred eeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 485 HKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 485 HrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.8e-06 Score=76.22 Aligned_cols=46 Identities=35% Similarity=0.491 Sum_probs=41.0
Q ss_pred EEEEcCCCCCHHHHHHHhCC---CHHhHHHhcC--CCCCCCCCCCcccccc
Q 005923 195 LTYMVTWGDSISAIAQLFNV---DERSVLDANK--LSQDDLIFPFTPILVP 240 (669)
Q Consensus 195 ~tY~v~~GDtl~~Ia~~f~v---~~~~l~~~N~--l~~~~~l~p~~~l~iP 240 (669)
.+|+|++|||||+||++|.. ....|.++|+ +..++.|+|||.|.||
T Consensus 96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 47999999999999999954 4679999998 7778899999999987
|
|
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.2e-05 Score=57.77 Aligned_cols=45 Identities=16% Similarity=0.214 Sum_probs=41.2
Q ss_pred eeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEe
Q 005923 63 TFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIP 110 (669)
Q Consensus 63 ~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP 110 (669)
.|++++ |||+++||..|+ ++..+|+++|+.. ....+.+|+.|.||
T Consensus 2 ~~~v~~-gdt~~~ia~~~~-~~~~~~~~~N~~~-~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKK-GDTLSSIAQRYG-ISVEELLKLNGLS-DPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECC-CCCHHHHHHHHC-cCHHHHHHHcCCC-CccccCCCCEEecC
Confidence 488998 999999999999 9999999999885 56789999999987
|
This domain may have a general peptidoglycan binding function. |
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.3e-05 Score=81.78 Aligned_cols=47 Identities=13% Similarity=0.057 Sum_probs=44.1
Q ss_pred eeeeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEe
Q 005923 60 AYLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIP 110 (669)
Q Consensus 60 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP 110 (669)
.|.+|+|++ ||||++||++|| +++..|+++|++. .+.|.+||.|+||
T Consensus 292 ~~~~YiVq~-GDTL~sIAkRYG-VSV~~L~r~N~L~--~~~L~~GQ~L~IP 338 (338)
T TIGR02907 292 KLRMCIVQE-GDTIETIAERYE-ISVSQLIRHNQLE--DFEVNEGQILYIP 338 (338)
T ss_pred ccEEEEECC-CCCHHHHHHHHC-cCHHHHHHHhCCC--ccccCCCCEEEeC
Confidence 578899999 999999999999 9999999999994 6899999999998
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0001 Score=72.32 Aligned_cols=115 Identities=20% Similarity=0.183 Sum_probs=77.7
Q ss_pred eEEEEEEECCCeeEEEEeccc----------------HHHHHHHHHhcCCC---CceeEeeEEEe-----cCceeEEEEe
Q 005923 380 GSVYRGSFKGDDAAVKVMKGD----------------VSSEINILKKINHS---NIIRLSGFCVH-----EGNTYLVYEF 435 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~~----------------~~~E~~~l~~l~H~---niv~l~g~~~~-----~~~~~lV~e~ 435 (669)
..|.+=..+|....+|..+.+ ..+++..+.+++.. ....++.+... ....+|+|||
T Consensus 45 ~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EY 124 (229)
T PF06176_consen 45 NYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEY 124 (229)
T ss_pred cEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEE
Confidence 345566668888999987643 22344444444322 22232333322 2345789999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
++|..|.++.. ++. .++..+..++.-||+.| ++|+|..|.|+++++++ +++.||+..+.
T Consensus 125 IeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 125 IEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred ecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECccccc
Confidence 99988766542 222 25566778899999999 99999999999998554 99999988764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.4e-05 Score=82.38 Aligned_cols=135 Identities=18% Similarity=0.266 Sum_probs=85.2
Q ss_pred hHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc------------------------------------------
Q 005923 363 QDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG------------------------------------------ 399 (669)
Q Consensus 363 ~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~------------------------------------------ 399 (669)
++.-+|..+. |.||+|++ +|+.||||+.+.
T Consensus 165 ~~~piaaASl-------aQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ 237 (538)
T KOG1235|consen 165 DEEPIAAASL-------AQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQ 237 (538)
T ss_pred Ccchhhhcch-------hheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHh
Confidence 3445788888 99999999 578899999753
Q ss_pred --cHHHHHHHHHhc----CCCCc---eeEeeEEE-ecCceeEEEEecCCCCHHHH--HhcCCCCCCCCCCHHHHHHHHHH
Q 005923 400 --DVSSEINILKKI----NHSNI---IRLSGFCV-HEGNTYLVYEFADNGALSDW--LHSNRYQTSDNLTWKQRVQIAYD 467 (669)
Q Consensus 400 --~~~~E~~~l~~l----~H~ni---v~l~g~~~-~~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~q 467 (669)
||..|++-..++ .|-+. |.+=.++. ......|+||||+|..+.|. +.+. .++...+..-+.+
T Consensus 238 ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~------gi~~~~i~~~l~~ 311 (538)
T KOG1235|consen 238 ELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR------GISPHDILNKLVE 311 (538)
T ss_pred hcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc------CCCHHHHHHHHHH
Confidence 233344333332 34441 11222222 23467999999999866554 3333 2554443333333
Q ss_pred HHHHHHHHHhCCCCCeEeeCCCCCCeeecC----CCcEEEcccCCccccCCC
Q 005923 468 VANALNYLHKYTNPPYVHKNLKTSNILLDT----NLRAKITNFGLARSAESD 515 (669)
Q Consensus 468 ia~~L~yLH~~~~~~ivHrDik~~NILl~~----~~~~kl~DfGla~~~~~~ 515 (669)
...-+-+ ..| ++|.|=.|.||++.. ++.+.+-|||+.......
T Consensus 312 ~~~~qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 312 AYLEQIF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHH--hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2222222 235 999999999999984 678999999999877543
|
|
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=5.6e-05 Score=70.11 Aligned_cols=48 Identities=19% Similarity=0.349 Sum_probs=39.6
Q ss_pred eEEEEecCCcchhhhHhhhhcCchhHHHHHhcCC--CC-CCCCCCCceEEEe
Q 005923 128 TTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNP--VD-SRNLTVGLDLFVP 176 (669)
Q Consensus 128 ~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~--~~-~~~l~~G~~L~ip 176 (669)
..|+|+ +|||||+||.++|..-...+.|.++|+ +. +..|+|||+|.||
T Consensus 96 ~~y~Vk-~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 96 QFYTVK-SGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred eEEEEC-CCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 579999 999999999555554456789999997 44 4589999999998
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00047 Score=72.12 Aligned_cols=68 Identities=13% Similarity=0.153 Sum_probs=52.9
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCC---CCceeEeeEEEec---CceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINH---SNIIRLSGFCVHE---GNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~e~ 435 (669)
++.|.. +.||+-...+..+.+|..+. .+..|.+.|+.+.- -.+.+++++|..+ +..+||||+
T Consensus 22 i~~G~~-------~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 22 ISEQPY-------AALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred cCCccc-------eeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 677887 88999877666677787654 46789999999853 4688889888643 668999999
Q ss_pred cCCCCH
Q 005923 436 ADNGAL 441 (669)
Q Consensus 436 ~~~gsL 441 (669)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00069 Score=67.48 Aligned_cols=131 Identities=22% Similarity=0.293 Sum_probs=76.4
Q ss_pred eEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCC--CceeEeeEEEec---CceeEEEEecCCCCHHH------
Q 005923 380 GSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHS--NIIRLSGFCVHE---GNTYLVYEFADNGALSD------ 443 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~e~~~~gsL~~------ 443 (669)
+.||+...++..+++|.... .+..|..+++.+... .+.++++++... ...+++|+++++..+.+
T Consensus 11 n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~ 90 (239)
T PF01636_consen 11 NRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQ 90 (239)
T ss_dssp SEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHH
T ss_pred eeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccc
Confidence 78999999888999999854 366788998888533 356777655333 34689999999987777
Q ss_pred ----------HH---hcCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh----CCCCCeE
Q 005923 444 ----------WL---HSNRYQTSDNLTWKQ---------RVQI------------AYDVAN-ALNYLHK----YTNPPYV 484 (669)
Q Consensus 444 ----------~l---~~~~~~~~~~l~~~~---------~~~i------------~~qia~-~L~yLH~----~~~~~iv 484 (669)
.+ +... .....+.+.. .... ...+.. .++.+++ .....++
T Consensus 91 ~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (239)
T PF01636_consen 91 RPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLI 169 (239)
T ss_dssp HHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE
T ss_pred cccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEE
Confidence 11 1110 0111111111 0000 111222 3334432 1345599
Q ss_pred eeCCCCCCeeec-CCCcEEEcccCCccc
Q 005923 485 HKNLKTSNILLD-TNLRAKITNFGLARS 511 (669)
Q Consensus 485 HrDik~~NILl~-~~~~~kl~DfGla~~ 511 (669)
|+|+.+.|||++ +++.+-|.||+.+..
T Consensus 170 HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 170 HGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp -SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred EeccccccceeeeccceeEEEecccceE
Confidence 999999999999 667678999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=65.84 Aligned_cols=121 Identities=25% Similarity=0.292 Sum_probs=84.2
Q ss_pred eEEEEEEE-CCCeeEEEEeccc-------------------------------HHHHHHHHHhcC--CCCceeEeeEEEe
Q 005923 380 GSVYRGSF-KGDDAAVKVMKGD-------------------------------VSSEINILKKIN--HSNIIRLSGFCVH 425 (669)
Q Consensus 380 G~Vy~g~~-~g~~vavK~~~~~-------------------------------~~~E~~~l~~l~--H~niv~l~g~~~~ 425 (669)
..||+|.- ++..+|||+.+.. ..+|..-|+++. +-.+.+-+++.
T Consensus 62 A~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~-- 139 (268)
T COG1718 62 ANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR-- 139 (268)
T ss_pred eEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec--
Confidence 68999886 5889999998531 124677777763 34445555443
Q ss_pred cCceeEEEEecCCCCH-HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 EGNTYLVYEFADNGAL-SDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
+..|||||+....+ .-.|+ .-.+.......+..++++.|.-|-. .+ +||+||..-|||+. ++.+.|
T Consensus 140 --~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 140 --NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred --CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEE
Confidence 45799999965310 00111 1123333566777888888888876 66 99999999999999 889999
Q ss_pred cccCCccccCC
Q 005923 504 TNFGLARSAES 514 (669)
Q Consensus 504 ~DfGla~~~~~ 514 (669)
+|||-|.....
T Consensus 208 ID~~QaV~~~h 218 (268)
T COG1718 208 IDVSQAVTIDH 218 (268)
T ss_pred EECccccccCC
Confidence 99999876653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00093 Score=62.90 Aligned_cols=121 Identities=21% Similarity=0.329 Sum_probs=86.2
Q ss_pred HHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc-----HHHHHHHHHhcCCCCcee-EeeEEEecCceeEEEEecCC
Q 005923 365 LKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD-----VSSEINILKKINHSNIIR-LSGFCVHEGNTYLVYEFADN 438 (669)
Q Consensus 365 l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~-----~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~ 438 (669)
..++.|.+ |.||.|.+.|..+|+|+-+.| +..|+++|..++-.++.. ++.|- ..++.|||+.|
T Consensus 28 ~~L~KG~~-------s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 28 KELAKGTT-------SVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhcccc-------cEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 35899999 999999999999999998654 788999999998766644 44443 33455999998
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC--CCeeecCCCcEEEcccCCcccc
Q 005923 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT--SNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 439 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~--~NILl~~~~~~kl~DfGla~~~ 512 (669)
-.|.++-.. .+-+++ ..+++.---|...+ |-|+.|.- .||++.++ .+.|+||.-|..-
T Consensus 97 ~~L~~~~~~--------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~-~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG--------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDR-DVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc--------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCC-cEEEEEccchhhc
Confidence 888877642 122333 33444433355556 88888764 46666544 9999999998743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0006 Score=81.45 Aligned_cols=140 Identities=15% Similarity=0.319 Sum_probs=83.9
Q ss_pred HHhCCCCcccceeeEEEEEEECC----CeeEEEEec--------ccHHHHHHHHHhcC-CCCc--eeEeeEEEec---Cc
Q 005923 367 IATGSFSEENRIQGSVYRGSFKG----DDAAVKVMK--------GDVSSEINILKKIN-HSNI--IRLSGFCVHE---GN 428 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g----~~vavK~~~--------~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~ 428 (669)
++.|.+ +.+|+-...+ ..+++|+.. .++.+|.++|+.+. |.++ .+++++|.+. +.
T Consensus 46 l~gG~s-------n~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 46 FGHGQS-------NPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred eCCCCc-------CceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 455655 6677766643 356666642 24779999999995 6654 8888888654 46
Q ss_pred eeEEEEecCCCCHHH--------------------H---HhcCCCC------CCCCCCH--HHHHHHH------------
Q 005923 429 TYLVYEFADNGALSD--------------------W---LHSNRYQ------TSDNLTW--KQRVQIA------------ 465 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~--------------------~---l~~~~~~------~~~~l~~--~~~~~i~------------ 465 (669)
.|+||||+++..+.+ . ||.-... ...+..+ .++.++.
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999999754321 1 2221000 0011111 1221111
Q ss_pred ---HHHHHHHHHHHhCC--------CCCeEeeCCCCCCeeecC-CCc-EEEcccCCccccC
Q 005923 466 ---YDVANALNYLHKYT--------NPPYVHKNLKTSNILLDT-NLR-AKITNFGLARSAE 513 (669)
Q Consensus 466 ---~qia~~L~yLH~~~--------~~~ivHrDik~~NILl~~-~~~-~kl~DfGla~~~~ 513 (669)
-.+...+++|..+- .+.+||+|+++.|||++. +.+ .-|.||.++....
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 12334466775432 134999999999999985 334 5789999887543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00067 Score=79.75 Aligned_cols=197 Identities=17% Similarity=0.200 Sum_probs=139.0
Q ss_pred HHHHHHHHHhcCCCCceeEeeEEEecCce----eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005923 401 VSSEINILKKINHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476 (669)
Q Consensus 401 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH 476 (669)
...|+..+.++.|+|++.+++|-.++... .+..|++..-++...+..- ..++....+.+..++..||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHH
Confidence 34578888899999999999997765432 3456777777777777543 56888899999999999999999
Q ss_pred hCCCCCeEeeCCCCC---CeeecCCCcEEEc--ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCch-
Q 005923 477 KYTNPPYVHKNLKTS---NILLDTNLRAKIT--NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK- 550 (669)
Q Consensus 477 ~~~~~~ivHrDik~~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~- 550 (669)
+.. ..|.-+..+ +.-.+..+...++ ||+.++........ ....-+..|.++|......+..+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---------~~~~~~~~~~~~e~~~~~~~~~~r 371 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---------FSDLLAEIRNADEDLKENTAKKSR 371 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---------hhhcCccccccccccccccchhhh
Confidence 986 667666665 5555666777777 99988876544321 11233456788888876665544
Q ss_pred -hhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccC
Q 005923 551 -LDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629 (669)
Q Consensus 551 -sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~d 629 (669)
.|+|.+|..+.-+..|........ ....+++ ......+.+...+|+..+
T Consensus 372 ~~dL~~lgll~~~~~~~~~i~~~~~----------------------~~~~~l~--------~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 372 LTDLWCLGLLLLQLSQGEDISEKSA----------------------VPVSLLD--------VLSTSELLDALPKCLDED 421 (1351)
T ss_pred hhHHHHHHHHHhhhhhcCccccccc----------------------chhhhhc--------cccchhhhhhhhhhcchh
Confidence 799999999999988765432110 0001111 011114678889999999
Q ss_pred CCCCCCHHHHHHHHH
Q 005923 630 LNARPSISEVFVTLS 644 (669)
Q Consensus 630 P~~RPt~~evl~~L~ 644 (669)
+.+|++..+++...-
T Consensus 422 ~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 422 SEERLSALELLTHPF 436 (1351)
T ss_pred hhhccchhhhhhchh
Confidence 999999999998753
|
|
| >smart00257 LysM Lysin motif | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0003 Score=49.53 Aligned_cols=43 Identities=14% Similarity=0.128 Sum_probs=37.7
Q ss_pred eecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEE
Q 005923 64 FRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLI 109 (669)
Q Consensus 64 y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~I 109 (669)
|++++ |||+++||..|+ ++..+|.++|+.. ....+.+|+.|.|
T Consensus 2 ~~v~~-gdt~~~ia~~~~-~~~~~~~~~N~~~-~~~~~~~g~~l~i 44 (44)
T smart00257 2 YTVKK-GDTLSSIARRYG-ISVSDLLELNNIL-DPDNLQVGQKLKI 44 (44)
T ss_pred eEeCC-CCCHHHHHHHhC-CCHHHHHHHcCCC-CccccCCCCEEeC
Confidence 78888 999999999999 9999999999854 5678889988764
|
|
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00025 Score=63.89 Aligned_cols=46 Identities=28% Similarity=0.468 Sum_probs=42.7
Q ss_pred eEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEee
Q 005923 128 TTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPL 177 (669)
Q Consensus 128 ~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~ 177 (669)
..|+|+ .||||+.|| +.|+ .+...|+++|.+..+.+++||.|.+|.
T Consensus 67 ~~~~V~-~gdtL~~Ia-~~~~--~tv~~l~~~n~l~~~~i~~gq~l~~~~ 112 (124)
T COG1388 67 VTYTVK-KGDTLSKIA-RKYG--VTVAELKQLNNLSSDKIKVGQKLKLPV 112 (124)
T ss_pred ceEEEe-cCCCHHHHH-HHhC--CCHHHHHHHhccCCCceecCcEEEEec
Confidence 579999 999999999 7787 888999999999988999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=4.7e-05 Score=83.78 Aligned_cols=176 Identities=18% Similarity=0.183 Sum_probs=125.1
Q ss_pred HHhCCCCcccceeeEEEEEEECCC-eeEEEEecc--cHHHHHHHHHhcCCCC-ceeEeeEEEecCceeEEEEecCCC-CH
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKG--DVSSEINILKKINHSN-IIRLSGFCVHEGNTYLVYEFADNG-AL 441 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~-~vavK~~~~--~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL 441 (669)
.+.+.+ ++++|.+-..+ ...++.+.. ...-++++|.+++||| .+..++-+..+...++++++...| +-
T Consensus 250 fvK~al-------tknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 250 FVKGAL-------TKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHh-------cCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 566777 78888876432 233555543 3456899999999999 777777777777889999999887 21
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCC
Q 005923 442 SDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521 (669)
Q Consensus 442 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 521 (669)
..-.. ...-.+..-+...+.+.-.+++++||+.- =+|+| ||+..+ ...|..||+....+....
T Consensus 323 ~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----- 385 (829)
T KOG0576|consen 323 ALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----- 385 (829)
T ss_pred cccCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-----
Confidence 11110 01112334455566777888999999864 48998 777654 678999999887765432
Q ss_pred cccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 005923 522 YGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV 570 (669)
Q Consensus 522 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~ 570 (669)
..+...+|+.|+|||+.....+..+.|+|+.|+--.++--|-.|-
T Consensus 386 ----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 245578999999999999999999999999998666666555543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0024 Score=64.32 Aligned_cols=32 Identities=22% Similarity=0.458 Sum_probs=26.6
Q ss_pred CCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 480 NPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 480 ~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
.+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34499999999999998766567999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.006 Score=61.28 Aligned_cols=128 Identities=20% Similarity=0.299 Sum_probs=73.6
Q ss_pred eEEEEEEEC---CCeeEEEEecc------cHHHHHHHHHhcCCCCc-eeEeeEEEecCceeEEEEecCCCCHHHH-----
Q 005923 380 GSVYRGSFK---GDDAAVKVMKG------DVSSEINILKKINHSNI-IRLSGFCVHEGNTYLVYEFADNGALSDW----- 444 (669)
Q Consensus 380 G~Vy~g~~~---g~~vavK~~~~------~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~----- 444 (669)
..+|+.... +..+.+|.... +..+|+.+++.+...++ .++++.+. ..+||||+++.++...
T Consensus 12 N~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l~~~~~~~~ 87 (235)
T cd05157 12 NKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTLEPEDLRNP 87 (235)
T ss_pred ceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcCCHHHccCh
Confidence 578887765 46788887643 34579999999854433 44444332 2489999998665321
Q ss_pred ------------HhcCCCCCC------CCC-CHHHHHHHHH----------------------HHHHHHHHH----HhC-
Q 005923 445 ------------LHSNRYQTS------DNL-TWKQRVQIAY----------------------DVANALNYL----HKY- 478 (669)
Q Consensus 445 ------------l~~~~~~~~------~~l-~~~~~~~i~~----------------------qia~~L~yL----H~~- 478 (669)
+|....... ... -|..+..+.. .+...+..| ...
T Consensus 88 ~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 167 (235)
T cd05157 88 KIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLKELLSALN 167 (235)
T ss_pred HHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHHHHhcccC
Confidence 111110100 111 1222222211 111111222 111
Q ss_pred CCCCeEeeCCCCCCeeecC-CCcEEEcccCCccc
Q 005923 479 TNPPYVHKNLKTSNILLDT-NLRAKITNFGLARS 511 (669)
Q Consensus 479 ~~~~ivHrDik~~NILl~~-~~~~kl~DfGla~~ 511 (669)
....++|+|+.+.|||+++ +..+.++||..|..
T Consensus 168 ~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 168 SPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred CCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2235999999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0036 Score=63.91 Aligned_cols=127 Identities=14% Similarity=0.151 Sum_probs=75.4
Q ss_pred eEEEEEEECCCeeEEEEecc-------cHHHHHHHHHhcCCCCc-eeEeeEEEecCceeEEEEecCCCCHHHH-------
Q 005923 380 GSVYRGSFKGDDAAVKVMKG-------DVSSEINILKKINHSNI-IRLSGFCVHEGNTYLVYEFADNGALSDW------- 444 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~------- 444 (669)
+.+|+...++..+++|.... +..+|.++++.+....+ .++++.+ ..++||||++|..+...
T Consensus 10 n~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~~~~~~~~ 85 (256)
T TIGR02721 10 NRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLDQFVALDL 85 (256)
T ss_pred CCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccccccCchh
Confidence 67888877787888887532 46789999999965433 3445443 23799999998655321
Q ss_pred ----------HhcCCCCCCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEeeCCCCCCeeecCCC
Q 005923 445 ----------LHSNRYQTSDNLTWKQR-VQIAYD---------VANALNYLHKY-----TNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 445 ----------l~~~~~~~~~~l~~~~~-~~i~~q---------ia~~L~yLH~~-----~~~~ivHrDik~~NILl~~~~ 499 (669)
||... .....++.... .++..+ +...+..+... ..+.++|+|+.+.||++++++
T Consensus 86 ~~~la~~l~~lH~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~ 164 (256)
T TIGR02721 86 LLELAALLHQLHSQP-RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG 164 (256)
T ss_pred HHHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC
Confidence 22211 11122222211 111111 11122222221 123599999999999999877
Q ss_pred cEEEcccCCcccc
Q 005923 500 RAKITNFGLARSA 512 (669)
Q Consensus 500 ~~kl~DfGla~~~ 512 (669)
+.|+||..+...
T Consensus 165 -~~lIDwE~a~~g 176 (256)
T TIGR02721 165 -LKLIDWEYASDG 176 (256)
T ss_pred -CEEEeccccCcC
Confidence 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.016 Score=56.54 Aligned_cols=92 Identities=24% Similarity=0.313 Sum_probs=66.9
Q ss_pred HHHHHHHHHhcC------CCCceeEeeEEEecCceeEEEEecCCC------CHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 005923 401 VSSEINILKKIN------HSNIIRLSGFCVHEGNTYLVYEFADNG------ALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468 (669)
Q Consensus 401 ~~~E~~~l~~l~------H~niv~l~g~~~~~~~~~lV~e~~~~g------sL~~~l~~~~~~~~~~l~~~~~~~i~~qi 468 (669)
..+|+.-..++. +.+|.+++|+...+....+|+|.+.+. +|.+++... .++. ... ..+
T Consensus 58 ~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~---~~L 127 (199)
T PF10707_consen 58 NRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELR---QAL 127 (199)
T ss_pred HHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHH---HHH
Confidence 345776666655 789999999999888889999997653 788888653 2554 333 334
Q ss_pred HHHHHHHHhCCCCCeEeeCCCCCCeeecCC---C-cEEEcc
Q 005923 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTN---L-RAKITN 505 (669)
Q Consensus 469 a~~L~yLH~~~~~~ivHrDik~~NILl~~~---~-~~kl~D 505 (669)
-+-.+||-+.+ |+.+|++|.||++..+ . .+.|+|
T Consensus 128 ~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 128 DEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 44456777777 9999999999999543 2 566776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.016 Score=60.04 Aligned_cols=134 Identities=20% Similarity=0.316 Sum_probs=70.1
Q ss_pred HHhCCCCcccceeeEEEEEEECCCeeEEEEecc----cHHHHHHHHHhcC---CCCceeEeeEEEecCceeEEEEecCCC
Q 005923 367 IATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG----DVSSEINILKKIN---HSNIIRLSGFCVHEGNTYLVYEFADNG 439 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g 439 (669)
++.|.. ..+|+-..+++.+.||.-.. .|..|.+-|+.|. --.+.+.+++...++..+||+||++.+
T Consensus 25 v~GG~i-------~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 25 VSGGDI-------NEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp E--SSS-------SEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred cCCCCh-------hheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 556666 67888887888999998753 3788999999883 446788999888777889999999876
Q ss_pred --C------HHH---HHhc-CCCC----------------CCCCCCHH-----HHHHHHHHHHH-----------HHHH-
Q 005923 440 --A------LSD---WLHS-NRYQ----------------TSDNLTWK-----QRVQIAYDVAN-----------ALNY- 474 (669)
Q Consensus 440 --s------L~~---~l~~-~~~~----------------~~~~l~~~-----~~~~i~~qia~-----------~L~y- 474 (669)
+ |.. .||. .... +...=+|. +|+....+.+. .++-
T Consensus 98 ~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~ 177 (288)
T PF03881_consen 98 SPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERL 177 (288)
T ss_dssp ---CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHH
Confidence 1 111 2333 1100 00012332 12221111111 1111
Q ss_pred ---HHhC-CCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 475 ---LHKY-TNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 475 ---LH~~-~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
|+.. -.|.++|+||.+.|++.+.++.+.|.|=.
T Consensus 178 ~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 178 PSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 2211 25789999999999999999889998843
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.02 Score=62.09 Aligned_cols=65 Identities=20% Similarity=0.157 Sum_probs=47.4
Q ss_pred HHHhCCCCcccceeeEEEEEEECCC--eeEEEEec--------------ccHHHHHHHHHhcC---CCCceeEeeEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGD--DAAVKVMK--------------GDVSSEINILKKIN---HSNIIRLSGFCVHE 426 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~--~vavK~~~--------------~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 426 (669)
+++.|++ ..||+....+. .+.||.-. .....|.+.|..+. -.++.+++.+ +.
T Consensus 33 elggGn~-------N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~ 103 (401)
T PRK09550 33 EIGDGNL-------NLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE 103 (401)
T ss_pred EcCCCce-------EEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence 3788888 89999998643 79999732 12456888888763 2467778877 45
Q ss_pred CceeEEEEecCCC
Q 005923 427 GNTYLVYEFADNG 439 (669)
Q Consensus 427 ~~~~lV~e~~~~g 439 (669)
+..++||||+++.
T Consensus 104 ~~~~lVME~L~~~ 116 (401)
T PRK09550 104 ELAVTVMEDLSDH 116 (401)
T ss_pred CCCEEEEecCCCc
Confidence 6689999999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.056 Score=52.63 Aligned_cols=104 Identities=18% Similarity=0.323 Sum_probs=74.9
Q ss_pred eEEEEEEECCCeeEEEEecc----------------------------cHHHHHHHHHhc---CCCCc--eeEeeEEEec
Q 005923 380 GSVYRGSFKGDDAAVKVMKG----------------------------DVSSEINILKKI---NHSNI--IRLSGFCVHE 426 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~----------------------------~~~~E~~~l~~l---~H~ni--v~l~g~~~~~ 426 (669)
|.||+.+.+|..+|+|.++. .|..|.+...+| .+.++ |+.+||..-.
T Consensus 52 ~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~ 131 (207)
T PF13095_consen 52 GYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLT 131 (207)
T ss_pred eEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEc
Confidence 78999999999999999421 144577776666 45566 9999997422
Q ss_pred C------------------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC
Q 005923 427 G------------------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNL 488 (669)
Q Consensus 427 ~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDi 488 (669)
. .+.+|.||++... .++-. -+.+|.+-|..+|..+ |+-+|+
T Consensus 132 ~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~----~~~~~~~dl~~~~k~g---I~~~Dv 190 (207)
T PF13095_consen 132 EDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIR----DIPQMLRDLKILHKLG---IVPRDV 190 (207)
T ss_pred hHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchh----HHHHHHHHHHHHHHCC---eeeccC
Confidence 0 2357888776532 13333 3456667788899999 999999
Q ss_pred CCCCeeecCCCcEEEcccCCc
Q 005923 489 KTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 489 k~~NILl~~~~~~kl~DfGla 509 (669)
++.|.. .-||+|||.+
T Consensus 191 ~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 191 KPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cccccc-----CCEEEecccC
Confidence 999986 4689999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 669 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 4eby_A | 212 | Crystal Structure Of The Ectodomain Of A Receptor L | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 6e-80
Identities = 98/315 (31%), Positives = 151/315 (47%), Gaps = 39/315 (12%)
Query: 356 SLTLYKFQDLKIATGSFSEENRIQ----------GSVYRGSFKGDDAAVKVMKGDVS--- 402
+ F +LK T +F E G VY+G AVK + V
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 403 --------SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSD 454
EI ++ K H N++ L GF + LVY + NG+L D L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP- 129
Query: 455 NLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
L+W R +IA AN +N+LH ++H+++K++NILLD AKI++FGLAR++E
Sbjct: 130 -LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
+T +VGT YMAPE + G ITPK D+++FGVV+LE+++G AV D+
Sbjct: 186 FAQT------VMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV--DE 236
Query: 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
+ E +LL + +E + + +ID + N+ +M +A C N RP
Sbjct: 237 HREPQLLLDIKEEIEDE---EKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 635 SISEVFVTLSKIWSS 649
I +V L ++ +S
Sbjct: 293 DIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 4e-79
Identities = 90/299 (30%), Positives = 152/299 (50%), Gaps = 27/299 (9%)
Query: 356 SLTLYKFQDLKIATGSFSEENRIQ----GSVYRGSFK-GDDAAVKVMKGDVS-------- 402
L + ++L++A+ +FS +N + G VY+G G AVK +K + +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
+E+ ++ H N++RL GFC+ LVY + NG+++ L R ++ L W +R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQ 134
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE-HEQGG 521
+IA A L YLH + +P +H+++K +NILLD A + +FGLA+ + + H
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---- 190
Query: 522 YGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581
+T V GT G++APEY+ G + K DVF +GV++LEL++G+ A + + +
Sbjct: 191 ----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 582 Y-ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ L + KL +D L+ Y + + Q+A CT RP +SEV
Sbjct: 247 MLLDWVKGLLKEK---KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-75
Identities = 92/331 (27%), Positives = 149/331 (45%), Gaps = 45/331 (13%)
Query: 335 SLFPQASNSLSHPQGFRSAVESLTL-YKFQDLKIATGSFSEENRIQ----GSVYRGSFK- 388
S + +A+NS++ V + DL+ AT +F + I G VY+G +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 389 GDDAAVKVMKGDVS-------SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGAL 441
G A+K + S +EI L H +++ L GFC L+Y++ +NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 442 SDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501
L+ + +++W+QR++I A L+YLH +H+++K+ NILLD N
Sbjct: 123 KRHLY-GSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178
Query: 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVL 561
KIT+FG+++ + L+ V GT GY+ PEY G +T K DV++FGVV+
Sbjct: 179 KITDFGISKKGTELDQTH------LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 562 ELLSGREAVTGDQNCEAELLYASISRVLEESNV---------REKLRGFIDPSLRNEYPL 612
E+L R A+ S E N+ +L +DP+L ++
Sbjct: 233 EVLCARSAI-------------VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279
Query: 613 DLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
+ A C A RPS+ +V L
Sbjct: 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-73
Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 50/323 (15%)
Query: 362 FQDLKIATGSFSEENRIQ----GSVYRGSFKGDDAAVKVMK-GDVSS-----EINILKKI 411
++L + G V++ + AVK+ D S E+ L +
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM 75
Query: 412 NHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
H NI++ G + +L+ F + G+LSD+L +N ++W + IA
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAET 129
Query: 468 VANALNYLH-------KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+A L YLH P H+++K+ N+LL NL A I +FGLA E+ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVI-----TPKLDVFAFGVVVLELLSGREAVTGDQN 575
T VGT YMAPE +E + ++D++A G+V+ EL S A G +
Sbjct: 190 ------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 576 CEAELLYASISRV------LEESNVREKLRGFIDPSLRNEYPLDLAFS-MAQLAKNCTAH 628
E L + ++E V +K R P LR+ + + + + + C H
Sbjct: 244 -EYMLPFEEEIGQHPSLEDMQEVVVHKKKR----PVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 629 DLNARPSISEVFVTLSKIWSSSS 651
D AR S V ++++ ++
Sbjct: 299 DAEARLSAGCVGERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-64
Identities = 64/317 (20%), Positives = 118/317 (37%), Gaps = 50/317 (15%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK-GDVSS-----EINILKKINHSNIIRL 419
I G + G+VY+GS AVKV + + I + + H NI R
Sbjct: 20 LIGRGRY-------GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 420 SGFCVHEGNT-----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
LV E+ NG+L +L + W ++A+ V L Y
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAY 126
Query: 475 LH------KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
LH + P H++L + N+L+ + I++FGL+ + + G
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 529 HVVGTYGYMAPEYIENGV-------ITPKLDVFAFGVVVLELLSGREAVTGDQNCEA-EL 580
VGT YMAPE +E V ++D++A G++ E+ + ++ ++
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 581 LYASISRV------LEESNVREKLRGFIDPSLRNEYPLDLAF--SMAQLAKNCTAHDLNA 632
+ + ++ REK R P + + S+ + ++C D A
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQR----PKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 633 RPSISEVFVTLSKIWSS 649
R + ++++
Sbjct: 303 RLTAQXAEERMAELMMI 319
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-59
Identities = 72/324 (22%), Positives = 132/324 (40%), Gaps = 50/324 (15%)
Query: 356 SLTLYKFQDL----KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK-----GDVSSEIN 406
SL + ++++ + G+F G V + ++ D A+K ++ E+
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAF-------GVVCKAKWRAKDVAIKQIESESERKAFIVELR 53
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
L ++NH NI++L G C++ LV E+A+ G+L + LH T +
Sbjct: 54 QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCL 109
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR-AKITNFGLARSAESDEHEQGGYGLQ 525
+ + YLH +H++LK N+LL KI +FG A ++
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----------H 159
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
+T + G+ +MAPE E + K DVF++G+++ E+++ R+ +++A
Sbjct: 160 MTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-- 216
Query: 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
V R P L P + L C + D + RPS+ E+ ++
Sbjct: 217 --------VHNGTR----PPLIKNLPKPI----ESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 646 IWSSSSDWDPSDELNNSRSLSRGS 669
+ D + SL G
Sbjct: 261 LMRYFPGADEPLQYPCQHSLPPGE 284
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-59
Identities = 81/306 (26%), Positives = 133/306 (43%), Gaps = 56/306 (18%)
Query: 361 KFQDL----KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINI 407
+ DL KI GSF G+V+R + G D AVK++ + E+ I
Sbjct: 35 PWCDLNIKEKIGAGSF-------GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+K++ H NI+ G N +V E+ G+L LH + + L ++R+ +AYD
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYD 145
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
VA +NYLH NPP VH+NLK+ N+L+D K+ +FGL+R S
Sbjct: 146 VAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS------ 198
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR---EAVTGDQNCEAELLYAS 584
GT +MAPE + + K DV++FGV++ EL + + + Q
Sbjct: 199 --AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---------V 247
Query: 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644
++ V + R + + A + + C ++ RPS + + L
Sbjct: 248 VAAV-----GFKCKR----LEIPRNLNPQV----AAIIEGCWTNEPWKRPSFATIMDLLR 294
Query: 645 KIWSSS 650
+ S+
Sbjct: 295 PLIKSA 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-56
Identities = 81/312 (25%), Positives = 132/312 (42%), Gaps = 51/312 (16%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK-GDVSS-----EINILKKINHSNIIRL 419
+I G + G V+ G ++G+ AVKV + +S EI + H NI+
Sbjct: 44 QIGKGRY-------GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 420 SGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
+ + YL+ ++ +NG+L D+L S L K +++AY + L +L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHL 150
Query: 476 H-----KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
H P H++LK+ NIL+ N I + GLA SD +E
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP----PNTR 206
Query: 531 VGTYGYMAPEYIENGVITP------KLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
VGT YM PE ++ + D+++FG+++ E+ V+G E +L Y
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR--CVSGGIVEEYQLPYHD 264
Query: 585 ISRV------LEESNVREKLRGFIDPSLRNEYPLDLAF-SMAQLAKNCTAHDLNARPSIS 637
+ + E +KLR PS N + D M +L C AH+ +R +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 638 EVFVTLSKIWSS 649
V TL+K+ S
Sbjct: 321 RVKKTLAKMSES 332
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-56
Identities = 86/309 (27%), Positives = 122/309 (39%), Gaps = 65/309 (21%)
Query: 361 KFQDL----KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----------DVSSEI 405
F +L I G F G VYR + GD+ AVK + +V E
Sbjct: 5 DFAELTLEEIIGIGGF-------GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+ + H NII L G C+ E N LV EFA G L+ L R + V A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWA 111
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLD--------TNLRAKITNFGLARSAESDEH 517
+A +NYLH P +H++LK+SNIL+ +N KIT+FGLAR
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT- 170
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577
G Y +MAPE I + + DV+++GV++ ELL+G G
Sbjct: 171 ---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221
Query: 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
V L P A+L ++C D ++RPS +
Sbjct: 222 V------AYGVAMN-------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFT 262
Query: 638 EVFVTLSKI 646
+ L+ I
Sbjct: 263 NILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-55
Identities = 71/324 (21%), Positives = 136/324 (41%), Gaps = 55/324 (16%)
Query: 351 RSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-DVSS-----E 404
R+ +TL + + G + G V+RGS++G++ AVK+ D S E
Sbjct: 4 RTVARDITLLE----CVGKGRY-------GEVWRGSWQGENVAVKIFSSRDEKSWFRETE 52
Query: 405 INILKKINHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
+ + H NI+ + ++ +L+ + + G+L D+L L
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVS 106
Query: 461 RVQIAYDVANALNYLH-----KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515
++I +A+ L +LH P H++LK+ NIL+ N + I + GLA
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---- 162
Query: 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITP------KLDVFAFGVVVLELLSGREA 569
+ VGT YMAPE ++ + ++D++AFG+V+ E+
Sbjct: 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR--M 220
Query: 570 VTGDQNCEAELLYASISRV------LEESNVREKLRGFIDPSLRNEYPLDLAFS-MAQLA 622
V+ + + + + + + ++ R P++ N + D + +A+L
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLM 276
Query: 623 KNCTAHDLNARPSISEVFVTLSKI 646
K C + +AR + + TL+KI
Sbjct: 277 KECWYQNPSARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-54
Identities = 62/305 (20%), Positives = 111/305 (36%), Gaps = 47/305 (15%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKV---------MKGDVSSEINILKKINHSNI 416
+ G F + + + + + + + E+ +++ + H N+
Sbjct: 17 VLGKGCFGQ-------AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
++ G + + E+ G L + S Q W QRV A D+A+ + YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLH 125
Query: 477 KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL------QLTRHV 530
+H++L + N L+ N + +FGLAR ++ + G + V
Sbjct: 126 SMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590
VG +MAPE I K+DVF+FG+V+ E++ A +
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----------DYLPRTMDF 232
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650
NVR L + P + S + C D RPS ++ L +
Sbjct: 233 GLNVRGFLDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 651 SDWDP 655
+ P
Sbjct: 285 AGHLP 289
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 3e-54
Identities = 72/311 (23%), Positives = 128/311 (41%), Gaps = 49/311 (15%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-DVSS-----EINILKKINHSNIIRL 419
I G F G V+RG ++G++ AVK+ + S EI + H NI+
Sbjct: 49 SIGKGRF-------GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 420 SGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
+ T +LV ++ ++G+L D+L+ +T + +++A A+ L +L
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHL 155
Query: 476 HKYT-----NPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
H P H++LK+ NIL+ N I + GLA H
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHR 211
Query: 531 VGTYGYMAPEYIENGVITP------KLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
VGT YMAPE +++ + + D++A G+V E+ G + + +L Y
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS--IGGIHEDYQLPYYD 269
Query: 585 ISRV------LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638
+ + + +KLR I ++ L MA++ + C + AR +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR---VMAKIMRECWYANGAARLTALR 326
Query: 639 VFVTLSKIWSS 649
+ TLS++
Sbjct: 327 IKKTLSQLSQQ 337
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-54
Identities = 61/304 (20%), Positives = 120/304 (39%), Gaps = 61/304 (20%)
Query: 361 KFQDL----KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINI 407
F+ L K+ G +++G ++G+D VKV+K D + E
Sbjct: 8 DFKQLNFLTKLNENHS-------GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 408 LKKINHSNIIRLSGFCVH--EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
L+ +H N++ + G C + L+ + G+L + LH + + Q V+ A
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFA 117
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
D+A + +LH P L + ++++D ++ A+I+ + S +S
Sbjct: 118 LDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----------- 165
Query: 526 LTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582
+ ++APE ++ D+++F V++ EL++ N E
Sbjct: 166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---- 219
Query: 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642
+V E LR P++ P ++ +++L K C D RP +
Sbjct: 220 --GMKV-----ALEGLR----PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
Query: 643 LSKI 646
L K+
Sbjct: 265 LEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 72/318 (22%), Positives = 131/318 (41%), Gaps = 54/318 (16%)
Query: 345 SHPQGFRSAVESLTLYKFQDL----KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD 400
H G R A + + + +I +GSF G+VY+G + GD AVK++
Sbjct: 7 HHHHGSRDAADDWEI-PDGQITVGQRIGSGSF-------GTVYKGKWHGD-VAVKMLNVT 57
Query: 401 VSS---------EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ 451
+ E+ +L+K H NI+ G+ +V ++ + +L LH++
Sbjct: 58 APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASE-- 114
Query: 452 TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511
K+ + IA A ++YLH +H++LK++NI L + KI +FGLA
Sbjct: 115 --TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITP---KLDVFAFGVVVLELLSGRE 568
+ G+ +MAPE I P + DV+AFG+V+ EL++G+
Sbjct: 170 KSRWSGSHQFEQ------LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAH 628
+ N + I ++ ++ L ++ + M +L C
Sbjct: 224 PYSNINNRDQ------IIEMVGRGSLSPDL---------SKVRSNCPKRMKRLMAECLKK 268
Query: 629 DLNARPSISEVFVTLSKI 646
+ RPS + + ++
Sbjct: 269 KRDERPSFPRILAEIEEL 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-52
Identities = 67/313 (21%), Positives = 124/313 (39%), Gaps = 69/313 (22%)
Query: 361 KFQDL----KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS----------- 403
++ +I G F G V++G A+K + S
Sbjct: 17 ADNEIEYEKQIGKGGF-------GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 404 ---EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
E+ I+ +NH NI++L G + +V EF G L L + + W
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP----IKWSV 123
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-----NLRAKITNFGLARSAESD 515
++++ D+A + Y+ NPP VH++L++ NI L + + AK+ +FGL++ +
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182
Query: 516 EHEQGGYGLQLTRHVVGTYGYMAPEYI--ENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
++G + +MAPE I E T K D ++F +++ +L+G
Sbjct: 183 -----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
Query: 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633
+ + + E LR P++ + P L + + C + D R
Sbjct: 232 SYGKIKFINM---------IREEGLR----PTIPEDCPPRL----RNVIELCWSGDPKKR 274
Query: 634 PSISEVFVTLSKI 646
P S + LS++
Sbjct: 275 PHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 57/299 (19%), Positives = 111/299 (37%), Gaps = 56/299 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS---------EINILKKINHSNI 416
I G F G VY G + G+ A++++ + + E+ ++ H N+
Sbjct: 40 LIGKGRF-------GQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
+ G C+ + ++ L + + L + QIA ++ + YLH
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH 147
Query: 477 KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGY 536
+HK+LK+ N+ D N + IT+FGL + + + L R G +
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL---RIQNGWLCH 200
Query: 537 MAPEYIENGVI---------TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
+APE I + DVFA G + EL + E + +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR------------EWPFKTQPA 248
Query: 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
+ ++ P+L + + ++ + C A + RP+ +++ L K+
Sbjct: 249 EAIIWQMGTGMK----PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-40
Identities = 80/365 (21%), Positives = 137/365 (37%), Gaps = 63/365 (17%)
Query: 310 KKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIAT 369
++T P PK + +T+ K+
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMER--------TDITMKH----KLGG 230
Query: 370 GSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS------EINILKKINHSNIIRLSG 421
G + G VY G +K AVK +K D E ++K+I H N+++L G
Sbjct: 231 GQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 422 FCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNP 481
C E Y++ EF G L D+L Q ++ + +A +++A+ YL K
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKN-- 338
Query: 482 PYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEY 541
++H+NL N L+ N K+ +FGL+R D + + + APE
Sbjct: 339 -FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 390
Query: 542 IENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKL-R 599
+ + K DV+AFGV++ E+ + G G + V E L +
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEK 434
Query: 600 GFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPSDEL 659
+ R E P + +L + C + + RPS +E+ ++ SS D ++
Sbjct: 435 DY-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489
Query: 660 NNSRS 664
R
Sbjct: 490 LGKRG 494
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 59/305 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS--------E 404
E L L + +I G+F G V+ G + D+ AVK + + E
Sbjct: 114 EDLVLGE----QIGRGNF-------GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQE 162
Query: 405 INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
ILK+ +H NI+RL G C + Y+V E G +L + L K +Q+
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQM 218
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ-GGYG 523
D A + YL +H++L N L+ KI++FG++R + GG
Sbjct: 219 VGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR 275
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLY 582
+ + APE + G + + DV++FG+++ E S G N +
Sbjct: 276 QVPVK-------WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----- 323
Query: 583 ASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641
RE + +G R P ++ +L + C A++ RPS S ++
Sbjct: 324 -----------TREFVEKGG-----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
Query: 642 TLSKI 646
L I
Sbjct: 368 ELQSI 372
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 73/322 (22%), Positives = 128/322 (39%), Gaps = 59/322 (18%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS------EIN 406
+T+ K+ G + G VY G +K AVK +K D E
Sbjct: 13 TDITMKH----KLGGGQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA 61
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
++K+I H N+++L G C E Y++ EF G L D+L ++ + +A
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMAT 118
Query: 467 DVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
+++A+ YL ++H++L N L+ N K+ +FGL+R D +
Sbjct: 119 QISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583
+ + APE + + K DV+AFGV++ E+ + G G +
Sbjct: 174 FPIK-------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------ 220
Query: 584 SISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642
V E L + + R E P + +L + C + + RPS +E+
Sbjct: 221 ----------VYELLEKDY-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265
Query: 643 LSKIWSSSSDWDPSDELNNSRS 664
++ SS D ++ R
Sbjct: 266 FETMFQESSISDEVEKELGKRG 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 73/317 (23%), Positives = 122/317 (38%), Gaps = 53/317 (16%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVS------ 402
L ++ G+F GSV + AVK ++
Sbjct: 23 RHLKYIS----QLGKGNF-------GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF 71
Query: 403 -SEINILKKINHSNIIRLSGFCVHEGN--TYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
EI ILK ++ I++ G G LV E+ +G L D+L +R L
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR----ARLDAS 127
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ + + + + YL VH++L NIL+++ KI +FGLA+ D+
Sbjct: 128 RLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY- 183
Query: 520 GGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
Y VV G + APE + + + + + DV++FGVV+ EL + D+
Sbjct: 184 --Y-------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDK 229
Query: 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
+C + + + +L ++ R P + +L K C A RP
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
Query: 635 SISEVFVTLSKIWSSSS 651
S S + L +WS S
Sbjct: 290 SFSALGPQLDMLWSGSR 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 67/322 (20%), Positives = 122/322 (37%), Gaps = 62/322 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVSS----- 403
L + ++ G+F GSV + AVK ++
Sbjct: 10 RHLKFLQ----QLGKGNF-------GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58
Query: 404 --EINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
EI ILK + H NI++ G C G L+ E+ G+L D+L ++ + +
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHI 114
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ +Q + + YL Y+H++L T NIL++ R KI +FGL + D+
Sbjct: 115 KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF- 170
Query: 520 GGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
+ V G + APE + + DV++FGVV+ EL + E
Sbjct: 171 --F-------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221
Query: 575 NCEAELL----YASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629
++ + ++ E L R P + + C ++
Sbjct: 222 AEFMRMIGNDKQGQMIV----FHLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNN 272
Query: 630 LNARPSISEVFVTLSKIWSSSS 651
+N RPS ++ + + +I + +
Sbjct: 273 VNQRPSFRDLALRVDQIRDNMA 294
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 82/315 (26%), Positives = 135/315 (42%), Gaps = 56/315 (17%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKGDVSS------EINI 407
ESL L K+ G F G V+ G++ G A+K +K S E +
Sbjct: 184 ESLRLEV----KLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV 232
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+KK+ H +++L E Y+V E+ G+L D+L + L Q V +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQ 288
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+A+ + Y+ + YVH++L+ +NIL+ NL K+ +FGLAR E +E+
Sbjct: 289 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASIS 586
+ + APE G T K DV++FG+++ EL + GR G N E
Sbjct: 346 K-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------- 389
Query: 587 RVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
V +++ RG+ R P + S+ L C + RP+ + L
Sbjct: 390 -------VLDQVERGY-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
Query: 646 IW-SSSSDWDPSDEL 659
+ S+ + P + L
Sbjct: 438 YFTSTEPQYQPGENL 452
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 15/214 (7%)
Query: 57 SCQAYLTFRSNPSYNTPVTIDYLFKTS-------HPNLIASINSITNVTATLPTDTPVLI 109
SC L + T I+ +S + + I NS + + VL+
Sbjct: 4 SCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLV 63
Query: 110 PVNCSCSGGGDGDYYQFNTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTV 169
P C C GD+ N +Y+++ +TY VA + Y LTT +++ ++NP + N+ +
Sbjct: 64 PFPCECQ---PGDFLGHNFSYSVRQE-DTYERVAISNYANLTTMESLQARNPFPATNIPL 119
Query: 170 GLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDD 229
L V + C+C + F +TY + DS+S+IA+ V + N +
Sbjct: 120 SATLNVLVNCSCGDESV-SKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGV--N 176
Query: 230 LIFPFTPILVPLKTAPSKIQLPVPSPPPSSPHTT 263
+ VP + P S H
Sbjct: 177 FNSGNGIVYVPGRDPNGAFP-PFKSSKQDGVHHH 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 67/317 (21%), Positives = 128/317 (40%), Gaps = 68/317 (21%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVS------ 402
K + +G+F G+VY+G + + A+K ++ S
Sbjct: 15 TEFKKIK----VLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 403 --SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
E ++ +++ ++ RL G C+ L+ + G L D++ ++ DN+ +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK----DNIGSQY 118
Query: 461 RVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
+ +A +NYL + VH++L N+L+ T KIT+FGLA+ ++E E
Sbjct: 119 LLNWCVQIAKGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 519 QGGYGLQL-TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576
G ++ + +MA E I + + T + DV+++GV V EL++ G + G
Sbjct: 174 YHAEGGKVPIK-------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 577 EAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
E + L +G R P + + + C D ++RP
Sbjct: 227 E----------------ISSILEKGE-----RLPQPPICTIDVYMIMRKCWMIDADSRPK 265
Query: 636 ISEVFVTLSKIWSSSSD 652
E+ + SK+
Sbjct: 266 FRELIIEFSKMARDPQR 282
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 76/300 (25%), Positives = 135/300 (45%), Gaps = 57/300 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVS-----SEINILK 409
+ L L + I G F G V G ++G+ AVK +K D + +E +++
Sbjct: 193 KELKLLQ----TIGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMT 241
Query: 410 KINHSNIIRLSGFCVHE-GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
++ HSN+++L G V E G Y+V E+ G+L D+L S L ++ + DV
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDV 298
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
A+ YL +VH++L N+L+ + AK+++FGL + A S + +L
Sbjct: 299 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLP- 349
Query: 529 HVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISR 587
+ APE + + K DV++FG+++ E+ S GR Y I
Sbjct: 350 -----VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------YPRIP- 391
Query: 588 VLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
L++ V ++ +G+ + + P ++ + KNC D RP+ ++ L I
Sbjct: 392 -LKD--VVPRVEKGY-----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 68/322 (21%), Positives = 121/322 (37%), Gaps = 62/322 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVSS----- 403
L + ++ G+F GSV + AVK ++
Sbjct: 41 RHLKFLQ----QLGKGNF-------GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 89
Query: 404 --EINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
EI ILK + H NI++ G C G L+ E+ G+L D+L ++ + +
Sbjct: 90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHI 145
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ +Q + + YL Y+H++L T NIL++ R KI +FGL + D+
Sbjct: 146 KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY- 201
Query: 520 GGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
Y V G + APE + + DV++FGVV+ EL + E
Sbjct: 202 --Y-------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 252
Query: 575 NCEAELL----YASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629
++ + ++ E L R P + + C ++
Sbjct: 253 AEFMRMIGNDKQGQMIV----FHLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNN 303
Query: 630 LNARPSISEVFVTLSKIWSSSS 651
+N RPS ++ + + +I +
Sbjct: 304 VNQRPSFRDLALRVDQIRDQMA 325
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKGDVSS------EINI 407
LT + +I +G F G V+ G + D A+K ++ S E +
Sbjct: 8 SELTFVQ----EIGSGQF-------GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEV 56
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+ K++H +++L G C+ + LV EF ++G LSD+L + R + + + D
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLD 112
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
V + YL + +H++L N L+ N K+++FG+ R D++
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ + +PE + K DV++FGV++ E+ S
Sbjct: 170 K-------WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 72/323 (22%), Positives = 119/323 (36%), Gaps = 56/323 (17%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVS------ 402
L + + G F G V + + AVK +K D
Sbjct: 31 RYLKKIR----DLGEGHF-------GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG 79
Query: 403 --SEINILKKINHSNIIRLSGFCVHEGN--TYLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI+IL+ + H +II+ G C G LV E+ G+L D+L + +
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGL 133
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
Q + A + + YLH Y+H++L N+LLD + KI +FGLA++
Sbjct: 134 AQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190
Query: 519 QGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
Y V G + APE ++ DV++FGV + ELL+ D
Sbjct: 191 ---Y-------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH-----CD 235
Query: 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633
+ + + + + +L ++ R P + L KNC + + R
Sbjct: 236 SSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFR 295
Query: 634 PSISEVFVTLSKIWSSSSDWDPS 656
P+ + L + PS
Sbjct: 296 PTFENLIPILKTVHEKYQGQAPS 318
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKGDVSS------EINI 407
E +TL K ++ +G F G V G +KG D AVK++K S E
Sbjct: 8 EEITLLK----ELGSGQF-------GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQT 56
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+ K++H +++ G C E Y+V E+ NG L ++L S+ L Q +++ YD
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYD 112
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
V + +L + ++H++L N L+D +L K+++FG+ R D++
Sbjct: 113 VCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ + APE + K DV+AFG+++ E+ S
Sbjct: 170 K-------WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 50/225 (22%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVS-----SEINILK 409
+ L L + I G F G V G ++G+ AVK +K D + +E +++
Sbjct: 21 KELKLLQ----TIGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMT 69
Query: 410 KINHSNIIRLSGFCVHE-GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
++ HSN+++L G V E G Y+V E+ G+L D+L S L ++ + DV
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDV 126
Query: 469 ANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
A+ YL + + VH++L N+L+ + AK+++FGL + +
Sbjct: 127 CEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTK----EASS-------- 169
Query: 527 TRHVVGTYG------YMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ APE + + K DV++FG+++ E+ S
Sbjct: 170 -----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 82/315 (26%), Positives = 135/315 (42%), Gaps = 56/315 (17%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKGDVSS------EINI 407
ESL L K+ G F G V+ G++ G A+K +K S E +
Sbjct: 267 ESLRLEV----KLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV 315
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+KK+ H +++L E Y+V E+ G+L D+L + L Q V +A
Sbjct: 316 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQ 371
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+A+ + Y+ + YVH++L+ +NIL+ NL K+ +FGLAR E +E+
Sbjct: 372 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 428
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASIS 586
+ + APE G T K DV++FG+++ EL + GR G N E
Sbjct: 429 K-------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------- 472
Query: 587 RVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
V +++ RG+ R P + S+ L C + RP+ + L
Sbjct: 473 -------VLDQVERGY-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
Query: 646 IW-SSSSDWDPSDEL 659
+ S+ + P + L
Sbjct: 521 YFTSTEPQYQPGENL 535
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 66/317 (20%), Positives = 122/317 (38%), Gaps = 62/317 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVS------ 402
L + + G F G V + + AVK +K +
Sbjct: 21 RFLKRIR----DLGEGHF-------GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD 69
Query: 403 --SEINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI IL+ + H NI++ G C +G L+ EF +G+L ++L N+ + +
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK----NKINL 125
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
KQ+++ A + ++YL YVH++L N+L+++ + KI +FGL ++ E+D+
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 519 QGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572
Y V + APE + DV++FGV + ELL+ +
Sbjct: 183 ---Y-------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 573 DQNCEAELL--YASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629
+ + ++ + + L G R P + + QL + C
Sbjct: 233 MALFLKMIGPTHGQMT----VTRLVNTLKEGK-----RLPCPPNCPDEVYQLMRKCWEFQ 283
Query: 630 LNARPSISEVFVTLSKI 646
+ R S + +
Sbjct: 284 PSNRTSFQNLIEGFEAL 300
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKGDVSS------EINI 407
+ LT K ++ TG F G V G ++G D A+K++K S E +
Sbjct: 24 KDLTFLK----ELGTGQF-------GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKV 72
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+ ++H +++L G C + +++ E+ NG L ++L R++ +Q +++ D
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKD 128
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
V A+ YL ++H++L N L++ K+++FGL+R DE+
Sbjct: 129 VCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
R + PE + + K D++AFGV++ E+ S
Sbjct: 186 R-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 77/322 (23%), Positives = 130/322 (40%), Gaps = 67/322 (20%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVSS------ 403
L L K + G F GSV G+ K +D AVK MK D SS
Sbjct: 34 NLLILGK----ILGEGEF-------GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE 82
Query: 404 ---EINILKKINHSNIIRLSGFCVHEG-----NTYLVYEFADNGALSDWLHSNRYQTSD- 454
E +K +H N+IRL G C+ ++ F G L +L +R +T
Sbjct: 83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142
Query: 455 NLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS- 511
++ + ++ D+A + YL + +H++L N +L ++ + +FGL++
Sbjct: 143 HIPLQTLLKFMVDIALGMEYLSNRNF-----LHRDLAARNCMLRDDMTVCVADFGLSKKI 197
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAV 570
D + QG + ++A E + + V T K DV+AFGV + E+ + G
Sbjct: 198 YSGDYYRQGRIAKMPVK-------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
Query: 571 TGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL 630
G QN E + + ++ R + P D + ++ +C D
Sbjct: 251 PGVQNHE----------MYD----------YLLHGHRLKQPEDCLDELYEIMYSCWRTDP 290
Query: 631 NARPSISEVFVTLSKIWSSSSD 652
RP+ S + + L K+ S D
Sbjct: 291 LDRPTFSVLRLQLEKLLESLPD 312
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 68/329 (20%), Positives = 129/329 (39%), Gaps = 68/329 (20%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVSS------ 403
+ TL + + G F GSV K +D AVK++K D+ +
Sbjct: 23 QQFTLGR----MLGKGEF-------GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71
Query: 404 ---EINILKKINHSNIIRLSGFCVHEGNT------YLVYEFADNGALSDWLHSNR-YQTS 453
E +K+ +H ++ +L G + ++ F +G L +L ++R +
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 454 DNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511
NL + V+ D+A + YL + +H++L N +L ++ + +FGL+R
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNF-----IHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 512 -AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREA 569
D + QG + ++A E + + + T DV+AFGV + E+++ G+
Sbjct: 187 IYSGDYYRQGCASKLPVK-------WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629
G +N E + ++ R + P + + L C + D
Sbjct: 240 YAGIENAE----------IYN----------YLIGGNRLKQPPECMEEVYDLMYQCWSAD 279
Query: 630 LNARPSISEVFVTLSKIWSSSSDWDPSDE 658
RPS + + + L I S S +
Sbjct: 280 PKQRPSFTCLRMELENILGHLSVLSTSQD 308
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 71/309 (22%), Positives = 123/309 (39%), Gaps = 66/309 (21%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVSS------ 403
E + L + I G F G V++G + + A+K K S
Sbjct: 15 ERIELGR----CIGEGQF-------GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 63
Query: 404 --EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
E +++ +H +I++L G +++ E G L +L +Y L
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS----LDLASL 118
Query: 462 VQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ AY ++ AL YL ++ VH+++ N+L+ +N K+ +FGL+R E + +
Sbjct: 119 ILYAYQLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEA 578
G + +MAPE I T DV+ FGV + E+L G + G +N +
Sbjct: 174 ASKGKLPIK-------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND- 225
Query: 579 ELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
V ++ G R P + ++ L C A+D + RP +
Sbjct: 226 ---------------VIGRIENGE-----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 265
Query: 638 EVFVTLSKI 646
E+ LS I
Sbjct: 266 ELKAQLSTI 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-35
Identities = 77/387 (19%), Positives = 140/387 (36%), Gaps = 70/387 (18%)
Query: 287 FLLLLVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPPK----TPLDCADYSLFPQASN 342
LV ++ P L + + + DY+ +
Sbjct: 316 GYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEED 375
Query: 343 SLSHPQGFRSAV--ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVK 395
+ + P + E + L + I G F G V++G + + A+K
Sbjct: 376 TYTMPSTRDYEIQRERIELGR----CIGEGQF-------GDVHQGIYMSPENPAMAVAIK 424
Query: 396 VMKGDVS--------SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHS 447
K S E +++ +H +I++L G +++ E G L +L
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV 483
Query: 448 NRYQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITN 505
+ +L + AY ++ AL YL ++ VH+++ N+L+ +N K+ +
Sbjct: 484 RK----FSLDLASLILYAYQLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGD 534
Query: 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
FGL+R E + + G + +MAPE I T DV+ FGV + E+L
Sbjct: 535 FGLSRYMEDSTYYKASKGKLPIK-------WMAPESINFRRFTSASDVWMFGVCMWEILM 587
Query: 566 -GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKN 624
G + G +N + V+ I+ R P + ++ L
Sbjct: 588 HGVKPFQGVKNND----------VIG----------RIENGERLPMPPNCPPTLYSLMTK 627
Query: 625 CTAHDLNARPSISEVFVTLSKIWSSSS 651
C A+D + RP +E+ LS I
Sbjct: 628 CWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 72/315 (22%), Positives = 124/315 (39%), Gaps = 66/315 (20%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVS------- 402
E + L + + G F G VY G + AVK K D +
Sbjct: 12 EDVVLNR----ILGEGFF-------GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF 60
Query: 403 -SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
SE I+K ++H +I++L G E T+++ E G L +L N+ ++L
Sbjct: 61 MSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNK----NSLKVLTL 115
Query: 462 VQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
V + + A+ YL VH+++ NIL+ + K+ +FGL+R E +++ +
Sbjct: 116 VLYSLQICKAMAYLESINC-----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK 170
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEA 578
+ +M+PE I T DV+ F V + E+LS G++ +N +
Sbjct: 171 ASVTRLPIK-------WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD- 222
Query: 579 ELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
V L +G R P + L C +D + RP +
Sbjct: 223 ---------------VIGVLEKGD-----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFT 262
Query: 638 EVFVTLSKIWSSSSD 652
E+ +LS ++ D
Sbjct: 263 ELVCSLSDVYQMEKD 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 87/325 (26%), Positives = 139/325 (42%), Gaps = 72/325 (22%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDD----AAVKVMKGDVS-------- 402
+ I G+F G V + K D AA+K MK S
Sbjct: 25 NDIKFQD----VIGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 403 SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR-----------Y 450
E+ +L K+ +H NII L G C H G YL E+A +G L D+L +R
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 451 QTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508
T+ L+ +Q + A DVA ++YL ++ +H++L NIL+ N AKI +FGL
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQF-----IHRDLAARNILVGENYVAKIADFGL 188
Query: 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE 568
+R + + + G R +MA E + V T DV+++GV++ E++S
Sbjct: 189 SR--GQEVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS--- 236
Query: 569 AVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAFSMAQLAKNCTA 627
G Y ++ E + EKL G+ R E PL+ + L + C
Sbjct: 237 --LGGTP------YCGMT--CAE--LYEKLPQGY-----RLEKPLNCDDEVYDLMRQCWR 279
Query: 628 HDLNARPSISEVFVTLSKIWSSSSD 652
RPS +++ V+L+++
Sbjct: 280 EKPYERPSFAQILVSLNRMLEERKT 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/232 (26%), Positives = 112/232 (48%), Gaps = 42/232 (18%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
E +T+ + ++ GSF G VY G KG A+K + S
Sbjct: 25 EKITMSR----ELGQGSF-------GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN---- 455
+E +++K+ N +++RL G T ++ E G L +L S R ++N
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 456 -LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS-AE 513
+ + +Q+A ++A+ + YL+ +VH++L N ++ + KI +FG+ R E
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+D + +GG GL R +M+PE +++GV T DV++FGVV+ E+ +
Sbjct: 191 TDYYRKGGKGLLPVR-------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 71/327 (21%), Positives = 121/327 (37%), Gaps = 69/327 (21%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
+++TL + + G+F G VY G G AVK + S
Sbjct: 30 KNITLIR----GLGHGAF-------GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 78
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN--LT 457
E I+ K NH NI+R G + +++ E G L +L R + S L
Sbjct: 79 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 458 WKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARS- 511
+ +A D+A YL + ++H+++ N LL AKI +FG+AR
Sbjct: 139 MLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAV 570
+ + +GG + + +M PE G+ T K D ++FGV++ E+ S G
Sbjct: 194 YRASYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 571 TGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629
N E V E + G R + P + + ++ C H
Sbjct: 247 PSKSNQE----------------VLEFVTSGG-----RMDPPKNCPGPVYRIMTQCWQHQ 285
Query: 630 LNARPSISEVFVTLSKIWSSSSDWDPS 656
RP+ + + + + +
Sbjct: 286 PEDRPNFAIILERIEYCTQDPDVINTA 312
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 64/284 (22%), Positives = 106/284 (37%), Gaps = 64/284 (22%)
Query: 307 RNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK 366
+ + G++P P+ + Y +A + + K
Sbjct: 5 HHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAG----RSFTREIEASRIHIEK----I 56
Query: 367 IATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVSS--------EINILKKINH 413
I +G G V G + A+K +K + E +I+ + +H
Sbjct: 57 IGSGDS-------GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
NIIRL G +V E+ +NG+L +L ++ Q T Q V + V +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMR 165
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
YL YVH++L N+L+D+NL K+++FGL+R E D
Sbjct: 166 YLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP----------------- 205
Query: 534 YGY------------MAPEYIENGVITPKLDVFAFGVVVLELLS 565
APE I + DV++FGVV+ E+L+
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 69/317 (21%), Positives = 127/317 (40%), Gaps = 68/317 (21%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA----AVKVMKGDVS-------- 402
++L + +++ G+F GSV +G ++ A+KV+K
Sbjct: 9 DNLLIAD---IELGCGNF-------GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 58
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E I+ ++++ I+RL G C E LV E A G L +L R + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE----IPVSNVA 113
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
++ + V+ + YL + +VH++L N+LL AKI++FGL+++ +D+ Y
Sbjct: 114 ELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY---Y 167
Query: 523 GLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576
+ G + APE I + + DV+++GV + E LS G++ +
Sbjct: 168 -------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220
Query: 577 EAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
E V + +G R E P + + L +C + RP
Sbjct: 221 E----------------VMAFIEQGK-----RMECPPECPPELYALMSDCWIYKWEDRPD 259
Query: 636 ISEVFVTLSKIWSSSSD 652
V + + S +
Sbjct: 260 FLTVEQRMRACYYSLAS 276
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 55/302 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVS--------SEINILKKIN 412
I G F G VY G+ +D AVK + +E I+K +
Sbjct: 32 VIGRGHF-------GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 413 HSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
H N++ L G C+ EG+ +V + +G L +++ + N T K + VA
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKG 140
Query: 472 LNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
+ YL K+ VH++L N +LD K+ +FGLAR D +++ Y +
Sbjct: 141 MKYLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTG 191
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
+MA E ++ T K DV++FGV++ EL++ Y +
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR-----------GAPPYPDV---- 236
Query: 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649
+ + ++ R P + ++ C RPS SE+ +S I+S+
Sbjct: 237 --NT--FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292
Query: 650 SS 651
Sbjct: 293 FI 294
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 36/220 (16%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKGDVSS------EINI 407
E+L L + ++ G F G V+ G + G AVK +K S E N+
Sbjct: 13 ETLKLVE----RLGAGQF-------GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANL 61
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+K++ H ++RL E Y++ E+ +NG+L D+L + LT + + +A
Sbjct: 62 MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQ 117
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+A + ++ + Y+H++L+ +NIL+ L KI +FGLAR E +E Y T
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-----Y----T 165
Query: 528 RHVVGTYGY--MAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ APE I G T K DV++FG+++ E+++
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 67/315 (21%), Positives = 126/315 (40%), Gaps = 64/315 (20%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVS------ 402
K + +G+F G+VY+G + + A+K ++ S
Sbjct: 15 TEFKKIK----VLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 403 --SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
E ++ +++ ++ RL G C+ L+ + G L D++ ++ DN+ +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK----DNIGSQY 118
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+ +A +NYL VH++L N+L+ T KIT+FGLA+ ++E E
Sbjct: 119 LLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 521 GYGLQL-TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEA 578
G ++ + +MA E I + + T + DV+++GV V EL++ G + G E
Sbjct: 176 AEGGKVPIK-------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE- 227
Query: 579 ELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
+ L +G R P + + C D ++RP
Sbjct: 228 ---------------ISSILEKGE-----RLPQPPICTIDVYMIMVKCWMIDADSRPKFR 267
Query: 638 EVFVTLSKIWSSSSD 652
E+ + SK+
Sbjct: 268 ELIIEFSKMARDPQR 282
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 80/334 (23%), Positives = 129/334 (38%), Gaps = 66/334 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVSS----- 403
+T K I G F G VY+G K A+K +K +
Sbjct: 44 SCVTRQK----VIGAGEF-------GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD 92
Query: 404 ---EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
E I+ + +H NIIRL G ++ E+ +NGAL +L + + Q
Sbjct: 93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQ 148
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
V + +A + YL YVH++L NIL+++NL K+++FGL+R E D
Sbjct: 149 LVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-- 203
Query: 521 GYGLQLTRHVVGT---YGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576
T G + APE I T DV++FG+V+ E+++ G N
Sbjct: 204 ------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
Query: 577 EAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
E V + + GF R P+D ++ QL C + RP
Sbjct: 258 E----------------VMKAINDGF-----RLPTPMDCPSAIYQLMMQCWQQERARRPK 296
Query: 636 ISEVFVTLSKIWSSSSDWDPSDELNNSRSLSRGS 669
+++ L K+ + + + S+ S
Sbjct: 297 FADIVSILDKLIRAPDSLKTLADFDPRVSIRLPS 330
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 77/388 (19%), Positives = 139/388 (35%), Gaps = 70/388 (18%)
Query: 303 YRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKF 362
+ RRR S V ++ SL+ +A + + QG + L+
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73
Query: 363 QDLKIATGSFSEENRIQ------------GSVYRGSFKGDDA-----AVKVMKGDVS--- 402
+ ++ + + G VY G+ +D AVK +
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 403 -----SEINILKKINHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
+E I+K +H N++ L G C+ EG+ +V + +G L +++ + N
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNP 189
Query: 457 TWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
T K + VA + +L K+ VH++L N +LD K+ +FGLAR
Sbjct: 190 TVKDLIGFGLQVAKGMKFLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 515 DEHEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569
E + T +MA E ++ T K DV++FGV++ EL++
Sbjct: 245 KEFD---------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR--- 292
Query: 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629
Y + + + ++ R P + ++ C
Sbjct: 293 --------GAPPYPDV------NT--FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPK 336
Query: 630 LNARPSISEVFVTLSKIWSSSSDWDPSD 657
RPS SE+ +S I+S+
Sbjct: 337 AEMRPSFSELVSRISAIFSTFIGEHYVH 364
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 59/308 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-DAAVKVMKGDVSS------EINI 407
ESL L K K+ G F G V+ ++ AVK MK S E N+
Sbjct: 188 ESLKLEK----KLGAGQF-------GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV 236
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+K + H +++L E Y++ EF G+L D+L S+ + + +
Sbjct: 237 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQ 292
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+A + ++ + Y+H++L+ +NIL+ +L KI +FGLAR E +E+ T
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---------T 340
Query: 528 RHVVGTYGY--MAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584
+ APE I G T K DV++FG++++E+++ GR G N E
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------- 393
Query: 585 ISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
V L RG+ R P + + + C + RP+ + L
Sbjct: 394 ---------VIRALERGY-----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439
Query: 644 SKIWSSSS 651
++++
Sbjct: 440 DDFYTATE 447
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 73/318 (22%), Positives = 119/318 (37%), Gaps = 71/318 (22%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVSS------ 403
+ L L + K+ GSF G V RG + AVK +K DV S
Sbjct: 18 KDLRLLE----KLGDGSF-------GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 404 ----EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
E+N + ++H N+IRL G + +V E A G+L D L ++ +
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQ----GHFLLG 121
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ A VA + YL ++H++L N+LL T KI +FGL R+ ++
Sbjct: 122 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH- 177
Query: 520 GGYGLQLTRHVVGTYG------YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572
Y V + APE ++ + D + FGV + E+ + G+E G
Sbjct: 178 --Y--------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
Query: 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA 632
+ I +++ R L P D + + C AH
Sbjct: 228 LNGSQ-------ILHKIDKEGER--L----------PRPEDCPQDIYNVMVQCWAHKPED 268
Query: 633 RPSISEVFVTLSKIWSSS 650
RP+ + L + +
Sbjct: 269 RPTFVALRDFLLEAQPTD 286
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 72/326 (22%), Positives = 122/326 (37%), Gaps = 67/326 (20%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
+++TL + + G+F G VY G G AVK + S
Sbjct: 71 KNITLIR----GLGHGAF-------GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 119
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN--LT 457
E I+ K NH NI+R G + +++ E G L +L R + S L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 458 WKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARS- 511
+ +A D+A YL + ++H+++ N LL AKI +FG+AR
Sbjct: 180 MLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAV 570
+ + +GG + + +M PE G+ T K D ++FGV++ E+ S G
Sbjct: 235 YRAGYYRKGGCAMLPVK-------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 571 TGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL 630
N E VLE F+ R + P + + ++ C H
Sbjct: 288 PSKSNQE----------VLE----------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQP 327
Query: 631 NARPSISEVFVTLSKIWSSSSDWDPS 656
RP+ + + + + +
Sbjct: 328 EDRPNFAIILERIEYCTQDPDVINTA 353
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 62/308 (20%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMK------GDVSSEINILKKI 411
F+++ + G+F G V + D A+K ++ + SE+ +L +
Sbjct: 7 DFEEIAVLGQGAF-------GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 412 NHSNIIRLSGFCVHEGNT-------------YLVYEFADNGALSDWLHSNRYQTSDNLTW 458
NH ++R + N ++ E+ +NG L D +HS + W
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
+ QI AL+Y+H +H++LK NI +D + KI +FGLA++
Sbjct: 120 RLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 519 QGGYGLQLTRH------VVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVT 571
L +GT Y+A E ++ G K+D+++ G++ E++ T
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS--T 230
Query: 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLN 631
G E N+ +KLR + ++ + ++ + HD N
Sbjct: 231 GM----------------ERVNILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273
Query: 632 ARPSISEV 639
RP +
Sbjct: 274 KRPGARTL 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 62/333 (18%), Positives = 117/333 (35%), Gaps = 60/333 (18%)
Query: 339 QASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVY--RGSFKGDDAAVK 395
+S F+ + + + ++ + G F V G G A+K
Sbjct: 8 HHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGF-------SYVDLVEGLHDGHFYALK 60
Query: 396 VM-------KGDVSSEINILKKINHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDW 444
+ + + E ++ + NH NI+RL +C+ E +L+ F G L +
Sbjct: 61 RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE 120
Query: 445 LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504
+ + LT Q + + + L +H Y H++LK +NILL + +
Sbjct: 121 I-ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLM 176
Query: 505 NFGLARSAESD-EHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVV 560
+ G A E + LQ T Y APE + VI + DV++ G V+
Sbjct: 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
Query: 561 LELLSGR---EAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFS 617
++ G + + + + ++ + P S
Sbjct: 237 YAMMFGEGPYDM----VFQKGDSVALAVQN-------------------QLSIPQSPRHS 273
Query: 618 --MAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648
+ QL + D + RP I + LS++ +
Sbjct: 274 SALWQLLNSMMTVDPHQRPHIPLL---LSQLEA 303
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 64/314 (20%), Positives = 122/314 (38%), Gaps = 62/314 (19%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVS------ 402
L K + +G F G+V++G + + +KV++
Sbjct: 13 TELRKLK----VLGSGVF-------GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 403 --SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
+ + ++H++I+RL G C LV ++ G+L D + +R L +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHR----GALGPQL 116
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+ +A + YL ++ VH+NL N+LL + + ++ +FG+A D+ +
Sbjct: 117 LLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 521 GYGLQL-TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEA 578
+ + +MA E I G T + DV+++GV V EL++ G E G + E
Sbjct: 174 YSEAKTPIK-------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE- 225
Query: 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638
+ +LE +G R P + + C D N RP+ E
Sbjct: 226 ------VPDLLE--------KGE-----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKE 266
Query: 639 VFVTLSKIWSSSSD 652
+ +++
Sbjct: 267 LANEFTRMARDPPR 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 71/313 (22%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVSS------ 403
++++ K + G F G V G K A+K +K +
Sbjct: 45 TNISIDK----VVGAGEF-------GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 404 --EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
E +I+ + +H NIIRL G +V E+ +NG+L +L + Q T Q
Sbjct: 94 LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQL 149
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
V + +A+ + YL YVH++L NIL+++NL K+++FGL R E D
Sbjct: 150 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA--- 203
Query: 522 YGLQLTRHVVGTYG------YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQ 574
T G + +PE I T DV+++G+V+ E++S G
Sbjct: 204 --------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 575 NCEAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633
N + V + + G+ R P+D ++ QL +C D N R
Sbjct: 256 NQD----------------VIKAVDEGY-----RLPPPMDCPAALYQLMLDCWQKDRNNR 294
Query: 634 PSISEVFVTLSKI 646
P ++ L K+
Sbjct: 295 PKFEQIVSILDKL 307
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVS--------SEINILKKIN 412
I G F G VY G + A+K + E +++ +N
Sbjct: 28 VIGKGHF-------GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 413 HSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
H N++ L G + EG +++ + +G L ++ S + N T K + VA
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARG 136
Query: 472 LNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
+ YL K+ VH++L N +LD + K+ +FGLAR E+ Y +Q RH
Sbjct: 137 MEYLAEQKF-----VHRDLAARNCMLDESFTVKVADFGLARDILDREY----YSVQQHRH 187
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+ A E ++ T K DV++FGV++ ELL+
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 82/336 (24%), Positives = 137/336 (40%), Gaps = 86/336 (25%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA---------AVKVMKGDVS--- 402
+ LTL K + G F G V G D AVK++K D +
Sbjct: 81 DKLTLGK----PLGEGCF-------GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD 129
Query: 403 -----SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR------- 449
SE+ ++K I H NII L G C +G Y++ E+A G L ++L + R
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 450 ----YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKI 503
+ +T+K V Y +A + YL K +H++L N+L+ N KI
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKI 244
Query: 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGV 558
+FGLAR D + Y T G +MAPE + + V T + DV++FGV
Sbjct: 245 ADFGLAR----DINNIDYY-------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293
Query: 559 VVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAF 616
++ E+ + G G E + + L+ G R + P +
Sbjct: 294 LMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGH-----RMDKPANCTN 332
Query: 617 SMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652
+ + ++C + RP+ ++ L +I + +++
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 76/316 (24%), Positives = 121/316 (38%), Gaps = 60/316 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK--------GDVSSEINILK 409
+ D + G+ +V+RG K GD A+KV E +LK
Sbjct: 11 WLLSD-ILGQGAT-------ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 410 KINHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
K+NH NI++L F + E T L+ EF G+L L + L + + +
Sbjct: 63 KLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVL 118
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLRAKITNFGLARSAESDEHEQGG 521
DV +N+L + VH+N+K NI+ D K+T+FG AR E DE
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----- 170
Query: 522 YGLQLTRHVVGTYGYMAPEYIENGVI--------TPKLDVFAFGVVVLELLSGR---EAV 570
+ GT Y+ P+ E V+ +D+++ GV +G
Sbjct: 171 ----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 571 TGDQNCEAELLYASISRVLEE--SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAH 628
G + + E++Y I+ S V++ G ID S L+ + L A+
Sbjct: 227 EGPRRNK-EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 629 DLNARP----SISEVF 640
L A + F
Sbjct: 286 ILEADQEKCWGFDQFF 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 63/308 (20%), Positives = 108/308 (35%), Gaps = 65/308 (21%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVM--------KGDVSSEINILK 409
F+ ++ + G F G V+ K DD A+K + + V E+ L
Sbjct: 6 DFEPIQCLGRGGF-------GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58
Query: 410 KINHSNIIRLSGFCVHEGNT------------YLVYEFADNGALSDWLHSNRYQT--SDN 455
K+ H I+R + + T Y+ + L DW++ +
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515
+ +QIA A+ +LH +H++LK SNI + K+ +FGL + + D
Sbjct: 119 VCLHIFLQIA----EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 516 EHEQ----GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571
E EQ VGT YM+PE I + K+D+F+ G+++ ELL
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQM 231
Query: 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLN 631
E +R P L + + ++ +
Sbjct: 232 ------------------ERVRTLTDVRNLKFPPLFTQKYPCE----YVMVQDMLSPSPM 269
Query: 632 ARPSISEV 639
RP +
Sbjct: 270 ERPEAINI 277
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 60/248 (24%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
++L L K + G F G V + + AVK++K + S
Sbjct: 23 KNLVLGK----TLGEGEF-------GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELR 71
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR---------- 449
SE N+LK++NH ++I+L G C +G L+ E+A G+L +L +R
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 450 ---------YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTN 498
+ LT + A+ ++ + YL K VH++L NIL+
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEG 186
Query: 499 LRAKITNFGLARS-AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFG 557
+ KI++FGL+R E D + + G + +MA E + + + T + DV++FG
Sbjct: 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVK-------WMAIESLFDHIYTTQSDVWSFG 239
Query: 558 VVVLELLS 565
V++ E+++
Sbjct: 240 VLLWEIVT 247
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 79/321 (24%), Positives = 141/321 (43%), Gaps = 74/321 (23%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA----AVKVMKGDVSS------- 403
+ LTL +D ++ +G+F G+V +G ++ AVK++K + +
Sbjct: 16 KLLTL---EDKELGSGNF-------GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 404 --EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
E N+++++++ I+R+ G C E LV E A+ G L+ +L NR ++ K
Sbjct: 66 LAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNR-----HVKDKNI 119
Query: 462 VQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+++ + V+ + YL + VH++L N+LL T AKI++FGL+++ +DE+
Sbjct: 120 IELVHQVSMGMKYLEESNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY- 173
Query: 520 GGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGD 573
Y T+G + APE I + K DV++FGV++ E S G++ G
Sbjct: 174 --Y-------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
Query: 574 QNCEAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA 632
+ E V L +G R P M L C +D+
Sbjct: 225 KGSE----------------VTAMLEKGE-----RMGCPAGCPREMYDLMNLCWTYDVEN 263
Query: 633 RPSISEVFVTLSKIWSSSSDW 653
RP + V + L + +
Sbjct: 264 RPGFAAVELRLRNYYYDVVNE 284
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
+L K + G+F G V + G AVK++K
Sbjct: 46 NNLQFGK----TLGAGAF-------GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 403 ---SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR--------- 449
SE+ I+ + H NI+ L G C H G ++ E+ G L ++L
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 450 YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507
+ + + + + VA + +L +H+++ N+LL AKI +FG
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFG 209
Query: 508 LARSAESDEHEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGVVVLE 562
LAR D Y +V +MAPE I + V T + DV+++G+++ E
Sbjct: 210 LAR----DIMNDSNY-------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 563 LLS 565
+ S
Sbjct: 259 IFS 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 52/240 (21%), Positives = 92/240 (38%), Gaps = 52/240 (21%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
++ + ++ F G VY+G G A+K +K
Sbjct: 9 SAVRFME----ELGEDRF-------GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE 57
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR---------- 449
E + ++ H N++ L G + +++ + +G L ++L
Sbjct: 58 EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 450 -YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506
L V + +A + YL H VHK+L T N+L+ L KI++
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDL 172
Query: 507 GLARS-AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
GL R +D ++ G L R +MAPE I G + D++++GVV+ E+ S
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIR-------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 64/290 (22%), Positives = 112/290 (38%), Gaps = 51/290 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA--AVKVM---------KGDVSSEINILKKINHS 414
I TGS+ G + K D K + K + SE+N+L+++ H
Sbjct: 13 TIGTGSY-------GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 415 NIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
NI+R + NT Y+V E+ + G L+ + + L + +++ + AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLAL 124
Query: 473 NYLHKYTNPPY--VHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
H+ ++ + +H++LK +N+ LD K+ +FGLAR D +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--------TSFAKTF 176
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590
VGT YM+PE + K D+++ G ++ EL + T E L I
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI----- 228
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
G + Y +L ++ RPS+ E+
Sbjct: 229 -------REGKFRR-IPYRYSDEL----NEIITRMLNLKDYHRPSVEEIL 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 51/239 (21%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKG-------D 400
+ L + ++ G+F G V+ AVK +K D
Sbjct: 15 RDIVLKR----ELGEGAF-------GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD 63
Query: 401 VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR----------- 449
E +L + H +I++ G C +V+E+ +G L+ +L ++
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 450 YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507
Q L Q + IA +A+ + YL +VH++L T N L+ NL KI +FG
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFG 178
Query: 508 LARS-AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
++R +D + GG+ + R +M PE I T + DV++FGV++ E+ +
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 82/331 (24%), Positives = 130/331 (39%), Gaps = 76/331 (22%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
+ L L K + G+F G V G D AVK++K +
Sbjct: 27 DRLKLGK----PLGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 75
Query: 403 ---SEINILKKI-NHSNIIRLSGFCVHEGN-TYLVYEFADNGALSDWLHSNR-------- 449
SE+ IL I +H N++ L G C G ++ EF G LS +L S R
Sbjct: 76 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 450 ---YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKIT 504
D LT + + ++ VA + +L K +H++L NILL KI
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKIC 190
Query: 505 NFGLARS-AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563
+FGLAR + ++ + G + +MAPE I + V T + DV++FGV++ E+
Sbjct: 191 DFGLARDIYKDPDYVRKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 564 LS-GREAVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAFSMAQL 621
S G Y + E +L+ G R P M Q
Sbjct: 244 FSLGASP------------YPGVKIDEE---FCRRLKEGT-----RMRAPDYTTPEMYQT 283
Query: 622 AKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652
+C + + RP+ SE+ L + +++
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 64/298 (21%), Positives = 104/298 (34%), Gaps = 65/298 (21%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRG--SFKGDDAAVKVMK---------GDVSSEINIL 408
KF I GSF +VY+G + + A ++ E +L
Sbjct: 28 LKFDIE-IGRGSF-------KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 79
Query: 409 KKINHSNIIRLSGFCV----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
K + H NI+R + LV E +G L +L + + K
Sbjct: 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSW 134
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAESDEHEQGGYG 523
+ L +LH PP +H++LK NI + KI + GLA +
Sbjct: 135 CRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF------- 186
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD---QNCEAEL 580
+ V+GT +MAPE E +DV+AFG+ +LE+ T + C+
Sbjct: 187 ---AKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMA------TSEYPYSECQN-- 234
Query: 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638
A I R + P ++ + + C + + R SI +
Sbjct: 235 -AAQIYRRVTSGVKPASFDKVAIPEVKE------------IIEGCIRQNKDERYSIKD 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 58/284 (20%), Positives = 107/284 (37%), Gaps = 57/284 (20%)
Query: 353 AVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD---VSSEIN 406
V+ F++++ I +G F G V++ + D +K +K + E+
Sbjct: 4 TVDKRFGMDFKEIELIGSGGF-------GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK 56
Query: 407 ILKKINHSNIIRL----------------SGFCVHEGNTYLVYEFADNGALSDWLHSNRY 450
L K++H NI+ + ++ EF D G L W+ R
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 451 QT-SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509
+ L + QI ++Y+H ++++LK SNI L + KI +FGL
Sbjct: 117 EKLDKVLALELFEQIT----KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569
S ++D GT YM+PE I + ++D++A G+++ ELL +
Sbjct: 170 TSLKNDG---------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
Query: 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFI------DPSLR 607
E + + + +K + + P R
Sbjct: 221 AF-----ETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDR 259
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 73/328 (22%), Positives = 124/328 (37%), Gaps = 55/328 (16%)
Query: 329 LDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSF 387
+D + + R + TL F+ K I G F VYR +
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQF-------SEVYRAAC 53
Query: 388 KGDDA--AVKVM----------KGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEF 435
D A+K + + D EI++LK++NH N+I+ + + +V E
Sbjct: 54 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113
Query: 436 ADNGALSDWLHSNRYQT---SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSN 492
AD G LS + + Q + WK VQ+ +AL ++H +H+++K +N
Sbjct: 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL----CSALEHMHSRR---VMHRDIKPAN 166
Query: 493 ILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLD 552
+ + K+ + GL R S +VGT YM+PE I K D
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSD 218
Query: 553 VFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPL 612
+++ G ++ E+ + + GD+ L I + P + Y
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KI------------EQCDYPPLPSDHYSE 265
Query: 613 DLAFSMAQLAKNCTAHDLNARPSISEVF 640
+L QL C D RP ++ V+
Sbjct: 266 EL----RQLVNMCINPDPEKRPDVTYVY 289
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-32
Identities = 77/377 (20%), Positives = 140/377 (37%), Gaps = 74/377 (19%)
Query: 310 KKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLY------KFQ 363
++ + + G P P P ++ P ++ L+
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 364 DLKIATGSFSEENRIQGSVYRGSFKGDDA----AVKVMKGDVS--------SEINILKKI 411
D+++ G+F GSV +G ++ A+KV+K E I+ ++
Sbjct: 341 DIELGCGNF-------GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
++ I+RL G C E LV E A G L +L R + + ++ + V+
Sbjct: 394 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMG 448
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
+ YL + +VH+NL N+LL AKI++FGL+++ +D+ Y
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY---Y--------T 494
Query: 532 GTYG------YMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584
+ APE I + + DV+++GV + E LS G++ + E
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------- 547
Query: 585 ISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
V + +G R E P + + L +C + RP V +
Sbjct: 548 ---------VMAFIEQGK-----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593
Query: 644 SKIW-SSSSDWDPSDEL 659
+ S +S + L
Sbjct: 594 RACYYSLASKVEGGSAL 610
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 82/336 (24%), Positives = 138/336 (41%), Gaps = 86/336 (25%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA---------AVKVMKGDVS--- 402
+ LTL K + G+F G V G D AVK++K D +
Sbjct: 35 DKLTLGK----PLGEGAF-------GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD 83
Query: 403 -----SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR------- 449
SE+ ++K I H NII L G C +G Y++ E+A G L ++L + R
Sbjct: 84 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 450 ----YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKI 503
+ +T+K V Y +A + YL K +H++L N+L+ N KI
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKI 198
Query: 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGV 558
+FGLAR D + Y T G +MAPE + + V T + DV++FGV
Sbjct: 199 ADFGLAR----DINNIDYY-------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 559 VVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAF 616
++ E+ + G G E + + L+ G R + P +
Sbjct: 248 LMWEIFTLGGSPYPGIPVEE----------------LFKLLKEGH-----RMDKPANCTN 286
Query: 617 SMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652
+ + ++C + RP+ ++ L +I + +++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 50/238 (21%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKG-------D 400
+ L ++ G+F G V+ AVK +K D
Sbjct: 41 RDIVLKW----ELGEGAF-------GKVFLAECHNLLPEQDKMLVAVKALKEASESARQD 89
Query: 401 VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN----- 455
E +L + H +I+R G C +V+E+ +G L+ +L S+
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 456 -----LTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508
L Q + +A VA + YL +VH++L T N L+ L KI +FG+
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGM 204
Query: 509 ARS-AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
+R +D + GG + R +M PE I T + DV++FGVV+ E+ +
Sbjct: 205 SRDIYSTDYYRVGGRTMLPIR-------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 78/335 (23%), Positives = 122/335 (36%), Gaps = 83/335 (24%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
L+ K + G+F G V + G AVK++K
Sbjct: 23 NRLSFGK----TLGAGAF-------GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71
Query: 403 ---SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN--- 455
SE+ +L + NH NI+ L G C G T ++ E+ G L ++L R +
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 456 ----------LTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKI 503
L + + +Y VA + +L +H++L NILL KI
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKI 186
Query: 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGV 558
+FGLAR D Y VV +MAPE I N V T + DV+++G+
Sbjct: 187 CDFGLAR----DIKNDSNY-------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 559 VVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAFS 617
+ EL S Y + + + ++ GF R P
Sbjct: 236 FLWELFSL-----------GSSPYPGMPVDSK---FYKMIKEGF-----RMLSPEHAPAE 276
Query: 618 MAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652
M + K C D RP+ ++ + K S S++
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 78/322 (24%), Positives = 124/322 (38%), Gaps = 60/322 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------VSSEINILK 409
+ D+ + G+ +V+RG K GD A+KV E +LK
Sbjct: 11 WLLSDI-LGQGAT-------ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 410 KINHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
K+NH NI++L F + E T L+ EF G+L L + L + + +
Sbjct: 63 KLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVL 118
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLRAKITNFGLARSAESDEHEQGG 521
DV +N+L + VH+N+K NI+ D K+T+FG AR E DE
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----- 170
Query: 522 YGLQLTRHVVGTYGYMAPEYIENGVI--------TPKLDVFAFGVVVLELLSGR---EAV 570
+ GT Y+ P+ E V+ +D+++ GV +G
Sbjct: 171 ----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 571 TGDQNCEAELLYASISRVLEE--SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAH 628
G + + E++Y I+ S V++ G ID S L+ + L A+
Sbjct: 227 EGPRRNK-EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 629 DLNA----RPSISEVFVTLSKI 646
L A + F S I
Sbjct: 286 ILEADQEKCWGFDQFFAETSDI 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 50/293 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----VSSEINILKKIN-HS 414
+ +D + G+ VYRG F D AVK + + E+ +L++ + H
Sbjct: 26 FCPKD-VLGHGAEGTI------VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHP 78
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
N+IR Y+ E L +++ + + + + + L +
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG----LEPITLLQQTTSGLAH 133
Query: 475 LHKYTNPPYVHKNLKTSNILL-----DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
LH VH++LK NIL+ ++A I++FGL + H
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-----FSRRSG 185
Query: 530 VVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586
V GT G++APE + T +D+F+ G V ++S G
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------- 234
Query: 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ L L +L + A D RPS V
Sbjct: 235 ----QRQANILLGACSLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 64/301 (21%), Positives = 114/301 (37%), Gaps = 55/301 (18%)
Query: 352 SAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA--AVKVM---------KGD 400
+S+ Y KI GSF G D +K + + +
Sbjct: 18 LYFQSMEKYVRLQ-KIGEGSF-------GKAILVKSTEDGRQYVIKEINISRMSSKEREE 69
Query: 401 VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQT-SDNLTWK 459
E+ +L + H NI++ G+ Y+V ++ + G L +++ + ++
Sbjct: 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
VQI AL ++H +H+++K+ NI L + ++ +FG+AR S
Sbjct: 130 WFVQI----CLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST---- 178
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579
++L R +GT Y++PE EN K D++A G V+ EL + + A
Sbjct: 179 ----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-- 232
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
L I + G P + Y DL L + RPS++ +
Sbjct: 233 -LVLKI------------ISGSFPP-VSLHYSYDL----RSLVSQLFKRNPRDRPSVNSI 274
Query: 640 F 640
Sbjct: 275 L 275
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 77/341 (22%), Positives = 131/341 (38%), Gaps = 90/341 (26%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
E+L K + +G+F G V + G AVK++K
Sbjct: 45 ENLEFGK----VLGSGAF-------GKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 93
Query: 403 ---SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR--------- 449
SE+ ++ ++ +H NI+ L G C G YL++E+ G L ++L S R
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 450 ---------YQTSDNLTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTN 498
+ + LT++ + AY VA + +L VH++L N+L+
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHG 208
Query: 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDV 553
KI +FGLAR D Y VV +MAPE + G+ T K DV
Sbjct: 209 KVVKICDFGLAR----DIMSDSNY-------VVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 554 FAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYP 611
+++G+++ E+ S G Y I + ++ GF + + P
Sbjct: 258 WSYGILLWEIFSLGVNP------------YPGIPVDAN---FYKLIQNGF-----KMDQP 297
Query: 612 LDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652
+ + ++C A D RPS + L + + +
Sbjct: 298 FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 60/248 (24%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS----- 402
++ + I G+F G V++ G AVK++K + S
Sbjct: 47 NNIEYVR----DIGEGAF-------GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 95
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN---- 455
E ++ + ++ NI++L G C L++E+ G L+++L S T +
Sbjct: 96 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 456 ---------------LTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTN 498
L+ +++ IA VA + YL K +VH++L T N L+ N
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGEN 210
Query: 499 LRAKITNFGLARS-AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFG 557
+ KI +FGL+R+ +D ++ G R +M PE I T + DV+A+G
Sbjct: 211 MVVKIADFGLSRNIYSADYYKADGNDAIPIR-------WMPPESIFYNRYTTESDVWAYG 263
Query: 558 VVVLELLS 565
VV+ E+ S
Sbjct: 264 VVLWEIFS 271
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-31
Identities = 70/309 (22%), Positives = 115/309 (37%), Gaps = 59/309 (19%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK----GDVSSEINILKKI-NH 413
L + + GS V++GSF+G AVK M EI +L + +H
Sbjct: 16 LVVSEK-ILGYGSSGTV------VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDH 68
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWL--HSNRYQTSDNLTWKQRVQIAYDVANA 471
N+IR + Y+ E N L D + + + + + +A+
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDT-------------NLRAKITNFGLARSAESDEHE 518
+ +LH +H++LK NIL+ T NLR I++FGL + +S +
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS- 183
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVI-------TPKLDVFAFGVVVLELLSGREAVT 571
+ GT G+ APE +E T +D+F+ G V +LS +
Sbjct: 184 ---SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 572 GDQNCEAELLYASISRVLEESNVREKLRGFID-PSLRNEYPLDLAFSMAQLAKNCTAHDL 630
GD+ ESN+ +RG ++ + L L HD
Sbjct: 241 GDKY-------------SRESNI---IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284
Query: 631 NARPSISEV 639
RP+ +V
Sbjct: 285 LKRPTAMKV 293
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 52/331 (15%), Positives = 114/331 (34%), Gaps = 94/331 (28%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA---------AVKVMKGDVSS-- 403
E L + + G+F +++G + +KV+ +
Sbjct: 8 EDLIFNE----SLGQGTF-------TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS 56
Query: 404 -----EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTW 458
+++ K++H +++ G CV LV EF G+L +L N+ + +
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK----NCINI 112
Query: 459 KQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDT--------NLRAKITNFGL 508
++++A +A A+++L + +H N+ NILL K+++ G+
Sbjct: 113 LWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 509 ARSAESDEHEQGGYGLQLTRHVVGTYGY-----MAPEYIENGVI-TPKLDVFAFGVVVLE 562
+ + + + PE IEN D ++FG + E
Sbjct: 168 SITVLPKD-----------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210
Query: 563 LLS-GREAVTGDQNCEAELLYASISRVLEESNVREKL-RGFIDPSLRNEYPLDLAFSMAQ 620
+ S G + ++ + + P+ + +A
Sbjct: 211 ICSGGDKPLSALDSQR----------------KLQFYEDRHQLPAPKAA-------ELAN 247
Query: 621 LAKNCTAHDLNARPSISEVFVTLSKIWSSSS 651
L NC ++ + RPS + L+ +++
Sbjct: 248 LINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 83/340 (24%), Positives = 138/340 (40%), Gaps = 86/340 (25%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA---------AVKVMKGDVS--- 402
+ L L K + G+F G V G D AVK++K D +
Sbjct: 69 DRLVLGK----PLGEGAF-------GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 117
Query: 403 -----SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN- 455
SE+ ++K I H NII L G C +G Y++ E+A G L ++L + R +
Sbjct: 118 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 456 ----------LTWKQRVQIAYDVANALNYL--HKYTNPPYVHKNLKTSNILLDTNLRAKI 503
L+ K V AY VA + YL K +H++L N+L+ + KI
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKI 232
Query: 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYG-----YMAPEYIENGVITPKLDVFAFGV 558
+FGLAR D H Y T G +MAPE + + + T + DV++FGV
Sbjct: 233 ADFGLAR----DIHHIDYY-------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281
Query: 559 VVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAF 616
++ E+ + G G E + + L+ G R + P +
Sbjct: 282 LLWEIFTLGGSPYPGVPVEE----------------LFKLLKEGH-----RMDKPSNCTN 320
Query: 617 SMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDPS 656
+ + ++C + RP+ ++ L +I + +S+ +
Sbjct: 321 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 68/321 (21%), Positives = 103/321 (32%), Gaps = 62/321 (19%)
Query: 333 DYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDD 391
S +AS +L P S ES FQ L + GS+ G V++ K D
Sbjct: 30 RVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSY-------GEVFKVRSKEDG 82
Query: 392 A--AVKVMKGDVSS---------EINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNG 439
AVK E+ +K+ H +RL G YL E
Sbjct: 83 RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-P 141
Query: 440 ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499
+L + + W D AL +LH VH ++K +NI L
Sbjct: 142 SLQQHCEAWGASLPEAQVWG----YLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRG 194
Query: 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVV 559
R K+ +FGL + G YMAPE ++ DVF+ G+
Sbjct: 195 RCKLGDFGLLVELGTA---------GAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGLT 244
Query: 560 VLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAFSM 618
+LE+ E G + ++LR G++ P +L
Sbjct: 245 ILEVACNMELPHGGEG-------------------WQQLRQGYLPPEFTAGLSSEL---- 281
Query: 619 AQLAKNCTAHDLNARPSISEV 639
+ D R + +
Sbjct: 282 RSVLVMMLEPDPKLRATAEAL 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 69/326 (21%), Positives = 122/326 (37%), Gaps = 65/326 (19%)
Query: 338 PQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRG-SFKGDDAAVKV 396
+ + F+S +Y I +G V++ + K A+K
Sbjct: 8 SSGVDLGTENLYFQSMSVKGRIYSILKQ-IGSGGS-------SKVFQVLNEKKQIYAIKY 59
Query: 397 M-KGDVS--------SEINILKKINH--SNIIRLSGFCVHEGNTYLVYEFADNGALSDWL 445
+ + +EI L K+ IIRL + + + Y+V E N L+ WL
Sbjct: 60 VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL 118
Query: 446 HSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505
+ ++ +R ++ A++ +H++ VH +LK +N L+ + K+ +
Sbjct: 119 KKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 169
Query: 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----------GVITPKLDVF 554
FG+A + D + VGT YM PE I++ I+PK DV+
Sbjct: 170 FGIANQMQPDTTSV------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 555 AFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDL 614
+ G ++ + G+ + I N KL IDP+ E+P
Sbjct: 224 SLGCILYYMTYGK------------TPFQQI------INQISKLHAIIDPNHEIEFPDIP 265
Query: 615 AFSMAQLAKNCTAHDLNARPSISEVF 640
+ + K C D R SI E+
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELL 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 71/361 (19%), Positives = 124/361 (34%), Gaps = 66/361 (18%)
Query: 303 YRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKF 362
+ +S P K D + + +Y
Sbjct: 2 HHHHHSSGLVPRGS-GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60
Query: 363 QDLKIATGSFSEENRIQGSVYRG-SFKGDDAAVK-VMKGDVSS--------EINILKKIN 412
I +G V++ + K A+K V + + EI L K+
Sbjct: 61 LKQ-IGSGGS-------SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 413 H--SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
IIRL + + + Y+V E N L+ WL + ++ +R ++
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-----SIDPWERKSYWKNMLE 166
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
A++ +H++ VH +LK +N L+ + K+ +FG+A + D +
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV------VKDSQ 216
Query: 531 VGTYGYMAPEYIEN-----------GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579
VG YM PE I++ I+PK DV++ G ++ + G+
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------ 264
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ I N KL IDP+ E+P + + K C D R SI E+
Sbjct: 265 TPFQQI------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 640 F 640
Sbjct: 319 L 319
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 1e-29
Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 44/296 (14%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------VSSEINILK 409
++ ++ ++ TG F G V R + G+ A+K + + EI I+K
Sbjct: 16 WEMKE-RLGTGGF-------GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 410 KINHSNIIRL------SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
K+NH N++ L E+ + G L +L N+++ L
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRT 125
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN---LRAKITNFGLARSAESDEHEQG 520
+ D+++AL YLH+ +H++LK NI+L L KI + G A+ + E
Sbjct: 126 LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---- 178
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
L VGT Y+APE +E T +D ++FG + E ++G +
Sbjct: 179 -----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ--PVQ 231
Query: 581 LYASI-SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
+ + + E V + L G + S P L+ +A + L
Sbjct: 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 65/304 (21%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRG-SFKGDDAAVK-VMKGDVSS--------EINILK 409
Y I +G V++ + K A+K V + + EI L
Sbjct: 11 YSILKQ-IGSGGS-------SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 410 KINH--SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
K+ IIRL + + + Y+V E N L+ WL + ++ +R +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-----SIDPWERKSYWKN 116
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+ A++ +H++ VH +LK +N L+ + K+ +FG+A + D +
Sbjct: 117 MLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV------VK 166
Query: 528 RHVVGTYGYMAPEYIEN-----------GVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576
VGT YM PE I++ I+PK DV++ G ++ + G+
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--------- 217
Query: 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636
+ I N KL IDP+ E+P + + K C D R SI
Sbjct: 218 ---TPFQQI------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268
Query: 637 SEVF 640
E+
Sbjct: 269 PELL 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 48/250 (19%), Positives = 87/250 (34%), Gaps = 37/250 (14%)
Query: 397 MKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQT--SD 454
S +I + + N + + Y+ + L DW++
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 455 NLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
+ +QIA A+ +LH +H++LK SNI + K+ +FGL + +
Sbjct: 164 GVCLHIFIQIA----EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 515 DEHEQGGYGLQLTRH----VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV 570
DE EQ VGT YM+PE I + K+D+F+ G+++ ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
Query: 571 TGDQNCEAELLYASISRVLEESNVREKLR-GFIDPSLRNEYPLDLAFSMAQLAKNCTAHD 629
E + +R +YP + ++ +
Sbjct: 277 M------------------ERVRIITDVRNLKFPLLFTQKYP-----QEHMMVQDMLSPS 313
Query: 630 LNARPSISEV 639
RP +++
Sbjct: 314 PTERPEATDI 323
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 44/258 (17%), Positives = 91/258 (35%), Gaps = 49/258 (18%)
Query: 339 QASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK 398
SN + + + + + Y+ + G F + A+K +
Sbjct: 12 NYSNLIYLNKYVKEKDKYINDYRIIR-TLNQGKF-------NKIILCEKDNKFYALKKYE 63
Query: 399 ------------------------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434
D +E+ I+ I + + G + Y++YE
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123
Query: 435 FADNGALSDWLHSN---RYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTS 491
+ +N ++ + + + + I V N+ +Y+H N H+++K S
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPS 181
Query: 492 NILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITP 549
NIL+D N R K+++FG + + GTY +M PE+ N
Sbjct: 182 NILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGA 231
Query: 550 KLDVFAFGVVVLELLSGR 567
K+D+++ G+ + +
Sbjct: 232 KVDIWSLGICLYVMFYNV 249
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 35/226 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRG--SFKGDDAAVKVMKGDVSSEINILKK------- 410
YK D K+ G S VY + A+K + + LK+
Sbjct: 13 YKIVD-KLGGGGMST-------VYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 411 ---INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
++H NI+ + + YLV E+ + LS+++ S+ L+ +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQ 119
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+ + + + H VH+++K NIL+D+N KI +FG+A++ L T
Sbjct: 120 ILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-------SLTQT 169
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
HV+GT Y +PE + D+++ G+V+ E+L G G+
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 34/280 (12%), Positives = 82/280 (29%), Gaps = 47/280 (16%)
Query: 321 RVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQG 380
+ P + + + ++ F+ + + ++ + G+F
Sbjct: 33 GLSKPVSS--YPNTFEWQCKLPAIKPKTEFQLGSKLVYVHH----LLGEGAF-------A 79
Query: 381 SVYRGSFKGDDA-------AVKVMKGDVSSE-------INILKKINHSNIIRLSGFCVHE 426
VY + + +KV K E + LK ++ + +
Sbjct: 80 QVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHK 486
+ LV E G L + ++ + + + A + + +H +H
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHG 196
Query: 487 NLKTSNILL-----------DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
++K N +L D + + + G + + + T G
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG------TIFTAKCETSG 250
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575
+ E + N ++D F V +L G ++
Sbjct: 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 63/330 (19%), Positives = 118/330 (35%), Gaps = 62/330 (18%)
Query: 366 KIATGSFSEENRIQGSVY--RGSFKGDDAAVKVM-------KGDVSSEINILKKI-NHSN 415
+A G F VY + G + A+K + + E+ +KK+ H N
Sbjct: 35 VLAEGGF-------AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 416 IIRL---SGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
I++ + E +T +L+ G L ++L + ++ L+ ++I Y
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQT 145
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD----EHEQGGYGL 524
A+ ++H PP +H++LK N+LL K+ +FG A + Q +
Sbjct: 146 CRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 525 QLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581
+ T Y PE I+ N I K D++A G ++ L +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP------------ 252
Query: 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFS--MAQLAKNCTAHDLNARPSISEV 639
E+ + G + P L + + R SI+EV
Sbjct: 253 -------FEDGAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299
Query: 640 FVTLSKIWSSSSDWDPSDELNNSRSLSRGS 669
L +I +++ + +P + + G
Sbjct: 300 VHQLQEI-AAARNVNPKSPITELLEQNGGY 328
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINIL 408
Y+ K+ +G++ G V K + A+K+++ + E+ +L
Sbjct: 39 YQRVK-KLGSGAY-------GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
K ++H NI++L F + N YLV E G L D I V
Sbjct: 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD-----EIIHRMKFNEVDAAVIIKQV 145
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQ 525
+ + YLHK+ VH++LK N+LL++ + KI +FGL+ E+ + +
Sbjct: 146 LSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE----- 197
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+GT Y+APE + K DV++ GV++ LL+G
Sbjct: 198 ----RLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGY 234
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 27/206 (13%)
Query: 380 GSVYRG--SFKGDDAAVKVMKGDVSSEINILK----------KINHSNIIRLSGFCVHEG 427
G VY + + A+K+M +SS+ ++ +++ + F +G
Sbjct: 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107
Query: 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487
Y+ + L+ L L + V I + +AL+ H H++
Sbjct: 108 QLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRD 159
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI 547
+K NIL+ + A + +FG+A + + L + VGT YMAPE
Sbjct: 160 VKPENILVSADDFAYLVDFGIASATTDE-------KLTQLGNTVGTLYYMAPERFSESHA 212
Query: 548 TPKLDVFAFGVVVLELLSGREAVTGD 573
T + D++A V+ E L+G GD
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGD 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 41/223 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK----------GDVSSEINI 407
YK Q + GSF G V K G + AVKV+ + E+ +
Sbjct: 28 YKGQR-VLGKGSF-------GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
LK+++H NI++L F +G YLV E G L D + + +I
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD-----EIISRKRFSEVDAARIIRQ 134
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGL 524
V + + Y+HK VH++LK N+LL++ + +I +FGL+ E+ + +
Sbjct: 135 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---- 187
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+GT Y+APE + +G K DV++ GV++ LLSG
Sbjct: 188 -----KIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGC 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 38/225 (16%)
Query: 356 SLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKV----------MKGDVS 402
L F+ + + G F G+VY K A+KV ++ +
Sbjct: 5 QWALEDFEIGRPLGKGKF-------GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E+ I + H NI+RL G+ YL+ E+A G + L ++
Sbjct: 58 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTA 112
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
++ANAL+Y H +H+++K N+LL + KI +FG + A S
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 165
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ GT Y+ PE IE + K+D+++ GV+ E L G+
Sbjct: 166 ----D--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINIL 408
Y + GSF G V + + + AVKV+ + E+ +L
Sbjct: 24 YNIVC-MLGKGSF-------GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
KK++H NI++L + Y+V E G L D + +I V
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD-----EIIKRKRFSEHDAARIIKQV 130
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQ 525
+ + Y+HK+ VH++LK NILL++ + KI +FGL+ + + +
Sbjct: 131 FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD----- 182
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+GT Y+APE + G K DV++ GV++ LLSG
Sbjct: 183 ----RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 36/264 (13%)
Query: 315 PVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLT-LYKFQDLKIATGSFS 373
+V DY F + PQ S+ Y + ++ +G+F
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILE-ELGSGAF- 64
Query: 374 EENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCV 424
G V+R K G K + V +EI+I+ +++H +I L
Sbjct: 65 ------GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484
+ L+ EF G L D + + Y ++ + + L ++H+++ V
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS---IV 171
Query: 485 HKNLKTSNILLDT--NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI 542
H ++K NI+ +T KI +FGLA DE + + T + APE +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---------IVKVTTATAEFAAPEIV 222
Query: 543 ENGVITPKLDVFAFGVVVLELLSG 566
+ + D++A GV+ LLSG
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 38/225 (16%)
Query: 356 SLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VS 402
T+ F + + G F G+VY K A+KV+ +
Sbjct: 10 KFTIDDFDIGRPLGKGKF-------GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 403 SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
EI I + H NI+R+ + YL+ EFA G L L + ++
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----FDEQRSA 117
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
++A+AL+Y H+ +H+++K N+L+ KI +FG + A S
Sbjct: 118 TFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL------- 167
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
R + GT Y+ PE IE K+D++ GV+ E L G
Sbjct: 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 54/271 (19%), Positives = 102/271 (37%), Gaps = 36/271 (13%)
Query: 308 NSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLT-LYKFQDLK 366
K+ + ++Y + +PQ + + Y + +
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE-E 164
Query: 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVM-------KGDVSSEINILKKINHSNII 417
+ TG+F G V+R + + G++ A K + K V EI + + H ++
Sbjct: 165 LGTGAF-------GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 418 RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK 477
L + ++YEF G L + + + ++ + V+ V L ++H+
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHE 273
Query: 478 YTNPPYVHKNLKTSNILLDTNLRA--KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
YVH +LK NI+ T K+ +FGL + + + GT
Sbjct: 274 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---------VKVTTGTAE 321
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ APE E + D+++ GV+ LLSG
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 55/261 (21%), Positives = 102/261 (39%), Gaps = 40/261 (15%)
Query: 323 PPPKTPLDCADYSLFPQASNSLSHPQGF--RSAVESLTLYKFQDLK-IATGSFSEENRIQ 379
P P P + + + + P V+ + ++ + + G F
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGF------- 54
Query: 380 GSVYRGSFK--GDDAAVKV----------MKGDVSSEINILKKINHSNIIRLSGFCVHEG 427
+ S + A K+ + +S EI+I + + H +++ GF
Sbjct: 55 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114
Query: 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487
++V E +L + LH R ++ QI YLH+ +H++
Sbjct: 115 FVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQI----VLGCQYLHRNR---VIHRD 166
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV-GTYGYMAPEYIENGV 546
LK N+ L+ +L KI +FGLA E D + V+ GT Y+APE +
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGE---------RKKVLCGTPNYIAPEVLSKKG 217
Query: 547 ITPKLDVFAFGVVVLELLSGR 567
+ ++DV++ G ++ LL G+
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKV--------MKGDVSSEINILK 409
+ F+ K+ +G+F G V+ + G + +K + +EI +LK
Sbjct: 24 FIFKR-KLGSGAF-------GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK 75
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
++H NII++ N Y+V E + G L + + S L+ ++ +
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS-AQARGKALSEGYVAELMKQMM 134
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQL 526
NAL Y H VHK+LK NIL + KI +FGLA +SD +
Sbjct: 135 NALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---------EH 182
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ + GT YMAPE +T K D+++ GVV+ LL+G
Sbjct: 183 STNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTG 221
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 24/218 (11%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK--GDVSSEINILKK 410
E + Q + GSF G V+R K G AVK ++ E+
Sbjct: 55 EEVHWMTHQPR-VGRGSF-------GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAG 106
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
++ I+ L G + E + G+L + L + +
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALE 161
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
L YLH +H ++K N+LL ++ RA + +FG A + D G L +
Sbjct: 162 GLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD---GLGKSLLTGDY 215
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ GT +MAPE + K+D+++ ++L +L+G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 370 GSFSEENRIQGSVYRGSFK--GDDAAVKV----------MKGDVSSEINILKKINHSNII 417
GSF VYR G + A+K+ M V +E+ I ++ H +I+
Sbjct: 22 GSF-------AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 418 RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK 477
L + YLV E NG ++ +L + S+N QI + YLH
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGMLYLHS 130
Query: 478 YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV-GTYGY 536
+ +H++L SN+LL N+ KI +FGLA + + + GT Y
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---------KHYTLCGTPNY 178
Query: 537 MAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
++PE + DV++ G + LL GR
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 51/233 (21%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK------------------- 398
Y K+ +G++ G V K + A+KV+K
Sbjct: 38 YFKVR-KLGSGAY-------GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 399 -GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
++ +EI++LK ++H NII+L + YLV EF + G L + +
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE-----QIINRHKFD 144
Query: 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAES 514
I + + + YLHK+ VH+++K NILL+ L KI +FGL+
Sbjct: 145 ECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
D + +GT Y+APE + K DV++ GV++ LL G
Sbjct: 202 DYKLRD---------RLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 52/225 (23%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM-------KGDVSSEINILKK 410
K+ KI G+ G+VY G + A++ M K + +EI ++++
Sbjct: 21 KYTRFEKIGQGAS-------GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY---D 467
+ NI+ + ++V E+ G+L+D + QIA +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------QIAAVCRE 124
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
AL +LH +H+++K+ NILL + K+T+FG Q+T
Sbjct: 125 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCA--------------QIT 167
Query: 528 RH------VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+VGT +MAPE + PK+D+++ G++ +E++ G
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSS 403
Y + ++ +G F+ V + K G + A K +K ++
Sbjct: 13 FYDIGE-ELGSGQFAI-------VKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E++IL+++ H NII L + + L+ E G L D ++L+ ++
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD-----FLAQKESLSEEEATS 119
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLRAKITNFGLARSAESDEHEQ 519
+ + +NYLH H +LK NI+L K+ +FGLA E
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--- 173
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+++ GT ++APE + + + D+++ GV+ LLSG
Sbjct: 174 ------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 34/217 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKI 411
Y + + G F G V+R K +K V EI+IL
Sbjct: 7 YMIAE-DLGRGEF-------GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
H NI+ L +++EF + + ++++ + L ++ V + V A
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEA 114
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
L +LH + H +++ NI+ T + KI FG AR + + R
Sbjct: 115 LQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------NFRL 162
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ Y APE ++ V++ D+++ G +V LLSG
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSS 403
Y + ++ +G F+ V + K G + A K +K ++
Sbjct: 13 FYDIGE-ELGSGQFAI-------VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E++IL+++ H N+I L + + L+ E G L D ++L+ ++
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD-----FLAQKESLSEEEATS 119
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLRAKITNFGLARSAESDEHEQ 519
+ + +NYLH H +LK NI+L K+ +FGLA E
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--- 173
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+++ GT ++APE + + + D+++ GV+ LLSG
Sbjct: 174 ------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 52/225 (23%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM-------KGDVSSEINILKK 410
KI GS G V K G AVK+M + + +E+ I++
Sbjct: 46 LLDSYVKIGEGST-------GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY---D 467
H N++ + + +++ EF GAL+D + R QIA
Sbjct: 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE---------QIATVCEA 149
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
V AL YLH +H+++K+ +ILL + R K+++FG Q++
Sbjct: 150 VLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCA--------------QIS 192
Query: 528 RH------VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ +VGT +MAPE I + ++D+++ G++V+E++ G
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 50/232 (21%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKV----------------MKGDV 401
Y+ ++ + G S V R K + AVK+ ++
Sbjct: 19 YEPKE-ILGRGVSSV-------VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 402 SSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
E++IL+K++ H NII+L +LV++ G L D+L L+ K+
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKE 125
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+I + + LHK VH++LK NILLD ++ K+T+FG + + E
Sbjct: 126 TRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---- 178
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVI------TPKLDVFAFGVVVLELLSG 566
R V GT Y+APE IE + ++D+++ GV++ LL+G
Sbjct: 179 -----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 43/233 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGD-----DAAVKVMKGDVSSEINILKK---- 410
Y+ + + G SE V+ D D AVKV++ D++ + + +
Sbjct: 14 YELGE-ILGFGGMSE-------VHLAR---DLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 411 ------INHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
+NH I+ + E Y+V E+ D L D +H+ +T K+
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKR 117
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+++ D ALN+ H+ +H+++K +NI++ K+ +FG+AR+
Sbjct: 118 AIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD-----S 169
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
G + T V+GT Y++PE + + DV++ G V+ E+L+G TGD
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 65/298 (21%), Positives = 116/298 (38%), Gaps = 59/298 (19%)
Query: 304 RRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQ 363
+++ + R P ++ A+ A + F+S L +
Sbjct: 28 HLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWA 87
Query: 364 DLK-----------IATGSFSEENRIQGSVYRGSFK--GDDAAVKV-------------- 396
K I G S V R + G + AVK+
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSV-------VRRCVHRATGHEFAVKIMEVTAERLSPEQLE 140
Query: 397 -MKGDVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSD 454
++ E +IL+++ H +II L +LV++ G L D+L
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---- 196
Query: 455 NLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
L+ K+ I + A+++LH VH++LK NILLD N++ ++++FG + E
Sbjct: 197 -LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI------TPKLDVFAFGVVVLELLSG 566
E R + GT GY+APE ++ + ++D++A GV++ LL+G
Sbjct: 253 GE---------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-------GDVSSEINILKK 410
+ F + + +G+FSE V+ + G A+K +K + +EI +LKK
Sbjct: 11 FIFME-VLGSGAFSE-------VFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK 62
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
I H NI+ L + YLV + G L D + T K + V +
Sbjct: 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-----YTEKDASLVIQQVLS 117
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQLT 527
A+ YLH+ VH++LK N+L T N + IT+FGL++ ++ +
Sbjct: 118 AVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----------GIM 164
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
GT GY+APE + + +D ++ GV+ LL G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 57/279 (20%), Positives = 106/279 (37%), Gaps = 41/279 (14%)
Query: 306 RRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDL 365
++S+ + A + + P F + +
Sbjct: 29 DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88
Query: 366 -------KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILK 409
+ G F G V++ G A K++K +V +EI+++
Sbjct: 89 YTVSKTEILGGGRF-------GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
+++H+N+I+L + + LV E+ D G L D + Y NLT + +
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY----NLTELDTILFMKQIC 197
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+ ++H+ +H +LK NIL + KI +FGLAR + E
Sbjct: 198 EGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---------KL 245
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ GT ++APE + ++ D+++ GV+ LLSG
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 37/214 (17%)
Query: 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKV----------MKGDVSSEINILKKINHS 414
+ G F + S + A K+ + +S EI+I + + H
Sbjct: 23 LGKGGF-------AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 415 NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNY 474
+++ GF ++V E +L + LH R ++ QI Y
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQI----VLGCQY 130
Query: 475 LHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV-GT 533
LH+ +H++LK N+ L+ +L KI +FGLA E D + V+ GT
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---------RKKVLCGT 178
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
Y+APE + + ++DV++ G ++ LL G+
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKV-----MKG----DVSSEINIL 408
Y + GSF G V + + + AVKV K + E+ +L
Sbjct: 24 YNIVC-MLGKGSF-------GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
KK++H NI++L + Y+V E G L D + +I V
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD-----EIIKRKRFSEHDAARIIKQV 130
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQ 525
+ + Y+HK+ VH++LK NILL++ + KI +FGL+ + +
Sbjct: 131 FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---------T 178
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ +GT Y+APE + G K DV++ GV++ LLSG
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 48/229 (20%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 354 VESLTLYKFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS------- 403
V L F+ + ++ G+ G V++ S K G A K++ ++
Sbjct: 27 VGELKDDDFEKISELGAGNG-------GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 79
Query: 404 -EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E+ +L + N I+ G +G + E D G+L + + + +
Sbjct: 80 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-----LKKAGRIPEQILG 134
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
+++ V L YL + +H+++K SNIL+++ K+ +FG++
Sbjct: 135 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG------------ 180
Query: 523 GLQLTRHV----VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
QL + VGT YM+PE ++ + + D+++ G+ ++E+ GR
Sbjct: 181 --QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 30/223 (13%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM--------KGDVSSEINILK 409
Y+ Q+ I +G+ V + A+K + ++ EI +
Sbjct: 17 YELQE-VIGSGAT-------AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS 68
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY--- 466
+ +H NI+ V + +LV + G++ D + + IA
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
+V L YLHK +H+++K NILL + +I +FG++ G
Sbjct: 129 EVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLA----TGGDITRNK 181
Query: 527 TRH-VVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
R VGT +MAPE +E K D+++FG+ +EL +G
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 8e-24
Identities = 47/236 (19%), Positives = 93/236 (39%), Gaps = 32/236 (13%)
Query: 348 QGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK------- 398
QG S + Y+ I G +V +K G+ V+ +
Sbjct: 15 QGMSSFLPEGGCYELLT-VIGKGFED-----LMTVNLARYKPTGEYVTVRRINLEACSNE 68
Query: 399 --GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
+ E+++ K NH NI+ + + ++V F G+ D + ++ +
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-- 126
Query: 457 TWKQRVQIAY---DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513
+ IAY V AL+Y+H YVH+++K S+IL+ + + ++ S
Sbjct: 127 ----ELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI--TPKLDVFAFGVVVLELLSGR 567
S Q ++ V +++PE ++ + K D+++ G+ EL +G
Sbjct: 180 SHGQRQRVVH-DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSSE 404
Y+ + ++ +G F V + K G + A K +K ++ E
Sbjct: 7 YEMGE-ELGSGQF-------AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 58
Query: 405 INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
+NIL++I H NII L ++ + L+ E G L D ++LT + Q
Sbjct: 59 VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD-----FLAEKESLTEDEATQF 113
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLRAKITNFGLARSAESDEHEQG 520
+ + ++YLH H +LK NI+L N R K+ +FG+A E+
Sbjct: 114 LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---- 166
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+++ GT ++APE + + + D+++ GV+ LLSG
Sbjct: 167 -----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSS 403
Y + ++ +G F V + K G A K +K D+
Sbjct: 12 YYDTGE-ELGSGQF-------AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E++ILK+I H N+I L ++ + L+ E G L D ++LT ++ +
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-----FLAEKESLTEEEATE 118
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT----NLRAKITNFGLARSAESDEHEQ 519
+ N + YLH H +LK NI+L R KI +FGLA +
Sbjct: 119 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--- 172
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+++ GT ++APE + + + D+++ GV+ LLSG
Sbjct: 173 ------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 345 SHPQGFRSAVESLTLYKFQDLKIATGSFSE----ENRIQGSVY------RGSFKGDDAAV 394
+P+ R Y + +G+ E R + F A
Sbjct: 3 VYPKALRD------EYIMSK-TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 55
Query: 395 KVMKGDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSD 454
+V +EI ILKK+NH II++ F + Y+V E + G L D + N+
Sbjct: 56 ADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---- 110
Query: 455 NLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARS 511
L Y + A+ YLH+ +H++LK N+LL + + KIT+FG ++
Sbjct: 111 -LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI---TPKLDVFAFGVVVLELLSG 566
L R + GT Y+APE + + +D ++ GV++ LSG
Sbjct: 167 LGET---------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 64/273 (23%), Positives = 103/273 (37%), Gaps = 41/273 (15%)
Query: 304 RRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQ 363
+ T L + SL P S+ ++ +
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD------FFEVE 58
Query: 364 DLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-----GDVSSEINILKKINHSNI 416
++ G+ S VYR K A+KV+K V +EI +L +++H NI
Sbjct: 59 S-ELGRGATSI-------VYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH 476
I+L LV E G L D + Y + + + A+ YLH
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLH 165
Query: 477 KYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
+ VH++LK N+L T + KI +FGL++ E L + V GT
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---------VLMKTVCGT 213
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
GY APE + P++D+++ G++ LL G
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINIL 408
Y ++ ++ G+FS V R K G + A K++ + E I
Sbjct: 8 YDVKE-ELGKGAFSV-------VRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 59
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
+K+ H NI+RL E YLV++ G L + + + + + +
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQI 114
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQ 525
++ Y H VH+NLK N+LL + K+ +FGLA +
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---------E 162
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
GT GY++PE ++ + +D++A GV++ LL G
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM--------KGDVSSEINI 407
L+ + KI GSF G V++G A+K++ D+ EI +
Sbjct: 22 ELFTKLE-KIGKGSF-------GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY- 466
L + + + + G + + +++ E+ G+ D L + QIA
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET---------QIATI 124
Query: 467 --DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
++ L+YLH +H+++K +N+LL + K+ +FG+A
Sbjct: 125 LREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG-------------- 167
Query: 525 QLT-----RH-VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
QLT R+ VGT +MAPE I+ K D+++ G+ +EL G
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 366 KIATGSFSE----ENRIQGSVY------RGSFKGDDAAVKVMKGDVSSEINILKKINHSN 415
+ +G+ E R + F A +V +EI ILKK+NH
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
II++ F + Y+V E + G L D + N+ L Y + A+ YL
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLLAVQYL 255
Query: 476 HKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
H+ +H++LK N+LL + + KIT+FG ++ L R + G
Sbjct: 256 HENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---------SLMRTLCG 303
Query: 533 TYGYMAPEYIENGVI---TPKLDVFAFGVVVLELLSG 566
T Y+APE + + +D ++ GV++ LSG
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 49/251 (19%), Positives = 90/251 (35%), Gaps = 56/251 (22%)
Query: 352 SAVESLTLYKFQDL-KIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS----- 403
++S +F +L KI +G F GSV++ + D A+K K ++
Sbjct: 3 MGMKSRYTTEFHELEKIGSGEF-------GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ 55
Query: 404 ----EINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTW 458
E+ + HS+++R + + + E+ + G+L+D + S Y+
Sbjct: 56 NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKE 114
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-------------------L 499
+ + V L Y+H + VH ++K SNI + +
Sbjct: 115 AELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGV 558
KI + G S + G ++A E + EN PK D+FA +
Sbjct: 172 MFKIGDLGHVTRISS------------PQVEEGDSRFLANEVLQENYTHLPKADIFALAL 219
Query: 559 VVLELLSGREA 569
V+
Sbjct: 220 TVVCAAGAEPL 230
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 37/223 (16%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINI 407
Y ++ G F V + K G + A K +K ++ EI +
Sbjct: 29 FYILTSKELGRGKF-------AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81
Query: 408 LKKINHS-NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
L+ +I L + L+ E+A G + + ++ ++ +++
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIK 138
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYG 523
+ + YLH+ VH +LK NILL + KI +FG++R
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC------- 188
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
R ++GT Y+APE + IT D++ G++ LL+
Sbjct: 189 --ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 26/178 (14%)
Query: 397 MKGDVSSEINILKKINHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQT 452
V EI ILKK++H N+++L V + Y+V+E + G + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 453 SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512
+ Q D+ + YLH +H+++K SN+L+ + KI +FG+
Sbjct: 137 DQARFYFQ------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV---- 183
Query: 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGR 567
S+E + L T VGT +MAPE + LDV+A GV + + G+
Sbjct: 184 -SNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 38/219 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKV-----MKG--DVSSEINILKK 410
Y ++ I GS+ G V K A K ++ EI I+K
Sbjct: 11 YTLEN-TIGRGSW-------GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKS 62
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
++H NIIRL + YLV E G L + R +I DV +
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFE-----RVVHKRVFRESDAARIMKDVLS 117
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQLT 527
A+ Y HK H++LK N L T + K+ +FGLA + + +
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT------- 167
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
VGT Y++P+ +E G+ P+ D ++ GV++ LL G
Sbjct: 168 --KVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 42/222 (18%)
Query: 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-----GDVSSEINILKK 410
++ + K+ GS+ GSVY+ K G A+K + ++ EI+I+++
Sbjct: 29 EVFDVLE-KLGEGSY-------GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ 80
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
+ ++++ G + ++V E+ G++SD + + LT + I
Sbjct: 81 CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLK 136
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH- 529
L YLH +H+++K NILL+T AK+ +FG+A QLT
Sbjct: 137 GLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAG--------------QLTDTM 179
Query: 530 -----VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
V+GT +MAPE I+ D+++ G+ +E+ G
Sbjct: 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM---KGDVSSEINILKK-INH 413
Y+ ++ I GS+S R K + AVK++ K D + EI IL + H
Sbjct: 24 YEVKE-DIGVGSYSV-------CKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQH 75
Query: 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
NII L Y+V E G L D + ++ + ++ + + + +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-----FSEREASAVLFTITKTVE 130
Query: 474 YLHKYTNPPYVHKNLKTSNILL----DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
YLH VH++LK SNIL +I +FG A+ ++ L
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--------GLLMT 179
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T ++APE +E D+++ GV++ +L+G
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 37/224 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK------------GDVSSEI 405
Y+ + I G FS V R + G AVK++ D+ E
Sbjct: 26 YELCE-VIGKGPFSV-------VRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+I + H +I+ L +G Y+V+EF D L + R +
Sbjct: 78 SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYM 136
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGY 522
+ AL Y H +H+++K +LL + + K+ FG+A
Sbjct: 137 RQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG------ 187
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ VGT +MAPE ++ +DV+ GV++ LLSG
Sbjct: 188 --LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 38/221 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINIL 408
Y+ + ++ G+FS V R G + A ++ + E I
Sbjct: 13 YQLFE-ELGKGAFSV-------VRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
+ + H NI+RL EG+ YL+++ G L + + + Y + +
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-----YSEADASHCIQQI 119
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQ 525
A+ + H+ VH+NLK N+LL + K+ +FGLA E ++ Q
Sbjct: 120 LEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--------Q 168
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
GT GY++PE + +D++A GV++ LL G
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM-------KGDVSSEINILK 409
+Y+ Q+ + G+ V + AVK++ + V E+ +L
Sbjct: 13 VYQLQEDVLGEGAH-------ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65
Query: 410 KI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
+ H N++ L F E YLV+E G++ + + + DV
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS-----HIHKRRHFNELEASVVVQDV 120
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQ 525
A+AL++LH N H++LK NIL + KI +F L + + +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKL-----DVFAFGVVVLELLSG 566
L G+ YMAPE +E + D+++ GV++ LLSG
Sbjct: 178 LLT-PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---------GDVSSEINIL 408
Y ++ ++ G+FS V R K G + A K++ + E I
Sbjct: 31 YDVKE-ELGKGAFSV-------VRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
+K+ H NI+RL E YLV++ G L + + + + + +
Sbjct: 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQI 137
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQ 525
++ Y H VH+NLK N+LL + K+ +FGLA +
Sbjct: 138 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---------E 185
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
GT GY++PE ++ + +D++A GV++ LL G
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 360 YKFQDLK--IATGSFSEENRIQGSVYRGSFK--GDDAAVKV----MKGDVSSEINILKKI 411
Y + GSFS + K AVK+ M+ + EI LK
Sbjct: 10 YDLDLKDKPLGEGSFSI-------CRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLC 62
Query: 412 -NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
H NI++L + +T+LV E + G L + R + + + + I + +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE-----RIKKKKHFSETEASYIMRKLVS 117
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
A++++H VH++LK N+L + NL KI +FG AR D Q
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--------QPL 166
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ T Y APE + D+++ GV++ +LSG
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 367 IATGSFSEENRIQGSVYRG--SFKGDDAAVKVMK-------GDVSSEINILKKINHSNII 417
+ G++ G VY G A+K + + EI + K + H NI+
Sbjct: 30 LGKGTY-------GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 418 RLSGFCVHEGNTYLVYEFADNGALSDWLHSN--RYQTSDNLTWKQRVQIAYDVANALNYL 475
+ G G + E G+LS L S + ++ + L YL
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI----GFYTKQILEGLKYL 138
Query: 476 HKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGLA-RSAESDEHEQGGYGLQLTRHVVGT 533
H VH+++K N+L++T + KI++FG + R A + + GT
Sbjct: 139 HDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---------FTGT 186
Query: 534 YGYMAPEYIENGVI--TPKLDVFAFGVVVLELLSGR 567
YMAPE I+ G D+++ G ++E+ +G+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 55/261 (21%), Positives = 87/261 (33%), Gaps = 68/261 (26%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK------------GDVSSEI 405
Y + I GS+ G V A+K+M + +E+
Sbjct: 28 YHLKG-AIGQGSY-------GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL-------------------- 445
++KK++H NI RL E LV E G L D L
Sbjct: 80 RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 446 ---------------HSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
H R K I + +AL+YLH H+++K
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKP 196
Query: 491 SNILL--DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-- 546
N L + + K+ +FGL++ + + GT ++APE +
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY----YGMTTKAGTPYFVAPEVLNTTNES 252
Query: 547 ITPKLDVFAFGVVVLELLSGR 567
PK D ++ GV++ LL G
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGA 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 9e-22
Identities = 43/210 (20%), Positives = 75/210 (35%), Gaps = 40/210 (19%)
Query: 380 GSVYRG---SFKGDDAAVKVMK--GDVS------SEINILKKINHSNIIRLSGFCVHEGN 428
G +Y + G +K + GD +E L ++ H +I+++ F H
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153
Query: 429 T-----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPY 483
Y+V E+ +L L + + ++ AL+YLH
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGL 203
Query: 484 VHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE 543
V+ +LK NI+L + K+ + G S ++ GT G+ APE +
Sbjct: 204 VYNDLKPENIMLTEE-QLKLIDLGAVSRINS------------FGYLYGTPGFQAPEIVR 250
Query: 544 NGVITPKLDVFAFGVVVLELLSGREAVTGD 573
G T D++ G + L G
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLPTRNGR 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 40/351 (11%), Positives = 79/351 (22%), Gaps = 80/351 (22%)
Query: 335 SLFPQASNSLSHPQGFRSAVESLTLYKFQDLK----IATGSFSEENRIQGSVYRGSFK-- 388
+ +A + PQ + V+SL + LK + G V+
Sbjct: 34 AAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR-------SVVFLVRDVER 86
Query: 389 GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFC--------------- 423
+D A+KV + ++ +
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 424 -----------VHEGNTYLVYEFADNGALSDWLHSNRYQTSDN--LTWKQRVQIAYDVAN 470
N L+ A L + + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIR 205
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
L VH + N+ + + R + + +
Sbjct: 206 LAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----------RGPAS 251
Query: 531 VGTYGYMAPEYI--ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588
Y E++ T L+ + G+ + + L + ++
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF------------LPFGLVTPG 299
Query: 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
++ S R LR SL L + L D R E
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 367 IATGSFSEENRIQGSVYRG--SFKGDDAAVKVM---------KGDVSSEINILKKINHSN 415
I G+F V G + A+K++ + E+ I+K +NH N
Sbjct: 23 IGKGNF-------AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
I++L E YL+ E+A G + D+L ++ + K+ + +A+ Y
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-----MKEKEARSKFRQIVSAVQYC 130
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
H+ VH++LK N+LLD ++ KI +FG S+E G G
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGF-----SNEFTVG----GKLDAFCGAPP 178
Query: 536 YMAPEYIEN-GVITPKLDVFAFGVVVLELLSGR 567
Y APE + P++DV++ GV++ L+SG
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM-------KGDVSSEINILKK 410
++ + ++ G+F G VY+ K G AA KV+ D EI IL
Sbjct: 20 VWEIVGELGDGAF-------GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT 72
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY---D 467
+H I++L G H+G +++ EF GA+ + ++ QI
Sbjct: 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQ 125
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+ ALN+LH +H++LK N+L+ ++ +FG+ SA++ + L
Sbjct: 126 MLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGV--SAKNLK--------TLQ 172
Query: 528 RH--VVGTYGYMAPEYIENGVIT-----PKLDVFAFGVVVLELLSG 566
+ +GT +MAPE + + K D+++ G+ ++E+
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 47/244 (19%), Positives = 95/244 (38%), Gaps = 36/244 (14%)
Query: 338 PQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AV 394
P+ F+ K + GSF +V A+
Sbjct: 8 PRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSF-------STVVLARELATSREYAI 60
Query: 395 KVMKGD----------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
K+++ V+ E +++ +++H ++L + Y +A NG L +
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 445 LHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503
+ + + D + ++ +AL YLH +H++LK NILL+ ++ +I
Sbjct: 121 I--RKIGSFDE----TCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQI 171
Query: 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563
T+FG A+ + + VGT Y++PE + D++A G ++ +L
Sbjct: 172 TDFGTAKVLSPESKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225
Query: 564 LSGR 567
++G
Sbjct: 226 VAGL 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 53/276 (19%), Positives = 93/276 (33%), Gaps = 39/276 (14%)
Query: 308 NSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVES-----LTLYKF 362
+ P P P P P TP + P +S ++ + YK
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 363 QDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM--KGDVSSEINILKKI-NHSNII 417
+ G G V + K + A+K++ E+ + + +I+
Sbjct: 66 TSQVLGLGIN-------GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 118
Query: 418 RLSGFC----VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
R+ +V E D G L + + T ++ +I + A+
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQ 175
Query: 474 YLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
YLH H+++K N+L N K+T+FG A+ S
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---------P 223
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
T Y+APE + D+++ GV++ LL G
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 45/233 (19%)
Query: 356 SLTLYKFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS--------E 404
T +DL +I G++ GSV + K G AVK ++ V +
Sbjct: 18 DFTAEDLKDLGEIGRGAY-------GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 405 INILKK-INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
++++ + + I++ G EG+ ++ E + + D + + +
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
I ALN+L + +H+++K SNILLD + K+ +FG++
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG------------- 174
Query: 524 LQLT-----RHVVGTYGYMAPEYIENGVITP----KLDVFAFGVVVLELLSGR 567
QL G YMAPE I+ + DV++ G+ + EL +GR
Sbjct: 175 -QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 31/180 (17%), Positives = 56/180 (31%), Gaps = 31/180 (17%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEG--NTYLVYEFA--DNGALSDWLHSNRYQTSDNLTW 458
+++K +IR+ + + +Y + + L S T +L
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVH 205
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
R+Q+ V L LH Y VH L+ +I+LD +T F
Sbjct: 206 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD------ 256
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYI-----------ENGVITPKLDVFAFGVVVLELLSGR 567
+ G+ PE ++T D +A G+V+ +
Sbjct: 257 ------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 53/250 (21%), Positives = 95/250 (38%), Gaps = 44/250 (17%)
Query: 337 FPQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRG--SFKGDDAAV 394
+ ++ E Y + +G+F G V+ K + V
Sbjct: 3 LEEPPKAVELEGLAACEGEYSQKYSTMSP-LGSGAF-------GFVWTAVDKEKNKEVVV 54
Query: 395 KVMK---------------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNG 439
K +K G V+ EI IL ++ H+NII++ ++G LV E +G
Sbjct: 55 KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG 114
Query: 440 A-LSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498
L ++ + L I + +A+ YL +H+++K NI++ +
Sbjct: 115 LDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAED 166
Query: 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-NGVITPKLDVFAFG 557
K+ +FG A E + L GT Y APE + N P+L++++ G
Sbjct: 167 FTIKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLG 217
Query: 558 VVVLELLSGR 567
V + L+
Sbjct: 218 VTLYTLVFEE 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 367 IATGSFSEENRIQGSVYRG--SFKGDDAAVKV----------MKGDVSSEINILKKINHS 414
+ G+F G V G G AVK+ + G + EI LK H
Sbjct: 19 LGVGTF-------GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 415 NIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
+II+L + V T ++V E+ G L D++ + + QI +A+
Sbjct: 72 HIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QIL----SAV 124
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
+Y H++ VH++LK N+LLD ++ AKI +FGL S+ G + L+ + G
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-----SNMMSDGEF-LRTS---CG 172
Query: 533 TYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGR 567
+ Y APE I P++D+++ GV++ LL G
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 44/234 (18%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 356 SLTLYKFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS--------E 404
+ ++L ++ +G+ G V++ F+ G AVK M+ + +
Sbjct: 21 QAEINDLENLGEMGSGTC-------GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 405 INILKK-INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
++++ K + I++ G + + ++ E A + + + +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-----RMQGPIPERILGK 128
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
+ + AL YL + +H+++K SNILLD + K+ +FG++
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISG------------- 173
Query: 524 LQLTRHV-----VGTYGYMAPEYIENGVI-----TPKLDVFAFGVVVLELLSGR 567
+L G YMAPE I+ + DV++ G+ ++EL +G+
Sbjct: 174 -RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 38/219 (17%), Positives = 81/219 (36%), Gaps = 35/219 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM--KGDVSSEINILKKI-NHS 414
Y+ + G G V + G A+K++ E++ +
Sbjct: 30 YQLSKQVLGLGVN-------GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGP 82
Query: 415 NIIRLSGFC----VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
+I+ + + ++ E + G L + + T ++ +I D+
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGT 139
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
A+ +LH + H+++K N+L + + K+T+FG A+ +
Sbjct: 140 AIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----------L 186
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
+ T Y+APE + D+++ GV++ LL G
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 60/238 (25%)
Query: 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK------GDVSSEINILK 409
+++ + + G++ G VY+G G AA+KVM ++ EIN+LK
Sbjct: 24 GIFELVE-LVGNGTY-------GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK 75
Query: 410 KI-NHSNIIRLSG------FCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
K +H NI G + +LV EF G+++D + + + T
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE------E 129
Query: 463 QIAY---DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
IAY ++ L++LH++ +H+++K N+LL N K+ +FG++
Sbjct: 130 WIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSA--------- 177
Query: 520 GGYGLQLTRH------VVGTYGYMAPEYIENGVIT-----PKLDVFAFGVVVLELLSG 566
QL R +GT +MAPE I K D+++ G+ +E+ G
Sbjct: 178 -----QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 29/191 (15%)
Query: 389 GDDAAVKV--------MKGDVSSEINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADN 438
+ AVK+ ++ EI I K +NH N+++ + YL E+
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--YGHRREGNIQYLFLEYCSG 89
Query: 439 GALSDWLHSN-RYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
G L D + + D + Q+ + YLH H+++K N+LLD
Sbjct: 90 GELFDRIEPDIGMPEPDAQRFFH--QLM----AGVVYLHGIG---ITHRDIKPENLLLDE 140
Query: 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAF 556
KI++FGL + + + L + GT Y+APE ++ +DV++
Sbjct: 141 RDNLKISDFGL--ATVFRYNNRER----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 557 GVVVLELLSGR 567
G+V+ +L+G
Sbjct: 195 GIVLTAMLAGE 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 44/227 (19%), Positives = 89/227 (39%), Gaps = 46/227 (20%)
Query: 362 FQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS--------EINILKK 410
+ + ++ G++ G V + G AVK ++ V+S +++I +
Sbjct: 9 LEPIMELGRGAY-------GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 411 -INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
++ + G EG+ ++ E D D + + +IA +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR- 528
AL +LH + +H+++K SN+L++ + K+ +FG++ L
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG--------------YLVDD 163
Query: 529 ----HVVGTYGYMAPEYIENGVITP----KLDVFAFGVVVLELLSGR 567
G YMAPE I + K D+++ G+ ++EL R
Sbjct: 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 52/229 (22%), Positives = 86/229 (37%), Gaps = 46/229 (20%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRG--SFKGDDAAVKVMK-----------GDVSSEIN 406
Y DL + GS+ G V S AVK++K +V EI
Sbjct: 7 YLMGDL-LGEGSY-------GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQ 58
Query: 407 ILKKINHSNIIRLSGFCVHEGNT----YLVYEFADNGA--LSDWLHSNRYQTSDNLTWKQ 460
+L+++ H N+I+L V Y+V E+ G + D + R+ +
Sbjct: 59 LLRRLRHKNVIQL--VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
Q+ + L YLH VHK++K N+LL T KI+ G+ +
Sbjct: 117 --QLI----DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV--AEALHPFAAD 165
Query: 521 GYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGR 567
R G+ + PE K+D+++ GV + + +G
Sbjct: 166 D----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 53/227 (23%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK----------GDVSSEINI 407
F DL +I GSF G+VY + A+K M D+ E+
Sbjct: 55 LFSDLREIGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY- 466
L+K+ H N I+ G + E +LV E+ G+ SD L ++ + +IA
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV-------EIAAV 159
Query: 467 --DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
L YLH + +H+++K NILL K+ +FG A
Sbjct: 160 THGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSAS-------------- 202
Query: 525 QLTRH--VVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSG 566
+ VGT +MAPE I + G K+DV++ G+ +EL
Sbjct: 203 IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 29/191 (15%)
Query: 389 GDDAAVKV--------MKGDVSSEINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADN 438
+ AVK+ ++ EI I K +NH N+++ + YL E+
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--YGHRREGNIQYLFLEYCSG 89
Query: 439 GALSDWLHSN-RYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
G L D + + D + Q+ + YLH H+++K N+LLD
Sbjct: 90 GELFDRIEPDIGMPEPDAQRFFH--QLM----AGVVYLHGIG---ITHRDIKPENLLLDE 140
Query: 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAF 556
KI++FGL + + + L + GT Y+APE ++ +DV++
Sbjct: 141 RDNLKISDFGL--ATVFRYNNRER----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 557 GVVVLELLSGR 567
G+V+ +L+G
Sbjct: 195 GIVLTAMLAGE 205
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 8e-19
Identities = 29/179 (16%), Positives = 55/179 (30%), Gaps = 30/179 (16%)
Query: 403 SEINILKKINHSNIIRLSGFCVHEG--NTYLVYEFA--DNGALSDWLHSNRYQTSDNLTW 458
+++K +IR+ + + +Y + + L S T +L
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVH 210
Query: 459 KQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHE 518
R+Q+ V L LH Y VH L+ +I+LD +T F +
Sbjct: 211 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---- 263
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYI----------ENGVITPKLDVFAFGVVVLELLSGR 567
+ G+ PE ++T D + G+ + +
Sbjct: 264 --------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 58/274 (21%)
Query: 340 ASNSLSHPQGFRSAVESL---TLYKFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAA 393
+ H G E+L ++ K+++L + GS+ G V + K G A
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSY-------GMVMKCRNKDTGRIVA 54
Query: 394 VKVMKGD-----VSS----EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDW 444
+K V EI +LK++ H N++ L C + YLV+EF D+ + D
Sbjct: 55 IKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDD 113
Query: 445 LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504
L + L ++ + + + N + + H + +H+++K NIL+ + K+
Sbjct: 114 LELFP----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLC 166
Query: 505 NFGLARSAESDEHEQGGYGLQLTR--HVVGTYGYMAPE-------YIENGVITPKLDVFA 555
+FG AR+ V T Y APE Y +DV+A
Sbjct: 167 DFGFART----------LAAPGEVYDDEVATRWYRAPELLVGDVKY------GKAVDVWA 210
Query: 556 FGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
G +V E+ G GD + + LY I L
Sbjct: 211 IGCLVTEMFMGEPLFPGD--SDIDQLY-HIMMCL 241
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 60/241 (24%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKGDVSS-----EINILK 409
L++++ K+ G++ G VY+ K D A+K ++G S EI +L+
Sbjct: 21 LFEYEGCKVGRGTY-------GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR 73
Query: 410 KINHSNIIRLSGFCVHEGNT--YLVYEFADN---GALSDWLHSNRYQTSDNLTWKQRVQI 464
++ H N+I L + + +L++++A++ + S + L +
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 465 AYDVANALNYLHKYTNPPYV-HKNLKTSNILLDTNLRA----KITNFGLARSAESDEHEQ 519
Y + + ++YLH +V H++LK +NIL+ KI + G AR
Sbjct: 134 LYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGFARL-------- 181
Query: 520 GGYGL------QLTRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSG 566
+ L VV T+ Y APE Y T +D++A G + ELL+
Sbjct: 182 --FNSPLKPLADLDPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS 232
Query: 567 R 567
Sbjct: 233 E 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 367 IATGSFSEENRIQGSVYRG--SFKGDDAAVKV----------MKGDVSSEINILKKINHS 414
+ GSF G V A+K M V EI+ LK + H
Sbjct: 17 LGEGSF-------GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 415 NIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
+II+L + V T +V E+A G L D++ + T D + QI A+
Sbjct: 70 HIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QII----CAI 121
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
Y H++ VH++LK N+LLD NL KI +FGL+ L+ + G
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF------LKTS---CG 169
Query: 533 TYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGR 567
+ Y APE I P++DV++ G+V+ +L GR
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 367 IATGSFSEENRIQGSVYRG--SFKGDDAAVKV----------MKGDVSSEINILKKINHS 414
+ G+F G V G G AVK+ + G + EI LK H
Sbjct: 24 LGVGTF-------GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 415 NIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
+II+L + V + ++V E+ G L D++ N + QI + +
Sbjct: 77 HIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QIL----SGV 129
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
+Y H++ VH++LK N+LLD ++ AKI +FGL S+ G + L+ + G
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL-----SNMMSDGEF-LRTS---CG 177
Query: 533 TYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGR 567
+ Y APE I P++D+++ GV++ LL G
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 73/335 (21%), Positives = 131/335 (39%), Gaps = 84/335 (25%)
Query: 338 PQASNSLSHPQGFRSAVESLTLYKFQDL-KIATGSFSEENRIQGSVYRGSFK-GDDAAVK 395
+S F+ +E K+Q L K+ G++ G VY+ G A+K
Sbjct: 4 HHHHSSGRENLYFQGLME-----KYQKLEKVGEGTY-------GVVYKAKDSQGRIVALK 51
Query: 396 VMKGDVSS---------EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLH 446
++ D EI++LK+++H NI+ L E LV+EF + L L
Sbjct: 52 RIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLD 110
Query: 447 SNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV-HKNLKTSNILLDTNLRAKITN 505
N+ L Q Y + + + H++ + H++LK N+L++++ K+ +
Sbjct: 111 ENK----TGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLAD 162
Query: 506 FGLARSAESDEHEQGGYGL---QLTRHVVGTYGYMAPE-------YIENGVITPKLDVFA 555
FGLAR+ +G+ T VV T Y AP+ Y + +D+++
Sbjct: 163 FGLARA----------FGIPVRSYTHEVV-TLWYRAPDVLMGSKKY------STSVDIWS 205
Query: 556 FGVVVLELLSGREAVTGDQNCEAELLYASISRVL----EES--NVRE-------KLRGFI 602
G + E+++G+ G + + L I +L V+E + F
Sbjct: 206 IGCIFAEMITGKPLFPGV--TDDDQLP-KIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 603 DPSLRNEYP------LDLAFSMAQL--AKNCTAHD 629
+ P +DL +M K +A D
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 78/373 (20%), Positives = 126/373 (33%), Gaps = 112/373 (30%)
Query: 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDD-------AAVKVMKGDVS----- 402
+ L L K + G+F G V G D AVK++K +
Sbjct: 22 DRLKLGK----PLGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 70
Query: 403 ---SEINILKKI-NHSNIIRLSGFCVHEGN-TYLVYEFADNGALSDWLHSNRYQTSDNLT 457
SE+ IL I +H N++ L G C G ++ EF G LS +L S R + T
Sbjct: 71 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130
Query: 458 WKQRVQIAYDVANA----------------------------LNYLHKYTNPPYVHKNLK 489
R + D A L+ + + P ++K+
Sbjct: 131 KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFL 190
Query: 490 TS------------------------------NILLDTNLRAKITNFGLARSA-ESDEHE 518
T NILL KI +FGLAR + ++
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 519 QGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578
+ G + +MAPE I + V T + DV++FGV++ E+ S
Sbjct: 251 RKGDARLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LG 292
Query: 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638
Y + + E+ + R P M Q +C + + RP+ SE
Sbjct: 293 ASPYPGVK-------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 345
Query: 639 VFVTLSKIWSSSS 651
+ L + +++
Sbjct: 346 LVEHLGNLLQANA 358
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 36/193 (18%)
Query: 389 GDDAAVKV------MKGDVSSEINILKKINHSNIIRLSGFCVHEGNT--YLVYEFADNGA 440
+ AVK + +V EI + + H NI+R V T ++ E+A G
Sbjct: 45 KELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGE 102
Query: 441 LSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-- 498
L + + + + D + + Q+ + ++Y H H++LK N LLD +
Sbjct: 103 LYERICNAGRFSEDEARFFFQ-QL----LSGVSYCHSMQ---ICHRDLKLENTLLDGSPA 154
Query: 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN----GVITPKLDVF 554
R KI +FG ++S+ + VGT Y+APE + G DV+
Sbjct: 155 PRLKICDFGYSKSSVLHS---------QPKSTVGTPAYIAPEVLLRQEYDG---KIADVW 202
Query: 555 AFGVVVLELLSGR 567
+ GV + +L G
Sbjct: 203 SCGVTLYVMLVGA 215
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 57/251 (22%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK------GDVSS---EINIL 408
K++ + KI GS+ G V++ + G A+K EI +L
Sbjct: 4 KYEKIGKIGEGSY-------GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRML 56
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ-IAYD 467
K++ H N++ L + +LV+E+ D+ + L + ++L V+ I +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHL-----VKSITWQ 110
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
A+N+ HK+ +H+++K NIL+ + K+ +FG AR
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARL----------LTGPSD 157
Query: 528 R--HVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578
V T Y +PE Y P +DV+A G V ELLSG G +
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGVPLWPGK--SDV 209
Query: 579 ELLYASISRVL 589
+ LY I + L
Sbjct: 210 DQLY-LIRKTL 219
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 61/279 (21%), Positives = 116/279 (41%), Gaps = 69/279 (24%)
Query: 338 PQASNSLSHPQGFRSAVESLTLYKFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAV 394
S S+S S + +++ + K+ G++ G VY+ + A+
Sbjct: 18 GPGSMSVSAAPSATS------IDRYRRITKLGEGTY-------GEVYKAIDTVTNETVAI 64
Query: 395 KVMKGDVSS---------EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL 445
K ++ + E+++LK++ H NII L H +L++E+A+N L ++
Sbjct: 65 KRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM 123
Query: 446 HSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA---- 501
N +++ + Y + N +N+ H +H++LK N+LL + +
Sbjct: 124 DKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPV 175
Query: 502 -KITNFGLARSAESDEHEQGGYGL---QLTRHVVGTYGYMAPE-------YIENGVITPK 550
KI +FGLAR+ +G+ Q T ++ T Y PE Y +
Sbjct: 176 LKIGDFGLARA----------FGIPIRQFTHEII-TLWYRPPEILLGSRHY------STS 218
Query: 551 LDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
+D+++ + E+L GD E + L+ I VL
Sbjct: 219 VDIWSIACIWAEMLMKTPLFPGD--SEIDQLFK-IFEVL 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 72/297 (24%)
Query: 380 GSVYRGSFK--GDDAAVKVMKGD------VSS--EINILKKINHSNIIRLSGFCVHEGNT 429
+VY+G K G A+K +K D ++ EI+++K++ H NI+RL E
Sbjct: 19 ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL 78
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ-IAYDVANALNYLHKYTNPPYVHKNL 488
LV+EF DN L ++ S + V+ + + L + H+ +H++L
Sbjct: 79 TLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDL 134
Query: 489 KTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL---QLTRHVVGTYGYMAPE----- 540
K N+L++ + K+ +FGLAR+ +G+ + VV T Y AP+
Sbjct: 135 KPQNLLINKRGQLKLGDFGLARA----------FGIPVNTFSSEVV-TLWYRAPDVLMGS 183
Query: 541 --YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL----EES-- 592
Y + +D+++ G ++ E+++G+ G + E L I ++ E
Sbjct: 184 RTY------STSIDIWSCGCILAEMITGKPLFPGT--NDEEQLK-LIFDIMGTPNESLWP 234
Query: 593 ------------------NVREKLRGFIDPSLRNEYPLDLAFSMAQL--AKNCTAHD 629
++R+ L+ L + +D + QL +A
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL-DGNLMDFLHGLLQLNPDMRLSAKQ 290
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 63/311 (20%), Positives = 119/311 (38%), Gaps = 77/311 (24%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD------VSS--EINILK 409
+ L K+ G++ +VY+G K + A+K ++ + ++ E+++LK
Sbjct: 3 TYIKLDKLGEGTY-------ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK 55
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
+ H+NI+ L E + LV+E+ D L +L + + + +
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDC----GNIINMHNVKLFLFQLL 110
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL---QL 526
L Y H+ +H++LK N+L++ K+ +FGLAR+ +
Sbjct: 111 RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA----------KSIPTKTY 157
Query: 527 TRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579
VV T Y P+ Y + ++D++ G + E+ +GR G E
Sbjct: 158 DNEVV-TLWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGRPLFPGS--TVEE 208
Query: 580 LLYASISRVL----EES--NVRE-------KLRGFIDPSLRNEYP------LDLAFSMAQ 620
L+ I R+L EE+ + + +L + P DL + Q
Sbjct: 209 QLHF-IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQ 267
Query: 621 L--AKNCTAHD 629
+A D
Sbjct: 268 FEGRNRISAED 278
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 66/303 (21%), Positives = 124/303 (40%), Gaps = 62/303 (20%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EINIL 408
K++ L KI G+F G V++ + G A+K + + EI IL
Sbjct: 18 KYEKLAKIGQGTF-------GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 70
Query: 409 KKINHSNIIRLSGFCV--------HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
+ + H N++ L C +G+ YLV++F ++ L+ L + + T +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVK----FTLSE 125
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
++ + N L Y+H+ +H+++K +N+L+ + K+ +FGLAR+ ++ Q
Sbjct: 126 IKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 521 GYGLQLTRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
+ T VV T Y PE Y P +D++ G ++ E+ + + G+
Sbjct: 183 N---RYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRSPIMQGN 232
Query: 574 QNCEAELLYASISRVL----EES--NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTA 627
E L IS++ E NV + L + + ++ A
Sbjct: 233 T--EQHQLAL-ISQLCGSITPEVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYA 288
Query: 628 HDL 630
DL
Sbjct: 289 LDL 291
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 6e-17
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 380 GSVYRGSFK-GDDAAVKVMKGD-----VSS----EINILKKINHSNIIRLSGFCVHEGNT 429
G VY+ G+ A+K ++ + + S EI+ILK++ HSNI++L +
Sbjct: 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489
LV+E D L L L + N + Y H +H++LK
Sbjct: 76 VLVFEHLDQD-LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLK 127
Query: 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL---QLTRHVVGTYGYMAPE------ 540
N+L++ KI +FGLAR+ +G+ + T +V T Y AP+
Sbjct: 128 PQNLLINREGELKIADFGLARA----------FGIPVRKYTHEIV-TLWYRAPDVLMGSK 176
Query: 541 -YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
Y + +D+++ G + E+++G G EA+ L I R+L
Sbjct: 177 KY------STTIDIWSVGCIFAEMVNGTPLFPGV--SEADQLM-RIFRIL 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-17
Identities = 49/227 (21%), Positives = 92/227 (40%), Gaps = 34/227 (14%)
Query: 355 ESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV---------- 401
+ + F D + + G F G V+ K A K +
Sbjct: 180 QPMGEDWFLDFRVLGRGGF-------GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 402 SSEINILKKINHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
E IL K++ I+ L+ + + + LV + G + ++ N + + +
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPR 290
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+ + + L +LH+ ++++LK N+LLD + +I++ GLA E + G
Sbjct: 291 AIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV-----ELKAG 342
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
T+ GT G+MAPE + +D FA GV + E+++ R
Sbjct: 343 Q---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 8e-17
Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 70/292 (23%)
Query: 380 GSVYRGSFK--GDDAAVKVMKGDVSS---------EINILKKINHSNIIRLSGFCVHEGN 428
G+V++ + + A+K ++ D EI +LK++ H NI+RL +
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNL 488
LV+EF D L + S +L + + + L + H +H++L
Sbjct: 76 LTLVFEFCDQD-LKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDL 127
Query: 489 KTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL---QLTRHVVGTYGYMAPE----- 540
K N+L++ N K+ NFGLAR+ +G+ + VV T Y P+
Sbjct: 128 KPQNLLINRNGELKLANFGLARA----------FGIPVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 541 --YIENGVITPKLDVFAFGVVVLELLSGREAV-TGDQNCEAELLYASISRVL----EES- 592
Y + +D+++ G + EL + + G+ + L I R+L EE
Sbjct: 177 KLY------STSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLK-RIFRLLGTPTEEQW 227
Query: 593 -------NVREKLRGFIDPSLRNEYP------LDLAFSMAQL--AKNCTAHD 629
+ + SL N P DL ++ + + +A +
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 60/262 (22%), Positives = 102/262 (38%), Gaps = 48/262 (18%)
Query: 321 RVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQ 379
V P LD ++ F Q P +T F+ + + G F
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQP---------VTKNTFRQYRVLGKGGF------- 197
Query: 380 GSVYRGSFKGDDA--AVKVMKGDV----------SSEINILKKINHSNIIRLSGFCVH-E 426
G V + A K ++ +E IL+K+N ++ L+ + +
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETK 256
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVH 485
LV + G L ++ + R A ++ L LH+ V+
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFP----EARAVFYAAEICCGLEDLHRER---IVY 309
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
++LK NILLD + +I++ GLA +G Q + VGT GYMAPE ++N
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV-----HVPEG----QTIKGRVGTVGYMAPEVVKNE 360
Query: 546 VITPKLDVFAFGVVVLELLSGR 567
T D +A G ++ E+++G+
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 52/284 (18%), Positives = 97/284 (34%), Gaps = 65/284 (22%)
Query: 307 RNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK 366
+ + + ++ G P L + S Y+ L
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLH-------ATKLAPGKEKEPLES------QYQVGPL- 50
Query: 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-------------GDVSSEINILKKI 411
+ +G F GSVY G A+K ++ V E+ +LKK+
Sbjct: 51 LGSGGF-------GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 412 NHS--NIIRLSGFCVHEGNTYLVYEFADN-GALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
+ +IRL + + L+ E + L D++ L + + V
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQV 158
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAESDEHEQGGYGLQLT 527
A+ + H +H+++K NIL+D N K+ +FG + Y
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS-----GALLKDTVY----- 205
Query: 528 RHVVGTYGYMAPEYIE----NGVITPKLDVFAFGVVVLELLSGR 567
GT Y PE+I +G V++ G+++ +++ G
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHG---RSAAVWSLGILLYDMVCGD 246
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 23/171 (13%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT-----YLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI IL + H NII ++ Y+V + + +D L+ + + +L+
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TD-LY--KLLKTQHLS- 126
Query: 459 KQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
+ Y + L Y+H + +H++LK SN+LL+T KI +FGLAR A+ D
Sbjct: 127 NDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
G LT +V T Y APE + N T +D+++ G ++ E+LS R
Sbjct: 184 HTG----FLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 48/171 (28%), Positives = 71/171 (41%), Gaps = 25/171 (14%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT-----YLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI +L +H NI+ L VH YLV E L+ +H R S
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISP---- 133
Query: 459 KQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
Q +Q Y + L+ LH VH++L NILL N I +F LAR +D +
Sbjct: 134 -QHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
T +V Y APE + T +D+++ G V+ E+ + +
Sbjct: 190 --------KTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 404 EINILKKINHSNIIRL-----SGFCVHEGN-TYLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ ++K +NH NII L + E Y+V E D ++ L L
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQVIQM---ELD 125
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+R+ + Y + + +LH + +H++LK SNI++ ++ KI +FGLAR+A +
Sbjct: 126 -HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+T +VV T Y APE I +D+++ G ++ E++ G
Sbjct: 182 M--------MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 53/262 (20%), Positives = 96/262 (36%), Gaps = 41/262 (15%)
Query: 320 GRVPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRI 378
G K + F + + + + L +F +K + TGSF
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF------ 54
Query: 379 QGSVYRGSFKGDDA--AVKVMKGD----------VSSEINILKKINHSNIIRLSGFCVHE 426
G V K A+K++ +E IL+ +N +++L
Sbjct: 55 -GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVH 485
N Y+V E+ G + + H R + A + YLH ++
Sbjct: 114 SNLYMVMEYVAGGEM--FSHLRRIGRFSE----PHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
++LK N+L+D ++T+FG A+ + T + GT +APE I +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWTLCGTPEALAPEIILSK 213
Query: 546 VITPKLDVFAFGVVVLELLSGR 567
+D +A GV++ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGY 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 65/257 (25%), Positives = 102/257 (39%), Gaps = 61/257 (23%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
EI +L++++H NII L H+ N LV++F + L + N LT
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLV----LTPSHIKA 116
Query: 464 IAYDVANALNYLHKYTNPPYV-HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
L YLH++ ++ H++LK +N+LLD N K+ +FGLA+S +
Sbjct: 117 YMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKS----------F 162
Query: 523 GL---QLTRHVVGTYGYMAPE-------YIENGVITPKLDVFAFGVVVLELLSGREAVTG 572
G T VV T Y APE Y +D++A G ++ ELL + G
Sbjct: 163 GSPNRAYTHQVV-TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRVPFLPG 215
Query: 573 DQNCEAELLYASISRVL----EES--NVREKLRGFID------PSLRNEYP------LDL 614
D + + L I L EE ++ L ++ L + + LDL
Sbjct: 216 D--SDLDQLT-RIFETLGTPTEEQWPDMC-SLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271
Query: 615 AFSMAQL--AKNCTAHD 629
+ TA
Sbjct: 272 IQGLFLFNPCARITATQ 288
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 50/255 (19%), Positives = 85/255 (33%), Gaps = 54/255 (21%)
Query: 338 PQASNSLSHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGS--FKGDDAAVK 395
P + + P G + Y+ L + G F G+V+ G A+K
Sbjct: 11 PAPPGTPTPPPGGKDREAFEAEYRLGPL-LGKGGF-------GTVFAGHRLTDRLQVAIK 62
Query: 396 VM-------------KGDVSSEINILKKIN----HSNIIRLSGFCVHEGNTYLVYEFADN 438
V+ E+ +L K+ H +IRL + + LV E
Sbjct: 63 VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLP 122
Query: 439 GA-LSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497
L D++ L V A+ + H VH+++K NIL+D
Sbjct: 123 AQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174
Query: 498 -NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE----NGVITPKLD 552
AK+ +FG Y GT Y PE+I +
Sbjct: 175 RRGCAKLIDFGS-----GALLHDEPY-----TDFDGTRVYSPPEWISRHQYHA---LPAT 221
Query: 553 VFAFGVVVLELLSGR 567
V++ G+++ +++ G
Sbjct: 222 VWSLGILLYDMVCGD 236
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 30/172 (17%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT------YLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ +LK + H N+I L + YLV F +D L + + L
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TD-LG--KLMKHEKLG 126
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+ R+Q + Y + L Y+H +H++LK N+ ++ + KI +FGLAR A+S+
Sbjct: 127 -EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
+T +VV T Y APE I N + T +D+++ G ++ E+++G+
Sbjct: 182 ---------MTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT------YLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ ++K +NH NII L + YLV E D ++ L Q
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LC----QVIQMEL 161
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+R+ + Y + + +LH +H++LK SNI++ ++ KI +FGLAR+A +
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+T +VV T Y APE I +D+++ G ++ E++ +
Sbjct: 219 M--------MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 39/245 (15%)
Query: 338 PQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AV 394
S + +T+ +F+ LK + G+F G V K A+
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTF-------GKVILVKEKATGRYYAM 178
Query: 395 KVMKGDV----------SSEINILKKINHSNIIRLSGFCVH-EGNTYLVYEFADNGALSD 443
K++K +V +E +L+ H + L + V E+A+ G L
Sbjct: 179 KILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFF 237
Query: 444 WLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502
L R + D R + ++ +AL+YLH N V+++LK N++LD + K
Sbjct: 238 HLSRERVFSED------RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIK 289
Query: 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLE 562
IT+FGL + D + GT Y+APE +E+ +D + GVV+ E
Sbjct: 290 ITDFGLCKEGIKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 563 LLSGR 567
++ GR
Sbjct: 342 MMCGR 346
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 51/250 (20%), Positives = 93/250 (37%), Gaps = 46/250 (18%)
Query: 355 ESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV---------- 401
LT+ F + I G F G VY A+K +
Sbjct: 184 IHLTMNDFSVHRIIGRGGF-------GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA 236
Query: 402 SSEINILKKINHSN---IIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
+E +L ++ + I+ +S + H + + + G L L + +
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA--- 292
Query: 458 WKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
++ A ++ L ++H V+++LK +NILLD + +I++ GLA +
Sbjct: 293 ---DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQN 575
VGT+GYMAPE ++ GV D F+ G ++ +LL G +
Sbjct: 347 ----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396
Query: 576 CEAELLYASI 585
+ +
Sbjct: 397 KDKHEIDRMT 406
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 404 EINILKKINHSNIIRL--------------SGFCVHEGNTYLVYEFADNGALSDWLHSNR 449
EI I+++++H NI+++ G + Y+V E+ + +D L
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LA--N 110
Query: 450 YQTSDNLTWKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFG 507
L ++ + Y + L Y+H + +H++LK +N+ ++T +L KI +FG
Sbjct: 111 VLEQGPLL-EEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSG 566
LAR + +G L+ +V T Y +P + + T +D++A G + E+L+G
Sbjct: 167 LARIMDPHYSHKG----HLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
Query: 567 R 567
+
Sbjct: 222 K 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 44/230 (19%)
Query: 357 LTLYKFQDLK-IATGSFSE----ENRIQGSVYRGSFKGDDAAVKVMK-------GDVS-- 402
+ ++ +K I G+F E ++ VY A+K++ D +
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY---------AMKLLSKFEMIKRSDSAFF 116
Query: 403 -SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
E +I+ N +++L + Y+V E+ G L + + + Y + R
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA---R 171
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
A +V AL+ +H ++H+++K N+LLD + K+ +FG +
Sbjct: 172 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM-------KMNK 220
Query: 522 YGLQLTRHVVGTYGYMAPEYIEN----GVITPKLDVFAFGVVVLELLSGR 567
G+ VGT Y++PE +++ G + D ++ GV + E+L G
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT-----YLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI ILK H NII + + Y++ E +D LH R ++ L+
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TD-LH--RVISTQMLS- 110
Query: 459 KQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
+Q Y A+ LH +H++LK SN+L+++N K+ +FGLAR +
Sbjct: 111 DDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 518 ---EQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
E G + V T Y APE + + +DV++ G ++ EL R
Sbjct: 168 DNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 31/172 (18%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT------YLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ +LK + H N+I L + YLV F +D L +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGL---KFS 124
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
++++Q + Y + L Y+H + VH++LK N+ ++ + KI +FGLAR A+++
Sbjct: 125 -EEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
+T +VV T Y APE I + + +D+++ G ++ E+L+G+
Sbjct: 180 ---------MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 30/172 (17%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT------YLVYEFADNGALSDWLHSNRYQTSDNLT 457
E+ +LK + H N+I L + YLV +D L+ LT
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LN--NIVKCQKLT 130
Query: 458 WKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
VQ + Y + L Y+H + +H++LK SN+ ++ + KI +FGLAR +
Sbjct: 131 -DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
+T +V T Y APE + N + +D+++ G ++ ELL+GR
Sbjct: 186 ---------MTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 54/236 (22%)
Query: 355 ESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD----------V 401
E + F+ L+ I GSF G V A+K M V
Sbjct: 10 EDVNFDHFEILRAIGKGSF-------GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 402 SSEINILKKINHSNIIRLSGFCVH-----EGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
E+ I++ + H ++ L E + ++V + G L RY N+
Sbjct: 63 FKELQIMQGLEHPFLVNL-----WYSFQDEEDMFMVVDLLLGGDL-------RYHLQQNV 110
Query: 457 TWK-QRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514
+K + V++ ++ AL+YL +H+++K NILLD + IT+F +A
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI---TPKLDVFAFGVVVLELLSGR 567
+ + GT YMAPE + + +D ++ GV ELL GR
Sbjct: 168 ET---------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---EINILKKINHS 414
+ D K I GSF G VY+ G+ A+K + D E+ I++K++H
Sbjct: 55 SYTDTKVIGNGSF-------GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHC 107
Query: 415 NIIRLSGFCVHEGNT------YLVYEF--ADNGALSDWLHSNRYQTSDNLTWKQRVQ-IA 465
NI+RL F G LV ++ ++ + V+
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYM 162
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA-KITNFGLARSAESDEHEQGGYGL 524
Y + +L Y+H + H+++K N+LLD + K+ +FG A+ E
Sbjct: 163 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-------- 211
Query: 525 QLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
++ Y Y APE I T +DV++ G V+ ELL G+
Sbjct: 212 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 52/233 (22%), Positives = 96/233 (41%), Gaps = 43/233 (18%)
Query: 355 ESLTLYKFQDLK-IATGSFSE----ENRIQGSVYRGSFKGDDAAVKVMK-------GDVS 402
L F+ LK I G+F E + + V+ A+K++ + +
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVF---------AMKILNKWEMLKRAETA 119
Query: 403 ---SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
E ++L + I L + N YLV ++ G L L + + +
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-- 177
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
R +A ++ A++ +H+ YVH+++K NIL+D N ++ +FG +
Sbjct: 178 -RFYLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL-------KL 225
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGR 567
G + VGT Y++PE ++ G P+ D ++ GV + E+L G
Sbjct: 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 33/194 (17%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT-----YLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI IL ++ IIRL + + Y+V E AD SD L ++T LT
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LK-KLFKTPIFLT- 127
Query: 459 KQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE- 516
++ ++ I Y++ N++H +H++LK +N LL+ + K+ +FGLAR+ S++
Sbjct: 128 EEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 517 --------------HEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVL 561
QLT HVV T Y APE I T +D+++ G +
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 562 ELLSGREAVTGDQN 575
ELL+ ++ D
Sbjct: 244 ELLNMLQSHINDPT 257
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 60/274 (21%), Positives = 104/274 (37%), Gaps = 71/274 (25%)
Query: 347 PQGFRSAVESLTLYKFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS 403
P G + +++ + +I G++ G+VY+ G A+K ++
Sbjct: 2 PLGSMA------TSRYEPVAEIGVGAY-------GTVYKARDPHSGHFVALKSVRVPNGG 48
Query: 404 ------------EINILKKIN---HSNIIRL-----SGFCVHEGNTYLVYEFADNGALSD 443
E+ +L+++ H N++RL + E LV+E D L
Sbjct: 49 GGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRT 107
Query: 444 WLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503
+L T K + L++LH VH++LK NIL+ + K+
Sbjct: 108 YLDKAPPPGLPAETIKD---LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161
Query: 504 TNFGLARSAESDEHEQGGYG--LQLTRHVVGTYGYMAPE------YIENGVITPKLDVFA 555
+FGLAR Y + LT VV T Y APE Y +D+++
Sbjct: 162 ADFGLARI----------YSYQMALTPVVV-TLWYRAPEVLLQSTY------ATPVDMWS 204
Query: 556 FGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
G + E+ + G+ EA+ L I ++
Sbjct: 205 VGCIFAEMFRRKPLFCGN--SEADQLG-KIFDLI 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 357 LTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD----------VSS 403
+L FQ L+ + TGSF G V+ + + A+KV+K + +
Sbjct: 3 YSLQDFQILRTLGTGSF-------GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 55
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E +L + H IIR+ G +++ ++ + G L + + Q N +
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPN----PVAK 109
Query: 464 I-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
A +V AL YLH ++++LK NILLD N KIT+FG A+
Sbjct: 110 FYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--------- 157
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+T + GT Y+APE + +D ++FG+++ E+L+G
Sbjct: 158 --DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 56/257 (21%), Positives = 102/257 (39%), Gaps = 61/257 (23%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRG-SFK--GDDAAVKVMKGDVSS---------EINI 407
+++ + +I G++ G V++ K G A+K ++ E+ +
Sbjct: 12 QYECVAEIGEGAY-------GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 64
Query: 408 LKKIN---HSNIIRL-----SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWK 459
L+ + H N++RL E LV+E D L+ +L T K
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIK 123
Query: 460 QRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
+ + + L++LH + VH++LK NIL+ ++ + K+ +FGLAR
Sbjct: 124 D---MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI-------- 169
Query: 520 GGYGLQLTR-HVVGTYGYMAPE------YIENGVITPKLDVFAFGVVVLELLSGREAVTG 572
Y Q+ VV T Y APE Y +D+++ G + E+ + G
Sbjct: 170 --YSFQMALTSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRKPLFRG 221
Query: 573 DQNCEAELLYASISRVL 589
+ + L I V+
Sbjct: 222 S--SDVDQLGK-ILDVI 235
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 58/251 (23%)
Query: 362 FQDLK-IATGSFSE----ENRIQGSVYRGSFKGDDAAVKVMK-------GDVS---SEIN 406
F+ LK I G+FSE + + G VY A+K+M G+VS E +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVY---------AMKIMNKWDMLKRGEVSCFREERD 113
Query: 407 ILKKINHSNIIRLSGFCVH-----EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR 461
+L + I +L H E YLV E+ G L L + + R
Sbjct: 114 VLVNGDRRWITQL-----HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA---R 165
Query: 462 VQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
+A ++ A++ +H+ YVH+++K NILLD ++ +FG +
Sbjct: 166 FYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL-------KLRA 214
Query: 522 YGLQLTRHVVGTYGYMAPEYIEN-------GVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
G + VGT Y++PE ++ G P+ D +A GV E+ G+ D
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
Query: 575 NCEAELLYASI 585
E Y I
Sbjct: 275 TAE---TYGKI 282
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 31/183 (16%)
Query: 404 EINILKKIN-HSNIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
EI IL +++ H NI+ L + + YLV+++ + +D LH ++ L
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TD-LH--AVIRANILE-PV 109
Query: 461 RVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519
Q + Y + + YLH +H+++K SNILL+ K+ +FGL+RS +
Sbjct: 110 HKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 520 GGYGL--------------QLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELL 564
L LT +V T Y APE + T +D+++ G ++ E+L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 565 SGR 567
G+
Sbjct: 226 CGK 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 40/223 (17%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRG-SFKGDDAAVKVMKGDVSS---EINILKKINHSN 415
+ + K I GSF G V++ + D+ A+K + D E+ I++ + H N
Sbjct: 41 AYTNCKVIGNGSF-------GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPN 93
Query: 416 IIRLSGFCVHEGNT------YLVYEFADNGALSDWLH--SNRYQTSDNLTWKQRVQ-IAY 466
++ L F G+ LV E+ ++ S Y ++ Y
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA-KITNFGLARSAESDEHEQGGYGLQ 525
+ +L Y+H H+++K N+LLD K+ +FG A+ + E
Sbjct: 149 QLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--------P 197
Query: 526 LTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
++ Y Y APE I T +D+++ G V+ EL+ G+
Sbjct: 198 NVSYICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 40/219 (18%), Positives = 73/219 (33%), Gaps = 55/219 (25%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVM--KGDVSSEINILKKI-NHS 414
YK + G G V + K + A+K++ E+ + +
Sbjct: 19 YKVTSQVLGLGIN-------GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCP 71
Query: 415 NIIRLSGFC----VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
+I+R+ +V E D G L + + T ++ +I +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGE 128
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQLT 527
A+ YLH H+++K N+L + N K+T+FG A+ E Y
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTGEKYD---- 176
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSG 566
D+++ GV++ LL G
Sbjct: 177 ---------------------KSCDMWSLGVIMYILLCG 194
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 40/226 (17%)
Query: 357 LTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV----------SS 403
+T+ F LK + G+F G V K A+K+++ +V +
Sbjct: 2 VTMNDFDYLKLLGKGTF-------GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 404 EINILKKINHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E +L+ H + L + V E+A+ G L L R T + R
Sbjct: 55 ESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RA 107
Query: 463 QI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGG 521
+ ++ +AL YLH V++++K N++LD + KIT+FGL + E
Sbjct: 108 RFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGIS 157
Query: 522 YGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
G + GT Y+APE +E+ +D + GVV+ E++ GR
Sbjct: 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 50/239 (20%)
Query: 350 FRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVY---RGSFKGDDA--AVKVMKGDV-- 401
+ E +F+ LK + GSF G V+ + S A+KV+K
Sbjct: 14 VKEGHEKADPSQFELLKVLGQGSF-------GKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 402 -------SSEINILKKINHSNIIRLSGFCVH-----EGNTYLVYEFADNGALSDWLHSNR 449
E +IL ++NH I++L H EG YL+ +F G L L
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKL-----HYAFQTEGKLYLILDFLRGGDLFTRLSKEV 121
Query: 450 YQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508
T + V+ ++A AL++LH ++++LK NILLD K+T+FGL
Sbjct: 122 MFTEE------DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
++ + E + GT YMAPE + T D ++FGV++ E+L+G
Sbjct: 173 SKESIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 38/199 (19%)
Query: 404 EINILKKINHSNIIRLSGFCVHEGNT-----YLVYEFADNGALSDWLHSNRYQTSDNLTW 458
EI IL ++NH +++++ + + Y+V E AD SD ++T LT
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SD-FK-KLFRTPVYLT- 154
Query: 459 KQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517
+ ++ + Y++ + Y+H +H++LK +N L++ + K+ +FGLAR+ + E+
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 518 EQGGYGL--------------------QLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAF 556
+ QLT HVV T Y APE I T +DV++
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILLQENYTEAIDVWSI 270
Query: 557 GVVVLELLSGREAVTGDQN 575
G + ELL+ +
Sbjct: 271 GCIFAELLNMIKENVAYHA 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 52/246 (21%)
Query: 345 SHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVY---RGSFKGDDA--AVKVMK 398
S E + F+ L+ + G + G V+ + + A+KV+K
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGY-------GKVFQVRKVTGANTGKIFAMKVLK 54
Query: 399 GDV-----------SSEINILKKINHSNIIRLSGFCVH-----EGNTYLVYEFADNGALS 442
+ +E NIL+++ H I+ L G YL+ E+ G L
Sbjct: 55 KAMIVRNAKDTAHTKAERNILEEVKHPFIVDL-----IYAFQTGGKLYLILEYLSGGELF 109
Query: 443 DWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501
L D +++ AL +LH+ ++++LK NI+L+
Sbjct: 110 MQLEREGIFMED------TACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHV 160
Query: 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVL 561
K+T+FGL + + D +T GT YMAPE + +D ++ G ++
Sbjct: 161 KLTDFGLCKESIHDG--------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 562 ELLSGR 567
++L+G
Sbjct: 213 DMLTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 80/435 (18%), Positives = 137/435 (31%), Gaps = 52/435 (11%)
Query: 175 VPLRCACPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDA----NKLSQDDL 230
VP C ++ + + L +D + D +
Sbjct: 148 VPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKS 207
Query: 231 IFPFTPILVPLKTAPSKIQLPVPSPPPSSPHTTLTPPSHSSTSSKKWVFIGAGIGAFLLL 290
+ P + S L+ + + F+G+ L
Sbjct: 208 ESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISEL 267
Query: 291 LVATLFAFLFCLYRRRRNSKKNPTPVLTPGRVPPPKTPLDCADYSLFPQASNSLSHPQGF 350
A + + L + P P + + A +A +
Sbjct: 268 QKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTIS 327
Query: 351 RSAV----ESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV-- 401
+ + + L F L + GSF G V KG D AVK++K DV
Sbjct: 328 KFDNNGNRDRMKLTDFNFLMVLGKGSF-------GKVMLSERKGTDELYAVKILKKDVVI 380
Query: 402 --------SSEINILKKIN-HSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQ 451
E +L + +L C Y V E+ + G L +
Sbjct: 381 QDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 452 TSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510
A ++A L +L ++++LK N++LD+ KI +FG+ +
Sbjct: 440 KEP------HAVFYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCK 490
Query: 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV 570
E G T+ GT Y+APE I +D +AFGV++ E+L+G+
Sbjct: 491 -------ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542
Query: 571 TGDQNCEAELLYASI 585
G+ E L+ SI
Sbjct: 543 EGEDEDE---LFQSI 554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 46/229 (20%), Positives = 87/229 (37%), Gaps = 45/229 (19%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVS------SEINILKKI 411
+FQ + G+F G+V G K G A+K + D + L +
Sbjct: 24 RFQVERMAGQGTF-------GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL 76
Query: 412 NHSNIIRLSGFCVHEGNT-------YLVYEFADNGALSDWLHS---NRYQTSDNLTWKQR 461
+H NI++L + G +V E+ LH N Y+
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNYYRRQVAPPPIL- 130
Query: 462 VQ-IAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-TNLRAKITNFGLARSAESDEHEQ 519
++ + + ++ LH + H+++K N+L++ + K+ +FG A+ E
Sbjct: 131 IKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP-- 187
Query: 520 GGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGR 567
++ Y Y APE I T +D+++ G + E++ G
Sbjct: 188 ------NVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 353 AVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV-------- 401
A++ L L F L+ I GS+ V K D A+KV+K ++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSY-------AKVLLVRLKKTDRIYAMKVVKKELVNDDEDID 54
Query: 402 --SSEINILKKI-NHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLT 457
+E ++ ++ NH ++ L C E + V E+ + G L + R +
Sbjct: 55 WVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--- 110
Query: 458 WKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+ + +++ ALNYLH+ ++++LK N+LLD+ K+T++G+ + E
Sbjct: 111 ---HARFYSAEISLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK-----E 159
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
+ G T GT Y+APE + +D +A GV++ E+++GR
Sbjct: 160 GLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 58/262 (22%), Positives = 109/262 (41%), Gaps = 41/262 (15%)
Query: 322 VPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQG 380
+P + + + + A SL L F L+ I GS+
Sbjct: 14 IPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY-------A 66
Query: 381 SVYRGSFKGDDA--AVKVMKGDV----------SSEINILKKI-NHSNIIRLSGFCVH-E 426
V K D A++V+K ++ +E ++ ++ NH ++ L C E
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTE 125
Query: 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVH 485
+ V E+ + G L + R + + + +++ ALNYLH+ ++
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHERGI---IY 176
Query: 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG 545
++LK N+LLD+ K+T++G+ + E + G T GT Y+APE +
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPG---DTTSTFCGTPNYIAPEILRGE 228
Query: 546 VITPKLDVFAFGVVVLELLSGR 567
+D +A GV++ E+++GR
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGR 250
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 49/232 (21%)
Query: 384 RGSF----------KGDDAAVKVMKGDVS------SEINILKKINH------SNIIRLSG 421
+GSF A+K+++ + EI IL+ + N+I +
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166
Query: 422 FCVHEGNTYLVYE-FADNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYT 479
+ + +E + N L + + N++Q S L K A+ + L+ LHK
Sbjct: 167 NFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRK----FAHSILQCLDALHKNR 220
Query: 480 NPPYVHKNLKTSNILLDTNLRA--KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYM 537
+H +LK NILL R+ K+ +FG + EH++ +Q +R Y
Sbjct: 221 ---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQ-SRF------YR 266
Query: 538 APEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
APE I +D+++ G ++ ELL+G + G+ E + L A + +L
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE--DEGDQL-ACMIELL 315
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 66/266 (24%), Positives = 99/266 (37%), Gaps = 51/266 (19%)
Query: 322 VPPPKTPLDCADYSLFPQASNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQG 380
+ P+ P P A + + S+ F LK I GSF G
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLG--PSSNPHAKPSDFHFLKVIGKGSF-------G 52
Query: 381 SVYRGSFKGDDA--AVKVMKGDV----------SSEINIL-KKINHSNIIRLSGFCVH-- 425
V K ++ AVKV++ SE N+L K + H ++ L H
Sbjct: 53 KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL-----HFS 107
Query: 426 ---EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNP 481
Y V ++ + G L L R R + A ++A+AL YLH
Sbjct: 108 FQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALGYLHSLN-- 159
Query: 482 PYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEY 541
V+++LK NILLD+ +T+FGL + T GT Y+APE
Sbjct: 160 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--------STTSTFCGTPEYLAPEV 210
Query: 542 IENGVITPKLDVFAFGVVVLELLSGR 567
+ +D + G V+ E+L G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 41/232 (17%)
Query: 352 SAVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV------- 401
++ L + F+ ++ + GSF G V K AVKV+K DV
Sbjct: 15 NSSNRLGIDNFEFIRVLGKGSF-------GKVMLARVKETGDLYAVKVLKKDVILQDDDV 67
Query: 402 ---SSEINILKKI-NHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
+E IL NH + +L C + V EF + G L + +R
Sbjct: 68 ECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-- 124
Query: 457 TWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515
R + A ++ +AL +LH ++++LK N+LLD K+ +FG+ +
Sbjct: 125 ----RARFYAAEIISALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCK----- 172
Query: 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
E G T GT Y+APE ++ + P +D +A GV++ E+L G
Sbjct: 173 --EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 352 SAVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDV------- 401
S L + F K + GSF G V+ FK + A+K +K DV
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSF-------GKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 61
Query: 402 ---SSEINILKK-INHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
E +L H + + + N + V E+ + G L + Q+
Sbjct: 62 ECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKF 115
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
+ A ++ L +LH V+++LK NILLD + KI +FG+ +
Sbjct: 116 DLSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCK------ 166
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567
E T GT Y+APE + +D ++FGV++ E+L G+
Sbjct: 167 -ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 57/243 (23%), Positives = 92/243 (37%), Gaps = 41/243 (16%)
Query: 341 SNSLSHPQGFRSAVESLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVM 397
+ + + + L F L + GSF G V KG D AVK++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSF-------GKVMLSERKGTDELYAVKIL 53
Query: 398 KGDV----------SSEINILKKI-NHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWL 445
K DV E +L + +L C Y V E+ + G L +
Sbjct: 54 KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI 112
Query: 446 HSNRYQTSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504
A ++A L +L ++++LK N++LD+ KI
Sbjct: 113 QQVGRFKEP------HAVFYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIA 163
Query: 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564
+FG+ + E G T+ GT Y+APE I +D +AFGV++ E+L
Sbjct: 164 DFGMCK-------ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
Query: 565 SGR 567
+G+
Sbjct: 216 AGQ 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 2e-10
Identities = 31/221 (14%), Positives = 61/221 (27%), Gaps = 71/221 (32%)
Query: 345 SHPQGFRSAVESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVM------- 397
P F + + L + + KI G F E V++ A+K++
Sbjct: 8 KGPVPFSHCLPTEKLQRCE--KIGEGVFGE-------VFQTIADHTPVAIKIIAIEGPDL 58
Query: 398 --------KGDVSSEINILKKI---------NHSNIIRLSGFCVHEG------------- 427
++ EI I K++ I L+ +G
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 428 -----------------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
++V EF G + + + + I + +
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL------SSLATAKSILHQLTA 172
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511
+L + H++L N+LL K+ +S
Sbjct: 173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 40/203 (19%), Positives = 82/203 (40%), Gaps = 46/203 (22%)
Query: 393 AVKVMKGDVS------SEINILKKIN-----------HSNIIRLSGFCVHEGNTY----L 431
A+K+++GD EI +L+++N ++I++L H+G +
Sbjct: 48 AMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM 107
Query: 432 VYEF-ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490
V+E +N L + ++ + QI+ + L+Y+H+ +H ++K
Sbjct: 108 VFEVLGEN--LLALIKKYEHRG---IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKP 160
Query: 491 SNILLDTNLRA------KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN 544
N+L++ KI + G A E +Q TR Y +PE +
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSIQ-TRE------YRSPEVLLG 209
Query: 545 GVITPKLDVFAFGVVVLELLSGR 567
D+++ ++ EL++G
Sbjct: 210 APWGCGADIWSTACLIFELITGD 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 63/388 (16%), Positives = 114/388 (29%), Gaps = 106/388 (27%)
Query: 302 LYRRRRNSKKNPTPVLTPGRVP--PPKTPLDCADYSLFPQASNSLSH-PQGF-RSAVESL 357
+Y +R+ N V V P L A L P A N L G ++ +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP-AKNVLIDGVLGSGKT---WV 166
Query: 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSSEINILKKINHSNII 417
L K+ + ++ ++ + K ++ V++ +L+K+ +
Sbjct: 167 ALDVCLSYKV-------QCKMDFKIFWLNLKNCNSPETVLE--------MLQKLLYQIDP 211
Query: 418 RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTS----DNLTWKQRVQIAYDVANALN 473
+ H N L L L S Y+ N+ + A+++
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQA-ELRRLLKSKPYENCLLVLLNV-QNAKAWNAFNL----- 264
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAK-ITNF--GLARSAESDEHEQGGYGLQLTRHV 530
+ ILL T R K +T+F + S +H LT
Sbjct: 265 ----------------SCKILLTT--RFKQVTDFLSAATTTHISLDHHSMT----LTP-- 300
Query: 531 VGTYGYMAPEYIENGVITPKLDVFA--FGVVVLELLSGREAVTGDQNCEAELLYASISRV 588
E + +L RE +T + + I+
Sbjct: 301 --------DE---------VKSLLLKYLDCRPQDL--PREVLTTN-----PRRLSIIAES 336
Query: 589 LEESNVR---------EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ + +KL I+ SL P + ++ + +A I +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE----YRKMFDRLSVFPPSAH--IPTI 390
Query: 640 FVTLSKIWSSSSDWDPSDELN--NSRSL 665
LS IW D +N + SL
Sbjct: 391 --LLSLIWFDVIKSDVMVVVNKLHKYSL 416
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 4e-06
Identities = 63/447 (14%), Positives = 123/447 (27%), Gaps = 119/447 (26%)
Query: 218 SVLDANKLSQDDLI--FPF-----------TP--ILVPLKTAPSKIQLPVPSPPPSSPHT 262
+ + + + F +P +L L+ +I S S +
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 263 TLTPPSHSSTSSKKWVFIGAGIGAFLLLL-----VATLFAFLF-C--LYRRRRNSKKNPT 314
L HS + + + LL+L AF C L R +
Sbjct: 224 KL--RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFL 281
Query: 315 PVLTPGRVP-----PPKTP----------LDCADYSLFPQA---------------SNSL 344
T + TP LDC L + + L
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341
Query: 345 SHPQGFR------------SAVESLT--LYK--FQDLKIATGSFSEENRIQGSVYRGSFK 388
+ ++ S++ L Y+ F L + F I +
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAHIPTILL-SLIW 396
Query: 389 GDDAAVKVMKGDVSSEIN---ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWL 445
D VM V ++++ +++K + I + + YL + + L
Sbjct: 397 FDVIKSDVM--VVVNKLHKYSLVEKQPKESTISI-----P--SIYLELKVKLENEYA--L 445
Query: 446 HS---NRYQTSDNLTWKQRVQIAYDVANALNYLHKY-----TNPPYVHKNLKTSNILLDT 497
H + Y + D Y + + N + + + LD
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLD-----QYFYSHIGHHLKNIEHPERMTLFRMVFLDF 500
Query: 498 N-LRAKITNFGLARSAESDE----HEQGGYGLQLTRH------VVGTYGYMAPEYIENGV 546
L KI + A +A + Y + + +V P+ EN +
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI 560
Query: 547 ITPKLDVFAFGVVVLELLSGREAVTGD 573
+ D ++ + L++ EA+ +
Sbjct: 561 CSKYTD-----LLRIALMAEDEAIFEE 582
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 20/200 (10%), Positives = 48/200 (24%), Gaps = 57/200 (28%)
Query: 380 GSVYRG--SFKGDDAAVKVMKGDVS----------SEINILKKINHSNIIRLSGFCVHEG 427
++ + A+ + S L +I+ + R+
Sbjct: 45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104
Query: 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKN 487
+V E+ G+L + ++ + ++ +A A + H+
Sbjct: 105 GGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA---GVALSI 154
Query: 488 LKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI 547
S + + + + M
Sbjct: 155 DHPSRVRVSIDGDVV----------------------------LAYPATMPDA------- 179
Query: 548 TPKLDVFAFGVVVLELLSGR 567
P+ D+ G + LL R
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 48/223 (21%), Positives = 92/223 (41%), Gaps = 45/223 (20%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS----EINILKKI-N 412
+Q + K+ G +SE V+ + VK++K EI IL+ +
Sbjct: 37 DYQLVRKLGRGKYSE-------VFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG 89
Query: 413 HSNIIRLSGFCV----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ-IAYD 467
NII L + LV+E +N +D YQT LT ++ Y+
Sbjct: 90 GPNIITL--ADIVKDPVSRTPALVFEHVNN---TD-FK-QLYQT---LT-DYDIRFYMYE 138
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA-KITNFGLARSAESDEHEQGGYGLQL 526
+ AL+Y H +H+++K N+++D R ++ ++GLA + +
Sbjct: 139 ILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--------EY 187
Query: 527 TRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGRE 568
V Y + PE + + + LD+++ G ++ ++ +E
Sbjct: 188 NVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 389 GDDAAVKVMKGDVS------SEINILKKINH------SNIIRLSGFCVHEGNTYLVYE-F 435
+ A+K++K + E+ +L+ +N I+ L + + LV+E
Sbjct: 79 QEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138
Query: 436 ADNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494
+ N L D L + ++ S NLT K A + AL +L +H +LK NIL
Sbjct: 139 SYN--LYDLLRNTNFRGVSLNLTRK----FAQQMCTALLFLAT-PELSIIHCDLKPENIL 191
Query: 495 LDTNLRA--KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLD 552
L R+ KI +FG S+ ++ +Q +R Y +PE + +D
Sbjct: 192 LCNPKRSAIKIVDFG---SS-CQLGQRIYQYIQ-SRF------YRSPEVLLGMPYDLAID 240
Query: 553 VFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
+++ G +++E+ +G +G E + + I VL
Sbjct: 241 MWSLGCILVEMHTGEPLFSG--ANEVDQM-NKIVEVL 274
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 54/239 (22%)
Query: 355 ESLTLYKFQDLK-IATGSFSEENRIQGSVY---RGSFKGDDA--AVKVMKGDV------- 401
E + + F+ LK + TG++ G V+ + S A+KV+K
Sbjct: 49 EKVGIENFELLKVLGTGAY-------GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 101
Query: 402 ----SSEINILKKINHSN-IIRLSGFCVH-----EGNTYLVYEFADNGALSDWLHSNRYQ 451
+E +L+ I S ++ L H E +L+ ++ + G L L
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTL-----HYAFQTETKLHLILDYINGGELFTHLSQRERF 156
Query: 452 TSDNLTWKQRVQI-AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510
T VQI ++ AL +LHK +++++K NILLD+N +T+FGL++
Sbjct: 157 TEH------EVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207
Query: 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI--TPKLDVFAFGVVVLELLSGR 567
+DE E GT YMAP+ + G +D ++ GV++ ELL+G
Sbjct: 208 EFVADETE-------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 48/257 (18%), Positives = 88/257 (34%), Gaps = 75/257 (29%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---EINILKKINHS 414
K+ K + TGSF G V G A+K + D E++I+K ++H
Sbjct: 8 KYSLGKTLGTGSF-------GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 415 NIIRLSGFCVHEGNT---------------------------------------YLVYEF 435
NII+L + ++ E+
Sbjct: 61 NIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 436 ADNGALSDWLH--SNRYQTSDNLTWKQRVQ-IAYDVANALNYLHKYTNPPYVHKNLKTSN 492
LH + S + Y + A+ ++H H+++K N
Sbjct: 120 VP----DT-LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQN 171
Query: 493 ILLDTNL-RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPK 550
+L+++ K+ +FG A+ E ++ + Y APE + TP
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRF-YRAPELMLGATEYTPS 222
Query: 551 LDVFAFGVVVLELLSGR 567
+D+++ G V EL+ G+
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 49/232 (21%), Positives = 82/232 (35%), Gaps = 60/232 (25%)
Query: 393 AVKVMKGDVS------SEINILKKINH------SNIIRLSGFCVHEGNTYLVYE-FADNG 439
A+K+++ EIN+LKKI + +S + G+ + +E N
Sbjct: 49 ALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKN- 107
Query: 440 ALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498
++L N +Q +AY + +AL +LH+ H +LK NIL +
Sbjct: 108 -TFEFLKENNFQPYPLPHVRH----MAYQLCHALRFLHENQ---LTHTDLKPENILFVNS 159
Query: 499 LRAKITNFGLAR----------------SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI 542
+ N + SA + +HE + TRH Y PE
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSA-TFDHEHHTTIVA-TRH------YRPPE-- 209
Query: 543 ENGVI-----TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
VI DV++ G ++ E G E L + ++L
Sbjct: 210 ---VILELGWAQPCDVWSIGCILFEYYRGFTLFQTH--ENREHL-VMMEKIL 255
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 3e-07
Identities = 16/68 (23%), Positives = 31/68 (45%)
Query: 187 AASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAPS 246
+ L + + GD+++ +A + V + AN+L +D IF + +P+ T P
Sbjct: 8 CSPVRERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILTEPR 67
Query: 247 KIQLPVPS 254
+ PS
Sbjct: 68 DLFNSGPS 75
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 46/257 (17%), Positives = 82/257 (31%), Gaps = 67/257 (26%)
Query: 393 AVKVMKGDVSS------EINILKKINHSN--------IIRLSG-FCVH--EGN-TYLVYE 434
A+KV+K EI +LK + +S+ +++L F + G +V+E
Sbjct: 66 AMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE 125
Query: 435 FA-DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493
+ L W+ + YQ L +I V L+YLH +H ++K NI
Sbjct: 126 VLGHH--LLKWIIKSNYQG---LPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 494 LLDTNLRAKITNFGLARSAESDEHEQGG-------------------------------- 521
LL N + A +
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 522 ------YGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR---EAVTG 572
+ + + T Y + E + D+++ + EL +G E +G
Sbjct: 239 DLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298
Query: 573 DQNCEAELLYASISRVL 589
++ E A I +L
Sbjct: 299 EEYTRDEDHIALIIELL 315
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 66/228 (28%)
Query: 384 RGSF-----------KGDDAAVKVMKGDVS------SEINILKKINH------SNIIRLS 420
G+F G AVK++K SEI +L+ +N +++
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83
Query: 421 GFCVHEGNTYLVYE-FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT 479
+ H G+ +V+E + D++ N + ++AY + ++N+LH
Sbjct: 84 EWFEHHGHICIVFELLGLS--TYDFIKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK 138
Query: 480 NPPYVHKNLKTSNILLDTNLRAKITNFGLAR----------------SAESDEHEQGGYG 523
H +LK NIL + + N + R SA + + E
Sbjct: 139 ---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TYDDEHHSTL 194
Query: 524 LQLTRHVVGTYGYMAPEYIENGVI-----TPKLDVFAFGVVVLELLSG 566
+ TRH Y APE VI + DV++ G +++E G
Sbjct: 195 VS-TRH------YRAPE-----VILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 52/217 (23%), Positives = 82/217 (37%), Gaps = 68/217 (31%)
Query: 393 AVKVMKGDVS------SEINILKKINH-----SNIIRLSGFCVHEGNTYLVYE-FADNGA 440
AVKV++ E +ILKKI + +NI++ G ++ + L++E +
Sbjct: 64 AVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPS-- 121
Query: 441 LSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499
L + + N Y ++ ALNYL K + H +LK NILLD
Sbjct: 122 LYEIITRNNYNGFHIEDIKL----YCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174
Query: 500 RA-------------------------KITNFGLARSAESDEHEQGGYGLQLTRHVVGTY 534
K+ +FG A + + + G + TR
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA-TFKSDYHGSIIN-TRQ----- 224
Query: 535 GYMAPEYIENGVI-----TPKLDVFAFGVVVLELLSG 566
Y APE VI D+++FG V+ EL +G
Sbjct: 225 -YRAPE-----VILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 18/85 (21%), Positives = 29/85 (34%), Gaps = 3/85 (3%)
Query: 182 PSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPL 241
G T V GD++ I + F+ D + N + +DLI+P + VP
Sbjct: 50 FRWVSGGGGGGGTATVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPT 109
Query: 242 KTAPSKIQLPVPSPPPSSPHTTLTP 266
K + S+ L
Sbjct: 110 KGGSGG---GAGNFWDSARDVRLVD 131
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 34/194 (17%), Positives = 61/194 (31%), Gaps = 36/194 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRG--SFKGDDAAVKVMKGDVSS-----EINILKKI- 411
YK +I GSF G ++ G A+K + E K +
Sbjct: 12 YKVGR-RIGEGSF-------GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
+ I + F + LV + L L + K A +
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDL-----LGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAK-----ITNFGLA---RSAESDEHEQGGYG 523
+ +H+ + V++++K N L+ + +FG+ R + +H
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 524 LQLTRHVVGTYGYM 537
L+ GT YM
Sbjct: 176 KNLS----GTARYM 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 33/176 (18%), Positives = 61/176 (34%), Gaps = 46/176 (26%)
Query: 366 KIATGSFSEENRIQGSVYRGS----------FKGDDAAVKV--MKGDVSSEINI------ 407
+ G +Y + + ++K+ G + +E N
Sbjct: 49 FQTRDNQ-------GILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 408 ---------LKKINHSNIIRLSGFCVHEGN-TYLVYE-FADNGALSDWLHSNRYQTSDNL 456
L I GF VH+ +LV + L L + L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHV---L 156
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT--NFGLAR 510
+ + +Q+A + +AL +LH+ YVH N+ NI +D ++++T +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 33/175 (18%), Positives = 63/175 (36%), Gaps = 47/175 (26%)
Query: 366 KIATGSFSEENRIQGSVYRGS--FKGDDAAVKVMKGDVSS------EINILKKINHSNII 417
KI +G F G +Y K + A V+K + E+ +++ + I
Sbjct: 44 KIGSGGF-------GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 418 RL-----------------SGFCVHEGNTY--LVYE-FADNGALSDWLHSNRYQTSDNLT 457
+ SG +G +Y +V E + L N
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQNG-----TFK 149
Query: 458 WKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT--NFGLAR 510
+Q+ + + L Y+H+ YVH ++K +N+LL ++ ++GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 669 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.4 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 99.3 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 99.25 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 99.13 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 99.1 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 99.09 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.86 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 98.68 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.66 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.16 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.99 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.98 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.58 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.03 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.41 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.37 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.3 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.97 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 95.92 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.24 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 94.18 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.79 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.91 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.96 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.59 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=440.24 Aligned_cols=251 Identities=23% Similarity=0.403 Sum_probs=209.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
++|.+ ++|.|+| |+||+|.+. ++.||||+++. +|.+|+.+|++++|||||+++|+|.
T Consensus 28 ~~~~~-~lG~G~f-------G~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 28 VRFME-ELGEDRF-------GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp EEEEE-EEEECSS-------CEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CeEee-EeccCCC-------cEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 34444 4999999 999999973 46799999853 4889999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
+++..+|||||+++|+|.++|+..... ....|+|.++++|+.|||.||+|||+++ ||||||||+||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NI 176 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNV 176 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccce
Confidence 999999999999999999999754211 1246999999999999999999999999 99999999999
Q ss_pred eecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 005923 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~ 572 (669)
||++++.+||+|||+++....... ........||++|||||++.++.++.++|||||||+||||+| |+.||.+
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADY------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGC------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EECCCCCEEECCcccceeccCCCc------eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999997654321 123345679999999999999999999999999999999999 8999987
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
....+. +. .+ ....+.+.|.+++..+.+||.+||+.||.+||||.||++.|+.+.
T Consensus 251 ~~~~~~------~~-~i-------------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 251 YSNQDV------VE-MI-------------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp CCHHHH------HH-HH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCHHHH------HH-HH-------------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 653211 10 11 011223456677888999999999999999999999999998653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=440.02 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=203.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
++|.|+| |+||+|++. +..||||+++. +|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 48 ~LG~G~f-------G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 48 ELGEGAF-------GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp EEEECSS-------EEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred EEccCCC-------cEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4999999 999999874 56799999963 48899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 432 VYEFADNGALSDWLHSNRYQ----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
||||+++|+|.++|++.+.. ....|+|.++++|+.|||.||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 99999999999999875311 2346999999999999999999999998 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 580 (669)
||+|||+++....... ........||+.|||||++.+..++.++|||||||+||||+| |+.||.+....+.
T Consensus 198 Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-- 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-- 269 (329)
T ss_dssp EECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--
T ss_pred EEcccccceeccCCCc------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999997654321 122345679999999999999999999999999999999999 8999987553221
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
+..+.. ..+.+.|..++.++.+|+.+||+.||.+||||+||++.|+.|.+....
T Consensus 270 ----~~~i~~--------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~ 323 (329)
T 4aoj_A 270 ----IDCITQ--------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323 (329)
T ss_dssp ----HHHHHH--------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred ----HHHHHc--------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence 111111 112345566778899999999999999999999999999999887543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=435.99 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=211.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|.+.+ ++|+|+| |+||+|++. +..||||+++. +|.+|+++|++++|||||+++|+|.+
T Consensus 15 ~~l~~-~lG~G~f-------G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 15 IVLKR-ELGEGAF-------GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp EEEEE-EEEC--C-------CCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred eEEee-EEeeCCC-------cEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 44444 4999999 999999873 56799999963 47899999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNR--------YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
++..+|||||+++|+|.++|+..+ ......|+|.++++|+.|||.||+|||+++ |+||||||+|||+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECC
Confidence 999999999999999999998642 123457999999999999999999999998 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~ 576 (669)
++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.+....
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGC------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred CCcEEECCcccceecCCCCc------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999997654321 122334578999999999999999999999999999999999 89999875532
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
+. +..+.. ..+.+.|..++.++.+|+.+||+.||.+||||+||++.|+++...++.
T Consensus 238 ~~------~~~i~~--------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 238 EV------IECITQ--------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp HH------HHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred HH------HHHHHc--------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 11 111111 112345566778899999999999999999999999999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=426.55 Aligned_cols=247 Identities=28% Similarity=0.518 Sum_probs=199.5
Q ss_pred HHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|+| |+||+|++++ .||||+++. +|.+|+++|++++|||||+++|+|. ++..+|||||+
T Consensus 43 ~iG~G~f-------G~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~ 113 (307)
T 3omv_A 43 RIGSGSF-------GTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWC 113 (307)
T ss_dssp ECCCCSS-------SEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEeeCCC-------cEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcC
Confidence 4899999 9999999875 599999862 4788999999999999999999985 46789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++|+|.++|+..+ ..++|.++++|+.|||.||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 114 ~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 114 EGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp SSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999997642 46999999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccCCcccceeeeccccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
. ........||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+...... . ...+
T Consensus 187 ~------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~----~~~~---- 250 (307)
T 3omv_A 187 G------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--I----IFMV---- 250 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHH----
T ss_pred c------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--H----HHHH----
Confidence 1 123445689999999999964 4689999999999999999999999986543211 0 0111
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
......+.+ ...+.+++..+.+|+.+||+.||.+||||.||++.|+.|..+
T Consensus 251 ----~~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 251 ----GRGYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ----HTTCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ----hcCCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111222222 234456677899999999999999999999999999988754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=416.40 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=199.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc----H--HHHHHHHHhcCCCCceeEeeEEEecC----ce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----V--SSEINILKKINHSNIIRLSGFCVHEG----NT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~----~--~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 429 (669)
|.+++ ++|.|+| |+||+|+++|+.||||+++.+ + +.|+..+.+++|||||+++|+|.+++ ..
T Consensus 5 i~L~~-~iG~G~f-------G~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 5 IVLQE-SIGKGRF-------GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp EEEEE-EEEECSS-------SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred EEEEE-EEeeCCC-------eEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 34444 4999999 999999999999999999643 2 34566667889999999999998764 47
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-----TNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+|||||+++|+|.++|+.. .++|..+++|+.|++.||+|||++ ..++|+||||||+||||++++++||+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 9999999999999999864 499999999999999999999987 23459999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccC------CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG------VITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
|||+|+......... ........||+.|||||++.+. .++.++|||||||+||||+||+.|+......+.
T Consensus 151 DFGla~~~~~~~~~~----~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 151 DLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp CCTTCEEEETTTTEE----SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eCCCCccccCCCCce----eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 999998765432111 1123346899999999999764 467899999999999999999887653221100
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
++... ........+....+.+..++...| .+++..+.+|+.+||+.||.+||||.||++.|++|...
T Consensus 227 --p~~~~--~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 227 --PYYDL--VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp --TTTTT--SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --cchhc--ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00000 000000001111122223333322 35667899999999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=426.03 Aligned_cols=256 Identities=30% Similarity=0.450 Sum_probs=209.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcCC-CCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKINH-SNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H-~niv~l~g~ 422 (669)
.|++.+ ++|.|+| |+||+|.+.+ +.||||.++. ++.+|+++|++++| ||||+++|+
T Consensus 65 ~~~l~~-~LG~G~f-------G~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 65 RLKLGK-PLGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HeEEee-EEecCCC-------eEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 344444 4899999 9999999853 4699999853 37789999999965 899999999
Q ss_pred EEec-CceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 005923 423 CVHE-GNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490 (669)
Q Consensus 423 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~ 490 (669)
|.+. +..+|||||+++|+|.++|++.+. .....|+|.+++.|+.|||.||+|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9765 568999999999999999986431 11346999999999999999999999999 99999999
Q ss_pred CCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCC
Q 005923 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREA 569 (669)
Q Consensus 491 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p 569 (669)
+|||+++++.+||+|||+|+....+.. ...+....||+.|||||++.++.++.++|||||||+||||+| |+.|
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cceeeCCCCCEEECcchhhhhcccCCC------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 999999999999999999997754321 123345678999999999999999999999999999999998 8999
Q ss_pred CCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
|.+....+. +...+. ...+...|..++.++.++|.+||+.||.+||||.||+++|+++.+.
T Consensus 288 f~~~~~~~~------~~~~i~-------------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 288 YPGVKIDEE------FCRRLK-------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp STTCCCSHH------HHHHHH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHH------HHHHHH-------------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 986543211 111111 1123345566777899999999999999999999999999999865
Q ss_pred C
Q 005923 650 S 650 (669)
Q Consensus 650 ~ 650 (669)
.
T Consensus 349 ~ 349 (353)
T 4ase_A 349 N 349 (353)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=415.07 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=206.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc--HHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~--~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
.|++.+ ++|.|+| |.||+|+.. |+.||||+++.+ ..+|+.+|++++|||||++++++.+++..|||||
T Consensus 59 ~~~~~~-~lG~G~f-------G~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 59 WMTHQP-RVGRGSF-------GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp EEEEEE-EEEEETT-------EEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred heEeCc-EeccCCC-------eEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 344444 4999999 999999984 889999999754 4589999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccCCccccC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAE 513 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfGla~~~~ 513 (669)
|+++|+|.++|++. +.+++..+..|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999865 35999999999999999999999999 99999999999999987 69999999999875
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
....... ........||+.|||||++.+..++.++|||||||++|||++|+.||.+....+.. ..+....
T Consensus 203 ~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~- 272 (336)
T 4g3f_A 203 PDGLGKS---LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEP- 272 (336)
T ss_dssp --------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSC-
T ss_pred CCCcccc---eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCC-
Confidence 4332110 11223467999999999999999999999999999999999999999865432211 1111110
Q ss_pred HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 594 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
+. ....+..++..+.+++.+||+.||.+|||+.|+++.|.+.....
T Consensus 273 ----------~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 273 ----------PP-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ----------CG-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----------CC-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 00 01234456678899999999999999999999999998877543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=415.95 Aligned_cols=246 Identities=23% Similarity=0.396 Sum_probs=201.0
Q ss_pred ccccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 355 ~~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.++..|++.+ ++|+|+| |+||+|+.. |+.||||+++. .+.+|+++|++++|||||++++++
T Consensus 21 ~sme~Y~~~~-~lG~G~f-------g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~ 92 (350)
T 4b9d_A 21 QSMEKYVRLQ-KIGEGSF-------GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF 92 (350)
T ss_dssp SCCCCEEEEE-EC-------------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccceEEeE-EEecCCC-------eEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE
Confidence 4556777766 4999999 999999984 88999999852 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
.+++..||||||+++|+|.++|...+ ...+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||
T Consensus 93 ~~~~~~yiVmEy~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl 166 (350)
T 4b9d_A 93 EENGSLYIVMDYCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQL 166 (350)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEE
Confidence 99999999999999999999997642 345899999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+
T Consensus 167 ~DFGla~~~~~~~--------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------ 232 (350)
T 4b9d_A 167 GDFGIARVLNSTV--------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------ 232 (350)
T ss_dssp CSTTEESCCCHHH--------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------
T ss_pred cccccceeecCCc--------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------
Confidence 9999999765321 22345689999999999999999999999999999999999999998765321
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+..+... -. ...+..++.++.+|+.+||+.||.+|||++|++++
T Consensus 233 ~~~~i~~~---------~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 233 LVLKIISG---------SF-----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHT---------CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcC---------CC-----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111 01 12234456678999999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=402.04 Aligned_cols=239 Identities=26% Similarity=0.421 Sum_probs=193.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe---
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH--- 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~--- 425 (669)
|++++ ++|.|+| |.||+|... +..||+|++.. .+.+|+++|++++|||||+++++|..
T Consensus 28 ~~~~~-~iG~G~f-------g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 28 LKFDI-EIGRGSF-------KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred EEeee-EEecCcC-------cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 35544 5999999 999999984 77899999853 37789999999999999999999875
Q ss_pred -cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEE
Q 005923 426 -EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKI 503 (669)
Q Consensus 426 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl 503 (669)
++..||||||+++|+|.+++++. ..+++..+..|+.||+.||+|||+++ ++|+||||||+||||+. ++.+||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEE
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEE
Confidence 34579999999999999999865 46999999999999999999999975 56999999999999984 799999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+|+..... ......||+.|||||++.+ .++.++|||||||++|||+||+.||.+..... ....
T Consensus 174 ~DFGla~~~~~~----------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~ 240 (290)
T 3fpq_A 174 GDLGLATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR 240 (290)
T ss_dssp CCTTGGGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH
T ss_pred EeCcCCEeCCCC----------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHH
Confidence 999999864321 2345789999999998865 69999999999999999999999997644321 1110
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. +..-.. ....+...+.++.+|+.+||+.||.+|||++|+++
T Consensus 241 ----~---------i~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 241 ----R---------VTSGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----H---------HTTTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----H---------HHcCCC---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 111011 11222334456899999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=407.94 Aligned_cols=235 Identities=25% Similarity=0.415 Sum_probs=200.7
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec-------ccHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-------GDVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
++|.|+| |+||+|... |+.||||+++ ..+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 81 ~iG~G~f-------G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 81 KIGEGST-------GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp EEEECSS-------CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EeecCcC-------eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4999999 999999984 8899999984 24789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++|+|.+++.+. .+++.++..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999754 4999999999999999999999999 9999999999999999999999999999775432
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+. ...
T Consensus 225 --------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~------------ 281 (346)
T 4fih_A 225 --------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKM------------ 281 (346)
T ss_dssp --------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH------------
T ss_pred --------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHH------------
Confidence 223457899999999999999999999999999999999999999987653211 111
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+..-..+. ...+..++.++.+|+.+||+.||.+|||+.|++++
T Consensus 282 -i~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 282 -IRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -HHHSSCCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HHcCCCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111 12334566788999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=401.97 Aligned_cols=255 Identities=21% Similarity=0.391 Sum_probs=210.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|+|+| |+||+++. .|+.||||+++. .+.+|+++|++++|||||++++++.+
T Consensus 32 ~dy~i~~~-lG~G~f-------g~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 32 EDFKFGKI-LGEGSF-------STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp GGEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccEEEEE-EecccC-------eEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 34666664 999999 99999998 488999999852 36789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..||||||+++|+|.+++.+. +.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~D 175 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEE
Confidence 99999999999999999999765 45999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+|+....... .......+||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..+ ...
T Consensus 176 FGla~~~~~~~~------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~-- 244 (311)
T 4aw0_A 176 FGTAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFA-- 244 (311)
T ss_dssp CTTCEECCTTTT------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH--
T ss_pred cCCceecCCCCC------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--
Confidence 999998754321 123455789999999999999999999999999999999999999998755321 111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH---HHHhhcCCCCCCC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT---LSKIWSSSSDWDP 655 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~---L~~i~~~~~~~~~ 655 (669)
.+... ...+|.....++.+|+.+||+.||.+|||++|++.. ++-=+-...||+.
T Consensus 245 -~i~~~---------------~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 245 -KIIKL---------------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp -HHHHT---------------CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred -HHHcC---------------CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 11111 112344556678999999999999999999987532 2222345678875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=409.46 Aligned_cols=240 Identities=25% Similarity=0.404 Sum_probs=202.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec-------ccHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-------GDVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
|++.+ ++|.|+| |.||+|... |+.||||+++ ..+.+|+.+|++++|||||++++++.+++..|
T Consensus 153 y~~~~-~iG~G~f-------G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 153 LDNFI-KIGEGST-------GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp EEEEE-EEEECSS-------CEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cEeee-EeccCcC-------cEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 44444 4999999 999999984 8899999984 24789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
|||||+++|+|.++++.. .+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 225 iVmEy~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccce
Confidence 999999999999999754 4899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+. ..
T Consensus 296 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~------- 357 (423)
T 4fie_A 296 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK------- 357 (423)
T ss_dssp ECCSSC--------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH-------
T ss_pred ECCCCC--------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH-------
Confidence 765432 123457899999999999999999999999999999999999999987653211 11
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.....+.+ ..+..++.++.+|+.+||+.||.+|||+.|++++
T Consensus 358 ------~i~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 358 ------MIRDNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ------HHHHSCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------HHHcCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111121 2233455678999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=386.10 Aligned_cols=238 Identities=26% Similarity=0.434 Sum_probs=188.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+ ++|+|+| |+||++.. .|+.||||+++. .+.+|+++|++++|||||++++++.+
T Consensus 13 g~Y~i~~-~lG~G~f-------g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 13 GNYQIVK-TLGEGSF-------GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp -CCEEEE-EEEC----------CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred eCeEEEE-EEecCcC-------eEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4577666 4999999 99999997 488999999852 36789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..|+||||+ +|+|.+++.+. +.+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~D 155 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIAD 155 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECC
T ss_pred CCEEEEEEeCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEee
Confidence 99999999999 68999999764 46999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+|+...... ......||+.|||||.+.+..+ +.++||||+||++|||++|+.||.+....+ ....
T Consensus 156 FGla~~~~~~~---------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~ 223 (275)
T 3hyh_A 156 FGLSNIMTDGN---------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKN 223 (275)
T ss_dssp SSCC------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred cCCCeecCCCC---------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH
Confidence 99998764322 2334689999999999998876 579999999999999999999998754321 1111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+... ....|..++.++.+|+.+||+.||.+|||++|++++
T Consensus 224 ---i~~~---------------~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 224 ---ISNG---------------VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---HHHT---------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---HHcC---------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 012344456678999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=395.38 Aligned_cols=249 Identities=28% Similarity=0.403 Sum_probs=198.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
..|++.+. +|+|+| |+||+++. .++.||||+++. .+.+|+++|++++|||||++++++
T Consensus 24 ~~Y~i~~~-lG~G~f-------g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 24 SQFELLKV-LGQGSF-------GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp GGEEEEEE-EECGGG-------CEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE
T ss_pred cccEEEEE-EecCCC-------eEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 34666664 999999 99999986 256799999852 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
.+++..||||||+++|+|.+++.+. +.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl 167 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKL 167 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEe
Confidence 9999999999999999999999865 46999999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+|+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||.+.+..+ .
T Consensus 168 ~DFGla~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~-- 234 (304)
T 3ubd_A 168 TDFGLSKESIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---T-- 234 (304)
T ss_dssp ESSEEEEC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--
T ss_pred cccccceeccCCC--------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---H--
Confidence 9999998654322 12344689999999999999999999999999999999999999998765321 1
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHHHhhcCCCCCC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI-----SEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~L~~i~~~~~~~~ 654 (669)
+..+... ....|..++.++.+|+.+||+.||.+|||+ +|++++ -+-...||+
T Consensus 235 -~~~i~~~---------------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H---p~f~~idw~ 291 (304)
T 3ubd_A 235 -MTMILKA---------------KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH---SFFSTIDWN 291 (304)
T ss_dssp -HHHHHHC---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS---GGGTTCCHH
T ss_pred -HHHHHcC---------------CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC---ccccCCCHH
Confidence 1111110 123445566788999999999999999985 555532 233345664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=380.26 Aligned_cols=257 Identities=22% Similarity=0.368 Sum_probs=183.6
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC--
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG-- 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 427 (669)
|++.+ .+|+|+| |.||+|+.. |+.||||+++. .+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~-~lG~G~f-------g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 7 FEPIQ-CLGRGGF-------GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp EEEEE-EEEECC---------EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred CEEee-EEecCCC-------eEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 44434 3899999 999999974 88999999852 3678999999999999999999987654
Q ss_pred ----------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 428 ----------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 428 ----------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
..|+||||+++|+|.+++.... ......+..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTM 153 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECC
Confidence 3699999999999999998652 2234677889999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCc----ccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGY----GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
++.+||+|||+|+............ ........+||+.|||||.+.+..|+.++|||||||++|||++ ||.+.
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 9999999999999875533211000 0111234579999999999999999999999999999999996 66532
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCC
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDW 653 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~ 653 (669)
.. . ...+.. +.. ... .+........+.+|+.+||+.||.+|||+.|++++ -+-...||
T Consensus 231 ~~--~---~~~~~~----------~~~---~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h---~~~~~~~~ 288 (299)
T 4g31_A 231 ME--R---VRTLTD----------VRN---LKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN---AVFEDLDF 288 (299)
T ss_dssp HH--H---HHHHHH----------HHT---TCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS---GGGCCC--
T ss_pred cH--H---HHHHHH----------Hhc---CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC---HhhCCCCC
Confidence 11 0 011110 111 011 11122334457889999999999999999999863 22234566
Q ss_pred C
Q 005923 654 D 654 (669)
Q Consensus 654 ~ 654 (669)
.
T Consensus 289 p 289 (299)
T 4g31_A 289 P 289 (299)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=380.88 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=199.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe--
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH-- 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~-- 425 (669)
.|++.+ ++|.|+| |.||+|.. .|+.||||+++. .+.+|+++|++++|||||++++++..
T Consensus 55 ~Y~~~~-~lG~G~f-------G~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 55 EYEIIE-TIGNGAY-------GVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp SEEEEE-EEEECSS-------CEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CeEEEE-EEecccC-------eEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 466655 4999999 99999998 488999999963 25689999999999999999999764
Q ss_pred ----cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 426 ----EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 426 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
.+..||||||++ |+|.+++.+. +.+++..+..|+.||+.||+|||+++ ||||||||+|||++.++.+
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred ccccCCEEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCE
Confidence 357899999996 6899999754 46999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
||+|||+|+.+....... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+
T Consensus 198 Ki~DFGla~~~~~~~~~~----~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--- 270 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEH----QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--- 270 (398)
T ss_dssp EECCCTTCBCC-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---
T ss_pred EEeecceeeecccCcccc----ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---
Confidence 999999999765432111 1223457899999999998875 56999999999999999999999998765432
Q ss_pred HHHHHHHHHhhhhH-----------HhhhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--
Q 005923 581 LYASISRVLEESNV-----------REKLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT-- 642 (669)
Q Consensus 581 ~~~~~~~~~~~~~~-----------~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~-- 642 (669)
....+......... ...+..+ .+. ...+ .....++.+|+.+||+.||.+|||+.|++++
T Consensus 271 ~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 271 QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSL-PPR--QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp HHHHHHHHHCCCCGGGTC-----CHHHHHHSS-CCC--CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcC-CCc--CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 22222222211110 0001111 000 0111 1234568899999999999999999999875
Q ss_pred HHHh
Q 005923 643 LSKI 646 (669)
Q Consensus 643 L~~i 646 (669)
|++.
T Consensus 348 f~~~ 351 (398)
T 4b99_A 348 LAKY 351 (398)
T ss_dssp GTTT
T ss_pred hCcC
Confidence 5444
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=367.57 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=194.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc-----cHHHHHHHHHhc-CCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG-----DVSSEINILKKI-NHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~-----~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+| |+||+|+.+ ++.||+|.+.. .+.+|+++|+++ +|||||++++++.+++
T Consensus 22 ~Y~i~~-~lG~G~f-------g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 22 VFKIED-KIGEGTF-------SSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp TCEEEE-EEEECSS-------EEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cEEEEE-EEecccC-------cEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 477766 4999999 999999863 56799998853 367899999998 6999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEccc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNF 506 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~Df 506 (669)
+.|+||||+++|+|.++++ .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999999983 3899999999999999999999999 9999999999999877 79999999
Q ss_pred CCccccCCCccccCC--------------------cccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHc
Q 005923 507 GLARSAESDEHEQGG--------------------YGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLS 565 (669)
Q Consensus 507 Gla~~~~~~~~~~~~--------------------~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~ellt 565 (669)
|+|+........... .........+||+.|||||++.+. .++.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 999865432211000 001122345799999999999875 58999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHHhhhhHHh-------------------------hhhccc--CCcc---------CCC
Q 005923 566 GREAVTGDQNCEAELLYASISRVLEESNVRE-------------------------KLRGFI--DPSL---------RNE 609 (669)
Q Consensus 566 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~l~~~~--d~~l---------~~~ 609 (669)
|+.||....+.. . ....+...+....... .++..- .+.+ ..+
T Consensus 243 G~~Pf~~~~~~~-~-~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 243 GRYPFYKASDDL-T-ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp TCSSSSCCSSHH-H-HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred CCCCCCCCCCHH-H-HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 999997554322 1 1122222221111000 000000 0000 001
Q ss_pred CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 610 YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 610 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.....+.++.+|+.+||+.||.+|||++|++++
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 112334568899999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=359.31 Aligned_cols=273 Identities=31% Similarity=0.553 Sum_probs=223.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
..|++.+. +|.|+| |.||+|..+ ++.||||++.. .+.+|++++++++||||+++++++.+++..
T Consensus 39 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 39 NNFDHKFL-IGHGVF-------GKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCSCCCC-SCBCSS-------SEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred hccCccce-eecCCC-------eeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34555553 899999 999999985 78999998753 467899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++|+|.+++.... .....++|..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999999997653 23346999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+....... ........||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+......+..
T Consensus 187 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~--- 257 (321)
T 2qkw_B 187 KKGTELDQ------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV--- 257 (321)
T ss_dssp EECSSSSC------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH---
T ss_pred cccccccc------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh---
Confidence 86543221 112233568999999999999999999999999999999999999998644322111111111
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
.......+...+++.+....+.+++..+.+++.+||+.||.+|||+.|+++.|+.+.....+
T Consensus 258 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 258 -ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp -HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred -hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 11112345566777777777888999999999999999999999999999999999876544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=386.59 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=202.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
..|.+.+ ++|.|+| |.||++.. .|+.||+|+++. .+.+|+++|++++|||||++++++.+++.
T Consensus 157 ~~Y~i~~-~lG~G~f-------g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 157 DHYDIHE-ELGTGAF-------GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GTEEEEE-EEEEETT-------EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred cccEEEE-EEeeccC-------eEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4566666 3999999 99999998 488999999853 36789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC--CcEEEccc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN--LRAKITNF 506 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~--~~~kl~Df 506 (669)
.||||||+++|+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeec
Confidence 99999999999999999653 246999999999999999999999999 9999999999999854 89999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+|+.+.... ......||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+. +.
T Consensus 302 G~a~~~~~~~---------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~ 366 (573)
T 3uto_A 302 GLTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LR 366 (573)
T ss_dssp SSCEECCTTS---------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HH
T ss_pred cceeEccCCC---------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HH
Confidence 9999875432 23456899999999999999999999999999999999999999987654221 11
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+... +..+.......++..+.+|+.+||+.||.+|||+.|++++
T Consensus 367 ~i~~~-----------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 367 NVKSC-----------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHTT-----------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHhC-----------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 1111122223455678999999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=386.71 Aligned_cols=241 Identities=22% Similarity=0.323 Sum_probs=196.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHH---HHHHHhcCCCCceeEeeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSE---INILKKINHSNIIRLSGF 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E---~~~l~~l~H~niv~l~g~ 422 (669)
..|.+.++ +|.|+| |+||+++. .|+.||+|+++.. +..| +.+++.++|||||+++++
T Consensus 189 ddf~i~k~-LG~G~f-------G~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~ 260 (689)
T 3v5w_A 189 NDFSVHRI-IGRGGF-------GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 260 (689)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred HHeEEEEE-EecccC-------eEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE
Confidence 34555553 999999 99999998 4889999998531 2233 566677799999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+.+++..||||||++||+|.++|.+. +.+++..+..++.||+.||+|||+++ ||||||||+||||+.++++|
T Consensus 261 f~~~~~lylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 261 FHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEE
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEE
Confidence 99999999999999999999999865 46999999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
|+|||+|+...... ....+||+.|||||++.+ ..|+.++||||+||+||||++|+.||.+....+....
T Consensus 333 L~DFGlA~~~~~~~----------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i 402 (689)
T 3v5w_A 333 ISDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402 (689)
T ss_dssp ECCCTTCEECSSCC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH
T ss_pred ecccceeeecCCCC----------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 99999998765322 334689999999999975 5799999999999999999999999985432211111
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
...... . ...+|..++.++.+|+.+||+.||.+|++ ++||+++
T Consensus 403 ---~~~i~~-------------~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 403 ---DRMTLT-------------M--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---HHHHHH-------------C--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---HHhhcC-------------C--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111110 0 12345556678899999999999999998 6777654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=356.02 Aligned_cols=254 Identities=31% Similarity=0.523 Sum_probs=200.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ .+|.|+| |.||+|..+|+.||||+++. .+.+|++++++++||||+++++++.+.+..
T Consensus 38 ~y~i~~-~lG~G~~-------g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 38 DLNIKE-KIGAGSF-------GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred Hceeee-EeecCCC-------eEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 455555 3899999 99999999999999999853 367899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999997642 1224899999999999999999999985 56999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+... ..
T Consensus 187 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------~~- 251 (309)
T 3p86_A 187 RLKASTF--------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AV- 251 (309)
T ss_dssp -----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HH-
T ss_pred ccccccc--------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-
Confidence 8654321 11234578999999999999999999999999999999999999998654321100 00
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.. .......+..++..+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 252 ---------~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 252 ---------GF---KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---------HH---SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---------Hh---cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 00 01122344556678999999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=363.14 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=208.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
.|++.+ .+|.|+| |.||+|... +..||||+++. ++.+|+.+|+++ +||||++++
T Consensus 82 ~~~~~~-~LG~G~f-------g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 82 KLTLGK-PLGEGCF-------GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp GEEEEE-EESCCSS-------SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred HCEeee-EEeeCCC-------eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 455555 3999999 999999863 23599999863 367899999999 899999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
++|..++..++||||+++|+|.+++...+. .....+++..++.++.||+.||+|||+++ |+|||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlk 230 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence 999999999999999999999999987531 12346899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||++.++.+||+|||+++........ .......+|..|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~ 304 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTT------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred hhhEEECCCCCEEEccccCCcccCcccce------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999876543211 11223457889999999999999999999999999999999 999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+....+.. . . +. ...+...+..++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 305 p~~~~~~~~~~---~----~---------~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 305 PYPGIPVEELF---K----L---------LK----EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp SSTTCCGGGHH---H----H---------HH----TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHH---H----H---------Hh----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99865432110 0 0 00 111233445566789999999999999999999999999999986
Q ss_pred CC
Q 005923 649 SS 650 (669)
Q Consensus 649 ~~ 650 (669)
..
T Consensus 365 ~~ 366 (370)
T 2psq_A 365 LT 366 (370)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=354.82 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=207.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||+|... +..||||+++. ++.+|+.++++++||||+++++++.
T Consensus 49 ~~y~i~~~-lG~G~~-------g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 49 SRIHIEKI-IGSGDS-------GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp GGEEEEEE-EEETTT-------EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hHeEEeeE-EEeCCC-------cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34665554 999999 999999983 33599999864 3678999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..++||||+++|+|.++++.. ...+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~ 193 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVS 193 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred eCCccEEEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEEC
Confidence 999999999999999999999754 246999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++........ ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+..
T Consensus 194 Dfg~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---- 264 (325)
T 3kul_A 194 DFGLSRVLEDDPDA-----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI---- 264 (325)
T ss_dssp CCSSCEECC----C-----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----
T ss_pred CCCcccccccCccc-----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH----
Confidence 99999976543211 112233456788999999999999999999999999999999 99999865432110
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
..+. .......+..++..+.+++.+||+.||.+|||+.||++.|+++......
T Consensus 265 ------------~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 265 ------------SSVE----EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ------------HHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ------------HHHH----cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 0010 1122334455667899999999999999999999999999999876443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=353.37 Aligned_cols=269 Identities=32% Similarity=0.582 Sum_probs=215.8
Q ss_pred HHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecC
Q 005923 367 IATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
+|.|+| |.||+|.. +|+.||||+++. .+.+|++++++++||||+++++++...+..++||||++
T Consensus 38 lg~G~~-------g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 110 (326)
T 3uim_A 38 LGRGGF-------GKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 110 (326)
T ss_dssp EECCSS-------SEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCT
T ss_pred EecCCC-------cEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEecc
Confidence 555555 99999987 478899999853 46789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcc
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEH 517 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~ 517 (669)
+|+|.++++... .....++|..+..|+.|++.||+|||++..++|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 188 (326)
T 3uim_A 111 NGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 188 (326)
T ss_dssp TCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS-
T ss_pred CCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc-
Confidence 999999998753 334569999999999999999999999922239999999999999999999999999998765432
Q ss_pred ccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchh--HHHHHHHHHHHHHhhhhHH
Q 005923 518 EQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC--EAELLYASISRVLEESNVR 595 (669)
Q Consensus 518 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 595 (669)
........||..|+|||.+.+..++.++||||||+++|||++|+.||...... .......+ +......
T Consensus 189 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~ 258 (326)
T 3uim_A 189 ------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW----VKGLLKE 258 (326)
T ss_dssp ------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH----HTTTTSS
T ss_pred ------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH----HHHHhhc
Confidence 12234456999999999999999999999999999999999999999621100 00001111 1111122
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDP 655 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 655 (669)
..+..+.+..+...++.+.+..+.+++.+||+.||.+|||+.||+++|++... ...|+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~-~~~~~~ 317 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL-AERWEE 317 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC-SSSCC-
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch-hhhhhh
Confidence 34556677777778888999999999999999999999999999999987532 234544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=357.29 Aligned_cols=267 Identities=27% Similarity=0.411 Sum_probs=204.9
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc------HHHHHHHHHhcCCCCceeEeeEEEecCc--
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD------VSSEINILKKINHSNIIRLSGFCVHEGN-- 428 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~~~~-- 428 (669)
...|++.+. +|.|+| |.||+|++.++.||||+++.. ...|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPLQLLEV-KARGRF-------GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEEEEEEE-EECSTT-------CEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred hhhchhhhe-ecccCc-------eEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 345666664 999999 999999999999999998642 4568888999999999999999987553
Q ss_pred --eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeeCCCCCCeeec
Q 005923 429 --TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY----------TNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 429 --~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~----------~~~~ivHrDik~~NILl~ 496 (669)
.++||||+++|+|.++++.. .++|..++.++.|++.||+|||+. + |+||||||+|||++
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLK 165 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEEC
Confidence 69999999999999999764 399999999999999999999998 7 99999999999999
Q ss_pred CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCC
Q 005923 497 TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-----VITPKLDVFAFGVVVLELLSGREAVT 571 (669)
Q Consensus 497 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDV~S~Gvvl~elltg~~p~~ 571 (669)
.++.+||+|||+++........ .......||..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSA------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCC------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred CCCeEEEccCCcccccccccCc------cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999876543211 112335789999999999873 55678999999999999999999997
Q ss_pred CCchhHHHHHHHHHHHHHhhhhHHh----hhhcccCCccCCC-CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 572 GDQNCEAELLYASISRVLEESNVRE----KLRGFIDPSLRNE-YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+..+..... +.. .......... .......+.+... .+...+..+.+|+.+||+.||.+|||+.||++.|++|
T Consensus 240 ~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 240 GPVDEYMLP-FEE--EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SCCCCCCCT-THH--HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhccc-hhh--hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 543211000 000 0000000000 1111112222111 1234567799999999999999999999999999998
Q ss_pred hcC
Q 005923 647 WSS 649 (669)
Q Consensus 647 ~~~ 649 (669)
...
T Consensus 317 ~~~ 319 (322)
T 3soc_A 317 QRL 319 (322)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=368.76 Aligned_cols=248 Identities=27% Similarity=0.468 Sum_probs=207.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEecC-ceeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHEG-NTYLV 432 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV 432 (669)
.|++.+ .+|.|+| |.||+|.++|+.||||+++. .+.+|+.+|++++||||+++++++.+.+ ..++|
T Consensus 194 ~~~~~~-~lG~G~f-------g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 194 ELKLLQ-TIGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred HeEEEe-eecCcCC-------eeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 344444 4899999 99999999999999999974 4789999999999999999999987765 78999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 266 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EECCTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999999999998652 234799999999999999999999999 999999999999999999999999999854
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
.... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+..
T Consensus 340 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------------ 396 (450)
T 1k9a_A 340 SSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------ 396 (450)
T ss_dssp C-----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH------------
T ss_pred cccc-----------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------
Confidence 3221 12356889999999999999999999999999999998 99999865432110
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCC
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSS 651 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 651 (669)
..+ ....+...|..++..+.+||.+||+.||.+|||+.|+++.|+.+.....
T Consensus 397 ----~~i----~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 397 ----PRV----EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp ----HHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred ----HHH----HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 001 0112334556677889999999999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=363.06 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=205.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|.+.+ .+|.|+| |.||+|.+. +..||||.++. ++.+|+++|++++||||++++++|..++.
T Consensus 115 ~~~~~~-~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 115 DLVLGE-QIGRGNF-------GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GEEEEE-EEEEETT-------EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HeEEee-EeccCCC-------CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 344444 4899999 999999994 78899999863 46789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++|+|.++++... ..+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred cEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCC
Confidence 999999999999999997642 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++........ .......++..|+|||.+.++.++.++||||||+++|||++ |+.||.+....+. ..
T Consensus 260 s~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~ 326 (377)
T 3cbl_A 260 SREEADGVYA------ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------RE 326 (377)
T ss_dssp CEECTTSEEE------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HH
T ss_pred ceecCCCcee------ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HH
Confidence 9865432211 01112345778999999999999999999999999999998 9999986543211 00
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
. +....+.+.|..++..+.+|+.+||+.||.+|||+.||++.|+++..
T Consensus 327 ~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 327 F-------------VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp H-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-------------HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1 11112234455566789999999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=360.53 Aligned_cols=251 Identities=29% Similarity=0.491 Sum_probs=194.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.+. +|.|+| |.||+|+.. +..||||.++. ++.+|+.++++++||||+++++++.+
T Consensus 46 ~~~~~~~-lG~G~f-------g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 46 NISIDKV-VGAGEF-------GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GCCCCEE-EEECSS-------SEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hceeeeE-EeeCCC-------eEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 4555554 899999 999999874 56799999863 47789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.++++.. ...+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECc
Confidence 99999999999999999999754 246999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++........ ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.
T Consensus 191 fg~a~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~------ 259 (373)
T 2qol_A 191 FGLGRVLEDDPEA-----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV------ 259 (373)
T ss_dssp C---------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH------
T ss_pred CccccccccCCcc-----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 9999876543211 111223345778999999999999999999999999999998 9999986543211
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
...+ +...+...+..++..+.+++.+||+.||.+||++.||++.|+++...
T Consensus 260 -~~~i-------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 260 -IKAV-------------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -HHHH-------------HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHHH-------------HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0000 11122233445667899999999999999999999999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.56 Aligned_cols=246 Identities=34% Similarity=0.557 Sum_probs=196.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+. +|.|+| |.||+|...++.+|||+++. .+.+|++++++++||||+++++++.++
T Consensus 7 ~~~~~~~~-lg~G~~-------g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 7 AELTLEEI-IGIGGF-------GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp TSEEEEEE-EEEETT-------EEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred hheeeeee-eccCCC-------eEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 34555553 999999 99999999999999999752 366899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC--------C
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--------N 498 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~--------~ 498 (669)
+..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++..+++||||||+|||++. +
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999999999964 35899999999999999999999988666899999999999986 7
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
+.+||+|||+++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.+......
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222 (271)
T ss_dssp CCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred cceEEccCCccccccccc----------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 789999999998654322 1234689999999999999999999999999999999999999986543211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
.. ...........+..++..+.+++.+||+.||.+|||+.|+++.|++|
T Consensus 223 ~~-------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 AY-------------------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HH-------------------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HH-------------------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00 00111222334455567899999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.84 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=206.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ ++|.|+| |.||++.. +++.||+|+++. ++.+|++++++++||||+++++++.+++..++
T Consensus 11 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 11 ELTFVQ-EIGSGQF-------GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GEEEEE-EEEECSS-------CEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred hceeeh-eecCCCc-------cEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 455545 3899999 99999998 577899999863 47899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp EEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEeCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccc
Confidence 999999999999997542 46899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ..
T Consensus 156 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~~---- 218 (269)
T 4hcu_A 156 VLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VE---- 218 (269)
T ss_dssp BCCHHH-------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HH----
T ss_pred cccccc-------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------HH----
Confidence 644321 11223456788999999999999999999999999999999 9999986543211 00
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.+.. ......+...+..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 219 ------~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 219 ------DIST----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp ------HHHT----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ------HHhc----CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 0111 1112223344567899999999999999999999999999997653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.69 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=204.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
..|.+.+. +|.|+| |.||++... +..+|+|.+.. .+.+|++++++++||||+++++++.+++.
T Consensus 10 ~~~~~~~~-lG~G~~-------g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 10 SDLIHGEV-LGKGCF-------GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81 (310)
T ss_dssp GGEEEEEE-EECCSS-------EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hHeeccce-ecCCCC-------EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence 34555553 899999 999999984 78899998742 47789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++|+|.++++.. ...++|..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTT
T ss_pred eEEEEEecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccc
Confidence 99999999999999999864 246999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCc------ccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 509 ARSAESDEHEQGGY------GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 509 a~~~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
++............ .........||..|+|||.+.+..++.++||||||+++|||++|..|+...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~- 233 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG- 233 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-
Confidence 98765433211000 00111246799999999999999999999999999999999999998874322110000
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
......+.. ..+..++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 234 ---------~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 234 ---------LNVRGFLDR--------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---------BCHHHHHHH--------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------hhhhccccc--------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000011111 11223345688999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.02 Aligned_cols=267 Identities=25% Similarity=0.430 Sum_probs=203.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.+ ++|.|+| |.||++.+ .++.||||+++. .+.+|++++++++||||+++++++..
T Consensus 11 ~~~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 11 HLKFLQ-QLGKGNF-------GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred Hhhhhh-eeeccCC-------EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 455555 3899999 99999985 477899999863 46789999999999999999999865
Q ss_pred c--CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 E--GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
. ...++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEE
Confidence 4 45899999999999999998652 35999999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++........ ........++..|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus 156 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---- 226 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEF-----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR---- 226 (295)
T ss_dssp CCCCSCC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH----
T ss_pred ccCcccccccCCcce-----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh----
Confidence 999999876543211 12223346778899999999999999999999999999999999988643211000
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..............+...+....+...+..++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000000000000011111222223344566677899999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=370.28 Aligned_cols=249 Identities=27% Similarity=0.480 Sum_probs=208.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
|++.+ ++|.|+| |.||+|.++ +..||||.++. ++.+|+.+|++++||||++++++|..++..++
T Consensus 222 ~~~~~-~lG~G~f-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 222 ITMKH-KLGGGQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp EEEEE-ESGGGTT-------SSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeee-EecCCCC-------eEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 44444 4999999 999999996 77899999864 47789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.++++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 294 v~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEccCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999998642 346999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+..
T Consensus 368 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~----------- 429 (495)
T 1opk_A 368 MTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------- 429 (495)
T ss_dssp CTTCCE-------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----------
T ss_pred ccCCce-------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----------
Confidence 654321 11222456788999999999999999999999999999999 99999865432210
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+ .+....+...+..++..+.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 430 -----~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 430 -----E----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -----H----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -----H----HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 0 0111223344556677899999999999999999999999999988653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.87 Aligned_cols=242 Identities=23% Similarity=0.410 Sum_probs=201.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
..|++.+ .+|.|+| |.||+|.. +++.||||++.. .+.+|+.++++++||||+++++++..++.
T Consensus 20 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 20 KKYTRFE-KIGQGAS-------GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GTBCCCE-EEEEETT-------EEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hceeeee-eeccCCC-------eEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 3455555 3899999 99999986 588999999852 36789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999764 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+........ ..
T Consensus 163 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~ 228 (297)
T 3fxz_A 163 CAQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LI 228 (297)
T ss_dssp CEECCSTTC--------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH
T ss_pred ceecCCccc--------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH
Confidence 987654321 1234579999999999999999999999999999999999999998655322111 00
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... .......+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus 229 ~~~------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 229 ATN------------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHH------------CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HhC------------CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 011123345566778999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.32 Aligned_cols=272 Identities=34% Similarity=0.589 Sum_probs=213.3
Q ss_pred ccchhHHHHHhCCCCcc------ccee----eEEEEEEECCCeeEEEEecc-----------cHHHHHHHHHhcCCCCce
Q 005923 359 LYKFQDLKIATGSFSEE------NRIQ----GSVYRGSFKGDDAAVKVMKG-----------DVSSEINILKKINHSNII 417 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~------~~~~----G~Vy~g~~~g~~vavK~~~~-----------~~~~E~~~l~~l~H~niv 417 (669)
.|.+.+++..+.+|... ..++ |.||+|..+++.+|||++.. .+.+|+.++++++||||+
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 34555555555555444 2332 89999999999999999842 367899999999999999
Q ss_pred eEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 418 RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 418 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
++++++.+++..++||||+++|+|.+++...+ ....++|..++.++.|++.||+|||+++ ++||||||+|||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 99999999999999999999999999997542 2356999999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
++.+||+|||+++....... ........||..|+|||.+.+ .++.++||||||+++|||++|+.||.+.....
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQ------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp TCCEEECCCTTCEECCSCSS------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred CCcEEEeecccccccccccc------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999987654221 112334578999999998865 58999999999999999999999998643321
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
.. ..+...... ....+..++++.+ ...+...+..+.+++.+||+.||.+|||+.||++.|+++..
T Consensus 242 ~~---~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LL---LDIKEEIED--EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BT---THHHHHHHT--TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HH---HHHHHHhhh--hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 10 011111111 0122344455544 34567788899999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=354.27 Aligned_cols=260 Identities=28% Similarity=0.475 Sum_probs=210.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC---------CeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG---------DDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g---------~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
.|.+.+ .+|.|+| |.||+|...+ ..||||+++. ++.+|+++++++ +||||++++
T Consensus 70 ~y~i~~-~LG~G~~-------g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 70 RLVLGK-PLGEGAF-------GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred heEeee-EEecCCC-------eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 455544 3999999 9999999632 4699999864 367899999999 999999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
++|..++..++||||+++|+|.+++...+. .....+++..++.|+.||+.||+|||+.+ |+|||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 218 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 999999999999999999999999987531 11246999999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||+++++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~ 292 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTT------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cceEEEcCCCcEEEcccCccccccccccc------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999876543211 11233467889999999999999999999999999999999 999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+....+. ... +.. ......+..++.++.+++.+||+.||.+|||+.||++.|+++..
T Consensus 293 p~~~~~~~~~-------~~~---------~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 293 PYPGVPVEEL-------FKL---------LKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp SSTTCCHHHH-------HHH---------HHT----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHH-------HHH---------HHc----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9986543210 011 111 11223344556678999999999999999999999999999997
Q ss_pred CCCCCCC
Q 005923 649 SSSDWDP 655 (669)
Q Consensus 649 ~~~~~~~ 655 (669)
...+.+.
T Consensus 353 ~~~~~~~ 359 (382)
T 3tt0_A 353 LTSNQEM 359 (382)
T ss_dssp HSCSCC-
T ss_pred HHhcCCC
Confidence 7655544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.23 Aligned_cols=250 Identities=26% Similarity=0.500 Sum_probs=206.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ ++|.|+| |.||+|.++ +..||||+++. ++.+|+.+|++++||||+++++++. ++..++
T Consensus 189 ~~~~~~-~lG~G~f-------g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 189 SLKLEK-KLGAGQF-------GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp GEEEEE-EEECCSS-------EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HeEEEE-EcccCCc-------eEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 345544 4999999 999999995 67899999974 4789999999999999999999986 678899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.++++..+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 260 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EECCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 999999999999997542 135889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......++..|+|||.+..+.++.++||||||+++|||++ |+.||.+....+.. . .+.
T Consensus 334 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~----~i~ 399 (454)
T 1qcf_A 334 IEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R----ALE 399 (454)
T ss_dssp BCCHHH-------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H----HHH
T ss_pred cCCCce-------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHH
Confidence 654321 11122356788999999999999999999999999999999 99999875532110 0 010
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
...+.+.+..++..+.+++.+||+.||.+|||+++|++.|+.+....
T Consensus 400 -------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 400 -------------RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -------------cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 01122345566778999999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=340.44 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=198.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc----HHHHHHHHHh--cCCCCceeEeeEEEec----Cc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----VSSEINILKK--INHSNIIRLSGFCVHE----GN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~----~~~E~~~l~~--l~H~niv~l~g~~~~~----~~ 428 (669)
.|++.+ .+|.|+| |.||+|..+++.||||+++.+ +..|.+++.. ++||||+++++++... ..
T Consensus 9 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 9 DITLLE-CVGKGRY-------GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GCEEEE-EEEECSS-------EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cEEEEE-eeccCCC-------cEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 455555 3899999 999999999999999998643 4567777777 7999999999997653 45
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeeCCCCCCeeecCCCc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH--------KYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
.++||||+++|+|.++++.. .+++..+++++.|++.||+||| +.+ |+||||||+|||++.++.
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSC
T ss_pred eEEehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCC
Confidence 79999999999999999643 5999999999999999999999 777 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccC------CCCchhhHHHHHHHHHHHHcC--------
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG------VITPKLDVFAFGVVVLELLSG-------- 566 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~s~~sDV~S~Gvvl~elltg-------- 566 (669)
+||+|||+++......... ........||..|+|||.+.+. .++.++||||||+++|||++|
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQL----DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp EEECCCTTCEEEETTTTEE----ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred EEEeeCCCeeecccccccc----cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 9999999998654432110 0112335799999999999876 456799999999999999999
Q ss_pred --CCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 567 --REAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLR-NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 567 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+.||.......... ..+..... .....+.+. ...+..++..+.+++.+||+.||.+|||+.||++.|
T Consensus 228 ~~~~pf~~~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSF--EDMRKVVC--------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CCCCTTTTTSCSSCCH--HHHHHHHT--------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccccCCCCcch--hhhhHHHh--------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 78876432211000 01111110 011111111 112345778899999999999999999999999999
Q ss_pred HHh
Q 005923 644 SKI 646 (669)
Q Consensus 644 ~~i 646 (669)
++|
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=349.42 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=205.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|++.+ .+|.|+| |.||+|...+ +.||||.++. .+.+|+.++++++||||+++++++
T Consensus 48 ~~~~~~-~lg~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 48 NIEYVR-DIGEGAF-------GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp GCEEEE-EEEECSS-------CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HCeeee-eeeecCC-------eeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 455544 3899999 9999999864 6799999864 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQ-------------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv 484 (669)
.+++..++||||+++|+|.+++...... ....+++..++.|+.||+.||+|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999864211 1256999999999999999999999999 99
Q ss_pred eeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 005923 485 HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564 (669)
Q Consensus 485 HrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ell 564 (669)
||||||+|||+++++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||+
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCcc------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 999999999999999999999999987643321 11223456789999999999999999999999999999999
Q ss_pred c-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 565 S-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 565 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+ |+.||.+....+. .. .+. +. .....+..++..+.+++.+||+.||.+|||+.|+++.|
T Consensus 271 t~g~~p~~~~~~~~~------~~-~~~------------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 271 SYGLQPYYGMAHEEV------IY-YVR------------DG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp TTTCCTTTTSCHHHH------HH-HHH------------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCCCcCCCCChHHH------HH-HHh------------CC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 9 9999986543211 00 000 00 01223445566799999999999999999999999999
Q ss_pred HHhhcC
Q 005923 644 SKIWSS 649 (669)
Q Consensus 644 ~~i~~~ 649 (669)
+++...
T Consensus 331 ~~~~~~ 336 (343)
T 1luf_A 331 QRMCER 336 (343)
T ss_dssp HHTTC-
T ss_pred HHHHhh
Confidence 998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.17 Aligned_cols=252 Identities=24% Similarity=0.448 Sum_probs=197.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
..|++.+. +|.|+| |.||++.++++.||||.++. .+.+|++++++++||||+++++++. +..++|
T Consensus 8 ~~~~~~~~-lg~G~~-------g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv 77 (307)
T 2eva_A 8 KEIEVEEV-VGRGAF-------GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77 (307)
T ss_dssp GGEEEEEE-EECCSS-------SEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred hHeeeeeE-eecCCC-------ceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence 34555553 899999 99999999999999999864 4778999999999999999999985 458999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc-EEEcccCCccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR-AKITNFGLARS 511 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~-~kl~DfGla~~ 511 (669)
|||+++|+|.++++... ....+++..++.++.|++.||+|||+.+..+|+||||||+|||++.++. +||+|||+++.
T Consensus 78 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999998652 2235889999999999999999999932223999999999999998876 79999999976
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... ....||..|+|||.+.+..++.++||||||+++|||++|+.||........... .
T Consensus 156 ~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~----- 215 (307)
T 2eva_A 156 IQTHM-----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----W----- 215 (307)
T ss_dssp --------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH----H-----
T ss_pred ccccc-----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH----H-----
Confidence 54321 224689999999999999999999999999999999999999975432211110 0
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.... ......+..++..+.+++.+||+.||.+|||++|+++.|+.+....
T Consensus 216 -----~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 216 -----AVHN----GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp -----HHHT----TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred -----HHhc----CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000 0112233345567899999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=334.24 Aligned_cols=261 Identities=18% Similarity=0.239 Sum_probs=206.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-----cHHHHHHHHHhc-CCCCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-----DVSSEINILKKI-NHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 430 (669)
.|++.+. +|.|+| |.||+|.. +|+.||||+++. .+.+|+.+++++ +|+|++++++++.++...+
T Consensus 11 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 11 HYKVGRR-IGEGSF-------GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TEEEEEE-EEECSS-------CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ceEEEEE-EeecCC-------EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 4555554 899999 99999995 688999999853 578999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc-----EEEcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR-----AKITN 505 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~-----~kl~D 505 (669)
+||||+ +|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 83 lv~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 999999 89999999864 245999999999999999999999999 999999999999987766 99999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++.......... ..........||..|+|||.+.+..++.++||||||+++|||++|+.||.+............+
T Consensus 155 fg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 155 FGMVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred Ccccccccccccccc-ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 999987654322110 0011234567999999999999999999999999999999999999999864332222211111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
........ ... ....++..+.+++.+||+.||.+||++++|++.|+++...
T Consensus 234 ~~~~~~~~----~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 234 GEKKQSTP----LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHHSC----HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhhccCcc----HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 11111000 000 0112345789999999999999999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.64 Aligned_cols=257 Identities=24% Similarity=0.425 Sum_probs=204.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec----------ccHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK----------GDVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+ .+|.|+| |.||++.. .+..||+|.+. ..+.+|+.++++++||||+++++++.++
T Consensus 12 ~y~i~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 12 RYKIVD-KLGGGGM-------STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp TEEEEE-EEEEETT-------EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred cEEEEE-EEccCCC-------EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 455555 3899999 99999987 47889999873 2367899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++... +.+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+||
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999765 35999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++...... ........||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+.. .
T Consensus 156 g~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~ 222 (294)
T 4eqm_A 156 GIAKALSETS-------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------I 222 (294)
T ss_dssp SSSTTC--------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------H
T ss_pred CCcccccccc-------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------H
Confidence 9998764332 12234467999999999999999999999999999999999999999875532110 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhcCCCCCC
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-SISEVFVTLSKIWSSSSDWD 654 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~~~~~~ 654 (669)
.. +.... +......+.+++..+.+++.+||+.||.+|| ++.++.+.|+++.......+
T Consensus 223 ~~---------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 223 KH---------IQDSV-PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HH---------HSSCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred HH---------hhccC-CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 01 11110 1111122334556789999999999999998 99999999998876654433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=340.96 Aligned_cols=266 Identities=18% Similarity=0.255 Sum_probs=209.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-----cHHHHHHHHHhc-CCCCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-----DVSSEINILKKI-NHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 430 (669)
.|++.+. +|.|+| |.||+|.. +|+.||||+++. .+.+|+++++++ +||||+++++++..++..+
T Consensus 10 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 10 NFRVGKK-IGCGNF-------GELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TEEEEEE-CCC-CT-------TSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred CeEEEEE-eeccCC-------ceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 3555553 899999 99999996 588999999853 588999999999 9999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc-----EEEcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR-----AKITN 505 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~-----~kl~D 505 (669)
+||||+ +|+|.+++... ...+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 82 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp EEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred EEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 999999 89999999864 246999999999999999999999999 999999999999998887 99999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++.......... ..........||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+.......+
T Consensus 154 Fg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 154 FALAKEYIDPETKKH-IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred cccceeeecCCCCcc-ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 999997644322110 0011234568999999999999999999999999999999999999999864432222211211
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC-------CCCCCC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS-------SSDWDP 655 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~-------~~~~~~ 655 (669)
........ .. .+. ...+ ++.+++.+||+.||.+||++++|.+.|+++... ..||+.
T Consensus 233 ~~~~~~~~----~~-----~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 233 GDTKRATP----IE-----VLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHHHHSC----HH-----HHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred HhhhccCC----HH-----HHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 11100000 00 000 1123 789999999999999999999999999988744 367874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=335.62 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=202.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec--
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE-- 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~-- 426 (669)
..|++.+ .+|.|+| |.||+|.++++.+|||+++. .+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 10 KQLNFLT-KLNENHS-------GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGCEEEE-EEEEETT-------EEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred HHhHHHH-HhcCCCc-------ceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3455555 3899999 99999999999999999863 367899999999999999999999876
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.++++... ...+++..++.++.|++.||+|||+++ ++++||||||+|||++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred CCeEeeecccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEec
Confidence 67899999999999999998642 236999999999999999999999875 56999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITP---KLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~---~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
|++...... ...||..|+|||.+.+..++. ++||||||+++|||++|+.||.+....+..
T Consensus 158 ~~~~~~~~~-------------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---- 220 (271)
T 3kmu_A 158 DVKFSFQSP-------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---- 220 (271)
T ss_dssp GSCCTTSCT-------------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH----
T ss_pred cceeeeccc-------------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH----
Confidence 887654322 236789999999998765444 899999999999999999999865432110
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
... .. .......+..++..+.+++.+||+.||.+|||++|+++.|+++..
T Consensus 221 --~~~---------~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 221 --MKV---------AL----EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --HHH---------HH----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --HHH---------Hh----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 000 11 112223444556779999999999999999999999999998854
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.49 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=204.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|++.+ .+|.|+| |.||+|.+. +..||||+++. ++.+|+.++++++||||+++++++
T Consensus 72 ~~~~~~-~LG~G~f-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 72 NITLIR-GLGHGAF-------GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp GEEEEE-ECCCCSS-------SCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HeEEee-EeeeCCC-------EEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 345444 3899999 999999963 45799999853 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC--
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRY--QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-- 499 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-- 499 (669)
..++..++||||+++|+|.+++...+. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTT
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCC
Confidence 999999999999999999999987532 12246999999999999999999999999 99999999999999544
Q ss_pred -cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhH
Q 005923 500 -RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577 (669)
Q Consensus 500 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~ 577 (669)
.+||+|||+++....... ........+|..|+|||.+.+..++.++|||||||++|||++ |..||.+....+
T Consensus 221 ~~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~ 294 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294 (367)
T ss_dssp CCEEECCCHHHHHHHHHSS------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ceEEECCCccccccccccc------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 599999999986532211 112234567899999999999999999999999999999998 999998655321
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. .. . +. .......+..++..+.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 295 ~---~~----~---------i~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 295 V---LE----F---------VT----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp H---HH----H---------HH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H---HH----H---------HH----cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 00 0 00 0111233445566789999999999999999999999999988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.42 Aligned_cols=250 Identities=24% Similarity=0.449 Sum_probs=202.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
..|++.+ ++|.|+| |.||++..++ ..||+|+++. ++.+|++++++++||||+++++++.+++..+
T Consensus 24 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 24 KDLTFLK-ELGTGQF-------GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp GGEEEEE-ECC---C-------EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHHhHh-hcCCCCC-------ceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 3455545 3899999 9999999864 4799999863 4778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 96 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred EEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccc
Confidence 9999999999999997632 35999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHH
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 169 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---------- 231 (283)
T 3gen_A 169 YVLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---------- 231 (283)
T ss_dssp GBCCHHH-------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------
T ss_pred ccccccc-------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH----------
Confidence 7644321 11223456788999999999999999999999999999998 99999865432110
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..+.. ......+...+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 232 ------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 232 ------EHIAQ----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ------HHHHT----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHhc----ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00111 111222334456789999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=346.32 Aligned_cols=249 Identities=26% Similarity=0.471 Sum_probs=199.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCe----eEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDD----AAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~----vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.|++.+ .+|.|+| |.||+|.+. ++. ||+|.++. .+.+|+.++++++||||++++++|.
T Consensus 16 ~y~~~~-~lG~G~~-------g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 16 EFKKIK-VLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp GEEEEE-EEEEETT-------EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred Hcccce-EEeeCCC-------eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 455544 3899999 999999973 443 58887642 4778999999999999999999997
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.+ ..++|+||+++|+|.+++...+ ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~-~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 88 TS-TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp SS-SEEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred cC-CeEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEc
Confidence 64 5789999999999999998652 46999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+..
T Consensus 160 Dfg~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---- 229 (327)
T 3poz_A 160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---- 229 (327)
T ss_dssp CTTHHHHHTTTCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----
T ss_pred cCcceeEccCCccc------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----
Confidence 99999876543211 12233456889999999999999999999999999999999 99999865432210
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.. +........+..++..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 230 ---~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 230 ---SI-------------LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---HH-------------HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---HH-------------HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 01 111112233445566789999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=363.20 Aligned_cols=250 Identities=28% Similarity=0.500 Sum_probs=201.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ ++|.|+| |.||+|.+++ ..||||+++. ++.+|+++|++++||||+++++++.+ +..++
T Consensus 185 ~~~~~~-~lG~G~f-------g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 185 SLRLEV-KLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp GEEEEE-EEEECSS-------CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred Hceeee-eecCCCC-------eEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 344444 4999999 9999999975 5799999864 47899999999999999999999865 77899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 256 v~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EehhhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999999997531 235899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||.+....+. .. .
T Consensus 330 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~~-~-- 393 (452)
T 1fmk_A 330 IEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LD-Q-- 393 (452)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HH-H--
T ss_pred cCCCce-------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------HH-H--
Confidence 653221 11223456789999999999999999999999999999999 9999986553211 00 0
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
+ ....+.+.+..++..+.+++.+||+.||.+|||+++|++.|+.+....
T Consensus 394 -------i----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 394 -------V----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -------H----HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -------H----HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 0 011223445566778999999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.80 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=203.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ .+|.|+| |.||++..++ ..||+|+++. ++.+|++++++++||||+++++++.+++..++
T Consensus 9 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 9 EITLLK-ELGSGQF-------GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp GEEEEE-EEEEETT-------EEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred heeeee-eeccCCC-------ceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 344444 3899999 9999999864 4799999864 47789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp EEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred EEEccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCcccee
Confidence 999999999999997642 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ..
T Consensus 154 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~-- 218 (268)
T 3sxs_A 154 VLDDQY-------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KV-- 218 (268)
T ss_dssp CCTTCE-------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HH--
T ss_pred cchhhh-------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HH--
Confidence 654321 11223456778999999999999999999999999999999 999997654321100 00
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
.. ......+...+..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 219 --------~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 219 --------SQ----GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --------HT----TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --------Hc----CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 00 00112233345578999999999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.57 Aligned_cols=240 Identities=26% Similarity=0.459 Sum_probs=200.5
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
+..|++.+. +|.|+| |.||+|.. .|+.||||+++. .+.+|+++|++++||||+++++++..
T Consensus 14 ~~~y~~~~~-lG~G~~-------g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 14 IGNYRLLKT-IGKGNF-------AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp ETTEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCCEEEEEE-EeeCCC-------EEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 345666553 899999 99999997 588999999853 25689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~D 157 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIAD 157 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECS
T ss_pred CCEEEEEEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEee
Confidence 99999999999999999999764 35999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVIT-PKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+++....... .....||+.|+|||.+.+..+. .++|||||||++|||++|+.||.+....+.
T Consensus 158 FG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------ 222 (328)
T 3fe3_A 158 FGFSNEFTVGGK---------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------ 222 (328)
T ss_dssp TTCCGGGSSSCG---------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------
T ss_pred ccCceecCCCCc---------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------
Confidence 999987654321 2345799999999999988875 899999999999999999999987553211
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...... . ....|...+..+.+|+.+||+.||.+|||++|++++
T Consensus 223 ~~~i~~-------------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 223 RERVLR-------------G--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHH-------------C--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHh-------------C--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001110 0 112334455678999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.27 Aligned_cols=256 Identities=30% Similarity=0.438 Sum_probs=204.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSG 421 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g 421 (669)
..|++.+ .+|.|+| |.||+|.+. ++.||||+++. .+.+|+++++++ +||||+++++
T Consensus 22 ~~y~~~~-~lG~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 22 DRLKLGK-PLGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp GGEEEEE-EEEECSS-------EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceeece-eecCCCC-------ceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3455555 3899999 999999853 46799999864 377899999999 7999999999
Q ss_pred EEEecCc-eeEEEEecCCCCHHHHHhcCCCCC------------------------------------------------
Q 005923 422 FCVHEGN-TYLVYEFADNGALSDWLHSNRYQT------------------------------------------------ 452 (669)
Q Consensus 422 ~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~------------------------------------------------ 452 (669)
+|.+.+. .++||||+++|+|.++++..+...
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9987654 899999999999999998653100
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcccc
Q 005923 453 -------------SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519 (669)
Q Consensus 453 -------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 519 (669)
...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 248 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-- 248 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT--
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc--
Confidence 122899999999999999999999999 99999999999999999999999999987644321
Q ss_pred CCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhh
Q 005923 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEESNVREKL 598 (669)
Q Consensus 520 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 598 (669)
........||..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.. ...+.
T Consensus 249 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~-------- 310 (359)
T 3vhe_A 249 ----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLK-------- 310 (359)
T ss_dssp ----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHH--------
T ss_pred ----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHH--------
Confidence 122334578899999999999999999999999999999998 99999865432110 00111
Q ss_pred hcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 599 RGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. ......+..++..+.+++.+||+.||.+|||+.|++++|+++...
T Consensus 311 -~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 311 -E----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -c----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 011223344556789999999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=346.48 Aligned_cols=273 Identities=25% Similarity=0.397 Sum_probs=207.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|++.+ .+|.|+| |.||++.+ .+..||||+++. .+.+|++++++++||||+++++++.
T Consensus 23 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 23 RHLKYIS-QLGKGNF-------GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp GGEEEEE-EEEEETT-------EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhh-hccCCCC-------eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 3455555 3999999 99999995 467899999853 3778999999999999999999987
Q ss_pred e--cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 425 H--EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 425 ~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
. +...++||||+++|+|.+++...+ ..+++..++.|+.|++.||+|||+.+ ++||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEE
Confidence 4 456899999999999999997642 35899999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+|||+++........ ........+|..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 168 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-- 240 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDY-----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-- 240 (327)
T ss_dssp ECCGGGCEECCTTCSE-----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--
T ss_pred EcccccceecccCCcc-----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--
Confidence 9999999876543211 112234568888999999999999999999999999999999999987532210000
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSDWDP 655 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~ 655 (669)
.. ..........+...+........+..++..+.+++.+||+.||.+|||+.|+++.|+.+.....+|+.
T Consensus 241 --~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 241 --MG-CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp --CC-----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred --cc-cccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 00 00000001111222222333445566677899999999999999999999999999999988877765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.61 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=207.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|++.+ .+|.|+| |.||+|.. .+..||||.++. .+.+|+.+++++ +||||++++++
T Consensus 24 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 24 RLSFGK-TLGAGAF-------GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhHHH-hhCccCC-------cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 455555 3899999 99999986 246899999863 367899999999 99999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQ-------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
+..++..++||||+++|+|.+++...+.. ....+++..++.++.|++.||+|||+++ ++|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 99999999999999999999999875311 1235899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||++.++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 246 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTT------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEEcCCCCEEEcccccccccccccc------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999987654321 112334567889999999999999999999999999999999 999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+...... . ...+. . ......+...+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 247 p~~~~~~~~~--~----~~~~~---------~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 247 PYPGMPVDSK--F----YKMIK---------E----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp SSTTCCSSHH--H----HHHHH---------H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccchhH--H----HHHhc---------c----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 9976543211 0 00111 1 11112233445678999999999999999999999999999987
Q ss_pred CCC
Q 005923 649 SSS 651 (669)
Q Consensus 649 ~~~ 651 (669)
...
T Consensus 308 ~~~ 310 (313)
T 1t46_A 308 EST 310 (313)
T ss_dssp HTC
T ss_pred Hhh
Confidence 543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=370.66 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=201.6
Q ss_pred chhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 361 KFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 361 ~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.+.+.++|.|+| |.||+|.+. +..||||+++. ++.+|+++|++++|||||+++++|.. +.
T Consensus 338 ~~~~~~LG~G~f-------G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 338 LIADIELGCGNF-------GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp EEEEEEEEECSS-------SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eEcCcEEecCCC-------cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 334445899999 999999873 45699999863 37789999999999999999999965 67
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCST
T ss_pred eEEEEEeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 99999999999999999754 346999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++........ ........++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.. .
T Consensus 483 a~~~~~~~~~-----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~ 550 (613)
T 2ozo_A 483 SKALGADDSY-----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------A 550 (613)
T ss_dssp TTTCC-------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------H
T ss_pred cccccCCCce-----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------H
Confidence 9876543211 111223346789999999999999999999999999999998 99999875542210 0
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.+ ....+...+..++..+.+||.+||+.||.+||++.+|++.|+.++...
T Consensus 551 ~i-------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 551 FI-------------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HH-------------HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HH-------------HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01 111223455567788999999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.52 Aligned_cols=256 Identities=27% Similarity=0.477 Sum_probs=205.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSG 421 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g 421 (669)
..|.+.+. +|.|+| |.||+|.. .+..||||.++. .+.+|+.+++++ +||||+++++
T Consensus 45 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 45 ENLEFGKV-LGSGAF-------GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHceeeee-ecCCCC-------ceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34555553 899999 99999997 244799999853 367899999999 8999999999
Q ss_pred EEEecCceeEEEEecCCCCHHHHHhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005923 422 FCVHEGNTYLVYEFADNGALSDWLHSNRYQ------------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPY 483 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 483 (669)
++..++..++||||+++|+|.+++...+.. ....+++..++.++.||+.||+|||+++ |
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 193 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---C 193 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 999999999999999999999999865311 0134899999999999999999999999 9
Q ss_pred EeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 005923 484 VHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563 (669)
Q Consensus 484 vHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~el 563 (669)
+||||||+|||++.++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 267 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCcc------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHH
Confidence 9999999999999999999999999987644321 1223345678899999999999999999999999999999
Q ss_pred Hc-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 564 LS-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 564 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
++ |+.||.+...... +...+. .......+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus 268 ~t~g~~p~~~~~~~~~------~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 268 FSLGVNPYPGIPVDAN------FYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp TTTSCCSSTTCCCSHH------HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCcccCCcHHH------HHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 98 9999986543211 001111 111223344556779999999999999999999999999
Q ss_pred HHHhhcC
Q 005923 643 LSKIWSS 649 (669)
Q Consensus 643 L~~i~~~ 649 (669)
|+.+...
T Consensus 329 l~~~~~~ 335 (344)
T 1rjb_A 329 LGCQLAD 335 (344)
T ss_dssp HHHHC--
T ss_pred HHHHHHH
Confidence 9998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.54 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=206.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|.+.+ .+|.|+| |.||++.. .+..||||+++. .+.+|++++++++||||+++++++
T Consensus 24 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 24 NLVLGK-TLGEGEF-------GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp GEEEEE-EEEECSS-------SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred heeeee-eecccCC-------eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 455555 3899999 99999986 236799999863 366899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQ-------------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv 484 (669)
.+++..++||||+++|+|.+++...+.. ....+++..+++++.||+.||+|||+++ ++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 9999999999999999999999875321 1234899999999999999999999999 99
Q ss_pred eeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 005923 485 HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564 (669)
Q Consensus 485 HrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ell 564 (669)
||||||+|||+++++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||+
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 246 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccc------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999876543211 1122345778899999999999999999999999999999
Q ss_pred c-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 565 S-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 565 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+ |+.||.+....... . . +.. ......+..++..+.+++.+||+.||.+|||+.|+++.|
T Consensus 247 t~g~~p~~~~~~~~~~---~----~---------~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 247 TLGGNPYPGIPPERLF---N----L---------LKT----GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp TTSCCSSTTCCGGGHH---H----H---------HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHH---H----H---------hhc----CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9 99999865432210 0 0 111 111233445566789999999999999999999999999
Q ss_pred HHhhcC
Q 005923 644 SKIWSS 649 (669)
Q Consensus 644 ~~i~~~ 649 (669)
+++...
T Consensus 307 ~~~~~~ 312 (314)
T 2ivs_A 307 EKMMVK 312 (314)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.49 Aligned_cols=263 Identities=25% Similarity=0.442 Sum_probs=204.6
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|++.+ ++|.|+| |.||++.+ .++.||+|+++. .+.+|++++++++||||+++++++..
T Consensus 23 ~~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 23 LKRIR-DLGEGHF-------GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhh-ccCCCCc-------eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 44444 3899999 99999995 477899999863 36789999999999999999999987
Q ss_pred c--CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 E--GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
. ...++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl 167 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKI 167 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEE
Confidence 6 56899999999999999996542 45999999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++........ ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...
T Consensus 168 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~ 238 (302)
T 4e5w_A 168 GDFGLTKAIETDKEY-----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLK 238 (302)
T ss_dssp CCCTTCEECCTTCCE-----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHH
T ss_pred CcccccccccCCCcc-----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----Hhh
Confidence 999999876543211 12234457888999999999999999999999999999999999886432110 000
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
... ..........+...+........+..++..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 239 MIG-PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHC-SCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccC-CcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 000000011111112222233445566678999999999999999999999999999885
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.57 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=208.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.|++.+ .+|.|+| |.||+|... +..||+|.++. .+.+|++++++++||||+++++++.+++..+
T Consensus 14 ~~~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 14 DITMKH-KLGGGQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp GEEEEE-ESGGGTT-------CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ceeEEe-ecCCCCc-------eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 345444 3899999 999999985 77899999864 3678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 86 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999864 2356999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHH
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
....... .......+|..|+|||.+.+..++.++||||||+++|||++ |..||.+.......
T Consensus 160 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~---------- 222 (288)
T 3kfa_A 160 LMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---------- 222 (288)
T ss_dssp TSCSSSS-------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----------
T ss_pred eccCCcc-------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence 7654321 12233456788999999999999999999999999999999 99998765432110
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+.+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 223 ------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 223 ------ELLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ------HHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHhc----cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 01111 112233445567899999999999999999999999999998864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.22 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=199.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCe----eEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDD----AAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~----vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.|++.+ .+|.|+| |.||+|.+. ++. ||+|.+.. .+.+|+.++++++||||++++++|.
T Consensus 14 ~y~~~~-~lG~G~~-------g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 14 ELRKLK-VLGSGVF-------GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp TEEEEE-EEECCSS-------CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred Hceeee-eeeecCC-------ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 344444 3899999 999999974 444 77787642 4668999999999999999999985
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++..++||||+++|+|.+++...+ ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~ 157 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVA 157 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEEC
T ss_pred -CCccEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEEC
Confidence 667899999999999999997642 45899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++....... ........+|..|+|||.+.++.++.++||||||+++|||++ |+.||.+....+...
T Consensus 158 Dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--- 228 (325)
T 3kex_A 158 DFGVADLLPPDDK------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD--- 228 (325)
T ss_dssp SCSGGGGSCCCTT------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH---
T ss_pred CCCcccccCcccc------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH---
Confidence 9999998754332 112334567889999999999999999999999999999999 999998654322110
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.+. .......+..++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 229 ----~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 229 ----LLE-------------KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ----HHH-------------TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ----HHH-------------cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 010 0111222333445688999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.26 Aligned_cols=249 Identities=26% Similarity=0.458 Sum_probs=205.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ .+|.|+| |.||++.. +++.||+|.++. ++.+|++++++++||||+++++++.+++..++
T Consensus 9 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 9 ELTFVQ-EIGSGQF-------GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GEEEEE-EEEEETT-------EEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeee-EecCCCc-------eeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 455545 3899999 99999998 567899999864 47789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp EECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccc
Confidence 999999999999998642 45899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ...
T Consensus 154 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~--- 217 (267)
T 3t9t_A 154 VLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VED--- 217 (267)
T ss_dssp BCCHHH-------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHH---
T ss_pred cccccc-------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHH---
Confidence 643221 11223456788999999999999999999999999999999 8999876543211 000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+.. ......+...+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 218 -------i~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 218 -------IST----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -------HHT----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------Hhc----CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000 011122334456789999999999999999999999999999765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.00 Aligned_cols=252 Identities=29% Similarity=0.490 Sum_probs=198.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.|++.+. +|.|+| |.||+|.... ..||||.++. ++.+|+.++++++||||+++++++.
T Consensus 45 ~~~~~~~-lG~G~~-------g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 45 CVTRQKV-IGAGEF-------GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp TEEEEEE-EEECSS-------SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HhhcccE-EecCCC-------eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3444443 899999 9999998742 2499999863 3678999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
..+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 189 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVS 189 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEEC
Confidence 999999999999999999999764 246999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++........ ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. .
T Consensus 190 Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~- 260 (333)
T 1mqb_A 190 DFGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M- 260 (333)
T ss_dssp CCCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-
T ss_pred CCCcchhhcccccc-----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H-
Confidence 99999876543211 111223456788999999999999999999999999999999 9999976543210 0
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.. +.. ..+...+..++..+.+++.+||+.||.+||++.|+++.|+++....
T Consensus 261 ---~~---------~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 261 ---KA---------IND----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ---HH---------HHT----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---HH---------HHC----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 100 1112234455677899999999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=334.59 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=205.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE----CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF----KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~----~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|.+.+..+|.|+| |.||+|.+ ++..||||+++. .+.+|++++++++||||+++++++ ..
T Consensus 10 ~~~i~~~~lg~G~~-------g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 10 NLLIADIELGCGNF-------GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp GEEEEEEEEECCTT-------EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred HhhhhhccccccCc-------eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 34444435999999 99999986 366799999864 366899999999999999999999 56
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcc
Confidence 7799999999999999999643 246999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++........ ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.. .
T Consensus 155 g~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~-- 224 (287)
T 1u59_A 155 GLSKALGADDSY-----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A-- 224 (287)
T ss_dssp TTCEECTTCSCE-----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H--
T ss_pred cceeeeccCcce-----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---H--
Confidence 999876543211 111223456889999999999999999999999999999998 99999865432110 0
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
. +.. ..+...+..++..+.+++.+||+.||.+||++.|+++.|++++.+.
T Consensus 225 --~---------i~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 225 --F---------IEQ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp --H---------HHT----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --H---------Hhc----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 000 1112334456678999999999999999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.39 Aligned_cols=248 Identities=26% Similarity=0.427 Sum_probs=192.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||+|... +..||+|.++. .+.+|+.++++++||||+++++++
T Consensus 15 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 85 (281)
T 1mp8_A 15 ERIELGRC-IGEGQF-------GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 85 (281)
T ss_dssp GGEEEEEE-EEECSS-------SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred HHeEEEeE-eeecCC-------eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence 34555553 899999 999999883 34589999753 367899999999999999999998
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.++..++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 86 TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred ccCccEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEEC
Confidence 4567899999999999999997642 45999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+.. .
T Consensus 159 Dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~ 228 (281)
T 1mp8_A 159 DFGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G 228 (281)
T ss_dssp C--------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H
T ss_pred ccccccccCcccc-------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---H
Confidence 9999987654321 11223456788999999999999999999999999999997 99999865432210 0
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
.+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 229 -------------~i~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 229 -------------RIEN----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp -------------HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHc----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000 01122344556778999999999999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.42 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=206.4
Q ss_pred chhHHHHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 361 KFQDLKIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 361 ~~~~l~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
++.+ ++|.|+| |.||++.+ +++.||||+++. .+.+|++++++++||||+++++++.+.
T Consensus 34 ~~~~-~lG~G~~-------g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 34 KKIR-DLGEGHF-------GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp EEEE-EEEECSS-------EEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhh-eecCCCC-------eEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 4444 3899999 99999876 467899999864 267899999999999999999999874
Q ss_pred --CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 427 --GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 427 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred CCceEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEEC
Confidence 5679999999999999999764 3899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++........ ........+|..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 177 Dfg~a~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~---- 247 (318)
T 3lxp_A 177 DFGLAKAVPEGHEY-----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL---- 247 (318)
T ss_dssp CGGGCEECCTTCSE-----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH----
T ss_pred Cccccccccccccc-----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh----
Confidence 99999877543211 122334567889999999999999999999999999999999999986532110000
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
............+...++.......+..++..+.+|+.+||+.||.+|||+.|+++.|+++...-
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 248 -IGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp -HCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 00000000011122222233334455666778999999999999999999999999999987543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=339.72 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=200.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||++... |+.||+|+++. .+.+|+++|++++||||+++++++..
T Consensus 5 ~~y~~~~~-lG~G~f-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 5 NDFDYLKL-LGKGTF-------GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred HHeEEEEE-EecCCC-------eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 34555453 899999 999999984 88999999864 25679999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.+..++||||+++|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEee
Confidence 99999999999999999999764 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+....+ ....
T Consensus 149 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~- 216 (337)
T 1o6l_A 149 FGLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFEL- 216 (337)
T ss_dssp CTTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-
T ss_pred ccchhhcccCC--------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHH-
Confidence 99998643321 12344679999999999999999999999999999999999999998654321 1111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
+.. . ...+|...+..+.+++.+||+.||.+|| ++.|++++
T Consensus 217 --i~~-------------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 217 --ILM-------------E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --HHH-------------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --HHc-------------C--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 110 0 1123445566789999999999999999 89999765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=332.34 Aligned_cols=246 Identities=26% Similarity=0.508 Sum_probs=198.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec--------------ccHHHHHHHHHhcCCCCceeEee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK--------------GDVSSEINILKKINHSNIIRLSG 421 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~--------------~~~~~E~~~l~~l~H~niv~l~g 421 (669)
..|++.+ .+|.|+| |.||+|.. +++.||+|++. ..+.+|++++++++||||+++++
T Consensus 19 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 19 NEIEYEK-QIGKGGF-------GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG 90 (287)
T ss_dssp TTEEEEE-ECCCCSS-------SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccceehh-ccccCCc-------eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence 3455555 3999999 99999998 57889999984 34678999999999999999999
Q ss_pred EEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc-
Q 005923 422 FCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR- 500 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~- 500 (669)
++.+. .++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++++||||||+|||++.++.
T Consensus 91 ~~~~~--~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 91 LMHNP--PRMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp EETTT--TEEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTT
T ss_pred eecCC--CeEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCC
Confidence 98544 37999999999999999754 246999999999999999999999985 56999999999999988776
Q ss_pred ----EEEcccCCccccCCCccccCCcccceeeeccccccccccccc--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Q 005923 501 ----AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI--ENGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574 (669)
Q Consensus 501 ----~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~ 574 (669)
+||+|||+++..... .....||..|+|||.+ ....++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVHS-----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CSCCEEECCCTTCBCCSSC-----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CceeEEeCCCCcccccccc-----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999999999854332 2335789999999998 45667899999999999999999999998644
Q ss_pred hhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
....... . ...........+..++..+.+++.+||+.||.+|||+.|+++.|++|
T Consensus 233 ~~~~~~~----~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 233 YGKIKFI----N-------------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCHHHHH----H-------------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccHHHHH----H-------------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 3221110 0 00111222334455667899999999999999999999999999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=373.43 Aligned_cols=248 Identities=28% Similarity=0.504 Sum_probs=200.9
Q ss_pred chhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 361 KFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 361 ~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.+++.++|.|+| |.||+|.+. +..||||+++. ++.+|+++|++++|||||+++++|. ++
T Consensus 371 ~l~~~~LG~G~f-------G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~ 442 (635)
T 4fl3_A 371 TLEDKELGSGNF-------GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE 442 (635)
T ss_dssp EEEEEEEEECSS-------EEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred cccCCEeccCCC-------EEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 333435899999 999999762 46799999863 4678999999999999999999995 55
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++|+|.++++.. ..+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTT
T ss_pred CEEEEEEccCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcC
Confidence 689999999999999999764 45999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++........ ........+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+..
T Consensus 515 la~~~~~~~~~-----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------- 582 (635)
T 4fl3_A 515 LSKALRADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------- 582 (635)
T ss_dssp HHHHTTC------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------
T ss_pred CccccccCccc-----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 99876543211 112233456789999999999999999999999999999998 99999876542210
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. .+ ....+...+..++.++.+|+.+||+.||.+||++.+|++.|++++..
T Consensus 583 ~---------~i----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 583 A---------ML----EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp H---------HH----HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred H---------HH----HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 01 11122344556677899999999999999999999999999988753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.53 Aligned_cols=271 Identities=17% Similarity=0.271 Sum_probs=202.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEeccc---HHH---------------HHHHHHhcCC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKGD---VSS---------------EINILKKINH 413 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~~---~~~---------------E~~~l~~l~H 413 (669)
.|++.+. +|.|+| |.||+|.+. ++.||||++..+ +.+ |+..+.+++|
T Consensus 36 ~y~~~~~-lG~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (364)
T 3op5_A 36 AWKVGLP-IGQGGF-------GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKY 107 (364)
T ss_dssp EEEEEEE-CCCC-C-------CEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred eEEEEEE-EecCCC-------eEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence 5666664 999999 999999884 367999998542 233 4445566679
Q ss_pred CCceeEeeEEEec----CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 414 SNIIRLSGFCVHE----GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 414 ~niv~l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
|||+++++++... ...+|||||+ +|+|.+++... ...+++..++.|+.||+.||+|||+++ |+|||||
T Consensus 108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlk 179 (364)
T 3op5_A 108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIK 179 (364)
T ss_dssp CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCC
Confidence 9999999999875 4589999999 99999999764 246999999999999999999999999 9999999
Q ss_pred CCCeeec--CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCC
Q 005923 490 TSNILLD--TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567 (669)
Q Consensus 490 ~~NILl~--~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~ 567 (669)
|+|||++ .++.+||+|||+++.......... ..........||..|+|||.+.+..++.++||||||+++|||++|+
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA-YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCC-SSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccc-cccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999 889999999999987654322110 0011123456999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 568 EAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 568 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
.||.+........ ....... ...+..++++.+. +..++.++.+++.+||+.||.+||++.+|++.|+++.
T Consensus 259 ~Pf~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 259 LPWEDNLKDPKYV--RDSKIRY-----RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CTTGGGTTCHHHH--HHHHHHH-----HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCccccccCHHHH--HHHHHHh-----hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 9998533221111 1111111 1122222222221 1233457899999999999999999999999999987
Q ss_pred cC-------CCCCCCC
Q 005923 648 SS-------SSDWDPS 656 (669)
Q Consensus 648 ~~-------~~~~~~~ 656 (669)
.. ..||+..
T Consensus 329 ~~~~~~~~~~~dw~~~ 344 (364)
T 3op5_A 329 KAIGSKDDGKLDLSVV 344 (364)
T ss_dssp HHTTCCCCCCCCC---
T ss_pred HHcCCCcCCccceEec
Confidence 53 4567653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.42 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=198.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc----HHHHHHHHHhc--CCCCceeEeeEEEec----Cc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----VSSEINILKKI--NHSNIIRLSGFCVHE----GN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~----~~~E~~~l~~l--~H~niv~l~g~~~~~----~~ 428 (669)
.|++.+ .+|.|+| |.||+|..+++.||||++... +..|.+++..+ +||||+++++++... ..
T Consensus 38 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 38 QIQMVK-QIGKGRY-------GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HCEEEE-EEEEETT-------EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ceEEEe-EeecCCC-------eEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 455555 3899999 999999999999999998643 34566666554 899999999999877 67
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEeeCCCCCCeeecCCCc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY--------TNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~--------~~~~ivHrDik~~NILl~~~~~ 500 (669)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||++ + |+||||||+|||++.++.
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred eEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 89999999999999999754 499999999999999999999988 6 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCch------hhHHHHHHHHHHHHcC--------
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK------LDVFAFGVVVLELLSG-------- 566 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~------sDV~S~Gvvl~elltg-------- 566 (669)
+||+|||+++......... ........||..|+|||.+.+...+.+ +||||||+++|||++|
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV----DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp EEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred EEEEeCCCceeeccccccc----cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 9999999998765432111 111234579999999999988776665 9999999999999999
Q ss_pred --CCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCC-CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 567 --REAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNE-YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 567 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+.||......... ........ ......+.+... .+.+++..+.+++.+||+.||.+|||+.||++.|
T Consensus 257 ~~~~p~~~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPS--YEDMREIV--------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CCCCTTTTTSCSSCC--HHHHHHHH--------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cccccHhhhcCCCCc--hhhhHHHH--------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 5666532211100 00000000 011111111111 1237788899999999999999999999999999
Q ss_pred HHhhcCC
Q 005923 644 SKIWSSS 650 (669)
Q Consensus 644 ~~i~~~~ 650 (669)
+++..+.
T Consensus 327 ~~l~~~~ 333 (337)
T 3mdy_A 327 AKMSESQ 333 (337)
T ss_dssp HHHHHTT
T ss_pred HHHHhhc
Confidence 9997653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.11 Aligned_cols=235 Identities=26% Similarity=0.429 Sum_probs=197.1
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 436 (669)
.+|.|+| |.||+|.. +|+.||||+++. .+.+|+.++++++||||+++++++..++..++||||+
T Consensus 52 ~lg~G~~-------g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 52 KIGEGST-------GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEETT-------EEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EeccCCC-------eEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 4899999 99999998 488999999853 3678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCc
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~ 516 (669)
++|+|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 125 ~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 125 QGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 999999998643 4999999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHh
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVRE 596 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (669)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+. . .
T Consensus 196 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~------~----------~ 251 (321)
T 2c30_A 196 P--------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------M----------K 251 (321)
T ss_dssp C--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H----------H
T ss_pred c--------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H----------H
Confidence 1 12345799999999999999999999999999999999999999986543211 0 0
Q ss_pred hhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 597 KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 597 ~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.....+.+ ..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111 1223445678999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=346.57 Aligned_cols=273 Identities=23% Similarity=0.362 Sum_probs=196.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc----HHHHHHH--HHhcCCCCceeEeeEEEe-----c
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----VSSEINI--LKKINHSNIIRLSGFCVH-----E 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~----~~~E~~~--l~~l~H~niv~l~g~~~~-----~ 426 (669)
..|++.+. +|.|+| |.||+|+.+++.||||+++.. +..|.++ +..++||||+++++.+.. .
T Consensus 13 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 13 DNLKLLEL-IGRGRY-------GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TSEEEEEE-EEECSS-------EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred HHhheeee-cccCCC-------eEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 45565553 999999 999999999999999998642 3444444 445899999999986643 2
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeeCCCCCCeeecC
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY---------TNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~---------~~~~ivHrDik~~NILl~~ 497 (669)
...++||||+++|+|.+++... .+++..+++++.||+.||+|||+. + |+||||||+|||++.
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECT
T ss_pred ceEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcC
Confidence 3568999999999999999765 368999999999999999999998 7 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-------CCCCchhhHHHHHHHHHHHHcCCCCC
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-------GVITPKLDVFAFGVVVLELLSGREAV 570 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDV~S~Gvvl~elltg~~p~ 570 (669)
++.+||+|||+++.....................||..|+|||.+.+ ..++.++||||||+++|||++|+.|+
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999987654322111111122334579999999999987 45678999999999999999998877
Q ss_pred CCCchhHH-HHHHHHHHHHHhhhhHHh----hhhcccCCccCC--CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 571 TGDQNCEA-ELLYASISRVLEESNVRE----KLRGFIDPSLRN--EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 571 ~~~~~~~~-~~~~~~~~~~~~~~~~~~----~l~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
........ ...... .......... .......+.+.. .....++..+.+|+.+||+.||.+|||+.|+++.|
T Consensus 236 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 236 FPGESVPEYQMAFQT--EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp STTSCCCCCCCTTHH--HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCccchhHHHHhhhc--ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 53221100 000000 0000000000 000111111111 11234667899999999999999999999999999
Q ss_pred HHhhcC
Q 005923 644 SKIWSS 649 (669)
Q Consensus 644 ~~i~~~ 649 (669)
+++...
T Consensus 314 ~~ll~~ 319 (336)
T 3g2f_A 314 AELMMI 319 (336)
T ss_dssp HHHHHC
T ss_pred HHHHHH
Confidence 999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=368.16 Aligned_cols=250 Identities=28% Similarity=0.500 Sum_probs=206.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ ++|.|.| |.||+|.+++ ..||||+++. ++.+|+++|++++|+||+++++++.+ +..++
T Consensus 268 ~~~~~~-~lG~G~f-------g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 268 SLRLEV-KLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hhhhhe-ecccCCC-------eEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 344444 4999999 9999999975 5799999864 47899999999999999999999865 77899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.++|+... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 339 v~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EECCCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eeehhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 999999999999997531 235899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......++..|+|||.+.++.++.++||||||++||||++ |+.||.+....+. +. .
T Consensus 413 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------~~-~-- 476 (535)
T 2h8h_A 413 IEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LD-Q-- 476 (535)
T ss_dssp CCCHHH-------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------HH-H--
T ss_pred cCCCce-------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HH-H--
Confidence 653221 11123456789999999999999999999999999999999 9999986553211 00 0
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
+ ....+...+..++..+.+||.+||+.||.+|||+++|++.|+.+....
T Consensus 477 -------i----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 477 -------V----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -------H----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -------H----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 0 011223344566678999999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.92 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=198.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec--------ccHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK--------GDVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
..|++.+. +|.|+| |.||+|... ++.||||+++ ..+.+|+.++++++||||+++++++.+++
T Consensus 7 ~~y~i~~~-lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 7 EDWDLVQT-LGEGAY-------GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TCEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhceeeeE-EecCCC-------EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34555553 999999 999999884 7889999974 34778999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEee
Confidence 999999999999999998643 45999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++....... ........||..|+|||.+.+..+ +.++||||||+++|||++|+.||.+........ .
T Consensus 151 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~--- 219 (323)
T 3tki_A 151 LATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--S--- 219 (323)
T ss_dssp TCEECEETTE------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--H---
T ss_pred ccceeccCCc------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--H---
Confidence 9986643221 122334679999999999988775 789999999999999999999998644321110 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. +................+.+|+.+||+.||.+|||+.|+++.
T Consensus 220 ~-------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 220 D-------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp H-------------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred H-------------HhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 000011111123445678899999999999999999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.99 Aligned_cols=266 Identities=24% Similarity=0.347 Sum_probs=207.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
..|.+.+. +|.|+| |.||+|... ++.||||+++. .+.+|++++++++||||+++++++...+
T Consensus 9 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 9 HLWLLSDI-LGQGAT-------ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp EEEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCEEEEEE-ecCCCC-------eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 35666664 999999 999999985 88999999863 3568999999999999999999998765
Q ss_pred --ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee----cCCCcE
Q 005923 428 --NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLRA 501 (669)
Q Consensus 428 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl----~~~~~~ 501 (669)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred CceEEEEEeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence 6799999999999999998652 2234999999999999999999999999 9999999999999 788889
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE--------NGVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
||+|||+++....... .....||..|+|||.+. +..++.++||||||+++|||++|+.||...
T Consensus 156 kL~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp EECCCTTCEECCTTCC---------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred EEccCCCceecCCCCc---------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987654321 22356899999999986 578899999999999999999999999743
Q ss_pred chhHHHHHHHHHHHHHhhhhHH--hhhhccc--------CCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 574 QNCEAELLYASISRVLEESNVR--EKLRGFI--------DPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~--------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
...... ...+...+...... ..+.... +-......+......+.+++.+||+.||.+|||++|+++..
T Consensus 227 ~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 227 EGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TCGGGC--HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred Cccchh--HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 321111 11122222211100 0000000 00111245577888899999999999999999999999998
Q ss_pred HHhh
Q 005923 644 SKIW 647 (669)
Q Consensus 644 ~~i~ 647 (669)
++..
T Consensus 305 ~d~~ 308 (319)
T 4euu_A 305 SDIL 308 (319)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 7653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=339.61 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=193.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCC-----eeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGD-----DAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~-----~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.|++.+ .+|.|+| |.||+|..... .||||.++. .+.+|++++++++||||+++++++.
T Consensus 24 ~y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 24 QFTLGR-MLGKGEF-------GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp -CEEEE-EEEEETT-------EEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred HeEEec-eecccCC-------eEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 455555 3899999 99999997432 799999863 3678999999999999999999998
Q ss_pred ecCce------eEEEEecCCCCHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 425 HEGNT------YLVYEFADNGALSDWLHSNRYQ-TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 425 ~~~~~------~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
..... ++||||+++|+|.+++...+.. ....+++..++.|+.|++.||+|||+++ ++||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence 77655 9999999999999999754321 2235999999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~ 576 (669)
++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYY------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp TSCEEECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCCEEEeeccccccccccccc------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 999999999999876443211 11223456788999999999999999999999999999999 89999865542
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
+... .+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 247 ~~~~----------------~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 247 EIYN----------------YLIG----GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp GHHH----------------HHHT----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHH----------------HHhc----CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 2100 0000 0112233445567899999999999999999999999999998765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.91 Aligned_cols=251 Identities=28% Similarity=0.509 Sum_probs=203.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|.+.+-.+|.|+| |.||+|.+. +..||||+++. ++.+|++++++++||||+++++++
T Consensus 16 ~~y~~~~~~lg~G~~-------g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 16 KLLTLEDKELGSGNF-------GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp GGEEEEEEEEEECSS-------EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred hhhhhccCccccccC-------eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 456665534999999 999999662 56799999853 367899999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
..+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEc
Confidence 677889999999999999999864 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++........ ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.
T Consensus 160 Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----- 229 (291)
T 1xbb_A 160 DFGLSKALRADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----- 229 (291)
T ss_dssp CCTTCEECCTTCSE-----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----
T ss_pred cCCcceeeccCCCc-----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----
Confidence 99999876543211 111223456788999999999999999999999999999999 9999986543211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
... +.. ......+..++..+.+++.+||+.||.+||++.|+++.|++++..
T Consensus 230 --~~~---------~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 230 --TAM---------LEK----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --HHH---------HHT----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --HHH---------HHc----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 001 111 111233445567899999999999999999999999999999854
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.40 Aligned_cols=240 Identities=25% Similarity=0.395 Sum_probs=191.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------------------------------cHH
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------------------------------DVS 402 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------------------------------~~~ 402 (669)
..|++.+. +|.|+| |.||+|.. +++.||||+++. .+.
T Consensus 13 ~~y~~~~~-lG~G~~-------g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 13 NQYTLKDE-IGKGSY-------GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp TTEEEEEE-EEC--C-------CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHH
T ss_pred cceEEEeE-EeecCC-------EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence 45666664 999999 99999987 477899999842 367
Q ss_pred HHHHHHHhcCCCCceeEeeEEEe--cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005923 403 SEINILKKINHSNIIRLSGFCVH--EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTN 480 (669)
Q Consensus 403 ~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 480 (669)
+|++++++++||||+++++++.+ ++..++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+++
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~- 157 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK- 157 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 89999999999999999999986 5678999999999999876532 46999999999999999999999999
Q ss_pred CCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCC---CCchhhHHHHH
Q 005923 481 PPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV---ITPKLDVFAFG 557 (669)
Q Consensus 481 ~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDV~S~G 557 (669)
|+||||||+|||++.++.+||+|||+++...... .......||..|+|||.+.+.. ++.++||||||
T Consensus 158 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 227 (298)
T 2zv2_A 158 --IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG 227 (298)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHH
T ss_pred --eeccCCCHHHEEECCCCCEEEecCCCcccccccc--------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHH
Confidence 9999999999999999999999999998765432 1223457899999999998765 37899999999
Q ss_pred HHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005923 558 VVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637 (669)
Q Consensus 558 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 637 (669)
+++|||++|+.||.+..... ... ... .... ..+.....+..+.+++.+||+.||.+|||+.
T Consensus 228 ~~l~~l~~g~~pf~~~~~~~---~~~---~~~---------~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~ 288 (298)
T 2zv2_A 228 VTLYCFVFGQCPFMDERIMC---LHS---KIK---------SQAL----EFPDQPDIAEDLKDLITRMLDKNPESRIVVP 288 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHH---HHH---HHH---------HCCC----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHHHHCCCCCCCccHHH---HHH---HHh---------cccC----CCCCccccCHHHHHHHHHHhhcChhhCCCHH
Confidence 99999999999998654211 000 000 0001 1111123445789999999999999999999
Q ss_pred HHHH
Q 005923 638 EVFV 641 (669)
Q Consensus 638 evl~ 641 (669)
|+++
T Consensus 289 e~l~ 292 (298)
T 2zv2_A 289 EIKL 292 (298)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.43 Aligned_cols=242 Identities=23% Similarity=0.362 Sum_probs=195.0
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFC 423 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~ 423 (669)
+..|++.++ +|.|+| |.||+++.. ++.+|+|+++.. +..|..++.++ +||||+++++++
T Consensus 51 ~~~y~~~~~-LG~G~f-------G~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 51 LQDFDLLRV-IGRGSY-------AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp GGGEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhHcEEEEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 345555553 999999 999999984 678999998642 56899999887 899999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
..++..++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL 194 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKL 194 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEE
Confidence 9999999999999999999999865 35999999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH--H
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL--L 581 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~--~ 581 (669)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .
T Consensus 195 ~DFGla~~~~~~~--------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~ 266 (396)
T 4dc2_A 195 TDYGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266 (396)
T ss_dssp CCCTTCBCCCCTT--------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC
T ss_pred eecceeeecccCC--------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh
Confidence 9999998643221 22345689999999999999999999999999999999999999997432211000 0
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
...+.. .+... ...+|..+...+.+|+.+||+.||.+||++
T Consensus 267 ~~~~~~------------~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 267 EDYLFQ------------VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHH------------HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHH------------HHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 000000 01111 123444566778999999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=339.18 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=206.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC---------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK---------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
.|.+.+. +|.|+| |.||+|... +..||||+++. .+.+|+++++++ +||||++++
T Consensus 36 ~y~~~~~-lG~G~~-------g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 36 KLTLGKP-LGEGAF-------GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp GEEEEEE-EEECSS-------CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HeEEeeE-EeecCc-------eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 4555553 899999 999999863 45799999864 366899999999 899999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
+++..++..++||||+++|+|.+++...+.. ....+++..++.++.||+.||+|||+.+ ++|||||
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 184 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 184 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCc
Confidence 9999999999999999999999999865311 1235899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||++.++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSS------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cceEEEcCCCCEEEcccccccccccccc------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999987654321 111233456789999999999999999999999999999999 999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+....+. . ..+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 259 p~~~~~~~~~---~----~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 259 PYPGIPVEEL---F----KLLKE-------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp SSTTCCHHHH---H----HHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCcCCHHHH---H----HHHhc-------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9986543211 0 01110 01122334455678999999999999999999999999999986
Q ss_pred CCC
Q 005923 649 SSS 651 (669)
Q Consensus 649 ~~~ 651 (669)
...
T Consensus 319 ~~~ 321 (334)
T 2pvf_A 319 LTT 321 (334)
T ss_dssp HHC
T ss_pred ccc
Confidence 543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=331.05 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=199.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECC-----CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKG-----DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|.+.+. +|.|+| |.||+|.+.+ ..||+|.++. .+.+|+.++++++||||+++++++.
T Consensus 12 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 12 EDVVLNRI-LGEGFF-------GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp GGEEEEEE-EEECSS-------SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceEEEEE-EEecCC-------eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 34555553 899999 9999998743 2499999864 3678999999999999999999985
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++..++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+
T Consensus 84 -~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 84 -EEPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEEC
T ss_pred -CCCCEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeC
Confidence 456799999999999999997642 45899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .
T Consensus 156 Dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~ 225 (281)
T 3cc6_A 156 DFGLSRYIEDEDY-------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---G 225 (281)
T ss_dssp CCCGGGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---H
T ss_pred ccCCCcccccccc-------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---H
Confidence 9999987654321 11223456889999999999999999999999999999998 99999754432211 0
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.+. .- .....+..++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 226 ----~~~---------~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 226 ----VLE---------KG----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ----HHH---------HT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHh---------cC----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 000 00 01122334456789999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.87 Aligned_cols=242 Identities=27% Similarity=0.436 Sum_probs=198.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|.+.+. +|.|+| |.||++... |..+|+|+++. ++.+|+.+|++++||||+++++++
T Consensus 12 ~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 12 YYDTGEE-LGSGQF-------AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp HEEEEEE-EECCSS-------EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceEeceE-EeeCCC-------eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3555553 899999 999999984 78999998852 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC----
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---- 499 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---- 499 (669)
.+++..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCC
Confidence 9999999999999999999999653 46999999999999999999999999 99999999999999887
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.+||+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+..
T Consensus 156 ~~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 226 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226 (326)
T ss_dssp CEEECCCTTCEECCTTSC---------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred CEEEEECCCCeECCCCCc---------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 899999999987653321 23357899999999999999999999999999999999999999875532110
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. ... .............+..+.+++.+||+.||.+|||+.|++++
T Consensus 227 ---~~---~~~-----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 227 ---AN---VSA-----------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---HH---HHH-----------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---HH---HHh-----------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000 00011111112334568999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=332.85 Aligned_cols=248 Identities=28% Similarity=0.474 Sum_probs=199.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEec-CceeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHE-GNTYL 431 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~l 431 (669)
..|++.+. +|.|+| |.||++..+|+.||||.++. .+.+|++++++++||||+++++++.+. +..++
T Consensus 21 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 21 KELKLLQT-IGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGEEEEEE-EEECSS-------CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhceEEeE-EecCCC-------ceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 45666554 899999 99999999999999999864 367899999999999999999997654 47899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp EECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccc
Confidence 999999999999997642 123889999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 167 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~----------- 224 (278)
T 1byg_A 167 ASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----------- 224 (278)
T ss_dssp --------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-----------
T ss_pred ccccc-----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------
Confidence 54321 12356889999999999999999999999999999998 99999764432110
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
..+. .......+..++..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 225 -----~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 225 -----PRVE----KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----HHHT----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHHh----cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0111 11122334455678999999999999999999999999999997644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.19 Aligned_cols=241 Identities=25% Similarity=0.416 Sum_probs=198.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|.+.+. +|.|+| |.||++... |..+|+|+++. .+.+|+.+|++++||||+++++++
T Consensus 13 ~y~~~~~-LG~G~f-------g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 13 FYDIGEE-LGSGQF-------AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp TEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ceEEeeE-EeeCcC-------EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 4555553 999999 999999984 88999999853 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC----
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---- 499 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---- 499 (669)
.+++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCcc
Confidence 9999999999999999999999653 46999999999999999999999999 99999999999998876
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.
T Consensus 157 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~- 226 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET- 226 (361)
T ss_dssp CEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-
T ss_pred CEEEEecCCceEcCCCC---------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 79999999998765432 12345799999999999999999999999999999999999999987653211
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
... +... ...+........+..+.+|+.+||..||.+|||+.|+++
T Consensus 227 --~~~---i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 --LAN---ITAV-----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --HHH---HHTT-----------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHH---HHhc-----------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 1100 000111111233456899999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.64 Aligned_cols=254 Identities=27% Similarity=0.470 Sum_probs=192.4
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--C---CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe-
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--G---DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH- 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g---~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~- 425 (669)
|++.+. +|.|+| |.||+|.+. + ..+|||.++. ++.+|+.++++++||||++++++|..
T Consensus 91 ~~~~~~-LG~G~f-------g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 91 VHFNEV-IGRGHF-------GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEE-EECCSS-------SEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred eecCcE-eeeCCC-------eEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 455553 999999 999999873 1 2579998853 36789999999999999999999765
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D 235 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVAD 235 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred CCCeEEEEECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEee
Confidence 45789999999999999999754 245899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++......... ........+|..|+|||.+.+..++.++||||||+++|||++ |..||.+....+...
T Consensus 236 FG~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---- 307 (373)
T 3c1x_A 236 FGLARDMYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---- 307 (373)
T ss_dssp C-------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH----
T ss_pred cccccccccccccc----ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH----
Confidence 99998764332110 111233467889999999999999999999999999999999 566666543321100
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
.... ..+...+..++..+.+++.+||+.||.+|||+.|+++.|+++......
T Consensus 308 --~~~~--------------~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 308 --YLLQ--------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp --HHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --HHHc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0000 011223344566799999999999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=342.51 Aligned_cols=239 Identities=26% Similarity=0.416 Sum_probs=195.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||++... |+.||||+++.+ +..|..+++++ +||||+++++++.
T Consensus 23 ~~y~~~~~-lG~G~f-------g~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 23 DNFEFIRV-LGKGSF-------GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ 94 (353)
T ss_dssp CCEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hheEEEEE-EeeCCC-------EEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence 44665553 999999 999999984 788999998642 45789999988 7999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEc
Confidence 999999999999999999999765 35999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ...
T Consensus 167 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~- 234 (353)
T 3txo_A 167 DFGMCKEGICNG--------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE- 234 (353)
T ss_dssp CCTTCBCSCC-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH-
T ss_pred cccceeecccCC--------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH-
Confidence 999998643321 22345689999999999999999999999999999999999999998765321 111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI------SEVFV 641 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~ 641 (669)
.+.. . ...+|......+.+++.+||+.||.+||++ .|+++
T Consensus 235 --~i~~-------------~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 235 --AILN-------------D--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --HHHH-------------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --HHHc-------------C--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111 0 112344455678999999999999999998 67765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=339.80 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=204.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSG 421 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g 421 (669)
..|.+.+. +|.|+| |.||+|...+ ..||+|.++. .+.+|+.+++++ +||||+++++
T Consensus 46 ~~~~~~~~-lG~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 46 NNLQFGKT-LGAGAF-------GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp TSEEEEEE-EEECSS-------EEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHceeeeE-eccCCC-------cceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34555553 999999 9999999742 3699999864 367899999999 8999999999
Q ss_pred EEEecCceeEEEEecCCCCHHHHHhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 005923 422 FCVHEGNTYLVYEFADNGALSDWLHSNRY---------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSN 492 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~N 492 (669)
++.+++..++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 99999999999999999999999975420 01245899999999999999999999999 9999999999
Q ss_pred eeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 005923 493 ILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVT 571 (669)
Q Consensus 493 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~ 571 (669)
||++.++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSN------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTT------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred EEECCCCeEEECccccccccccccc------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999986643321 112234567889999999999999999999999999999999 889987
Q ss_pred CCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
+....... ..... . ......+..++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 269 ~~~~~~~~------~~~~~---------~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 269 GILVNSKF------YKLVK---------D----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp TCCSSHHH------HHHHH---------H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchhHHH------HHHHh---------c----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 65432110 01111 0 11112233345678999999999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=330.98 Aligned_cols=252 Identities=27% Similarity=0.512 Sum_probs=191.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ ++|.|+| |.||+|..++ .+|+|+++. .+.+|++++++++||||+++++++ .....
T Consensus 25 ~y~~~~-~lG~G~~-------g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 25 QITVGQ-RIGSGSF-------GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp SCEEEE-EEEECSS-------EEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ceeeee-EecCCCC-------eEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 345444 4999999 9999999765 599999852 367899999999999999999976 56678
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 95 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred EEEEEecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceec
Confidence 9999999999999999654 246999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+....... ........||..|+|||.+. +..++.++||||||+++|||++|+.||.+....+. . .
T Consensus 168 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----~ 235 (289)
T 3og7_A 168 TEKSRWSG------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----I 235 (289)
T ss_dssp ----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--H----H
T ss_pred cccccccc------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--H----H
Confidence 86543221 11223457899999999986 67789999999999999999999999986543221 1 1
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
..... ....+.+ ......++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 236 ~~~~~--------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 236 EMVGR--------GSLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHH--------TSCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHhcc--------cccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111 1111111 12233455678999999999999999999999999998864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=336.57 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=199.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.|.+.+. +|.|+| |.||++... +..+|+|.++. .+.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~y~~~~~-lG~G~~-------g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 6 KYMIAED-LGRGEF-------GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred ceEeeeE-EecCCC-------eEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 4555553 899999 999999984 77899999853 3678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC--CCcEEEcccCC
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNFGL 508 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~DfGl 508 (669)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 78 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEeCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 999999999999999754 246999999999999999999999999 999999999999987 78999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+....+. +..+
T Consensus 151 a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i 215 (321)
T 1tki_A 151 ARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENI 215 (321)
T ss_dssp CEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred CeECCCCC---------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHH
Confidence 98765432 23346789999999999998899999999999999999999999987553211 1111
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... .. ..........+.++.+++.+||+.||.+|||+.|++++
T Consensus 216 ~~~---------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 216 MNA---------EY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHT---------CC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HcC---------CC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 110 00 00000111335678999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.52 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=196.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
..|.+.+. +|.|+| |.||+|... +..||+|.++. .+.+|+.++++++||||+++++++
T Consensus 34 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 34 NLLILGKI-LGEGEF-------GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp GGEEEEEE-EEC-CC-------CCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHeeeccc-eeecCC-------eEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 45666664 899999 999999874 23699999862 367899999999999999999999
Q ss_pred EecCc-----eeEEEEecCCCCHHHHHhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 424 VHEGN-----TYLVYEFADNGALSDWLHSNRY-QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 424 ~~~~~-----~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
.+.+. .++||||+++|+|.+++...+. .....+++..++.++.||+.||.|||+++ ++||||||+|||+++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 87653 4999999999999999965432 23356999999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~ 576 (669)
++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYY------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp TSCEEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCcEEEeecCcceeccccccc------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 999999999999876543211 11233457889999999999999999999999999999999 88888765432
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCC
Q 005923 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSS 651 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 651 (669)
+... .+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++...-.
T Consensus 257 ~~~~----------------~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 257 EMYD----------------YLLH----GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp GHHH----------------HHHT----TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHH----------------HHHc----CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 2100 0000 11123344556779999999999999999999999999999986543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.93 Aligned_cols=257 Identities=35% Similarity=0.550 Sum_probs=206.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCe--eEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDD--AAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~--vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||++... +.. +++|.++. .+.+|+++++++ +||||+++++++.
T Consensus 25 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 25 NDIKFQDV-IGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp GGCEEEEE-EECGGG-------CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred HHccceee-eecCCC-------ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 45665554 899999 999999874 443 48998853 367899999999 8999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
+++..++||||+++|+|.+++...+. .....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 173 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 173 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceE
Confidence 99999999999999999999986520 12346999999999999999999999999 99999999999
Q ss_pred eecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 005923 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTG 572 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~ 572 (669)
|++.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcCCCeEEEcccCcCccccccc---------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999997543211 1123456789999999999999999999999999999998 9999986
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
....+. . +.+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++......
T Consensus 245 ~~~~~~----------~------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 245 MTCAEL----------Y------EKLPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp CCHHHH----------H------HHGGG----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CcHHHH----------H------HHhhc----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 543210 0 01111 112233445567799999999999999999999999999999987655
Q ss_pred CC
Q 005923 653 WD 654 (669)
Q Consensus 653 ~~ 654 (669)
+.
T Consensus 305 ~~ 306 (327)
T 1fvr_A 305 YV 306 (327)
T ss_dssp SB
T ss_pred cc
Confidence 43
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=341.37 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=196.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec------------ccHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK------------GDVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.|++.+. +|.|+| |.||++.. +|+.||||+++ ..+.+|+.++++++||||+++++++.
T Consensus 25 ~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 25 VYELCEV-IGKGPF-------SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96 (351)
T ss_dssp HEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceEEeeE-EeeCCC-------EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4565553 899999 99999987 47899999974 23678999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc---E
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR---A 501 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~---~ 501 (669)
+++..++||||+++|+|.+++.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCE
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcE
Confidence 9999999999999999999886542 12345899999999999999999999999 999999999999986654 9
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+... ..
T Consensus 173 kl~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~ 240 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGL--------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL 240 (351)
T ss_dssp EECCCTTCEECCTTSC--------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH
T ss_pred EEecCcceeEecCCCe--------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH
Confidence 9999999987654321 12345799999999999999999999999999999999999999986431 11
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
... .... ... .........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~---i~~~---------~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 FEG---IIKG---------KYK--MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHH---HHHT---------CCC--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH---HHcC---------CCC--CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 1110 000 000001123457899999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=333.24 Aligned_cols=245 Identities=23% Similarity=0.451 Sum_probs=195.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--C-------CeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--G-------DDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g-------~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~ 422 (669)
.|.+.+ .+|.|+| |.||+|... + ..||+|.++. .+.+|++++++++||||++++++
T Consensus 9 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 9 DLIFNE-SLGQGTF-------TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp GEEEEE-EEEEETT-------EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred Heeeee-eeccCCC-------ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 455555 3899999 999999874 2 4699999853 36789999999999999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc--
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR-- 500 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~-- 500 (669)
+..++..++||||+++|+|.+++...+ ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGG
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccc
Confidence 999999999999999999999998652 34899999999999999999999999 999999999999998887
Q ss_pred ------EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 501 ------AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 501 ------~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
+||+|||+++..... ....+|..|+|||.+.+ ..++.++||||||+++|||++|..++...
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPK------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCH------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccceeeeccCcccccccCc------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999999999765432 12457889999999987 77999999999999999999976665543
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCC
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSS 651 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 651 (669)
....... ..... . ...+...+..+.+++.+||+.||.+|||+.|+++.|+++.+...
T Consensus 222 ~~~~~~~------~~~~~-------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 222 LDSQRKL------QFYED-------R--------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp SCHHHHH------HHHHT-------T--------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred cchHHHH------HHhhc-------c--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 3211100 00000 0 11112223457899999999999999999999999999987543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=329.24 Aligned_cols=249 Identities=29% Similarity=0.520 Sum_probs=203.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-CeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-DDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ .+|.|+| |.||+|..++ ..||||.++. .+.+|++++++++||||+++++++. ++..++
T Consensus 14 ~y~~~~-~lg~G~~-------g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 14 TLKLVE-RLGAGQF-------GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp GEEEEE-EEEEETT-------EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hhhhee-eecCCCC-------eEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 455555 3899999 9999999864 5799999863 3778999999999999999999985 567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.
T Consensus 85 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 999999999999996531 125899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ...
T Consensus 159 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~--- 222 (279)
T 1qpc_A 159 IEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQN--- 222 (279)
T ss_dssp CSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHH---
T ss_pred ccCccc-------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH------HHH---
Confidence 654321 11223456788999999999999999999999999999999 8999876543211 000
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+.. ......+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 223 -------~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 223 -------LER----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -------HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------Hhc----ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 100 111223344556789999999999999999999999999998765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.73 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=202.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc----cHHHHHHHHHh--cCCCCceeEeeEEEecC----c
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG----DVSSEINILKK--INHSNIIRLSGFCVHEG----N 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~ 428 (669)
.|.+.+ .+|.|+| |.||+|..+|+.||||+++. .+.+|.+++.. ++||||+++++++.... .
T Consensus 43 ~y~~~~-~lg~G~~-------g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 43 TIVLQE-SIGKGRF-------GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HCEEEE-EEEEETT-------EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cEEEEe-eecCCCC-------cEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 455555 3899999 99999999999999999964 35678888888 78999999999998776 7
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeeCCCCCCeeecCCCc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH--------KYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
.++||||+++|+|.+++.+. .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred eEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 89999999999999999754 4899999999999999999999 777 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccC------CCCchhhHHHHHHHHHHHHcC--------
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG------VITPKLDVFAFGVVVLELLSG-------- 566 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~s~~sDV~S~Gvvl~elltg-------- 566 (669)
+||+|||+++......... ........||..|+|||.+.+. .++.++||||||+++|||++|
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp EEECCCTTCEEEETTTTEE----EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred EEEEECCCceecccccccc----ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999998764432110 0122345789999999999875 334789999999999999999
Q ss_pred --CCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCC-CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 567 --REAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNE-YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 567 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+.||.......... ..+... .......+.+... ...++...+.+|+.+||+.||.+|||+.||++.|
T Consensus 262 ~~~~p~~~~~~~~~~~--~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSV--EEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCTTTTTSCSSCCH--HHHHHH--------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccCccccCcCcccH--HHHHHH--------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 67776432111000 000000 0111111221111 1236677899999999999999999999999999
Q ss_pred HHhhcC
Q 005923 644 SKIWSS 649 (669)
Q Consensus 644 ~~i~~~ 649 (669)
+++...
T Consensus 332 ~~i~~~ 337 (342)
T 1b6c_B 332 SQLSQQ 337 (342)
T ss_dssp HHHHHT
T ss_pred HHHHHH
Confidence 999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=339.38 Aligned_cols=250 Identities=26% Similarity=0.476 Sum_probs=195.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCe----eEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDD----AAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~----vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
.|++.+ .+|.|+| |.||+|... ++. |++|.++. .+.+|+.++++++||||++++++|.
T Consensus 16 ~y~~~~-~lG~G~~-------g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 16 EFKKIK-VLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp TEEEEE-EEEECSS-------EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred HceEEE-EeeeCCC-------eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 455555 3899999 999999973 444 47776632 4778999999999999999999997
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.+ ..++|+||+.+|+|.+++...+ ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~-~~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 88 TS-TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp SS-SEEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred cC-CceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEc
Confidence 64 5889999999999999998652 45999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+..
T Consensus 160 DfG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---- 229 (327)
T 3lzb_A 160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---- 229 (327)
T ss_dssp CTTC----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----
T ss_pred cCcceeEccCcccc------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----
Confidence 99999876543211 11223456889999999999999999999999999999999 99999865432211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.. +........+..++..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 230 ---~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 230 ---SI-------------LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---HH-------------HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---HH-------------HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 00 1111122334445667899999999999999999999999999998543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.68 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=199.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECC-----CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKG-----DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||+|.... ..+|+|.++. .+.+|+.++++++||||++++++|.
T Consensus 25 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 25 LIVHFNEV-IGRGHF-------GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp EEEEEEEE-EEEETT-------EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred eehhhcce-eeecCC-------ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 34666664 999999 9999998732 2479998853 3678999999999999999999975
Q ss_pred e-cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 425 H-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 425 ~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
. ++..++||||+++|+|.++++.. ...+++..++.|+.|++.||+|||+++ ++||||||+|||+++++.+||
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl 169 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKV 169 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEE
Confidence 4 45789999999999999999754 246899999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCC-CCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE-AVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~-p~~~~~~~~~~~~~ 582 (669)
+|||+++......... ........+|..|+|||.+.+..++.++||||||+++|||++|.. |+.+....+...
T Consensus 170 ~Dfg~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-- 243 (298)
T 3f66_A 170 ADFGLARDMYDKEYYS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-- 243 (298)
T ss_dssp CSCGGGCCCSCGGGCB----C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH--
T ss_pred Ccccccccccccchhc----cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH--
Confidence 9999998765433211 122334567889999999999999999999999999999999554 554433221100
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.... ......+..++..+.+++.+||+.||.+|||+.|+++.|+++...-
T Consensus 244 ----~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 244 ----YLLQ--------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----HHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----HHhc--------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 0111223344567899999999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.15 Aligned_cols=237 Identities=26% Similarity=0.402 Sum_probs=198.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||++.. +|+.+|+|+++. .+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 6 QDFQILRT-LGTGSF-------GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp GGEEEEEE-EEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred HHcEEEEE-EeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 34555553 899999 99999998 488999999864 24579999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEee
Confidence 99999999999999999999864 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.+....+. .
T Consensus 150 fg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~ 212 (318)
T 1fot_A 150 FGFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------Y 212 (318)
T ss_dssp CSSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H
T ss_pred cCcceecCCc-----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------H
Confidence 9999875432 2335789999999999999999999999999999999999999986543211 1
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
..++. .. ..+|......+.+++.+||+.||.+|| +++|++++
T Consensus 213 ~~i~~-------------~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 213 EKILN-------------AE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHH-------------CC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHh-------------CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111 11 123344556789999999999999999 88998854
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.98 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=201.3
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CC---eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce-eE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GD---DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT-YL 431 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~---~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~l 431 (669)
.+|.|+| |.||+|.+. +. .+|+|.++. .+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 28 ~lg~G~~-------g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 28 VIGKGHF-------GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEETT-------EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eeccCCC-------ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 3899999 999999872 22 689999863 366899999999999999999999876665 99
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+.+|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 99999999999999763 256899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
........ ........++..|+|||.+.+..++.++||||||+++|||++|..|+..........
T Consensus 174 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~----------- 238 (298)
T 3pls_A 174 ILDREYYS----VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT----------- 238 (298)
T ss_dssp TTTGGGGC----SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH-----------
T ss_pred ccCCcccc----cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH-----------
Confidence 64432111 122344678899999999999999999999999999999999776665433211100
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
..+.. ......+..++..+.+++.+||+.||.+|||+.|+++.|+++...-..
T Consensus 239 ----~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 239 ----HFLAQ----GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ----HHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ----HHhhc----CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 00111 111223344556789999999999999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.97 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=196.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+| |+||+|.. +++.||||+++. .+.+|+.++++++||||+++++++.+++
T Consensus 3 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 3 KYEKLE-KIGEGTY-------GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp SEEEEE-EEEECSS-------SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred Cceeee-EecCCCC-------eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 344444 3899999 99999998 478899999852 3668999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 75 KLTLVFEFCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp EEEEEEECCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 99999999985 677766543 246999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++...... .......||..|+|||.+.+.. ++.++||||||+++|||++|..|+....+.. .....+.
T Consensus 147 ~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~ 216 (292)
T 3o0g_A 147 LARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIF 216 (292)
T ss_dssp TCEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHH
T ss_pred cceecCCcc--------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHH
Confidence 998764332 1123357899999999998766 7999999999999999999998876443322 1122222
Q ss_pred HHHhhhhHH--hhhhcccCC---------ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVR--EKLRGFIDP---------SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~--~~l~~~~d~---------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
......... .......+. .............+.+|+.+||+.||.+|||++|++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 222111100 001110000 00011222455678999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.27 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=197.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
..|++.+ ++|.|+| |.||++.. +|+.||+|+++. .+.+|++++++++||||+++++++.+++
T Consensus 21 ~~y~~~~-~lG~G~~-------g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 21 EKYQKLE-KVGEGTY-------GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEEEEEE-EEEECSS-------CEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred hhhHhhh-hccCCCC-------eEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 4566555 3899999 99999998 578899999853 3668999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++ +|.+++...+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEcCCCC-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCc
Confidence 99999999984 8999887542 45999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++...... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+. ...+.
T Consensus 165 ~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~ 233 (311)
T 3niz_A 165 LARAFGIPV--------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIF 233 (311)
T ss_dssp TCEETTSCC--------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHH
T ss_pred CceecCCCc--------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHH
Confidence 998764322 11233578999999999876 5689999999999999999999999986554321 11222
Q ss_pred HHHhhhhHH-----hhhhcccCCccC--C-----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVR-----EKLRGFIDPSLR--N-----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~-----~~l~~~~d~~l~--~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+...... ..+..+.+.... . ........++.+|+.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 222111100 000000000000 0 0111234568899999999999999999999863
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=305.84 Aligned_cols=180 Identities=24% Similarity=0.366 Sum_probs=162.2
Q ss_pred CCcc-eeeeeecCCCCCCHHHHHHhhCCCCh--------HHHhhhc-CCCCCCCCCCCCCcEEEeeecccCCCCCCccee
Q 005923 56 PSCQ-AYLTFRSNPSYNTPVTIDYLFKTSHP--------NLIASIN-SITNVTATLPTDTPVLIPVNCSCSGGGDGDYYQ 125 (669)
Q Consensus 56 ~~c~-~~~~y~~~~~g~tl~~Ia~~~~~~~~--------~~i~~~N-~~~~~~~~l~~gq~l~IP~~c~c~~~~~~~~~~ 125 (669)
.+|+ +|+.|+|++ ||||+.||++|| +++ ++|+++| ++. +.+.|.+||.|+||.+|.|.... +.+
T Consensus 3 ~~C~~a~~~Y~V~~-GDTL~~IA~~~~-vsv~~~~~~~~~~I~~~Np~l~-~~~~l~~Gq~L~IP~~~~~~~~~---~~~ 76 (212)
T 4eby_A 3 TSCPLALASYYLEN-GTTLSVINQNLN-SSIAPYDQINFDPILRYNSNIK-DKDRIQMGSRVLVPFPCECQPGD---FLG 76 (212)
T ss_dssp CCCSCEEEEEECCT-TCCHHHHHHHTC-CSSSCCCSSCCHHHHTTCTTCS-CTTSCCTTCEEEEEECCEEETTT---EEE
T ss_pred CCCccceEEEEeCC-CCCHHHHHHHHC-CCchhccccCHHHHHHhccCCC-CcCccCCCCEEEEeccccccCCc---ccc
Confidence 3799 999999999 999999999999 998 9999999 996 67899999999999999998543 677
Q ss_pred eeeEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEeeecCCCCcccccCCceEEEEEEcCCCCCH
Q 005923 126 FNTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSI 205 (669)
Q Consensus 126 ~~~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~~c~c~~~~~~~~~~~~~~tY~v~~GDtl 205 (669)
+..+|+|+ +|||||.||+++|+|++++++|+++|++.++.|++||+|.||..|.|++. +.+.+.+..++|+|++||||
T Consensus 77 ~~~~Y~V~-~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~-~~~~~~~~~~~Y~V~~GDTL 154 (212)
T 4eby_A 77 HNFSYSVR-QEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDE-SVSKDFGLFVTYPLRPEDSL 154 (212)
T ss_dssp EEEEEECC-TTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCT-TTCSSCCCEEEEECCTTCCH
T ss_pred CceEEEec-CCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCc-ccccCCCCeEEEEECCCCcH
Confidence 88999999 99999999977999999999999999977779999999999999999875 45556667789999999999
Q ss_pred HHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCCCC
Q 005923 206 SAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKTAP 245 (669)
Q Consensus 206 ~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~~P 245 (669)
|+||+|||+++++|++||++.+ ..+.+|+ |+||.++.+
T Consensus 155 ~~IA~~fgvsv~~L~~~N~~~~-~~~~~g~-l~IP~~~~~ 192 (212)
T 4eby_A 155 SSIARSSGVSADILQRYNPGVN-FNSGNGI-VYVPGRDPN 192 (212)
T ss_dssp HHHHHHHTSCHHHHHHHSTTCC-TTSCSSE-EEEECCCTT
T ss_pred HHHHHHHCcCHHHHHHhcCCCc-cCCCCCE-EEecCCCCC
Confidence 9999999999999999999853 5666666 999999854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.01 Aligned_cols=238 Identities=26% Similarity=0.415 Sum_probs=199.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|.+.+. +|.|+| |.||+|.. .++.||||+++. .+.+|+.++++++||||+++++++..
T Consensus 9 ~~Y~i~~~-lG~G~~-------g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 9 GPYIIRET-LGEGSF-------GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp TTEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCEEEEEE-EecCCC-------eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 45666664 999999 99999998 588999999853 36789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+ +|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECC
T ss_pred CCEEEEEEECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEE
Confidence 99999999999 68999998764 35999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+++...... ......||+.|+|||.+.+..+ ++++||||||+++|||++|+.||.+....
T Consensus 152 FG~s~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------- 214 (336)
T 3h4j_B 152 FGLSNIMTDGN---------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-------- 214 (336)
T ss_dssp SSCTBTTTTSB---------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST--------
T ss_pred eccceeccCCc---------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH--------
Confidence 99998765432 1233579999999999988776 78999999999999999999999764321
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+....+. .. ....|...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 215 -----------~~~~~i~-~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 215 -----------NLFKKVN-SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----------TCBCCCC-SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----------HHHHHHH-cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0111111 11 123445566778999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.32 Aligned_cols=262 Identities=23% Similarity=0.385 Sum_probs=190.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
..|++.+ ++|.|+| |.||+|... |+.||+|.++. .+.+|++++++++||||+++++++..++
T Consensus 5 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 5 SQFKQLE-KLGNGTY-------ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ----------------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred cceeEee-EECCCCC-------EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 3455555 4999999 999999874 78999999852 3678999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRY-QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
..++||||++ |+|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 152 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDF 152 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcC
Confidence 9999999998 599999875421 12245999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++....... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ...+
T Consensus 153 g~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i 221 (317)
T 2pmi_A 153 GLARAFGIPVN--------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLI 221 (317)
T ss_dssp SSCEETTSCCC--------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH
T ss_pred ccceecCCCcc--------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHH
Confidence 99987643221 1233578999999999976 4689999999999999999999999987654321 1222
Q ss_pred HHHHhhhhH--Hhhhhcc--cCCcc------------CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNV--REKLRGF--IDPSL------------RNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~--~~~l~~~--~d~~l------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+..... ....... ..+.+ ....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 222111100 0000000 00000 001112334578999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.10 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=194.6
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
+..|++.+. +|.|+| |.||+|.. +|..||+|+++. ++.+|+.++++++||||+++++++.
T Consensus 31 ~~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 31 LANFRIEKK-IGRGQF-------SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGGEEEEEE-EECC---------CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccceEEEEe-ecCCCC-------ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 345666664 999999 99999997 588999999852 3678999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.++..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEE
Confidence 9999999999999999999997532 12356899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.+........
T Consensus 179 Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---- 246 (310)
T 2wqm_A 179 DLGLGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---- 246 (310)
T ss_dssp CC--------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH----
T ss_pred eccceeeecCCC--------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH----
Confidence 999998764322 11233568999999999999999999999999999999999999997543211110
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. . .+... ......+...+..+.+++.+||+.||.+|||+.||++.|+++...
T Consensus 247 ~-~---------~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 247 C-K---------KIEQC---DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp H-H---------HHHTT---CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-H---------Hhhcc---cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0 0 01110 011111233456789999999999999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.85 Aligned_cols=266 Identities=17% Similarity=0.232 Sum_probs=205.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC----------CCeeEEEEecc--cHHHHHHHHHhcCCCCcee-------
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK----------GDDAAVKVMKG--DVSSEINILKKINHSNIIR------- 418 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----------g~~vavK~~~~--~~~~E~~~l~~l~H~niv~------- 418 (669)
..|.+.+. +|.|+| |.||+|... ++.||+|.++. .+.+|++++++++||||++
T Consensus 42 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSF-QTRDNQ-------GILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEE-EEEETT-------EEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEE-ecCCCC-------eEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhcc
Confidence 45666664 999999 999999984 67899999975 4899999999999999988
Q ss_pred --------EeeEEEe-cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 419 --------LSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 419 --------l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
+++++.. ++..++||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence 6777776 67789999999 999999998641 246999999999999999999999999 9999999
Q ss_pred CCCeeecCCC--cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCC
Q 005923 490 TSNILLDTNL--RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567 (669)
Q Consensus 490 ~~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~ 567 (669)
|+|||++.++ .+||+|||+++.......... ..........||..|+|||.+.+..++.++||||||+++|||++|+
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA-YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC-CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCcccc-ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999998 999999999987654321110 0011123357999999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 568 EAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 568 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
.||.+...... ......... ......+.+... .....+..+.+++.+||+.||.+|||++||++.|+++.
T Consensus 266 ~pf~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 266 LPWTNCLPNTE-DIMKQKQKF------VDKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp CTTGGGTTCHH-HHHHHHHHH------HHSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcccCCcCHH-HHHHHHHhc------cCChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 99985432111 111111111 111122222111 11123467899999999999999999999999999998
Q ss_pred cC
Q 005923 648 SS 649 (669)
Q Consensus 648 ~~ 649 (669)
..
T Consensus 336 ~~ 337 (352)
T 2jii_A 336 QD 337 (352)
T ss_dssp HH
T ss_pred Hh
Confidence 44
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=340.18 Aligned_cols=270 Identities=20% Similarity=0.331 Sum_probs=200.4
Q ss_pred cccccchhHHHHHhC--CCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeE
Q 005923 356 SLTLYKFQDLKIATG--SFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGF 422 (669)
Q Consensus 356 ~~~~~~~~~l~~~~g--~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~ 422 (669)
....|++.+. +|.| +| |.||++... |+.||||+++. .+.+|+.++++++||||++++++
T Consensus 23 ~~~~y~~~~~-lG~G~~~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 23 EGGCYELLTV-IGKGFEDL-------MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp CGGGEEEEEE-EEEETTTT-------EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCcEEEEec-ccCCcCCc-------eEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3456776664 8999 99 999999985 88999999863 35679999999999999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+.+++..++||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~k 168 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVY 168 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEE
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 999999999999999999999998652 245999999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
|+|||++........... ..........||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+...
T Consensus 169 l~dfg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp ECCGGGCEECEETTEECS-CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred Ecccccceeecccccccc-ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999876533221110 00112233478999999999987 679999999999999999999999998644322111
Q ss_pred HHHHHHHHHh----hhhH-Hh-------------hhhccc---------CCccCCCCcHHHHHHHHHHHHHhcccCCCCC
Q 005923 581 LYASISRVLE----ESNV-RE-------------KLRGFI---------DPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633 (669)
Q Consensus 581 ~~~~~~~~~~----~~~~-~~-------------~l~~~~---------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 633 (669)
........ .... .+ .+...+ ........+......+.+|+.+||+.||.+|
T Consensus 248 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 325 (389)
T 3gni_B 248 --EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325 (389)
T ss_dssp --HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred --HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 10000000 0000 00 000000 0000112333455678999999999999999
Q ss_pred CCHHHHHHH
Q 005923 634 PSISEVFVT 642 (669)
Q Consensus 634 Pt~~evl~~ 642 (669)
||+.|++++
T Consensus 326 pta~ell~h 334 (389)
T 3gni_B 326 PSASTLLNH 334 (389)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhcC
Confidence 999999865
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=325.41 Aligned_cols=261 Identities=19% Similarity=0.299 Sum_probs=201.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec-----ccHHHHHHHHHhcCCCCceeEeeEE-EecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK-----GDVSSEINILKKINHSNIIRLSGFC-VHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~ 430 (669)
.|++.+. +|.|+| |.||+|.. .++.||||++. ..+.+|++++++++|++++..++++ ..++..+
T Consensus 10 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 10 RYRLGRK-IGSGSF-------GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -CEEEEE-EEECSS-------SEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ceEEeee-ecCCCC-------eEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 4555553 899999 99999996 57899999864 3588999999999998877777766 4556779
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee---cCCCcEEEcccC
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNFG 507 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DfG 507 (669)
+||||+ +|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 89999999753 245999999999999999999999999 9999999999999 788999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++.......... ..........||..|+|||.+.+..++.++||||||+++|||++|+.||.+............+..
T Consensus 154 ~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 4hgt_A 154 LAKKYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TCEECBCTTTCCB-CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred cceeccCcccCcc-CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence 9987654332110 001123356789999999999999999999999999999999999999985432211111111110
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..... ... .....++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 233 ~~~~~----~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 233 KKMST----PIE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHS----CHH---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccc----hhh---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 00000 000 00112245789999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.92 Aligned_cols=243 Identities=21% Similarity=0.294 Sum_probs=197.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+. +|.|+| |.||++... ++.+|+|+++. .+.+|+.+++.++||||+++++++.++
T Consensus 70 ~y~~~~~-LG~G~f-------G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 70 DYEVVKV-IGRGAF-------GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp GEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccEEEEE-EEcCCC-------EEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4554443 899999 999999984 77899999853 267899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.+++++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999754 3899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV----ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+.
T Consensus 213 G~a~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---- 281 (410)
T 3v8s_A 213 GTCMKMNKEG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---- 281 (410)
T ss_dssp TTCEECCTTS-------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----
T ss_pred ceeEeeccCC-------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH----
Confidence 9998765432 11233568999999999998765 78999999999999999999999987653211
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA--RPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 642 (669)
...++... ..+ ..+....++..+.+|+.+||+.+|.+ ||+++||+++
T Consensus 282 --~~~i~~~~------~~~-----~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 282 --YSKIMNHK------NSL-----TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --HHHHHTHH------HHC-----CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --HHHHHhcc------ccc-----cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11111110 000 01111234567899999999999988 9999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.94 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=193.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||++.. +++.||||+++. .+.+|++++++++||||+++++++..
T Consensus 12 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 12 DRYELGEI-LGFGGM-------SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp TTEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred CcEEEEEE-EccCCC-------EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 34666553 999999 99999996 578899999864 35689999999999999999999987
Q ss_pred cCce----eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 426 EGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 426 ~~~~----~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
.... ++||||+++|+|.++++.. +.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCE
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCE
Confidence 6544 9999999999999999764 35999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
||+|||+++........ ........||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+..
T Consensus 156 kl~Dfg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-- 228 (311)
T 3ork_A 156 KVMDFGIARAIADSGNS-----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-- 228 (311)
T ss_dssp EECCCSCC-----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--
T ss_pred EEeeccCcccccccccc-----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--
Confidence 99999999876543211 12233467899999999999999999999999999999999999999876532210
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHhhcCCCC
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF-VTLSKIWSSSSD 652 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl-~~L~~i~~~~~~ 652 (669)
. ..... ....+ ......++..+.+++.+||+.||.+||+..+++ ..|.++......
T Consensus 229 ~----~~~~~--------~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 229 Y----QHVRE--------DPIPP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp H----HHHHC--------CCCCH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred H----HHhcC--------CCCCc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 0 01100 00000 001122455789999999999999999666544 557666554433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.17 Aligned_cols=241 Identities=25% Similarity=0.345 Sum_probs=197.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|.+.+. +|.|+| |.||++... ++.+|+|+++. .+.+|+++|++++||||+++++++.+
T Consensus 15 ~~y~i~~~-LG~G~f-------G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 15 DHFEILRA-IGKGSF-------GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp GGEEEEEE-EECCTT-------CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred HHeEEEEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34555553 999999 999999984 67899999853 35689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.+..++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEec
Confidence 99999999999999999999754 45999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeeccccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 159 FG~a~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~ 229 (384)
T 4fr4_A 159 FNIAAMLPRET---------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229 (384)
T ss_dssp CTTCEECCTTC---------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH
T ss_pred cceeeeccCCC---------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence 99998764332 2344679999999999974 45899999999999999999999999854332211111
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-ISEVFV 641 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 641 (669)
..+ . . ....+|...+..+.+|+.+||+.||.+||+ +++++.
T Consensus 230 ~~~----~---------~-----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 230 HTF----E---------T-----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHH----H---------H-----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHH----h---------h-----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 110 0 0 012334455678899999999999999999 666654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.48 Aligned_cols=240 Identities=25% Similarity=0.398 Sum_probs=192.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc-----------cHHHHHHHHHhcCCCCceeEee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG-----------DVSSEINILKKINHSNIIRLSG 421 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H~niv~l~g 421 (669)
..|++.+. +|.|+| |.||++.. .|+.+|+|+++. .+.+|+++|++++||||+++++
T Consensus 17 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 17 ECFELLRV-LGKGGY-------GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp GGEEEEEE-EEEETT-------EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEE
T ss_pred HHeEEEEE-EEeCCC-------EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 34565553 999999 99999987 478899999863 2457999999999999999999
Q ss_pred EEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 422 FCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
++..++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~ 160 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHV 160 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcE
Confidence 999999999999999999999999764 35899999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
||+|||+++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+.
T Consensus 161 kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--- 229 (327)
T 3a62_A 161 KLTDFGLCKESIHDG--------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--- 229 (327)
T ss_dssp EECCCSCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred EEEeCCcccccccCC--------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---
Confidence 999999998643321 123345789999999999999999999999999999999999999987553211
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
+..+... ....|...+..+.+++.+||+.||.+|| ++.|++++
T Consensus 230 ---~~~i~~~---------------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 230 ---IDKILKC---------------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---HHHHHHT---------------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---HHHHHhC---------------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111110 1123334556789999999999999999 67777653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.53 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=193.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||+++.. ++.+|+|+++.. +.+|..+++++ +||||+++++++.
T Consensus 9 ~~y~~~~~-lG~G~f-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 9 QDFDLLRV-IGRGSY-------AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hheEEEEE-EEecCC-------eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 34555553 899999 999999984 778999998642 56799999988 8999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.++..++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999764 35999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH--HHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE--LLY 582 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~--~~~ 582 (669)
|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...
T Consensus 153 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 224 (345)
T 3a8x_A 153 DYGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 224 (345)
T ss_dssp CGGGCBCSCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CH
T ss_pred eccccccccCCC--------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccH
Confidence 999998643221 1234468999999999999999999999999999999999999999742211000 000
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
..+... +.... ...|...+..+.+|+.+||+.||.+||++
T Consensus 225 ~~~~~~------------i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 225 DYLFQV------------ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHH------------HHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHH------------HHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000000 01111 12344556678999999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.99 Aligned_cols=243 Identities=26% Similarity=0.422 Sum_probs=186.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ .+|.|+| |.||+|... ++.||||+++. .+.+|++++++++||||+++++++...+..++
T Consensus 54 ~y~~~~-~lG~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 54 FFEVES-ELGRGAT-------SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp TEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEee-EEeeCCC-------EEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 355555 3999999 999999985 67899999864 36689999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEcccCC
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGL 508 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DfGl 508 (669)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 126 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999999999754 45899999999999999999999999 999999999999975 89999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. ... ..
T Consensus 198 a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i 263 (349)
T 2w4o_A 198 SKIVEHQV---------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RI 263 (349)
T ss_dssp ------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HH
T ss_pred ccccCccc---------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HH
Confidence 98764321 12345789999999999999999999999999999999999999986543211 111 11
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... . .....+...+.+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 264 ~~~------~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 264 LNC------E-----YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HTT------C-----CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HhC------C-----CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0 001111223445678999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.57 Aligned_cols=238 Identities=25% Similarity=0.398 Sum_probs=197.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|.+.+. +|.|+| |.||++..+ |+.||+|+++.. +..|..++.++ +||||+++++++.
T Consensus 17 ~~y~~~~~-lG~G~f-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 17 EDFILHKM-LGKGSF-------GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp TTEEEEEE-EEECSS-------SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred HHeEEEEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 44555553 999999 999999984 778999998642 45788899887 8999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 999999999999999999999764 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+ ....
T Consensus 161 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~ 229 (345)
T 1xjd_A 161 DFGMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHS 229 (345)
T ss_dssp CCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred EChhhhhcccCC--------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHH
Confidence 999998643321 12345689999999999999999999999999999999999999998755321 1111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS-EVF 640 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 640 (669)
+ ... ...+|...+..+.+|+.+||+.||.+||++. |++
T Consensus 230 i---~~~---------------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 230 I---RMD---------------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp H---HHC---------------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred H---HhC---------------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 100 1123344556789999999999999999997 665
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=334.93 Aligned_cols=264 Identities=17% Similarity=0.225 Sum_probs=195.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEeccc------------------HHHHHHHHHhcCCC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKGD------------------VSSEINILKKINHS 414 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~~------------------~~~E~~~l~~l~H~ 414 (669)
..|.+.+. +|.|+| |.||+|.. .+..+|+|++..+ +.+|+..++.++||
T Consensus 37 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (345)
T 2v62_A 37 NQWVLGKK-IGSGGF-------GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYL 108 (345)
T ss_dssp CEEEEEEE-C-------------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCC
T ss_pred ceEEEEee-EeecCC-------eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccccc
Confidence 35666664 999999 99999998 4567999987532 34577778888999
Q ss_pred CceeEeeEEEe----cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 005923 415 NIIRLSGFCVH----EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490 (669)
Q Consensus 415 niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~ 490 (669)
||+++++++.. +...++||||+ +++|.+++... +.+++..++.|+.||+.||+|||+++ |+||||||
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 179 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKA 179 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred CcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCH
Confidence 99999999988 67889999999 99999999764 26999999999999999999999999 99999999
Q ss_pred CCeeecCCC--cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 005923 491 SNILLDTNL--RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE 568 (669)
Q Consensus 491 ~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~ 568 (669)
+|||++.++ .+||+|||+++.......... ..........||..|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 258 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ-YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKL 258 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSGGGCCCC-CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEccCCCCcEEEEeCCCceeccccccccc-chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999998887 999999999987654321110 00111234579999999999999999999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+........ ........... ...+..... +..++..+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 259 pf~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 259 PWEQNLKDPVAV-QTAKTNLLDEL--PQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TTGGGTTCHHHH-HHHHHHHHHTT--THHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred CccccccccHHH-HHHHHhhcccc--cHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 996432211111 11111111100 011111110 11344578999999999999999999999999988764
Q ss_pred C
Q 005923 649 S 649 (669)
Q Consensus 649 ~ 649 (669)
.
T Consensus 329 ~ 329 (345)
T 2v62_A 329 P 329 (345)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=325.24 Aligned_cols=260 Identities=19% Similarity=0.301 Sum_probs=201.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec-----ccHHHHHHHHHhcCCCCceeEeeEEE-ecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK-----GDVSSEINILKKINHSNIIRLSGFCV-HEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~ 430 (669)
.|++.+. +|.|+| |.||+|.. +|+.||||++. .++.+|+.++++++|++++..++++. .++..+
T Consensus 10 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 10 RYRLGRK-IGSGSF-------GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TEEEEEE-EEEETT-------EEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred EEEEEEE-EccCCC-------eEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 4555554 899999 99999996 58899999875 35789999999999988777666664 556779
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee---cCCCcEEEcccC
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNFG 507 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DfG 507 (669)
+||||+ +++|.+++...+ ..+++..++.++.|++.||+|||+++ ++||||||+|||+ ++++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 999999 899999997542 46999999999999999999999999 9999999999999 488999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++.......... ..........||..|+|||.+.+..++.++||||||+++|||++|+.||.+............+..
T Consensus 154 ~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 154 LAKKYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TCEECBCTTTCCB-CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred Ccccccccccccc-cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 9987654332110 001123446799999999999999999999999999999999999999985332111111111111
Q ss_pred -HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 588 -VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 588 -~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..... .. ..+..++..+.+++.+||+.||.+|||+.||++.|+++...
T Consensus 233 ~~~~~~-----~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 233 KKMSTP-----IE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHSC-----HH---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccCCc-----hH---------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 00000 00 00112345689999999999999999999999999999854
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.47 Aligned_cols=237 Identities=23% Similarity=0.383 Sum_probs=199.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||++... |+.||+|+++. .+.+|+++|++++||||+++++++.+
T Consensus 41 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 41 DQFDRIKT-LGTGSF-------GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GGEEEEEE-EEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred HHCEEEEE-eecCcC-------cEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34555553 899999 999999984 88999999853 35679999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++.+. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcc
Confidence 99999999999999999999864 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.+....+. .
T Consensus 185 Fg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~ 247 (350)
T 1rdq_E 185 FGFAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------Y 247 (350)
T ss_dssp CTTCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred cccceeccCC-----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------H
Confidence 9999876432 1235789999999999999999999999999999999999999987553211 1
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
..+.. . ...+|...+..+.+++.+||+.||.+||+ ++||+++
T Consensus 248 ~~i~~-------------~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 248 EKIVS-------------G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHH-------------C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHc-------------C--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11111 0 11234445667899999999999999998 8888754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.82 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=204.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|.+.+ .+|.|+| |.||+|... +..||||.++. .+.+|+.++++++||||+++++++
T Consensus 26 ~y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 26 KITMSR-ELGQGSF-------GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp GEEEEE-EEEECSS-------SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred heeeee-EeccCCc-------eEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 455555 3899999 999999864 56799999853 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRY-----QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
.+++..++||||+++|+|.+++...+. .....+++..+++++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 999999999999999999999975320 11245799999999999999999999999 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhH
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCE 577 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~ 577 (669)
+.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp CCEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred CeEEECcCccccccccccc------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 9999999999986643321 111223456889999999999999999999999999999999 888887654321
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. ..... ... ....+..++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 249 ~------~~~~~-------------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 249 V------LRFVM-------------EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp H------HHHHH-------------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred H------HHHHH-------------cCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 0 00000 000 1123344556789999999999999999999999999988653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.40 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=197.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+| |.||++.. .|+.+|+|+++. .+.+|++++++++||||+++++++.+++
T Consensus 12 ~Y~i~~-~LG~G~f-------g~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 12 EYQLFE-ELGKGAF-------SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HEEEEE-EEEEC---------CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred CeEEEE-EeccCCC-------eEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 455555 3899999 99999987 588899999853 3678999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec---CCCcEEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD---TNLRAKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~ 504 (669)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 999999999999999999764 45999999999999999999999999 99999999999998 46889999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+. ...
T Consensus 156 DFG~a~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~ 224 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQ 224 (444)
T ss_dssp CCSSCBCCCTTCC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH
T ss_pred cCceeEEecCCCc--------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHH
Confidence 9999987654321 12346799999999999999999999999999999999999999987553211 111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.. ....+. .+.....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 225 ---i~~------~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 225 ---IKA------GAYDFP-----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---HHH------TCCCCC-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHh------CCCCCC-----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 100 000111 11112345678999999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.99 Aligned_cols=242 Identities=24% Similarity=0.392 Sum_probs=197.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|.+.+. +|.|+| |.||++... |..+|+|+++. .+.+|+.++++++||||+++++++.+++
T Consensus 30 ~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 30 NYDVKEE-LGKGAF-------SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CeEEeeE-EecCCC-------eEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 4555553 899999 999999984 78999999853 3668999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC---CcEEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN---LRAKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~ 504 (669)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence 999999999999999999754 45899999999999999999999999 9999999999999865 459999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....
T Consensus 174 DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~ 241 (362)
T 2bdw_A 174 DFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQ 241 (362)
T ss_dssp CCTTCBCCTTCC---------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred ecCcceEecCCc---------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH
Confidence 999998765332 1233579999999999999999999999999999999999999998755321 1111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.. ...+ ........++..+.+|+.+||+.||.+|||+.|++++
T Consensus 242 ---i~~---------~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 242 ---IKA---------GAYD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---HHH---------TCCC--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---HHh---------CCCC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 100 0000 0011112345678999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.20 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=188.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
..|.+.+. +|.|+| |.||++.. .++.||||+++. .+.+|+.++++++||||+++++++...+..
T Consensus 20 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 20 DRYDFVKD-IGSGNF-------GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp TTEEEEEE-ESSSTT-------SSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CcEEEEEE-eccCCC-------EEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 35666553 999999 99999998 478899999863 477999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc--EEEcccC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR--AKITNFG 507 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~--~kl~DfG 507 (669)
++||||+++|+|.+++... +.+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 92 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecC
Confidence 9999999999999999764 35999999999999999999999999 999999999999987765 9999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPK-LDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~-sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++...... ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||.+...... ....+
T Consensus 164 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~- 231 (361)
T 3uc3_A 164 YSKSSVLHS---------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI- 231 (361)
T ss_dssp CC------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH-
T ss_pred ccccccccC---------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH-
Confidence 998543221 1233579999999999998888766 8999999999999999999985432111 00111
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+.......+.....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 232 ------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 ------------QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------------HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------------HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111111122345678999999999999999999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=332.33 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=190.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec--------ccHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK--------GDVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|++.+. +|.|+| |.||+|.. +|+.||||+++ ..+.+|+++|++++||||++++++|.+...
T Consensus 7 ~y~~~~~-lG~G~~-------g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 7 DFEPIQC-MGRGGF-------GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HEEEEEE-EECC-C-------SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred cCceeeE-ecCCCC-------eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 3444443 899999 99999998 48899999985 247789999999999999999999865432
Q ss_pred ---------------------------------------------------------eeEEEEecCCCCHHHHHhcCCCC
Q 005923 429 ---------------------------------------------------------TYLVYEFADNGALSDWLHSNRYQ 451 (669)
Q Consensus 429 ---------------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~ 451 (669)
.++||||+++|+|.+++....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-- 156 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-- 156 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--
Confidence 799999999999999998753
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCc----cccee
Q 005923 452 TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY----GLQLT 527 (669)
Q Consensus 452 ~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~----~~~~~ 527 (669)
.....++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............ .....
T Consensus 157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 157 SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 3345688889999999999999999999 9999999999999999999999999999876542111000 00122
Q ss_pred eecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccC
Q 005923 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLR 607 (669)
Q Consensus 528 ~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~ 607 (669)
....||..|+|||.+.+..++.++||||||+++|||++|..++.. .. ... ...... . .
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~---~~~----------~~~~~~---~-~ 291 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RV---RII----------TDVRNL---K-F 291 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HH---HHH----------HHHHTT---C-C
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HH---HHH----------HHhhcc---C-C
Confidence 345799999999999999999999999999999999998665311 00 000 001010 0 0
Q ss_pred CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 608 NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 608 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..........+.+++.+||+.||.+|||+.|++++
T Consensus 292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 11123444567899999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.52 Aligned_cols=243 Identities=27% Similarity=0.419 Sum_probs=193.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc---------cHHHHHHHHHhcCC--CCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG---------DVSSEINILKKINH--SNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~H--~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||++.. +++.||||+++. .+.+|+.+|++++| +||+++++++..
T Consensus 9 ~~y~i~~~-lG~G~~-------g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 9 RIYSILKQ-IGSGGS-------SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CEEEEEEE-ESCCSS-------EEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CEEEEEEE-EecCCC-------eEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 34666553 999999 99999987 467899999852 36789999999976 999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||| +.+|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++ ++.+||+|
T Consensus 81 ~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 81 DQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred CCEEEEEEe-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEee
Confidence 999999999 5678999999864 46899999999999999999999999 99999999999997 67899999
Q ss_pred cCCccccCCCccccCCcccceeeeccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----------GVITPKLDVFAFGVVVLELLSGREAVTGDQ 574 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDV~S~Gvvl~elltg~~p~~~~~ 574 (669)
||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 151 FG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 151 FGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp CSSSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCcccc------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 999987654321 112334679999999999975 778999999999999999999999997543
Q ss_pred hhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... ..+..++++.....++......+.+|+.+||+.||.+|||+.|++++
T Consensus 225 ~~~------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 225 NQI------------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SHH------------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHH------------------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 211 11122233333344455555678999999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=326.02 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=194.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|++.+ .+|.|+| |.||+|..+ |+.+|+|+++. .+.+|++++++++||||+++++++..++.
T Consensus 3 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 3 KYHGLE-KIGEGTY-------GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp SEEEEE-EEEEETT-------EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred cchhhh-hcccCCC-------EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 344444 3899999 999999985 78899999842 36689999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEEEecCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECcc
Confidence 9999999985 999999754 246999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
++...... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+ . ...+..
T Consensus 147 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~-~~~~~~ 215 (288)
T 1ob3_A 147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--Q-LMRIFR 215 (288)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H-HHHHHH
T ss_pred ccccCccc--------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--H-HHHHHH
Confidence 98754321 11233568999999999976 458999999999999999999999998755322 1 111211
Q ss_pred HHhhhhHH--hhhhc--ccCCccC-------CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEESNVR--EKLRG--FIDPSLR-------NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~--~~l~~--~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+...... ..... ..++.+. .......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111000 00000 0111110 01122345678999999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.43 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=198.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+ .+|.|+| |+||++... ++.+|+|+++. .+.+|..++.+++||||++++++|.++
T Consensus 75 ~y~~~~-~LG~G~f-------G~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 75 DFEILK-VIGRGAF-------GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred heEEEE-EEEeCCC-------EEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344444 3899999 999999985 67899999853 277899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..+|||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999763 246999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
|+++....... .......||+.|+|||++. .+.++.++|||||||++|||++|+.||.+....+.
T Consensus 220 Gla~~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--- 289 (437)
T 4aw2_A 220 GSCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--- 289 (437)
T ss_dssp TTCEECCTTSC-------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---
T ss_pred hhhhhcccCCC-------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---
Confidence 99987654321 1223467999999999997 56789999999999999999999999987653221
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNA--RPSISEVFVT 642 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 642 (669)
.. .++... ..+.-+. ....+...+.+|+++||..+|.+ ||+++|++++
T Consensus 290 ~~---~i~~~~------~~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 290 YG---KIMNHK------ERFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HH---HHHTHH------HHCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HH---hhhhcc------ccccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11 111110 0011111 11234567899999999888887 9999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=338.03 Aligned_cols=240 Identities=25% Similarity=0.387 Sum_probs=197.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||++... |+.||+|+++.. +..|..++..+ +||||+++++++.
T Consensus 20 ~~y~~~~~-lG~G~f-------g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 20 TDFNFLMV-LGKGSF-------GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp TTEEEEEE-EEEETT-------EEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred HHcEEEEE-EeeCCC-------EEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 44555554 899999 999999985 578999998642 45789999887 7999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
..+..|+||||+++|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEE
Confidence 999999999999999999999864 35999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+ ...
T Consensus 164 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~- 231 (353)
T 2i0e_A 164 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ- 231 (353)
T ss_dssp CCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH-
T ss_pred eCCcccccccCC--------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHH-
Confidence 999998643221 12345679999999999999999999999999999999999999998755321 111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
.+.. . ...+|...+..+.+|+.+||+.||.+||+ ++|++++
T Consensus 232 --~i~~-------------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 232 --SIME-------------H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --HHHH-------------C--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --HHHh-------------C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 1 11234455678899999999999999996 4666543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.52 Aligned_cols=266 Identities=26% Similarity=0.438 Sum_probs=204.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE------CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF------KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.+ .+|.|+| |.||++.+ +++.||||+++. .+.+|++++++++||||+++++++..
T Consensus 42 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 42 HLKFLQ-QLGKGNF-------GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp GEEEEE-EEECCSS-------EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred Hceeee-eeccCCC-------eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 455555 3899999 99999985 477899999853 47789999999999999999999876
Q ss_pred cC--ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 EG--NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~~--~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
.+ ..++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEE
Confidence 54 6899999999999999998652 45999999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++........ ........++..|+|||.+.+..++.++||||||+++|||++|..|+....... ..
T Consensus 187 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~----~~ 257 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEY-----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF----MR 257 (326)
T ss_dssp CCCTTCEECCSSCSE-----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH----HH
T ss_pred ecCcchhhccccccc-----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH----HH
Confidence 999999876543211 111223457788999999999999999999999999999999998876321100 00
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
..............+...+....+...+..++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00000000000011111122222233455566789999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=327.24 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=193.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+| |.||++... |+.||+|++.. .+.+|++++++++||||+++++++..++
T Consensus 4 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 4 KYEKIG-KIGEGSY-------GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEee-EEeecCC-------eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 344444 3899999 999999984 78999998742 3568999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEEEeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCC
Confidence 999999999999999988754 45899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++....... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+.... +.
T Consensus 148 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~ 216 (311)
T 4agu_A 148 FARLLTGPSD--------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IR 216 (311)
T ss_dssp TCEECC--------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HH
T ss_pred CchhccCccc--------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence 9987653321 1234578999999999976 6789999999999999999999999987654322111 11
Q ss_pred HHHhhhhH--------HhhhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNV--------REKLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~--------~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+..... .........+......+ ...+..+.+++.+||+.||.+|||++|++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 11111000 00000000000000000 1344568999999999999999999999865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=332.45 Aligned_cols=256 Identities=30% Similarity=0.432 Sum_probs=204.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSG 421 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g 421 (669)
..|++.+. +|.|+| |.||+|.. .++.||||+++. .+.+|+++++++ +||||+++++
T Consensus 27 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 27 DRLKLGKP-LGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hheeeeeE-EcCCCc-------eeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34555553 899999 99999985 246799999864 366899999999 7999999999
Q ss_pred EEEecC-ceeEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 422 FCVHEG-NTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 422 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
++...+ ..++||||+++|+|.+++...+.. ....+++..++.++.|++.||+|||+.+ ++|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 998755 489999999999999999865311 0123899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||++.++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cceEEECCCCCEEECCCccccccccCcc------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999987644321 112234567889999999999999999999999999999998 999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+....+.. ...+. .- .....+...+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 250 p~~~~~~~~~~------~~~~~---------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 250 PYPGVKIDEEF------CRRLK---------EG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp SSTTCCCSHHH------HHHHH---------HT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccchhHHH------HHHhc---------cC----ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99764432110 00010 00 0112233445678999999999999999999999999999876
Q ss_pred C
Q 005923 649 S 649 (669)
Q Consensus 649 ~ 649 (669)
.
T Consensus 311 ~ 311 (316)
T 2xir_A 311 A 311 (316)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=328.42 Aligned_cols=234 Identities=24% Similarity=0.312 Sum_probs=186.0
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhc-CCCCceeEeeEEEecC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKI-NHSNIIRLSGFCVHEG 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 427 (669)
|++.+ ++|.|+| |+||+|... |+.||||+++. ....|+..+.++ +||||++++++|.+++
T Consensus 59 y~~~~-~LG~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 59 FQRLS-RLGHGSY-------GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp EEEEE-EEEEETT-------EEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eeeeh-eeccCCC-------eEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 44444 3899999 999999984 88999998853 133455555555 8999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+ +|+|.+++...+ ..++|..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEEEEEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence 999999999 679999987652 46999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++...... ......||..|+|||++.+ .++.++||||||+++|||++|..++.+.... .
T Consensus 203 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~---- 262 (311)
T 3p1a_A 203 LLVELGTAG---------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW------Q---- 262 (311)
T ss_dssp TCEECC---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH------H----
T ss_pred eeeecccCC---------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH------H----
Confidence 998764332 1233568999999999876 7999999999999999999998877642210 0
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+ .........+..++..+.+++.+||+.||.+|||+.|+++
T Consensus 263 ---------~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 ---------QL---RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---------HH---TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------HH---hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00 0011111122334567899999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=338.30 Aligned_cols=236 Identities=27% Similarity=0.409 Sum_probs=190.6
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecC
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
+|.|+| |.||+|.. +|..||+|+++. .+.+|+++|++++||||+++++++..++..++||||++
T Consensus 97 lG~G~~-------g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 97 LGGGRF-------GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp CC------------CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EecCcC-------EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 899999 99999987 478999999864 46789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee--cCCCcEEEcccCCccccCCC
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL--DTNLRAKITNFGLARSAESD 515 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl--~~~~~~kl~DfGla~~~~~~ 515 (669)
+|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 170 ~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 170 GGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp TCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999999997542 35899999999999999999999999 9999999999999 66789999999999876543
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
.. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+ . +..++..
T Consensus 243 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~----~~~i~~~---- 303 (373)
T 2x4f_A 243 EK---------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--T----LNNILAC---- 303 (373)
T ss_dssp CB---------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H----HHHHHHT----
T ss_pred cc---------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--H----HHHHHhc----
Confidence 21 223468999999999999999999999999999999999999998765321 1 1111111
Q ss_pred hhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .+........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 304 -----~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 304 -----RW--DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -----CC--CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cC--CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 01111112345678999999999999999999999973
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.36 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=176.6
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADN 438 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~ 438 (669)
.+|.|+| |.||++... ++.||||+++. .+.+|+.+++++. ||||+++++++.+++..++||||+++
T Consensus 18 ~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 18 PLGEGSF-------SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CSEEETT-------EEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred ccccCCC-------eEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 4899999 999999984 78899999865 3668999999997 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC---cEEEcccCCccccCCC
Q 005923 439 GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---RAKITNFGLARSAESD 515 (669)
Q Consensus 439 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~DfGla~~~~~~ 515 (669)
|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999864 46999999999999999999999999 99999999999997665 8999999999865443
Q ss_pred ccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH
Q 005923 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVR 595 (669)
Q Consensus 516 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (669)
. .......||..|+|||.+.+..++.++||||||+++|||++|+.||.+........ ...
T Consensus 163 ~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------------~~~ 222 (325)
T 3kn6_A 163 N--------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT------------SAV 222 (325)
T ss_dssp -----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC------------CHH
T ss_pred C--------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc------------cHH
Confidence 2 12234568999999999999999999999999999999999999998543210000 000
Q ss_pred hhhhcccCCcc--CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 596 EKLRGFIDPSL--RNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 596 ~~l~~~~d~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.+..+..... ..+....++.++.+|+.+||+.||.+|||+.|+++.
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11111111111 111112345678999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.39 Aligned_cols=237 Identities=27% Similarity=0.388 Sum_probs=189.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHH-HHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINI-LKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~-l~~l~H~niv~l~g~~~ 424 (669)
..|++.+. +|.|+| |.||+++.+ +..+|+|+++.. +..|..+ ++.++||||+++++++.
T Consensus 38 ~~y~~~~~-lG~G~f-------g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 38 SDFHFLKV-IGKGSF-------GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp GGEEEEEE-EECCTT-------CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE
T ss_pred hheEEEEE-EeeCCC-------eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 45555554 899999 999999984 678999998542 3345555 46689999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEe
Confidence 999999999999999999999764 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. ..
T Consensus 182 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~- 249 (373)
T 2r5t_A 182 DFGLCKENIEHN--------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD- 249 (373)
T ss_dssp CCCBCGGGBCCC--------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HH-
T ss_pred eCccccccccCC--------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HH-
Confidence 999998643221 123456899999999999999999999999999999999999999987553211 11
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 639 (669)
.++. .. ..++......+.+|+.+||+.||.+||++.+.
T Consensus 250 --~i~~-------------~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 250 --NILN-------------KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp --HHHH-------------SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred --HHHh-------------cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 1111 01 12233445678999999999999999998543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.45 Aligned_cols=238 Identities=27% Similarity=0.450 Sum_probs=196.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+ .+|.|+| |.||++... +..+|+|++.. .+.+|+.++++++||||+++++++.+
T Consensus 9 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 9 EDFEIGR-PLGKGKF-------GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp GGEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccEEEee-EEecCCC-------eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 4455555 3999999 999999985 56799999843 36689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999764 35899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||++....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+
T Consensus 153 fg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~ 219 (279)
T 3fdn_A 153 FGWSVHAPSSR----------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRI 219 (279)
T ss_dssp CCEESCC------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH
T ss_pred ccccccCCccc----------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHHH
Confidence 99986544321 2335789999999999999999999999999999999999999986543211 0000
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 220 -------------~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 220 -------------SR-----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -------------HH-----TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -------------Hh-----CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0112334455678999999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.50 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=199.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
..|++.+. +|.|+| |.||+|... |+.+|+|+++. .+.+|+++|++++||||+++++++.+++.
T Consensus 51 ~~y~i~~~-LG~G~~-------g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 51 DYYDILEE-LGSGAF-------GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GTEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEE-EecCCC-------EEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 34565553 899999 999999984 78899999853 36789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC--CCcEEEccc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNF 506 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~Df 506 (669)
.++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEec
Confidence 99999999999999999753 246999999999999999999999999 999999999999974 578999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+....+. ..
T Consensus 196 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~ 260 (387)
T 1kob_A 196 GLATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQ 260 (387)
T ss_dssp TTCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HH
T ss_pred ccceecCCCc---------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 9998765432 12345789999999999999999999999999999999999999987553211 11
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+... +..........++..+.+++.+||+.||.+|||+.|+++.
T Consensus 261 ~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 261 NVKRC-----------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHC-----------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhC-----------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11000 0011112223445678999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.23 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=200.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-------CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-------KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGF 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~ 422 (669)
..|++.+. +|.|+| |.||+|.+ .+..||||.++. ++.+|+.++++++||||++++++
T Consensus 30 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 30 KNITLIRG-LGHGAF-------GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp GGCEEEEE-CC--CS-------SCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hheEEEEE-EcCCCC-------eeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 34555553 899999 99999985 356799999853 36789999999999999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQ--TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--- 497 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~--- 497 (669)
+.+++..++||||+++|+|.+++...+.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSST
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCC
Confidence 99999999999999999999999875321 1245999999999999999999999999 999999999999984
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~ 576 (669)
+..+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 252 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252 (327)
T ss_dssp TCCEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cceEEECccccccccccccc------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence 45699999999986533221 111233567889999999999999999999999999999998 98998765432
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+. .. . +.. ......+..++..+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 253 ~~---~~----~---------~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 253 EV---LE----F---------VTS----GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HH---HH----H---------HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HH---HH----H---------Hhc----CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 10 00 0 000 011223344556789999999999999999999999999988754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.75 Aligned_cols=240 Identities=24% Similarity=0.372 Sum_probs=193.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||++.. .|+.||||+++. .+.+|+.++++++||||++++++|..
T Consensus 148 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 148 NEFEYLKL-LGKGTF-------GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp GGEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE
T ss_pred HHcEEeEE-EeeCcC-------EEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 34555553 999999 99999997 478999999863 24578899999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEEC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999765 358999999999999999999998 88 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||.+...... ...
T Consensus 292 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~ 360 (446)
T 4ejn_A 292 DFGLCKEGIKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FEL 360 (446)
T ss_dssp CCCCCCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH
T ss_pred cCCCceeccCCC--------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHH
Confidence 999998643322 123446899999999999999999999999999999999999999987553211 110
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
+.. . ...+|...+..+.+|+.+||+.||.+|| +++|++++
T Consensus 361 ---i~~-------------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 361 ---ILM-------------E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---HHH-------------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---HHh-------------C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 110 0 1123444556789999999999999999 99999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=323.24 Aligned_cols=243 Identities=26% Similarity=0.461 Sum_probs=199.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec---ccHHHHHHHHHhcCCCCceeEeeEEEe--------
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK---GDVSSEINILKKINHSNIIRLSGFCVH-------- 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 425 (669)
.|++.+. +|.|+| |.||++... ++.||+|.++ ..+.+|++++++++||||+++++++..
T Consensus 12 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 12 DFKEIEL-IGSGGF-------GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HEEEEEE-EECSSS-------CCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccceeee-eccCCc-------eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3444443 899999 999999985 8899999986 358899999999999999999999864
Q ss_pred --------cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 426 --------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 426 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
....++||||+++|+|.+++...+ ...+++..++.++.|++.||.|||+++ ++||||||+|||+++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD 157 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence 445799999999999999997642 246999999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
++.+||+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 225 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK---------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--- 225 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC---------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---
T ss_pred CCCEEECcchhheecccccc---------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---
Confidence 99999999999987654321 123468999999999999999999999999999999999988763210
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.. . ..+. +..+ +...+..+.+++.+||+.||.+|||+.|+++.|..+...
T Consensus 226 --~~-------~------~~~~---~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 --KF-------F------TDLR---DGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --HH-------H------HHHH---TTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --HH-------H------HHhh---cccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00 0 0010 1111 122345678999999999999999999999999988654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=333.57 Aligned_cols=232 Identities=27% Similarity=0.420 Sum_probs=191.4
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|+| |.||+|.. +|+.||||+++. ++.+|++++++++||||+++++++..++..++||
T Consensus 61 ~lG~G~~-------g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 61 EIGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp EEEECSS-------EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEccCCC-------EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3899999 99999996 588899999852 3678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+. |+|.+++...+ ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 68999886542 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
.. ....||..|+|||.+. .+.++.++||||||+++|||++|+.||.+....+. +.....
T Consensus 206 ~~------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~ 267 (348)
T 1u5q_A 206 PA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ 267 (348)
T ss_dssp SB------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH
T ss_pred CC------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh
Confidence 32 2246899999999985 57789999999999999999999999986543211 111111
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
. ..+.. .+...+..+.+++.+||+.||.+|||++|+++..
T Consensus 268 ~----------~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 268 N----------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp S----------CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred c----------CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0 01111 1223345688999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=322.01 Aligned_cols=240 Identities=26% Similarity=0.428 Sum_probs=178.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||+|.. +|+.||||.++. .+.+|+.++++++||||+++++++.+
T Consensus 11 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 11 EDFKVGNL-LGKGSF-------AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred ccceeeee-ecCCCc-------eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 45665553 899999 99999997 588999999853 36689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEe
Confidence 99999999999999999999754 246999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 156 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------- 219 (278)
T 3cok_A 156 FGLATQLKMPHE--------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------- 219 (278)
T ss_dssp CTTCEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------
T ss_pred ecceeeccCCCC--------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------
Confidence 999987643221 1223568999999999999999999999999999999999999998644211
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+....... ...+...+..+.+++.+||+.||.+|||++|+++
T Consensus 220 -----------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 220 -----------TLNKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---------------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----------HHHHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 011111111 1233445567899999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=339.81 Aligned_cols=241 Identities=20% Similarity=0.296 Sum_probs=186.8
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--cHHHHHHHHHh-cCCCCceeEeeEEEe----cCceeEEEEec
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--DVSSEINILKK-INHSNIIRLSGFCVH----EGNTYLVYEFA 436 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~lV~e~~ 436 (669)
.+|.|+| |.||++... |+.||||+++. .+.+|++++.+ .+||||+++++++.. ++..++||||+
T Consensus 69 ~LG~G~~-------g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 69 VLGLGIN-------GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEETT-------EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeeeccC-------eEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 4899999 999999984 78899999964 46789988755 589999999999875 56789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEcccCCccccC
Q 005923 437 DNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAE 513 (669)
Q Consensus 437 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DfGla~~~~ 513 (669)
++|+|.+++... ....+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 142 ~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 142 DGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp CSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999999864 2246999999999999999999999999 999999999999997 7899999999998654
Q ss_pred CCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH-HHHHHHHHHHhhh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE-LLYASISRVLEES 592 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~ 592 (669)
... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+....... ..... +..
T Consensus 216 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~-- 281 (400)
T 1nxk_A 216 SHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRM-- 281 (400)
T ss_dssp --------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHH--
T ss_pred CCC---------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHc--
Confidence 321 123457899999999999999999999999999999999999999864321100 00000 000
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+ .+.......++.++.+|+.+||+.||.+|||+.|++++
T Consensus 282 ------~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 282 ------GQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ------TCC---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------Ccc---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00011112345678999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.16 Aligned_cols=252 Identities=26% Similarity=0.444 Sum_probs=194.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC---CC--eeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK---GD--DAAVKVMKG----------DVSSEINILKKINHSNIIRLSGF 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---g~--~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~ 422 (669)
..|++.+. +|.|+| |.||+|.++ ++ .||||+++. ++.+|++++++++||||++++++
T Consensus 18 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 18 KDLRLLEK-LGDGSF-------GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp GGEEEEEE-CC-----------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hHeeeeee-ecCCCc-------eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 35666553 899999 999999863 22 589998853 35689999999999999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+..+ ..++||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+|
T Consensus 90 ~~~~-~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~k 161 (291)
T 1u46_A 90 VLTP-PMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 161 (291)
T ss_dssp ECSS-SCEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEE
T ss_pred EccC-CceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEE
Confidence 9765 4899999999999999997642 35899999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELL 581 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 581 (669)
|+|||+++........ ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.
T Consensus 162 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--- 233 (291)
T 1u46_A 162 IGDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--- 233 (291)
T ss_dssp ECCCTTCEECCC-CCE-----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---
T ss_pred Eccccccccccccccc-----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---
Confidence 9999999876543211 112334567889999999999999999999999999999999 9999986543210
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.... .........+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 234 ---~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 234 ---LHKI-------------DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---HHHH-------------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---HHHH-------------HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0000 011111223345567789999999999999999999999999988654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.83 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=196.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------------cHHHHHHHHHhcC---CCCceeEee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------------DVSSEINILKKIN---HSNIIRLSG 421 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~---H~niv~l~g 421 (669)
.|++.+ ++|.|+| |.||+|.. .++.||||+++. .+.+|+.++++++ ||||+++++
T Consensus 10 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 10 RYEPVA-EIGVGAY-------GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp CCEEEE-EECCSSS-------CCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ceEEEE-EEecCCC-------eEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 455555 3899999 99999996 588999999852 4668888888775 999999999
Q ss_pred EEEecC-----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec
Q 005923 422 FCVHEG-----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 422 ~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~ 496 (669)
+|.... ..++||||+. |+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVT 154 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEEC
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEc
Confidence 998755 4799999997 59999998652 244999999999999999999999999 99999999999999
Q ss_pred CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchh
Q 005923 497 TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576 (669)
Q Consensus 497 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~ 576 (669)
.++.+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCC---------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred CCCCEEEeeCccccccCCCc---------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999998764322 123457899999999999999999999999999999999999999876542
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhh------cccCCccC---CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 577 EAELLYASISRVLEESNVREKLR------GFIDPSLR---NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+. ...+............-. ....+... .....+....+.+|+.+||+.||.+|||+.|++++
T Consensus 226 ~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 226 DQ---LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HH---HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH---HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 21 112211111110000000 00000000 00011344678999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=327.86 Aligned_cols=252 Identities=20% Similarity=0.336 Sum_probs=195.0
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
+..|++.+. +|.|.| |.||++.. +++.||+|+++. .+.+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 2h34_A 33 FGPYRLRRL-VGRGGM-------GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104 (309)
T ss_dssp -CCEEEEEE-EEECSS-------SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eccEEEEEE-EcCCCC-------eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 355666664 899999 99999997 477899999853 3668999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
.++..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 105 IDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp ETTEEEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred eCCeEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEe
Confidence 999999999999999999999864 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.+.... .
T Consensus 177 Dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~---- 242 (309)
T 2h34_A 177 DFGIASATTDEKL-------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---V---- 242 (309)
T ss_dssp SCCC-----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---H----
T ss_pred cCccCcccccccc-------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---H----
Confidence 9999987644321 1223456899999999999999999999999999999999999999865421 1
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhcC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-SISEVFVTLSKIWSS 649 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~ 649 (669)
+...+ ...... ....+..++..+.+++.+||+.||.+|| +++++++.|+++...
T Consensus 243 ~~~~~---------~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 243 MGAHI---------NQAIPR--PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHHH---------HSCCCC--GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHHHh---------ccCCCC--ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11111 110100 0122334455789999999999999999 999999999988654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.80 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=196.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhcC-----CCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKIN-----HSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~-----H~niv~l~g~~~~ 425 (669)
.|.+.+ ++|.|+| |.||++.. +++.||||+++. .+..|++++++++ ||||+++++++..
T Consensus 36 ~y~~~~-~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 36 AFLVIR-KMGDGTF-------GRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EEEEEE-EEcccCC-------eEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 455555 3899999 99999998 578899999863 3567999999996 9999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC--------
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-------- 497 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-------- 497 (669)
.+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccccc
Confidence 99999999999 899999998652 345999999999999999999999999 999999999999975
Q ss_pred -----------------CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHH
Q 005923 498 -----------------NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560 (669)
Q Consensus 498 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl 560 (669)
++.+||+|||+++..... .....||..|+|||.+.+..++.++|||||||++
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC-----------CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999865432 1235789999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH---Hhh----hhccc-CCccCCCCc--------------------H
Q 005923 561 LELLSGREAVTGDQNCEAELLYASISRVLEESNV---REK----LRGFI-DPSLRNEYP--------------------L 612 (669)
Q Consensus 561 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----l~~~~-d~~l~~~~~--------------------~ 612 (669)
|||++|+.||.+....+.. ..+......... ... ....+ ...+....+ .
T Consensus 250 ~ell~g~~pf~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHL---AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHH---HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHCCCCCCCCcHHHHH---HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 9999999999876543211 111111111000 000 00000 000000011 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 613 DLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 613 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.....+.+|+.+||+.||.+|||+.|+++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11256789999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.00 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=192.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc---------cHHHHHHHHHhcC--CCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG---------DVSSEINILKKIN--HSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~---------~~~~E~~~l~~l~--H~niv~l~g~~~~~ 426 (669)
.|++.+. +|.|+| |.||++... ++.||||+++. .+.+|+.+|++++ ||||+++++++..+
T Consensus 57 ~y~~~~~-LG~G~f-------g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~ 128 (390)
T 2zmd_A 57 IYSILKQ-IGSGGS-------SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128 (390)
T ss_dssp EEEEEEE-EECCSS-------EEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ceEEEEE-EccCCC-------eEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence 4666554 999999 999999874 77899999842 3678999999996 59999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||| +.+|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++ ++.+||+||
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCC
T ss_pred CEEEEEEe-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEec
Confidence 99999999 5678999999865 35899999999999999999999999 99999999999996 589999999
Q ss_pred CCccccCCCccccCCcccceeeeccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----------GVITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 199 G~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 199 GIANQMQPDTT------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp SSSCCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CccccccCCCc------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 99987654321 112334579999999999875 4689999999999999999999999976432
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. ..+..++++......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 273 ~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 273 QI------------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HH------------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH------------------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 11112223333333344445678999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=333.27 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=197.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---cHHHHHHHHHhc-CCCCceeEeeEEEecCceeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---DVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 432 (669)
.|++.+ .+|.|+| |.||++..+ |+.+|||+++. +..+|++++.++ +||||+++++++.+++..++|
T Consensus 23 ~y~~~~-~lG~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 23 GYEVKE-DIGVGSY-------SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEE-EEeeCCC-------EEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 455555 3899999 999999984 77899999964 467899999998 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC----CcEEEcccCC
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN----LRAKITNFGL 508 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~----~~~kl~DfGl 508 (669)
|||+++|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+
T Consensus 95 ~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp ECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999754 45999999999999999999999999 9999999999998443 3599999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.+............ +
T Consensus 167 a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i 235 (342)
T 2qr7_A 167 AKQLRAEN--------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---I 235 (342)
T ss_dssp CEECBCTT--------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---H
T ss_pred cccCcCCC--------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---H
Confidence 98764332 122345789999999999988899999999999999999999999985432111111111 1
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .. ..+........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 236 ~~---------~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 236 GS---------GK--FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HH---------CC--CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc---------CC--cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 00 011122233455678999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.18 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=199.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
|.+.+ .+|.|.| |.||++... ++.+|+|.++. .+.+|+.++++++||||+++++++.
T Consensus 7 y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (283)
T 3bhy_A 7 YEMGE-ELGSGQF-------AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78 (283)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhHH-hhcccCc-------eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec
Confidence 44444 3899999 999999984 78999998753 3678999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC----c
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL----R 500 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~----~ 500 (669)
+++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred CCCeEEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence 999999999999999999999764 35899999999999999999999999 99999999999998877 8
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+||+|||+++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.+....+.
T Consensus 151 ~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-- 219 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-- 219 (283)
T ss_dssp EEECCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--
T ss_pred eEEEecccceeccCCC---------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--
Confidence 9999999998764322 12335689999999999999999999999999999999999999987543211
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHhhcCCC
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV--TLSKIWSSSS 651 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~~~~~ 651 (669)
... .. . .............+..+.+++.+||+.||.+|||+.|+++ .++.+.....
T Consensus 220 -~~~---~~----------~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 220 -LTN---IS----------A-VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp -HHH---HH----------T-TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred -HHH---hH----------h-cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 000 00 0 0001111111233456899999999999999999999998 4676655433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.67 Aligned_cols=232 Identities=23% Similarity=0.376 Sum_probs=195.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------------cHHHHHHHHHhcCCCCceeEee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------------DVSSEINILKKINHSNIIRLSG 421 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g 421 (669)
.|++.+ .+|.|+| |.||+|.. +++.||||+++. .+.+|+.++++++||||+++++
T Consensus 25 ~y~~~~-~lG~G~~-------g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 96 (335)
T 3dls_A 25 KYSTMS-PLGSGAF-------GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD 96 (335)
T ss_dssp HEEEEE-ECSSSSS-------CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEE
T ss_pred ceEEEe-EEEecCC-------EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 455555 3899999 99999986 578899998853 3567999999999999999999
Q ss_pred EEEecCceeEEEEecCCC-CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 422 FCVHEGNTYLVYEFADNG-ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
++.+++..++||||+.+| +|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 97 IFENQGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp EEECSSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred EEeeCCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 999999999999999877 999999764 35999999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
+||+|||+++...... ......||..|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 169 ~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---- 235 (335)
T 3dls_A 169 IKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---- 235 (335)
T ss_dssp EEECCCTTCEECCTTC---------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----
T ss_pred EEEeecccceECCCCC---------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----
Confidence 9999999998765432 1234578999999999998877 8899999999999999999999975221
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...... ..+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 236 -----------------~~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -----------------TVEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----------------GTTTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----------------HHhhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1222345678999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.59 Aligned_cols=250 Identities=15% Similarity=0.214 Sum_probs=202.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEE-------ECCCeeEEEEecc----cHHHHHHHHHhcC---CCCceeEeeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGS-------FKGDDAAVKVMKG----DVSSEINILKKIN---HSNIIRLSGFC 423 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~-------~~g~~vavK~~~~----~~~~E~~~l~~l~---H~niv~l~g~~ 423 (669)
..|.+.+. +|.|+| |.||+|. ..++.||||+++. ++..|++++++++ |+||+++++++
T Consensus 65 ~~y~~~~~-lG~G~~-------g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 65 KLVYVHHL-LGEGAF-------AQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SEEEEEEE-EEECSS-------EEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEEEEEEE-eeccCC-------EEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34555553 999999 9999994 2578899999975 4677888888887 99999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC------
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT------ 497 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~------ 497 (669)
..++..++||||+++|+|.++++..+......++|..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 99999999999999999999998643333467999999999999999999999999 999999999999998
Q ss_pred -----CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 005923 498 -----NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTG 572 (669)
Q Consensus 498 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~ 572 (669)
++.+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccccCCEEEeeCchhhhhhccCC------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999986542211 1233456799999999999999999999999999999999999999864
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhhcC
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR-PSISEVFVTLSKIWSS 649 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~evl~~L~~i~~~ 649 (669)
..... ..+ +..+. .++ ....+.+++..|++.+|.+| |++.++.+.|+++...
T Consensus 288 ~~~~~------------------~~~----~~~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 288 NEGGE------------------CKP----EGLFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EETTE------------------EEE----CSCCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCc------------------eee----chhcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 32210 011 11111 111 23467899999999999999 6889999999888764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.49 Aligned_cols=242 Identities=24% Similarity=0.423 Sum_probs=198.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|.+.+ .+|.|+| |.||++... |..+|+|.++. .+.+|+.++++++||||+++++++
T Consensus 13 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 13 FYDIGE-ELGSGQF-------AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp HEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cEEEee-EeeecCC-------EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 455555 3999999 999999984 78899999853 267899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC----
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---- 499 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---- 499 (669)
.+++..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcC
Confidence 9999999999999999999999754 45899999999999999999999999 99999999999999887
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.+||+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+.
T Consensus 157 ~~kl~Dfg~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 226 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET- 226 (321)
T ss_dssp CEEECCCTTCEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-
T ss_pred CEEEccCccceecCcccc---------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-
Confidence 799999999987654321 2335689999999999999999999999999999999999999987553211
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....... ........+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 227 -----~~~i~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 227 -----LANITSV-----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -----HHHHHTT-----------CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -----HHHHHhc-----------ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0001111112334568999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.53 Aligned_cols=239 Identities=29% Similarity=0.486 Sum_probs=199.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|.+.+. +|.|+| |.||+|... |+.||||+++. .+.+|+.++++++||||+++++++..
T Consensus 16 ~~Y~l~~~-LG~G~f-------g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 16 GHYILGDT-LGVGTF-------GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp TTEEEEEE-EECCSS-------SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCEEEEEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45666554 999999 999999984 88999999853 35689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.+..++||||+++|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~D 159 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD 159 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEe
Confidence 99999999999999999999753 45999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+++...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.+..... ...
T Consensus 160 FG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~- 226 (476)
T 2y94_A 160 FGLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFK- 226 (476)
T ss_dssp CSSCEECCTTC---------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHH-
T ss_pred ccchhhccccc---------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHH-
Confidence 99998765432 1234579999999999998765 789999999999999999999998654321 111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+ .+.. ...|..+...+.+|+.+||+.||.+|||+.|++++
T Consensus 227 --~i-------------~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 227 --KI-------------CDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --HH-------------HTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --HH-------------hcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11 1111 12233445678999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.34 Aligned_cols=241 Identities=26% Similarity=0.412 Sum_probs=192.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe--
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH-- 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~-- 425 (669)
.|++.+ ++|.|+| |.||+|... +..||+|.++. .+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~~-~lg~G~~-------g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 27 FLKFDI-EIGRGSF-------KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred eEEeee-eccCCCC-------eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 455555 3999999 999999984 66789998853 36789999999999999999999875
Q ss_pred --cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-CCCcEE
Q 005923 426 --EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-TNLRAK 502 (669)
Q Consensus 426 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~-~~~~~k 502 (669)
+...++||||+++|+|.+++... ..+++..++.|+.|++.||+|||+.+ ++++||||||+|||++ +++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEE
T ss_pred CCCceEEEEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEE
Confidence 34589999999999999999764 35899999999999999999999875 4699999999999997 789999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+|||++....... .....||..|+|||.+. +.++.++||||||+++|||++|+.||.+....... .
T Consensus 173 l~Dfg~~~~~~~~~----------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~ 239 (290)
T 1t4h_A 173 IGDLGLATLKRASF----------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y 239 (290)
T ss_dssp ECCTTGGGGCCTTS----------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H
T ss_pred EeeCCCcccccccc----------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--H
Confidence 99999997544321 23457899999999887 45899999999999999999999999864432110 0
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. .+..... ....+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 240 ~-------------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 240 R-------------RVTSGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp H-------------HHTTTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H-------------HHhccCC---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 0000000 111222334568999999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.32 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=194.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
..|++.+. +|.|+| |.||+|... +..+|+|+++. .+.+|++++++++||||+++++++
T Consensus 26 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 26 KKYHLKGA-IGQGSY-------GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp HHEEEEEE-EEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeecce-eeecCC-------eEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 44665553 899999 999999884 67899998852 366799999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCC-----------------------------------CCCCCCHHHHHHHHHHH
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQ-----------------------------------TSDNLTWKQRVQIAYDV 468 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~qi 468 (669)
.+++..++||||+++|+|.+++...... ....+++..++.|+.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999999631100 01124678889999999
Q ss_pred HHHHHHHHhCCCCCeEeeCCCCCCeeecCCC--cEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc--
Q 005923 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNL--RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-- 544 (669)
Q Consensus 469 a~~L~yLH~~~~~~ivHrDik~~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-- 544 (669)
+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......... ........||..|+|||.+.+
T Consensus 178 ~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----YYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc----cccccccCCCccccCchhhccCC
Confidence 99999999999 99999999999998766 89999999998654322110 112334679999999999975
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHH
Q 005923 545 GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKN 624 (669)
Q Consensus 545 ~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~ 624 (669)
..++.++||||||+++|||++|+.||.+....+. ....+.. .. ....+.....+..+.+++.+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~---------~~--~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNK---------KL--CFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC---------CC--CTTSGGGGGSCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhc---------cc--ccCCcccccCCHHHHHHHHH
Confidence 7789999999999999999999999987553211 1111110 00 01111122345678999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 005923 625 CTAHDLNARPSISEVFVT 642 (669)
Q Consensus 625 Cl~~dP~~RPt~~evl~~ 642 (669)
||+.||.+|||+.|+++.
T Consensus 314 ~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HSCSCTTTSCCHHHHHHS
T ss_pred HcCCChhHCCCHHHHhcC
Confidence 999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=339.80 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=208.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
..|.+.+. +|.|+| |.||+|... |+.||||+++. .+.+|++++++++||||+++++++...+
T Consensus 9 ~~y~i~~~-LG~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 9 HLWLLSDI-LGQGAT-------ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EEEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CceEEEEE-EEcCCC-------eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 35666664 999999 999999985 88999999863 3568999999999999999999998765
Q ss_pred --ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee----cCCCcE
Q 005923 428 --NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNLRA 501 (669)
Q Consensus 428 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl----~~~~~~ 501 (669)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence 6799999999999999997652 2234999999999999999999999999 9999999999999 778889
Q ss_pred EEcccCCccccCCCccccCCcccceeeeccccccccccccccc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--------GVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
||+|||+++....... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 kL~DFG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 156 KLTDFGAARELEDDEQ---------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp EECCGGGCEECCCGGG---------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred EEecCCCceEccCCCc---------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999987654321 223568999999999875 56788999999999999999999999743
Q ss_pred chhHHHHHHHHHHHHHhhhhHH--hhhhcccC--------CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 574 QNCEAELLYASISRVLEESNVR--EKLRGFID--------PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~d--------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
...... ...+...+...... ..+....+ .......+..+...+.+++.+||+.||.+||+++|+++.|
T Consensus 227 ~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 227 EGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp TCTTTC--HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred Ccccch--HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 221100 11122222211100 00000000 0111234577888899999999999999999999999999
Q ss_pred HHhhcC
Q 005923 644 SKIWSS 649 (669)
Q Consensus 644 ~~i~~~ 649 (669)
+++...
T Consensus 305 ~~il~~ 310 (396)
T 4eut_A 305 SDILHR 310 (396)
T ss_dssp HHHHTC
T ss_pred HHHhhc
Confidence 998864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.06 Aligned_cols=242 Identities=23% Similarity=0.363 Sum_probs=197.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+. +|.|+| |.||++... +..||+|+++. .+.+|+.++++++||||+++++++..++
T Consensus 7 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 7 NYDVKEE-LGKGAF-------SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhh-hcCcCC-------eEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 4555553 899999 999999884 78999999853 3568999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc---EEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR---AKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~---~kl~ 504 (669)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++. +||+
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEe
Confidence 999999999999999998765 35899999999999999999999999 999999999999976655 9999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||++........ .....||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+.. ..
T Consensus 151 Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~ 218 (284)
T 3kk8_A 151 DFGLAIEVNDSEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQ 218 (284)
T ss_dssp CCTTCEECCSSCB---------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH
T ss_pred eceeeEEcccCcc---------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---HH
Confidence 9999987654321 23357899999999999999999999999999999999999999875532111 00
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. ....... ......++..+.+++.+||+.||.+|||+.|+++.
T Consensus 219 ---~~------~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 219 ---IK------AGAYDYP-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---HH------HTCCCCC-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---HH------hccccCC-----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0000011 11112345678999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.89 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=195.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+. +|.|+| |.||+++. +|+.||+|+++. .+.+|.+++.+++||||+++++++.++
T Consensus 62 ~f~~~~~-lG~G~f-------G~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 62 DFEILKV-IGRGAF-------SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp GEEEEEE-EEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hEEEEEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 4554443 899999 99999998 488999999853 367899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+||
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999997642 35999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-------NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
|+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+.
T Consensus 207 Gla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~- 278 (412)
T 2vd5_A 207 GSCLKLRADGT-------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET- 278 (412)
T ss_dssp TTCEECCTTSC-------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-
T ss_pred hhheeccCCCc-------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-
Confidence 99987654321 1123457999999999997 35789999999999999999999999987654221
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR---PSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~~ 642 (669)
... ++... . .+.-+ ..+..++.++.+|+.+||. +|.+| |+++|++++
T Consensus 279 --~~~---i~~~~---~---~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 --YGK---IVHYK---E---HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --HHH---HHTHH---H---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --HHH---HHhcc---c---CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111 11100 0 00011 1123345678999999999 99998 588888754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.66 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=196.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|++.+ .+|.|+| |.||++... ++.||||+++. .+.+|+.++++++||||+++++++.+++.
T Consensus 8 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 8 DWDLVQ-TLGEGAY-------GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HEEEEE-EEEECSS-------SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ceEEEE-EeecCCC-------cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 455555 3899999 999999984 78999999852 36789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCC
Confidence 99999999999999998643 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+........ ........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||.+........ . .
T Consensus 152 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~---~ 220 (276)
T 2yex_A 152 ATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--S---D 220 (276)
T ss_dssp CEECEETTE------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--H---H
T ss_pred ccccCCCcc------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--H---H
Confidence 986543221 112234578999999999988765 789999999999999999999998654321110 0 0
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
... ...........+..+.+++.+||+.||.+|||+.|+++
T Consensus 221 ~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 221 WKE-------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHT-------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhh-------------cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000 00001112344567899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=327.89 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=197.8
Q ss_pred ccccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 355 ~~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
..+..|++.+. +|.|+| |.||++... |+.||||++.. .+.+|+.++++++||||+++++++
T Consensus 22 ~~~~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 93 (331)
T 4aaa_A 22 QSMEKYENLGL-VGEGSY-------GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC 93 (331)
T ss_dssp BCGGGEEEEEE-GGGGTT-------SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhheeeeE-EeecCC-------EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence 34556776664 999999 999999985 78899998742 256899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
.+++..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 94 KKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred ecCCEEEEEEecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEE
Confidence 9999999999999999998887643 35999999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
+|||+++...... .......||..|+|||.+.+. .++.++||||||+++|||++|+.||.+....+...
T Consensus 166 ~Dfg~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-- 235 (331)
T 4aaa_A 166 CDFGFARTLAAPG--------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY-- 235 (331)
T ss_dssp CCCTTC--------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--
T ss_pred EeCCCceeecCCc--------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--
Confidence 9999998764332 112335689999999999875 78999999999999999999999998765432111
Q ss_pred HHHHHHHhhh--------hHHhhhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 583 ASISRVLEES--------NVREKLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~--------~~~~~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... ...... ...........+.+....+ ..++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 236 HIM-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHH-HHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHH-HHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 111000 0000111111122211111 1345678999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.19 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=196.4
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
+..|++.+ ++|.|+| |.||++.. +++.||||+++. .+.+|++++++++||||+++++++.+
T Consensus 33 ~~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 33 IDRYRRIT-KLGEGTY-------GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp GGGEEEEE-EEEECSS-------SEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred hhhEEEEE-EEEecCC-------eEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 34566655 3999999 99999987 478899999852 35689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee-----cCCCc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL-----DTNLR 500 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl-----~~~~~ 500 (669)
++..++||||++ |+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||+ ++++.
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCE
T ss_pred CCEEEEEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccce
Confidence 999999999998 5999999765 35999999999999999999999999 9999999999999 45566
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
+||+|||+++...... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+
T Consensus 176 ~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-- 245 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPI--------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-- 245 (329)
T ss_dssp EEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred EEECcCCCccccCCcc--------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--
Confidence 9999999998764322 112335679999999999874 48999999999999999999999998765422
Q ss_pred HHHHHHHHHHhhhhHH-----hhhhcc-------cCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhh
Q 005923 580 LLYASISRVLEESNVR-----EKLRGF-------IDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~-----~~l~~~-------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 647 (669)
.. ..+...+...... ..+..+ ....+....+..+..++.+|+.+||+.||.+|||+.|++++ -+
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h---p~ 321 (329)
T 3gbz_A 246 QL-FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH---PY 321 (329)
T ss_dssp HH-HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS---GG
T ss_pred HH-HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC---cc
Confidence 11 1111111110000 000000 00000001112244678999999999999999999999853 34
Q ss_pred cCCCCCCC
Q 005923 648 SSSSDWDP 655 (669)
Q Consensus 648 ~~~~~~~~ 655 (669)
-...+|+|
T Consensus 322 f~~~~~~P 329 (329)
T 3gbz_A 322 FSHNDFDP 329 (329)
T ss_dssp GSSSCSCC
T ss_pred cCCCCCCC
Confidence 44566765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.34 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=197.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc-----------cHHHHHHHHHhc-CCCCceeEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG-----------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
..|++.+. +|.|+| |.||++.. .++.||||+++. .+.+|+++|+++ +||||++++
T Consensus 54 ~~y~~~~~-lG~G~~-------g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 54 ENFELLKV-LGTGAY-------GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp GGEEEEEE-EEETTT-------EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cceEEEEE-eccCCC-------EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEE
Confidence 45665554 899999 99999987 578999999852 356799999999 699999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
+++..++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 197 (355)
T 1vzo_A 126 YAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGH 197 (355)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred EEEeeCceEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCc
Confidence 9999999999999999999999999764 35899999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
+||+|||+++....... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 198 ~kl~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 270 (355)
T 1vzo_A 198 VVLTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270 (355)
T ss_dssp EEESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred EEEeeCCCCeecccCCC-------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch
Confidence 99999999987643321 12234579999999999986 4478999999999999999999999975432111
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVTL 643 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 643 (669)
.. ........ ....++..++..+.+|+.+||+.||.+|| +++|+++..
T Consensus 271 ~~--~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 271 QA--EISRRILK---------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HH--HHHHHHHH---------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HH--HHHHHHhc---------------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 10 00001100 01233445566789999999999999999 899988653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.13 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=200.2
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
...|.+.+. +|.|+| |.||++... ++.+|+|++.. .+.+|+.++++++||||+++++++.
T Consensus 40 ~~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 40 RRRYVRGRF-LGKGGF-------AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp TEEEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCceEEEEE-EeeCCC-------eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 345666664 999999 999999984 67899999753 3568999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEe
Confidence 999999999999999999998764 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+..
T Consensus 184 Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----- 250 (335)
T 2owb_A 184 DFGLATKVEYDGE--------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----- 250 (335)
T ss_dssp CCTTCEECCSTTC--------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----
T ss_pred eccCceecccCcc--------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-----
Confidence 9999987643221 123357899999999999999999999999999999999999999865432110
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..... . ....+..+...+.+++.+||+.||.+|||+.|+++.
T Consensus 251 -~~~~~---------~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 251 -LRIKK---------N------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -HHHHH---------T------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -HHHhc---------C------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0 011233445678999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=318.88 Aligned_cols=238 Identities=26% Similarity=0.404 Sum_probs=198.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|.| |.||++... +..||+|++.. .+.+|++++++++||||+++++++.+
T Consensus 14 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 14 DDFDIGRP-LGKGKF-------GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhceeehe-ecCCCC-------eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 44555553 899999 999999984 66799999842 36789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEec
Confidence 99999999999999999999765 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||++....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+..
T Consensus 158 fg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------ 221 (284)
T 2vgo_A 158 FGWSVHAPSLR----------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------ 221 (284)
T ss_dssp CTTCEECSSSC----------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------
T ss_pred ccccccCcccc----------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------
Confidence 99997654321 12356899999999999999999999999999999999999999865432110
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... .. ....+...+..+.+++.+||+.||.+|||++|++++
T Consensus 222 ~~~~-------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 222 RRIV-------------NV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHH-------------TT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHh-------------cc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0000 00 112334455678999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.10 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=198.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+. +|.|+| |.||+|... +..+|+|++.. .+.+|++++++++||||+++++++.+++..
T Consensus 10 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 10 YYTLENT-IGRGSW-------GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp HEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hEEeeeE-EeecCC-------EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 4555553 899999 999999985 55789999853 467899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee---cCCCcEEEccc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNF 506 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~Df 506 (669)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+|||+ +.++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 9999999999999999764 35899999999999999999999999 9999999999999 78899999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|++....... ......||..|+|||.+.+. ++.++||||||+++|||++|+.||.+....+.. .
T Consensus 154 g~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~ 217 (277)
T 3f3z_A 154 GLAARFKPGK---------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------L 217 (277)
T ss_dssp TTCEECCTTS---------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H
T ss_pred ccceeccCcc---------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------H
Confidence 9998765432 12335789999999998754 899999999999999999999999875532110 0
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhc
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPL----DLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIWS 648 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~ 648 (669)
..... . ...+. ..+..+.+++.+||+.||.+|||+.|+++. +++...
T Consensus 218 ~~~~~-------------~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 218 KIREG-------------T--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHC-------------C--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHhC-------------C--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 01000 0 01111 235678999999999999999999999863 554443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=333.99 Aligned_cols=267 Identities=20% Similarity=0.344 Sum_probs=201.7
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|.+.+ .+|.|+| |.||++... +..||+|+++. .+.+|+.++++++||||+++++++..++.
T Consensus 34 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 34 DFEKIS-ELGAGNG-------GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp GEEEEE-EEEECSS-------CEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cceeee-eecCCCC-------eEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 344444 3899999 999999985 78899999863 36789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEEECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECC
Confidence 99999999999999999765 3589999999999999999999985 8 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+..........
T Consensus 178 ~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 247 (360)
T 3eqc_A 178 VSGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247 (360)
T ss_dssp CCHHHHHH----------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----
T ss_pred CCcccccc----------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccc
Confidence 99765321 12335789999999999999999999999999999999999999986554322111100000
Q ss_pred H--Hhh---------------------hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--
Q 005923 588 V--LEE---------------------SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT-- 642 (669)
Q Consensus 588 ~--~~~---------------------~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~-- 642 (669)
. ... ....+.+..+.........+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp --------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0 000 000000111111111111112345578999999999999999999999975
Q ss_pred HHHhhcCCC
Q 005923 643 LSKIWSSSS 651 (669)
Q Consensus 643 L~~i~~~~~ 651 (669)
+++......
T Consensus 328 ~~~~~~~~~ 336 (360)
T 3eqc_A 328 IKRSDAEEV 336 (360)
T ss_dssp HHHHHHSCC
T ss_pred hhcchHhhh
Confidence 444444333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=323.26 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=196.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe-
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH- 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~- 425 (669)
..|++.+. +|.|+| |.||++.. +++.+|+|.++. .+.+|++++++++||||+++++++..
T Consensus 6 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 6 EDYEVLYT-IGTGSY-------GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGEEEEEE-EEECSS-------SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hheeeehh-ccCCCC-------cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 34555553 899999 99999998 478899999852 36789999999999999999998864
Q ss_pred -cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeeCCCCCCeeecCCCcEE
Q 005923 426 -EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT--NPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 426 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivHrDik~~NILl~~~~~~k 502 (669)
++..++||||+++|+|.+++...+ .....+++..++.++.|++.||+|||+.+ ..+++||||||+|||++.++.+|
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence 467899999999999999997642 12345999999999999999999999976 23599999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+|||+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ ..
T Consensus 157 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~ 225 (279)
T 2w5a_A 157 LGDFGLARILNHDT--------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA 225 (279)
T ss_dssp ECCCCHHHHC---C--------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH
T ss_pred EecCchheeecccc--------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HH
Confidence 99999998764322 11223568999999999999999999999999999999999999998654321 00
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
. .+.. .. ....+...+..+.+++.+||+.||.+|||+.||++.+.
T Consensus 226 ~----~i~~----~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 226 G----KIRE----GK---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp H----HHHH----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred H----HHhh----cc---------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0 0000 00 11223345567899999999999999999999997653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.75 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=183.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcC-CCCceeEeeEEEe---
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKIN-HSNIIRLSGFCVH--- 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~-H~niv~l~g~~~~--- 425 (669)
.|++.+. +|.|+| |.||++.. .++.||||++.. .+.+|+.+++++. ||||+++++++..
T Consensus 29 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 29 RLRVRRV-LAEGGF-------AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EEEEEEE-EECCSS-------EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eEEEEEE-EccCCc-------eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 4565554 999999 99999998 688999998842 3678999999996 9999999999953
Q ss_pred -----cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 426 -----EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 426 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
....++||||+. |+|.+++.... ....+++..++.|+.||+.||+|||+++ ++|+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSC
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCC
Confidence 335799999996 79999987532 2346999999999999999999999875 46999999999999999999
Q ss_pred EEEcccCCccccCCCccccCC----cccceeeeccccccccccccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 501 AKITNFGLARSAESDEHEQGG----YGLQLTRHVVGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~l---~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
+||+|||+++........... ..........||..|+|||.+ .+..++.++||||||+++|||++|+.||.+.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876543211000 000111235689999999998 5677899999999999999999999999753
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.... +++.......+......+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 257 ~~~~-----------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 257 AKLR-----------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hHHH-----------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 2210 00001111111222345789999999999999999999999999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.19 Aligned_cols=261 Identities=19% Similarity=0.308 Sum_probs=203.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec-----ccHHHHHHHHHhcCC-CCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK-----GDVSSEINILKKINH-SNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~ 430 (669)
.|++.+. +|.|.| |.||+|.. .++.||||+++ .++..|+++++.++| +++..+..++...+..+
T Consensus 8 ~y~i~~~-LG~G~f-------G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 8 KFRLGRK-IGSGSF-------GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TEECCCC-CEECSS-------CEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cEEEEEE-EeeCCC-------EEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 4555553 999999 99999997 48899999875 358899999999987 55666666667777889
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee---cCCCcEEEcccC
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNFG 507 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DfG 507 (669)
|||||+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||
T Consensus 80 lvme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCC
Confidence 999999 89999999753 246999999999999999999999999 9999999999999 688999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++.......... ..........||..|+|||.+.+..++.++|||||||+||||++|+.||.+.........+..+..
T Consensus 152 la~~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 152 LAKKYRDTSTHQH-IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TCEECBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred cceeccCCccccc-cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 9987654332110 001122356899999999999999999999999999999999999999986543222222221111
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
... ...+.. .+..++.++.+++.+||+.||.+||++.+|++.|+++...
T Consensus 231 ~~~----~~~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 231 KKV----ATSIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHH----HSCHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccc----cccHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 110 001111 0112345789999999999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.62 Aligned_cols=243 Identities=31% Similarity=0.455 Sum_probs=190.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|.+.+ ++|.|+| |.||++... +..+|+|++.. .+.+|++++++++||||+++++++.+.+.
T Consensus 23 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 23 LFIFKR-KLGSGAF-------GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HEEEEE-EEEECSS-------CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred heeecc-eeccCCC-------eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 455555 4899999 999999984 78899999853 36789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee---cCCCcEEEcc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITN 505 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~D 505 (669)
.++||||+++|+|.+++.... .....+++..++.|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEeCCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999999999986532 12356999999999999999999999999 9999999999999 4568899999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++...... ......||..|+|||.+. +.++.++||||||+++|||++|+.||.+....+...
T Consensus 171 fg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~----- 235 (285)
T 3is5_A 171 FGLAELFKSDE---------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ----- 235 (285)
T ss_dssp CCCCCC-------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----
T ss_pred eecceecCCcc---------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh-----
Confidence 99998764432 123457899999999886 578999999999999999999999998754321100
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. .. ..+..... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 -~~--------~~---~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 236 -KA--------TY---KEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -HH--------HH---CCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -hh--------cc---CCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 01111100 1113456889999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=328.58 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=199.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEe---
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVH--- 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~--- 425 (669)
..|++.+. +|.|+| |.||++.. +++.||||+++. .+.+|++++++++||||+++++++..
T Consensus 29 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 29 KHYLFIQK-LGEGGF-------SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEEEEEEE-EEC--C-------EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred eEEEEEEE-ecCCCC-------eEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 45666664 999999 99999996 588999998742 46789999999999999999999973
Q ss_pred -cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 426 -EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 426 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
....++||||+++|+|.+++...+ .....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEE
Confidence 347799999999999999997642 22356999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccC-CcccceeeecccccccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 505 NFGLARSAESDEHEQG-GYGLQLTRHVVGTYGYMAPEYIENGV---ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 505 DfGla~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
|||+++.......... ...........||..|+|||.+.+.. ++.++||||||+++|||++|+.||..........
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 9999886543211000 00000112346799999999987654 6899999999999999999999985311000000
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
...+.. ....+.+...+..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 257 --------------~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 257 --------------ALAVQN----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --------------HHHHHC----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred --------------hHHhhc----cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 000111 1111222344567899999999999999999999999999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=328.65 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=195.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
..|++.+. +|.|+| |.||+|..++ .+|+|+++. .+.+|+.++++++||||+++++++.+++.
T Consensus 33 ~~~~~~~~-lg~G~~-------g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 33 EQLEIGEL-IGKGRF-------GQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SCEECCCB-CCCSSS-------SEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred HHeEEeeE-eccCCc-------eEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 44566554 999999 9999999875 589998852 46789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++ ++.+||+|||+
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred eEEEeecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999754 246899999999999999999999999 99999999999998 67999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN---------GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
++......... .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.......
T Consensus 176 ~~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGR---REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred ccccccccccc---cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 87653221110 0112234568999999999874 45799999999999999999999999865432110
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.. +..-..+... +..++..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 253 ------~~----------~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 253 ------WQ----------MGTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ------HH----------HHTTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ------HH----------hccCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 0011111111 1123346889999999999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.59 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=190.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhc-CCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKI-NHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 428 (669)
.|.+.+-.+|.|+| |.||++.. +++.||||+++. .+.+|++++.++ +||||+++++++.+++.
T Consensus 13 ~y~i~~~~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 13 VYQLQEDVLGEGAH-------ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp SCEECCCCCCCCSS-------EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eEEecCceecCCce-------EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 45553334899999 99999987 588999999853 367899999995 79999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc---EEEcc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR---AKITN 505 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~---~kl~D 505 (669)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred EEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999999999999764 35899999999999999999999999 999999999999988766 99999
Q ss_pred cCCccccCCCccccCCcccceeeeccccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
||+++.......... ..........||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+..+
T Consensus 158 fg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSP-ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp TTCCC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred ccCccccccCCcccc-ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 999987643221100 00111233569999999999975 568899999999999999999999998643211000
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCc----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYP----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.......... ......+..... ..+ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~----~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 237 DRGEACPACQ----NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ----CCHHHH----HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccchhHH----HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000000 000000000000 111 1234578999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.54 Aligned_cols=240 Identities=24% Similarity=0.378 Sum_probs=199.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|.+.+. +|.|+| |.||++... ++.+|+|++.. .+.+|+.++++++||||+++++++.+
T Consensus 15 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 15 RRYVRGRF-LGKGGF-------AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp EEEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cceEEEEE-EeecCC-------EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 45666554 999999 999999985 77899998743 35679999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEe
Confidence 99999999999999999998764 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+..
T Consensus 159 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------ 224 (294)
T 2rku_A 159 FGLATKVEYDGE--------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------ 224 (294)
T ss_dssp CTTCEECCSTTC--------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------
T ss_pred ccCceecccCcc--------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------
Confidence 999987643221 123357899999999999999999999999999999999999999865432110
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... ... ...+......+.+++.+||+.||.+|||+.|+++.
T Consensus 225 ~~~~-------------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 225 LRIK-------------KNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHH-------------TTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHh-------------hcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000 12233445678999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.79 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=192.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|.+.+ ++|.|+| |.||+|... ++.||+|+++. .+.+|++++++++||||+++++++..++..
T Consensus 4 y~~~~-~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 4 YIKLD-KLGEGTY-------ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 75 (324)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred eEEEE-EEcCCCC-------EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence 44444 3899999 999999984 78899999863 244799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||++ |+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEEEECCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEEecccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccc
Confidence 99999998 5999999764 246999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
+...... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+ ....+...
T Consensus 148 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~ 216 (324)
T 3mtl_A 148 RAKSIPT--------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRI 216 (324)
T ss_dssp ECC--------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred ccccCCc--------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 8654322 11233578999999999876 668999999999999999999999998765432 12222222
Q ss_pred HhhhhHH--------hhhhcccCCccCC----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 589 LEESNVR--------EKLRGFIDPSLRN----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 589 ~~~~~~~--------~~l~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+...... +.......+.... .........+.+|+.+||+.||.+|||++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 2111000 0000000011100 0111334568899999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.01 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=190.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcC-CCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKIN-HSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~-H~niv~l~g~~~~ 425 (669)
..|++.+ .+|.|+| |.||+|.. .|+.||||++.. .+.+|+.+++++. ||||+++++++..
T Consensus 9 ~~y~~~~-~lG~G~~-------g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 9 RKYELVK-KLGKGAY-------GIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp TTEEEEE-C--------------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CceEEEE-EeeeCCC-------eEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 3455555 3999999 99999987 488999998843 2557999999997 9999999999975
Q ss_pred cC--ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 EG--NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~~--~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
++ ..|+||||++ |+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred CCCCEEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 54 6899999998 5999999753 4899999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccC-------------Ccccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCC
Q 005923 504 TNFGLARSAESDEHEQG-------------GYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREA 569 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p 569 (669)
+|||+++.......... ...........||..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 99999987643211000 000112334689999999999987 6789999999999999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhhhhHHhhhhccc------------------CCccCCCC------------cHHHHHHHH
Q 005923 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFI------------------DPSLRNEY------------PLDLAFSMA 619 (669)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------------------d~~l~~~~------------~~~~~~~l~ 619 (669)
|.+....+. ...+...+..+.. +.+..+. .......+ +..+...+.
T Consensus 231 f~~~~~~~~---~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (388)
T 3oz6_A 231 FPGSSTMNQ---LERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306 (388)
T ss_dssp CCCSSHHHH---HHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred CCCCCHHHH---HHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence 987654321 1222222211110 0000000 00000000 113345689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 620 QLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 620 ~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
+|+.+||+.||.+|||++|++++ |+.+
T Consensus 307 dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 307 DLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 99999999999999999999987 5544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=320.05 Aligned_cols=240 Identities=23% Similarity=0.420 Sum_probs=198.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|+..+ .+|.|+| |.||+|.. .++.||||+++. .+.+|+.++++++||||+++++++.+++.
T Consensus 23 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 23 LFTKLE-KIGKGSF-------GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp TEEEEE-EEEECSS-------SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HHHHhh-hhcccCC-------eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 355444 3899999 99999987 478899999852 46789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 95 ~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999999964 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... . .
T Consensus 166 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~----~ 230 (303)
T 3a7i_A 166 AGQLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---F----L 230 (303)
T ss_dssp CEECBTTBC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H----H
T ss_pred ceecCcccc--------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---H----H
Confidence 987654321 123357899999999999999999999999999999999999999765432110 0 0
Q ss_pred HhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 589 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
+.....+. .+..++..+.+++.+||+.||.+|||+.|+++..
T Consensus 231 ---------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 231 ---------IPKNNPPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---------HHHSCCCC----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---------hhcCCCCC----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00111111 2223345689999999999999999999999763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.52 Aligned_cols=238 Identities=24% Similarity=0.396 Sum_probs=192.8
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEEecC
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFAD 437 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 437 (669)
+|.|+| |.||+|.. ++..||||.++. .+.+|+.++++++||||+++++++..++..++||||++
T Consensus 30 lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 30 LGKGTY-------GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp EEECSS-------SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeecCc-------EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 899999 99999998 477899998753 36789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CCcEEEcccCCccccCCCc
Q 005923 438 NGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGLARSAESDE 516 (669)
Q Consensus 438 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DfGla~~~~~~~ 516 (669)
+++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999998652 2345789999999999999999999999 999999999999987 8999999999998764322
Q ss_pred cccCCcccceeeecccccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 517 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
. ......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||........... ..
T Consensus 178 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~------ 238 (295)
T 2clq_A 178 P--------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-----KV------ 238 (295)
T ss_dssp -----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-----HH------
T ss_pred C--------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-----hh------
Confidence 1 123356899999999997754 89999999999999999999999974332111100 00
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... ......+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus 239 --~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 239 --GMF-----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --HHH-----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --ccc-----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 01123344556678999999999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.56 Aligned_cols=243 Identities=24% Similarity=0.337 Sum_probs=199.2
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
|++.++ +|.|+| |.||++.. +|+.||+|+++. .+.+|+++|++++||||+++++++.+++
T Consensus 186 f~~~~~-LG~G~f-------G~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 186 FRQYRV-LGKGGF-------GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp EEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eEEEEE-EeeCCC-------EEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 444443 899999 99999998 488999999853 2567999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecc
Confidence 9999999999999999997642 245999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........ .+..
T Consensus 332 la~~~~~~~---------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~ 399 (576)
T 2acx_A 332 LAVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVER 399 (576)
T ss_dssp TCEECCTTC---------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHH
T ss_pred cceecccCc---------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHH
Confidence 998765432 1234589999999999999999999999999999999999999998643211000 0000
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
. +.. ....++...+..+.+|+.+||+.||.+|| +++||+++
T Consensus 400 ~---------i~~-----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 400 L---------VKE-----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp H---------HHH-----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred H---------hhc-----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 000 01223445567789999999999999999 67888754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=354.46 Aligned_cols=239 Identities=25% Similarity=0.389 Sum_probs=199.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc----------HHHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|++.++ +|.|+| |.||++... ++.||||+++.+ +..|..+|..+ +||||+++++++.
T Consensus 341 ~~f~~~~~-LG~G~f-------G~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 341 TDFNFLMV-LGKGSF-------GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp TTEEEEEE-SSBTTT-------BCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred cceEEEEE-EccCCC-------EEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 44555553 999999 999999984 667999998642 45788899887 7999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+.+..||||||+++|+|.++++.. +.+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence 999999999999999999999864 35999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+....+ ..
T Consensus 485 DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~-- 551 (674)
T 3pfq_A 485 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF-- 551 (674)
T ss_dssp CCTTCEECCCTT--------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH--
T ss_pred ecceeeccccCC--------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HH--
Confidence 999998643322 12345689999999999999999999999999999999999999998765321 11
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI-----SEVFV 641 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 641 (669)
. .++... ..+|.....++.+|+.+||+.||.+||++ +||++
T Consensus 552 -~-------------~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 552 -Q-------------SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -H-------------HHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -H-------------HHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 111111 23455667789999999999999999998 66654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.97 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=191.0
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
...|++.+. +|.|+| |.||++.. .|+.||||+++. .+.+|+.+|++++||||+++++++..
T Consensus 61 ~~~y~~~~~-lG~G~~-------g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 132 (464)
T 3ttj_A 61 LKRYQNLKP-IGSGAQ-------GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 132 (464)
T ss_dssp ETTEEEEEE-EEECSS-------CEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cCCeEEEEE-eecCCC-------eEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEcc
Confidence 345665553 899999 99999987 478899999853 35689999999999999999999975
Q ss_pred cC------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 426 EG------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 426 ~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
.+ ..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 133 ~~~~~~~~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 133 QKTLEEFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred CCccccCCeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCC
Confidence 53 46999999986 57777743 3899999999999999999999999 99999999999999999
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 202 ~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-- 270 (464)
T 3ttj_A 202 TLKILDFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-- 270 (464)
T ss_dssp CEEECCCCCC-----CC---------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred CEEEEEEEeeeecCCCc---------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999998764321 2334689999999999999999999999999999999999999998765422
Q ss_pred HHHHHHHHHHhhhhHH------hhhhcccCCc--cC----------------CCCcHHHHHHHHHHHHHhcccCCCCCCC
Q 005923 580 LLYASISRVLEESNVR------EKLRGFIDPS--LR----------------NEYPLDLAFSMAQLAKNCTAHDLNARPS 635 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~------~~l~~~~d~~--l~----------------~~~~~~~~~~l~~li~~Cl~~dP~~RPt 635 (669)
.+..+...+...... ...+.+++.. .. ..........+.+|+.+||+.||.+|||
T Consensus 271 -~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 349 (464)
T 3ttj_A 271 -QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349 (464)
T ss_dssp -HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred -HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence 122222222111000 0011111100 00 0001122567899999999999999999
Q ss_pred HHHHHHH
Q 005923 636 ISEVFVT 642 (669)
Q Consensus 636 ~~evl~~ 642 (669)
++|++++
T Consensus 350 a~e~L~H 356 (464)
T 3ttj_A 350 VDDALQH 356 (464)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.05 Aligned_cols=241 Identities=27% Similarity=0.447 Sum_probs=198.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|.+.+. +|.|+| |.||++.. +|+.||+|.++. .+.+|++++++++||||+++++++.+++..
T Consensus 10 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 10 TFIFMEV-LGSGAF-------SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp HEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceeeee-ccCCCC-------ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 4555553 899999 99999998 488999999863 367899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee---cCCCcEEEccc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKITNF 506 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~Df 506 (669)
++||||+++|+|.+++... +.+++..+..++.|++.||+|||+.+ ++||||||+|||+ ++++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999999999999764 35899999999999999999999999 9999999999999 78899999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+ ....
T Consensus 154 g~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~-- 218 (304)
T 2jam_A 154 GLSKMEQNGI----------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEK-- 218 (304)
T ss_dssp STTCCCCCBT----------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH--
T ss_pred CcceecCCCc----------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH--
Confidence 9997653321 123468999999999999999999999999999999999999998654321 1111
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.. ... ..........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 219 -i~~---------~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 219 -IKE---------GYY--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -HHH---------CCC--CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -HHc---------CCC--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 110 000 11112223455678999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.34 Aligned_cols=243 Identities=23% Similarity=0.409 Sum_probs=195.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ .+|.|+| |.||+|... |+.||+|.++. ++.+|+.++++++||||+++++++..++..++
T Consensus 30 ~y~~~~-~lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 30 VFDVLE-KLGEGSY-------GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp CEEEEE-ECC-----------CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhe-eeccCCC-------eEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 355444 3899999 999999985 78999999863 47789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 102 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 99999999999999743 246999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ...
T Consensus 175 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~--- 237 (314)
T 3com_A 175 LTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMI--- 237 (314)
T ss_dssp CBTTBS--------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH---
T ss_pred hhhhcc--------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHH---
Confidence 643221 123356899999999999999999999999999999999999999865432110 000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.....+. ...+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 238 -------~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 238 -------PTNPPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -------HHSCCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -------hcCCCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001111 12234455678999999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=342.23 Aligned_cols=239 Identities=22% Similarity=0.330 Sum_probs=196.1
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVYE 434 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 434 (669)
+|+|+| |.||++.. .|+.||+|+++. .+..|+++|++++||||+++++++..++..|+|||
T Consensus 193 LG~G~f-------G~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 193 LGRGGF-------GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp EEECSS-------SEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeCCC-------eEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 899999 99999998 488999999853 25679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCC
Q 005923 435 FADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAES 514 (669)
Q Consensus 435 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~ 514 (669)
|+++|+|.+++.... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred eccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999997642 22356999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhH
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (669)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........ ........
T Consensus 342 ~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~---- 407 (543)
T 3c4z_A 342 GQ--------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLE---- 407 (543)
T ss_dssp TC--------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHH----
T ss_pred CC--------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhh----
Confidence 32 11234579999999999999999999999999999999999999998643211000 00111111
Q ss_pred HhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005923 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSI-----SEVFV 641 (669)
Q Consensus 595 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 641 (669)
. ...+|..++..+.+|+.+||+.||.+||++ +||+.
T Consensus 408 ---------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 ---------Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---------C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---------c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 113344556788999999999999999976 56654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=354.38 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=198.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.+. +|.|+| |.||+|.+. +..||||.++. .+.+|+.++++++||||+++++++.
T Consensus 391 ~y~i~~~-LG~G~f-------G~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 391 RIELGRC-IGEGQF-------GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GEEEEEE-EECCSS-------CCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cEEEeeE-EeeCCC-------EEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3444443 899999 999999984 34589998753 4678999999999999999999984
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.++++..+ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEe
Confidence 567899999999999999998642 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |..||.+....+.
T Consensus 535 FG~a~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~------ 601 (656)
T 2j0j_A 535 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------ 601 (656)
T ss_dssp CCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------
T ss_pred cCCCeecCCCcc-------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH------
Confidence 999987654321 11223456789999999999999999999999999999997 9999986553211
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
+..+.. ..+...+..++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 602 ~~~i~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 602 IGRIEN--------------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHc--------------CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 000100 01122344556788999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.42 Aligned_cols=255 Identities=19% Similarity=0.340 Sum_probs=197.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----cHHHHHHHHHhcC-CCCceeEeeEEEe--cCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----DVSSEINILKKIN-HSNIIRLSGFCVH--EGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~ 428 (669)
..|++.+. +|.|+| |.||+|.. +++.||||+++. .+.+|++++++++ ||||+++++++.+ ...
T Consensus 36 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 36 DDYQLVRK-LGRGKY-------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CceEEEEE-ecccCC-------eEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 45666554 999999 99999987 588999999863 5788999999997 9999999999987 567
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfG 507 (669)
.++||||+++++|.+++.. +++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 108 ~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 8999999999999999852 889999999999999999999999 99999999999999776 89999999
Q ss_pred CccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++....... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...+.
T Consensus 177 ~a~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~ 245 (330)
T 3nsz_A 177 LAEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIA 245 (330)
T ss_dssp TCEECCTTCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHH
T ss_pred CceEcCCCCc---------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHH
Confidence 9987654321 233578899999999987 67899999999999999999999999754332211 11122
Q ss_pred HHHhhhhHHhhhhc---ccCC----------------ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRG---FIDP----------------SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~---~~d~----------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+......+.+.. ..++ ......+..++..+.+|+.+||+.||.+|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22221111111110 0000 01112223356778999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.79 Aligned_cols=251 Identities=19% Similarity=0.280 Sum_probs=184.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+| |.||++.. +|+.||+|+++.. +..|...++.++||||+++++++.+++
T Consensus 8 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 8 DLEPIM-ELGRGAY-------GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG 79 (290)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhhhHH-hcCCCCC-------eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence 445444 3899999 99999998 5889999998642 223444577789999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
..++||||++ |+|.+++.... .....+++..++.|+.|++.||+|||++ + ++||||||+|||++.++.+||+||
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC
T ss_pred CEEEEEehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 9999999997 59988876521 1235699999999999999999999998 8 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeeccccccccccccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI----ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+++....... .....||..|+|||.+ .+..++.++||||||+++|||++|+.||.........
T Consensus 155 g~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--- 222 (290)
T 3fme_A 155 GISGYLVDDVA---------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--- 222 (290)
T ss_dssp ------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH---
T ss_pred CCccccccccc---------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH---
Confidence 99987644321 2234689999999996 5677899999999999999999999999753322111
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHhhcC
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV--TLSKIWSS 649 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i~~~ 649 (669)
+..... . ......+...+..+.+++.+||+.||.+|||+.|+++ .++...+.
T Consensus 223 --~~~~~~---------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~ 276 (290)
T 3fme_A 223 --LKQVVE---------E----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276 (290)
T ss_dssp --HHHHHH---------S----CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred --HHHHhc---------c----CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence 111111 0 0111112234567899999999999999999999998 45544433
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=335.55 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=195.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---HHHHHHHHHhcCCCCceeEeeEEEecC------
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---VSSEINILKKINHSNIIRLSGFCVHEG------ 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l~H~niv~l~g~~~~~~------ 427 (669)
.|+..+. +|.|+| |.||+|.. .|+.||||++..+ ..+|+++|++++||||+++++++...+
T Consensus 55 ~y~~~~~-lG~G~f-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 55 SYTDTKV-IGNGSF-------GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred eEEeeeE-EeeCCC-------EEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 3555443 899999 99999998 4889999998643 457999999999999999999986532
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-CcEEEccc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNF 506 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~Df 506 (669)
..++||||+++ +|.+.+.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEeehhcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccc
Confidence 36799999986 6777665321 12356999999999999999999999999 9999999999999965 67899999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++....... .....||..|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+ ..+
T Consensus 202 G~a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l-~~i 269 (420)
T 1j1b_A 202 GSAKQLVRGEP---------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QL-VEI 269 (420)
T ss_dssp TTCEECCTTCC---------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-HHH
T ss_pred hhhhhcccCCC---------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HH-HHH
Confidence 99987644321 1235789999999999764 79999999999999999999999998765422 11 222
Q ss_pred HHHHhhhhHHhhhhc-------ccCCccCC-----CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhh
Q 005923 586 SRVLEESNVREKLRG-------FIDPSLRN-----EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIW 647 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~-------~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~ 647 (669)
...+..... +.+.. +..+.+.. .++...+.++.+|+.+||+.||.+|||+.|++++ ++++.
T Consensus 270 ~~~lg~p~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 270 IKVLGTPTR-EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCH-HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhCCCCH-HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 222211111 11111 11111110 1222345678999999999999999999999864 45444
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.91 Aligned_cols=239 Identities=28% Similarity=0.471 Sum_probs=190.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|.+.+. +|.|.| |.||+|... |+.||||.++. .+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~i~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 11 GHYVLGDT-LGVGTF-------GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp TTEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccEEEEee-ecCCCC-------eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34666553 899999 999999984 88999999853 35689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d 154 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD 154 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEee
Confidence 99999999999999999999764 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+++...... ......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....... ....
T Consensus 155 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~ 222 (276)
T 2h6d_A 155 FGLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKK 222 (276)
T ss_dssp CCGGGCCCC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred cccccccCCCc---------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHH
Confidence 99998765432 1233568999999999988765 689999999999999999999998654321 1111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+..- ....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 223 -------------~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 223 -------------IRGG-----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------------HHHC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------------hhcC-----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 011233345678999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=328.33 Aligned_cols=235 Identities=27% Similarity=0.416 Sum_probs=191.5
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------------cHHHHHHHHHhc-CCCCceeEeeEEEecC
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------------DVSSEINILKKI-NHSNIIRLSGFCVHEG 427 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------------~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 427 (669)
.+|.|+| |.||+|... |+.||||+++. .+.+|+.+++++ +||||+++++++...+
T Consensus 101 ~lg~G~~-------g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 101 VIGRGVS-------SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp EEEECSS-------EEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred EEecCCC-------EEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 3899999 999999984 88999998842 256799999999 7999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999754 35999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeeccccccccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN------GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
++....... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||.+..... .
T Consensus 246 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~- 313 (365)
T 2y7j_A 246 FSCHLEPGE---------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--M- 313 (365)
T ss_dssp TCEECCTTC---------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H-
T ss_pred cccccCCCc---------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--H-
Confidence 998765432 1234578999999999864 358899999999999999999999998654321 1
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.. .+... ... ...+.....+..+.+++.+||+.||.+|||+.|+++
T Consensus 314 ~~---~i~~~---------~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LR---MIMEG---------QYQ--FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH---HHHHT---------CCC--CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH---HHHhC---------CCC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01 01100 000 000000123456899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.31 Aligned_cols=237 Identities=22% Similarity=0.327 Sum_probs=191.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhc-CCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKI-NHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l-~H~niv~l~g~~~~~ 426 (669)
.|++.+ .+|.|+| |.||++... ++.||+|.++. ++.+|+..+.++ +||||+++++++.++
T Consensus 12 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 12 EFHELE-KIGSGEF-------GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HEEEEE-EEEEETT-------EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred hhhhhh-hhcCCCc-------eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 344444 3899999 999999984 88999999863 356789999998 999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---------
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--------- 497 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~--------- 497 (669)
+..++||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------
T ss_pred CeEEEEEEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccc
Confidence 99999999999999999997642 11245899999999999999999999999 999999999999984
Q ss_pred ----------CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcC
Q 005923 498 ----------NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSG 566 (669)
Q Consensus 498 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg 566 (669)
...+||+|||+++...... ...||..|+|||.+.+. .++.++||||||+++|||++|
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 227 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred ccccccccCCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence 4489999999998765422 13589999999999876 667899999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 567 REAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 567 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..++...... . .+..-. ....+..++..+.+++.+||+.||.+|||+.|++++
T Consensus 228 ~~~~~~~~~~------~-------------~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 228 EPLPRNGDQW------H-------------EIRQGR----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCCCSSSHHH------H-------------HHHTTC----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCcchhHH------H-------------HHHcCC----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 8776543210 0 000000 122333455678999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.17 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=192.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+. +|.|+| |.||+|.. .|+.||||++.. .+.+|+++|++++||||+++++++...
T Consensus 25 ~~y~~~~~-lG~G~~-------g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 25 AVYRDLQP-VGSGAY-------GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp SSEEEEEE-C-------------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred ceEEEeEE-eeecCC-------eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 45665553 999999 99999997 488999999842 356899999999999999999999765
Q ss_pred C------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 G------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
+ ..++||||+ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCC
Confidence 3 459999999 78999999753 4899999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
+||+|||+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+
T Consensus 167 ~kl~Dfg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-- 233 (367)
T 1cm8_A 167 LKILDFGLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-- 233 (367)
T ss_dssp EEECCCTTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred EEEEeeecccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 999999999875432 123468999999999987 789999999999999999999999998765422
Q ss_pred HHHHHHHHHHhhhh-----------HHhhhhcc---cCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--H
Q 005923 580 LLYASISRVLEESN-----------VREKLRGF---IDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--L 643 (669)
Q Consensus 580 ~~~~~~~~~~~~~~-----------~~~~l~~~---~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L 643 (669)
....+........ ....+..+ ....+ ..........+.+|+.+||+.||.+|||+.|++++ +
T Consensus 234 -~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 234 -QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp -HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred -HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 1122222211110 00111111 11111 11122345678999999999999999999999884 4
Q ss_pred HHh
Q 005923 644 SKI 646 (669)
Q Consensus 644 ~~i 646 (669)
+.+
T Consensus 312 ~~~ 314 (367)
T 1cm8_A 312 ESL 314 (367)
T ss_dssp TTT
T ss_pred Hhh
Confidence 444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=332.73 Aligned_cols=264 Identities=20% Similarity=0.334 Sum_probs=198.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---HHHHHHHHHhcCCCCceeEeeEEEec-------
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---VSSEINILKKINHSNIIRLSGFCVHE------- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l~H~niv~l~g~~~~~------- 426 (669)
.|++.+. +|.|+| |.||+|.. +|+.||||++..+ ..+|+++|++++||||+++++++...
T Consensus 8 ~y~~~~~-lG~G~f-------g~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 8 KYSLGKT-LGTGSF-------GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp TEEEEEE-EECC-C-------EEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred eEEEEEE-EEeccC-------EEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4555553 899999 99999987 5889999998643 56899999999999999999998543
Q ss_pred -------------------------------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005923 427 -------------------------------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475 (669)
Q Consensus 427 -------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yL 475 (669)
...++||||++ |+|.+.+.... .....+++..+..++.||+.||+||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 58888876421 1235699999999999999999999
Q ss_pred HhCCCCCeEeeCCCCCCeeec-CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhH
Q 005923 476 HKYTNPPYVHKNLKTSNILLD-TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDV 553 (669)
Q Consensus 476 H~~~~~~ivHrDik~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV 553 (669)
|+.+ |+||||||+|||++ .++.+||+|||+++....... .....+|..|+|||.+.+. .++.++||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---------SVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---------CCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---------CcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 9999 99999999999998 689999999999987644321 2235679999999998875 48999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhh------hc-----ccCCccCCCCcHHHHHHHHHHH
Q 005923 554 FAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKL------RG-----FIDPSLRNEYPLDLAFSMAQLA 622 (669)
Q Consensus 554 ~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------~~-----~~d~~l~~~~~~~~~~~l~~li 622 (669)
|||||++|||++|+.||.+....+. ...+...+......... .. +....+....+...+..+.+|+
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence 9999999999999999987654321 12222222211111100 00 0011111123344566789999
Q ss_pred HHhcccCCCCCCCHHHHHHH--HHHhh
Q 005923 623 KNCTAHDLNARPSISEVFVT--LSKIW 647 (669)
Q Consensus 623 ~~Cl~~dP~~RPt~~evl~~--L~~i~ 647 (669)
.+||+.||.+|||+.|++++ ++.+.
T Consensus 303 ~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred HHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 99999999999999999864 55554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.85 Aligned_cols=238 Identities=23% Similarity=0.372 Sum_probs=193.0
Q ss_pred HHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhc-CCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 433 (669)
.+|.|+| |.||++... ++.||+|+++. .+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 36 ~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 36 ELGRGKF-------AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp EEEEETT-------EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eeCCCCC-------eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 4899999 999999984 88999999853 467899999999 4699999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEcccCCcc
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLAR 510 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DfGla~ 510 (669)
||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 109 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp ECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred EecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999999998653 2356999999999999999999999999 999999999999988 7899999999998
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+... .+ .
T Consensus 183 ~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i---~- 246 (327)
T 3lm5_A 183 KIGHAC---------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL---NI---S- 246 (327)
T ss_dssp EC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH---H-
T ss_pred ccCCcc---------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HH---H-
Confidence 764332 1234578999999999999999999999999999999999999998755322110 00 0
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ............++..+.+++.+||+.||.+|||++|+++.
T Consensus 247 ---------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 ---------Q-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---------H-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---------h-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00111122223455678999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=335.34 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=185.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------------cHHHHHHHHHhcCCCCceeEee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------------DVSSEINILKKINHSNIIRLSG 421 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g 421 (669)
.|.+.+ .+|.|+| |.||+|... ++.||||+++. .+.+|+++|++++||||+++++
T Consensus 136 ~y~~~~-~LG~G~~-------g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~ 207 (419)
T 3i6u_A 136 EYIMSK-TLGSGAC-------GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207 (419)
T ss_dssp TEEEEE-EEEECSS-------SEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCE
T ss_pred cEEEEe-EEeeCCC-------eEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 355544 3899999 999999984 67999999853 3678999999999999999999
Q ss_pred EEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC---
Q 005923 422 FCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN--- 498 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~--- 498 (669)
++. .+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 208 ~~~-~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 208 FFD-AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp EEE-SSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSS
T ss_pred EEe-cCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCc
Confidence 984 55689999999999999988654 46999999999999999999999999 9999999999999654
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
+.+||+|||+++...... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||.+...
T Consensus 279 ~~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp CCEEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ceEEEeecccceecCCCc---------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 469999999998765322 2334679999999999863 6788999999999999999999999985432
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... .... +.. ... ..........+..+.+++.+||+.||.+|||+.|++++
T Consensus 350 ~~~--~~~~----i~~--------~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 350 QVS--LKDQ----ITS--------GKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SCC--HHHH----HHT--------TCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHH--HHHH----Hhc--------CCC--CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 110 0000 000 000 00001112335678999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.85 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=196.4
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
+..|++.+. +|.|+| |.||+|.. +|+.||||++.. .+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 16 VSKYEKLAK-IGQGTF-------GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGGEEEEEE-CSSCST-------TSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceeEEEE-EecCCC-------cEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 355666664 999999 99999998 478999998742 36689999999999999999999987
Q ss_pred --------cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 426 --------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 426 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
++..++||||+++ +|.+.+... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~ 159 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 159 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcC
Confidence 3468999999985 888888754 245999999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~ 576 (669)
++.+||+|||+++......... ........||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....
T Consensus 160 ~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 235 (351)
T 3mi9_A 160 DGVLKLADFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235 (351)
T ss_dssp TSCEEECCCTTCEECCCCSSSS----CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCCEEEccchhccccccccccc----ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999998765332111 122334678999999999876 55899999999999999999999999876543
Q ss_pred HHHHHHHHHHHHHhhhhHH--hhh-----hcccCC--ccCCCCcHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 577 EAELLYASISRVLEESNVR--EKL-----RGFIDP--SLRNEYPLD-----LAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~--~~l-----~~~~d~--~l~~~~~~~-----~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+. ...+.......... ... ...+.. ......... ....+.+|+.+||+.||.+|||++|+++.
T Consensus 236 ~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 236 HQ---LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HH---HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HH---HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 21 12222221110000 000 000000 000000011 13457899999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.01 Aligned_cols=258 Identities=27% Similarity=0.349 Sum_probs=195.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
..|++.+. +|.|+| |.||+|... |+.||||+++. .+.+|++++++++||||+++++++
T Consensus 10 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (346)
T 1ua2_A 10 KRYEKLDF-LGEGQF-------ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 81 (346)
T ss_dssp ---CEEEE-EEEETT-------EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccEEEeE-EeecCC-------EEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 34555553 899999 999999984 78899999852 356899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
.+.+..++||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 82 GHKSNISLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp CCTTCCEEEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eeCCceEEEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEE
Confidence 999999999999986 899998754 246889999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
+|||+++...... .......||..|+|||.+.+. .++.++||||||+++|||++|..||.+....+ . .
T Consensus 154 ~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~-~ 222 (346)
T 1ua2_A 154 ADFGLAKSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--Q-L 222 (346)
T ss_dssp CCCGGGSTTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H-H
T ss_pred EecccceeccCCc--------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--H-H
Confidence 9999998764332 112345789999999999764 58999999999999999999999998765422 1 1
Q ss_pred HHHHHHHhhhhHH--h---hhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 583 ASISRVLEESNVR--E---KLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~~~~--~---~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+.......... . .+...+........+ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1111111110000 0 000000000001111 2334678999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.99 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=182.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+. +|.|+| |.||+|.. .++.||||++.. .+.+|+++|++++||||+++++++...
T Consensus 53 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 53 DRYEIRHL-IGTGSY-------GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124 (458)
T ss_dssp TTEEECCC---------------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCeEEeeE-eeecCC-------eEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 34666554 999999 99999987 478999999853 366899999999999999999999543
Q ss_pred -----CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 427 -----GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 427 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
...|+||||+. |+|.+++... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 125 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 125 DVEKFDELYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp CTTTCCCEEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred CcccCceEEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCE
Confidence 46899999985 7999999754 46999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCc-------------------ccceeeeccccccccccccc-ccCCCCchhhHHHHHHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGY-------------------GLQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVL 561 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~l-~~~~~s~~sDV~S~Gvvl~ 561 (669)
||+|||+++............ .........||..|+|||++ .+..++.++|||||||++|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 999999999765332110000 00123346789999999986 5667999999999999999
Q ss_pred HHHc-----------CCCCCCCCchh-----------------HHHHHHHHHHHHHhhhhH-----------Hhhhhccc
Q 005923 562 ELLS-----------GREAVTGDQNC-----------------EAELLYASISRVLEESNV-----------REKLRGFI 602 (669)
Q Consensus 562 ellt-----------g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~-----------~~~l~~~~ 602 (669)
||++ |+.+|.+.... ........+...+..... ...++.+.
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 355 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC
T ss_pred HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC
Confidence 9999 55555543210 001111222222211110 00011100
Q ss_pred C---CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 603 D---PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 603 d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. ..+...+ ......+.+|+.+||+.||.+|||++|++++
T Consensus 356 ~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 356 KREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCCCCGGGGS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCHHHHC-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0011111 1235678999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.08 Aligned_cols=240 Identities=15% Similarity=0.195 Sum_probs=185.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEec----------ccHHHHH---HHHHhcCCCCceeEe--
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMK----------GDVSSEI---NILKKINHSNIIRLS-- 420 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~----------~~~~~E~---~~l~~l~H~niv~l~-- 420 (669)
..|.+.+ .+|.|+| |.||+|.. +|+.||||+++ ..+.+|+ ++|++++||||++++
T Consensus 73 ~~y~~~~-~lG~G~~-------g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 73 RTLVRGT-VLGQEDP-------YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp EEEEEEE-EEEEETT-------EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred ceEEEcc-eeecCCC-------EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 3455555 3999999 99999996 48899999985 2367899 455566899999998
Q ss_pred -----eEEEecC-----------------ceeEEEEecCCCCHHHHHhcCCCCC--CCCCCHHHHHHHHHHHHHHHHHHH
Q 005923 421 -----GFCVHEG-----------------NTYLVYEFADNGALSDWLHSNRYQT--SDNLTWKQRVQIAYDVANALNYLH 476 (669)
Q Consensus 421 -----g~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qia~~L~yLH 476 (669)
+++...+ ..++||||+ +|+|.+++...+... ...++|..++.|+.||+.||+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 6655443 378999999 689999998642111 124567899999999999999999
Q ss_pred hCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-----------
Q 005923 477 KYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG----------- 545 (669)
Q Consensus 477 ~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------- 545 (669)
+++ |+||||||+|||++.++.+||+|||+++.... ......| ..|+|||.+.+.
T Consensus 224 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 288 (377)
T 3byv_A 224 HYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------RVVSSVS-RGFEPPELEARRATISYHRDRRT 288 (377)
T ss_dssp HTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred hCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----------cccCCCC-cCccChhhhcccccccccccccc
Confidence 999 99999999999999999999999999986432 1234567 999999999987
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHh
Q 005923 546 VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNC 625 (669)
Q Consensus 546 ~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~C 625 (669)
.++.++|||||||++|||++|+.||.+..... ....+.. ....++..+.+|+.+|
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~-------------------~~~~~~~------~~~~~~~~~~~li~~~ 343 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALG-------------------GSEWIFR------SCKNIPQPVRALLEGF 343 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC------C-------------------CSGGGGS------SCCCCCHHHHHHHHHH
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCccccccc-------------------chhhhhh------hccCCCHHHHHHHHHH
Confidence 89999999999999999999999997533210 1111111 0123345789999999
Q ss_pred cccCCCCCCCHHHHHH--HHHHh
Q 005923 626 TAHDLNARPSISEVFV--TLSKI 646 (669)
Q Consensus 626 l~~dP~~RPt~~evl~--~L~~i 646 (669)
|+.||.+|||+.|+++ .++++
T Consensus 344 L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 344 LRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp TCSSGGGCCCHHHHHTSHHHHHH
T ss_pred cCCCchhCCCHHHHhhChHHHHH
Confidence 9999999999999986 34444
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.01 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=198.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.+ .+|.|+| |.||++... ++.||||+++. .+.+|+++|++++||||+++++++.+.
T Consensus 22 ~~y~~~~-~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 22 ERYNIVC-MLGKGSF-------GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp HHEEEEE-EEECCSS-------SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cceEEeE-EEeecCC-------EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 3455555 4999999 999999984 88999999842 367899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec---CCCcEEE
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD---TNLRAKI 503 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl 503 (669)
+..++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEE
Confidence 9999999999999999999764 35999999999999999999999999 99999999999995 4568999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.
T Consensus 166 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----- 230 (486)
T 3mwu_A 166 IDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----- 230 (486)
T ss_dssp CSCSCTTTBCCC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----
T ss_pred EECCcCeECCCCC---------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----
Confidence 9999998764432 1234579999999999875 599999999999999999999999987653211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
+..+... .. ....+....++..+.+|+.+||+.||.+|||+.|++++ +++.
T Consensus 231 -~~~i~~~---------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 231 -LKRVETG---------KY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -HHHHHHT---------CC--CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -HHHHHhC---------CC--CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 1111100 00 01111123445678999999999999999999999985 4443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.83 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=196.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------------cHHHHHHHHHhcC-CCCcee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------------DVSSEINILKKIN-HSNIIR 418 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------------~~~~E~~~l~~l~-H~niv~ 418 (669)
..|++.+. +|.|.| |.||++.. +|+.||||+++. .+.+|+++++++. ||||++
T Consensus 17 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (298)
T 1phk_A 17 ENYEPKEI-LGRGVS-------SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 88 (298)
T ss_dssp TTEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred hccceeee-ecCCCc-------eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34555553 899999 99999998 467899999842 3567999999995 999999
Q ss_pred EeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 419 LSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 419 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
+++++..++..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDD 160 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCC
Confidence 999999999999999999999999999764 35899999999999999999999999 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeecccccccccccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE------NGVITPKLDVFAFGVVVLELLSGREAVTG 572 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDV~S~Gvvl~elltg~~p~~~ 572 (669)
+.+||+|||+++...... ......|+..|+|||.+. ...++.++||||||+++|||++|+.||.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcEEEecccchhhcCCCc---------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 999999999998765432 123356899999999985 45689999999999999999999999986
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
....+. . ..... ... ....+.....+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~---~---~~~~~---------~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 232 RKQMLM---L---RMIMS---------GNY--QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SSHHHH---H---HHHHH---------TCC--CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccHHHH---H---HHHhc---------CCc--ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 543211 0 00110 000 1111122345567899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.69 Aligned_cols=256 Identities=19% Similarity=0.309 Sum_probs=198.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEec------------------------ccHHHHHHHHHhcCC
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK------------------------GDVSSEINILKKINH 413 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~------------------------~~~~~E~~~l~~l~H 413 (669)
..|.+.+. +|.|+| |.||++..+|+.||||.++ ..+.+|+.++++++|
T Consensus 31 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 31 NDYRIIRT-LNQGKF-------NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp TTEEEEEE-EECCSS-------CCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred CceEEEEE-EcCCCC-------eEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 45666654 899999 9999999999999999984 446789999999999
Q ss_pred CCceeEeeEEEecCceeEEEEecCCCCHHHH------HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEee
Q 005923 414 SNIIRLSGFCVHEGNTYLVYEFADNGALSDW------LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHK 486 (669)
Q Consensus 414 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHr 486 (669)
|||+++++++.+++..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ .+ ++||
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~ 176 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHR 176 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECC
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---Eeec
Confidence 9999999999999999999999999999998 5432 24579999999999999999999999 88 9999
Q ss_pred CCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCc-hhhHHHHHHHHHHHH
Q 005923 487 NLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITP-KLDVFAFGVVVLELL 564 (669)
Q Consensus 487 Dik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-~sDV~S~Gvvl~ell 564 (669)
||||+|||++.++.+||+|||+++..... ......|+..|+|||.+.+. .++. ++||||||+++|||+
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence 99999999999999999999999876432 12345789999999999887 6666 999999999999999
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHHhhhhH-HhhhhcccCCc---cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005923 565 SGREAVTGDQNCEAELLYASISRVLEESNV-REKLRGFIDPS---LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640 (669)
Q Consensus 565 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 640 (669)
+|+.||........ . .. .+...... ......+..+. .........+..+.+++.+||+.||.+|||+.|++
T Consensus 247 ~g~~pf~~~~~~~~-~-~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l 321 (348)
T 2pml_X 247 YNVVPFSLKISLVE-L-FN---NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321 (348)
T ss_dssp HSSCSSCCSSCSHH-H-HH---HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred hCCCCCCCCCcHHH-H-HH---HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 99999986543111 0 00 01000000 00000000000 00001134556789999999999999999999998
Q ss_pred HH
Q 005923 641 VT 642 (669)
Q Consensus 641 ~~ 642 (669)
++
T Consensus 322 ~h 323 (348)
T 2pml_X 322 KH 323 (348)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.36 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=184.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|++.+. +|.|+| |.||++.. +++.||||.++. ++.+|+.++++++||||+++++++..++.
T Consensus 16 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 16 DYELQEV-IGSGAT-------AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp CCEEEEE-CC---C-------CCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred hhhhhhe-eccccc-------eEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4555553 899999 99999987 588999998752 36689999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 429 TYLVYEFADNGALSDWLHSNR---YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
.++||||+++|+|.+++.... ......+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEe
Confidence 999999999999999997421 112356999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+++......... .........||..|+|||.+.+ ..++.++||||||+++|||++|+.||..........
T Consensus 165 fg~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---- 237 (303)
T 2vwi_A 165 FGVSAFLATGGDIT---RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---- 237 (303)
T ss_dssp CHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH----
T ss_pred ccchheeccCCCcc---chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH----
Confidence 99998764432110 0112234578999999999976 568999999999999999999999998654322110
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....... ........++ ......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 238 --~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 238 --LTLQNDP-PSLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp --HHHTSSC-CCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HHhccCC-Cccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0111000 0000000111 1122334568999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.27 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=196.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhc------CCCCceeEeeEEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKI------NHSNIIRLSGFCV 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l------~H~niv~l~g~~~ 424 (669)
.|++.+. +|.|+| |.||+|... ++.||||+++. .+.+|+.+++.+ +|+||+++++++.
T Consensus 98 ry~~~~~-LG~G~f-------g~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 98 RYEVLKV-IGKGSF-------GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TEEEEEE-EEESSS-------EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cEEEEEE-cccCcc-------EEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 3555553 999999 999999884 67899999964 356788888887 5779999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc--EE
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR--AK 502 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~--~k 502 (669)
..+..++||||+. |+|.+++...+ ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEE
T ss_pred cCCeEEEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceE
Confidence 9999999999996 69999998753 245999999999999999999999999 999999999999999887 99
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.||.+....+. .
T Consensus 243 L~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~---l 308 (429)
T 3kvw_A 243 VIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ---L 308 (429)
T ss_dssp ECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H
T ss_pred EeecccceecCCc-----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 9999999764332 2235789999999999999999999999999999999999999987654321 1
Q ss_pred HHHHHHHhhhhHH-----hhhhcccCCcc---------------------------C---------CCCcHHHHHHHHHH
Q 005923 583 ASISRVLEESNVR-----EKLRGFIDPSL---------------------------R---------NEYPLDLAFSMAQL 621 (669)
Q Consensus 583 ~~~~~~~~~~~~~-----~~l~~~~d~~l---------------------------~---------~~~~~~~~~~l~~l 621 (669)
..+...+...... .....+++... + ...+......+.+|
T Consensus 309 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dl 388 (429)
T 3kvw_A 309 ACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388 (429)
T ss_dssp HHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHH
T ss_pred HHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHH
Confidence 1222221111000 00111111100 0 00001124568999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 005923 622 AKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 622 i~~Cl~~dP~~RPt~~evl~~ 642 (669)
+++||+.||.+|||+.|++++
T Consensus 389 i~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 389 LKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCChhhCCCHHHHhCC
Confidence 999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.14 Aligned_cols=244 Identities=25% Similarity=0.467 Sum_probs=190.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhc-CCCCceeEeeEEEe---
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKI-NHSNIIRLSGFCVH--- 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~niv~l~g~~~~--- 425 (669)
..|++.+. +|.|+| |.||+|.. +|+.||||+++. .+.+|+.+++++ +||||+++++++..
T Consensus 24 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 24 GIFELVEL-VGNGTY-------GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp TTEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CcEEEEEE-eccCCC-------EEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 45666554 899999 99999998 688999999853 477899999999 79999999999987
Q ss_pred ---cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 426 ---EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 426 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
.+..++||||+++|+|.+++...+ ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 457899999999999999998642 246899999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
|+|||++....... .......||..|+|||.+. +..++.++||||||+++|||++|+.||.+.....
T Consensus 170 l~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 241 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241 (326)
T ss_dssp ECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EeeCcCceecCcCc--------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 99999998764321 1123357899999999997 5678999999999999999999999997654321
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. ..... ...+.+ .+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 242 ~~------~~~~~----------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 AL------FLIPR----------NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH------HHHHH----------SCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH------HHhhc----------CccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10 00000 001111 112334578999999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.37 Aligned_cols=264 Identities=22% Similarity=0.372 Sum_probs=194.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEeccc---HHHHHHHHHhcCCCCceeEeeEEEecCc------
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKGD---VSSEINILKKINHSNIIRLSGFCVHEGN------ 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~~---~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 428 (669)
.|++.++ +|.|+| |.||++.. ++..+|+|++..+ ..+|+++|++++||||+++++++...+.
T Consensus 41 ~Y~~~~~-lG~G~~-------g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 41 AYTNCKV-IGNGSF-------GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEE-EEEETT-------EEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred eEEEeEE-EeeCCC-------eEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4665554 999999 99999998 4556899887532 4579999999999999999999976543
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-CCCcEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-TNLRAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~DfG 507 (669)
.++||||++++.+....+.. .....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 78999999875443333221 12356999999999999999999999999 99999999999999 79999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+++....... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+. + ..+.
T Consensus 188 ~a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l-~~i~ 255 (394)
T 4e7w_A 188 SAKILIAGEP---------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--L-VEII 255 (394)
T ss_dssp TCEECCTTCC---------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHH
T ss_pred CcccccCCCC---------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHH
Confidence 9987644321 2235789999999999764 589999999999999999999999987654321 1 1222
Q ss_pred HHHhhhhHH---hhhhcccCCcc--------CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhh
Q 005923 587 RVLEESNVR---EKLRGFIDPSL--------RNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIW 647 (669)
Q Consensus 587 ~~~~~~~~~---~~l~~~~d~~l--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~ 647 (669)
..+...... ..-..+.+..+ ...++...+..+.+|+.+||+.||.+|||+.|++++ ++++.
T Consensus 256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 222111100 00001111111 011222345678999999999999999999999975 44443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.42 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=192.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-----------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-----------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-----------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|.+.+. +|.|+| |.||++.. ++..+|+|+++. .+.+|++++++++||||+++++++.
T Consensus 5 ~~y~i~~~-lg~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 5 GKYLMGDL-LGEGSY-------GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp CCBCCCCE-EEECSS-------CEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeEeeE-EecCCC-------eEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 34565554 899999 99999998 477899999853 3668999999999999999999984
Q ss_pred --ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 425 --HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 425 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+.+..++||||+++| |.+++... ....+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+|
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEE
Confidence 445789999999876 88888764 2356999999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCC--CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI--TPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
|+|||+++....... ........||..|+|||.+.+... +.++||||||+++|||++|+.||.+....+.
T Consensus 150 l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-- 221 (305)
T 2wtk_C 150 ISALGVAEALHPFAA------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-- 221 (305)
T ss_dssp ECCCTTCEECCTTCS------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred eeccccccccCcccc------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--
Confidence 999999987643221 112334568999999999986543 7899999999999999999999986543211
Q ss_pred HHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... +.. . ....+..++..+.+++.+||+.||.+|||+.|++++
T Consensus 222 -~~~----i~~--------~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 222 -FEN----IGK--------G------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHH----HHH--------C------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHH----Hhc--------C------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000 0 012233445678999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.89 Aligned_cols=259 Identities=20% Similarity=0.245 Sum_probs=197.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhcC--------CCCceeEee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKIN--------HSNIIRLSG 421 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~--------H~niv~l~g 421 (669)
..|++.+. +|.|+| |.||++.. .++.||||+++. .+.+|++++++++ |+||+++++
T Consensus 37 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 37 GRYHVIRK-LGWGHF-------STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp TTEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred CeEEEEEE-eeecCC-------eeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34666554 899999 99999987 477899999964 3668999999985 788999999
Q ss_pred EEE----ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeec
Q 005923 422 FCV----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 422 ~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~ 496 (669)
++. .+...++||||+ +|+|.+++... ....+++..++.|+.||+.||+|||++ + |+||||||+|||++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~ 181 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence 998 456789999999 56777777654 224699999999999999999999998 8 99999999999998
Q ss_pred CCC-------------------------------------------------cEEEcccCCccccCCCccccCCccccee
Q 005923 497 TNL-------------------------------------------------RAKITNFGLARSAESDEHEQGGYGLQLT 527 (669)
Q Consensus 497 ~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~ 527 (669)
.++ .+||+|||+++..... .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----------~ 250 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----------F 250 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------S
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------C
Confidence 775 8999999999876432 1
Q ss_pred eecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH---HHHHHHHHHHHHhhhhHHh-----hhh
Q 005923 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE---AELLYASISRVLEESNVRE-----KLR 599 (669)
Q Consensus 528 ~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~-----~l~ 599 (669)
....||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+ .......+...+....... ...
T Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 23468999999999999999999999999999999999999998543221 1111122222221111000 000
Q ss_pred cccCCc-------------------cCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 600 GFIDPS-------------------LRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 600 ~~~d~~-------------------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.... -....+......+.+|+.+||+.||.+|||+.|++++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001000 0013456777889999999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.21 Aligned_cols=244 Identities=24% Similarity=0.397 Sum_probs=193.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
..|++.+. +|.|+| |.||+|... +..+|+|.++. ++.+|++++++++||||+++++++..++.
T Consensus 19 ~~y~i~~~-lg~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 19 EVWEIVGE-LGDGAF-------GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp GTEEEEEE-EECSTT-------CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred cceeecce-eccCCC-------eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 45665553 899999 999999985 78899999853 46789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred EEEEEEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999998753 245999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+....... .......||..|+|||.+. +..++.++||||||+++|||++|+.||........
T Consensus 164 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 230 (302)
T 2j7t_A 164 SAKNLKTL--------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----- 230 (302)
T ss_dssp HHHHHHHH--------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred Cccccccc--------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----
Confidence 86432211 1122356899999999984 67789999999999999999999999986543211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....... ..+ ....+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 231 -~~~~~~~----------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 231 -LLKIAKS----------DPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -HHHHHHS----------CCC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -HHHHhcc----------CCc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111100 001 112234455678999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.30 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=198.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE---CCCeeEEEEecc------cHHHHHHHHHhcCCCC------ceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF---KGDDAAVKVMKG------DVSSEINILKKINHSN------IIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~---~g~~vavK~~~~------~~~~E~~~l~~l~H~n------iv~l~g~~ 423 (669)
.|++.+. +|.|+| |.||++.. +++.||||+++. .+.+|++++++++|++ ++++++++
T Consensus 15 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 15 RYEIVDT-LGEGAF-------GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TEEEEEE-EEEETT-------EEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred ceEEEEE-EecCCC-------eEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 4555553 899999 99999987 477899999964 4678999999987654 99999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC------
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT------ 497 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~------ 497 (669)
..++..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEE
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccc
Confidence 9999999999999 889999998652 246899999999999999999999999 999999999999987
Q ss_pred -------------CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 005923 498 -------------NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564 (669)
Q Consensus 498 -------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ell 564 (669)
++.+||+|||+++..... .....||..|+|||.+.+..++.++||||||+++|||+
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred cCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH
Confidence 678999999999865432 12357899999999999999999999999999999999
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHHhhhhHH--h-----------------------hhhcccCCcc-CCCCcHHHHHHH
Q 005923 565 SGREAVTGDQNCEAELLYASISRVLEESNVR--E-----------------------KLRGFIDPSL-RNEYPLDLAFSM 618 (669)
Q Consensus 565 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-----------------------~l~~~~d~~l-~~~~~~~~~~~l 618 (669)
+|+.||.+....+... .+.......... . .+.....+.. ....+...+..+
T Consensus 229 ~g~~pf~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (339)
T 1z57_A 229 LGFTVFPTHDSKEHLA---MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305 (339)
T ss_dssp HSSCSCCCSCHHHHHH---HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred hCCCCCCCCChHHHHH---HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence 9999998765432211 111111110000 0 0000000000 012234566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 005923 619 AQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 619 ~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+|+.+||+.||.+|||+.|+++.
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhCcCcccccCHHHHhcC
Confidence 999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.53 Aligned_cols=241 Identities=27% Similarity=0.408 Sum_probs=192.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+| |.||++... +..+|+|+++. .+.+|+.++++++||||++++++|.+++
T Consensus 38 ~y~~~~-~lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 38 MYQRVK-KLGSGAY-------GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HEEEEE-EEECC----------EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CeEEee-EEecCCC-------EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 455555 4999999 999999984 77899999853 3678999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~ 504 (669)
..++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEE
Confidence 999999999999999998764 35899999999999999999999999 999999999999976 4559999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||.+....+. ...
T Consensus 182 DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~ 248 (494)
T 3lij_A 182 DFGLSAVFENQK---------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LRK 248 (494)
T ss_dssp CCTTCEECBTTB---------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH
T ss_pred ECCCCeECCCCc---------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 999998765432 123457999999999886 5699999999999999999999999987654211 111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+... ...+ ..+....++..+.+|+.+||+.||.+|||+.|++++
T Consensus 249 ---i~~~------~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 249 ---VEKG------KYTF-----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---HHHT------CCCC-----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---HHhC------CCCC-----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1000 0000 011112345678999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=339.61 Aligned_cols=241 Identities=29% Similarity=0.431 Sum_probs=197.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+. +|.|+| |.||++.. .|+.||||++.. .+.+|+.++++++||||+++++++.+.
T Consensus 27 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 27 RYKGQRV-LGKGSF-------GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK 98 (484)
T ss_dssp HEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ceEEeeE-EecCCC-------EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4555553 899999 99999998 488999999842 367899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee---cCCCcEEE
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL---DTNLRAKI 503 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl 503 (669)
+..++||||+.+|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred CEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999999999754 45999999999999999999999999 9999999999999 56789999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++...... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||.+....+.
T Consensus 171 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----- 235 (484)
T 3nyv_A 171 IDFGLSTHFEASK---------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI----- 235 (484)
T ss_dssp CCTTHHHHBCCCC---------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----
T ss_pred EeeeeeEEccccc---------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence 9999998765432 1233579999999999876 699999999999999999999999987653211
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+.. ... ....+....++..+.+|+.+||+.||.+|||+.|++++
T Consensus 236 -~~~i~~---------~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 236 -LKKVEK---------GKY--TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -HHHHHH---------CCC--CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHc---------CCC--CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111100 000 01111223455678999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.87 Aligned_cols=241 Identities=28% Similarity=0.412 Sum_probs=190.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------------cHHHHHHHHHhcCCCCceeEee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------------DVSSEINILKKINHSNIIRLSG 421 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g 421 (669)
.|.+.+ .+|.|+| |.||+|... ++.||||+++. .+.+|++++++++||||+++++
T Consensus 11 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 82 (322)
T 2ycf_A 11 EYIMSK-TLGSGAC-------GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 82 (322)
T ss_dssp HEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceeEee-EEecCCC-------EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence 355555 3899999 999999984 67899998742 3678999999999999999999
Q ss_pred EEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc-
Q 005923 422 FCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR- 500 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~- 500 (669)
++..+ ..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 83 ~~~~~-~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 83 FFDAE-DYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EEESS-SEEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred EEcCC-ceEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 98654 589999999999999999653 46999999999999999999999999 999999999999987654
Q ss_pred --EEEcccCCccccCCCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 501 --AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 501 --~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
+||+|||+++...... ......||..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCEEECCCTTCEECCCCH---------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred CeEEEccCccceeccccc---------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9999999998764321 123356899999999974 56789999999999999999999999975432
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
... ....+ .. .. . ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 225 ~~~--~~~~~----~~----~~----~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 225 QVS--LKDQI----TS----GK----Y--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSC--HHHHH----HH----TC----C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHH--HHHHH----Hh----Cc----c--ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 110 00000 00 00 0 0000111233467899999999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.12 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=187.5
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
...|++.+. +|.|+| |.||++.. .++.||||+++. .+.+|+.++++++||||+++++++..
T Consensus 24 ~~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 24 LKRYQNLKP-IGSGAQ-------GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 95 (371)
T ss_dssp ETTEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheeEeee-eEecCC-------EEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecc
Confidence 345666553 899999 99999987 478899999853 35689999999999999999999976
Q ss_pred cC------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 426 EG------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 426 ~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
.+ ..++||||++ |+|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~ 164 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164 (371)
T ss_dssp CCSTTTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTS
T ss_pred ccccccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCC
Confidence 54 6799999997 489998863 3899999999999999999999999 99999999999999999
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.+....+.
T Consensus 165 ~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~- 234 (371)
T 2xrw_A 165 TLKILDFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ- 234 (371)
T ss_dssp CEEECCCCC-------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred CEEEEEeeccccccccc---------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 99999999998654321 12345789999999999999999999999999999999999999987654221
Q ss_pred HHHHHHHHHHhhhh--HH----hhhhccc--CCcc----------------CCCCcHHHHHHHHHHHHHhcccCCCCCCC
Q 005923 580 LLYASISRVLEESN--VR----EKLRGFI--DPSL----------------RNEYPLDLAFSMAQLAKNCTAHDLNARPS 635 (669)
Q Consensus 580 ~~~~~~~~~~~~~~--~~----~~l~~~~--d~~l----------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 635 (669)
+..+...+.... .. ..+..++ .+.. ....+......+.+|+.+||+.||.+|||
T Consensus 235 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 312 (371)
T 2xrw_A 235 --WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312 (371)
T ss_dssp --HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred --HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence 111111000000 00 0000000 0000 00111234667999999999999999999
Q ss_pred HHHHHHH
Q 005923 636 ISEVFVT 642 (669)
Q Consensus 636 ~~evl~~ 642 (669)
++|++++
T Consensus 313 ~~e~l~h 319 (371)
T 2xrw_A 313 VDEALQH 319 (371)
T ss_dssp HHHHHHS
T ss_pred HHHHhCC
Confidence 9999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=313.26 Aligned_cols=258 Identities=22% Similarity=0.370 Sum_probs=197.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE---CCCeeEEEEecc---------cHHHHHHHHHhc---CCCCceeEeeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF---KGDDAAVKVMKG---------DVSSEINILKKI---NHSNIIRLSGF 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~---~g~~vavK~~~~---------~~~~E~~~l~~l---~H~niv~l~g~ 422 (669)
..|++.+ .+|.|+| |.||++.. +|+.||+|+++. .+.+|+.+++++ +||||++++++
T Consensus 11 ~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 11 QQYECVA-EIGEGAY-------GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GTEEEEE-EEEEETT-------EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred hceeeee-eeccccc-------EEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 3455555 3899999 99999997 367899998852 466888888877 89999999999
Q ss_pred EE-----ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 423 CV-----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 423 ~~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
+. .....++||||+. |+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~ 155 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS 155 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcC
Confidence 97 4567899999998 69999998652 345999999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
++.+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+....+
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226 (326)
T ss_dssp TCCEEECSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCCEEEecCcccccccCCC---------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999999999998764322 1233578999999999999999999999999999999999999998765422
Q ss_pred HHHHHHHHHHHHhhhhHHhhhh------cccC---CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 578 AELLYASISRVLEESNVREKLR------GFID---PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~------~~~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+...+........-. .... ...........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 227 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 227 ---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp ---HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111211111100000000 0000 000011223455678999999999999999999999853
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=336.72 Aligned_cols=241 Identities=28% Similarity=0.390 Sum_probs=193.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------------------cHHHHHHHHHhcCCCCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------------------DVSSEINILKKINHSNI 416 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------------------~~~~E~~~l~~l~H~ni 416 (669)
.|.+.+ ++|.|+| |.||++... +..+|+|+++. .+.+|+.+|++++||||
T Consensus 37 ~Y~~~~-~lG~G~~-------g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 108 (504)
T 3q5i_A 37 SYFKVR-KLGSGAY-------GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI 108 (504)
T ss_dssp TEEEEE-EEEC--C-------EEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTB
T ss_pred ceEEEe-EecccCC-------eEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCC
Confidence 455555 4999999 999999984 67899999852 25679999999999999
Q ss_pred eeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec
Q 005923 417 IRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 417 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~ 496 (669)
+++++++.+++..++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence 99999999999999999999999999999764 35999999999999999999999999 99999999999998
Q ss_pred CCC---cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 497 TNL---RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 497 ~~~---~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
.++ .+||+|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.+.
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDY---------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTS---------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCccEEEEECCCCEEcCCCC---------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 775 69999999998765432 123457999999999987 56899999999999999999999999876
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+. ... +... .. ..........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 251 ~~~~~---~~~---i~~~---------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 251 NDQDI---IKK---VEKG---------KY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp SHHHH---HHH---HHHC---------CC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHH---HHH---HHcC---------CC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 54211 111 1000 00 00000012234678999999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.20 Aligned_cols=268 Identities=24% Similarity=0.380 Sum_probs=182.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEe--cC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVH--EG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~--~~ 427 (669)
.|.+..-++|.|+| |.||+|... +..||||+++. .+.+|+.+|++++||||+++++++.. +.
T Consensus 21 ~y~~~g~~lG~G~~-------g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 21 LFEYEGCKVGRGTY-------GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HEECSSCCCC------------EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhcCcEeeecCC-------eEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 35555546999999 999999964 67899999864 47789999999999999999999965 56
Q ss_pred ceeEEEEecCCCCHHHHHhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee----cCCC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRY----QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL----DTNL 499 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl----~~~~ 499 (669)
..++||||+. |+|.+++...+. .....+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence 7899999997 589888864321 12235999999999999999999999999 9999999999999 7789
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
.+||+|||+++........ ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 244 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244 (405)
T ss_dssp CEEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred cEEEEECCCceecCCCCcc-----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccc
Confidence 9999999999876542211 122344678999999999987 4589999999999999999999999975443100
Q ss_pred ------HHHHHHHHHHHhhhhHH--hhh----------hcccCCccCC--------CCcHHHHHHHHHHHHHhcccCCCC
Q 005923 579 ------ELLYASISRVLEESNVR--EKL----------RGFIDPSLRN--------EYPLDLAFSMAQLAKNCTAHDLNA 632 (669)
Q Consensus 579 ------~~~~~~~~~~~~~~~~~--~~l----------~~~~d~~l~~--------~~~~~~~~~l~~li~~Cl~~dP~~ 632 (669)
......+...+...... ..+ ..+....... .........+.+|+.+||+.||.+
T Consensus 245 ~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~ 324 (405)
T 3rgf_A 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324 (405)
T ss_dssp --CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGG
T ss_pred ccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCccc
Confidence 01111222221110000 000 0000000000 000011346789999999999999
Q ss_pred CCCHHHHHHH
Q 005923 633 RPSISEVFVT 642 (669)
Q Consensus 633 RPt~~evl~~ 642 (669)
|||++|++++
T Consensus 325 R~ta~e~L~h 334 (405)
T 3rgf_A 325 RITSEQAMQD 334 (405)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=319.44 Aligned_cols=268 Identities=20% Similarity=0.291 Sum_probs=190.1
Q ss_pred ccccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 355 ESLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 355 ~~~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..+..|++.+ .+|.|+| |.||+|... |..||||++.. ...+|++.+.+++||||+++++++...
T Consensus 20 ~~~~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 20 KEMDRFQVER-MAGQGTF-------GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHTTEEEC------------------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhccceEEEE-EEecCCC-------eEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 3445677766 4999999 999999984 78999998853 356778888889999999999999765
Q ss_pred Cc-------eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeeCCCCCCeeecC
Q 005923 427 GN-------TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH--KYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 427 ~~-------~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~ivHrDik~~NILl~~ 497 (669)
+. .++||||+++ +|.+.+.... .....+++..+..++.|++.||.||| +.+ |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 44 7899999986 6655554321 23356899999999999999999999 888 999999999999997
Q ss_pred -CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 498 -NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 498 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
++.+||+|||+++....... .....||..|+|||.+.+.. ++.++||||||+++|||++|+.||.+...
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEP---------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSC---------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcEEEeeCCCceecCCCCC---------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 89999999999987654321 22356899999999987654 89999999999999999999999987654
Q ss_pred hHHHHHHHHHHHHHhhhhHHhhhhcccCC---------------ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005923 576 CEAELLYASISRVLEESNVREKLRGFIDP---------------SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640 (669)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~---------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 640 (669)
.+. ...+...+.... .+.+..+... ......+......+.+|+.+||+.||.+|||+.|++
T Consensus 238 ~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 238 AGQ---LHEIVRVLGCPS-REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp HHH---HHHHHHHHCCCC-HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHH---HHHHHHHcCCCC-HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 321 122222111110 0111110000 000112223567899999999999999999999999
Q ss_pred HH--HHHhhc
Q 005923 641 VT--LSKIWS 648 (669)
Q Consensus 641 ~~--L~~i~~ 648 (669)
++ ++++..
T Consensus 314 ~hp~f~~~~~ 323 (360)
T 3e3p_A 314 CHPYFDELHD 323 (360)
T ss_dssp TSGGGGGGGC
T ss_pred cCccccccCC
Confidence 75 555543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=314.79 Aligned_cols=243 Identities=27% Similarity=0.413 Sum_probs=190.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc---------cHHHHHHHHHhcC--CCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG---------DVSSEINILKKIN--HSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~---------~~~~E~~~l~~l~--H~niv~l~g~~~~ 425 (669)
..|++.+. +|.|+| |.||++... ++.||||+++. .+.+|++++++++ |+||+++++++..
T Consensus 28 ~~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 28 RIYSILKQ-IGSGGS-------SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEEEEEE-EECCSS-------EEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred ceEEEEEE-ecCCCC-------EEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34666553 999999 999999884 77899999842 3678999999997 5999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||| +.+++|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+|||+++ +.+||+|
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 999999999 5678999999864 35899999999999999999999999 999999999999964 8999999
Q ss_pred cCCccccCCCccccCCcccceeeeccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-----------GVITPKLDVFAFGVVVLELLSGREAVTGDQ 574 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDV~S~Gvvl~elltg~~p~~~~~ 574 (669)
||+++....... ........||..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 170 fg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 170 FGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp CSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccCccc------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 999987654321 112234578999999999875 578999999999999999999999997543
Q ss_pred hhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... .+..++++......+...+..+.+++.+||+.||.+||++.|+++.
T Consensus 244 ~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 244 NQIS------------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SHHH------------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH------------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2110 1111222233333444445678999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.76 Aligned_cols=243 Identities=14% Similarity=0.060 Sum_probs=175.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHHHHHHHHhc--CCCCceeEe-----
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSSEINILKKI--NHSNIIRLS----- 420 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l--~H~niv~l~----- 420 (669)
|++.+ .+|.|+| |.||+|.. +|+.||||+++.. +.+|+.+++.+ +||||++++
T Consensus 64 y~~~~-~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 64 LKLVE-PLRVGDR-------SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred eeeee-eccCCCC-------EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 55555 3999999 99999997 4788999998642 45675544444 699988755
Q ss_pred --eEEEec-----------------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHH
Q 005923 421 --GFCVHE-----------------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQR------VQIAYDVANALNYL 475 (669)
Q Consensus 421 --g~~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~qia~~L~yL 475 (669)
+++... ...++||||++ |+|.+++.... ..+.+..+ +.++.||+.||+||
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 444433 33799999999 89999998642 23455566 78889999999999
Q ss_pred HhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc--CCCCchhhH
Q 005923 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDV 553 (669)
Q Consensus 476 H~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV 553 (669)
|+++ |+||||||+|||++.++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++||
T Consensus 211 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~Di 276 (371)
T 3q60_A 211 QSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----------GPASSVPVTYAPREFLNASTATFTHALNA 276 (371)
T ss_dssp HHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----------EEGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred HHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----------ccCccCCcCCcChhhccCCCCCcCccccH
Confidence 9999 999999999999999999999999999865432 113467799999999987 789999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCC
Q 005923 554 FAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633 (669)
Q Consensus 554 ~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 633 (669)
|||||++|||++|+.||.+....... ..............+.......++..+.+|+.+||+.||.+|
T Consensus 277 wSlG~il~elltg~~Pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 344 (371)
T 3q60_A 277 WQLGLSIYRVWCLFLPFGLVTPGIKG------------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRR 344 (371)
T ss_dssp HHHHHHHHHHHHSSCSTTBCCTTCTT------------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTC
T ss_pred HHHHHHHHHHHhCCCCCCCcCccccc------------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhC
Confidence 99999999999999999865321100 000000011111122222223556789999999999999999
Q ss_pred CCHHHHHH
Q 005923 634 PSISEVFV 641 (669)
Q Consensus 634 Pt~~evl~ 641 (669)
||+.|+++
T Consensus 345 pt~~e~l~ 352 (371)
T 3q60_A 345 LLPLEAME 352 (371)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.36 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=187.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEec------------------ccHHHHHHHHHhcCCCCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMK------------------GDVSSEINILKKINHSNIIRL 419 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~------------------~~~~~E~~~l~~l~H~niv~l 419 (669)
.|.+.+. +|.|+| |.||+|.. +|..||||++. ..+.+|++++++++||||+++
T Consensus 23 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 23 PYTVQRF-ISSGSY-------GAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp SCEEEEE-EEEETT-------EEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred ceEEeEE-eccCCC-------EEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 4555553 888999 99999987 57889999884 246789999999999999999
Q ss_pred eeEEEecC-----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCee
Q 005923 420 SGFCVHEG-----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNIL 494 (669)
Q Consensus 420 ~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NIL 494 (669)
++++...+ ..++||||++ |+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99986532 5799999998 6999998754 246999999999999999999999999 999999999999
Q ss_pred ecCCCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 495 LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 495 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
++.++.+||+|||+++...... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp ECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EcCCCCEEEEecCccccccccc---------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999998544322 1234578999999999987 77999999999999999999999999876
Q ss_pred chhHHHHHHHHHHHHHhhhhH-----------HhhhhcccCCccC---CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005923 574 QNCEAELLYASISRVLEESNV-----------REKLRGFIDPSLR---NEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~-----------~~~l~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 639 (669)
...+. ...+......... ...+......... ...+......+.+|+.+||+.||.+|||+.|+
T Consensus 238 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 314 (362)
T 3pg1_A 238 TFYNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314 (362)
T ss_dssp SHHHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHH---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 53221 1122111111110 1111111110000 01112334568999999999999999999999
Q ss_pred HHH
Q 005923 640 FVT 642 (669)
Q Consensus 640 l~~ 642 (669)
+++
T Consensus 315 l~h 317 (362)
T 3pg1_A 315 LRH 317 (362)
T ss_dssp HTS
T ss_pred HcC
Confidence 875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.99 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=196.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec--
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE-- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~-- 426 (669)
.|++.+. +|.|+| |.||++.. ++..||||+++. .+.+|++++++++||||+++++++...
T Consensus 28 ~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 28 RYTNLSY-IGEGAY-------GMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEEEEEE-eecCCC-------eEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 5666554 999999 99999987 477899999862 467899999999999999999999754
Q ss_pred ---CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 427 ---GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 427 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
...++||||+. |+|.+++... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cccceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEE
Confidence 36799999997 5999999754 4999999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
+|||+++........ ........||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+..
T Consensus 170 ~Dfg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--- 241 (364)
T 3qyz_A 170 CDFGLARVADPDHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--- 241 (364)
T ss_dssp CCCTTCEECCGGGCB-----CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---
T ss_pred EeCcceEecCCCCCc-----cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---
Confidence 999999876543211 111234579999999998765 45899999999999999999999999876543211
Q ss_pred HHHHHHHhhhhHH-----------hhhhcccCCccC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 583 ASISRVLEESNVR-----------EKLRGFIDPSLR--NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~~~~-----------~~l~~~~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+...+...... .....+..+... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 242 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 242 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1222211111100 001111110000 00012234568999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.99 Aligned_cols=245 Identities=23% Similarity=0.363 Sum_probs=173.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc--------HHHHHH-HHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------VSSEIN-ILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~--------~~~E~~-~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+. +|.|+| |.||++... |+.||||+++.. +..|+. +++.++||||+++++++..++
T Consensus 23 ~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 23 DLKDLGE-IGRGAY-------GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp SEEC-CE-EEECSS-------EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred Hhhehhe-eccCCC-------EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 4554443 899999 999999985 889999998642 334555 677789999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
..++||||+++ +|.+++..........+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999985 888887642112235699999999999999999999998 8 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeeccccccccccccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI----ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
|+++....... .....||..|+|||.+ .+..++.++||||||+++|||++|+.||.+.....
T Consensus 171 g~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----- 236 (327)
T 3aln_A 171 GISGQLVDSIA---------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----- 236 (327)
T ss_dssp SSSCC---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------
T ss_pred CCceecccccc---------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----
Confidence 99987643221 1224689999999999 56778999999999999999999999997533210
Q ss_pred HHHHHHHhhhhHHhhhhcccC---CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 583 ASISRVLEESNVREKLRGFID---PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.+...+. +.+.......++..+.+++.+||+.||.+|||+.|+++.
T Consensus 237 -------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 237 -------------DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ----------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -------------HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 01111111 112222223455678999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.26 Aligned_cols=249 Identities=21% Similarity=0.380 Sum_probs=186.0
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEe------
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVH------ 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~------ 425 (669)
|++.+ .+|.|+| |.||+|.. +++.||||.++. .+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 8 FEEIA-VLGQGAF-------GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred chhhh-eeccCCc-------EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 44444 3899999 99999997 588999999863 36789999999999999999999865
Q ss_pred -------cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 426 -------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 426 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence 456799999999999999998642 35889999999999999999999999 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccC------CcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCC
Q 005923 499 LRAKITNFGLARSAESDEHEQG------GYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVT 571 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~ 571 (669)
+.+||+|||+++.......... ...........||..|+|||.+.+. .++.++||||||+++|||++ |+.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 9999999999987643211000 0001122345789999999999864 78999999999999999998 443
Q ss_pred CCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.... ... .. ..+.. ....+....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~--~~~---~~----------~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 230 TGME--RVN---IL----------KKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp SHHH--HHH---HH----------HHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cchh--HHH---HH----------Hhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 2111 000 00 01111 11122233444556678999999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=323.08 Aligned_cols=271 Identities=24% Similarity=0.317 Sum_probs=192.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.+. +|.|+| |.||+|... ++.||||+++. .+.+|+++|++++||||+++++++...
T Consensus 26 ~~y~~~~~-lG~G~~-------g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 26 DNYIIKHL-IGRGSY-------GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp TTEEEEEE-EEEETT-------EEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCEEEEEE-EeecCC-------EEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 45666664 999999 999999884 67899999863 366899999999999999999999766
Q ss_pred -----CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 427 -----GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 427 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
...|+||||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCE
Confidence 56899999987 5999999754 45999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCC--------------cccceeeeccccccccccccc-ccCCCCchhhHHHHHHHHHHHHcC
Q 005923 502 KITNFGLARSAESDEHEQGG--------------YGLQLTRHVVGTYGYMAPEYI-ENGVITPKLDVFAFGVVVLELLSG 566 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~l-~~~~~s~~sDV~S~Gvvl~elltg 566 (669)
||+|||+++........... ..........||..|+|||.+ ....++.++|||||||++|||++|
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999976543211000 000123456899999999986 566799999999999999999985
Q ss_pred CCCCC-----------CCchh--------------HHHHHHHHHHHHHhhhhH-----------HhhhhcccCCccCCC-
Q 005923 567 REAVT-----------GDQNC--------------EAELLYASISRVLEESNV-----------REKLRGFIDPSLRNE- 609 (669)
Q Consensus 567 ~~p~~-----------~~~~~--------------~~~~~~~~~~~~~~~~~~-----------~~~l~~~~d~~l~~~- 609 (669)
..|+. +.... ........+...+..... ...+..+ .......
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 327 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF-PHRKPINL 327 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS-CCCCCCCH
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC-CCCCCCCH
Confidence 44332 22100 001111222222221111 0111110 0000000
Q ss_pred --CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 610 --YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 610 --~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
.....+..+.+|+.+||+.||.+|||++|++++ |+.+
T Consensus 328 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 328 KQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 001245678999999999999999999999875 4444
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.76 Aligned_cols=241 Identities=26% Similarity=0.420 Sum_probs=194.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+. +|.|+| |.||++.. +++.||+|+++. .+.+|++++++++||||+++++++.+.+
T Consensus 23 ~y~i~~~-lg~G~~-------g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 23 RYNIVCM-LGKGSF-------GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cceeeEE-EcCCCC-------EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 4555553 899999 99999998 478999999843 3678999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC---CcEEEc
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN---LRAKIT 504 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~ 504 (669)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.+ +.+||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence 999999999999999998764 35899999999999999999999999 9999999999999754 479999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+++....... .....++..|+|||.+.+ .++.++||||||+++|||++|+.||.+....+ .
T Consensus 167 Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~---- 230 (287)
T 2wei_A 167 DFGLSTCFQQNTK---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--I---- 230 (287)
T ss_dssp STTGGGTBCCCSS---------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----
T ss_pred ccCcceeecCCCc---------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--H----
Confidence 9999987644321 123468899999999875 48999999999999999999999998754321 1
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+.. .... ...+....++..+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ~~~~~~---------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 231 LKRVET---------GKYA--FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHH---------CCCC--CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHc---------CCCC--CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000100 0000 0011112345678999999999999999999999973
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.77 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=178.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+. +|.|+| |.||+|.. .|+.||||+++. .+.+|+++|++++||||+++++++...
T Consensus 29 ~~y~~~~~-lG~G~~-------g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 29 ERYQNLSP-VGSGAY-------GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp TTEEEEEE-CC-----------CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CceEEeeE-EeecCC-------eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 45666553 899999 99999987 478999999853 356899999999999999999998754
Q ss_pred ------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 ------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
...++|+|++ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCC
Confidence 4579999999 6899998864 35999999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
+||+|||+++..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+
T Consensus 171 ~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-- 237 (367)
T 2fst_X 171 LKILDFGLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-- 237 (367)
T ss_dssp EEECC--------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EEEeecccccccccc-----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 999999999865432 123578999999999987 778999999999999999999999998765422
Q ss_pred HHHHHHHHHHhhhhH-----------HhhhhcccCCccCCCC---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNV-----------REKLRGFIDPSLRNEY---PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~-----------~~~l~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+...+..... ...++.+... -.... .......+.+|+.+||+.||.+|||+.|++++
T Consensus 238 -~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 238 -QLKLILRLVGTPGAELLKKISSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp -HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCC-CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCC-CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 12222222211110 0111111000 00000 01234568999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=313.42 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=186.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEE-----
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCV----- 424 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~----- 424 (669)
.|++.+ .+|.|+| |.||+|... ++.||+|+++. .+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 12 RYMDLK-PLGCGGN-------GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp TEEEEE-ECC------------CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred ceeEEE-EeccCCC-------eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 355444 3899999 999999985 78899998852 4678999999999999999999874
Q ss_pred ---------ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee
Q 005923 425 ---------HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL 495 (669)
Q Consensus 425 ---------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl 495 (669)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++ ++||||||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 153 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFI 153 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEE
Confidence 3457799999998 699999964 35899999999999999999999999 9999999999999
Q ss_pred c-CCCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 496 D-TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 496 ~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
+ +++.+||+|||+++........ ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 154 NTEDLVLKIGDFGLARIMDPHYSH-----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp ETTTTEEEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCeEEEccCccccccCCCccc-----ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 7 5679999999999876432211 111233567899999998875 77899999999999999999999999876
Q ss_pred chhHHHHHHHHHHHHHhh--hhHHhhhhccc---------CCccC-CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 574 QNCEAELLYASISRVLEE--SNVREKLRGFI---------DPSLR-NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~---------d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
...+.. ..+...... ......+...+ .+... ......++..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 229 HELEQM---QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SHHHHH---HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CHHHHH---HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 542211 111111000 00000000000 00000 0011234567899999999999999999999987
Q ss_pred H
Q 005923 642 T 642 (669)
Q Consensus 642 ~ 642 (669)
.
T Consensus 306 h 306 (320)
T 2i6l_A 306 H 306 (320)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.54 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=181.8
Q ss_pred HHHhCCCCcccceeeEEE-EEEECCCeeEEEEeccc----HHHHHHHHHhc-CCCCceeEeeEEEecCceeEEEEecCCC
Q 005923 366 KIATGSFSEENRIQGSVY-RGSFKGDDAAVKVMKGD----VSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNG 439 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy-~g~~~g~~vavK~~~~~----~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g 439 (669)
.+|.|+| |+|| .+..+|+.||||++..+ +.+|+.+|+++ +||||+++++++.+++..++||||+. |
T Consensus 22 ~LG~G~~-------g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 22 ILGYGSS-------GTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEECST-------TCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eEeeCCC-------eEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 4899999 9885 55668999999998654 56799999986 89999999999999999999999996 6
Q ss_pred CHHHHHhcCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC-------------CcEEEc
Q 005923 440 ALSDWLHSNRYQTS--DNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-------------LRAKIT 504 (669)
Q Consensus 440 sL~~~l~~~~~~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~-------------~~~kl~ 504 (669)
+|.+++........ ...++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 99999986531111 11234456789999999999999999 9999999999999654 589999
Q ss_pred ccCCccccCCCccccCCcccceeeeccccccccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCchh
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-------GVITPKLDVFAFGVVVLELLS-GREAVTGDQNC 576 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~ 576 (669)
|||+++......... ........||..|+|||++.+ ..++.++|||||||++|||++ |+.||.+....
T Consensus 171 DFG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 171 DFGLCKKLDSGQSSF----RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp CCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred ccccceecCCCCccc----eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999775432110 011234579999999999976 678999999999999999999 89998754322
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccC-CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 577 EAELLYASISRVLEESNVREKLRGFID-PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d-~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+.. . +....+ +......+..++.++.+++.+||+.||.+|||+.||++
T Consensus 247 ~~~--------i---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ESN--------I---------IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH--------H---------HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH--------H---------hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 110 0 111111 11122234567788999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=316.77 Aligned_cols=248 Identities=18% Similarity=0.299 Sum_probs=171.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEeccc--HHHHHH-HHHhcCCCCceeEeeEEEe----cCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--VSSEIN-ILKKINHSNIIRLSGFCVH----EGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~~--~~~E~~-~l~~l~H~niv~l~g~~~~----~~~~ 429 (669)
.|.+.+-.+|.|+| |.||++... |+.||||+++.. ..+|+. .++.++||||+++++++.. +...
T Consensus 29 ~y~i~~~~lG~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 29 DYQLSKQVLGLGVN-------GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp TEEEEEEEEEEETT-------EEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred eeEecceeeeeCCC-------eEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45553323899999 999999985 889999999654 333433 4566799999999999976 4458
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEccc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNF 506 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~Df 506 (669)
++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 9999999999999999864 2346999999999999999999999999 999999999999976 456999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||.+........ ...
T Consensus 176 g~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~ 242 (336)
T 3fhr_A 176 GFAKETTQNA----------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMK 242 (336)
T ss_dssp TTCEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred ccceeccccc----------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHH
Confidence 9998654321 233567999999999999999999999999999999999999997543211000 000
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..+. .....+.......++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 243 ---------~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 243 ---------RRIR-LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---------Hhhh-ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 000011111123455678999999999999999999999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.09 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=194.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec--
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE-- 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~-- 426 (669)
.|.+.+. +|.|+| |.||+|... |+.||||+++. .+.+|++++++++||||+++++++..+
T Consensus 12 ~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 12 DFQLKSL-LGEGAY-------GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp TEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ceEEeeE-EcCCCC-------eEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 4555553 899999 999999985 78899999852 356899999999999999999998754
Q ss_pred ---CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 427 ---GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 427 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
...++||||+. |+|.+++... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred CccceEEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEE
Confidence 57899999997 6999999753 4899999999999999999999999 999999999999999999999
Q ss_pred cccCCccccCCCccccCCc--ccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 504 TNFGLARSAESDEHEQGGY--GLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+|||+++............ .........||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+.
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 231 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-- 231 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Confidence 9999998765432111000 0011223578999999998765 7789999999999999999999999987653221
Q ss_pred HHHHHHHHHhhhh------------HHhhhhcccC---CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 581 LYASISRVLEESN------------VREKLRGFID---PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 581 ~~~~~~~~~~~~~------------~~~~l~~~~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+........ ..+.+..+.. ..+ ......++..+.+|+.+||+.||.+|||+.|++++
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 232 -LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp -HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111111110 0011111100 000 00112345678999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.05 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=191.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.+. +|.|+| |.||+|.. .|+.||||+++. .+.+|+.++++++||||+++++++...
T Consensus 42 ~~y~~~~~-lG~G~~-------g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 42 KTYVSPTH-VGSGAY-------GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TTEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ccEEEEeE-EecCCC-------eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 45665553 999999 99999987 478999999863 366899999999999999999999877
Q ss_pred Cce------eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 GNT------YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ~~~------~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
+.. ++||||+. |+|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred CCcccceeEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCC
Confidence 654 99999998 689888743 3999999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
+||+|||+++..... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+.
T Consensus 183 ~kL~Dfg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~- 250 (371)
T 4exu_A 183 LKILDFGLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ- 250 (371)
T ss_dssp EEECSTTCC-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EEEEecCcccccccC-----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 999999999865432 223568999999999987 7899999999999999999999999987653221
Q ss_pred HHHHHHHHHHhhhh-----------HHhhhhcccCCccCC---CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESN-----------VREKLRGFIDPSLRN---EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~-----------~~~~l~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+........ .......+.. .... .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 251 --LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp --HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCC-CcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 111111111100 0001111111 0000 0112335678999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.84 Aligned_cols=259 Identities=19% Similarity=0.319 Sum_probs=195.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------cHHHHHHHHHhcC-----------CCCcee
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------DVSSEINILKKIN-----------HSNIIR 418 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~-----------H~niv~ 418 (669)
..|.+.+. +|.|+| |.||+|.. +++.||||+++. .+.+|++++++++ |+||++
T Consensus 19 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 19 ARYILVRK-LGWGHF-------STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CeEEEEEe-eeecCC-------eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 34666553 999999 99999997 578999999864 3668999999886 899999
Q ss_pred EeeEEEecC----ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCe
Q 005923 419 LSGFCVHEG----NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNI 493 (669)
Q Consensus 419 l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NI 493 (669)
+++++...+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+||
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI 163 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 163 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence 999998655 789999999 889999998642 34599999999999999999999998 8 99999999999
Q ss_pred eec------CCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCC
Q 005923 494 LLD------TNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR 567 (669)
Q Consensus 494 Ll~------~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~ 567 (669)
|++ ..+.+||+|||+++...... ....||..|+|||.+.+..++.++||||||+++|||++|+
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEeccCCCcCcceEEEcccccccccCCCC-----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 994 44589999999998764321 2346899999999999999999999999999999999999
Q ss_pred CCCCCCchhHH---HHHHHHHHHHHhhhhHH-----hhhhcccCC-------------------ccCCCCcHHHHHHHHH
Q 005923 568 EAVTGDQNCEA---ELLYASISRVLEESNVR-----EKLRGFIDP-------------------SLRNEYPLDLAFSMAQ 620 (669)
Q Consensus 568 ~p~~~~~~~~~---~~~~~~~~~~~~~~~~~-----~~l~~~~d~-------------------~l~~~~~~~~~~~l~~ 620 (669)
.||.+...... ......+...+...... ...+.+++. ......+...+..+.+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence 99985432110 11111111111110000 000000000 0012355678889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 005923 621 LAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 621 li~~Cl~~dP~~RPt~~evl~~ 642 (669)
|+.+||+.||.+|||+.|++++
T Consensus 313 li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHhccCccccCCHHHHhhC
Confidence 9999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=315.21 Aligned_cols=231 Identities=24% Similarity=0.389 Sum_probs=192.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------------cHHHHHHHHHhcC--CCCceeEee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------------DVSSEINILKKIN--HSNIIRLSG 421 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~--H~niv~l~g 421 (669)
.|++.+. +|.|+| |.||+|.. +++.||||.++. .+.+|+.++++++ |+||+++++
T Consensus 44 ~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 44 QYQVGPL-LGSGGF-------GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp TEEEEEE-CSSSSS-------CEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred ceEEEEE-EeeCCC-------eEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 4666554 999999 99999987 578899999853 3557999999996 599999999
Q ss_pred EEEecCceeEEEEecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-CCC
Q 005923 422 FCVHEGNTYLVYEFADN-GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-TNL 499 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~-~~~ 499 (669)
++..++..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 99999999999999986 8999999764 35899999999999999999999999 99999999999999 789
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
.+||+|||+++...... .....||..|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 188 ~~kL~Dfg~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 254 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254 (320)
T ss_dssp EEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---
T ss_pred CEEEeeCcccccccccc----------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---
Confidence 99999999998765322 123468999999999987776 6889999999999999999999965211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
. .... ...+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 255 ---------~---------~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 ---------I---------IRGQ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------H---------HHCC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------h---------hccc------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 01122334578999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.28 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=184.1
Q ss_pred ccchhHHHHHhCCCCcccceeeE-EEEEEECCCeeEEEEecc----cHHHHHHHHHhc-CCCCceeEeeEEEecCceeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGS-VYRGSFKGDDAAVKVMKG----DVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~-Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 432 (669)
.|...++ +|.|+| |+ ||++..+++.||||++.. .+.+|+++|+++ +||||+++++++.+++..++|
T Consensus 25 ~y~~~~~-LG~G~~-------G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 25 SFCPKDV-LGHGAE-------GTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEE-EEECGG-------GCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEecCCe-eecCcC-------EEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3555554 999999 87 677778899999999864 367899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-----CCcEEEcccC
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-----NLRAKITNFG 507 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-----~~~~kl~DfG 507 (669)
|||+. |+|.+++.... ..+.+..++.++.||+.||+|||+++ |+||||||+|||++. ...+||+|||
T Consensus 97 ~E~~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EECCS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EECCC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 99996 69999998653 23445566789999999999999999 999999999999943 3468899999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccc---cCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
+++........ ........||..|+|||.+. ...++.++|||||||++|||++ |..||..........
T Consensus 169 ~a~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--- 240 (432)
T 3p23_A 169 LCKKLAVGRHS-----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--- 240 (432)
T ss_dssp EEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---
T ss_pred ceeeccCCCcc-----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---
Confidence 99876543211 11233467999999999997 4677889999999999999999 888886433211000
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+....... ...+......+.+|+.+||+.||.+|||+.||++
T Consensus 241 -------------~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 -------------LLGACSLDC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------------HTTCCCCTT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------------HhccCCccc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000011 1112344566889999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.92 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=195.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--C-CeeEEEEecc------cHHHHHHHHHhcCCCC------ceeEeeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--G-DDAAVKVMKG------DVSSEINILKKINHSN------IIRLSGF 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g-~~vavK~~~~------~~~~E~~~l~~l~H~n------iv~l~g~ 422 (669)
..|++.+. +|.|+| |.||++... + ..||+|+++. .+.+|+.++++++|++ ++.++++
T Consensus 19 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 19 ERYEIVGN-LGEGTF-------GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTEEEEEE-EEEETT-------EEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ccEEEEEE-eeccCC-------eEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 35666554 899999 999999973 3 5799999864 3667999999997765 9999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeee-------
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILL------- 495 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl------- 495 (669)
+...+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEE
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccc
Confidence 99999999999999 668888887642 246999999999999999999999999 9999999999999
Q ss_pred ------------cCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHH
Q 005923 496 ------------DTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLEL 563 (669)
Q Consensus 496 ------------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~el 563 (669)
+.++.+||+|||+++..... .....||..|+|||.+.+..++.++||||||+++|||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence 56889999999999864332 1235789999999999999999999999999999999
Q ss_pred HcCCCCCCCCchhHHHHHHHHHHHHHhhhhHH--h-----------------------hhhcccCCc-cCCCCcHHHHHH
Q 005923 564 LSGREAVTGDQNCEAELLYASISRVLEESNVR--E-----------------------KLRGFIDPS-LRNEYPLDLAFS 617 (669)
Q Consensus 564 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-----------------------~l~~~~d~~-l~~~~~~~~~~~ 617 (669)
++|+.||.+....+.. ..+.......... . .+.....+. ............
T Consensus 233 ~~g~~pf~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 233 YRGFTLFQTHENREHL---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HhCCCCCCCCCHHHHH---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 9999999876543221 1111111110000 0 000000000 001112344567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 618 MAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 618 l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.+|+.+||+.||.+|||+.|++++
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcC
Confidence 8999999999999999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=311.60 Aligned_cols=231 Identities=25% Similarity=0.414 Sum_probs=187.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------------cHHHHHHHHHhc----CCCCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------------DVSSEINILKKI----NHSNIIRL 419 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l----~H~niv~l 419 (669)
.|++.+. +|.|+| |.||+|.. +++.||||+++. .+.+|+.++.++ +|+||+++
T Consensus 32 ~y~~~~~-lg~G~~-------g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 32 EYRLGPL-LGKGGF-------GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp -CEEEEE-EEEETT-------EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred ceEEeeE-EEcCCC-------EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 4666553 899999 99999987 578899999843 245699999999 89999999
Q ss_pred eeEEEecCceeEEEEe-cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-C
Q 005923 420 SGFCVHEGNTYLVYEF-ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-T 497 (669)
Q Consensus 420 ~g~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~-~ 497 (669)
++++..++..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+|||++ +
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR 175 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence 9999999999999999 7899999999764 35899999999999999999999999 99999999999999 8
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVIT-PKLDVFAFGVVVLELLSGREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDV~S~Gvvl~elltg~~p~~~~~~~ 576 (669)
++.+||+|||+++...... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.....
T Consensus 176 ~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~- 244 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP----------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE- 244 (312)
T ss_dssp TTEEEECCCSSCEECCSSC----------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-
T ss_pred CCeEEEEEcchhhhcccCc----------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-
Confidence 8999999999998765432 1234689999999999877764 589999999999999999999964210
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 577 EAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
... . ....+..+...+.+++.+||+.||.+|||+.|+++.
T Consensus 245 -----------~~~---------~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -----------ILE---------A------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----------HHH---------T------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----------Hhh---------h------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 012233445678999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=314.20 Aligned_cols=192 Identities=24% Similarity=0.400 Sum_probs=163.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcC-CC-----CceeEeeEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKIN-HS-----NIIRLSGFC 423 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~-H~-----niv~l~g~~ 423 (669)
..|++.+. +|.|+| |.||+|... ++.||||+++. ++..|+.+++.++ |+ +|+++++++
T Consensus 54 ~~y~~~~~-lG~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 54 DRYEIDSL-IGKGSF-------GQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTEEEEEE-EEEETT-------EEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeEEEEEE-EeecCC-------EEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 45666554 999999 999999874 77899999964 3456888888885 54 499999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeeCCCCCCeeec--CCC
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK--YTNPPYVHKNLKTSNILLD--TNL 499 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~--~~~~~ivHrDik~~NILl~--~~~ 499 (669)
..++..++||||+. |+|.+++.... ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCC
Confidence 99999999999996 59999998652 2459999999999999999999995 45 99999999999994 478
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCch
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~ 575 (669)
.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 199 ~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CEEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cEEEEeccCceecccc-----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8999999999876432 1235789999999999999999999999999999999999999987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.38 Aligned_cols=251 Identities=22% Similarity=0.371 Sum_probs=191.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|.+.+. +|.|+| |.||+|.. .|+.||||+++. .+.+|+.++++++||||+++++++...
T Consensus 24 ~~y~~~~~-lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 24 KTYVSPTH-VGSGAY-------GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp TTEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ceEEEeee-EecCCC-------eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 34665553 899999 99999987 488999999853 356899999999999999999999876
Q ss_pred Cc------eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 GN------TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ~~------~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
+. .++||||+. |+|.+++.. .+++..+..++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCC
T ss_pred cccccceeEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCc
Confidence 54 499999997 588887742 3899999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
+||+|||+++..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+
T Consensus 165 ~kl~Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 231 (353)
T 3coi_A 165 LKILDFGLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-- 231 (353)
T ss_dssp EEECSTTCTTC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--
T ss_pred EEEeecccccCCCCC-----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 999999999865332 123468999999999887 778999999999999999999999998755322
Q ss_pred HHHHHHHHHHhhhh-----------HHhhhhcc---cCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESN-----------VREKLRGF---IDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~-----------~~~~l~~~---~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+........ ....+..+ ..+.+ .......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 232 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 232 -QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp -HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111211111100 00001111 01111 11223456678999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.25 Aligned_cols=244 Identities=22% Similarity=0.368 Sum_probs=174.1
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc---------HHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD---------VSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
+..|++.+ .+|.|+| |.||++.. +|+.||||+++.. +..+..+++.++||||+++++++.+
T Consensus 24 ~~~y~~~~-~lg~G~~-------g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 24 INDLENLG-EMGSGTC-------GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp GGGEEEEE-EC-------------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hccccccc-eeeecCC-------eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 34555555 3899999 99999998 4889999998632 2234456778899999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-TNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++..++||||+ ++.+..++... ...+++..++.++.|++.||+|||+. + ++||||||+|||++.++.+||+
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~ 167 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLC 167 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEEC
T ss_pred CCcEEEEEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEE
Confidence 99999999999 45555555432 24689999999999999999999995 8 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
|||+++...... ......||..|+|||.+. ...++.++||||||+++|||++|+.||....... .
T Consensus 168 dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~ 237 (318)
T 2dyl_A 168 DFGISGRLVDDK---------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-E 237 (318)
T ss_dssp CCTTC-----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-H
T ss_pred ECCCchhccCCc---------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-H
Confidence 999998664322 122346899999999994 5678999999999999999999999998643211 1
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+...... ..+.+ .....++..+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ----~~~~~~~~----------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 238 ----VLTKVLQE----------EPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----HHHHHHHS----------CCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----HHHHHhcc----------CCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 00111 1112344578999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=330.74 Aligned_cols=266 Identities=25% Similarity=0.365 Sum_probs=200.3
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe--
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH-- 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~-- 425 (669)
..|.+.+ .+|.|+| |.||+|.. +|+.||||+++. .+.+|++++++++||||+++++++..
T Consensus 14 grY~i~~-~LG~G~f-------G~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 14 GPWEMKE-RLGTGGF-------GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ---CCCC-CCCBCSS-------SBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCeEEEE-EEeeCCC-------eEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 4566666 3999999 99999987 478999998854 36789999999999999999999765
Q ss_pred ----cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc-
Q 005923 426 ----EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR- 500 (669)
Q Consensus 426 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~- 500 (669)
++..++||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSS
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCc
Confidence 667899999999999999998652 3346899999999999999999999999 999999999999987664
Q ss_pred --EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 501 --AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 501 --~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.+.....
T Consensus 161 ~~vKL~DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~- 230 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGE---------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV- 230 (676)
T ss_dssp CEEEECSCCCCCBTTSCC---------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-
T ss_pred eeEEEccccccccccccc---------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-
Confidence 9999999998765432 1234578999999999999999999999999999999999999997643211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCC--------ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDP--------SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE-----VFVTLSK 645 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~--------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e-----vl~~L~~ 645 (669)
.+.................... ......+...+..+.+++.+||+.||.+|||+.| .++.+..
T Consensus 231 ----~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 231 ----QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp ----HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred ----hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0000000000000000000000 0112234567788999999999999999999988 5677777
Q ss_pred hhcCC
Q 005923 646 IWSSS 650 (669)
Q Consensus 646 i~~~~ 650 (669)
+....
T Consensus 307 iL~~k 311 (676)
T 3qa8_A 307 ILSLK 311 (676)
T ss_dssp HHCCC
T ss_pred HHhcc
Confidence 77654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.49 Aligned_cols=224 Identities=13% Similarity=0.095 Sum_probs=177.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+ .+|.|+| |.||+|... ++.||||+++. .+.+|+.++++++||||+++++++.++
T Consensus 32 ~y~i~~-~lg~G~~-------g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 32 RYRLLI-FHGGVPP-------LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TEEEEE-EEEBSTT-------CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cEEEEE-EEcccCC-------eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 466665 4999999 999999985 78999999853 367899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..|+||||+++++|.+++... ....++.+|+.|++.||+|||+++ |+||||||+|||+++++.+||+++
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC
T ss_pred CcEEEEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec
Confidence 9999999999999999999532 355678899999999999999999 999999999999999999999854
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|. ++ .++.++||||||+++|||++|+.||.+....+.
T Consensus 174 ~~----------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------- 210 (286)
T 3uqc_A 174 AT----------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------- 210 (286)
T ss_dssp CC----------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC--------
T ss_pred cc----------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh--------
Confidence 32 22 268899999999999999999999986543110
Q ss_pred HHHhhhhHHhhhhcccCCccC--CCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 587 RVLEESNVREKLRGFIDPSLR--NEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
.......+..... .....+++..+.+++.+||+.||.+| |+.|+++.|+++......
T Consensus 211 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 211 --------LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp --------SEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred --------hHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 0000000010000 01112445678999999999999999 999999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.51 Aligned_cols=223 Identities=20% Similarity=0.335 Sum_probs=176.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--cHHHHHHHH-HhcCCCCceeEeeEEEe----cCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--DVSSEINIL-KKINHSNIIRLSGFCVH----EGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~ 429 (669)
.|.+..-.+|.|+| |.||++.. +++.||+|+++. .+.+|+.++ +..+||||+++++++.. +...
T Consensus 18 ~y~~~~~~lg~G~~-------g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 18 DYKVTSQVLGLGIN-------GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp TEEEEEEEEEEETT-------EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred chhhcCcccccCCC-------eEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 34443223899999 99999998 478999999964 467899988 55689999999999987 6778
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEccc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNF 506 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~Df 506 (669)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||++. ++.+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 99999999999999998652 346999999999999999999999999 999999999999998 789999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++.... ..++.++||||||+++|||++|+.||.+......
T Consensus 165 g~a~~~~~------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------- 206 (299)
T 3m2w_A 165 GFAKETTG------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------- 206 (299)
T ss_dssp TTCEECTT------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------
T ss_pred cccccccc------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--------
Confidence 99875432 2357799999999999999999999976432110
Q ss_pred HHHhhhhHHhhhh-cccCCccCCCCc----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLR-GFIDPSLRNEYP----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~-~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+. .+.... ...+ ..++..+.+++.+||+.||.+|||+.|++++
T Consensus 207 --------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 207 --------SPGMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ---------CCSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------hHHHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00011 111111 1112 2346679999999999999999999999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=328.11 Aligned_cols=231 Identities=23% Similarity=0.339 Sum_probs=185.4
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE---CCCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF---KGDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~---~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+. +|.|+| |.||++.. +|+.||||++.. .+.+|++++++++||||+++++++.+.
T Consensus 80 ~~y~i~~~-lg~G~~-------g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 80 GQYEVKGC-IAHGGL-------GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTEEEEEE-EEEETT-------EEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CceEEEEE-EeeCCC-------eEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 34666553 899999 99999987 368899998852 356899999999999999999999887
Q ss_pred Cc-----eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 427 GN-----TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 427 ~~-----~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
+. .||||||+++++|.+++.. .++|.+++.|+.||+.||+|||+++ |+||||||+|||++.+ .+
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~ 220 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QL 220 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cE
Confidence 66 6999999999999988753 4999999999999999999999999 9999999999999986 89
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
||+|||+++..... ....||+.|+|||.+.++. +.++||||||+++|||++|..|+.+....
T Consensus 221 kl~DFG~a~~~~~~------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----- 282 (681)
T 2pzi_A 221 KLIDLGAVSRINSF------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----- 282 (681)
T ss_dssp EECCCTTCEETTCC------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----
T ss_pred EEEecccchhcccC------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----
Confidence 99999999876432 2346899999999997764 89999999999999999998887642110
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHhh
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-ISEVFVTLSKIW 647 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~L~~i~ 647 (669)
.+. ...........+.+++.+||+.||.+||+ ++++...|..+.
T Consensus 283 ------------------~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 ------------------GLP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------------------SCC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------------------ccc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 00111223456889999999999999995 666666666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-33 Score=299.29 Aligned_cols=233 Identities=15% Similarity=0.206 Sum_probs=178.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEec---------------ccHHHHHHHHHhcC---------CC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMK---------------GDVSSEINILKKIN---------HS 414 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~---------H~ 414 (669)
.|++.+ .+|.|+| |.||+|+.+|+.||||+++ ..+.+|+.+|++++ ||
T Consensus 21 ~y~~~~-~lG~G~~-------g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 21 KLQRCE-KIGEGVF-------GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp HHHTCE-EEEEETT-------EEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred cchhee-eecccCc-------eEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 455545 3899999 9999999999999999986 33678999999986 77
Q ss_pred CceeEeeEEE-----------------e-------------cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHH
Q 005923 415 NIIRLSGFCV-----------------H-------------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464 (669)
Q Consensus 415 niv~l~g~~~-----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 464 (669)
||+++.+++. . ++..++||||+++|++.+.+.+ ..+++..++.|
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i 166 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSI 166 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHH
Confidence 7777777643 1 5788999999999987777643 34899999999
Q ss_pred HHHHHHHHHHHH-hCCCCCeEeeCCCCCCeeecCCC--------------------cEEEcccCCccccCCCccccCCcc
Q 005923 465 AYDVANALNYLH-KYTNPPYVHKNLKTSNILLDTNL--------------------RAKITNFGLARSAESDEHEQGGYG 523 (669)
Q Consensus 465 ~~qia~~L~yLH-~~~~~~ivHrDik~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~ 523 (669)
+.||+.||+||| +++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 167 ~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------- 235 (336)
T 2vuw_A 167 LHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------
T ss_pred HHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------
Confidence 999999999999 899 99999999999999887 8999999999865432
Q ss_pred cceeeecccccccccccccccCCCCchhhHHHHHHH-HHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhccc
Q 005923 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVV-VLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFI 602 (669)
Q Consensus 524 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 602 (669)
...||..|+|||.+.+.. +.++||||+|++ .+++++|..||.+. .+........... ...
T Consensus 236 -----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~--------~~~ 296 (336)
T 2vuw_A 236 -----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQ--------MTF 296 (336)
T ss_dssp -----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHT--------CCC
T ss_pred -----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhh--------hcc
Confidence 247899999999998766 999999998777 77788898887321 0000000011100 001
Q ss_pred CCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005923 603 DPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640 (669)
Q Consensus 603 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 640 (669)
........+..++.++.+|+.+||+.| |++|++
T Consensus 297 ~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 297 KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 111112234567888999999999976 999887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=299.60 Aligned_cols=233 Identities=15% Similarity=0.180 Sum_probs=173.3
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCC-CCcee--------
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINH-SNIIR-------- 418 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H-~niv~-------- 418 (669)
|++.++ +|.|+| |.||+|... |+.||||+++. .+.+|+.+++.++| +|...
T Consensus 80 ~~~~~~-LG~G~f-------G~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 80 LVRGTV-LGQEDP-------YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp EEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred EEEecc-cccCCC-------EEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 455453 999999 999999985 89999999862 36789999999977 22111
Q ss_pred -------------EeeEEEe-----cCceeEEEEecCCCCHHHHHhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005923 419 -------------LSGFCVH-----EGNTYLVYEFADNGALSDWLHSNR--YQTSDNLTWKQRVQIAYDVANALNYLHKY 478 (669)
Q Consensus 419 -------------l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~ 478 (669)
+..++.. ....+++|+++ +++|.+++.... ......++|..++.|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 12346667665 679999985210 01234588999999999999999999999
Q ss_pred CCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeeccccccccccccc----------ccCCCC
Q 005923 479 TNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYI----------ENGVIT 548 (669)
Q Consensus 479 ~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s 548 (669)
+ |+||||||+|||++.++.+||+|||+++..... .....| ..|+|||.+ .+..++
T Consensus 231 ~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~ 295 (413)
T 3dzo_A 231 G---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT 295 (413)
T ss_dssp T---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC
T ss_pred C---cccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCC
Confidence 9 999999999999999999999999998865432 233567 999999999 556688
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhccc
Q 005923 549 PKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAH 628 (669)
Q Consensus 549 ~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~ 628 (669)
.++|||||||++|||++|+.||.+....+ .....+... . .++..+.+|+.+||+.
T Consensus 296 ~~~DvwSlGvil~elltg~~Pf~~~~~~~-------------------~~~~~~~~~--~----~~~~~~~~li~~~l~~ 350 (413)
T 3dzo_A 296 FAFDTWTLGLAIYWIWCADLPNTDDAALG-------------------GSEWIFRSC--K----NIPQPVRALLEGFLRY 350 (413)
T ss_dssp HHHHHHHHHHHHHHHHHSSCCCCTTGGGS-------------------CSGGGGSSC--C----CCCHHHHHHHHHHTCS
T ss_pred chhhHHHHHHHHHHHHHCCCCCCCcchhh-------------------hHHHHHhhc--c----cCCHHHHHHHHHHccC
Confidence 99999999999999999999997644211 111111111 1 2335789999999999
Q ss_pred CCCCCCCHHHHHH
Q 005923 629 DLNARPSISEVFV 641 (669)
Q Consensus 629 dP~~RPt~~evl~ 641 (669)
||.+||++.|+++
T Consensus 351 dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 351 PKEDRLLPLQAME 363 (413)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCcCHHHHHh
Confidence 9999999877754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-28 Score=272.24 Aligned_cols=161 Identities=17% Similarity=0.190 Sum_probs=123.6
Q ss_pred CCCeeEEEEecc-----------------cHHHHHHHHHhc-CCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCC
Q 005923 388 KGDDAAVKVMKG-----------------DVSSEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR 449 (669)
Q Consensus 388 ~g~~vavK~~~~-----------------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~ 449 (669)
-|+.+++|++.. ++.+|+++|+++ +|+||+++++++++++..||||||++||+|.++|...
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~- 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG- 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-
Confidence 488999999853 377899999999 7999999999999999999999999999999999764
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeee
Q 005923 450 YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529 (669)
Q Consensus 450 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~ 529 (669)
+.++.. +|+.||+.||+|||+++ ||||||||+|||+++++++||+|||+|+...... .....
T Consensus 337 ----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--------~~~~t 398 (569)
T 4azs_A 337 ----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--------SWPTN 398 (569)
T ss_dssp ----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-----------CCSHH
T ss_pred ----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--------ccccC
Confidence 346654 58899999999999999 9999999999999999999999999998765432 12345
Q ss_pred cccccccccccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 005923 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE 568 (669)
Q Consensus 530 ~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~ 568 (669)
.+||+.|||||.+.+ .+..++|+|++|++++++.++..
T Consensus 399 ~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 399 LVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 789999999999875 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.4e-25 Score=246.32 Aligned_cols=181 Identities=20% Similarity=0.251 Sum_probs=145.5
Q ss_pred HHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 364 DLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 364 ~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
+-.+|.|+| |.||+|...+..+++|.... .+.+|+++|++++||||+++..++...+.
T Consensus 341 ~~~LG~G~f-------g~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 413 (540)
T 3en9_A 341 EHLIGKGAE-------ADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN 413 (540)
T ss_dssp -------CC-------EEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT
T ss_pred CCEEeeCCC-------EEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc
Confidence 335999999 99999999999999998521 25789999999999999977777778888
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.+|||||+++|+|.+++.. ++.|+.|++.||+|||+++ |+||||||+|||+++ ++||+|||+
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred cEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 9999999999999999863 4579999999999999999 999999999999998 999999999
Q ss_pred ccccCCCccccCCcccceeeeccccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCC
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN--GVITPKLDVFAFGVVVLELLSGREAV 570 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDV~S~Gvvl~elltg~~p~ 570 (669)
++.......... ......+...||+.|||||++.. ..|+..+|+|+..+-..+.+.++..+
T Consensus 476 a~~~~~~~~~~~-~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 476 GKISNLDEDKAV-DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CEECCCHHHHHH-HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CEECCCcccccc-chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 998755321100 00012345789999999999987 66888899999998888887766654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-20 Score=191.09 Aligned_cols=120 Identities=16% Similarity=0.182 Sum_probs=101.6
Q ss_pred HHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc-------------------------cHHHHHHHHHhcCCCCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG-------------------------DVSSEINILKKINHSNIIRL 419 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~-------------------------~~~~E~~~l~~l~H~niv~l 419 (669)
.+|.|.| |.||+|.. +|+.||+|.++. .+.+|+.+|++++ | +++
T Consensus 97 ~iG~G~~-------g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 97 LMGEGKE-------SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp EEEECSS-------EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EeccCCC-------ceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3899999 99999998 478999999852 2668999999999 5 666
Q ss_pred eeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 420 SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 420 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
.+++ +.+..++||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ ++
T Consensus 167 ~~~~-~~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 167 PKVY-AWEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp CCEE-EEETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TT
T ss_pred CeEE-eccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CC
Confidence 6655 4467799999999999988 421 123479999999999999999 99999999999999 99
Q ss_pred cEEEcccCCcccc
Q 005923 500 RAKITNFGLARSA 512 (669)
Q Consensus 500 ~~kl~DfGla~~~ 512 (669)
.+||+|||+++..
T Consensus 230 ~vkl~DFG~a~~~ 242 (282)
T 1zar_A 230 GIWIIDFPQSVEV 242 (282)
T ss_dssp EEEECCCTTCEET
T ss_pred cEEEEECCCCeEC
Confidence 9999999999743
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.7e-19 Score=171.58 Aligned_cols=108 Identities=17% Similarity=0.306 Sum_probs=92.9
Q ss_pred eeEEEEecCCcchhhhHhhhhcCchhH--------HHHHhcC-CCC-CCCCCCCceEEEeeecCCCCcccccCCceEEEE
Q 005923 127 NTTYTIQNHVETYLSVANNTYQGLTTC--------QAMMSQN-PVD-SRNLTVGLDLFVPLRCACPSRDQAASGFNHLLT 196 (669)
Q Consensus 127 ~~~y~V~~~gdT~~~IA~~~~~~lt~~--------~~l~~~N-~~~-~~~l~~G~~L~ip~~c~c~~~~~~~~~~~~~~t 196 (669)
..+|+|+ +|||||.|| ++|+ +++ ++|+++| .+. ++.|++||+|.||..|.|.... ......+
T Consensus 9 ~~~Y~V~-~GDTL~~IA-~~~~--vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----~~~~~~~ 80 (212)
T 4eby_A 9 LASYYLE-NGTTLSVIN-QNLN--SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----FLGHNFS 80 (212)
T ss_dssp EEEEECC-TTCCHHHHH-HHTC--CSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----EEEEEEE
T ss_pred eEEEEeC-CCCCHHHHH-HHHC--CCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----cccCceE
Confidence 4689999 999999999 6787 776 9999999 664 5699999999999999886421 1223468
Q ss_pred EEcCCCCCHHHHH-HHhC--CCHHhHHHhcCCCCCCCCCCCcccccccCC
Q 005923 197 YMVTWGDSISAIA-QLFN--VDERSVLDANKLSQDDLIFPFTPILVPLKT 243 (669)
Q Consensus 197 Y~v~~GDtl~~Ia-~~f~--v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~ 243 (669)
|+|++|||||.|| ++|+ +++++|++||++ .++.|++||.|.||...
T Consensus 81 Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~-~~~~l~~Gq~L~IP~~~ 129 (212)
T 4eby_A 81 YSVRQEDTYERVAISNYANLTTMESLQARNPF-PATNIPLSATLNVLVNC 129 (212)
T ss_dssp EECCTTCCHHHHHHTTTTTSSCHHHHHHHCCS-CTTCCCTTCEEEEEEEC
T ss_pred EEecCCCcHHHHHHHhcCCCCCHHHHHHhcCC-CcccCCCCCEEEEcCCC
Confidence 9999999999999 7999 999999999996 56789999999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=7.3e-17 Score=164.00 Aligned_cols=124 Identities=21% Similarity=0.237 Sum_probs=100.3
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCe--eEEEEecc-------------------------------cHHHHHHHHHh
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDD--AAVKVMKG-------------------------------DVSSEINILKK 410 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~--vavK~~~~-------------------------------~~~~E~~~l~~ 410 (669)
.+|+|.| |.||+|.. +|+. ||||+++. .+.+|+.+|++
T Consensus 54 ~ig~G~~-------g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 54 VISTGKE-------ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEECSS-------EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred EEeecce-------EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3899999 99999998 7888 99998632 35679999999
Q ss_pred cCCCCc--eeEeeEEEecCceeEEEEecCC-C----CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCC
Q 005923 411 INHSNI--IRLSGFCVHEGNTYLVYEFADN-G----ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLH-KYTNPP 482 (669)
Q Consensus 411 l~H~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ 482 (669)
++|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g--- 191 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE--- 191 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---
Confidence 988764 344432 467999999942 4 77776532 224456789999999999999 998
Q ss_pred eEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 483 YVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 483 ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
|+||||||+|||+++ .++|+|||+|....
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999999998 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.5e-13 Score=144.24 Aligned_cols=130 Identities=15% Similarity=0.194 Sum_probs=93.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEE-CCCeeEEEEeccc-----------------------------HHHHHHHHH
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKGD-----------------------------VSSEINILK 409 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~~-----------------------------~~~E~~~l~ 409 (669)
|.+.. .+|+|.| |.||+|.. +|+.||||+++.. ..+|...|.
T Consensus 97 Y~I~~-~IG~Gk~-------a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 97 YSVGS-RIGVGKE-------SDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp SEEEE-EEEECSS-------EEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecC-EeeeCCc-------eEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 44444 4899999 99999987 5889999987420 123566666
Q ss_pred hcCCCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 410 ~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
++.+.++....-+ .....+|||||++++.|.++.. . .....++.|++.+|.|||+.+ |||||||
T Consensus 169 rL~~~gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 169 ALYEEGFPVPEPI--AQSRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HHHHTTCSCCCEE--EEETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhcCCCCCeee--eccCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 6654443211111 1224589999999988865432 1 123568899999999999999 9999999
Q ss_pred CCCeeecCCC----------cEEEcccCCccccC
Q 005923 490 TSNILLDTNL----------RAKITNFGLARSAE 513 (669)
Q Consensus 490 ~~NILl~~~~----------~~kl~DfGla~~~~ 513 (669)
|.|||+++++ .+.|+||+-+....
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999998776 38999999887654
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.2e-12 Score=104.94 Aligned_cols=62 Identities=26% Similarity=0.397 Sum_probs=55.3
Q ss_pred CCceEEEeeecCCCCcccccCCceEEEEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccCC
Q 005923 169 VGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLKT 243 (669)
Q Consensus 169 ~G~~L~ip~~c~c~~~~~~~~~~~~~~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~~ 243 (669)
.||.|.||.. ....+|+|++|||||.||++||+++++|+++|++...+.|+|||.|.||...
T Consensus 3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~ 64 (77)
T 2djp_A 3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT 64 (77)
T ss_dssp CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence 6888888843 2367999999999999999999999999999999777899999999999865
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.9e-13 Score=125.72 Aligned_cols=94 Identities=15% Similarity=0.098 Sum_probs=73.9
Q ss_pred eeEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCC-CCCCCCceEEEeeecCCCCcccccCCceEEEEEEcCCCCCH
Q 005923 127 NTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDS-RNLTVGLDLFVPLRCACPSRDQAASGFNHLLTYMVTWGDSI 205 (669)
Q Consensus 127 ~~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~-~~l~~G~~L~ip~~c~c~~~~~~~~~~~~~~tY~v~~GDtl 205 (669)
..+|+|+ +|||||.|| ++|. +++.+|+++|.+.. +.|+|||+|.||....-+...... .......|+|+.||+|
T Consensus 62 ~~~y~V~-~GDTL~~IA-~~~~--~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~-~~~~~~~~~v~~GdtL 136 (167)
T 2l9y_A 62 TATVTVQ-QGDTLRDIG-RRFD--CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNF-WDSARDVRLVDGGKVL 136 (167)
T ss_dssp CEEEEEC-TTCCHHHHH-HHTT--CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCCG-GGGEEEEEEETTTTEE
T ss_pred CceEEEC-CCCcHHHHH-HHcC--CCHHHHHHHcCCCCcccccCCCEEEEcCCCCcccccccc-ccccceEEEeCCcCCh
Confidence 3689999 999999999 6786 88999999998875 599999999999754321101100 1112468999999999
Q ss_pred HHHHHHhCCCHHhHHHhcCC
Q 005923 206 SAIAQLFNVDERSVLDANKL 225 (669)
Q Consensus 206 ~~Ia~~f~v~~~~l~~~N~l 225 (669)
++||++||.++...+++|+.
T Consensus 137 ~aIA~r~G~~v~s~i~Ln~~ 156 (167)
T 2l9y_A 137 EAELRYSGGWNRSRIYLDEH 156 (167)
T ss_dssp EEEEEETTEEEEEEECGGGT
T ss_pred HHHHHHcCCceEEEEEcccc
Confidence 99999999988888888764
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-11 Score=115.02 Aligned_cols=95 Identities=13% Similarity=0.097 Sum_probs=71.8
Q ss_pred cceeeeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeecccCCCCCCcce-eeeeEEEEecCC
Q 005923 58 CQAYLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNCSCSGGGDGDYY-QFNTTYTIQNHV 136 (669)
Q Consensus 58 c~~~~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c~c~~~~~~~~~-~~~~~y~V~~~g 136 (669)
-.+-.+|+|++ ||||+.||+.|| ++..+|+++|++. +++.|.+||.|.||....-.... ..+. .....|+|+ +|
T Consensus 59 ~~~~~~y~V~~-GDTL~~IA~~~~-~~~~~l~~~N~~~-~~~~i~~Gq~L~ip~~~~~~~~~-~~~~~~~~~~~~v~-~G 133 (167)
T 2l9y_A 59 GGGTATVTVQQ-GDTLRDIGRRFD-CDFHEIARRNNIQ-NEDLIYPGQVLQVPTKGGSGGGA-GNFWDSARDVRLVD-GG 133 (167)
T ss_dssp CCSCEEEEECT-TCCHHHHHHHTT-CCHHHHHHHHTCC-GGGCCCTTEEEEESCCCCCSSSS-CCGGGGEEEEEEET-TT
T ss_pred CCCCceEEECC-CCcHHHHHHHcC-CCHHHHHHHcCCC-CcccccCCCEEEEcCCCCccccc-cccccccceEEEeC-Cc
Confidence 34567899999 999999999999 9999999999997 77999999999999764421100 0011 233679999 99
Q ss_pred cchhhhHhhhhcCchhHHHHHhcC
Q 005923 137 ETYLSVANNTYQGLTTCQAMMSQN 160 (669)
Q Consensus 137 dT~~~IA~~~~~~lt~~~~l~~~N 160 (669)
|||+.||++ |+ .+.++....|
T Consensus 134 dtL~aIA~r-~G--~~v~s~i~Ln 154 (167)
T 2l9y_A 134 KVLEAELRY-SG--GWNRSRIYLD 154 (167)
T ss_dssp TEEEEEEEE-TT--EEEEEEECGG
T ss_pred CChHHHHHH-cC--CceEEEEEcc
Confidence 999999955 55 4444544444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=2.3e-10 Score=115.83 Aligned_cols=122 Identities=18% Similarity=0.229 Sum_probs=99.7
Q ss_pred eEEEEEEECCCeeEEEEecc-------cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCC
Q 005923 380 GSVYRGSFKGDDAAVKVMKG-------DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ 451 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~ 451 (669)
+.||+....++.+++|.... ++.+|+.+++.+. |..+.++++++...+..|+||||++|.+|.+.+..
T Consensus 28 ~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---- 103 (263)
T 3tm0_A 28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---- 103 (263)
T ss_dssp SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT----
T ss_pred CeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC----
Confidence 67999988889999999863 5889999999995 67788999999888889999999999999876421
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------------
Q 005923 452 TSDNLTWKQRVQIAYDVANALNYLHKYT---------------------------------------------------- 479 (669)
Q Consensus 452 ~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------------------- 479 (669)
......++.+++.+|..||+..
T Consensus 104 ------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 177 (263)
T 3tm0_A 104 ------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp ------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHC
T ss_pred ------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhc
Confidence 1123478899999999999821
Q ss_pred ----CCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 480 ----NPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 480 ----~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 178 ~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13499999999999998765667999988753
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=99.10 E-value=3e-11 Score=128.00 Aligned_cols=112 Identities=12% Similarity=0.075 Sum_probs=86.1
Q ss_pred eeEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCC-----CCCCCCCceEEEeeecCCCCcc---------------c
Q 005923 127 NTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVD-----SRNLTVGLDLFVPLRCACPSRD---------------Q 186 (669)
Q Consensus 127 ~~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~-----~~~l~~G~~L~ip~~c~c~~~~---------------~ 186 (669)
..+|+|+ +||||++|| ++|+ ++.++|+++|... .+.|++||+|.||..-.- ... .
T Consensus 7 ~~~~~Vk-~GDTL~~Ia-~r~g--vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~-~l~~l~~~~~~~~~~~~~~ 81 (361)
T 2gu1_A 7 RIHYMVK-VGDTLSGIF-AQLG--VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMG-QLSRLIYHMSIVEKAIYTR 81 (361)
T ss_dssp CEEEECC-TTCCHHHHH-HHTT--CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTS-CEEEEEEEEETTEEEEEEE
T ss_pred ceEEEEC-CCCcHHHHH-HHcC--CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCC-cceEEEEEcCccceEEEEe
Confidence 4689999 999999999 7787 8889999999764 258999999999974210 000 0
Q ss_pred ccCC-----------ceEEEEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCC-----CCCCCCcccccccCC
Q 005923 187 AASG-----------FNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQD-----DLIFPFTPILVPLKT 243 (669)
Q Consensus 187 ~~~~-----------~~~~~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~-----~~l~p~~~l~iP~~~ 243 (669)
...+ .....+|.|+.|||||.||++||++.+.|++||++... ..|++|+.+.|+...
T Consensus 82 ~~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~~ 154 (361)
T 2gu1_A 82 ENDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVKQ 154 (361)
T ss_dssp CTTSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEEE
T ss_pred cCCCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEEE
Confidence 0011 11245799999999999999999999999999997543 459999999998753
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=99.09 E-value=7.1e-11 Score=86.54 Aligned_cols=46 Identities=30% Similarity=0.386 Sum_probs=42.8
Q ss_pred EEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccC
Q 005923 195 LTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLK 242 (669)
Q Consensus 195 ~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~ 242 (669)
.+|+|++|||||+||++||++.++|+++|+ ....|+|||.|.||+.
T Consensus 3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~--~~~~l~~G~~l~ip~~ 48 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS--DTANLQPGDKLTLFVK 48 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCS--CGGGCCTTEEEECCCC
T ss_pred EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC--CCCcCCcCCEEEEecC
Confidence 379999999999999999999999999999 6788999999999863
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-09 Score=115.88 Aligned_cols=113 Identities=11% Similarity=0.049 Sum_probs=85.2
Q ss_pred eeeeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCC---CCCCCCCCCcEEEeeecccCC-----------------CC
Q 005923 60 AYLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITN---VTATLPTDTPVLIPVNCSCSG-----------------GG 119 (669)
Q Consensus 60 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~---~~~~l~~gq~l~IP~~c~c~~-----------------~~ 119 (669)
.|..|+|++ ||||++|++.|| ++..+|+++|++.. +.+.|.+||.|.||....-.. ..
T Consensus 6 ~~~~~~Vk~-GDTL~~Ia~r~g-vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~ 83 (361)
T 2gu1_A 6 KRIHYMVKV-GDTLSGIFAQLG-VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREN 83 (361)
T ss_dssp -CEEEECCT-TCCHHHHHHHTT-CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECT
T ss_pred CceEEEECC-CCcHHHHHHHcC-CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecC
Confidence 478899999 999999999999 99999999998741 157899999999997532100 00
Q ss_pred CCcce---------eeeeEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCC------CCCCCCceEEEeee
Q 005923 120 DGDYY---------QFNTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDS------RNLTVGLDLFVPLR 178 (669)
Q Consensus 120 ~~~~~---------~~~~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~------~~l~~G~~L~ip~~ 178 (669)
...+. .....|+|+ .|||||.|| +.|+ ++.+.|+++|.+.. ..|++||+|.|+..
T Consensus 84 ~g~f~~~~~~~~~~~~~~~~~v~-igdSL~~iA-~~~G--vs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~ 153 (361)
T 2gu1_A 84 DGSFSYDFQEISGEWREILFSGE-INGSFSVSA-RRVG--LTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK 153 (361)
T ss_dssp TSCEEEEEEECCCEEEEEEEEEE-SSSCHHHHH-HHTT--CCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred CCcceeeecccCceEEEEEEEEE-ECCcHHHHH-HHcC--CCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence 00010 012468999 999999999 6777 78899999987542 46999999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.8e-09 Score=113.11 Aligned_cols=126 Identities=13% Similarity=0.290 Sum_probs=101.6
Q ss_pred eEEEEEEECCCeeEEEEec----------ccHHHHHHHHHhcC--CCCceeEeeEEEec---CceeEEEEecCCCCHHHH
Q 005923 380 GSVYRGSFKGDDAAVKVMK----------GDVSSEINILKKIN--HSNIIRLSGFCVHE---GNTYLVYEFADNGALSDW 444 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~----------~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~e~~~~gsL~~~ 444 (669)
+.||+....+..+++|+.. .++.+|..+++.+. +..+.++++++.+. +..++||||+++..+.+.
T Consensus 52 n~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~ 131 (359)
T 3dxp_A 52 NPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ 131 (359)
T ss_dssp SCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT
T ss_pred ceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC
Confidence 7899998888888898875 25778999999997 45688899998766 457999999998776431
Q ss_pred HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 005923 445 LHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT--------------------------------------------- 479 (669)
Q Consensus 445 l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------------- 479 (669)
. ...++..++..++.+++..|..||+..
T Consensus 132 ~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 204 (359)
T 3dxp_A 132 S-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWL 204 (359)
T ss_dssp T-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHG
T ss_pred c-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHH
Confidence 1 134788899999999999999999731
Q ss_pred ----------CCCeEeeCCCCCCeeecCCCc--EEEcccCCcccc
Q 005923 480 ----------NPPYVHKNLKTSNILLDTNLR--AKITNFGLARSA 512 (669)
Q Consensus 480 ----------~~~ivHrDik~~NILl~~~~~--~kl~DfGla~~~ 512 (669)
.+.++|+|+++.|||++.++. +.|.||+.+...
T Consensus 205 ~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 205 PQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp GGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999987753 689999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.86 E-value=5e-09 Score=105.21 Aligned_cols=119 Identities=16% Similarity=0.153 Sum_probs=91.8
Q ss_pred eEEEEEEEC-CCeeEEEEecc----cHHHHHHHHHhcCCCC--ceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCC
Q 005923 380 GSVYRGSFK-GDDAAVKVMKG----DVSSEINILKKINHSN--IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQT 452 (669)
Q Consensus 380 G~Vy~g~~~-g~~vavK~~~~----~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~ 452 (669)
+.||+.... |..+++|.... ++..|+.+++.+.+.+ +.+++++...++..++||||++|.+|. ...
T Consensus 34 ~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----- 106 (264)
T 1nd4_A 34 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----- 106 (264)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----
T ss_pred ceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----
Confidence 789998764 56799999764 4779999999996544 556888887777889999999998874 211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------------
Q 005923 453 SDNLTWKQRVQIAYDVANALNYLHKYT----------------------------------------------------- 479 (669)
Q Consensus 453 ~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------------------------- 479 (669)
.+ ...++.+++..|..||+..
T Consensus 107 ---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 180 (264)
T 1nd4_A 107 ---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 180 (264)
T ss_dssp ---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCC
Confidence 11 2356778888888888643
Q ss_pred --CCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 480 --NPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 480 --~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 181 ~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 181 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776677999999764
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=98.68 E-value=7.9e-09 Score=75.43 Aligned_cols=45 Identities=24% Similarity=0.318 Sum_probs=40.4
Q ss_pred eEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEee
Q 005923 128 TTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPL 177 (669)
Q Consensus 128 ~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~ 177 (669)
.+|+|+ +|||+|+|| ++|+ ++.++|+++|+ ....|++||+|.||+
T Consensus 3 ~~y~V~-~GDtl~~Ia-~~~~--~~~~~l~~~N~-~~~~l~~G~~l~ip~ 47 (48)
T 1e0g_A 3 ITYRVR-KGDSLSSIA-KRHG--VNIKDVMRWNS-DTANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEEC-TTCCHHHHH-HHHT--CCHHHHHHHCS-CGGGCCTTEEEECCC
T ss_pred EEEEEc-CCCcHHHHH-HHHC--cCHHHHHHhCC-CCCcCCcCCEEEEec
Confidence 579999 999999999 6776 77899999999 666999999999996
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.66 E-value=1.4e-08 Score=105.06 Aligned_cols=179 Identities=23% Similarity=0.292 Sum_probs=112.3
Q ss_pred eEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcC-CCC--ceeEeeEEEecC---ceeEEEEecCCCCHHHHHhcC
Q 005923 380 GSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKIN-HSN--IIRLSGFCVHEG---NTYLVYEFADNGALSDWLHSN 448 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~~~~gsL~~~l~~~ 448 (669)
..||+.. +.+++|+.+. .+.+|..+|+.+. +.. +.++++.....+ ..|+|||+++|..|.+....
T Consensus 34 n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~- 109 (304)
T 3sg8_A 34 CIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN- 109 (304)
T ss_dssp EEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH-
T ss_pred ceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc-
Confidence 5666642 6788998753 4678999999884 332 445555543333 34899999999888764432
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 005923 449 RYQTSDNLTWKQRVQIAYDVANALNYLHKYT------------------------------------------------- 479 (669)
Q Consensus 449 ~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------------------- 479 (669)
.++..++..++.+++..|..||+..
T Consensus 110 ------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 183 (304)
T 3sg8_A 110 ------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILEN 183 (304)
T ss_dssp ------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTC
T ss_pred ------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhc
Confidence 2777888888999999999988621
Q ss_pred ------CCCeEeeCCCCCCeeecC--CCcEEEcccCCccccCCCccccCC------cccceeeeccccccccc-cccccc
Q 005923 480 ------NPPYVHKNLKTSNILLDT--NLRAKITNFGLARSAESDEHEQGG------YGLQLTRHVVGTYGYMA-PEYIEN 544 (669)
Q Consensus 480 ------~~~ivHrDik~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~------~~~~~~~~~~gt~~y~a-PE~l~~ 544 (669)
.+.++|+|+++.||++++ +..+.|+||+.+............ .............+... |+....
T Consensus 184 ~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r 263 (304)
T 3sg8_A 184 EIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK 263 (304)
T ss_dssp GGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH
T ss_pred cccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH
Confidence 145899999999999998 456789999998764332110000 00000000000001111 222111
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCC
Q 005923 545 GVITPKLDVFAFGVVVLELLSGREAV 570 (669)
Q Consensus 545 ~~~s~~sDV~S~Gvvl~elltg~~p~ 570 (669)
. ....+.|++|.++|++.+|..++
T Consensus 264 ~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 264 Y--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp H--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred H--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 12268999999999999997654
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.64 E-value=2.9e-08 Score=80.40 Aligned_cols=52 Identities=13% Similarity=0.185 Sum_probs=47.7
Q ss_pred ceeeeeecCCCCCCHHHHHHhhCCCChHHHhhhcCCCCCCCCCCCCCcEEEeeec
Q 005923 59 QAYLTFRSNPSYNTPVTIDYLFKTSHPNLIASINSITNVTATLPTDTPVLIPVNC 113 (669)
Q Consensus 59 ~~~~~y~~~~~g~tl~~Ia~~~~~~~~~~i~~~N~~~~~~~~l~~gq~l~IP~~c 113 (669)
..+..|+|++ ||||+.||+.|| +++.+|+++|++. +.+.|.+||.|.||..-
T Consensus 13 ~~~~~y~V~~-GDTL~~IA~~~~-~~~~~l~~~N~l~-~~~~l~~Gq~l~iP~~~ 64 (77)
T 2djp_A 13 ERRLEHQLEP-GDTLAGLALKYG-VTMEQIKRANRLY-TNDSIFLKKTLYIPILT 64 (77)
T ss_dssp EEEEEECCCT-TCCHHHHHHHHT-CCHHHHHHHHTCC-CSSCGGGSSCEEEEEEC
T ss_pred CCcEEEEECC-CCcHHHHHHHHC-cCHHHHHHHcCCC-CccccCCCCEEEECCCC
Confidence 3688899999 999999999999 9999999999996 57899999999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.1e-05 Score=83.39 Aligned_cols=124 Identities=19% Similarity=0.258 Sum_probs=87.5
Q ss_pred eEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCC---CceeEeeEEE-ecCceeEEEEecCCCCHHHHHhcCCC
Q 005923 380 GSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHS---NIIRLSGFCV-HEGNTYLVYEFADNGALSDWLHSNRY 450 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~ 450 (669)
..||+. |..+++|+-+. .+..|.++|+.+.+. .+.+.+.++. ..+..++||||++|..|.+....
T Consensus 33 n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~--- 106 (306)
T 3tdw_A 33 NYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA--- 106 (306)
T ss_dssp EEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---
T ss_pred eeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---
Confidence 567776 67888998653 467899999999752 3566777764 34567899999999888764221
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------------
Q 005923 451 QTSDNLTWKQRVQIAYDVANALNYLHKY---------------------------------------------------- 478 (669)
Q Consensus 451 ~~~~~l~~~~~~~i~~qia~~L~yLH~~---------------------------------------------------- 478 (669)
.++..++..++.+++..|..||+.
T Consensus 107 ----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~ 182 (306)
T 3tdw_A 107 ----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTH 182 (306)
T ss_dssp ----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHC
T ss_pred ----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhC
Confidence 144555555666666666665542
Q ss_pred -----CCCCeEeeCCCCCCeeecC---CCc-EEEcccCCccccC
Q 005923 479 -----TNPPYVHKNLKTSNILLDT---NLR-AKITNFGLARSAE 513 (669)
Q Consensus 479 -----~~~~ivHrDik~~NILl~~---~~~-~kl~DfGla~~~~ 513 (669)
..+.++|+|+++.|||++. ++. ..|+||+.+....
T Consensus 183 ~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 183 PVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred cccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2234799999999999987 455 4899999987543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-05 Score=80.74 Aligned_cols=123 Identities=18% Similarity=0.184 Sum_probs=90.9
Q ss_pred eEEEEEEEC--CCeeEEEEecc----cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCCC
Q 005923 380 GSVYRGSFK--GDDAAVKVMKG----DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQT 452 (669)
Q Consensus 380 G~Vy~g~~~--g~~vavK~~~~----~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~ 452 (669)
..||+-... +..+.+|+... ++.+|...|+.+. +--+.++++++.+++..++|||++++.++.+.....
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~---- 114 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY---- 114 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----
T ss_pred CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----
Confidence 468887653 55788998753 5778999998884 334778899998888999999999998887765422
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------------
Q 005923 453 SDNLTWKQRVQIAYDVANALNYLHKYT----------------------------------------------------- 479 (669)
Q Consensus 453 ~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------------------------- 479 (669)
......++.+++..|.-||...
T Consensus 115 -----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 115 -----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp -----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred -----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 1223345666666666666421
Q ss_pred --CCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 480 --NPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 480 --~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
.+.++|+|+.+.|||++++..+-|.||+.+..
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877677999998864
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=3.7e-06 Score=78.36 Aligned_cols=47 Identities=32% Similarity=0.443 Sum_probs=41.6
Q ss_pred EEEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCccccccc
Q 005923 194 LLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPL 241 (669)
Q Consensus 194 ~~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~ 241 (669)
+++|+|++||||..||+||+++...|+++|+..+ ..|.+|+.+.||.
T Consensus 2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd-~~l~~g~~i~ip~ 48 (165)
T 4a1k_A 2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQ-AGLTAGQSIVIPG 48 (165)
T ss_dssp CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGG-GCCCTTCEEEETT
T ss_pred CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCC-CccCCCccccCcc
Confidence 4799999999999999999999999999998533 4478999999984
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=2.4e-05 Score=82.46 Aligned_cols=63 Identities=5% Similarity=0.164 Sum_probs=46.4
Q ss_pred eEEEEEEEC--------CCeeEEEEec----------ccHHHHHHHHHhcCC---CCceeEeeEEEec---CceeEEEEe
Q 005923 380 GSVYRGSFK--------GDDAAVKVMK----------GDVSSEINILKKINH---SNIIRLSGFCVHE---GNTYLVYEF 435 (669)
Q Consensus 380 G~Vy~g~~~--------g~~vavK~~~----------~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~e~ 435 (669)
..+|+.... +..+++|... .++..|..+|+.+.. -.+.++++++.+. +..++||||
T Consensus 35 n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~ 114 (357)
T 3ats_A 35 SETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDY 114 (357)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEEC
T ss_pred ceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEe
Confidence 678887664 6678888753 246789999998852 3577888887654 356899999
Q ss_pred cCCCCHH
Q 005923 436 ADNGALS 442 (669)
Q Consensus 436 ~~~gsL~ 442 (669)
++|..+.
T Consensus 115 l~G~~l~ 121 (357)
T 3ats_A 115 VEGVVPP 121 (357)
T ss_dssp CCCBCCC
T ss_pred cCCCChh
Confidence 9986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00032 Score=72.83 Aligned_cols=132 Identities=15% Similarity=0.226 Sum_probs=80.3
Q ss_pred eEEEEEEECCCeeEEEEecc---cHHHHHHHHHhcCC--CCceeEee------EEEecCceeEEEEecCCCCHH------
Q 005923 380 GSVYRGSFKGDDAAVKVMKG---DVSSEINILKKINH--SNIIRLSG------FCVHEGNTYLVYEFADNGALS------ 442 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~---~~~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~lV~e~~~~gsL~------ 442 (669)
+.||+...++..+++|+... ++..|..+++.+.. -.+.+++. +....+..++||||++|..+.
T Consensus 46 n~~~~v~~~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~ 125 (346)
T 2q83_A 46 ALVWKVHTDSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRPFELTVKQD 125 (346)
T ss_dssp CEEEEEEETTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBCCCTTSHHH
T ss_pred CcEEEEEeCCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCccCCCCCHHH
Confidence 68999888777789999864 34456677766631 23344443 122456779999999986542
Q ss_pred --------HHHhcCC--CC-C------CCCCCHHHHH-------------------------------HHHHHHHHHHHH
Q 005923 443 --------DWLHSNR--YQ-T------SDNLTWKQRV-------------------------------QIAYDVANALNY 474 (669)
Q Consensus 443 --------~~l~~~~--~~-~------~~~l~~~~~~-------------------------------~i~~qia~~L~y 474 (669)
..+|... .. . ...-.|.... .+...+..++++
T Consensus 126 ~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (346)
T 2q83_A 126 LEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDR 205 (346)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHHH
Confidence 1122211 00 0 0112343211 111224446667
Q ss_pred HHh----------CCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 475 LHK----------YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 475 LH~----------~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 206 l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 206 LLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 763 1235699999999999998888999999998754
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=3e-05 Score=72.21 Aligned_cols=46 Identities=26% Similarity=0.462 Sum_probs=41.5
Q ss_pred eEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEee
Q 005923 128 TTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPL 177 (669)
Q Consensus 128 ~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~ 177 (669)
.+|+|+ +||||+.|| ++|+ +..++|+++|+.....|.+|++|.||.
T Consensus 3 ~~y~V~-~GdtL~~IA-~~f~--~g~~~l~~aNp~vd~~l~~g~~i~ip~ 48 (165)
T 4a1k_A 3 LTYQVK-QGDTLNSIA-ADFR--ISTAALLQANPSLQAGLTAGQSIVIPG 48 (165)
T ss_dssp EEEECC-TTCCHHHHH-HHTT--CCHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred EEEEEC-CCCCHHHHH-HHhC--CCHHHHHHhCccCCCccCCCccccCcc
Confidence 689999 999999999 7888 888999999997666789999999984
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00062 Score=70.25 Aligned_cols=127 Identities=17% Similarity=0.207 Sum_probs=84.0
Q ss_pred eEEEEEEECCCeeEEEEecc----cHHHHHHHHHhcC---CCCceeEeeEEEecCceeEEEEecCCCCHH--------H-
Q 005923 380 GSVYRGSFKGDDAAVKVMKG----DVSSEINILKKIN---HSNIIRLSGFCVHEGNTYLVYEFADNGALS--------D- 443 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~gsL~--------~- 443 (669)
..+|+...++..+++|.... .+..|...|+.+. ...+.++++++..++..++||||+++..+. +
T Consensus 50 n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~ 129 (312)
T 3jr1_A 50 NEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEK 129 (312)
T ss_dssp SEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHH
T ss_pred eeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHH
Confidence 67999888888899998753 3678999998884 357888999888778899999999987542 1
Q ss_pred --HHhcCCCCC-----------------CCCCCHHHHH---HHHH----------------HHHHH-HHHHHh-CCCCCe
Q 005923 444 --WLHSNRYQT-----------------SDNLTWKQRV---QIAY----------------DVANA-LNYLHK-YTNPPY 483 (669)
Q Consensus 444 --~l~~~~~~~-----------------~~~l~~~~~~---~i~~----------------qia~~-L~yLH~-~~~~~i 483 (669)
.||...... ...-+|.... ++.. .+... ...|.. ...|.+
T Consensus 130 LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l 209 (312)
T 3jr1_A 130 IAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSI 209 (312)
T ss_dssp HHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEE
T ss_pred HHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCcee
Confidence 233321100 0012564321 1111 11111 123322 235779
Q ss_pred EeeCCCCCCeeecCCCcEEEcccC
Q 005923 484 VHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 484 vHrDik~~NILl~~~~~~kl~DfG 507 (669)
+|+|+.+.|++++.++ +.|.||.
T Consensus 210 ~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 210 LHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp ECSSCSGGGEEEETTE-EEECSCC
T ss_pred EeCCCCcCcEeecCCC-eEEEcCc
Confidence 9999999999999887 8899973
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00083 Score=71.67 Aligned_cols=64 Identities=14% Similarity=0.032 Sum_probs=43.3
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--------------cHHHHHHHHHhcCC--CC-ceeEeeEEEecC
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--------------DVSSEINILKKINH--SN-IIRLSGFCVHEG 427 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--------------~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~ 427 (669)
++.|.+ +.||++.. .+..++||.... .+..|.++|+.+.. +. +.+++.+ +.+
T Consensus 38 lg~G~~-------n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~ 108 (397)
T 2olc_A 38 IGDGNL-------NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 108 (397)
T ss_dssp CCSSSS-------EEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred CCCCce-------EEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC
Confidence 566666 89999965 467899996421 24679999988743 33 4456544 455
Q ss_pred ceeEEEEecCCC
Q 005923 428 NTYLVYEFADNG 439 (669)
Q Consensus 428 ~~~lV~e~~~~g 439 (669)
..++|||++++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 678999999864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0019 Score=69.54 Aligned_cols=80 Identities=9% Similarity=0.035 Sum_probs=49.5
Q ss_pred CCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC---CCCchhhHHHH
Q 005923 480 NPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG---VITPKLDVFAF 556 (669)
Q Consensus 480 ~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDV~S~ 556 (669)
.+.++|+|+++.|||++.++ ++|+||+.+......... ...... -...|++|+..... .-....++...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-----a~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-----GAYLGN--LILAFFAQDGHATQENDRKEYKQWILRT 302 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-----HHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-----HHHHHH--HHHHHHhcccccccccchHHHHHHHHHH
Confidence 45599999999999998776 999999998865432110 000000 12346666655321 11224556678
Q ss_pred HHHHHHHHcCC
Q 005923 557 GVVVLELLSGR 567 (669)
Q Consensus 557 Gvvl~elltg~ 567 (669)
...+|+.+++.
T Consensus 303 ~~~~~~~y~~~ 313 (420)
T 2pyw_A 303 IEQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 88888877653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0052 Score=63.69 Aligned_cols=130 Identities=13% Similarity=0.133 Sum_probs=76.1
Q ss_pred EEEEEEC-CCeeEEEEec----ccHHHHHHHHHhcCC--CCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCC----
Q 005923 382 VYRGSFK-GDDAAVKVMK----GDVSSEINILKKINH--SNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRY---- 450 (669)
Q Consensus 382 Vy~g~~~-g~~vavK~~~----~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---- 450 (669)
+|+.... |..+++|... .++..|+.+++.+.. -.+.+++.+.... -+++||++.+..+.+++.....
T Consensus 35 ~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~~~l~~~~~~~~~ 112 (333)
T 3csv_A 35 YQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFTEVINNDPAQEMP 112 (333)
T ss_dssp CEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHHHHHHHCGGGHHH
T ss_pred EEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchHHHhcCCCccHHH
Confidence 5566553 6677777653 467789999888853 2356677664333 3789999987777665532100
Q ss_pred ---------------CC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHHh---CCCCCeEeeCCCC
Q 005923 451 ---------------QT--SDNLTWKQRV-------Q-------------IAYDVANALNYLHK---YTNPPYVHKNLKT 490 (669)
Q Consensus 451 ---------------~~--~~~l~~~~~~-------~-------------i~~qia~~L~yLH~---~~~~~ivHrDik~ 490 (669)
.. ...++..... . ....+...++.+.. ...+.++|+|+.+
T Consensus 113 ~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~ 192 (333)
T 3csv_A 113 LYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHA 192 (333)
T ss_dssp HHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSG
T ss_pred HHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCc
Confidence 00 0111111100 0 00111222233311 1234599999999
Q ss_pred CCeeecCC----CcEEEcccCCccccC
Q 005923 491 SNILLDTN----LRAKITNFGLARSAE 513 (669)
Q Consensus 491 ~NILl~~~----~~~kl~DfGla~~~~ 513 (669)
.|||++.+ ..+.|+||+.+....
T Consensus 193 ~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 193 QNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp GGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 99999875 679999999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.012 Score=59.98 Aligned_cols=127 Identities=13% Similarity=0.114 Sum_probs=70.0
Q ss_pred eEEEEEEECCCeeEEEEecc------cHHHHHHHHHhcCCCCc-eeEeeEEEecCceeEEEEec-CCCCHHH--------
Q 005923 380 GSVYRGSFKGDDAAVKVMKG------DVSSEINILKKINHSNI-IRLSGFCVHEGNTYLVYEFA-DNGALSD-------- 443 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~------~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gsL~~-------- 443 (669)
..+|+. +.+++|+... +...|..+++.+....+ .+++++ ..+.-++|+||+ ++..|..
T Consensus 32 N~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~~~~~~~~~~ 105 (301)
T 3dxq_A 32 NLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMSPEKFKTRPG 105 (301)
T ss_dssp EEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECCHHHHHHSTT
T ss_pred ccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCCHhhHhhhHH
Confidence 577877 6677887643 34679988888753333 456654 344568999999 5543321
Q ss_pred ----------HHhcCCCCCCCCCC-HHHHHHHHHH--------------HHHHHHH----HHh-CCCCCeEeeCCCCCCe
Q 005923 444 ----------WLHSNRYQTSDNLT-WKQRVQIAYD--------------VANALNY----LHK-YTNPPYVHKNLKTSNI 493 (669)
Q Consensus 444 ----------~l~~~~~~~~~~l~-~~~~~~i~~q--------------ia~~L~y----LH~-~~~~~ivHrDik~~NI 493 (669)
-||........... +..+..+... +...+.. |.. ...+.++|+|+.+.||
T Consensus 106 ~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~HgDl~~~Ni 185 (301)
T 3dxq_A 106 SPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAACHCDPLCENF 185 (301)
T ss_dssp HHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEECSCCCGGGE
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceeeccCCCcCCE
Confidence 11221100001011 1111111111 1111111 211 2234589999999999
Q ss_pred eecCCCcEEEcccCCccccC
Q 005923 494 LLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~ 513 (669)
+ ..++.+.++||..+....
T Consensus 186 l-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 186 L-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp E-ECSSCEEECCCTTCEEEC
T ss_pred E-ECCCCEEEEecccccCCC
Confidence 9 566778999999887543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.023 Score=54.64 Aligned_cols=101 Identities=12% Similarity=0.114 Sum_probs=66.3
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccCCCcccc
Q 005923 440 ALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQ 519 (669)
Q Consensus 440 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 519 (669)
+|.+.|... ..+|++.+++-++.|.+.+|.-+-....+ ..+=+-+..|++..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 899999864 36799999999999999998776322111 1223446889999999988764 1110
Q ss_pred CCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCC
Q 005923 520 GGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGRE 568 (669)
Q Consensus 520 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~ 568 (669)
.....+.|||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 -----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122366888763 345788999999999999886443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.30 E-value=0.016 Score=59.39 Aligned_cols=132 Identities=12% Similarity=0.132 Sum_probs=78.2
Q ss_pred eEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCCC--ceeEeeE------EEecCceeEEEEecCCCCHHH---
Q 005923 380 GSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHSN--IIRLSGF------CVHEGNTYLVYEFADNGALSD--- 443 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e~~~~gsL~~--- 443 (669)
..+|+...++..+++|.... ++..|..++..+.... +.+++.. ....+..+++|+|++|..+..
T Consensus 36 n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~ 115 (322)
T 2ppq_A 36 NSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEA 115 (322)
T ss_dssp EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCH
T ss_pred cceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCH
Confidence 57888887766888998754 4667888888874222 3333321 122456789999999854311
Q ss_pred -----------HHhcC--CCCCC-----CCCCHHHHHHH------------HHHHHHHHHHHHhC----CCCCeEeeCCC
Q 005923 444 -----------WLHSN--RYQTS-----DNLTWKQRVQI------------AYDVANALNYLHKY----TNPPYVHKNLK 489 (669)
Q Consensus 444 -----------~l~~~--~~~~~-----~~l~~~~~~~i------------~~qia~~L~yLH~~----~~~~ivHrDik 489 (669)
.+|.. ..... ....|.....- ...+...+++++.. ..+.++|+|+.
T Consensus 116 ~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~ 195 (322)
T 2ppq_A 116 KHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLF 195 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCC
T ss_pred HHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCC
Confidence 12221 00000 00124331110 11244556666542 12359999999
Q ss_pred CCCeeecCCCcEEEcccCCccc
Q 005923 490 TSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~ 511 (669)
+.|||++++....|+||+.+..
T Consensus 196 ~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 196 QDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GGGEEEETTEEEEECCCTTCEE
T ss_pred ccCEEEeCCceEEEecchhccC
Confidence 9999999876568999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.027 Score=56.85 Aligned_cols=58 Identities=21% Similarity=0.280 Sum_probs=42.5
Q ss_pred eEEEEEEE-CCCeeEEEEecc-------cHHHHHHHHHhcCC---CCceeEeeEEEecCceeEEEEecCCCCH
Q 005923 380 GSVYRGSF-KGDDAAVKVMKG-------DVSSEINILKKINH---SNIIRLSGFCVHEGNTYLVYEFADNGAL 441 (669)
Q Consensus 380 G~Vy~g~~-~g~~vavK~~~~-------~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~e~~~~gsL 441 (669)
+.||+... +|+.+.+|+-.. .+..|...|+.+.- --+.+++++ +..++||||++.+..
T Consensus 29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCCC
T ss_pred eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccCC
Confidence 78999998 578999998532 36789999998842 234555554 245899999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.97 E-value=0.016 Score=61.28 Aligned_cols=128 Identities=12% Similarity=0.164 Sum_probs=78.9
Q ss_pred eEEEEEEEC---------CCeeEEEEec------ccHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCCCCHHH
Q 005923 380 GSVYRGSFK---------GDDAAVKVMK------GDVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSD 443 (669)
Q Consensus 380 G~Vy~g~~~---------g~~vavK~~~------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 443 (669)
..+|+.... +..+.+|+.- .++.+|..+++.+. +.-..++++++.+ .+||||++|..|..
T Consensus 64 N~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~ 139 (379)
T 3feg_A 64 NLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKT 139 (379)
T ss_dssp CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCG
T ss_pred ccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCCh
Confidence 457777653 3577888752 23568999998884 3223567776643 29999999754421
Q ss_pred -----------------HHhcCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHHH----hCC-C
Q 005923 444 -----------------WLHSNRYQTSDNL--TWKQRVQIAYDVAN-------------------ALNYLH----KYT-N 480 (669)
Q Consensus 444 -----------------~l~~~~~~~~~~l--~~~~~~~i~~qia~-------------------~L~yLH----~~~-~ 480 (669)
-||.......+.. -|.++.++..++.. .++.|. ... .
T Consensus 140 ~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~ 219 (379)
T 3feg_A 140 QELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSP 219 (379)
T ss_dssp GGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCC
T ss_pred hHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCC
Confidence 1222211111222 35666666655422 233443 222 2
Q ss_pred CCeEeeCCCCCCeeecCC----CcEEEcccCCccc
Q 005923 481 PPYVHKNLKTSNILLDTN----LRAKITNFGLARS 511 (669)
Q Consensus 481 ~~ivHrDik~~NILl~~~----~~~kl~DfGla~~ 511 (669)
..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 359999999999999876 7899999998864
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.023 Score=59.55 Aligned_cols=117 Identities=9% Similarity=0.023 Sum_probs=72.5
Q ss_pred eeeeEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCC--CCCCCCCCceEEEeeecCCCCccc-----ccCCceEEE--
Q 005923 125 QFNTTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPV--DSRNLTVGLDLFVPLRCACPSRDQ-----AASGFNHLL-- 195 (669)
Q Consensus 125 ~~~~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~--~~~~l~~G~~L~ip~~c~c~~~~~-----~~~~~~~~~-- 195 (669)
..+..|+|+ +||||..|-++....-.+..+|.+.... ....|+|||+|.+.+.-. ..... ...+...++
T Consensus 12 ~~W~~~~V~-~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~-~~l~~l~~~~~~~~~~~~v~i 89 (371)
T 3slu_A 12 AYWVQEAVQ-PGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGD-GGAREVQFFTDEDGERNLVAL 89 (371)
T ss_dssp CEEEEEECC-TTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTT-SCEEEEEEEECCTTEEEEEEE
T ss_pred CceEEEEEC-CCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCC-CCeEEEEEEecCCCceeEEEE
Confidence 456789999 9999999994332322333444443322 235899999999986421 00000 000110000
Q ss_pred -----EE----------------EcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCC----CCCCcccccccCC
Q 005923 196 -----TY----------------MVTWGDSISAIAQLFNVDERSVLDANKLSQDDL----IFPFTPILVPLKT 243 (669)
Q Consensus 196 -----tY----------------~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~----l~p~~~l~iP~~~ 243 (669)
.| .+.-.++|+..|.+.|++...+++.+.+-..+. |++|+.+.|....
T Consensus 90 ~~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~~ 162 (371)
T 3slu_A 90 EKKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYDS 162 (371)
T ss_dssp EEETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEEE
T ss_pred EecCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEEE
Confidence 12 233489999999999999988888876543333 8999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.024 Score=61.07 Aligned_cols=57 Identities=11% Similarity=0.172 Sum_probs=39.5
Q ss_pred eEEEEEEEC---------CCeeEEEEecc-----cHHHHHHHHHhcCCCCc-eeEeeEEEecCceeEEEEecCCCC
Q 005923 380 GSVYRGSFK---------GDDAAVKVMKG-----DVSSEINILKKINHSNI-IRLSGFCVHEGNTYLVYEFADNGA 440 (669)
Q Consensus 380 G~Vy~g~~~---------g~~vavK~~~~-----~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs 440 (669)
..+|+.... +..+.+|+... .+..|..+++.+...++ .++++.+.+ .+|+||+++..
T Consensus 87 N~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 87 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp EEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred cceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 578888764 46788998732 45679999988853333 567776532 38999998633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.59 E-value=0.08 Score=54.28 Aligned_cols=131 Identities=12% Similarity=0.170 Sum_probs=73.9
Q ss_pred eEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCC--CceeEeeE-----EEecCceeEEEEecCCCCHH---
Q 005923 380 GSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHS--NIIRLSGF-----CVHEGNTYLVYEFADNGALS--- 442 (669)
Q Consensus 380 G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~e~~~~gsL~--- 442 (669)
..||+.... |+.+++|..+. .+..|..+++.+... .+.+++.. ...++..++||||++|..+.
T Consensus 39 n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~ 118 (328)
T 1zyl_A 39 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 118 (328)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred cceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCC
Confidence 578887764 55799999852 356788888887422 24444443 12345567899999874321
Q ss_pred --H------H---HhcCC--CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC----CCCCeE
Q 005923 443 --D------W---LHSNR--YQ--TSDNLTWKQR----VQI---------------AYDVANALNYLHKY----TNPPYV 484 (669)
Q Consensus 443 --~------~---l~~~~--~~--~~~~l~~~~~----~~i---------------~~qia~~L~yLH~~----~~~~iv 484 (669)
. . +|... .. ....+++... ..+ ...+...++.+... ..+.++
T Consensus 119 ~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 198 (328)
T 1zyl_A 119 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 198 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeee
Confidence 1 1 22110 00 0112233211 001 11111223333321 234489
Q ss_pred eeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 485 HKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 485 HrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|+|+++.|||++ + .+.|+||+.+...
T Consensus 199 HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 199 HGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred eCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 999999999999 4 8999999988653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.44 E-value=0.027 Score=59.16 Aligned_cols=57 Identities=12% Similarity=0.161 Sum_probs=39.0
Q ss_pred eEEEEEEECC----------CeeEEEEecc------cHHHHHHHHHhcCCCC-ceeEeeEEEecCceeEEEEecCCCC
Q 005923 380 GSVYRGSFKG----------DDAAVKVMKG------DVSSEINILKKINHSN-IIRLSGFCVHEGNTYLVYEFADNGA 440 (669)
Q Consensus 380 G~Vy~g~~~g----------~~vavK~~~~------~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gs 440 (669)
..+|+....+ ..+++|+... +...|..+++.+...+ ..++++.. .-++||||++|..
T Consensus 47 N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e~i~G~~ 120 (369)
T 3c5i_A 47 NQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEEWLYGDP 120 (369)
T ss_dssp CEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEECCCSEE
T ss_pred ceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEEEecCCc
Confidence 5688877653 6788888643 3468999999885434 34666543 2378999998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.43 E-value=0.084 Score=57.24 Aligned_cols=58 Identities=17% Similarity=0.129 Sum_probs=41.3
Q ss_pred eEEEEEEECC--CeeEEEEecc------cHHHHHHHHHhcCCCCc-eeEeeEEEecCceeEEEEecCCCCH
Q 005923 380 GSVYRGSFKG--DDAAVKVMKG------DVSSEINILKKINHSNI-IRLSGFCVHEGNTYLVYEFADNGAL 441 (669)
Q Consensus 380 G~Vy~g~~~g--~~vavK~~~~------~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 441 (669)
..+|+....+ ..+++|+... +...|..+++.+...++ .++++.+. + .+||||+++..|
T Consensus 122 N~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 122 NILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred eEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence 5789888865 7788887632 23689999999975555 56777762 2 359999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.031 Score=58.07 Aligned_cols=62 Identities=13% Similarity=0.122 Sum_probs=42.2
Q ss_pred eEEEEEEECCCeeEEEEeccc-HHHHHHHHHhcCC---CCceeEeeE------EEecCceeEEEEecCCCCH
Q 005923 380 GSVYRGSFKGDDAAVKVMKGD-VSSEINILKKINH---SNIIRLSGF------CVHEGNTYLVYEFADNGAL 441 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~~-~~~E~~~l~~l~H---~niv~l~g~------~~~~~~~~lV~e~~~~gsL 441 (669)
..||+...++..+++|+.... ...|+.+++.+.. +++.+.+.. ...++..++||+|++|..+
T Consensus 37 N~vy~v~~~~g~~vLK~~~~~~~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 37 AFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp CEEEEEECSSCEEEEEEEECSSCCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred cceEEEEeCCCCEEEEEecCccchHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 478988876558899987643 3578888877742 224555532 2334667999999998655
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=94.18 E-value=0.053 Score=56.76 Aligned_cols=53 Identities=9% Similarity=-0.009 Sum_probs=44.2
Q ss_pred ceEEEEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCC----CCCCCCCCcccccccCC
Q 005923 191 FNHLLTYMVTWGDSISAIAQLFNVDERSVLDANKLS----QDDLIFPFTPILVPLKT 243 (669)
Q Consensus 191 ~~~~~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~----~~~~l~p~~~l~iP~~~ 243 (669)
..+-..|+|++||||.+|-+|+|++.+++.+.+... .-..|+|||++.+.+..
T Consensus 11 ~~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~ 67 (371)
T 3slu_A 11 TAYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGG 67 (371)
T ss_dssp CCEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECT
T ss_pred CCceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECC
Confidence 345678999999999999999999999999886643 45789999999998764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.79 E-value=0.035 Score=38.61 Aligned_cols=27 Identities=26% Similarity=0.380 Sum_probs=11.7
Q ss_pred eeehhhHHHHHHHHHHHHHHHhhhhcc
Q 005923 281 GAGIGAFLLLLVATLFAFLFCLYRRRR 307 (669)
Q Consensus 281 ~~~i~~~~l~~v~~~~~~~~~~~rr~~ 307 (669)
++++.++++++++++++++++++||+.
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 333433444444444444455444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.77 E-value=0.033 Score=38.65 Aligned_cols=29 Identities=28% Similarity=0.369 Sum_probs=12.2
Q ss_pred EeeehhhHHHHHHHHHHHHHHHhhhhccc
Q 005923 280 IGAGIGAFLLLLVATLFAFLFCLYRRRRN 308 (669)
Q Consensus 280 i~~~i~~~~l~~v~~~~~~~~~~~rr~~~ 308 (669)
|++++.++++++++++++++++++||+++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 33333333444444444444444444433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.96 E-value=1.1 Score=47.78 Aligned_cols=127 Identities=13% Similarity=0.218 Sum_probs=78.0
Q ss_pred eEEEEEEEC---------CCeeEEEEecc------cHHHHHHHHHhcCCCC-ceeEeeEEEecCceeEEEEecCCCCHHH
Q 005923 380 GSVYRGSFK---------GDDAAVKVMKG------DVSSEINILKKINHSN-IIRLSGFCVHEGNTYLVYEFADNGALSD 443 (669)
Q Consensus 380 G~Vy~g~~~---------g~~vavK~~~~------~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gsL~~ 443 (669)
..+|+.... +..+++|+... +..+|..+++.+...+ ..++++.+ .-++||||++|..|..
T Consensus 84 N~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~efI~G~~l~~ 159 (424)
T 3mes_A 84 NQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEFIDGEPLTT 159 (424)
T ss_dssp SEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEECCCSEECCT
T ss_pred cceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEEeCCccCCh
Confidence 468887775 57788887632 3568999999885323 45566543 2378999999865321
Q ss_pred -----------------HHhcCCC-----C---CCCCCCHHHHHHHHHHH-------------------HHHHHHHHhC-
Q 005923 444 -----------------WLHSNRY-----Q---TSDNLTWKQRVQIAYDV-------------------ANALNYLHKY- 478 (669)
Q Consensus 444 -----------------~l~~~~~-----~---~~~~l~~~~~~~i~~qi-------------------a~~L~yLH~~- 478 (669)
-||.... . ...+.-|.++.++..++ ...+.+|.+.
T Consensus 160 ~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~~~L~~~l 239 (424)
T 3mes_A 160 KQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEIDQLEELI 239 (424)
T ss_dssp GGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHHHHHHHHH
T ss_pred hhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHHHHHHHHH
Confidence 1121110 0 11122366555554433 2233444311
Q ss_pred --------------------CCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 479 --------------------TNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 479 --------------------~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 240 ~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 240 MGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred hhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 1234899999999999 8888999999998864
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.59 E-value=0.12 Score=35.73 Aligned_cols=18 Identities=28% Similarity=0.353 Sum_probs=7.3
Q ss_pred HHHHHHHHHHHHhhhhcc
Q 005923 290 LLVATLFAFLFCLYRRRR 307 (669)
Q Consensus 290 ~~v~~~~~~~~~~~rr~~ 307 (669)
+++++.++++++.+||+.
T Consensus 23 l~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 23 LVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhheehhhh
Confidence 333333344444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 669 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-22 | |
| d1y7ma2 | 48 | d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term | 3e-04 | |
| d1e0ga_ | 48 | d.7.1.1 (A:) Membrane-bound lytic murein transclyc | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-61
Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 50/302 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS---------EINILKK 410
+I +GSF G+VY+G + GD AVK++ + E+ +L+K
Sbjct: 10 ITVGQ-RIGSGSF-------GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
H NI+ G+ +V ++ + +L LH + + IA A
Sbjct: 61 TRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQ 115
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
++YLH +H++LK++NI L +L KI +FGLA G +
Sbjct: 116 GMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS------GSHQFEQL 166
Query: 531 VGTYGYMAPEYI---ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
G+ +MAPE I + + + DV+AFG+V+ EL++G+ + N
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------------ 214
Query: 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647
+ + RG++ P L + + +M +L C + RP ++ ++ +
Sbjct: 215 --RDQIIFMVGRGYLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
Query: 648 SS 649
S
Sbjct: 272 RS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-57
Identities = 68/293 (23%), Positives = 122/293 (41%), Gaps = 50/293 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVSS-----EINILKKINHS 414
K I G F G V G ++G+ AVK +K D ++ E +++ ++ HS
Sbjct: 9 LKLLQ-TIGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHS 60
Query: 415 NIIRLSGFCVHE-GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALN 473
N+++L G V E G Y+V E+ G+L D+L S L ++ + DV A+
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAME 117
Query: 474 YLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGT 533
YL +VH++L N+L+ + AK+++FGL + A S +
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----------TGKLP 163
Query: 534 YGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593
+ APE + + K DV++FG+++ E+ S +
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------- 208
Query: 594 VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
+ ++ + + P ++ ++ KNC D RPS ++ L I
Sbjct: 209 ----VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 68/303 (22%), Positives = 125/303 (41%), Gaps = 39/303 (12%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGDVS------SEINILKKINHSNIIRL 419
I G F G V+RG ++G++ AVK+ +EI + H NI+
Sbjct: 10 SIGKGRF-------GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 420 SGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
+ T +LV ++ ++G+L D+L+ +T + +++A A+ L +L
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHL 116
Query: 476 HK-----YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
H P H++LK+ NIL+ N I + GLA +S H
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD----TIDIAPNHR 172
Query: 531 VGTYGYMAPEYIENGV------ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
VGT YMAPE +++ + + D++A G+V E+ ++ +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 585 ISRVLEESNVREKLRGFIDPSLRNEY-PLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
S E + + P++ N + + MA++ + C + AR + + TL
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
Query: 644 SKI 646
S++
Sbjct: 293 SQL 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-54
Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 51/305 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKGDVSS--------EINI 407
D+++ G+F GSV +G ++ D A+KV+K E I
Sbjct: 10 LLIADIELGCGNF-------GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+ ++++ I+RL G C LV E A G L +L R + + ++ +
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQ 117
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
V+ + YL +VH++L N+LL AKI++FGL+++ +D+
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTAR 169
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
+ APE I + + DV+++GV + E LS +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------------ 217
Query: 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647
++ FI+ R E P + + L +C + RP V + +
Sbjct: 218 -------GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
Query: 648 SSSSD 652
S +
Sbjct: 271 YSLAS 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-54
Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 48/298 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKGDVSS------EINILKKIN 412
K + ++ G F G V+ G + AVK +K S E N++K++
Sbjct: 15 LKLVE-RLGAGQF-------GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
H ++RL + Y++ E+ +NG+L D+L + LT + + +A +A +
Sbjct: 67 HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGM 122
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
++ + Y+H++L+ +NIL+ L KI +FGLAR E +E+
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKF 172
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592
+ APE I G T K DV++FG+++ E+++ E++
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQN--------- 222
Query: 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650
++ R P + + QL + C RP+ + L ++++
Sbjct: 223 ---------LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (469), Expect = 6e-54
Identities = 78/318 (24%), Positives = 130/318 (40%), Gaps = 55/318 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQ-------------GSVYRGSFKGDD-----AAVKVMKGDV 401
+ F+D A F++E I G V G K A+K +K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 402 S--------SEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTS 453
+ SE +I+ + +H N+I L G ++ EF +NG+L +L N Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 454 DNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513
T Q V + +A + YL + YVH++L NIL+++NL K+++FGL+R E
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGD 573
D + + APE I+ T DV+++G+V+ E++S E D
Sbjct: 180 DDTSDPTYTS---ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNAR 633
+ + I+ R P+D ++ QL +C D N R
Sbjct: 237 MT-------------------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
Query: 634 PSISEVFVTLSKIWSSSS 651
P ++ TL K+ + +
Sbjct: 278 PKFGQIVNTLDKMIRNPN 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 55/325 (16%), Positives = 118/325 (36%), Gaps = 60/325 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKGDVSS--------EINILKKINHSN 415
++ G+ G V++ S K A K++ ++ E+ +L + N
Sbjct: 13 ELGAGNG-------GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
I+ G +G + E D G+L L + + +++ V L YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYL 120
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
+H+++K SNIL+++ K+ +FG++ + VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----------MANSFVGTRS 168
Query: 536 YMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI---------- 585
YM+PE ++ + + D+++ G+ ++E+ GR + E EL++
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 586 ---------SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKN----CTAHDLNA 632
S +S + +D + P + + ++ C +
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 633 RPSISEVFVTLSKIWSSSSDWDPSD 657
R + ++ + + SD + D
Sbjct: 289 RADLKQL---MVHAFIKRSDAEEVD 310
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-53
Identities = 63/297 (21%), Positives = 124/297 (41%), Gaps = 48/297 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKGDVSS------EINILKKIN 412
F +I +G F G V+ G + D A+K ++ S E ++ K++
Sbjct: 7 LTFVQ-EIGSGQF-------GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS 58
Query: 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
H +++L G C+ + LV+EF ++G LSD+L + R + + + + DV +
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA----AETLLGMCLDVCEGM 114
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
YL + +H++L N L+ N K+++FG+ R D++ +
Sbjct: 115 AYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-------STGTKF 164
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592
+ +PE + K DV++FGV++ E+ S + +++ +E++
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVED--------- 214
Query: 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649
I R P + + Q+ +C RP+ S + L++I S
Sbjct: 215 ---------ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-53
Identities = 69/309 (22%), Positives = 132/309 (42%), Gaps = 53/309 (17%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA----AVKVMKGDVSS---------EI 405
L +D ++ +G+F G+V +G ++ AVK++K + + E
Sbjct: 7 LLTLEDKELGSGNF-------GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 59
Query: 406 NILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
N+++++++ I+R+ G C E + LV E A+ G L+ +L NR+ + K +++
Sbjct: 60 NVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELV 113
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
+ V+ + YL +VH++L N+LL T AKI++FGL+++ +DE+ +
Sbjct: 114 HQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----K 165
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
H + APE I + K DV++FGV++ E S +
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------- 215
Query: 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
++ ++ R P M L C +D+ RP + V + L
Sbjct: 216 ---------GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
Query: 646 IWSSSSDWD 654
+ +
Sbjct: 267 YYYDVVNEG 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-52
Identities = 71/308 (23%), Positives = 126/308 (40%), Gaps = 49/308 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKGDVSS------EINILKKIN 412
+ + K+ G F G V+ G++ A+K +K S E ++KK+
Sbjct: 19 LRLEV-KLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 70
Query: 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
H +++L E Y+V E+ G+L D+L + Q V +A +A+ +
Sbjct: 71 HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIASGM 126
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
Y+ YVH++L+ +NIL+ NL K+ +FGLAR E +E+ +
Sbjct: 127 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKF 176
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592
+ APE G T K DV++FG+++ EL + RV
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG-------------------RVPYPG 217
Query: 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSS- 651
V ++ ++ R P + S+ L C + RP+ + L ++S+
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
Query: 652 DWDPSDEL 659
+ P + L
Sbjct: 278 QYQPGENL 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 1e-52
Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 48/307 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKGDVSS------EINILKKI 411
+ K+ G + G VY G +K AVK +K D E ++K+I
Sbjct: 19 ITMKH-KLGGGQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
H N+++L G C E Y++ EF G L D+L Q ++ + +A +++A
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSA 127
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
+ YL K ++H++L N L+ N K+ +FGL+R D +
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-------TAHAGAK 177
Query: 532 GTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591
+ APE + + K DV+AFGV++ E+ + + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------- 221
Query: 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSS 651
++ ++ R E P + +L + C + + RPS +E+ ++ SS
Sbjct: 222 ---LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
Query: 652 DWDPSDE 658
D ++
Sbjct: 279 ISDEVEK 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-51
Identities = 86/311 (27%), Positives = 132/311 (42%), Gaps = 63/311 (20%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGD----DAAVKVMKGDVS--------SEINI 407
KFQD I G+F G V + K D DAA+K MK S E+ +
Sbjct: 12 IKFQD-VIGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 408 LKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSD-----------N 455
L K+ +H NII L G C H G YL E+A +G L D+L +R +D
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 456 LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESD 515
L+ +Q + A DVA ++YL + ++H++L NIL+ N AKI +FGL+R E
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 516 EHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQN 575
+MA E + V T DV+++GV++ E++S
Sbjct: 181 VK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 576 CEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS 635
C +L + R E PL+ + L + C RPS
Sbjct: 232 C-------------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 272
Query: 636 ISEVFVTLSKI 646
+++ V+L+++
Sbjct: 273 FAQILVSLNRM 283
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 5e-50
Identities = 60/295 (20%), Positives = 119/295 (40%), Gaps = 50/295 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKGDVSS------EINILKKIN 412
F ++ TG F G V G ++ D A+K++K S E ++ ++
Sbjct: 6 LTFLK-ELGTGQF-------GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 57
Query: 413 HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
H +++L G C + +++ E+ NG L ++L R++ +Q +++ DV A+
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAM 113
Query: 473 NYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVG 532
YL + ++H++L N L++ K+++FGL+R DE+ +
Sbjct: 114 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-------SVGSKF 163
Query: 533 TYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591
+ PE + + K D++AFGV++ E+ S G+ N E
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------------- 209
Query: 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
I LR P + + + +C + RP+ + + +
Sbjct: 210 ------TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-50
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 49/299 (16%)
Query: 366 KIATGSFSEENRI----QGSVYRGSFKGDDA------AVKVMKGDVSS--------EINI 407
+I + + I G VY+G K A+K +K + E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+ + +H NIIRL G ++ E+ +NGAL +L + + Q V +
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRG 118
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+A + YL N YVH++L NIL+++NL K+++FGL+R E D T
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTT 170
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
+ APE I T DV++FG+V+ E+++ E + +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------ 218
Query: 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
++ I+ R P+D ++ QL C + RP +++ L K+
Sbjct: 219 -------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 73/322 (22%), Positives = 119/322 (36%), Gaps = 64/322 (19%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDD-------AAVKVMKGDVS--------SE 404
F + G+F G V + G AVK++K SE
Sbjct: 25 LSFGK-TLGAGAF-------GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 405 INILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN-------- 455
+ +L + NH NI+ L G C G T ++ E+ G L ++L R +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 456 -----LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510
L + + +Y VA + +L + +H++L NILL KI +FGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV 570
++D + + + +MAPE I N V T + DV+++G+ + EL S +
Sbjct: 194 DIKNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 571 TGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL 630
+ K I R P M + K C D
Sbjct: 248 YPGMPVD------------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 631 NARPSISEVFVTLSKIWSSSSD 652
RP+ ++ + K S S++
Sbjct: 290 LKRPTFKQIVQLIEKQISESTN 311
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 2e-49
Identities = 69/326 (21%), Positives = 105/326 (32%), Gaps = 71/326 (21%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK----------GDVSSEINI 407
F DL+ I GSF G+VY + A+K M D+ E+
Sbjct: 16 LFSDLREIGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
L+K+ H N I+ G + E +LV E+ A + L + + +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHG 123
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
L YLH +H+++K NILL K+ +FG A
Sbjct: 124 ALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------------A 168
Query: 528 RHVVGTYGYMAPEYIE---NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
VGT +MAPE I G K+DV++ G+ +EL +
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK----------------- 211
Query: 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV----F 640
L N L + +C RP+ + F
Sbjct: 212 --PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269
Query: 641 VTLSKIWSSSSD-----WDPSDELNN 661
V + + D D EL+N
Sbjct: 270 VLRERPPTVIMDLIQRTKDAVRELDN 295
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 69/314 (21%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDD-------AAVKVMKGDVSS--------E 404
+F + +G+F G V + G AVK++K S E
Sbjct: 39 LEFGK-VLGSGAF-------GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90
Query: 405 INILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN-------- 455
+ ++ ++ +H NI+ L G C G YL++E+ G L ++L S R + S++
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 456 ----------LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505
LT++ + AY VA + +L VH++L N+L+ KI +
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 207
Query: 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565
FGLAR SD + + + +MAPE + G+ T K DV+++G+++ E+ S
Sbjct: 208 FGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 566 GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNC 625
V I + + P + + ++C
Sbjct: 262 LGV------------------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSC 303
Query: 626 TAHDLNARPSISEV 639
A D RPS +
Sbjct: 304 WAFDSRKRPSFPNL 317
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-49
Identities = 62/290 (21%), Positives = 107/290 (36%), Gaps = 51/290 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKGD---------VSSEINILKKINHS 414
I TGS+ G + K D K + + SE+N+L+++ H
Sbjct: 11 TIGTGSY-------GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 415 NIIRLSGFCVHEGNT--YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANAL 472
NI+R + NT Y+V E+ + G L+ + + L + +++ + AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLAL 122
Query: 473 NYLHK--YTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
H+ +H++LK +N+ LD K+ +FGLAR D +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--------FAKAF 174
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590
VGT YM+PE + K D+++ G ++ EL + T E
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------- 221
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
L G I P + + ++ RPS+ E+
Sbjct: 222 -------LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-49
Identities = 69/296 (23%), Positives = 111/296 (37%), Gaps = 59/296 (19%)
Query: 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKGDVSS---------- 403
+L ++ + G F G+VY K A+KV+
Sbjct: 4 ALEDFEIGR-PLGKGKF-------GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E+ I + H NI+RL G+ YL+ E+A G + L ++
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTAT 110
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
++ANAL+Y H +H+++K N+LL + KI +FG + A S
Sbjct: 111 YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------- 160
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583
+ GT Y+ PE IE + K+D+++ GV+ E L G+ + E Y
Sbjct: 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK 214
Query: 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
ISR V F+ R+ L H+ + RP + EV
Sbjct: 215 RISR------VEFTFPDFVTEGARD------------LISRLLKHNPSQRPMLREV 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 64/297 (21%), Positives = 107/297 (36%), Gaps = 59/297 (19%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EINIL 408
KF D++I GSF +VY+G + A ++ + E +L
Sbjct: 11 LKF-DIEIGRGSF-------KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 62
Query: 409 KKINHSNIIRLSGFCV----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
K + H NI+R + LV E +G L +L + + K
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSW 117
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILL-DTNLRAKITNFGLARSAESDEHEQGGYG 523
+ L +LH PP +H++LK NI + KI + GLA +
Sbjct: 118 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-------- 168
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583
+ V+GT +MAPE E +DV+AFG+ +LE+ + + QN
Sbjct: 169 --FAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQ----- 220
Query: 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
I R + P ++ + + C + + R SI ++
Sbjct: 221 -IYRRVTSGVKPASFDKVAIPEVKE------------IIEGCIRQNKDERYSIKDLL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 54/285 (18%), Positives = 105/285 (36%), Gaps = 50/285 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD--------VSSEINILKKINHSN 415
+ G++ G V + + AVK++ + EI I K +NH N
Sbjct: 12 TLGEGAY-------GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 416 IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYL 475
+++ G YL E+ G L D + + + + + + + YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYL 119
Query: 476 HKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYG 535
H H+++K N+LLD KI++FGLA + E +L + GT
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE------RLLNKMCGTLP 170
Query: 536 YMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESNV 594
Y+APE ++ +DV++ G+V+ +L+G S+
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP------------------SDS 212
Query: 595 REKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
++ + + + + L + +AR +I ++
Sbjct: 213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 4e-48
Identities = 66/315 (20%), Positives = 122/315 (38%), Gaps = 69/315 (21%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVSS--------EINILKK 410
I G+F G V++ G AVK++K + S+ E ++ +
Sbjct: 20 DIGEGAF-------GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN--------------- 455
++ NI++L G C L++E+ G L+++L S T +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 456 ----LTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511
L+ +++ IA VA + YL + +VH++L T N L+ N+ KI +FGL+R+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571
S ++ + + +M PE I T + DV+A+GVV+ E+ S
Sbjct: 190 IYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLN 631
E++ ++ P + + L + C +
Sbjct: 244 YGMA-------------------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 284
Query: 632 ARPSISEVFVTLSKI 646
RPS + L ++
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 67/302 (22%), Positives = 111/302 (36%), Gaps = 54/302 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVSS----------E 404
+ + K+ GSF G V RG + AVK +K DV S E
Sbjct: 10 LRLLE-KLGDGSF-------GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 405 INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
+N + ++H N+IRL G +V E A G+L D L ++ + +
Sbjct: 62 VNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY 116
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
A VA + YL + ++H++L N+LL T KI +FGL R+ ++
Sbjct: 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY----- 168
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
+ H + + APE ++ + D + FGV + E+ + +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---------------- 212
Query: 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644
N + L R P D + + C AH RP+ + L
Sbjct: 213 --EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
Query: 645 KI 646
+
Sbjct: 271 EA 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 52/305 (17%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-----AVKVMKGDVS--------SEI 405
+ F ++ I G F G VY G+ +D AVK + +E
Sbjct: 28 IVHFNEV-IGRGHF-------GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79
Query: 406 NILKKINHSNIIRLSGFCVH-EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
I+K +H N++ L G C+ EG+ +V + +G L +++ + + N T K +
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGF 135
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGL 524
VA + +L + +VH++L N +LD K+ +FGLAR E + +
Sbjct: 136 GLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS----V 188
Query: 525 QLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
+MA E ++ T K DV++FGV++ EL++ D N
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--------- 239
Query: 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644
+ ++ R P + ++ C RPS SE+ +S
Sbjct: 240 ----------TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
Query: 645 KIWSS 649
I+S+
Sbjct: 290 AIFST 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 8e-47
Identities = 62/300 (20%), Positives = 121/300 (40%), Gaps = 55/300 (18%)
Query: 362 FQDLK-IATGSFSEENRIQGSVYRGSFKGDDA------AVKVMKGDVSS--------EIN 406
F+ +K + +G+F G+VY+G + + A+K ++ S E
Sbjct: 11 FKKIKVLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
++ +++ ++ RL G C L+ + G L D++ ++ DN+ + +
Sbjct: 64 VMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCV 118
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
+A +NYL + VH++L N+L+ T KIT+FGLA+ ++E E
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY------H 169
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586
+MA E I + + T + DV+++GV V EL++
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------- 218
Query: 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
++ ++ R P + + C D ++RP E+ + SK+
Sbjct: 219 --------ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 64/315 (20%), Positives = 117/315 (37%), Gaps = 58/315 (18%)
Query: 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKG-------DVSSEINILK 409
++ ++ G+F G VY+ K AA KV+ D EI+IL
Sbjct: 13 FWEIIG-ELGDGAF-------GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
+H NI++L +E N +++ EF GA+ + LT Q +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTL 120
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
+ALNYLH +H++LK NIL + K+ +FG++ Q
Sbjct: 121 DALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--------QRRDS 169
Query: 530 VVGTYGYMAPEYI-----ENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584
+GT +MAPE + ++ K DV++ G+ ++E+
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------ 223
Query: 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644
+ ++ + + ++ K C +++AR + S++ L
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSNFKD------------FLKKCLEKNVDARWTTSQL---LQ 268
Query: 645 KIWSSSSDWDPSDEL 659
+ + P EL
Sbjct: 269 HPFVTVDSNKPIREL 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 56/289 (19%), Positives = 111/289 (38%), Gaps = 52/289 (17%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD-------VSSEINILKK 410
K+ KI G+ G+VY G + A++ M + +EI ++++
Sbjct: 21 KYTRFEKIGQGAS-------GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
+ NI+ + ++V E+ G+L+D + Q + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQ 127
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHV 530
AL +LH +H+++K+ NILL + K+T+FG ++ + +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--------RSTM 176
Query: 531 VGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590
VGT +MAPE + PK+D+++ G++ +E++ G + LY +
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIAT---- 230
Query: 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ + + P L+ C D+ R S E+
Sbjct: 231 ------------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 72/321 (22%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA---------AVKVMKGDVS-------- 402
+ G+F G V G D AVK++K D +
Sbjct: 15 LVLGK-PLGEGAF-------GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 403 SEINILKKI-NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNR-----------Y 450
SE+ ++K I H NII L G C +G Y++ E+A G L ++L + R +
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 451 QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510
+ L+ K V AY VA + YL +H++L N+L+ + KI +FGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV 570
++ + T + +MAPE + + + T + DV++FGV++ E+ + +
Sbjct: 184 DIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 571 TGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDL 630
E+L + R + P + + + ++C
Sbjct: 238 YPGVP-------------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 278
Query: 631 NARPSISEVFVTLSKIWSSSS 651
+ RP+ ++ L +I + +S
Sbjct: 279 SQRPTFKQLVEDLDRIVALTS 299
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (408), Expect = 9e-45
Identities = 70/349 (20%), Positives = 126/349 (36%), Gaps = 55/349 (15%)
Query: 333 DYSLFPQASNSLSHPQGFRSAVESLT-LYKFQDLKIATGSFSEENRIQGSVYRGSFK--G 389
DY F + PQ S+ Y + ++ +G+F G V+R K G
Sbjct: 3 DYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILE-ELGSGAF-------GVVHRCVEKATG 54
Query: 390 DDAAVKVMKGD-------VSSEINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALS 442
K + V +EI+I+ +++H +I L + L+ EF G L
Sbjct: 55 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114
Query: 443 DWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--NLR 500
D + + Y+ ++ + + L ++H+ VH ++K NI+ +T
Sbjct: 115 DRIAAEDYK----MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASS 167
Query: 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVV 560
KI +FGLA DE + + T + APE ++ + D++A GV+
Sbjct: 168 VKIIDFGLATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 218
Query: 561 LELLSGREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQ 620
LLSG G+ + E ++ R D + ++
Sbjct: 219 YVLLSGLSPFAGEDDLE---TLQNVKRC--------------DWEFDEDAFSSVSPEAKD 261
Query: 621 LAKNCTAHDLNARPSISEVFVT--LSKIWSSSSDWDPSDELNNSRSLSR 667
KN + R ++ + L S+ + PS N R +
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 310
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-44
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 55/300 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDD-----AAVKVMKGDVSS--------EIN 406
+ I G F G V++G + + A+K K S E
Sbjct: 9 IELGR-CIGEGQF-------GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 407 ILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
+++ +H +I++L G E +++ E G L +L +Y +L + AY
Sbjct: 61 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAY 115
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
++ AL YL +VH+++ N+L+ +N K+ +FGL+R E + +
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK------- 165
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586
+MAPE I T DV+ FGV + E+L
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----------- 214
Query: 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
+ G I+ R P + ++ L C A+D + RP +E+ LS I
Sbjct: 215 --------NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-44
Identities = 63/301 (20%), Positives = 125/301 (41%), Gaps = 55/301 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVSS--------EINILKK 410
++ GSF G VY G KG A+K + S E +++K+
Sbjct: 27 ELGQGSF-------GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDN-----LTWKQRVQIA 465
N +++RL G T ++ E G L +L S R ++N + + +Q+A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
++A+ + YL+ +VH++L N ++ + KI +FG+ R ++ +
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY------YR 190
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
+ +M+PE +++GV T DV++FGVV+ E+ + E +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------- 240
Query: 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSK 645
E++ F+ + P + + +L + C ++ RPS E+ ++ +
Sbjct: 241 ---------NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
Query: 646 I 646
Sbjct: 292 E 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 75/320 (23%), Positives = 118/320 (36%), Gaps = 63/320 (19%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA-------AVKVMKGDVS--------SE 404
K + G+F G V G D AVK++K + SE
Sbjct: 15 LKLGK-PLGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 405 INILKKINH-SNIIRLSGFCVHEGNT-YLVYEFADNGALSDWLHSNRYQT---------- 452
+ IL I H N++ L G C G ++ EF G LS +L S R +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 453 -SDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511
D LT + + ++ VA + +L + +H++L NILL KI +FGLAR
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVT 571
D +MAPE I + V T + DV++FGV++ E+ S +
Sbjct: 184 IYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 572 GDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLN 631
+ E + R P M Q +C + +
Sbjct: 238 PGVKIDEEFCRR------------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 279
Query: 632 ARPSISEVFVTLSKIWSSSS 651
RP+ SE+ L + +++
Sbjct: 280 QRPTFSELVEHLGNLLQANA 299
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 2e-43
Identities = 60/322 (18%), Positives = 115/322 (35%), Gaps = 53/322 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS--------EINILK 409
Y F+D + TG+F V K A+K + EI +L
Sbjct: 11 YDFRD-VLGTGAF-------SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
KI H NI+ L G+ YL+ + G L D + + T + ++ + V
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVL 117
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
+A+ YLH K LD + + I++FGL++ + +
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---------VLST 168
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
GT GY+APE + + +D ++ GV+ LL G + + + L+ I +
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILKA- 224
Query: 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV----FVTLSK 645
+ + Y D++ S ++ D R + + ++
Sbjct: 225 -------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271
Query: 646 IWSSSSDWDPSDELNNSRSLSR 667
+ S+++ + + S+
Sbjct: 272 ALDKNIHQSVSEQIKKNFAKSK 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (396), Expect = 4e-43
Identities = 56/291 (19%), Positives = 109/291 (37%), Gaps = 52/291 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS-------EINILKK 410
Y + ++ TG+F G V+R + + G++ A K + S EI +
Sbjct: 28 YDIHE-ELGTGAF-------GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 79
Query: 411 INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
+ H ++ L + ++YEF G L + + + ++ + V+ V
Sbjct: 80 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCK 135
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
L ++H+ YVH +LK NI+ T + K+ +FGL + + +
Sbjct: 136 GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---------VK 183
Query: 529 HVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588
GT + APE E + D+++ GV+ LLSG G+ + E ++
Sbjct: 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKSC 240
Query: 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
D ++ + ++ + D N R +I +
Sbjct: 241 --------------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-42
Identities = 54/310 (17%), Positives = 110/310 (35%), Gaps = 58/310 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----------VSSEINI 407
+KF + GSF +V + A+K+++ V+ E ++
Sbjct: 10 FKFGK-ILGEGSF-------STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 408 LKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
+ +++H ++L + Y +A NG L ++ + +
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAE 116
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLT 527
+ +AL YLH +H++LK NILL+ ++ +IT+FG A+ + +
Sbjct: 117 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ------ARA 167
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
VGT Y++PE + D++A G ++ +L++G ++ I +
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKIIK 224
Query: 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT---LS 644
L ++P L + D R E+ +
Sbjct: 225 ------------------LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
Query: 645 KIWSSSSDWD 654
+ S W+
Sbjct: 267 HPFFESVTWE 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-41
Identities = 55/290 (18%), Positives = 105/290 (36%), Gaps = 51/290 (17%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDD--AAVKVMKGD------VSSEINILKKI 411
Y + + G F G V+R K +K V EI+IL
Sbjct: 7 YMIAE-DLGRGEF-------GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
H NI+ L +++EF + + ++++ ++ L ++ V + V A
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEA 114
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
L +LH H +++ NI+ T + KI FG AR + ++ R
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---------FRL 162
Query: 530 VVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589
+ Y APE ++ V++ D+++ G +V LLSG + N + + +I
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNA- 218
Query: 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ + E +++ + +R + SE
Sbjct: 219 -------------EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 145 bits (366), Expect = 1e-39
Identities = 62/304 (20%), Positives = 119/304 (39%), Gaps = 55/304 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS----------EINI 407
Y+ + + G V+ D AVKV++ D++ E
Sbjct: 9 YELGE-ILGFGGM-------SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 408 LKKINHSNIIRLSGFCVHEGNT----YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
+NH I+ + E Y+V E+ D L D +H+ +T K+ ++
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIE 115
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
+ D ALN+ H+ +H+++K +NI++ K+ +FG+AR+ +
Sbjct: 116 VIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS----- 167
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583
+ T V+GT Y++PE + + DV++ G V+ E+L+G TGD + Y
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQ 225
Query: 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-SISEVFVT 642
+ DP + L+ + + A + R + +E+
Sbjct: 226 HVRE---------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
Query: 643 LSKI 646
L ++
Sbjct: 271 LVRV 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 70/316 (22%), Positives = 118/316 (37%), Gaps = 64/316 (20%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSSE 404
Y + ++ +G F V + K G A K +K D+ E
Sbjct: 12 YDTGE-ELGSGQF-------AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 405 INILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQI 464
++ILK+I H N+I L ++ + L+ E G L D+L +LT ++ +
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEF 118
Query: 465 AYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN----LRAKITNFGLARSAESDEHEQG 520
+ N + YLH H +LK NI+L R KI +FGLA +
Sbjct: 119 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--- 172
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
+++ GT ++APE + + + D+++ GV+ LLSG GD E
Sbjct: 173 ------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--- 223
Query: 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVF 640
A++S V + +EY + + + D R +I +
Sbjct: 224 TLANVSAV--------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS- 268
Query: 641 VTLSKIWSSSSDWDPS 656
L W D +
Sbjct: 269 --LQHPWIKPKDTQQA 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (358), Expect = 1e-38
Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 67/305 (21%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS-------------- 403
Y+ ++ + G V R K + AVK++
Sbjct: 5 YEPKE-ILGRGVS-------SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 56
Query: 404 --EINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
E++IL+K++ H NII+L +LV++ G L D+L L+ K+
Sbjct: 57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKE 111
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+I + + LHK VH++LK NILLD ++ K+T+FG + + E
Sbjct: 112 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--- 165
Query: 521 GYGLQLTRHVVGTYGYMAPEYIE------NGVITPKLDVFAFGVVVLELLSGREAVTGDQ 574
R V GT Y+APE IE + ++D+++ GV++ LL+G +
Sbjct: 166 ------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219
Query: 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
+ +L +S + + D + ++ L R
Sbjct: 220 --QMLMLRMIMSG---------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 262
Query: 635 SISEV 639
+ E
Sbjct: 263 TAEEA 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 60/320 (18%), Positives = 112/320 (35%), Gaps = 50/320 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--DVSSEINILKKI-NHS 414
YK + G G V + K + A+K+++ E+ + +
Sbjct: 13 YKVTSQVLGLGIN-------GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCP 65
Query: 415 NIIRLSGFC----VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
+I+R+ +V E D G L + Q T ++ +I +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGE 122
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITNFGLARSAESDEHEQGGYGLQLT 527
A+ YLH H+++K N+L + N K+T+FG A+ S
Sbjct: 123 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-------- 171
Query: 528 RHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
T Y+APE + D+++ GV++ LL G + S
Sbjct: 172 -TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------------PPFYSNHG 218
Query: 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIW 647
+ ++ ++R N +++ + L +N + R +I+E ++ W
Sbjct: 219 LAISPGMKTRIR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPW 274
Query: 648 SSSSDWDPSDELNNSRSLSR 667
S P L+ SR L
Sbjct: 275 IMQSTKVPQTPLHTSRVLKE 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 2e-37
Identities = 56/313 (17%), Positives = 106/313 (33%), Gaps = 48/313 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-----GDVSSEINILKKIN 412
Y+ KI +GSF G +Y G+ G++ A+K+ + E I K +
Sbjct: 9 YRLGR-KIGSGSF-------GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 413 HSNIIRLSGFCVHEGNT-YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
I +C EG+ +V E + +R + K + +A + +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISR 115
Query: 472 LNYLHKYTNPPYVHKNLKTSNIL---LDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
+ Y+H ++H+++K N L I +FGLA+ Q + +
Sbjct: 116 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP-YRENK 171
Query: 529 HVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588
++ GT Y + + + D+ + G V++ G G + Y
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----- 226
Query: 589 LEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648
+ EK L YP + A C + + +P S + ++
Sbjct: 227 ----RISEKKMSTPIEVLCKGYPSEF----ATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 649 SSS-------DWD 654
DW+
Sbjct: 279 RQGFSYDYVFDWN 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (350), Expect = 1e-36
Identities = 58/317 (18%), Positives = 105/317 (33%), Gaps = 62/317 (19%)
Query: 357 LTLYKFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------- 403
LT+ F + I G F G VY G A+K +
Sbjct: 1 LTMNDFSVHRIIGRGGF-------GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN 53
Query: 404 ---EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
++++ + I+ +S + + + G L L + +
Sbjct: 54 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEAD 108
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
A ++ L ++H V+++LK +NILLD + +I++ GLA +
Sbjct: 109 MRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 161
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579
VGT+GYMAPE ++ GV D F+ G ++ +LL G + +
Sbjct: 162 ------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ + ++ E P + + L + D+N R
Sbjct: 216 EIDR------------------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGR 257
Query: 640 FVT--LSKIWSSSSDWD 654
+ S DW
Sbjct: 258 GAQEVKESPFFRSLDWQ 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 70/299 (23%), Positives = 115/299 (38%), Gaps = 51/299 (17%)
Query: 366 KIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS------------EINILKKI 411
+ G F +VY+ K + A+K +K S EI +L+++
Sbjct: 5 FLGEGQF-------ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 412 NHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
+H NII L H+ N LV++F + ++ LT
Sbjct: 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQG 112
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVV 531
L YLH++ +H++LK +N+LLD N K+ +FGLA+S S H V
Sbjct: 113 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQV 161
Query: 532 GTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL- 589
T Y APE + + +D++A G ++ ELL + GD + + I L
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLG 218
Query: 590 ----EESNVREKLRGFIDPSLRNEYPLDLAFSMA-----QLAKNCTAHDLNARPSISEV 639
E+ L ++ PL FS A L + + AR + ++
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (338), Expect = 8e-36
Identities = 50/315 (15%), Positives = 96/315 (30%), Gaps = 50/315 (15%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-----GDVSSEINILKKIN 412
YK +I GSF G ++ G+ A+K + E K +
Sbjct: 7 YKVGR-RIGEGSF-------GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 58
Query: 413 HSNII-RLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANA 471
I + F + LV + R + K A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLAR 113
Query: 472 LNYLHKYTNPPYVHKNLKTSNILLDTNLR-----AKITNFGLARSAESDEHEQGGYGLQL 526
+ +H+ V++++K N L+ + +FG+ + D + +
Sbjct: 114 VQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYRE 169
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586
+++ GT YM+ + + D+ A G V + L G G + + Y I
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646
+ + +RE GF + + +A P + SK+
Sbjct: 230 EKKQSTPLRELCAGFPEE-------------FYKYMHYARNLAFDATPDYDYLQGLFSKV 276
Query: 647 -------WSSSSDWD 654
+ DW+
Sbjct: 277 LERLNTTEDENFDWN 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-35
Identities = 54/267 (20%), Positives = 98/267 (36%), Gaps = 44/267 (16%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS----------EINI 407
+ + GSF G V+ FK + A+K +K DV E +
Sbjct: 4 FILHK-MLGKGSF-------GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 55
Query: 408 LKK-INHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
L H + + + N + V E+ + G L + S + A
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAA 110
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQL 526
++ L +LH V+++LK NILLD + KI +FG+ + + +
Sbjct: 111 EIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN------ 161
Query: 527 TRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586
GT Y+APE + +D ++FGV++ E+L G+ G + E +
Sbjct: 162 --TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIRMD 218
Query: 587 RVLEESNVREKLRGFI------DPSLR 607
+ ++ + + +P R
Sbjct: 219 NPFYPRWLEKEAKDLLVKLFVREPEKR 245
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (332), Expect = 9e-35
Identities = 64/311 (20%), Positives = 119/311 (38%), Gaps = 58/311 (18%)
Query: 356 SLTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------- 403
SL ++ + TGSF G V+ + G A+KV+K ++
Sbjct: 2 SLQDFQILR-TLGTGSF-------GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E +L + H IIR+ G +++ ++ + G L L ++
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKF 108
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
A +V AL YLH ++++LK NILLD N KIT+FG A+ +
Sbjct: 109 YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY------ 159
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583
+ GT Y+APE + +D ++FG+++ E+L+G +
Sbjct: 160 -----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----- 209
Query: 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643
++L + F + ++ DL + + ++ + N + +V
Sbjct: 210 -YEKILNA---ELRFPPFFNEDVK-----DLLSRL--ITRDLSQRLGNLQNGTEDV---K 255
Query: 644 SKIWSSSSDWD 654
+ W W+
Sbjct: 256 NHPWFKEVVWE 266
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 67/303 (22%), Positives = 111/303 (36%), Gaps = 49/303 (16%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EINIL 408
FQ + KI G++ G VY+ K G+ A+K ++ D + EI++L
Sbjct: 3 NFQKVEKIGEGTY-------GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
K++NH NI++L E YLV+EF D + + +
Sbjct: 56 KELNHPNIVKLLDVIHTENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
L + H +H++LK N+L++T K+ +FGLAR+
Sbjct: 112 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--------T 160
Query: 529 HVVGTYGYMAPE-YIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587
H V T Y APE + + +D+++ G + E+++ R GD + I R
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFR 217
Query: 588 VLEESNVREKLRGFIDPSLRNEYP-----------LDLAFSMAQLAKNCTAHDLNARPSI 636
L + P + +P L L +D N R S
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 637 SEV 639
Sbjct: 278 KAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 69/324 (21%), Positives = 117/324 (36%), Gaps = 51/324 (15%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS--------EINILK 409
++ +L I G++ G V + A+K + EI IL
Sbjct: 9 RYTNLSYIGEGAY-------GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 410 KINHSNIIRLSGFC----VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
+ H NII ++ + + + L L + L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFL 115
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
Y + L Y+H +H++LK SN+LL+T KI +FGLAR A+ D G
Sbjct: 116 YQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-- 170
Query: 526 LTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEA-----E 579
V T Y APE + N T +D+++ G ++ E+LS R G +
Sbjct: 171 ---EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMA-----QLAKNCTAHDLNARP 634
+L + L + + +N+ P + F A L + + R
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287
Query: 635 SISEVFVTLSKIWSSSSDWDPSDE 658
+ + L+ + +DPSDE
Sbjct: 288 EVEQA---LAHPY-LEQYYDPSDE 307
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 51/300 (17%), Positives = 101/300 (33%), Gaps = 49/300 (16%)
Query: 366 KIATGSFSEENRIQGSVYRGSFK---GDDAAVKVMKGDVSS---------EINILKKI-- 411
+I G++ G V++ G A+K ++ E+ +L+ +
Sbjct: 14 EIGEGAY-------GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 412 -NHSNIIRLSGFCV-----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIA 465
H N++RL C E LV+E D + + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMM 122
Query: 466 YDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQ 525
+ + L++LH + VH++LK NIL+ ++ + K+ +FGLAR
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT------ 173
Query: 526 LTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCE------AE 579
VV T Y APE + +D+++ G + E+ + G + +
Sbjct: 174 ---SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
+ + + + ++ D+ L C + R S
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (326), Expect = 3e-34
Identities = 62/302 (20%), Positives = 108/302 (35%), Gaps = 49/302 (16%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKGDVSS---------EINILK 409
K+ L KI G++ G VY+ G+ A+K ++ + EI+ILK
Sbjct: 3 KYHGLEKIGEGTY-------GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK 55
Query: 410 KINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVA 469
++ HSNI++L + LV+E D L +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLL 110
Query: 470 NALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
N + Y H +H++LK N+L++ KI +FGLAR+ + H
Sbjct: 111 NGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--------YTH 159
Query: 530 VVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588
+ T Y AP+ + + +D+++ G + E+++G G + I R+
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRI 216
Query: 589 LEESNVRE-----------KLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS 637
L N + +P + L S L D N R +
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
Query: 638 EV 639
+
Sbjct: 277 QA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 70/329 (21%), Positives = 118/329 (35%), Gaps = 47/329 (14%)
Query: 360 YKFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD---VSSEINILKKINH 413
+ D K I GSF G VY+ G+ A+K + D + E+ I++K++H
Sbjct: 20 VSYTDTKVIGNGSF-------GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 72
Query: 414 SNIIRLSGFCVHEGNT------YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYD 467
NI+RL F G LV ++ H +R + + L Y
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMYQ 130
Query: 468 VANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAESDEHEQGGYGLQL 526
+ +L Y+H + H+++K N+LLD + K+ +FG A+ E
Sbjct: 131 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV------- 180
Query: 527 TRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585
+ + Y APE I T +DV++ G V+ ELL G+ GD + + +
Sbjct: 181 --SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMA--------QLAKNCTAHDLNARPSIS 637
+RE + + L + AR +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 638 EVFVTLSKIWSSSSDWDPSDELNNSRSLS 666
E + + DP+ +L N R
Sbjct: 299 EA---CAHSFFDEL-RDPNVKLPNGRDTP 323
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 55/299 (18%), Positives = 104/299 (34%), Gaps = 71/299 (23%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGD-------------VSSE 404
Y+ + +G F GSVY G D+ A+K ++ D V E
Sbjct: 6 YQVGP-LLGSGGF-------GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 405 INILKKIN--HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
+ +LKK++ S +IRL + + L+ E + + R L +
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELAR 113
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN-LRAKITNFGLARSAESDEHEQGG 521
+ V A+ + H +H+++K NIL+D N K+ +FG + +
Sbjct: 114 SFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---- 166
Query: 522 YGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
GT Y PE+I V++ G+++ +++ G D+
Sbjct: 167 ------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220
Query: 581 LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEV 639
++ R + ++ L + C A + RP+ E+
Sbjct: 221 VF---------------FRQRVSSECQH------------LIRWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 45/271 (16%)
Query: 357 LTLYKFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVS----------S 403
+T+ F LK + G+F G V K G A+K+++ +V +
Sbjct: 2 VTMNDFDYLKLLGKGTF-------GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 404 EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
E +L+ H + L V E+A+ G L L R T ++
Sbjct: 55 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARF 109
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
++ +AL YLH V++++K N++LD + KIT+FGL + SD
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------- 159
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583
+ GT Y+APE +E+ +D + GVV+ E++ GR L
Sbjct: 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFEL 216
Query: 584 SISRVLE-ESNVREKLRGFI------DPSLR 607
+ + + + + + DP R
Sbjct: 217 ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 57/311 (18%), Positives = 114/311 (36%), Gaps = 51/311 (16%)
Query: 361 KFQDL-KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EINIL 408
K++ L KI G+F G V++ + G A+K + + EI IL
Sbjct: 11 KYEKLAKIGQGTF-------GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 63
Query: 409 KKINHSNIIRLSGFC--------VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
+ + H N++ L C +G+ YLV++F ++ + T +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSE 118
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
++ + N L Y+H+ +H+++K +N+L+ + K+ +FGLAR+ ++ Q
Sbjct: 119 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEA- 578
+ V T Y PE + P +D++ G ++ E+ + + G+
Sbjct: 176 NR----YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231
Query: 579 ----ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQ------LAKNCTAH 628
+L + V + E + D + + L
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291
Query: 629 DLNARPSISEV 639
D R +
Sbjct: 292 DPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 5e-30
Identities = 56/301 (18%), Positives = 109/301 (36%), Gaps = 45/301 (14%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFKGDDA--AVKVMKGDVSS---------EINIL 408
K++ L+ I G++ G+V++ + A+K ++ D EI +L
Sbjct: 3 KYEKLEKIGEGTY-------GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL 55
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
K++ H NI+RL + LV+EF D + N + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQL 110
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
L + H + +H++LK N+L++ N K+ NFGLAR+ +
Sbjct: 111 LKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-------CYSA 160
Query: 529 HVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL-------- 580
VV + + + +D+++ G + EL + + + + +L
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 581 --LYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISE 638
+ + + + SL N P L + L +N + R S E
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP-KLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 639 V 639
Sbjct: 280 A 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 1e-29
Identities = 61/313 (19%), Positives = 114/313 (36%), Gaps = 60/313 (19%)
Query: 356 SLTLYKFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS--------- 403
+ L +F +K + TGSF G V K G+ A+K++
Sbjct: 37 TAQLDQFDRIKTLGTGSF-------GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 404 -EINILKKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRV 462
E IL+ +N +++L N Y+V E+ G + L +
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHAR 144
Query: 463 QIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGY 522
A + YLH ++++LK N+L+D ++T+FG A+ +
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----- 196
Query: 523 GLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582
+ GT +APE I + +D +A GV++ E+ +G DQ + +Y
Sbjct: 197 ------TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IY 247
Query: 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQ-LAKNCTAHDLNARPSISEVFV 641
I + + DL + L + T N + ++++
Sbjct: 248 EKIVSG--------------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI-- 291
Query: 642 TLSKIWSSSSDWD 654
+ W +++DW
Sbjct: 292 -KNHKWFATTDWI 303
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 50/301 (16%), Positives = 112/301 (37%), Gaps = 43/301 (14%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EINIL 408
++DL+ + +G++ G+V G A+K + S E+ +L
Sbjct: 19 VYRDLQPVGSGAY-------GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 409 KKINHSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDV 468
K + H N+I L + +F + + L + + Y +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG-KLMKHEKLGEDRIQFLVYQM 130
Query: 469 ANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTR 528
L Y+H +H++LK N+ ++ + KI +FGLAR A+S ++T
Sbjct: 131 LKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----------EMTG 177
Query: 529 HVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS-- 586
+VV + + T +D+++ G ++ E+++G+ G + + ++
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 587 ------RVLEESNVREKLRGFIDPSLRN--EYPLDLAFSMAQLAKNCTAHDLNARPSISE 638
+ L+ + ++G + ++ + + L + D R + E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 639 V 639
Sbjct: 298 A 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-26
Identities = 64/320 (20%), Positives = 109/320 (34%), Gaps = 66/320 (20%)
Query: 359 LYKFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EIN 406
L ++Q+LK I +G+ G V + A+K + + E+
Sbjct: 16 LKRYQNLKPIGSGAQ-------GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 407 ILKKINHSNIIRLSGFCVHEGNT------YLVYEFADNGALSDWLHSNRYQTSDNLTWKQ 460
++K +NH NII L + YLV E D ++
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHER 120
Query: 461 RVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQG 520
+ Y + + +LH +H++LK SNI++ ++ KI +FGLAR+A +
Sbjct: 121 MSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--- 174
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA-- 578
V T Y APE I +D+++ G ++ E++ + G +
Sbjct: 175 ------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
Query: 579 -----------ELLYASISRVLEESNVREKLRGFIDPSL--------RNEYPLDLAFSMA 619
E + V R K G P L +E+ A
Sbjct: 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288
Query: 620 QLAKNCTAHDLNARPSISEV 639
L D R S+ +
Sbjct: 289 DLLSKMLVIDPAKRISVDDA 308
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 69/322 (21%), Positives = 123/322 (38%), Gaps = 61/322 (18%)
Query: 355 ESLTLYKFQDLK-IATGSFSEENRIQGSVYRG-----SFKGDDAAVKVMKGD-------- 400
E + + F+ LK + TG++ G V+ G A+KV+K
Sbjct: 19 EKVGIENFELLKVLGTGAY-------GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71
Query: 401 ---VSSEINILKKINHS-NIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNL 456
+E +L+ I S ++ L E +L+ ++ + G L L
Sbjct: 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RF 126
Query: 457 TWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDE 516
T + ++ AL +LHK +++++K NILLD+N +T+FGL++ +DE
Sbjct: 127 TEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183
Query: 517 HEQGGYGLQLTRHVVGTYGYMAPEYIENGV--ITPKLDVFAFGVVVLELLSGREAVTGDQ 574
E+ GT YMAP+ + G +D ++ GV++ ELL+G T D
Sbjct: 184 TER-------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236
Query: 575 NCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP 634
E+++ E R + YP +++ L + D R
Sbjct: 237 ---------------EKNSQAEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKRL 279
Query: 635 SISEVFVT--LSKIWSSSSDWD 654
++ +WD
Sbjct: 280 GCGPRDADEIKEHLFFQKINWD 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (261), Expect = 3e-25
Identities = 50/323 (15%), Positives = 109/323 (33%), Gaps = 59/323 (18%)
Query: 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD----VSSEINILKKIN- 412
Y+ K+ G + V+ + VK++K + EI IL+ +
Sbjct: 37 YQLVR-KLGRGKY-------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG 88
Query: 413 HSNIIRLSGFCVH--EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVAN 470
NII L+ LV+E +N + LT Y++
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILK 140
Query: 471 ALNYLHKYTNPPYVHKNLKTSNILLDT-NLRAKITNFGLARSAESDEHEQGGYGLQLTRH 529
AL+Y H +H+++K N+++D + + ++ ++GLA +
Sbjct: 141 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---------V 188
Query: 530 VVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREA-VTGDQNCEAELLYASISR 587
V + + PE + + + LD+++ G ++ ++ +E G N + + A +
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQ----------------LAKNCTAHDLN 631
+ + +K +DP + + +D
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 632 ARPSISEVFVTLSKIWSSSSDWD 654
+R + E + + + D
Sbjct: 309 SRLTAREA---MEHPYFYTVVKD 328
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 2e-22
Identities = 56/306 (18%), Positives = 111/306 (36%), Gaps = 53/306 (17%)
Query: 361 KFQDLK-IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGDVSS---------EINIL 408
++Q+L + +G++ GSV G AVK + S E+ +L
Sbjct: 19 RYQNLSPVGSGAY-------GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 409 KKINHSNIIRLSGFCV-----HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQ 463
K + H N+I L E N + L++ + + LT
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQF 125
Query: 464 IAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYG 523
+ Y + L Y+H +H++LK SN+ ++ + KI +FGLAR
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH----------TD 172
Query: 524 LQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA----- 578
++T +V + + +D+++ G ++ ELL+GR G + +
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMA-----QLAKNCTAHDLNAR 633
L+ + +L++ + + + F A L + D + R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 634 PSISEV 639
+ ++
Sbjct: 293 ITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.5 bits (236), Expect = 7e-22
Identities = 41/250 (16%), Positives = 92/250 (36%), Gaps = 45/250 (18%)
Query: 366 KIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKGD------VSSEINILKKINHSN-- 415
K+ G F +V+ A+K+++GD EI +L+++N ++
Sbjct: 20 KLGWGHF-------STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 416 ---------IIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAY 466
I++L H+G + + L + + QI+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 467 DVANALNYLHKYTNPPYVHKNLKTSNILLDTN------LRAKITNFGLARSAESDEHEQG 520
+ L+Y+H+ +H ++K N+L++ ++ KI + G A +
Sbjct: 133 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT--- 187
Query: 521 GYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580
+ + T Y +PE + D+++ ++ EL++G D+
Sbjct: 188 --------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
Query: 581 LYASISRVLE 590
I++++E
Sbjct: 240 DDDHIAQIIE 249
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Score = 36.7 bits (85), Expect = 3e-04
Identities = 14/47 (29%), Positives = 25/47 (53%), Gaps = 1/47 (2%)
Query: 194 LLTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVP 240
+LTY V GD++++IA F + ++L AN + I++P
Sbjct: 1 MLTYQVKQGDTLNSIAADFRISTAALLQANPSL-QAGLTAGQSIVIP 46
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Score = 36.5 bits (85), Expect = 3e-04
Identities = 14/48 (29%), Positives = 26/48 (54%), Gaps = 2/48 (4%)
Query: 195 LTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLK 242
+TY V GDS+S+IA+ V+ + V+ N + + P + + +K
Sbjct: 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFVK 48
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 669 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 99.38 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 99.37 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 99.06 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 99.06 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.57 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.59 | |
| d1ijwc_ | 47 | HIN recombinase (DNA-binding domain) {Synthetic} | 81.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 80.11 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=405.36 Aligned_cols=249 Identities=24% Similarity=0.439 Sum_probs=195.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
|++.+ ++|.|+| |.||+|.+. ++.||||+++. ++.+|++++++++|||||+++|+|..++..++|
T Consensus 7 ~~~~~-~iG~G~f-------g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 7 LTFVQ-EIGSGQF-------GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp EEEEE-EEECCSS-------CCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEEE-EEeeCCC-------eEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 44444 4899999 999999984 67899999863 478999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.+++... ...++|..+++|+.|||.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 ~E~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp EECCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred EEecCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheec
Confidence 9999999999999764 246899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEES 592 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 592 (669)
..... .......||..|+|||++.+..++.++|||||||++|||+|+..|+....... + .... +.
T Consensus 152 ~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~-~~~~---i~--- 216 (263)
T d1sm2a_ 152 LDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-E-VVED---IS--- 216 (263)
T ss_dssp --------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-H-HHHH---HH---
T ss_pred cCCCc-------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-H-HHHH---HH---
Confidence 54321 12234578999999999999999999999999999999999655554332211 1 1111 10
Q ss_pred hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 593 NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 593 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. ..+...|..++.++.+|+.+||+.||.+||||+||++.|++|.++
T Consensus 217 -------~----~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 217 -------T----GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -------H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------h----cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0 112233455567899999999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-49 Score=405.95 Aligned_cols=251 Identities=25% Similarity=0.443 Sum_probs=210.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
.|++.+ ++|.|+| |+||+|.+. |..||||+++. ++.+|+++|++++|||||+++|+|.+++..+
T Consensus 18 ~~~~~~-~iG~G~f-------g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 18 DITMKH-KLGGGQY-------GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp GEEEEE-ETTTTTT-------SSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEee-EEeeCCC-------eEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 344444 4999999 999999984 77899999863 4789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++|+|.+++... ....++|..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 90 iv~E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEeecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999764 2357999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
....... .......|+..|+|||++.++.++.++|||||||++|||++|..|+....+... +.
T Consensus 164 ~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~---- 226 (287)
T d1opja_ 164 LMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VY---- 226 (287)
T ss_dssp TCCSSSS-------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HH----
T ss_pred ecCCCCc-------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HH----
Confidence 7654321 222334688999999999999999999999999999999998877764333210 11
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..+....+.+.+..++.++.+|+.+||+.||.+||||+||++.|+.+.+.
T Consensus 227 ---------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 227 ---------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---------HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11112233455566777899999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-49 Score=408.87 Aligned_cols=254 Identities=31% Similarity=0.515 Sum_probs=198.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CC---eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GD---DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~---~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
..|++.++ +|.|+| |+||+|.+. ++ .||||.++. +|.+|+++|++++|||||+++|+|.
T Consensus 26 ~~~~~~~~-lG~G~f-------g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 26 SCVKIEQV-IGAGEF-------GEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp GGEEEEEE-EEECSS-------SEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hhcEEeeE-EeeCCC-------eEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 34666664 999999 999999984 22 478998742 4788999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..++||||+++|+|.+++... .+.++|.++++|+.||+.||+|||+++ |+||||||+||||++++.+||+
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~ 170 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 170 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred eCCEEEEEEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEEC
Confidence 999999999999999999998764 246999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYA 583 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 583 (669)
|||+++.......... ........||+.|||||.+.++.++.++|||||||++|||+| |+.||.+....+.
T Consensus 171 DFGla~~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~----- 242 (299)
T d1jpaa_ 171 DFGLSRFLEDDTSDPT---YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV----- 242 (299)
T ss_dssp CC--------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CcccceEccCCCCcce---eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH-----
Confidence 9999997754332110 111223467899999999999999999999999999999998 8999986543210
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
+. . +....+.+.+.+++..+.+|+.+||+.||.+||||.||++.|+++...
T Consensus 243 -~~-~-------------i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 243 -IN-A-------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -HH-H-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HH-H-------------HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 00 0 111223345566778899999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=406.26 Aligned_cols=251 Identities=26% Similarity=0.450 Sum_probs=208.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.+.+.|+++|.|+| |.||+|.++ +..||||+++. +|.+|+++|++++|||||+++|+|. .
T Consensus 9 ~~~~~~~~iG~G~f-------g~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~ 80 (285)
T d1u59a_ 9 NLLIADIELGCGNF-------GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 80 (285)
T ss_dssp GEEEEEEEEECCTT-------EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred CeEECCcEEecccC-------eEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-c
Confidence 45566667999999 999999873 34699999853 3778999999999999999999985 4
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..+|||||+++|+|.+++...+ ..+++..+++|+.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccc
Confidence 57899999999999999986542 46999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++........ ........||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....+. ..
T Consensus 154 Gla~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~-- 223 (285)
T d1u59a_ 154 GLSKALGADDSY-----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA-- 223 (285)
T ss_dssp TTCEECTTCSCE-----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH--
T ss_pred hhhhcccccccc-----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HH--
Confidence 999987553321 112234568999999999999999999999999999999998 8999986543211 00
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. + ....+.+.|..++.++.+|+.+||+.||.+||||.+|++.|+.++.+
T Consensus 224 --~---------i----~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 224 --F---------I----EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --H---------H----HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --H---------H----HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 1 11223345566778899999999999999999999999999987753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=402.38 Aligned_cols=252 Identities=27% Similarity=0.513 Sum_probs=199.9
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
|++.+ ++|+|+| |.||+|++++ .||||+++. .|.+|+++|++++|||||+++|++. ++..+
T Consensus 10 ~~~~~-~lG~G~f-------g~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 10 ITVGQ-RIGSGSF-------GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCCCS-EEEECSS-------CEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred EEEEE-EEeeCCC-------cEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 44444 3999999 9999999865 599999852 4778999999999999999999985 56789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
+||||+++|+|.++++..+ ..++|..+++|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 80 lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEEecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999999997542 46999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccCCcccceeeeccccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 511 SAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
....... ........||+.|||||++.+ +.++.++|||||||++|||+||+.||.+...... . ..
T Consensus 153 ~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~----~~ 220 (276)
T d1uwha_ 153 VKSRWSG------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IF 220 (276)
T ss_dssp C------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HH
T ss_pred eccccCC------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--H----HH
Confidence 7654321 122345689999999999964 4589999999999999999999999986543221 1 11
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
... +....+.+ ...+.+++..+.+|+.+||+.||.+||||+||++.|+.|..+
T Consensus 221 ~~~--------~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 221 MVG--------RGYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHH--------HTSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHh--------cCCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111 11112221 223445567899999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=402.98 Aligned_cols=248 Identities=28% Similarity=0.509 Sum_probs=203.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC----CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK----GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~----g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
+.++|.++|.|+| |.||+|.++ ++.||||+++. ++.+|+++|++++|||||+++|+|. .
T Consensus 8 ~~le~k~iG~G~f-------G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~ 79 (277)
T d1xbba_ 8 LTLEDKELGSGNF-------GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A 79 (277)
T ss_dssp EEEEEEEEEECSS-------EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S
T ss_pred CeecCCCcccCCC-------eEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-c
Confidence 4455556999999 999999874 34699999853 3778999999999999999999995 5
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..+|||||+++|+|.++++.. ..++|..+++|+.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DF 151 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 151 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred CCEEEEEEcCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccch
Confidence 5679999999999999999865 45999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 585 (669)
|+++........ ........||+.|||||.+.+..++.++|||||||++|||++ |+.||.+....+.
T Consensus 152 Gla~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~------- 219 (277)
T d1xbba_ 152 GLSKALRADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------- 219 (277)
T ss_dssp TTCEECCTTCSE-----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------
T ss_pred hhhhhccccccc-----cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-------
Confidence 999976543321 122334678999999999999999999999999999999998 8999986543211
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
...+ ....+.+.|..++.++.+|+.+||+.||.+||||+||++.|+..+.
T Consensus 220 ~~~i-------------~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 220 TAML-------------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHH-------------HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 0111 1112334556677889999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=402.14 Aligned_cols=251 Identities=25% Similarity=0.465 Sum_probs=205.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ ++|.|+| |.||+|.++ +..||||+++. .+.+|+++|++++|||||+++|+|. ++..++
T Consensus 14 ~~~~~~-~iG~G~f-------g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~i 84 (272)
T d1qpca_ 14 TLKLVE-RLGAGQF-------GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (272)
T ss_dssp GEEEEE-EEEEETT-------EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred HeEEeE-EEecCCC-------cEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEE
Confidence 344444 3899999 999999996 46799999964 4789999999999999999999885 567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.... ...++|..+++|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 85 v~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp EEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEE
Confidence 999999999999886542 235999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... .......||..|+|||++.++.++.++|||||||++|||+||..|+....... ....
T Consensus 159 ~~~~~~-------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~-------- 221 (272)
T d1qpca_ 159 IEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ-------- 221 (272)
T ss_dssp CSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH--------
T ss_pred ccCCcc-------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH--------
Confidence 754331 12234578999999999999999999999999999999999766655333211 0000
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS 650 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 650 (669)
.+. ...+...|..++.++.+|+.+||+.||++||||+||++.|+.+.+++
T Consensus 222 -----~i~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 222 -----NLE----RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp -----HHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHH----hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 111 11223345566678999999999999999999999999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=398.84 Aligned_cols=251 Identities=29% Similarity=0.477 Sum_probs=200.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECC------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKG------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|+++++ +|.|+| |.||+|.+++ ..||||+++. +|.+|+++|++++|||||+++|+|.+
T Consensus 9 ~~~~~~-iG~G~f-------G~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 9 VTRQKV-IGAGEF-------GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp EEEEEE-EEECSS-------SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEeeeE-EeeCCC-------eEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 444454 899999 9999999853 2589999853 47789999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+.+|+|.+++... ...++|.++++|+.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcc
Confidence 99999999999999999988764 256999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++........ ........||..|||||++.++.++.++|||||||++|||++|..|+........ . .
T Consensus 154 FGla~~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~-~--- 223 (283)
T d1mqba_ 154 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-V-M--- 223 (283)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-H-H---
T ss_pred cchhhcccCCCcc-----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-H-H---
Confidence 9999976543211 1122335689999999999999999999999999999999997777664332211 0 0
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
. .+....+.+.+.+++.++.+|+.+||+.||.+||||.||++.|+++...
T Consensus 224 -~-------------~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 224 -K-------------AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -H-------------HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -H-------------HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0 1112234455666778899999999999999999999999999998865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=388.62 Aligned_cols=246 Identities=24% Similarity=0.443 Sum_probs=206.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ ++|.|+| |.||+|+++ +..||||+++. ++.+|+.++++++||||++++|+|.+++..++
T Consensus 5 ~~~~~~-~iG~G~f-------g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 5 DLTFLK-ELGTGQF-------GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCC-CCCEETT-------EEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred HCEEeE-EEecCCC-------eEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 345555 4999999 999999996 55899999863 57899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.... ..+++..+++|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 77 v~Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp EEECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred EEEccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999999987542 46899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
...... .......||..|+|||.+.+..++.++|||||||++|||+| |+.||.+....+.. ..
T Consensus 150 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~--- 213 (258)
T d1k2pa_ 150 VLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EH--- 213 (258)
T ss_dssp CSSSSC-------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HH---
T ss_pred ccCCCc-------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HH---
Confidence 654332 11223568999999999999999999999999999999998 89999865532210 00
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+. ...+...|..++.++.+|+.+||+.||.+|||++||++.|.+|
T Consensus 214 -------i~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 214 -------IA----QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -------HH----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -------HH----hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11 1122344556667899999999999999999999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=401.39 Aligned_cols=251 Identities=28% Similarity=0.493 Sum_probs=204.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|++.+ .+|.|+| |+||+|++.+ ..||||.+.. .+.+|+.+|.++ +|||||+++++
T Consensus 38 ~~~l~~-~lG~G~f-------G~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 38 NLEFGK-VLGSGAF-------GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HeEEee-EEeeCCC-------eEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 345544 3899999 9999999843 2589998843 367899999998 89999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQ------------------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYV 484 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv 484 (669)
|.+.+..++||||+++|+|.++|+..+.. ....++|..++.|+.||+.||+|||+++ |+
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---Ii 186 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 186 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 99999999999999999999999865311 1245899999999999999999999999 99
Q ss_pred eeCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 005923 485 HKNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELL 564 (669)
Q Consensus 485 HrDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ell 564 (669)
||||||+|||++.++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||+
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCc------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 999999999999999999999999987654321 12233456899999999999999999999999999999999
Q ss_pred c-CCCCCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005923 565 S-GREAVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTL 643 (669)
Q Consensus 565 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 643 (669)
| |+.||.+....+. . ... +....+.+.|..++.++.+|+.+||+.||.+||||+||+++|
T Consensus 261 t~g~~Pf~~~~~~~~--~----~~~-------------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 261 SLGVNPYPGIPVDAN--F----YKL-------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp TTSCCSSTTCCCSHH--H----HHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCCCCCCCCCCHHHH--H----HHH-------------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 8 8999986543211 1 111 112233455666777899999999999999999999999999
Q ss_pred HH
Q 005923 644 SK 645 (669)
Q Consensus 644 ~~ 645 (669)
..
T Consensus 322 ~~ 323 (325)
T d1rjba_ 322 GC 323 (325)
T ss_dssp HH
T ss_pred hC
Confidence 63
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=390.39 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=199.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|++.+ ++|.|+| |+||+|+.. |+.||||+++. ++.+|+++|++++|||||++++++.+++.
T Consensus 6 dy~~~~-~lG~G~f-------g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 6 DWDLVQ-TLGEGAY-------GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 77 (271)
T ss_dssp EEEEEE-EEEEETT-------EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ceEEEE-EEecCcC-------eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence 455555 4999999 999999984 78999999742 47789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchh
Confidence 99999999999999999643 46999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
|+....... ........||+.|||||++.+..+ +.++|||||||++|||++|+.||.+........ ..
T Consensus 150 a~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~--- 218 (271)
T d1nvra_ 150 ATVFRYNNR------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD--- 218 (271)
T ss_dssp CEECEETTE------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HH---
T ss_pred heeeccCCc------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HH---
Confidence 997654321 122345689999999999988776 578999999999999999999998644321111 00
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+.............+.++.+|+.+||+.||.+|||++|+++
T Consensus 219 -------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 219 -------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -------------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------------HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011111222344567889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=385.33 Aligned_cols=238 Identities=27% Similarity=0.451 Sum_probs=201.7
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
+..|++.+ ++|.|+| |.||+|... ++.||+|+++. .+.+|+++|++++|||||++++++.
T Consensus 5 l~dy~i~~-~iG~G~f-------g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 5 LEDFEIGR-PLGKGKF-------GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGGEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhHeEEEE-EEecCCC-------cEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 34566555 4999999 999999984 77899999842 3668999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..++||||+++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~ 148 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIA 148 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeec
Confidence 999999999999999999999764 35999999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+|+...... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....+ ...
T Consensus 149 DFG~a~~~~~~~----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~- 214 (263)
T d2j4za1 149 DFGWSVHAPSSR----------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK- 214 (263)
T ss_dssp CCCSCSCCCCCC----------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH-
T ss_pred ccceeeecCCCc----------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHH-
Confidence 999998664322 234679999999999999999999999999999999999999998754321 111
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
.+. .. ....|..++.++.+|+.+||+.||.+|||++|+++
T Consensus 215 --~i~-------------~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 215 --RIS-------------RV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --HHH-------------TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHH-------------cC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 110 00 12234455678899999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=392.06 Aligned_cols=258 Identities=27% Similarity=0.474 Sum_probs=203.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNTYL 431 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 431 (669)
.|++.+ ++|.|+| |.||+|.++ +..||||+++. +|.+|+.+|++++|||||+++|+|. ++..++
T Consensus 18 ~~~i~~-~iG~G~f-------g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~l 88 (285)
T d1fmka3 18 SLRLEV-KLGQGCF-------GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 88 (285)
T ss_dssp GEEEEE-EEEECSS-------CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred HEEEee-EEeeCCC-------eEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEE
Confidence 455555 4999999 999999995 45799999863 4889999999999999999999984 567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 432 VYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 432 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
||||+++|+|.+++.... ...++|.+++.|+.||+.||+|||+++ |+||||||+||||++++++||+|||+++.
T Consensus 89 v~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEecCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhh
Confidence 999999999999987642 245999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 512 AESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
...... .......||..|+|||++..+.++.++||||||+++|||++|..|+....... +.. .
T Consensus 163 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~-~-------- 225 (285)
T d1fmka3 163 IEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVL-D-------- 225 (285)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHH-H--------
T ss_pred ccCCCc-------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHH-H--------
Confidence 654321 12233578999999999999999999999999999999999777765433221 110 0
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCC-CCCCCCC
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSS-SDWDPSD 657 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~-~~~~~~~ 657 (669)
.+. ...+.+.+..++.++.+++.+||+.||.+||||++|++.|+...... ..|.|.+
T Consensus 226 -----~i~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 226 -----QVE----RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp -----HHH----TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred -----HHH----hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 011 11233455566778999999999999999999999999999877554 3344433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=389.32 Aligned_cols=246 Identities=28% Similarity=0.472 Sum_probs=200.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEecc-----cHHHHHHHHHhcCCCCceeEeeEEEec-CceeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKG-----DVSSEINILKKINHSNIIRLSGFCVHE-GNTYLV 432 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 432 (669)
.|++.+. +|.|+| |.||+|.++|..||||+++. ++.+|++++++++||||++++|+|.++ +..++|
T Consensus 8 ~~~~~~~-lG~G~f-------g~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 8 ELKLLQT-IGKGEF-------GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GEEEEEE-EEECSS-------CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HeEEeEE-EecCCC-------eEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 3455453 899999 99999999999999999964 478999999999999999999999654 568999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+++|+|.++|+..+ ...++|..+++|+.||+.||+|||+.+ ++||||||+|||++.++.+|++|||+++..
T Consensus 80 ~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp ECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence 99999999999997642 234899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
.... ....+|..|+|||++.++.+++++||||||+++|||+| |+.|+......+.
T Consensus 154 ~~~~-----------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~------------- 209 (262)
T d1byga_ 154 SSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------------- 209 (262)
T ss_dssp -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------------
T ss_pred CCCC-----------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-------------
Confidence 4321 23467889999999999999999999999999999998 6777765433211
Q ss_pred hhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 592 SNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 592 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
...+....+.+.+..++.++.+|+.+||+.||.+||||.||+++|++|.+.
T Consensus 210 -------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 210 -------VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -------HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 011112234455666677899999999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=387.38 Aligned_cols=241 Identities=23% Similarity=0.413 Sum_probs=201.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ ++|.|+| |+||+|.. +|+.||||+++. .+.+|+++|++++|||||++++++.+++..
T Consensus 21 ~Y~~~~-~iG~G~f-------g~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 21 KYTRFE-KIGQGAS-------GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TBCSCE-ECCCSSS-------CEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccEEEE-EEecCcC-------cEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE
Confidence 355544 4999999 99999997 488999999852 377899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
|+||||+++|+|.+++.+. .+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 93 ~ivmEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp EEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhh
Confidence 9999999999999988753 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVL 589 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 589 (669)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .. ....
T Consensus 164 ~~~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~----~~~~ 229 (293)
T d1yhwa1 164 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL----YLIA 229 (293)
T ss_dssp EECCSTTC--------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH----HHHH
T ss_pred eeeccccc--------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HH----HHHH
Confidence 97654321 2334579999999999999999999999999999999999999998655321 11 1111
Q ss_pred hhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 590 EESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 590 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. .......+..++..+.+|+.+||+.||.+|||+.|++++
T Consensus 230 ~~------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 230 TN------------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HH------------CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred hC------------CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 011123345566789999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=382.06 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=193.1
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe---
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH--- 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~--- 425 (669)
|++++ ++|.|+| |+||+|... +..||+|.++. .+.+|+++|++++|||||++++++..
T Consensus 11 ~~~~~-~iG~G~f-------g~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 11 LKFDI-EIGRGSF-------KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred EEeee-EEecCcC-------cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 45554 5999999 999999984 67899999853 36789999999999999999999875
Q ss_pred -cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec-CCCcEEE
Q 005923 426 -EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD-TNLRAKI 503 (669)
Q Consensus 426 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl 503 (669)
+...++||||+++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ++|+||||||+|||++ +++.+||
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEE
Confidence 34579999999999999999765 35999999999999999999999875 5699999999999996 5789999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+..+.. ....
T Consensus 157 ~DFGla~~~~~~----------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~ 223 (270)
T d1t4ha_ 157 GDLGLATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR 223 (270)
T ss_dssp CCTTGGGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH
T ss_pred eecCcceeccCC----------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHH
Confidence 999999864332 2345689999999999875 69999999999999999999999997654321 1111
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. +..-.. ....+.....++.+|+.+||+.||++|||++|+++
T Consensus 224 ----~---------i~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 224 ----R---------VTSGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----H---------HTTTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----H---------HHcCCC---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 111011 11223334456899999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=388.70 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=188.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe--
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH-- 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~-- 425 (669)
.|++.+ .+|+|+| |+||+|+.. |+.||||.++. .+.+|+++|++++|||||++++++.+
T Consensus 5 dy~~~~-~iG~G~f-------g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 5 DYEVLY-TIGTGSY-------GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred hCEEeE-EEecCCC-------eEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 355555 4899999 999999984 78999999842 26789999999999999999999865
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeeCCCCCCeeecCCCcEEE
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYT--NPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivHrDik~~NILl~~~~~~kl 503 (669)
++..|+||||+++|+|.+++.+.. .....+++..++.++.||+.||+|||+++ ..+|+||||||+|||+++++.+||
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 456899999999999999997532 12356999999999999999999999865 235999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYA 583 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 583 (669)
+|||+++...... .......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+ ..
T Consensus 156 ~DFG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~- 223 (269)
T d2java1 156 GDFGLARILNHDT--------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA- 223 (269)
T ss_dssp CCHHHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH-
T ss_pred eeccceeecccCC--------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH-
Confidence 9999999865432 22345689999999999999999999999999999999999999998654321 11
Q ss_pred HHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 584 SISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 584 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
..+... .. ...|..++.++.+|+.+||+.||.+|||++|+++
T Consensus 224 --~~i~~~-------------~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 --GKIREG-------------KF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HHHHHT-------------CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHcC-------------CC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111110 00 1233445567899999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=384.40 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=199.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ ++|.|+| |.||+|.. +|..||||+++. .+.+|+++|++++|||||++++++.+++..
T Consensus 13 ~Y~i~~-~iG~G~f-------g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 13 FWEIIG-ELGDGAF-------GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 84 (288)
T ss_dssp TEEEEE-EEEEETT-------EEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CeEEeE-EEeeCCC-------cEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence 455555 4999999 99999998 477899999853 478899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
++||||+++|+|.+++.+. .+.+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 85 ~lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhh
Confidence 9999999999999998754 246999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-----NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
+...... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.+....+. .
T Consensus 158 ~~~~~~~--------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~--- 224 (288)
T d2jfla1 158 AKNTRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--L--- 224 (288)
T ss_dssp EECHHHH--------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H---
T ss_pred hccCCCc--------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--H---
Confidence 8654321 1223467999999999984 45689999999999999999999999987554321 1
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
..+... .......+..++.++.+|+.+||+.||.+|||++|+++
T Consensus 225 -~~i~~~------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 225 -LKIAKS------------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -HHHHHS------------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHcC------------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 00112334556678999999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=384.83 Aligned_cols=254 Identities=20% Similarity=0.385 Sum_probs=205.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+. +|.|+| |+||+|... |+.||||+++. .+.+|+++|++++||||+++++++.++
T Consensus 9 dy~i~~~-lG~G~f-------g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 9 DFKFGKI-LGEGSF-------STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp GEEEEEE-EEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCEEEEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 4666664 999999 999999984 78999999852 367899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..|+||||+++|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccc
Confidence 9999999999999999998765 46999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+|+....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .. .
T Consensus 153 G~a~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~ 220 (288)
T d1uu3a_ 153 GTAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IF---Q 220 (288)
T ss_dssp TTCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---H
T ss_pred ccceecccCCc------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HH---H
Confidence 99997754321 112344679999999999999999999999999999999999999998754321 11 1
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH---HhhcCCCCCCC
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS---KIWSSSSDWDP 655 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~---~i~~~~~~~~~ 655 (669)
.+.. . ...+|..++.++.+|+.+||+.||.+|||++|++..-. -=+-...||+.
T Consensus 221 ~i~~-------------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 221 KIIK-------------L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp HHHT-------------T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHc-------------C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 1111 0 11234455667899999999999999999999865422 11234567874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=390.89 Aligned_cols=264 Identities=20% Similarity=0.358 Sum_probs=200.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|++.+ ++|.|+| |+||+|... |+.||+|+++. .+.+|+.+|++++|||||+++++|.++++.
T Consensus 8 y~~~~-~iG~G~f-------g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 8 FEKIS-ELGAGNG-------GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp EEEEE-EEECCSS-------CCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CEEEE-EEecCCC-------eEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 44444 4999999 999999984 78899999853 367899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
++||||+++|+|.+++.+. +.+++..+..++.|++.||+|||+ ++ |+||||||+|||+++++++||+|||+
T Consensus 80 ~iVmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCC
Confidence 9999999999999999765 359999999999999999999997 48 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH-HH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI-SR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~ 587 (669)
|+..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+........ ..
T Consensus 152 a~~~~~~----------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 221 (322)
T d1s9ja_ 152 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221 (322)
T ss_dssp CHHHHHH----------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------
T ss_pred ccccCCC----------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcC
Confidence 9865322 123468999999999999999999999999999999999999999865543221110000 00
Q ss_pred HHhhh----------------------hHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--H
Q 005923 588 VLEES----------------------NVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--L 643 (669)
Q Consensus 588 ~~~~~----------------------~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L 643 (669)
..... ...+.+..................++.+|+.+||+.||.+|||++|++++ |
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 00000 00000000010000000011234568999999999999999999999984 6
Q ss_pred HHhhcC
Q 005923 644 SKIWSS 649 (669)
Q Consensus 644 ~~i~~~ 649 (669)
++....
T Consensus 302 ~~~~~~ 307 (322)
T d1s9ja_ 302 KRSDAE 307 (322)
T ss_dssp HHHHHS
T ss_pred CcCCcc
Confidence 655433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-46 Score=385.01 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=203.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECC-------CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKG-------DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
|++.+ ++|.|+| |+||+|++.| ..||||+++. ++.+|+++|++++||||++++++|.
T Consensus 15 ~~~~~-~lG~G~f-------G~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 15 IEYVR-DIGEGAF-------GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CEEEE-EEEECSS-------CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cEEeE-EEeeCCC-------eEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44444 4899999 9999999854 5799999853 4789999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRY-------------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVH 485 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH 485 (669)
.++..++||||+++|+|.++++.... .....++|..++.|+.|++.||+|||+++ +||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 99999999999999999999975321 12235899999999999999999999999 999
Q ss_pred eCCCCCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc
Q 005923 486 KNLKTSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS 565 (669)
Q Consensus 486 rDik~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt 565 (669)
|||||+|||+|.++.+||+|||+++....... ........||..|+|||.+.+..++.++|||||||++|||++
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcc------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 99999999999999999999999987654321 123345678899999999999999999999999999999999
Q ss_pred CCC-CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 005923 566 GRE-AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLS 644 (669)
Q Consensus 566 g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 644 (669)
|.. ||.+....+. ...+. + ..+.+.|.+++.++.+|+.+||+.||.+||||.||++.|+
T Consensus 238 ~~~~p~~~~~~~e~------~~~v~-------------~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 238 YGLQPYYGMAHEEV------IYYVR-------------D-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp TTCCTTTTSCHHHH------HHHHH-------------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCCCCCCHHHH------HHHHH-------------c-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 965 5655443211 11111 1 1123345566678999999999999999999999999999
Q ss_pred Hhh
Q 005923 645 KIW 647 (669)
Q Consensus 645 ~i~ 647 (669)
+|.
T Consensus 298 ~i~ 300 (301)
T d1lufa_ 298 RMC 300 (301)
T ss_dssp HTT
T ss_pred Hhc
Confidence 984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=380.35 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=193.4
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-----CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-----GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
.|++.+ .+|.|+| |.||+|.+. +..||||.++. .+.+|+++|++++|||||+++|+|.
T Consensus 8 ~~~l~~-~iG~G~f-------g~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 8 RIELGR-CIGEGQF-------GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GEEEEE-EEEECSS-------SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HeEEEE-EEeeCCC-------cEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 455555 3999999 999999874 23578888752 3778999999999999999999995
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..++||||+++|+|.+++...+ ..+++..++.++.||+.||+|||+++ ++||||||+|||+++++.+||+|
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred cCeEEEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEcc
Confidence 578899999999999999987642 46999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||.+....+..
T Consensus 152 fG~a~~~~~~~~-------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~----- 219 (273)
T d1mp8a_ 152 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----- 219 (273)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----
T ss_pred chhheeccCCcc-------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH-----
Confidence 999987654321 22334578999999999999999999999999999999998 88888765442210
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
..+. ...+.+.+..++..+.+|+.+||+.||.+|||+.||++.|++|.+
T Consensus 220 -~~i~--------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 220 -GRIE--------------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -HHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHH--------------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0011 011223455667789999999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=385.64 Aligned_cols=255 Identities=35% Similarity=0.551 Sum_probs=207.2
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEECC--C--eeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeEEE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFKG--D--DAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGFCV 424 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g--~--~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~ 424 (669)
..|++.+. +|+|+| |.||+|.+++ . .||||.++. ++.+|+++|+++ +|||||+++|+|.
T Consensus 10 ~~~~~~~~-iG~G~f-------g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 10 NDIKFQDV-IGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp GGCEEEEE-EECGGG-------CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred HHcEEEEE-EeeCCC-------cEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 45666664 999999 9999999853 3 478888742 478999999999 7999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNR-----------YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNI 493 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NI 493 (669)
+++..++||||+++|+|.++|+... ......|+|.++++++.||+.||.|||+++ ++||||||+||
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NI 158 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 158 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceE
Confidence 9999999999999999999997641 123457999999999999999999999998 99999999999
Q ss_pred eecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC-CCC
Q 005923 494 LLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA-VTG 572 (669)
Q Consensus 494 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p-~~~ 572 (669)
|++.++.+||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|..+ |.+
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcCCCceEEccccccccccccc---------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 99999999999999998654322 12335689999999999999999999999999999999997764 544
Q ss_pred CchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcCCCC
Q 005923 573 DQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSSSSD 652 (669)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~~ 652 (669)
....+ . . ..+. ...+.+.+..++.++.+|+.+||+.||++||||+||++.|+++.+....
T Consensus 230 ~~~~~--~-~-------------~~i~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 230 MTCAE--L-Y-------------EKLP----QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp CCHHH--H-H-------------HHGG----GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCHHH--H-H-------------HHHH----hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 33211 0 0 1111 1223445566777899999999999999999999999999999876543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=387.36 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=200.4
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CC----eeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GD----DAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~----~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
|++.+ .+|.|+| |+||+|.+. |+ .||+|.++. ++.+|+++|++++|||||+++|+|.+
T Consensus 11 y~~~~-~lG~G~f-------G~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 11 FKKIK-VLGSGAF-------GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp EEEEE-EEEECSS-------EEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred CEEee-EEecCCC-------eEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 44444 3899999 999999984 33 588998753 47789999999999999999999975
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
+..++++||+.+|+|.+++... ...++|..+++|+.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECC
T ss_pred -CCeeEEEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeec
Confidence 5678899999999999998765 256999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 584 (669)
||+++....... ........||..|+|||.+.++.++.++|||||||++|||+| |+.||.+....+..
T Consensus 155 FGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~----- 223 (317)
T d1xkka_ 155 FGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----- 223 (317)
T ss_dssp CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-----
T ss_pred cccceecccccc------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-----
Confidence 999998754332 122334578999999999999999999999999999999999 77887765432210
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
..+. ...+.+.|..++..+.+|+.+||+.||.+|||+.||++.|+++...
T Consensus 224 --~~i~-------------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 224 --SILE-------------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp --HHHH-------------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --HHHH-------------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 0111 1123345556777899999999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=379.79 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=195.8
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC-----CeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG-----DDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-----~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|++.+ ++|.|+| |.||+|++++ ..||||+++. +|.+|+++|++++|||||+++|+|
T Consensus 9 d~~~~~-~iG~G~f-------g~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 9 DLRLLE-KLGDGSF-------GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GEEEEE-ECC-----------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HeEEEE-EEecCCC-------eEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 355555 4999999 9999999742 2589998753 467899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEE
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKI 503 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 503 (669)
.+ +..++||||+++|+|.+++..+. ..+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl 152 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 152 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEE
T ss_pred ee-cchheeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceee
Confidence 54 57799999999999999887642 45999999999999999999999998 999999999999999999999
Q ss_pred cccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCchhHHHHHH
Q 005923 504 TNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GREAVTGDQNCEAELLY 582 (669)
Q Consensus 504 ~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 582 (669)
+|||+++........ ........|+..|+|||.+.+..++.++||||||+++|||+| |+.||.+....+.
T Consensus 153 ~DfGl~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---- 223 (273)
T d1u46a_ 153 GDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---- 223 (273)
T ss_dssp CCCTTCEECCC-CCE-----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----
T ss_pred ccchhhhhcccCCCc-----ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----
Confidence 999999987544321 123345678889999999999999999999999999999998 8999986553211
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKI 646 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 646 (669)
+..+.....+.+.+..++..+.+|+.+||+.||.+||||.||++.|.+.
T Consensus 224 ---------------~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 ---------------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111112233344556667899999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=381.35 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=203.1
Q ss_pred chhHHHHHhCCCCcccceeeEEEEEEECC-----CeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEec-
Q 005923 361 KFQDLKIATGSFSEENRIQGSVYRGSFKG-----DDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHE- 426 (669)
Q Consensus 361 ~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~- 426 (669)
.|.++ +|+|+| |+||+|.+.. ..||||+++. ++.+|+++|++++||||++++|+|.+.
T Consensus 30 ~~~~~-iG~G~f-------g~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 30 HFNEV-IGRGHF-------GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEE-EEEETT-------EEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred ccceE-EeecCC-------eEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence 34454 899999 9999999832 2589999852 478999999999999999999998764
Q ss_pred CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEccc
Q 005923 427 GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNF 506 (669)
Q Consensus 427 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~Df 506 (669)
+..++||||+++|+|.++++.. ...+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DF 174 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF 174 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSS
T ss_pred CceEEEEEEeecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecc
Confidence 5789999999999999999864 346889999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++......... ........||..|+|||.+..+.++.++||||||+++|||++|+.|+....... ....
T Consensus 175 G~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~ 245 (311)
T d1r0pa_ 175 GLARDMYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITV 245 (311)
T ss_dssp GGGCCTTTTTCCC----TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHH
T ss_pred cchhhcccccccc----ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHH
Confidence 9999775443211 112234578999999999999999999999999999999999888887533211 0000
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.+.. ..+...|..++.++.+|+.+||+.||.+||+|.||++.|+++++.
T Consensus 246 ~i~~--------------g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 246 YLLQ--------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHc--------------CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0110 112233445667899999999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-45 Score=381.40 Aligned_cols=242 Identities=25% Similarity=0.465 Sum_probs=189.3
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
.|++.+. +|.|+| |+||+|... |+.||||++.. .+.+|+++|++++|||||++++++.+++.
T Consensus 10 ~Y~~~~~-lG~G~f-------g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 10 IYDFRDV-LGTGAF-------SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp TEEEEEE-SBSGGG-------GGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ceEEEEE-EeeccC-------eEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3676664 999999 999999984 78899999853 35679999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec---CCCcEEEcc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD---TNLRAKITN 505 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~D 505 (669)
.|+||||+++|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEec
Confidence 99999999999999999754 46999999999999999999999999 99999999999994 578999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++...... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+. ..
T Consensus 154 FG~a~~~~~~~---------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~-- 219 (307)
T d1a06a_ 154 FGLSKMEDPGS---------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FE-- 219 (307)
T ss_dssp C---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH--
T ss_pred cceeEEccCCC---------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HH--
Confidence 99998764332 23346799999999999999999999999999999999999999987553211 01
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+.. . +.....+.+.+++.++.+|+.+||+.||.+|||++|++++
T Consensus 220 -~i~~---------~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 220 -QILK---------A--EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -HHHT---------T--CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -HHhc---------c--CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 0 1111122334556778999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-45 Score=381.40 Aligned_cols=230 Identities=25% Similarity=0.381 Sum_probs=191.7
Q ss_pred HHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEEE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLVY 433 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 433 (669)
++|.|+| |.||+|.. +|+.||||+++. ++.+|+++|++++|||||++++++.+++..|+||
T Consensus 22 ~lG~G~f-------g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 22 EIGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp EEEECSS-------SEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCC-------eEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4899999 99999997 477899999852 3678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCccccC
Q 005923 434 EFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSAE 513 (669)
Q Consensus 434 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~~ 513 (669)
||+++|+|..++... ..+++.++..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999998776543 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccCCcccceeeeccccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHh
Q 005923 514 SDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN---GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLE 590 (669)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 590 (669)
.. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||.+....+ . +.....
T Consensus 167 ~~------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~----~~~i~~ 228 (309)
T d1u5ra_ 167 PA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A----LYHIAQ 228 (309)
T ss_dssp SB------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H----HHHHHH
T ss_pred CC------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--H----HHHHHh
Confidence 32 23579999999999864 568999999999999999999999998654321 1 111111
Q ss_pred hhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 591 ESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 591 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
. ..+.+ .+..++..+.+|+.+||+.||.+|||++|+++
T Consensus 229 ~----------~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 N----------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp S----------CCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----------CCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 01111 12234567899999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=385.59 Aligned_cols=268 Identities=26% Similarity=0.399 Sum_probs=197.7
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEECCCeeEEEEeccc----HHH--HHHHHHhcCCCCceeEeeEEEecC----ce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFKGDDAAVKVMKGD----VSS--EINILKKINHSNIIRLSGFCVHEG----NT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g~~vavK~~~~~----~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~ 429 (669)
|.+++ ++|.|+| |.||+|+++|+.||||+++.+ +.. |+..+.+++|||||+++|+|.+++ ..
T Consensus 5 ~~l~~-~iG~G~f-------g~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 5 IVLQE-SIGKGRF-------GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp EEEEE-EEECCSS-------SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred EEEEE-EEeeCCC-------eEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 34444 3899999 999999999999999998643 333 445556789999999999998765 57
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKY-----TNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
++||||+++|+|.++|++. .++|.++++++.|++.||+|||+. ..++|+||||||+||||+.++.+||+
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 9999999999999999864 499999999999999999999974 12349999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCC------CCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV------ITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
|||+++......... ........||+.|+|||++.+.. ++.++|||||||+||||+||..|+........
T Consensus 151 DFGl~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 151 DLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp CCTTCEEEETTTTEE----CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred ecCccccccCCCcce----eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 999999765432211 11234568999999999987643 57799999999999999999887753221100
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCC-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEY-----PLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
.. ... ...............+..++... +.+....+.+|+.+||+.||.+||||.||++.|++|...
T Consensus 227 ~~--~~~--~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 227 PY--YDL--VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TT--TTT--SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ch--hhc--ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00 000 00000000011112222222222 234667799999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=382.64 Aligned_cols=255 Identities=30% Similarity=0.430 Sum_probs=194.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|++.+ ++|+|+| |.||+|.+. ++.||||+++. .+.+|..++.++ +|+||+.++++
T Consensus 14 ~y~~~~-~iG~G~f-------G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 14 RLKLGK-PLGRGAF-------GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp GEEEEE-EEEECSS-------CEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HEEEee-EEeecCC-------eEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 455555 4999999 999999973 24699999863 255677777777 68999999999
Q ss_pred EEecC-ceeEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 005923 423 CVHEG-NTYLVYEFADNGALSDWLHSNRYQ-----------TSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKT 490 (669)
Q Consensus 423 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~ 490 (669)
+.+++ ..++||||+++|+|.++++..+.. ....++|.+++.++.||+.||+|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87654 689999999999999999765311 1245899999999999999999999999 99999999
Q ss_pred CCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCC-CC
Q 005923 491 SNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR-EA 569 (669)
Q Consensus 491 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~-~p 569 (669)
+||||++++.+||+|||+|+....... ........||+.|+|||.+.++.++.++|||||||++|||++|. .|
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTT------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cceeECCCCcEEEccCcchhhcccccc------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 999999999999999999987654321 12233467999999999999999999999999999999999975 46
Q ss_pred CCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhcC
Q 005923 570 VTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWSS 649 (669)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 649 (669)
|.+....+. +...+. . ..+...|..++.++.+++.+||+.||.+|||++||+++|++|.++
T Consensus 237 ~~~~~~~~~------~~~~~~---------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 237 YPGVKIDEE------FCRRLK---------E----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp STTCCCSHH------HHHHHH---------H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHH------HHHHHh---------c----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 654432211 111111 1 112334555667899999999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=379.17 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=202.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEECC---------CeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFKG---------DDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLS 420 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~g---------~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~ 420 (669)
.|.+.+ ++|.|+| |.||+|+..+ ..||||+++. ++.+|...+.++ +|||||+++
T Consensus 14 ~~~l~~-~iG~G~f-------g~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 14 RLVLGK-PLGEGAF-------GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp GEEEEE-ECC------------CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HeEEee-EEeecCC-------cEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 344444 4899999 9999998732 3689999854 356788888888 899999999
Q ss_pred eEEEecCceeEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 421 GFCVHEGNTYLVYEFADNGALSDWLHSNRY-----------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 421 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
++|.+++..++||||+++|+|.+++...+. .....+++.++++++.||+.||+|||+++ |||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiK 162 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 162 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeec
Confidence 999999999999999999999999976531 12346999999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHc-CCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLS-GRE 568 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~ellt-g~~ 568 (669)
|+|||++.++.+||+|||+++........ .......||+.|+|||.+.++.++.++||||||+++|||++ |..
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~ 236 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTT------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccceeecCCCCeEeccchhhccccccccc------cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCC
Confidence 99999999999999999999977554321 22344678999999999999999999999999999999998 677
Q ss_pred CCCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 569 AVTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 569 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
||.+....+ .. .. +....+.+.|..++..+.+|+.+||+.||.+|||+.||++.|++|..
T Consensus 237 p~~~~~~~~---~~----~~-------------i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 237 PYPGVPVEE---LF----KL-------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp SSTTCCHHH---HH----HH-------------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHH---HH----HH-------------HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 776544311 11 11 11122334455566789999999999999999999999999999976
Q ss_pred CC
Q 005923 649 SS 650 (669)
Q Consensus 649 ~~ 650 (669)
.+
T Consensus 297 ~~ 298 (299)
T d1fgka_ 297 LT 298 (299)
T ss_dssp HC
T ss_pred cC
Confidence 43
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-44 Score=380.77 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=201.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
..|.+.+. +|.|+| |.||+|... |+.||||+++. .+.+|+.+|++++|||||++++++.+++.
T Consensus 26 ~~Y~i~~~-lG~G~f-------g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 26 DHYDIHEE-LGTGAF-------GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GTEEEEEE-EEEETT-------EEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred cCeEEEEE-EecCcC-------eEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45666664 999999 999999984 88999999853 36689999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC--CCcEEEccc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNF 506 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~Df 506 (669)
.+|||||+++|+|.+++.+. .+.+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeec
Confidence 99999999999999999653 246999999999999999999999999 999999999999954 678999999
Q ss_pred CCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 507 GLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 507 Gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
|+++...... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+ . +.
T Consensus 171 G~a~~~~~~~---------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~----~~ 235 (350)
T d1koaa2 171 GLTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--T----LR 235 (350)
T ss_dssp TTCEECCTTS---------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HH
T ss_pred chheeccccc---------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--H----HH
Confidence 9998765432 2345689999999999999999999999999999999999999998755321 1 11
Q ss_pred HHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.+... +..........++..+.+|+.+||+.||.+|||++|++++
T Consensus 236 ~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 236 NVKSC-----------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHT-----------CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHhC-----------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 0111112223445678999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=379.67 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=207.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhc-CCCCceeEeeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKI-NHSNIIRLSGF 422 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~ 422 (669)
.|++.+ ++|.|+| |.||+|++. +..||||+++. ++.+|+.+++++ +|||||+++|+
T Consensus 24 ~~~l~~-~iG~G~f-------g~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 24 RLSFGK-TLGAGAF-------GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GEEEEE-EEEECSS-------EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HeEEee-EEeecCC-------eEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 445544 4899999 999999873 34799999963 367899999999 79999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRY-------------QTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLK 489 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik 489 (669)
|.+++..++||||+++|+|.++++..+. .....+++..+++|+.||+.||+|||+++ ++|||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLK 172 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccc
Confidence 9999999999999999999999986531 12236999999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 005923 490 TSNILLDTNLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREA 569 (669)
Q Consensus 490 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p 569 (669)
|+|||++.++.+|++|||+++....... ........||+.|+|||.+.++.++.++|||||||++|||+|+..|
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTT------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccccccccCcccccccchheeccCCCc------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence 9999999999999999999997754321 1233456889999999999999999999999999999999995555
Q ss_pred -CCCCchhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 570 -VTGDQNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 570 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
+.+....+. +... ++...+...+..++..+.+|+.+||+.||.+||||+||+++|+++..
T Consensus 247 ~~~~~~~~~~------~~~~-------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 247 PYPGMPVDSK------FYKM-------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SSTTCCSSHH------HHHH-------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHH------HHHH-------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 444332111 1111 11122334445566789999999999999999999999999998876
Q ss_pred CC
Q 005923 649 SS 650 (669)
Q Consensus 649 ~~ 650 (669)
++
T Consensus 308 ~~ 309 (311)
T d1t46a_ 308 ES 309 (311)
T ss_dssp HT
T ss_pred cC
Confidence 54
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=373.97 Aligned_cols=242 Identities=27% Similarity=0.440 Sum_probs=200.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc-------------cHHHHHHHHHhcCCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG-------------DVSSEINILKKINHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~-------------~~~~E~~~l~~l~H~niv~l~g~~ 423 (669)
.|++.+ ++|+|+| |+||+|... |+.||||+++. .+.+|+++|++++|||||++++++
T Consensus 11 ~Y~~~~-~lG~G~f-------g~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 11 YYDTGE-ELGSGQF-------AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp TEEEEE-EEEECSS-------EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CEEEeE-EEecCCC-------eEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 466666 3999999 999999984 88999999842 367899999999999999999999
Q ss_pred EecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC----
Q 005923 424 VHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL---- 499 (669)
Q Consensus 424 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~---- 499 (669)
.+++..||||||+++|+|.+++... +.+++..++.++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSC
T ss_pred EECCEEEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCccc
Confidence 9999999999999999999999765 35999999999999999999999999 99999999999998776
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAE 579 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~ 579 (669)
.+|++|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.
T Consensus 155 ~vkl~DfG~a~~~~~~~~---------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~- 224 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET- 224 (293)
T ss_dssp CEEECCCTTCEECTTSCB---------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred ceEecchhhhhhcCCCcc---------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-
Confidence 599999999987754321 2345789999999999999999999999999999999999999987653221
Q ss_pred HHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 580 LLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+... ........+..++..+.+|+.+||+.||.+|||++|++++
T Consensus 225 -----~~~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 -----LANVSAV-----------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -----HHHHHTT-----------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----HHHHHhc-----------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111110 0111111223345678999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=375.21 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=202.9
Q ss_pred HHHhCCCCcccceeeEEEEEEEC-------CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecCcee
Q 005923 366 KIATGSFSEENRIQGSVYRGSFK-------GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 430 (669)
++|.|+| |+||+|.++ +..||||+++. .+.+|++++++++|||||+++|+|..++..+
T Consensus 27 ~lG~G~f-------G~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 27 ELGQGSF-------GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp EEEECSS-------SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeCCC-------eEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 4999999 999999874 35799999963 3679999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 431 LVYEFADNGALSDWLHSNR-----YQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
+||||+++|+|.++++..+ ......++|..+.+++.|++.||.|||+++ |+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999987532 112245899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCC-CCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGR-EAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~ 584 (669)
||+++....... ........||+.|+|||.+.++.++.++||||||+++|||+||. .|+.+....+ .
T Consensus 177 FGla~~~~~~~~------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~---- 244 (308)
T d1p4oa_ 177 FGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--V---- 244 (308)
T ss_dssp TTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--H----
T ss_pred cccceeccCCcc------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--H----
Confidence 999987654332 12233456899999999999999999999999999999999986 5554433211 0
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
+..+.+. .+.+.|..++..+.+|+.+||+.||.+||||.||+++|++..+
T Consensus 245 -------------~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 -------------LRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -------------HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------------HHHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0111111 1233455566789999999999999999999999999988755
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6e-44 Score=377.74 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=202.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
.|++.+ ++|.|+| |.||+|.. +|+.||||+++. .+.+|+.+|++++|||||++++++.+++..
T Consensus 30 ~Y~i~~-~lG~G~f-------g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 30 YYDILE-ELGSGAF-------GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp TEEEEE-EEEEETT-------EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ceEEEE-EEecCCC-------eEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 466655 3999999 99999997 488999999853 356899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec--CCCcEEEcccC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD--TNLRAKITNFG 507 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~--~~~~~kl~DfG 507 (669)
|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 102 ~ivmE~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEcCCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecc
Confidence 9999999999999988653 246999999999999999999999999 99999999999997 57899999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. +..
T Consensus 175 la~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~ 239 (352)
T d1koba_ 175 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQN 239 (352)
T ss_dssp TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHH
T ss_pred cceecCCCC---------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 999875432 23456789999999999999999999999999999999999999987654211 111
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.. .+..........++.++.+|+.+||+.||.+|||+.|++++
T Consensus 240 i~~-----------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 240 VKR-----------CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHH-----------CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHh-----------CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 01111222333456678999999999999999999999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.6e-44 Score=366.38 Aligned_cols=252 Identities=24% Similarity=0.419 Sum_probs=198.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
.|++.+. +|+|+| |.||+|.. .|+.||||+++. .+.+|+++|++++|||||++++++..+
T Consensus 8 rY~i~~~-lG~G~f-------g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 8 RYELGEI-LGFGGM-------SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp TEEEEEE-EEECSS-------EEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred eeEEeEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 3666663 999999 99999997 488999999853 367899999999999999999999876
Q ss_pred Cc----eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 427 GN----TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 427 ~~----~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+. .||||||+++|+|.+++... +.+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++..+
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEE
T ss_pred cCCCceEEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccce
Confidence 53 78999999999999998765 46999999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLY 582 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 582 (669)
++|||.++........ ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+ .
T Consensus 152 l~d~~~~~~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~-- 222 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNS-----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--V-- 222 (277)
T ss_dssp ECCCTTCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H--
T ss_pred eehhhhhhhhcccccc-----ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--H--
Confidence 9999999866443211 123445689999999999999999999999999999999999999998755322 1
Q ss_pred HHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhhc
Q 005923 583 ASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-SISEVFVTLSKIWS 648 (669)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~ 648 (669)
....+.. ++........+++.++.+++.+||+.||.+|| |++|++..|.++++
T Consensus 223 --~~~~~~~-----------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 223 --AYQHVRE-----------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp --HHHHHHC-----------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred --HHHHHhc-----------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1111111 00111112234456789999999999999999 89999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=373.97 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=201.9
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++.+. +|+|+| |.||+++. +|+.||||+++. .+.+|+.+|++++||||+++++++.+
T Consensus 5 ~dy~~~~~-lG~G~f-------g~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 5 NDFDYLKL-LGKGTF-------GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGEEEEEE-EEECSS-------EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred HhcEEEEE-EecCcC-------eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 34555554 899999 99999997 488999999853 25689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..|+||||+++|+|.+++.+. +.+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~D 148 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred ccccccceeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEee
Confidence 99999999999999999999875 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+ +...
T Consensus 149 FG~a~~~~~~~--------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~- 216 (337)
T d1o6la_ 149 FGLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFEL- 216 (337)
T ss_dssp CTTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-
T ss_pred cccccccccCC--------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHH-
Confidence 99998764432 12344689999999999999999999999999999999999999998765321 1111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
... . ...+|..++.++.+|+.+||+.||.+||+ +.|++++
T Consensus 217 --i~~-------------~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 217 --ILM-------------E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --HHH-------------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --Hhc-------------C--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 100 0 12334556677899999999999999995 7888763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-43 Score=370.72 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=200.6
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCV 424 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~ 424 (669)
+..|++.+ ++|.|+| |+||+++.. |+.||||+++. .+.+|+.+|++++|||||++++++.
T Consensus 3 l~dy~i~~-~lG~G~f-------g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 3 LQDFQILR-TLGTGSF-------GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGGEEEEE-EEEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hhHeEEEE-EEecCcC-------cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 34455555 3899999 999999974 88999999853 3568999999999999999999999
Q ss_pred ecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEc
Q 005923 425 HEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKIT 504 (669)
Q Consensus 425 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 504 (669)
+++..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~ 146 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKIT 146 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred eCCeeeeEeeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEe
Confidence 999999999999999999999765 45889999999999999999999999 9999999999999999999999
Q ss_pred ccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 505 NFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 505 DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
|||+|+..... .....||+.|||||.+.+..++.++|||||||++|||++|+.||.+....+.
T Consensus 147 DFG~a~~~~~~-----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------ 209 (316)
T d1fota_ 147 DFGFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------ 209 (316)
T ss_dssp CCSSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------
T ss_pred cCccceEeccc-----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------
Confidence 99999876532 2246799999999999999999999999999999999999999987553211
Q ss_pred HHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005923 585 ISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFVT 642 (669)
Q Consensus 585 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 642 (669)
...+... ....|..++.++.+++.+||+.||.+|| |++|++++
T Consensus 210 ~~~i~~~---------------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 210 YEKILNA---------------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHC---------------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHcC---------------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1111110 1123444556789999999999999996 89999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.6e-43 Score=358.25 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=199.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------------cHHHHHHHHHhcC-CCCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------------DVSSEINILKKIN-HSNIIRL 419 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------------~~~~E~~~l~~l~-H~niv~l 419 (669)
.|++.+ .+|+|+| |+||+++. +|+.+|||+++. .+.+|+.+|++++ ||||+++
T Consensus 4 ~y~~~~-~iG~G~~-------g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 75 (277)
T d1phka_ 4 NYEPKE-ILGRGVS-------SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 75 (277)
T ss_dssp TEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCEEce-EEecCcC-------eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 355545 3899999 99999997 578999999742 3668999999997 9999999
Q ss_pred eeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 420 SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 420 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
++++.+++..||||||+++|+|.++|+.+ ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM 147 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EeecccCcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCC
Confidence 99999999999999999999999999764 36999999999999999999999999 99999999999999999
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeeccccccccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN------GVITPKLDVFAFGVVVLELLSGREAVTGD 573 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDV~S~Gvvl~elltg~~p~~~~ 573 (669)
.+||+|||+++...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 148 ~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp CEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CeEEccchheeEccCCC---------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 99999999998765432 1234679999999999863 45688999999999999999999999876
Q ss_pred chhHHHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 574 QNCEAELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
...+. ...+... ...+.......++.++.+|+.+||+.||.+|||++||+++
T Consensus 219 ~~~~~------~~~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 219 KQMLM------LRMIMSG-----------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SHHHH------HHHHHHT-----------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHH------HHHHHhC-----------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 53211 1111111 0111222334566789999999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-43 Score=374.64 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=195.7
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc----------HHH---HHHHHHhcCCCCceeEeeE
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD----------VSS---EINILKKINHSNIIRLSGF 422 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~----------~~~---E~~~l~~l~H~niv~l~g~ 422 (669)
..|++.++ +|.|+| |.||+|+. .|+.||||++... +.+ |+.+++.++|||||+++++
T Consensus 4 ddy~i~~~-lG~G~f-------g~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~ 75 (364)
T d1omwa3 4 NDFSVHRI-IGRGGF-------GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 75 (364)
T ss_dssp TTEEEEEE-EEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred HhCeeeeE-EecCCC-------eEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE
Confidence 45666664 999999 99999998 4889999998531 233 4666777789999999999
Q ss_pred EEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEE
Q 005923 423 CVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAK 502 (669)
Q Consensus 423 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~k 502 (669)
+.+++..|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 76 ~~~~~~~~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 76 FHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEE
T ss_pred EEECCEEEEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEE
Confidence 99999999999999999999999765 35899999999999999999999999 99999999999999999999
Q ss_pred EcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHH
Q 005923 503 ITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELL 581 (669)
Q Consensus 503 l~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 581 (669)
|+|||+|+...... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+....+...
T Consensus 148 l~DFGla~~~~~~~----------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~- 216 (364)
T d1omwa3 148 ISDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE- 216 (364)
T ss_dssp ECCCTTCEECSSSC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-
T ss_pred EeeeceeeecCCCc----------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 99999998765432 233579999999999975 568999999999999999999999998654322111
Q ss_pred HHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005923 582 YASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFVT 642 (669)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 642 (669)
..+..... ....+..++.++.+|+.+||+.||.+||| ++|++++
T Consensus 217 ---------------~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 217 ---------------IDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---------------HHHHSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---------------HHHhcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 01111111 12334455667899999999999999999 5888753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-43 Score=369.42 Aligned_cols=236 Identities=23% Similarity=0.400 Sum_probs=199.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc----------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG----------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
..|++-+ ++|.|+| |.||++... |+.||||+++. .+.+|+++|++++|||||++++++..
T Consensus 41 d~y~i~~-~lG~G~f-------g~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 41 DQFDRIK-TLGTGSF-------GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GGEEEEE-EEEECSS-------CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCeEEEE-EeecCcC-------cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 3455555 3999999 999999984 88999999852 25689999999999999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
....++||||+.+|+|.+++.+. +.+++..++.|+.||+.||.|||+++ ||||||||+|||++.++++||+|
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~D 184 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred ccccccccccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeee
Confidence 99999999999999999999765 35999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+|+...... ....||+.|||||++.+..++.++|||||||++|||++|+.||.+..... . .
T Consensus 185 FG~a~~~~~~~-----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~ 247 (350)
T d1rdqe_ 185 FGFAKRVKGRT-----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---I---Y 247 (350)
T ss_dssp CTTCEECSSCB-----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H
T ss_pred ceeeeeccccc-----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---H---H
Confidence 99998765321 23579999999999999999999999999999999999999998754321 1 1
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARP-----SISEVFV 641 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 641 (669)
..+.. . ....+..++.++.+|+.+||+.||.+|+ |++|+++
T Consensus 248 ~~i~~---------~------~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 248 EKIVS---------G------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHH---------C------CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhc---------C------CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11111 0 1123344566789999999999999994 8999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=369.53 Aligned_cols=248 Identities=19% Similarity=0.266 Sum_probs=196.6
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc--cHHHHHHHHHhc-CCCCceeEeeEEEe----cCc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG--DVSSEINILKKI-NHSNIIRLSGFCVH----EGN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 428 (669)
..|++-+-.+|.|+| |+||+|.. +++.||||+++. .+.+|++++.++ +|||||++++++.+ +..
T Consensus 11 ~~y~i~~~~lG~G~f-------g~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGIN-------GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSS-------CEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccC-------eEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 345543213899999 99999997 478999999975 477899987665 89999999999875 456
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC---CCcEEEcc
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT---NLRAKITN 505 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~D 505 (669)
.|+||||+++|+|.+++.+. ....+++.++..|+.||+.||+|||+++ |+||||||+|||+++ ++.+||+|
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccc
Confidence 89999999999999999764 2346999999999999999999999999 999999999999975 56799999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++...... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+........
T Consensus 158 FG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----- 223 (335)
T d2ozaa1 158 FGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----- 223 (335)
T ss_dssp CTTCEECCCCC---------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred cceeeeccCCC---------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-----
Confidence 99998765432 1234579999999999999999999999999999999999999997644321000
Q ss_pred HHHHhhhhHHhhhhcccCCccCC--CCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRN--EYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.....+....... .....++.++.+|+.+||+.||.+|||+.|++.+
T Consensus 224 ----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 224 ----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----------HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0001111111111 1123456779999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=365.29 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=200.1
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
..|++.+ ++|.|+| |+||+|... |+.||||+++. .+.+|+++|++++|||||++++++.+++..
T Consensus 5 ~rY~i~~-~lG~G~f-------g~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 5 EKYMIAE-DLGRGEF-------GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred cceEEEE-EEecCCC-------eEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4566666 4999999 999999984 77899999863 366899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC--CCcEEEcccC
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT--NLRAKITNFG 507 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~DfG 507 (669)
||||||+++|+|.+++... ...+++.++..|+.||+.||+|||+++ |+||||||+|||++. ...+||+|||
T Consensus 77 ~lvmE~~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEEECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccc
Confidence 9999999999999999754 235999999999999999999999999 999999999999985 4589999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+++...... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.+....+. ...
T Consensus 150 ~~~~~~~~~---------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~ 214 (321)
T d1tkia_ 150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IEN 214 (321)
T ss_dssp TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH
T ss_pred hhhccccCC---------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 998764432 23446789999999999999999999999999999999999999987654211 111
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
+.... ..+.......++.++.+|+.+||+.||.+|||++|++++
T Consensus 215 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 215 IMNAE-----------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTC-----------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCC-----------CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 000001111334568999999999999999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=366.65 Aligned_cols=238 Identities=24% Similarity=0.367 Sum_probs=197.2
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----------cHHHHHHHHH-hcCCCCceeEeeEEEe
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----------DVSSEINILK-KINHSNIIRLSGFCVH 425 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~-~l~H~niv~l~g~~~~ 425 (669)
.|.+.+ .+|+|+| |+||+|.. .|+.||||+++. .+..|..++. .++|||||++++++.+
T Consensus 3 dy~i~~-~iG~G~f-------g~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 3 DFILHK-MLGKGSF-------GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp TEEEEE-EEEECSS-------SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CeEEee-EEecCCC-------cEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 355555 4899999 99999998 488999999953 2455777665 6899999999999999
Q ss_pred cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 426 EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 426 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
++..|+||||+++|+|.++++.. ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred CCceeEEEeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccc
Confidence 99999999999999999999765 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+
T Consensus 147 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i 215 (320)
T d1xjda_ 147 FGMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSI 215 (320)
T ss_dssp CTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred cchhhhccccc--------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence 99998764432 12234679999999999999999999999999999999999999998765321 11111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSIS-EVFV 641 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 641 (669)
.. - ...+|..++.++.+|+.+||+.||.+|||+. |+++
T Consensus 216 ---~~-----------~----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 ---RM-----------D----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---HH-----------C----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---Hc-----------C----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 00 0 1233445567789999999999999999995 7754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=362.28 Aligned_cols=250 Identities=26% Similarity=0.322 Sum_probs=192.6
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc------------cHHHHHHHHHhcCCCCceeEeeEEEecCceeEE
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG------------DVSSEINILKKINHSNIIRLSGFCVHEGNTYLV 432 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 432 (669)
+|.|+| |+||+|.. .|+.||||+++. .+.+|+++|++++|||||++++++.+++..++|
T Consensus 6 lG~G~f-------g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~iv 78 (299)
T d1ua2a_ 6 LGEGQF-------ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 78 (299)
T ss_dssp EEEETT-------EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred eccCcC-------eEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeeh
Confidence 899999 99999997 478999999742 366899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCcccc
Q 005923 433 YEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLARSA 512 (669)
Q Consensus 433 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla~~~ 512 (669)
|||+.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 mE~~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp EECCSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhhcchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccccc
Confidence 999998777666543 246889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhh
Q 005923 513 ESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEE 591 (669)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 591 (669)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..+.+ ....+.+.+..
T Consensus 151 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~ 219 (299)
T d1ua2a_ 151 GSPNR--------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGT 219 (299)
T ss_dssp TSCCC--------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCC
T ss_pred CCCcc--------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCC
Confidence 54321 12335789999999998754 57999999999999999999999998765432 12222222211
Q ss_pred hhHHh-----hhhcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 592 SNVRE-----KLRGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 592 ~~~~~-----~l~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
..... .......-......+ ......+.+|+.+||+.||.+|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 11000 000000000000111 1234578999999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=354.66 Aligned_cols=231 Identities=24% Similarity=0.386 Sum_probs=191.6
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-------------cHHHHHHHHHhcC--CCCceeEee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-------------DVSSEINILKKIN--HSNIIRLSG 421 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~--H~niv~l~g 421 (669)
.|.+.++ +|.|+| |.||+|.. +|+.||||+++. .+.+|+.+|++++ |||||++++
T Consensus 5 ~Y~i~~~-lG~G~f-------g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~ 76 (273)
T d1xwsa_ 5 QYQVGPL-LGSGGF-------GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 76 (273)
T ss_dssp TEEEEEE-EEEETT-------EEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred eEEEeEE-EeeCCC-------eEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence 4666664 999999 99999998 478999999853 2568999999997 899999999
Q ss_pred EEEecCceeEEEEecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-CC
Q 005923 422 FCVHEGNTYLVYEFADN-GALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-NL 499 (669)
Q Consensus 422 ~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-~~ 499 (669)
++.+++..++||||+.+ +++.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++. ++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 77 WFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTT
T ss_pred EEeeCCeEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCC
Confidence 99999999999999986 6888888754 35999999999999999999999999 999999999999985 47
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVI-TPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
.+||+|||+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+...
T Consensus 149 ~vkl~DFG~a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--- 215 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 215 (273)
T ss_dssp EEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---
T ss_pred eEEECccccceeccccc----------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---
Confidence 99999999998654321 234579999999999988765 5678999999999999999999975211
Q ss_pred HHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
.. +.. ..++..++.++.+|+.+||+.||.+|||++|++++
T Consensus 216 ---------i~---------~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 ---------II---------RGQ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---------HH---------HCC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------Hh---------hcc------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 000 11222345678999999999999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=353.07 Aligned_cols=261 Identities=26% Similarity=0.436 Sum_probs=196.4
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCc
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGN 428 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 428 (669)
|+..+ ++|+|+| |+||+|... |+.||||+++. .+.+|+++|++++|||||++++++.+++.
T Consensus 4 Y~~~~-~lG~G~f-------g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 4 FQKVE-KIGEGTY-------GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75 (298)
T ss_dssp EEEEE-EEEECSS-------SEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CEecc-EEecCcC-------eEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence 44433 3899999 999999984 88999999842 36789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGL 508 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGl 508 (669)
.|+||||+.+ ++.+++... ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 76 ~~iv~e~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 76 LYLVFEFLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEEECCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred eeEEEeecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCc
Confidence 9999999975 555555433 2356999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccCCcccceeeecccccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 509 ARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 509 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
|+...... .......||..|+|||.+.... ++.++|||||||++|||++|+.||.+....+ ... .+..
T Consensus 149 a~~~~~~~--------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~-~i~~ 217 (298)
T d1gz8a_ 149 ARAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLF-RIFR 217 (298)
T ss_dssp HHHHCCCS--------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-HHHH
T ss_pred ceeccCCc--------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHH-HHHH
Confidence 98765432 1233457999999999987655 5889999999999999999999998765322 111 1111
Q ss_pred HHhhhhHH--hhhhcccC--Ccc----CCCC---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 588 VLEESNVR--EKLRGFID--PSL----RNEY---PLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 588 ~~~~~~~~--~~l~~~~d--~~l----~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
........ .......+ ... .... ......++.+|+.+||+.||.+|||++|++++ |+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 11111000 00000000 000 0000 01233568999999999999999999999975 5444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=348.52 Aligned_cols=257 Identities=21% Similarity=0.342 Sum_probs=195.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC---CCeeEEEEecc---------cHHHHHHHHHhc---CCCCceeEeeEE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK---GDDAAVKVMKG---------DVSSEINILKKI---NHSNIIRLSGFC 423 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~---g~~vavK~~~~---------~~~~E~~~l~~l---~H~niv~l~g~~ 423 (669)
.|++.+ ++|.|+| |+||+|... ++.||||+++. .+.+|+.+|+.+ +||||++++++|
T Consensus 8 ~Y~i~~-~LG~G~f-------g~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 8 QYECVA-EIGEGAY-------GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp TEEEEE-EEEEETT-------EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CEEEEE-EEecccC-------eEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 455545 3999999 999999973 45689999852 366888888776 799999999998
Q ss_pred Ee-----cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCC
Q 005923 424 VH-----EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTN 498 (669)
Q Consensus 424 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~ 498 (669)
.. +...+++|||+.+|++....... ...+++..+..++.|++.||+|||+++ |+||||||+|||++++
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 152 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cccccccCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCC
Confidence 63 34679999999987766555432 356999999999999999999999999 9999999999999999
Q ss_pred CcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHH
Q 005923 499 LRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEA 578 (669)
Q Consensus 499 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~ 578 (669)
+.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+
T Consensus 153 ~~~kl~dfg~~~~~~~~~---------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~- 222 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD- 222 (305)
T ss_dssp CCEEECSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred CCeeecchhhhhhhcccc---------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-
Confidence 999999999998654332 2344689999999999999999999999999999999999999998765422
Q ss_pred HHHHHHHHHHHhhhhHHhhh------hccc---CCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 579 ELLYASISRVLEESNVREKL------RGFI---DPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l------~~~~---d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
....+...+........- .... ........+......+.+|+.+||+.||.+|||++|++++
T Consensus 223 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 223 --QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp --HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 112222222111100000 0000 0000112233445678899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-41 Score=347.02 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=192.8
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC-CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecCce
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK-GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEGNT 429 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~-g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 429 (669)
|+.-+ ++|+|+| |+||+|+.+ |+.||||+++. .+.+|+.+|++++|||||++++++.+++..
T Consensus 4 Y~~~~-~iG~G~f-------g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 4 YHGLE-KIGEGTY-------GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp EEEEE-EEEEETT-------EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCE
T ss_pred ceecc-EEecCCC-------cEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCce
Confidence 44333 3899999 999999984 78999999853 367899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccCCc
Q 005923 430 YLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFGLA 509 (669)
Q Consensus 430 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfGla 509 (669)
+++|||+.++.+..+.... +.+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 76 ~i~~e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp EEEEECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred eEEEEeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence 9999999887666665432 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHH
Q 005923 510 RSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRV 588 (669)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 588 (669)
........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+ .. ..+...
T Consensus 148 ~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~-~~i~~~ 216 (286)
T d1ob3a_ 148 RAFGIPVR--------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QL-MRIFRI 216 (286)
T ss_dssp HHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH-HHHHHH
T ss_pred eecccCcc--------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HH-HHHHHh
Confidence 87654321 12334688999999999764 56999999999999999999999998654322 11 111111
Q ss_pred HhhhhHH-----hhhhccc------CCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 589 LEESNVR-----EKLRGFI------DPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 589 ~~~~~~~-----~~l~~~~------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
....... ....... ++.............+.+|+++||+.||.+|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111000 0000000 000011122334567899999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6e-40 Score=338.89 Aligned_cols=260 Identities=19% Similarity=0.249 Sum_probs=204.0
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc-----cHHHHHHHHHhcCC-CCceeEeeEEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG-----DVSSEINILKKINH-SNIIRLSGFCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~ 430 (669)
.|++.+ ++|.|+| |.||+|+. +|+.||||+++. .+.+|+++++.++| +|++.+++++..+...+
T Consensus 6 ~Y~i~~-~iG~G~f-------G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 6 HYKVGR-RIGEGSF-------GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TEEEEE-EEEECSS-------CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ceEEEE-EEecCCC-------eEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 466666 3999999 99999997 478999999843 47889999999975 89999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC-----CCcEEEcc
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT-----NLRAKITN 505 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~-----~~~~kl~D 505 (669)
+||||+ +|+|.++++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|
T Consensus 78 ~vme~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEec-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcc
Confidence 999999 68999998764 246999999999999999999999999 999999999999974 57899999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASI 585 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 585 (669)
||+|+.......... ..........||+.|||||.+.+..++.++||||||+++|||++|+.||.+............+
T Consensus 150 FG~a~~~~~~~~~~~-~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 150 FGMVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred cceeEEcccCccccc-eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 999998654322111 1112234568999999999999999999999999999999999999999865432222211111
Q ss_pred HHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 586 SRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 586 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
........ ..+ + ...++.++.+++..|+..+|.+||+++.+.+.|+++..
T Consensus 229 ~~~~~~~~----~~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 229 GEKKQSTP----LRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHSC----HHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhccCCCC----hHH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 11111000 000 1 11234568999999999999999999999999988764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=349.71 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=193.4
Q ss_pred HHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---cHHHHHHHHHhcCCCCceeEeeEEEec------CceeEEEEe
Q 005923 367 IATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---DVSSEINILKKINHSNIIRLSGFCVHE------GNTYLVYEF 435 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~e~ 435 (669)
+|.|+| |+||+|+. .|+.||||+++. ...+|+++|++++||||++++++|... ...+|||||
T Consensus 28 LG~G~f-------g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 28 IGNGSF-------GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEETT-------EEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred EeeCcC-------eEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 899999 99999998 488999999864 356899999999999999999998643 246899999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccCCccccCC
Q 005923 436 ADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFGLARSAES 514 (669)
Q Consensus 436 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfGla~~~~~ 514 (669)
+++|.+..+.+.. .....+++.++..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 101 ~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 101 VPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp CSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred cCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9875444433322 12356999999999999999999999999 99999999999999775 899999999987654
Q ss_pred CccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHHHHhhhh
Q 005923 515 DEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISRVLEESN 593 (669)
Q Consensus 515 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 593 (669)
... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+ .+ ..+...+....
T Consensus 176 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l-~~i~~~~g~~~ 243 (350)
T d1q5ka_ 176 GEP---------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QL-VEIIKVLGTPT 243 (350)
T ss_dssp TSC---------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HH-HHHHHHHCCCC
T ss_pred Ccc---------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HH-HHHHHHhCCCh
Confidence 321 233578999999998875 568999999999999999999999998765432 11 22222221111
Q ss_pred H---HhhhhcccCCcc--------CCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhhcC
Q 005923 594 V---REKLRGFIDPSL--------RNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKIWSS 649 (669)
Q Consensus 594 ~---~~~l~~~~d~~l--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i~~~ 649 (669)
. ........+..+ ..........++.+|+.+||+.||.+|||+.|++++ |+++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 0 011111111111 011122345678999999999999999999999974 6666543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-40 Score=338.37 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=195.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEec-----ccHHHHHHHHHhcCCCCceeEee-EEEecCcee
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMK-----GDVSSEINILKKINHSNIIRLSG-FCVHEGNTY 430 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~~~ 430 (669)
.|++.+ ++|+|+| |.||+|... |+.||||+++ .++..|++++++++|+|++..++ +..+++..+
T Consensus 8 rY~l~~-~iG~G~f-------G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 8 RYRLGR-KIGSGSF-------GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TEEEEE-EEEECSS-------SEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred EEEEeE-EEeeCCC-------cEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 466666 4999999 999999974 7899999875 35888999999998877655554 455667789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeec---CCCcEEEcccC
Q 005923 431 LVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLD---TNLRAKITNFG 507 (669)
Q Consensus 431 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DfG 507 (669)
+||||+. |+|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||
T Consensus 80 ivme~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEECCC-CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEcC-Cchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence 9999994 5777776543 246999999999999999999999999 99999999999985 45679999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASISR 587 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 587 (669)
+|+.......... ..........||+.|||||.+.+..++.++|||||||++|||++|+.||.+...............
T Consensus 152 ~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 152 LAKKYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SCEECBCTTTCCB-CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred cceeccccccccc-eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 9998754332111 111223456899999999999999999999999999999999999999986543222111111100
Q ss_pred HHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhhc
Q 005923 588 VLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVTLSKIWS 648 (669)
Q Consensus 588 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 648 (669)
..... .. + .....++.++.+++.+||+.||.+||+++++.+.|+.+..
T Consensus 231 ~~~~~----~~-----~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 KKMST----PI-----E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHS----CH-----H----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCC----Ch-----h----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00000 00 0 0112344678999999999999999999999999988754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=342.62 Aligned_cols=262 Identities=21% Similarity=0.332 Sum_probs=191.9
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEe
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVH 425 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 425 (669)
+..|++-+ ++|.|+| |+||+|.. +|+.||||+++. ++.+|+++|++++|||++++++++..
T Consensus 9 ~~rY~i~~-~LG~G~f-------g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 9 VSKYEKLA-KIGQGTF-------GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGGEEEEE-EEEECSS-------SEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCCEEEEE-EEecCcC-------eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 45666655 4999999 99999998 488999998742 36789999999999999999999864
Q ss_pred --------cCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecC
Q 005923 426 --------EGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDT 497 (669)
Q Consensus 426 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~ 497 (669)
++..++||||+.++.+..+... ...++...+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~ 152 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 152 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred ccccccccCceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecC
Confidence 3467999999988766554432 346899999999999999999999999 999999999999999
Q ss_pred CCcEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchh
Q 005923 498 NLRAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNC 576 (669)
Q Consensus 498 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~ 576 (669)
++.+||+|||+++......... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+..+.
T Consensus 153 ~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~ 228 (318)
T d3blha1 153 DGVLKLADFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228 (318)
T ss_dssp TSCEEECCCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCcEEeeecceeeecccccccc----cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH
Confidence 9999999999998765433211 1122335799999999999765 6899999999999999999999999875542
Q ss_pred HHHHHHHHHHHHHhhhhHHhhhhcc--------cCCccCCCCc--H-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 577 EAELLYASISRVLEESNVREKLRGF--------IDPSLRNEYP--L-----DLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~~--------~d~~l~~~~~--~-----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
+. ...+......... +..... +........+ . .....+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~---~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 229 HQ---LALISQLCGSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HH---HHHHHHHHCCCCT-TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH---HHHHHHhcCCCCh-hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 21 1222222211100 000000 0000000000 1 11335678999999999999999999986
Q ss_pred H
Q 005923 642 T 642 (669)
Q Consensus 642 ~ 642 (669)
+
T Consensus 305 H 305 (318)
T d3blha1 305 H 305 (318)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-39 Score=340.48 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=190.9
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++.+ ++|.|+| |+||+|... |+.||||+++. .+.+|+++|++++|||||+++++|...+
T Consensus 19 ~Y~~i~-~lG~G~f-------g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 19 VYRDLQ-PVGSGAY-------GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp SEEEEE-EC-------------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cEEEEE-EEecCCC-------eEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 455444 4899999 999999974 88999999863 3568999999999999999999998654
Q ss_pred ------ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 428 ------NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 428 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
+.++||||+ +++|..+.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred cccccceEEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccc
Confidence 469999999 56888877653 4999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeeccccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIEN-GVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
|++|||+++...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+........
T Consensus 161 kl~Dfg~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~ 229 (346)
T d1cm8a_ 161 KILDFGLARQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229 (346)
T ss_dssp EECCCTTCEECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccccccceeccCCcc-----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence 999999998764322 23578999999999876 456899999999999999999999998765432211
Q ss_pred HHHHHHHHHhhhh--------------HHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HH
Q 005923 581 LYASISRVLEESN--------------VREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LS 644 (669)
Q Consensus 581 ~~~~~~~~~~~~~--------------~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~ 644 (669)
.+........ ....+.......+ ..........+.+|+.+||+.||.+|||+.|++++ |+
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 230 ---EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp ---HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred ---HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 1111111000 0001111111111 11122344568899999999999999999999985 66
Q ss_pred Hhh
Q 005923 645 KIW 647 (669)
Q Consensus 645 ~i~ 647 (669)
.+.
T Consensus 306 ~~~ 308 (346)
T d1cm8a_ 306 SLH 308 (346)
T ss_dssp TTC
T ss_pred cCC
Confidence 554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=340.10 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=192.5
Q ss_pred cchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------cHHHHHHHHHhcCCCCceeEeeEEEecC--
Q 005923 360 YKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------DVSSEINILKKINHSNIIRLSGFCVHEG-- 427 (669)
Q Consensus 360 ~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 427 (669)
|.+-+ ++|.|+| |+||+|..+ |+.||||+++. .+.+|+++|++++||||+++++++....
T Consensus 10 Y~~~~-~LG~G~f-------g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 10 YTNLS-YIGEGAY-------GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp EEEEE-ECC---C-------CCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eEEEE-EEeeccC-------eEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 44444 4999999 999999874 88999999852 3568999999999999999999997653
Q ss_pred --ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcc
Q 005923 428 --NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITN 505 (669)
Q Consensus 428 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 505 (669)
..+++++|+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcc
Confidence 235566777899999999754 4999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCccccCCcccceeeecccccccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHH
Q 005923 506 FGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIE-NGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYAS 584 (669)
Q Consensus 506 fGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 584 (669)
||+++........ ........||..|+|||.+. +..++.++||||+||+++||++|+.||.+....+... .
T Consensus 153 fG~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~---~ 224 (345)
T d1pmea_ 153 FGLARVADPDHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---H 224 (345)
T ss_dssp CTTCEECCGGGCB-----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---H
T ss_pred cCceeeccCCCcc-----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH---H
Confidence 9999876543321 12234567999999999985 4567899999999999999999999998765432211 1
Q ss_pred HHHHHhhhhHHhh-------h-hcccCCccCCCCc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHh
Q 005923 585 ISRVLEESNVREK-------L-RGFIDPSLRNEYP-----LDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 585 ~~~~~~~~~~~~~-------l-~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
............. . ............+ .....++.+|+.+||+.||.+|||+.|++++ |++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 1111111110000 0 0000000001111 1223468899999999999999999999975 5433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=332.48 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=198.5
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEecC
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHEG 427 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 427 (669)
.|++-+ ++|.|+| |+||+|+. +|+.||||+++. .+.+|+.+|++++||||+++++++.+..
T Consensus 3 ry~~i~-~LG~G~f-------g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 3 KYEKLE-KIGEGTY-------GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp SEEEEE-EEEECSS-------SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCEeee-EEecCcC-------eEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 344444 4899999 99999998 477899999852 3578999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcEEEcccC
Q 005923 428 NTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRAKITNFG 507 (669)
Q Consensus 428 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DfG 507 (669)
..++|+|++.+++|..++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred ceeEEeeeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecc
Confidence 999999999999998887654 46899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGV-ITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
.++....... ......++..|+|||.+.... ++.++|||||||++|||++|+.||....+.. .....+.
T Consensus 147 ~a~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~ 216 (292)
T d1unla_ 147 LARAFGIPVR--------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIF 216 (292)
T ss_dssp TCEECCSCCS--------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHH
T ss_pred hhhcccCCCc--------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHH
Confidence 9987654331 122345778899999987665 6999999999999999999999987544322 1122222
Q ss_pred HHHhhhhHH--hhhhcccC---------CccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005923 587 RVLEESNVR--EKLRGFID---------PSLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT 642 (669)
Q Consensus 587 ~~~~~~~~~--~~l~~~~d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 642 (669)
......... .......+ ..............+.+|+.+||+.||.+|||++|++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222111100 00000000 001112223445678999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=339.49 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=197.0
Q ss_pred ccccchhHHHHHhCCCCcccceeeEEEEEEE-----CCCeeEEEEecc-----------cHHHHHHHHHhcCC-CCceeE
Q 005923 357 LTLYKFQDLKIATGSFSEENRIQGSVYRGSF-----KGDDAAVKVMKG-----------DVSSEINILKKINH-SNIIRL 419 (669)
Q Consensus 357 ~~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H-~niv~l 419 (669)
+..|++.+ ++|+|+| |+||+|.. .|+.||||.++. .+.+|+++|++++| |||+++
T Consensus 23 l~~y~~~~-~IG~G~f-------g~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~ 94 (322)
T d1vzoa_ 23 IENFELLK-VLGTGAY-------GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94 (322)
T ss_dssp GGGEEEEE-EEEETTT-------EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred hhceEEEE-EEecCCC-------eEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEe
Confidence 45577666 4999999 99999986 367899998742 35689999999976 899999
Q ss_pred eeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 420 SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 420 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
++++.+....++||||+.+|+|.+++... +.+....+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 95 HYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNG 166 (322)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred eeeeccCCceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCC
Confidence 99999999999999999999999999865 35788999999999999999999999 99999999999999999
Q ss_pred cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCchhH
Q 005923 500 RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG--VITPKLDVFAFGVVVLELLSGREAVTGDQNCE 577 (669)
Q Consensus 500 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~ 577 (669)
.+||+|||+++....... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||.+....+
T Consensus 167 ~vkL~DFG~a~~~~~~~~-------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp CEEESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred CEEEeeccchhhhccccc-------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999987654321 223446799999999999764 46889999999999999999999998654322
Q ss_pred HHHHHHHHHHHHhhhhHHhhhhcccCCccCCCCcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005923 578 AELLYASISRVLEESNVREKLRGFIDPSLRNEYPLDLAFSMAQLAKNCTAHDLNARPS-----ISEVFV 641 (669)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 641 (669)
... .+... ... .....+...+.++.+|+.+||+.||.+||| ++|+++
T Consensus 240 ~~~---~i~~~--------~~~------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 240 SQA---EISRR--------ILK------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CHH---HHHHH--------HHH------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHH---HHHHh--------ccc------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 01000 000 012344456678999999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-38 Score=334.94 Aligned_cols=254 Identities=19% Similarity=0.333 Sum_probs=193.5
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc----cHHHHHHHHHhcC-CCCceeEeeEEEec--Cc
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG----DVSSEINILKKIN-HSNIIRLSGFCVHE--GN 428 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~ 428 (669)
..|++.+ ++|+|+| |+||+|+. .|+.||||+++. ++.+|+++|++++ ||||+++++++... ..
T Consensus 35 d~y~i~~-~LG~G~f-------g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 35 DDYQLVR-KLGRGKY-------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred cCeEEEE-EEecCcC-------eEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3466555 3999999 99999997 488999999864 4778999999995 99999999999744 46
Q ss_pred eeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC-cEEEcccC
Q 005923 429 TYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL-RAKITNFG 507 (669)
Q Consensus 429 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DfG 507 (669)
.++||||+.+|+|.++. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 107 ~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp EEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred eeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccc
Confidence 89999999999987653 34899999999999999999999999 99999999999998654 69999999
Q ss_pred CccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHHHHHHHH
Q 005923 508 LARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAELLYASIS 586 (669)
Q Consensus 508 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 586 (669)
+|+....... .....+|..|+|||.+.+. .++.++||||+||+++||++|+.||....+.... ...+.
T Consensus 176 ~a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~ 244 (328)
T d3bqca1 176 LAEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIA 244 (328)
T ss_dssp GCEECCTTCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHH
T ss_pred cceeccCCCc---------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHH
Confidence 9987654321 2345789999999998775 4799999999999999999999999865432211 11222
Q ss_pred HHHhhhhHHhh-----------hhcccCC--------ccCCCCcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005923 587 RVLEESNVREK-----------LRGFIDP--------SLRNEYPLDLAFSMAQLAKNCTAHDLNARPSISEVFV 641 (669)
Q Consensus 587 ~~~~~~~~~~~-----------l~~~~d~--------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 641 (669)
..+........ ....... .........+..++.+|+++||+.||.+|||++|+++
T Consensus 245 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22211111000 0000000 0111122334567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-38 Score=331.92 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=184.8
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|++.+ ++|.|+| |+||+|... |+.||||+++. .+.+|+.+|++++|||||++++++...
T Consensus 17 ~~Y~i~~-~LG~G~f-------g~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~ 88 (355)
T d2b1pa1 17 KRYQNLK-PIGSGAQ-------GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_dssp TTEEEEE-ECSCC---------CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CCeEEEE-EeecCcC-------eEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence 3465555 3999999 999999984 88999999863 366899999999999999999999643
Q ss_pred ------CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCc
Q 005923 427 ------GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLR 500 (669)
Q Consensus 427 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~ 500 (669)
...|+||||+.+ ++.+.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~iv~Ey~~~-~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 89 KTLEEFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred cccccCceeEEEEeccch-HHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccc
Confidence 577999999976 55555542 3899999999999999999999999 999999999999999999
Q ss_pred EEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 501 AKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 501 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
+|++|||+++...... ......+|..|+|||++.+..+++++||||+||+++||++|+.||.+..... .
T Consensus 158 ~kl~df~~~~~~~~~~---------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~ 226 (355)
T d2b1pa1 158 LKILDFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--Q 226 (355)
T ss_dssp EEECCCCC------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H
T ss_pred eeeechhhhhcccccc---------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--H
Confidence 9999999998765432 2234578999999999999999999999999999999999999998765321 1
Q ss_pred HHHHHHHHHhhhh----------HHhhhhcc-----------cCCc---cCCCCcHHHHHHHHHHHHHhcccCCCCCCCH
Q 005923 581 LYASISRVLEESN----------VREKLRGF-----------IDPS---LRNEYPLDLAFSMAQLAKNCTAHDLNARPSI 636 (669)
Q Consensus 581 ~~~~~~~~~~~~~----------~~~~l~~~-----------~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 636 (669)
. ..+...+.... ........ .... .....+......+.+|+++||+.||.+|||+
T Consensus 227 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta 305 (355)
T d2b1pa1 227 W-NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_dssp H-HHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred H-HHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 1 11111111000 00000000 0000 0111223456778999999999999999999
Q ss_pred HHHHHH
Q 005923 637 SEVFVT 642 (669)
Q Consensus 637 ~evl~~ 642 (669)
+|++++
T Consensus 306 ~elL~H 311 (355)
T d2b1pa1 306 DDALQH 311 (355)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-38 Score=332.37 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=192.0
Q ss_pred cccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEecc---------cHHHHHHHHHhcCCCCceeEeeEEEec
Q 005923 358 TLYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKG---------DVSSEINILKKINHSNIIRLSGFCVHE 426 (669)
Q Consensus 358 ~~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 426 (669)
..|+..+ ++|.|+| |+||+|.. +|+.||||+++. .+.+|+++|++++|||+|++++++...
T Consensus 18 ~rY~i~~-~LG~G~f-------g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 18 ERYQNLS-PVGSGAY-------GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89 (348)
T ss_dssp TTEEEEE-ECGGGTT-------SSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CCeEEEE-EEecCCC-------eEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence 3455545 3999999 99999987 488999999853 356899999999999999999998643
Q ss_pred -----CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCCcE
Q 005923 427 -----GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNLRA 501 (669)
Q Consensus 427 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~~~ 501 (669)
...+++++|+.+|+|.++++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred cccccCceEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccc
Confidence 3457788888999999999643 4999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCccccCCCccccCCcccceeeecccccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCchhHHHH
Q 005923 502 KITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENG-VITPKLDVFAFGVVVLELLSGREAVTGDQNCEAEL 580 (669)
Q Consensus 502 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 580 (669)
|++|||++...... .....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.+......
T Consensus 161 kl~dfg~a~~~~~~-----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-- 227 (348)
T d2gfsa1 161 KILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-- 227 (348)
T ss_dssp EECCC----CCTGG-----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred cccccchhcccCcc-----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--
Confidence 99999999765432 2335789999999987765 468999999999999999999999987654321
Q ss_pred HHHHHHHHHhhhhHH-------hhhhcccCC--cc-CCC---CcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHH
Q 005923 581 LYASISRVLEESNVR-------EKLRGFIDP--SL-RNE---YPLDLAFSMAQLAKNCTAHDLNARPSISEVFVT--LSK 645 (669)
Q Consensus 581 ~~~~~~~~~~~~~~~-------~~l~~~~d~--~l-~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--L~~ 645 (669)
...+.......... ......... .. ... ........+.+|+.+||+.||.+|||+.|++++ |++
T Consensus 228 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 228 -LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp -HHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred -HHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 11111111110000 000000000 00 000 011234568899999999999999999999974 555
Q ss_pred hh
Q 005923 646 IW 647 (669)
Q Consensus 646 i~ 647 (669)
+.
T Consensus 307 ~~ 308 (348)
T d2gfsa1 307 YH 308 (348)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-33 Score=298.47 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=188.1
Q ss_pred ccchhHHHHHhCCCCcccceeeEEEEEEE--CCCeeEEEEeccc------HHHHHHHHHhcC-----------CCCceeE
Q 005923 359 LYKFQDLKIATGSFSEENRIQGSVYRGSF--KGDDAAVKVMKGD------VSSEINILKKIN-----------HSNIIRL 419 (669)
Q Consensus 359 ~~~~~~l~~~~g~f~~~~~~~G~Vy~g~~--~g~~vavK~~~~~------~~~E~~~l~~l~-----------H~niv~l 419 (669)
+|++.+ ++|.|+| |+||+|+. +|+.||||+++.+ +.+|++++++++ |+||+++
T Consensus 14 rY~i~~-~LG~G~f-------g~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 14 RYILVR-KLGWGHF-------STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TEEEEE-EEEECSS-------EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cEEEEE-EEeeCCC-------eEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 366555 4999999 99999987 4889999999753 467999998875 5789999
Q ss_pred eeEEEec--CceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeeec
Q 005923 420 SGFCVHE--GNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHK-YTNPPYVHKNLKTSNILLD 496 (669)
Q Consensus 420 ~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDik~~NILl~ 496 (669)
++++... ...+++|++...+......... .....+++..+..++.||+.||+|||+ .+ |+||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 160 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred EEEeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeee
Confidence 9998754 3456677776665443333322 234578999999999999999999998 77 99999999999997
Q ss_pred CCC------cEEEcccCCccccCCCccccCCcccceeeecccccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 005923 497 TNL------RAKITNFGLARSAESDEHEQGGYGLQLTRHVVGTYGYMAPEYIENGVITPKLDVFAFGVVVLELLSGREAV 570 (669)
Q Consensus 497 ~~~------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDV~S~Gvvl~elltg~~p~ 570 (669)
.++ .+|++|||.++..... .....||+.|+|||.+.+..++.++||||+||+++||++|+.||
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCcccccceeeEeecccccccccc-----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 654 4999999999865432 12357899999999999999999999999999999999999999
Q ss_pred CCCchhH---HHHHHHHHHHHHhhhhHH-----hhhhcccC---------C----------ccCCCCcHHHHHHHHHHHH
Q 005923 571 TGDQNCE---AELLYASISRVLEESNVR-----EKLRGFID---------P----------SLRNEYPLDLAFSMAQLAK 623 (669)
Q Consensus 571 ~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~l~~~~d---------~----------~l~~~~~~~~~~~l~~li~ 623 (669)
....... ...........+...... .......+ . ......+.....++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence 7543211 011111111111110000 00000000 0 0012334567788999999
Q ss_pred HhcccCCCCCCCHHHHHHH--HHHh
Q 005923 624 NCTAHDLNARPSISEVFVT--LSKI 646 (669)
Q Consensus 624 ~Cl~~dP~~RPt~~evl~~--L~~i 646 (669)
+||+.||.+|||++|++++ |++.
T Consensus 310 ~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHCCCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999875 5544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=2.6e-20 Score=178.28 Aligned_cols=122 Identities=16% Similarity=0.186 Sum_probs=99.9
Q ss_pred HHHhCCCCcccceeeEEEEEEE-CCCeeEEEEecc-------------------------cHHHHHHHHHhcCCCCceeE
Q 005923 366 KIATGSFSEENRIQGSVYRGSF-KGDDAAVKVMKG-------------------------DVSSEINILKKINHSNIIRL 419 (669)
Q Consensus 366 ~~~~g~f~~~~~~~G~Vy~g~~-~g~~vavK~~~~-------------------------~~~~E~~~l~~l~H~niv~l 419 (669)
++|+|+| |.||+|.. +|+.||||+++. ....|...+.++.|.+++..
T Consensus 7 ~IG~G~~-------g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 7 LMGEGKE-------SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp EEEECSS-------EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred EeeeCcc-------eEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 4899999 99999986 688999998642 12357888999999999988
Q ss_pred eeEEEecCceeEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeeecCCC
Q 005923 420 SGFCVHEGNTYLVYEFADNGALSDWLHSNRYQTSDNLTWKQRVQIAYDVANALNYLHKYTNPPYVHKNLKTSNILLDTNL 499 (669)
Q Consensus 420 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDik~~NILl~~~~ 499 (669)
+++. ..+++|||++++.+.+ +++....+++.|++.+|+|||+++ |+||||||+|||++++
T Consensus 80 ~~~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~- 139 (191)
T d1zara2 80 YAWE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp EEEE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-
T ss_pred EEec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-
Confidence 7653 3479999998865432 334456689999999999999999 9999999999999965
Q ss_pred cEEEcccCCccccCC
Q 005923 500 RAKITNFGLARSAES 514 (669)
Q Consensus 500 ~~kl~DfGla~~~~~ 514 (669)
.++|+|||+|+....
T Consensus 140 ~~~liDFG~a~~~~~ 154 (191)
T d1zara2 140 GIWIIDFPQSVEVGE 154 (191)
T ss_dssp EEEECCCTTCEETTS
T ss_pred CEEEEECCCcccCCC
Confidence 589999999987653
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=99.38 E-value=1.1e-13 Score=98.50 Aligned_cols=46 Identities=30% Similarity=0.361 Sum_probs=42.6
Q ss_pred EEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCcccccccC
Q 005923 195 LTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPLK 242 (669)
Q Consensus 195 ~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~~ 242 (669)
++|+|++|||||+||++||+++++|++||++. +.|+|||.|.||++
T Consensus 3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~--~~l~~Gq~L~i~vk 48 (48)
T d1e0ga_ 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFVK 48 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG--GGCCTTEEEECCCC
T ss_pred EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc--ccCcCCCEEEEEeC
Confidence 58999999999999999999999999999984 36999999999974
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=99.37 E-value=6e-14 Score=100.41 Aligned_cols=46 Identities=33% Similarity=0.432 Sum_probs=43.0
Q ss_pred EEEEcCCCCCHHHHHHHhCCCHHhHHHhcCCCCCCCCCCCccccccc
Q 005923 195 LTYMVTWGDSISAIAQLFNVDERSVLDANKLSQDDLIFPFTPILVPL 241 (669)
Q Consensus 195 ~tY~v~~GDtl~~Ia~~f~v~~~~l~~~N~l~~~~~l~p~~~l~iP~ 241 (669)
++|+|++|||||+||+|||+++++|++||++.+ +.|+|||.|.||-
T Consensus 2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~-~~l~~Gq~L~IPg 47 (48)
T d1y7ma2 2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQ-AGLTAGQSIVIPG 47 (48)
T ss_dssp EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTC-SSCCTTCEEEETT
T ss_pred EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCC-CCCCCCCEEEeCC
Confidence 689999999999999999999999999999965 5799999999984
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=99.06 E-value=1.8e-11 Score=87.31 Aligned_cols=46 Identities=26% Similarity=0.462 Sum_probs=42.2
Q ss_pred eEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEee
Q 005923 128 TTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPL 177 (669)
Q Consensus 128 ~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~ 177 (669)
.+|+|+ +|||+|+|| ++|+ ++.++|+++|++..+.|++||+|.||.
T Consensus 2 i~y~V~-~GDTL~~IA-~~y~--v~~~~i~~~N~~~~~~l~~Gq~L~IPg 47 (48)
T d1y7ma2 2 LTYQVK-QGDTLNSIA-ADFR--ISTAALLQANPSLQAGLTAGQSIVIPG 47 (48)
T ss_dssp EEEECC-TTCCHHHHH-HHTT--SCCCCCCCTSCTTCSSCCTTCEEEETT
T ss_pred EEEEEC-CCCCHHHHH-HHhC--CCHHHHHHHcCCCCCCCCCCCEEEeCC
Confidence 479999 999999999 7888 889999999998877899999999983
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=99.06 E-value=2.9e-11 Score=85.77 Aligned_cols=46 Identities=22% Similarity=0.277 Sum_probs=41.6
Q ss_pred eEEEEecCCcchhhhHhhhhcCchhHHHHHhcCCCCCCCCCCCceEEEeee
Q 005923 128 TTYTIQNHVETYLSVANNTYQGLTTCQAMMSQNPVDSRNLTVGLDLFVPLR 178 (669)
Q Consensus 128 ~~y~V~~~gdT~~~IA~~~~~~lt~~~~l~~~N~~~~~~l~~G~~L~ip~~ 178 (669)
.+|+|+ +|||||.|| ++|+ +++++|+++|++.+ .|+|||+|.||++
T Consensus 3 v~y~V~-~GDTl~~IA-~~y~--vs~~~i~~~N~l~~-~l~~Gq~L~i~vk 48 (48)
T d1e0ga_ 3 ITYRVR-KGDSLSSIA-KRHG--VNIKDVMRWNSDTA-NLQPGDKLTLFVK 48 (48)
T ss_dssp CEEEEC-TTCCHHHHH-HHHT--CCHHHHHHHCSCGG-GCCTTEEEECCCC
T ss_pred EEEEEC-CCCCHHHHH-HHHC--CCHHHHHHHcCCcc-cCcCCCEEEEEeC
Confidence 579999 999999999 7888 99999999998854 7999999999963
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.08 E-value=1.2e-05 Score=78.35 Aligned_cols=122 Identities=18% Similarity=0.238 Sum_probs=88.9
Q ss_pred eEEEEEEECCCeeEEEEecc-------cHHHHHHHHHhcC-CCCceeEeeEEEecCceeEEEEecCCCCHHHHHhcCCCC
Q 005923 380 GSVYRGSFKGDDAAVKVMKG-------DVSSEINILKKIN-HSNIIRLSGFCVHEGNTYLVYEFADNGALSDWLHSNRYQ 451 (669)
Q Consensus 380 G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~ 451 (669)
..||+...++..+.+|+... ++.+|...+..+. +--+.+++.++.+++..++||+++++..+.+.....
T Consensus 28 ~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--- 104 (263)
T d1j7la_ 28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--- 104 (263)
T ss_dssp SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---
T ss_pred CcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---
Confidence 57999888888889998753 4678999988774 434677888888888899999999998876654221
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------------
Q 005923 452 TSDNLTWKQRVQIAYDVANALNYLHKYT---------------------------------------------------- 479 (669)
Q Consensus 452 ~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------------------- 479 (669)
.. ...++.+++..+..||+..
T Consensus 105 ----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 105 ----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp ----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred ----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 11 2234555555566666421
Q ss_pred ----CCCeEeeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 480 ----NPPYVHKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 480 ----~~~ivHrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
.+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876667999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.57 E-value=8.6e-05 Score=71.52 Aligned_cols=62 Identities=18% Similarity=0.173 Sum_probs=47.5
Q ss_pred eEEEEEEECC-CeeEEEEecc----cHHHHHHHHHhcCC--CCceeEeeEEEecCceeEEEEecCCCCH
Q 005923 380 GSVYRGSFKG-DDAAVKVMKG----DVSSEINILKKINH--SNIIRLSGFCVHEGNTYLVYEFADNGAL 441 (669)
Q Consensus 380 G~Vy~g~~~g-~~vavK~~~~----~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL 441 (669)
..||+...++ ..+.+|.... ++..|...++.+.. -.+.++++++.+++..++||+|+++.++
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 5789988864 4577888753 57889999988853 3356788888888889999999987544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.44 E-value=0.0037 Score=64.04 Aligned_cols=65 Identities=15% Similarity=0.038 Sum_probs=42.7
Q ss_pred HHhCCCCcccceeeEEEEEEEC--CCeeEEEEecc--------------cHHHHHHHHHhcC-C--CCceeEeeEEEecC
Q 005923 367 IATGSFSEENRIQGSVYRGSFK--GDDAAVKVMKG--------------DVSSEINILKKIN-H--SNIIRLSGFCVHEG 427 (669)
Q Consensus 367 ~~~g~f~~~~~~~G~Vy~g~~~--g~~vavK~~~~--------------~~~~E~~~l~~l~-H--~niv~l~g~~~~~~ 427 (669)
+|.|+. ..||+.... ++.+.||.-.. ....|.+.|+.+. + ..+.+++++ +++
T Consensus 34 ig~G~~-------N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 34 IGDGNL-------NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 104 (392)
T ss_dssp CCSSSS-------EEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred eCCCce-------EeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC
Confidence 566666 789988763 56788886421 1345888888763 2 345666655 456
Q ss_pred ceeEEEEecCCCC
Q 005923 428 NTYLVYEFADNGA 440 (669)
Q Consensus 428 ~~~lV~e~~~~gs 440 (669)
..++|||++.+..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 7789999998643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.20 E-value=0.054 Score=53.36 Aligned_cols=130 Identities=12% Similarity=0.154 Sum_probs=72.8
Q ss_pred eEEEEEEE-CCCeeEEEEecc------cHHHHHHHHHhcCCCCc--eeEe-----eEEEecCceeEEEEecCCCCH----
Q 005923 380 GSVYRGSF-KGDDAAVKVMKG------DVSSEINILKKINHSNI--IRLS-----GFCVHEGNTYLVYEFADNGAL---- 441 (669)
Q Consensus 380 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~e~~~~gsL---- 441 (669)
-.||+... +|..+++|+.+. .+..|...+..|....+ +..+ .....++..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 47999987 577899999864 36778888888743222 1111 122345667889999986321
Q ss_pred -HH---------HHhc----CCCCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHhC----CCCCeE
Q 005923 442 -SD---------WLHS----NRYQTSDNLTWK-------------------QRVQIAYDVANALNYLHKY----TNPPYV 484 (669)
Q Consensus 442 -~~---------~l~~----~~~~~~~~l~~~-------------------~~~~i~~qia~~L~yLH~~----~~~~iv 484 (669)
.. .+|. ........+++. .+..+...+...++.+... ....++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 11 1111 100011112211 1112222233333344332 123489
Q ss_pred eeCCCCCCeeecCCCcEEEcccCCccc
Q 005923 485 HKNLKTSNILLDTNLRAKITNFGLARS 511 (669)
Q Consensus 485 HrDik~~NILl~~~~~~kl~DfGla~~ 511 (669)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.59 E-value=0.11 Score=52.53 Aligned_cols=58 Identities=12% Similarity=0.194 Sum_probs=37.4
Q ss_pred eEEEEEEEC---------CCeeEEEEec-----ccHHHHHHHHHhcCCCCc-eeEeeEEEecCceeEEEEecCCCCH
Q 005923 380 GSVYRGSFK---------GDDAAVKVMK-----GDVSSEINILKKINHSNI-IRLSGFCVHEGNTYLVYEFADNGAL 441 (669)
Q Consensus 380 G~Vy~g~~~---------g~~vavK~~~-----~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 441 (669)
-.+|+.... ...+.+++.- .+..+|..+++.+.-.++ .++++++. -.+|+||+++..|
T Consensus 56 N~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~efi~g~~l 128 (395)
T d1nw1a_ 56 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEYIPSRPL 128 (395)
T ss_dssp EEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECCCCEEEC
T ss_pred cceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEEeccccC
Confidence 468887753 2346666542 235679999998853344 57777763 2689999987433
|
| >d1ijwc_ a.4.1.2 (C:) HIN recombinase (DNA-binding domain) {Synthetic} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: DNA/RNA-binding 3-helical bundle superfamily: Homeodomain-like family: Recombinase DNA-binding domain domain: HIN recombinase (DNA-binding domain) species: Synthetic
Probab=81.29 E-value=0.44 Score=32.01 Aligned_cols=24 Identities=13% Similarity=0.260 Sum_probs=22.1
Q ss_pred cCCCCCHHHHHHHhCCCHHhHHHh
Q 005923 199 VTWGDSISAIAQLFNVDERSVLDA 222 (669)
Q Consensus 199 v~~GDtl~~Ia~~f~v~~~~l~~~ 222 (669)
+..|.++..||+.|||+...|-++
T Consensus 18 ~~~G~s~~~iA~~~gVSr~TiYry 41 (47)
T d1ijwc_ 18 LEKGHPRQQLAIIFGIGVSTLYRY 41 (47)
T ss_dssp HHTTCCHHHHHHHHTCCHHHHHHH
T ss_pred HHCCCCHHHHHHHHCcCHHHHHhh
Confidence 467999999999999999999887
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=80.11 E-value=0.26 Score=47.66 Aligned_cols=29 Identities=17% Similarity=0.254 Sum_probs=26.3
Q ss_pred CeEeeCCCCCCeeecCCCcEEEcccCCcc
Q 005923 482 PYVHKNLKTSNILLDTNLRAKITNFGLAR 510 (669)
Q Consensus 482 ~ivHrDik~~NILl~~~~~~kl~DfGla~ 510 (669)
.+||+|+.+.||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999988777899999985
|